data_1iio_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iio _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.68 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.8 p . . . . . 0 C--O 1.215 -0.74 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 5' ' ' VAL . 54.1 tttm -45.05 -46.63 11.55 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.093 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -77.54 -32.88 54.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.829 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.68 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -64.86 -52.07 58.62 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.507 HG13 ' CG2' ' A' ' 5' ' ' VAL . 31.2 mt -65.48 -46.21 90.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 51.5 ttp85 -55.87 -30.53 61.68 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.49 -40.4 97.65 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.419 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 73.3 mt-30 -68.77 -31.17 70.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.688 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.6 mt -71.36 -45.82 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.068 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.199 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 69' ' ' GLU . 8.6 mm -57.87 -52.97 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.514 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.99 -36.61 93.28 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.387 -0.911 . . . . 0.0 110.941 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 12' ' ' GLN . . . -62.67 -29.79 70.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.285 -0.457 . . . . 0.0 111.103 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 30' ' ' LEU . 55.1 mt -81.26 -29.41 34.4 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.665 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.29 131.5 48.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.73 -34.74 4.62 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.716 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.528 ' N ' ' HB3' ' A' ' 33' ' ' ALA . . . -50.95 -179.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.576 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.562 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 73.0 m-20 -59.35 -120.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.704 ' CE1' ' C ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -59.92 178.53 0.24 Allowed Pre-proline 0 N--CA 1.455 -0.195 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.776 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.0 Cg_endo -65.38 65.65 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 119.799 0.964 . . . . 0.0 112.482 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.824 HG13 HG23 ' A' ' 71' ' ' VAL . 34.2 mm 107.57 61.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.585 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 3.0 m120 -64.35 65.07 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.577 ' HB3' ' CG ' ' A' ' 63' ' ' PHE . 60.6 p 57.48 156.52 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.596 ' O ' ' CB ' ' A' ' 31' ' ' MET . 54.2 Cg_exo -49.89 -32.65 30.82 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.397 1.398 . . . . 0.0 112.692 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -52.76 -57.68 9.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.35 0.595 . . . . 0.0 110.292 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.585 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.8 tp10 -76.41 -58.09 3.48 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.579 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.6 pp -50.59 -44.8 57.06 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.596 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 30.6 ttm -65.08 -31.06 72.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.37 -31.45 70.83 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.822 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.528 ' HB3' ' N ' ' A' ' 20' ' ' ALA . . . -69.84 -38.67 76.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.343 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 31' ' ' MET . 8.5 mp -26.91 129.75 0.18 Allowed Pre-proline 0 N--CA 1.47 0.54 0 CA-C-O 120.973 0.416 . . . . 0.0 111.881 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--N 1.351 0.659 0 C-N-CA 123.711 2.941 . . . . 0.0 114.274 -178.309 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.776 0.322 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 31.1 m -106.51 121.34 44.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 59.7 m -86.85 46.26 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.001 0.429 . . . . 0.0 110.821 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.402 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 18.7 ptpt . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.402 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 35.3 mt-10 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.857 0.36 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -142.31 139.62 31.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.935 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 41' ' ' THR . 59.8 pttt -173.8 -176.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.719 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -66.33 -42.59 87.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.819 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.402 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.0 t -67.7 -52.38 38.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 30.0 m-20 -71.1 -49.78 40.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 50' ' ' LYS . . . -87.65 -47.01 9.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.89 -26.8 2.11 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.373 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 16.2 pt20 -41.94 -36.89 1.18 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.08 0.467 . . . . 0.0 111.774 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.4 m -65.51 -33.17 61.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.032 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 28.3 mt -68.31 124.49 23.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.642 0.258 . . . . 0.0 110.56 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.4 ' OG1' ' OD1' ' A' ' 62' ' ' ASP . 72.1 p -84.1 -173.81 4.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.797 0.332 . . . . 0.0 111.551 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.06 -44.71 91.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.568 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -55.59 -23.98 30.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 111.118 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.56 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -64.54 -9.8 21.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.577 ' CG ' ' HB3' ' A' ' 26' ' ' SER . 2.6 m-85 -39.82 -70.97 0.15 Allowed Pre-proline 0 N--CA 1.464 0.231 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 50.7 Cg_endo -67.76 74.38 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.034 1.823 . . . . 0.0 112.079 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.08 143.96 38.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.12 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.527 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 99.2 mttt -68.94 68.4 0.16 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.475 0.655 . . . . 0.0 110.56 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.776 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 25.5 m 59.51 161.48 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.979 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.646 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.67 -30.59 22.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.817 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HA ' HD11 ' A' ' 14' ' ' ILE . 11.0 pt-20 -57.67 -48.43 79.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.441 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.543 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -71.1 -33.03 69.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.875 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.824 HG23 HG13 ' A' ' 24' ' ' ILE . 92.2 t -64.83 -41.85 93.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.852 0.358 . . . . 0.0 110.857 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.35 73.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.825 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.417 ' O ' HG22 ' A' ' 76' ' ' VAL . 56.3 m-20 -68.43 -37.5 80.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.391 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.3 m -66.8 -51.95 49.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.043 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 71' ' ' VAL . 76.0 mt -58.08 -51.9 65.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.489 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 5.3 m -56.22 -39.21 58.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -61.5 -53.15 60.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.728 0.299 . . . . 0.0 111.332 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -69.24 -40.54 77.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.57 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.17 -29.77 69.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.72 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.17 -55.1 0.43 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.787 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.5 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.023 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.695 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.9 p . . . . . 0 C--O 1.214 -0.799 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 86.1 tttt -45.32 -48.0 13.15 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.015 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -77.59 -31.22 52.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.816 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.695 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 22.7 m-20 -65.2 -52.26 55.91 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.489 HG13 ' CG2' ' A' ' 5' ' ' VAL . 22.5 mt -66.79 -46.5 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 46.4 ttp85 -56.39 -28.07 58.18 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.19 -42.91 94.04 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 66.9 mt-30 -67.07 -32.55 73.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.876 -0.662 . . . . 0.0 109.737 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.0 mt -70.33 -43.33 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.804 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' A' ' 69' ' ' GLU . 13.3 mm -58.06 -54.09 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.244 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.54 -36.85 93.66 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . . . -60.88 -28.43 68.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.109 -0.545 . . . . 0.0 110.936 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' HB3' ' CD1' ' A' ' 24' ' ' ILE . 52.7 mt -87.6 -29.66 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.282 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.16 85.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.838 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.94 -36.0 0.19 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.17 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.513 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -52.77 -174.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 112.116 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.612 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.0 m-20 -59.96 -119.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.704 ' CE2' ' HA ' ' A' ' 25' ' ' ASN . 0.3 OUTLIER -58.52 174.21 0.37 Allowed Pre-proline 0 CA--C 1.519 -0.212 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 176.273 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.864 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 44.6 Cg_endo -63.27 66.63 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 120.916 1.077 . . . . 0.0 112.242 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.695 HG13 HG23 ' A' ' 71' ' ' VAL . 20.2 mm 109.52 59.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.704 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.5 m120 -63.37 66.75 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 25' ' ' ASN . 85.5 p 56.28 153.64 0.07 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.716 ' O ' ' HB2' ' A' ' 31' ' ' MET . 76.1 Cg_exo -47.29 -32.88 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.512 1.475 . . . . 0.0 113.176 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -53.31 -57.46 10.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.339 0.59 . . . . 0.0 110.387 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.561 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.4 tp10 -76.25 -57.52 3.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.6 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.3 pp -49.97 -42.54 49.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.716 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 62.2 mtm -68.75 -29.98 68.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.64 -31.04 70.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.899 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.513 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -74.23 -38.57 63.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.102 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.508 ' HG ' ' HB3' ' A' ' 16' ' ' ALA . 8.0 mp -34.66 140.03 0.29 Allowed Pre-proline 0 N--CA 1.466 0.341 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo . . . . . 0 C--N 1.349 0.56 0 C-N-CA 123.248 2.632 . . . . 0.0 113.225 -178.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.466 ' N ' HD23 ' A' ' 34' ' ' LEU . 8.9 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.762 0.315 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 23.8 m -86.64 118.17 25.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.092 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 68.4 m -92.87 44.76 1.16 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 109.776 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.502 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.1 pttp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.119 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.502 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 75.6 mt-10 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.778 0.323 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -141.0 138.53 33.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.513 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 60.8 pttt -175.14 153.64 1.64 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.641 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.66 -28.3 2.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.624 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.403 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 44.1 t -70.82 -55.5 8.38 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.311 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -72.44 -54.32 9.65 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.4 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -82.48 -42.89 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.86 -25.81 1.02 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.491 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -41.66 -36.76 1.02 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.132 0.492 . . . . 0.0 111.583 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.53 -33.41 63.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.128 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.3 mt -68.85 119.83 13.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.703 0.287 . . . . 0.0 110.231 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.412 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 76.8 p -85.44 -175.31 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.711 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.67 -43.34 84.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.298 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 3.1 p30 -51.29 -26.63 7.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.918 0.389 . . . . 0.0 110.819 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.533 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 59.4 m-20 -73.26 3.73 5.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.707 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.526 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 1.4 t80 -42.63 -52.22 10.98 Favored Pre-proline 0 C--O 1.224 -0.262 0 O-C-N 122.588 -0.07 . . . . 0.0 111.15 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 97.6 Cg_endo -89.65 78.15 0.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.194 2.596 . . . . 0.0 111.187 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.2 OUTLIER -76.9 142.8 39.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.156 -178.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 22.9 tptm -69.66 65.41 0.21 Allowed 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.122 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.864 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 49.8 m 63.63 160.0 0.09 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.638 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.58 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.97 -27.34 13.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.938 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HA ' HD11 ' A' ' 14' ' ' ILE . 11.2 pt-20 -65.36 -38.78 91.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.075 0.464 . . . . 0.0 109.832 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 7.9 tp10 -68.01 -46.42 71.3 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.94 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.695 HG23 HG13 ' A' ' 24' ' ' ILE . 47.0 t -65.11 -43.17 95.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.516 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.17 -45.47 79.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.979 0.418 . . . . 0.0 110.25 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -70.3 -40.18 74.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.095 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.8 m -63.13 -50.15 71.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.069 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.4 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 67.0 mt -61.41 -52.47 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.702 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 7.1 m -58.52 -38.64 71.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -62.33 -56.79 15.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.748 0.308 . . . . 0.0 111.676 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -69.5 -38.97 77.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.74 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.84 -29.89 69.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.009 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.42 -55.87 0.42 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.006 -1.092 . . . . 0.0 113.291 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.1 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.339 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.642 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.6 p . . . . . 0 C--O 1.211 -0.968 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 84.8 tttt -44.31 -44.15 7.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.913 0.779 . . . . 0.0 109.417 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.4 -35.58 54.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.666 177.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.642 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 48.6 m-20 -64.02 -51.83 62.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.513 HG13 ' CG2' ' A' ' 5' ' ' VAL . 37.0 mt -65.12 -45.89 92.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 50.1 ttp180 -55.34 -30.41 60.22 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.53 -41.78 97.76 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 65.0 mt-30 -66.18 -29.86 70.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.692 -0.754 . . . . 0.0 109.735 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.6 mt -70.35 -45.58 74.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.962 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.1 mm -56.74 -52.96 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.512 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.82 -37.15 92.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.073 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 12' ' ' GLN . . . -60.47 -30.53 69.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.202 -0.499 . . . . 0.0 111.172 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.682 HD21 ' HB2' ' A' ' 30' ' ' LEU . 59.5 mt -82.74 -29.45 29.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.932 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.52 132.81 54.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.049 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.13 -33.89 5.22 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.964 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.568 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -51.95 -176.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 111.567 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.571 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.1 m-20 -60.9 -121.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.712 ' CE1' ' C ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -59.56 176.81 0.29 Allowed Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.746 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.3 Cg_endo -64.69 69.05 0.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 CA-C-N 119.773 0.954 . . . . 0.0 112.281 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.712 ' C ' ' CE1' ' A' ' 22' ' ' PHE . 51.5 mm 106.47 61.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.571 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.8 m120 -65.24 64.96 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 59.1 p 57.06 157.46 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.614 ' O ' ' CB ' ' A' ' 31' ' ' MET . 52.0 Cg_exo -50.9 -32.23 36.98 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.293 1.328 . . . . 0.0 112.86 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -52.71 -57.61 9.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.442 0.639 . . . . 0.0 110.421 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.571 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 41.8 tp10 -76.15 -58.15 3.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.682 ' HB2' HD21 ' A' ' 17' ' ' LEU . 3.9 pp -50.62 -42.95 56.67 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.614 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 30.0 ttm -63.27 -33.07 74.71 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.92 -28.32 66.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.835 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.568 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -71.16 -36.9 72.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.491 HD11 ' HA ' ' A' ' 31' ' ' MET . 10.3 mp -27.27 137.0 0.1 Allowed Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 121.094 0.473 . . . . 0.0 112.185 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo . . . . . 0 C--N 1.35 0.606 0 C-N-CA 124.249 3.299 . . . . 0.0 115.638 -177.292 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.476 HG23 ' HB3' ' A' ' 34' ' ' LEU . 15.2 t . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.775 0.321 . . . . 0.0 111.519 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.8 m -92.55 123.9 36.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.719 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.9 m -92.04 45.53 1.22 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.974 0.416 . . . . 0.0 110.73 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.025 -179.829 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.81 0.338 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -141.72 133.74 27.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.605 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -165.48 -177.55 4.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.735 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.553 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -66.56 -40.52 89.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.715 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -67.01 -59.92 3.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -68.84 -54.09 17.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.758 0.313 . . . . 0.0 111.691 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.56 -50.51 25.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.74 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -49.02 -26.49 6.01 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.412 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -41.21 -43.55 2.37 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.944 0.878 . . . . 0.0 110.943 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.407 ' HB ' ' HE2' ' A' ' 78' ' ' LYS . 10.4 m -66.01 -32.64 59.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.326 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 21.1 mt -68.9 116.84 9.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.819 0.343 . . . . 0.0 110.588 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.51 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 71.8 p -71.5 155.9 40.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.196 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.16 -39.98 45.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.323 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -53.44 -25.44 16.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.595 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 61.8 m-20 -70.57 3.47 3.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.541 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -38.64 -63.65 0.56 Allowed Pre-proline 0 N--CA 1.462 0.139 0 CA-C-N 117.895 0.316 . . . . 0.0 110.958 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 73.4 Cg_endo -74.55 79.0 2.61 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.469 2.113 . . . . 0.0 111.88 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.595 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -76.83 144.29 39.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.301 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.501 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 75.2 mmtt -70.21 65.88 0.28 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.465 0.65 . . . . 0.0 110.047 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.746 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 20.2 m 61.52 160.36 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.02 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.584 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.45 -28.11 12.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.657 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 16.2 pt-20 -60.95 -48.44 81.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.376 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.501 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -67.9 -32.14 72.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.021 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.652 HG22 HG13 ' A' ' 24' ' ' ILE . 80.5 t -62.27 -41.29 90.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 110.45 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.27 -51.03 71.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.987 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.53 -39.02 85.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.258 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.8 m -65.18 -51.65 59.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.956 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.455 HD11 HG22 ' A' ' 75' ' ' ILE . 57.4 mt -57.15 -54.58 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.767 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 5.7 m -57.14 -40.04 70.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.52 -53.28 44.58 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HE2' ' HB ' ' A' ' 57' ' ' VAL . 50.2 mtpt -73.33 -39.52 65.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 111.885 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.84 -29.96 70.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.72 -55.98 0.37 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.117 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.3 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.32 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.704 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.6 p . . . . . 0 C--O 1.215 -0.742 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 82.7 tttt -45.17 -47.76 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.008 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.75 -31.94 52.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.901 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.704 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -64.33 -52.17 59.75 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.502 HG13 ' CG2' ' A' ' 5' ' ' VAL . 28.9 mt -67.39 -46.18 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 48.3 ttp180 -55.45 -29.77 59.29 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.73 -43.53 93.98 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.419 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 69.3 mt-30 -66.9 -30.38 70.52 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.86 -0.67 . . . . 0.0 109.766 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.4 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 73.3 mt -70.52 -43.46 77.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.744 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.488 HD13 ' HA ' ' A' ' 69' ' ' GLU . 11.3 mm -57.61 -53.69 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.32 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.56 -36.4 92.43 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.405 -0.902 . . . . 0.0 110.855 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.457 ' HB2' ' HG ' ' A' ' 34' ' ' LEU . . . -60.55 -31.82 70.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.151 -0.524 . . . . 0.0 110.952 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.567 ' HB3' ' CD1' ' A' ' 24' ' ' ILE . 55.4 mt -82.12 -29.47 31.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.775 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.0 130.83 48.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.918 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.16 -34.37 4.48 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.879 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.555 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -52.06 -176.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.815 0.341 . . . . 0.0 111.594 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.585 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.6 m-20 -60.02 -119.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.713 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.79 178.39 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.797 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 48.9 Cg_endo -65.08 67.85 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.754 0.948 . . . . 0.0 112.131 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.799 HG13 HG22 ' A' ' 71' ' ' VAL . 44.3 mm 105.96 62.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.585 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.9 m120 -65.7 64.41 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.624 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 52.6 p 57.07 160.47 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.635 ' O ' ' HB2' ' A' ' 31' ' ' MET . 52.2 Cg_exo -52.56 -33.16 56.9 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.339 1.359 . . . . 0.0 112.971 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -52.48 -57.89 8.47 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.238 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.581 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 41.3 tp10 -76.6 -58.57 3.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.556 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.9 pp -50.65 -45.35 57.82 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.635 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 23.0 ttm -64.17 -31.49 72.7 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -70.28 -28.67 65.39 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.128 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.555 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -70.04 -37.45 75.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.725 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.551 ' HB3' HG22 ' A' ' 40' ' ' THR . 11.2 mp -31.78 145.6 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.112 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo . . . . . 0 C--N 1.348 0.549 0 C-N-CA 123.664 2.91 . . . . 0.0 113.973 -178.252 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 34' ' ' LEU . 12.9 t . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.685 0.279 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.472 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 25.4 m -91.61 125.87 36.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.972 0.415 . . . . 0.0 111.588 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.7 m -100.47 48.52 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.777 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 10.2 ptpp? . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.841 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.442 ' HG2' ' HB2' ' A' ' 43' ' ' LYS . 23.6 mt-10 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.68 0.276 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -140.64 140.57 35.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.039 0.447 . . . . 0.0 110.811 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.472 ' HD3' ' HA ' ' A' ' 41' ' ' THR . 59.5 pttt -173.54 170.81 4.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.719 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.549 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -59.65 -30.7 68.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.545 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.425 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 42.5 t -75.66 -62.05 1.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.449 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 52.4 m-20 -66.4 -51.06 60.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.406 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -78.95 -46.44 18.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.67 -26.32 1.76 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.596 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 17.2 pt20 -41.21 -38.63 1.15 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.04 0.448 . . . . 0.0 111.808 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.407 HG22 ' CD ' ' A' ' 78' ' ' LYS . 34.8 m -65.72 -30.16 49.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.408 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.407 HD12 ' CZ ' ' A' ' 65' ' ' PHE . 19.1 mt -66.91 121.67 16.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.756 0.312 . . . . 0.0 110.42 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.7 p -74.67 155.77 37.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.44 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.67 58.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.229 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.82 -23.29 29.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.544 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 15.5 m-20 -67.59 3.31 1.42 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.624 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -40.57 -55.19 4.55 Favored Pre-proline 0 C--O 1.227 -0.086 0 CA-C-N 117.77 0.259 . . . . 0.0 111.575 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 2.2 Cg_endo -82.39 78.16 3.5 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.896 2.397 . . . . 0.0 111.783 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CB ' HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -77.02 142.13 40.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.266 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.66 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.69 66.9 0.13 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.76 0.79 . . . . 0.0 110.59 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.797 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 15.5 m 61.85 159.87 0.06 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.953 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.663 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.61 -32.55 29.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.794 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.488 ' HA ' HD13 ' A' ' 14' ' ' ILE . 10.9 pt-20 -59.07 -46.1 89.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.417 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.66 ' HG2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -68.08 -33.17 74.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.19 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.799 HG22 HG13 ' A' ' 24' ' ' ILE . 72.8 t -64.77 -44.72 96.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.649 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.11 -49.53 71.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.76 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.25 -39.84 78.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.294 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.1 m -63.21 -52.62 61.53 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.406 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 58.4 mt -59.87 -52.6 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.716 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 14.1 m -57.81 -41.24 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -61.68 -51.41 68.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 111.278 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.407 ' CD ' HG22 ' A' ' 57' ' ' VAL . 66.8 mttm -71.54 -42.08 68.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.676 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.04 69.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.778 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.14 -55.7 0.44 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.664 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 19.0 mt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.337 -0.84 . . . . 0.0 110.983 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.661 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p . . . . . 0 C--O 1.215 -0.758 0 CA-C-O 119.993 -0.051 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 12.9 tmtt? -45.09 -46.41 11.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -77.57 -33.44 54.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.84 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.661 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 14.1 m-20 -64.21 -52.32 59.42 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.506 HG13 ' CG2' ' A' ' 5' ' ' VAL . 35.3 mt -66.62 -46.56 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 40.0 ttp180 -55.0 -29.76 58.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.32 -42.46 96.11 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.411 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 70.0 mt-30 -69.06 -30.71 69.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.991 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.7 mt -71.61 -45.18 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.045 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' A' ' 69' ' ' GLU . 10.6 mm -58.3 -52.01 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.262 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.39 -37.19 93.56 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.48 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -61.52 -28.54 69.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.946 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.597 HD23 ' HB2' ' A' ' 30' ' ' LEU . 45.7 mt -83.79 -29.56 27.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.874 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.52 126.02 25.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.815 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.66 -34.99 3.3 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.72 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.537 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -52.73 -175.04 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.913 0.387 . . . . 0.0 111.588 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.549 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.6 OUTLIER -61.58 -119.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.738 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.5 OUTLIER -59.45 179.21 0.21 Allowed Pre-proline 0 N--CA 1.454 -0.266 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 176.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.758 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.3 Cg_endo -64.97 67.21 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 CA-C-N 119.688 0.924 . . . . 0.0 112.179 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.842 HG13 HG22 ' A' ' 71' ' ' VAL . 41.9 mm 107.18 62.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.593 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.8 m120 -63.65 65.37 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 69.9 p 56.28 158.68 0.07 OUTLIER Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.688 ' O ' ' HB2' ' A' ' 31' ' ' MET . 50.7 Cg_exo -51.16 -34.23 47.25 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.316 1.344 . . . . 0.0 113.032 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -51.63 -57.68 8.49 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.38 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.588 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 43.7 tp10 -76.24 -58.11 3.48 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.597 ' HB2' HD23 ' A' ' 17' ' ' LEU . 3.8 pp -50.47 -43.95 55.53 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.688 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 23.5 ttm -64.03 -32.19 73.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.96 -29.53 66.67 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.042 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.537 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -68.81 -37.98 79.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.73 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.537 ' HB3' HG21 ' A' ' 40' ' ' THR . 11.2 mp -31.61 145.02 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.193 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo . . . . . 0 C--N 1.348 0.505 0 C-N-CA 123.635 2.89 . . . . 0.0 113.969 -178.188 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.537 HG21 ' HB3' ' A' ' 34' ' ' LEU . 15.0 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.665 0.269 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 27.8 m -90.71 125.78 35.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 111.597 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.3 m -100.29 50.43 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.097 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.435 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 61.6 pttt . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.643 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.435 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 23.5 mt-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.033 0.444 . . . . 0.0 111.473 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.407 ' CD2' ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -142.34 136.79 30.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.427 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 41' ' ' THR . 61.2 pttt -173.68 178.77 2.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.795 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.539 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -65.61 -39.71 91.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.836 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.401 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 45.3 t -66.83 -51.55 54.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.672 0.273 . . . . 0.0 111.704 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 38.8 m-20 -72.2 -51.42 21.25 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -88.39 -45.97 9.55 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.92 -27.52 1.48 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.203 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 16.0 pt20 -43.29 -35.62 1.54 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 111.333 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.51 -33.0 60.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.782 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.3 119.1 10.95 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 62' ' ' ASP . 76.2 p -77.26 155.89 31.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.754 0.312 . . . . 0.0 111.073 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.33 -40.21 11.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.593 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -53.86 -26.32 24.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.166 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.635 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -70.18 3.38 2.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.511 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -39.93 -65.33 0.44 Allowed Pre-proline 0 N--CA 1.463 0.217 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.156 -179.141 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 74.1 Cg_endo -74.06 78.26 2.6 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.307 2.005 . . . . 0.0 111.855 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.635 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.8 OUTLIER -76.8 143.65 39.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.246 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.494 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 75.1 mmtt -69.57 68.38 0.24 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.464 0.65 . . . . 0.0 110.05 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.758 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 31.8 m 59.66 160.96 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.976 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.682 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.47 -25.88 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.632 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 16.5 pt-20 -59.66 -48.86 80.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.43 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.498 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -74.13 -32.18 63.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.161 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.842 HG22 HG13 ' A' ' 24' ' ' ILE . 60.2 t -61.55 -46.93 95.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.399 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.85 -44.63 91.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.874 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 35.8 t70 -62.73 -42.62 99.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.337 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.6 m -63.76 -50.68 68.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.136 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.35 -52.58 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.542 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 73' ' ' ASP . 6.8 m -58.6 -43.52 87.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 74.4 m-20 -62.1 -54.1 46.13 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.619 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -69.88 -41.01 75.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 111.6 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.03 -29.92 69.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.734 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.25 -54.61 0.46 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.891 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 76' ' ' VAL . 17.7 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.073 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.657 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p . . . . . 0 C--O 1.214 -0.791 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -44.87 -45.27 10.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -77.16 -34.39 56.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.884 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.657 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -64.49 -51.86 60.84 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.515 HG13 ' CG2' ' A' ' 5' ' ' VAL . 35.0 mt -65.94 -50.13 72.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.7 OUTLIER -56.64 -29.28 62.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.14 -41.77 99.63 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.44 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 77.3 mt-30 -69.72 -31.98 70.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.455 -0.872 . . . . 0.0 110.195 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -71.06 -46.64 66.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.563 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 mm -58.72 -52.58 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.714 0.292 . . . . 0.0 110.401 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.85 -36.36 93.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.106 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.468 ' HB2' ' HG ' ' A' ' 34' ' ' LEU . . . -67.1 -25.03 66.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.279 -0.461 . . . . 0.0 111.547 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 30' ' ' LEU . 46.1 mt -82.31 -29.41 31.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.568 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.01 132.84 54.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.857 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.2 -33.93 5.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.674 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.574 ' N ' ' HB3' ' A' ' 33' ' ' ALA . . . -51.21 -179.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.375 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.551 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.6 m-20 -58.94 -119.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.739 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -61.22 179.24 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.306 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 176.268 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.806 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 46.7 Cg_endo -65.61 65.26 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 119.889 0.996 . . . . 0.0 112.291 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.769 HG13 HG23 ' A' ' 71' ' ' VAL . 31.9 mm 107.72 60.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.61 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.6 m120 -62.82 65.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.542 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 54.7 p 58.16 153.49 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 31' ' ' MET . 67.0 Cg_exo -48.26 -32.51 19.68 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.315 1.344 . . . . 0.0 112.628 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -52.88 -57.48 10.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.51 0.671 . . . . 0.0 110.503 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.61 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.4 tp10 -75.37 -57.8 3.67 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.556 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.4 pp -50.39 -41.59 52.27 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.64 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 37.0 ttm -64.61 -32.87 74.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -73.01 -23.17 60.59 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.574 ' HB3' ' N ' ' A' ' 20' ' ' ALA . . . -72.2 -49.71 33.35 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.469 ' C ' ' O ' ' A' ' 33' ' ' ALA . 7.9 mp -24.99 135.26 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 C--N 1.349 0.583 0 C-N-CA 123.916 3.077 . . . . 0.0 113.622 -178.5 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.743 0.306 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.405 ' CG2' ' OE2' ' A' ' 48' ' ' GLU . 17.3 m -76.74 127.37 32.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.722 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 57.4 m -112.28 45.81 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.88 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 60.2 pttt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 87.8 tt0 . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 121.135 0.493 . . . . 0.0 111.74 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -137.69 130.31 29.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.564 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.413 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 62.4 pttt -171.7 -161.37 0.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.879 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.481 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -74.31 -47.74 32.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.408 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.7 t -69.34 -50.87 42.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -69.2 -48.74 61.24 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 50' ' ' LYS . . . -95.66 -45.74 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -47.35 -28.47 4.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.84 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -43.38 -34.13 1.2 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.207 0.527 . . . . 0.0 111.357 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.412 HG22 ' HD3' ' A' ' 78' ' ' LYS . 30.5 m -65.51 -33.2 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.918 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.9 mt -64.72 125.28 24.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 110.681 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.5 p -77.39 155.87 31.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.261 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.57 -42.63 55.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.4 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -56.1 -22.66 29.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.858 0.361 . . . . 0.0 111.075 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.601 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 15.5 m-20 -68.3 3.3 1.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.546 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -40.57 -66.3 0.38 Allowed Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 117.943 0.338 . . . . 0.0 111.532 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.2 Cg_endo -70.44 76.06 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.373 2.049 . . . . 0.0 112.09 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.601 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -77.15 141.93 39.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.502 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.568 ' HE3' ' HA ' ' A' ' 66' ' ' LYS . 1.7 tpmt? -67.32 68.51 0.08 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.702 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.806 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 47.3 m 58.73 162.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.028 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.652 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.59 -26.23 8.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.949 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 23.1 pt-20 -60.23 -49.92 75.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.551 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.534 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -71.49 -35.59 70.85 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.655 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.769 HG23 HG13 ' A' ' 24' ' ' ILE . 55.8 t -63.19 -40.8 90.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.8 -51.65 68.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.985 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -67.09 -41.57 86.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.426 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.9 m -57.59 -50.1 74.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.677 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 71' ' ' VAL . 82.4 mt -60.13 -49.04 85.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.233 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 16.6 m -63.03 -41.87 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -58.59 -55.72 31.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.412 ' HD3' HG22 ' A' ' 57' ' ' VAL . 28.2 mtpp -71.89 -38.99 69.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 111.654 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.67 -29.69 69.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.563 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.1 -53.95 0.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.817 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.4 mt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.158 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.654 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p . . . . . 0 C--O 1.214 -0.785 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 81.7 tttt -44.34 -46.17 9.18 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.418 -0.801 . . . . 0.0 109.276 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -77.43 -34.18 54.66 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.824 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.654 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -63.77 -51.92 62.68 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.505 HG13 ' CG2' ' A' ' 5' ' ' VAL . 33.6 mt -66.69 -46.81 84.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 45.0 ttp180 -55.11 -30.14 59.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.76 -42.85 94.98 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.408 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 71.3 mt-30 -68.9 -30.01 68.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.815 -0.692 . . . . 0.0 110.063 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.4 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 70.1 mt -71.29 -44.66 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.806 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' A' ' 69' ' ' GLU . 11.3 mm -57.67 -53.11 49.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.252 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.45 -36.02 92.07 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.807 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.463 ' HB2' ' HG ' ' A' ' 34' ' ' LEU . . . -60.85 -31.69 71.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.068 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.562 HD22 ' HB2' ' A' ' 30' ' ' LEU . 48.0 mt -81.49 -29.45 33.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.552 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.06 128.31 36.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.797 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.15 -36.16 3.28 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.537 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 33' ' ' ALA . . . -52.59 -175.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.025 0.44 . . . . 0.0 111.492 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.619 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -61.56 -127.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.71 ' CD2' ' ND2' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -54.23 175.49 0.16 Allowed Pre-proline 0 CA--C 1.52 -0.209 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 176.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.785 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 35.3 Cg_endo -61.92 69.17 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 CA-C-N 119.814 0.969 . . . . 0.0 112.486 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.704 HG13 HG23 ' A' ' 71' ' ' VAL . 44.2 mm 105.68 64.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 177.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.71 ' ND2' ' CD2' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -65.77 63.89 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.142 -0.349 . . . . 0.0 111.367 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.63 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 39.1 p 57.98 160.31 0.09 OUTLIER Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.59 ' O ' ' CB ' ' A' ' 31' ' ' MET . 52.7 Cg_exo -52.65 -34.01 61.76 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.335 1.356 . . . . 0.0 113.042 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.44 -57.42 9.92 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.371 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.627 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -76.35 -58.34 3.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.62 HD21 HG23 ' A' ' 24' ' ' ILE . 3.9 pp -50.33 -45.76 55.12 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.59 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 27.7 ttm -64.26 -31.37 72.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.12 -30.66 68.98 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.854 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.503 ' HB3' ' CB ' ' A' ' 20' ' ' ALA . . . -69.28 -37.79 78.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.965 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.522 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.4 mp -32.75 140.34 0.21 Allowed Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.052 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo . . . . . 0 C--N 1.349 0.575 0 C-N-CA 123.534 2.822 . . . . 0.0 112.896 -179.23 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.47 HG23 ' CD2' ' A' ' 34' ' ' LEU . 11.3 t . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 120.515 0.198 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 30.8 m -93.15 115.62 28.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.795 0.331 . . . . 0.0 111.302 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 73.7 m -92.65 46.62 1.25 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 109.955 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 24.2 pttm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.093 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.487 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 70.1 mt-10 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.722 0.296 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -143.24 131.23 21.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 41' ' ' THR . 21.8 pttm -165.03 172.1 13.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.429 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.57 ' HB2' ' HG3' ' A' ' 31' ' ' MET . . . -59.38 -35.94 74.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.616 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.8 t -66.44 -58.4 5.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.41 ' O ' ' NE2' ' A' ' 56' ' ' GLN . 43.9 m-20 -71.84 -54.24 10.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.429 ' HB3' ' HB1' ' A' ' 79' ' ' ALA . . . -77.58 -46.02 23.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.76 -23.41 3.43 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.58 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.43 ' HG3' HG12 ' A' ' 57' ' ' VAL . 26.2 pt20 -42.52 -32.56 0.56 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.023 0.439 . . . . 0.0 111.447 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.433 HG21 ' HD2' ' A' ' 78' ' ' LYS . 34.0 m -78.33 27.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.415 HD11 ' CE2' ' A' ' 65' ' ' PHE . 39.8 mt -127.25 115.13 18.58 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.893 0.378 . . . . 0.0 110.046 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.8 p -67.52 155.88 38.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.958 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.06 -40.38 61.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.954 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -54.93 -23.47 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.669 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.521 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 13.4 m-20 -68.53 3.07 1.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.63 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.8 OUTLIER -39.43 -65.23 0.43 Allowed Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 117.81 0.277 . . . . 0.0 111.612 -179.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.9 Cg_endo -70.71 76.35 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.367 2.044 . . . . 0.0 112.093 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.545 ' CB ' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -77.02 140.46 40.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.84 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 22.8 tptm -66.0 67.64 0.05 OUTLIER 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.429 0.633 . . . . 0.0 110.608 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.785 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 34.6 m 60.19 159.88 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.962 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.643 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.57 -29.65 17.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.563 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HA ' HD11 ' A' ' 14' ' ' ILE . 10.9 pt-20 -58.88 -47.61 84.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.297 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.499 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -68.51 -35.73 77.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.204 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.704 HG23 HG13 ' A' ' 24' ' ' ILE . 89.8 t -61.92 -44.35 98.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 110.51 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.6 -49.49 72.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.964 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.414 ' O ' HG23 ' A' ' 76' ' ' VAL . 56.5 m-20 -69.86 -41.85 74.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.992 0.425 . . . . 0.0 111.21 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.4 m -59.33 -50.98 71.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.855 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 71' ' ' VAL . 69.3 mt -61.02 -52.98 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.397 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 13.5 m -60.35 -40.38 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -60.09 -54.16 49.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 111.417 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HD2' HG21 ' A' ' 57' ' ' VAL . 63.2 mttp -71.86 -41.11 68.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.86 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.429 ' HB1' ' HB3' ' A' ' 54' ' ' ALA . . . -67.1 -29.94 69.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.834 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.77 -55.8 0.44 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.676 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.8 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.141 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.729 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.8 p . . . . . 0 C--O 1.216 -0.709 0 CA-C-O 120.027 -0.035 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 86.3 tttt -45.76 -50.66 13.67 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -78.0 -27.77 49.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.172 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.729 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 33.8 t70 -66.96 -52.56 41.37 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.491 HG13 ' CG2' ' A' ' 5' ' ' VAL . 19.5 mt -69.6 -45.86 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 5.7 tmm_? -55.21 -31.96 61.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.09 -43.35 98.88 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 68.0 mt-30 -63.41 -29.91 71.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.673 -0.763 . . . . 0.0 109.552 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.21 -42.39 78.97 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.923 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.3 mm -57.7 -53.26 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.343 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.4 -38.06 90.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.327 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -61.77 -28.35 69.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.055 0.455 . . . . 0.0 111.28 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 30' ' ' LEU . 48.0 mt -83.45 -29.57 27.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.526 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.11 129.85 43.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.76 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.42 -33.86 4.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.668 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.586 ' N ' ' HB3' ' A' ' 33' ' ' ALA . . . -52.85 -174.29 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 111.423 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.561 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 76.8 m-20 -60.31 -119.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.734 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -60.63 -179.99 0.21 Allowed Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.748 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 41.6 Cg_endo -66.17 65.94 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 120.089 1.068 . . . . 0.0 112.336 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.819 HG13 HG22 ' A' ' 71' ' ' VAL . 50.4 mm 108.01 60.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.592 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.6 m120 -62.45 66.82 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 59.7 p 57.16 154.18 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.658 ' O ' ' CB ' ' A' ' 31' ' ' MET . 54.3 Cg_exo -48.66 -32.82 22.57 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.096 1.198 . . . . 0.0 112.65 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -52.21 -57.37 9.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.473 0.654 . . . . 0.0 110.739 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.592 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 40.2 tp10 -74.71 -57.93 3.61 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.566 ' HB2' HD21 ' A' ' 17' ' ' LEU . 3.6 pp -50.56 -40.4 52.05 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.658 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 40.1 ttm -63.88 -33.24 75.26 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -75.44 -20.49 58.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.586 ' HB3' ' N ' ' A' ' 20' ' ' ALA . . . -75.91 -42.93 47.49 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 40' ' ' THR . 6.9 mp -27.96 147.17 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo . . . . . 0 C--N 1.348 0.55 0 C-N-CA 124.051 3.168 . . . . 0.0 115.478 -177.288 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.54 HG21 ' HB3' ' A' ' 34' ' ' LEU . 5.2 t . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.769 0.319 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.424 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 11.8 m -76.17 124.13 26.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.963 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.6 m -90.44 44.66 1.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.528 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.441 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.5 pttm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.136 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 28.1 mt-10 . . . . . 0 N--CA 1.461 0.082 0 CA-C-O 120.816 0.341 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -140.83 138.01 33.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.08 0.466 . . . . 0.0 110.952 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 21.6 pttp -174.74 166.07 3.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.705 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.492 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.84 -40.47 21.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.074 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.6 t -72.01 -43.7 64.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.412 ' O ' ' NE2' ' A' ' 56' ' ' GLN . 38.2 t70 -69.14 -54.11 16.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 111.853 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.454 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -96.28 -45.77 6.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.58 -30.04 2.04 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.361 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 53' ' ' ASP . 18.7 pt20 -51.52 -28.86 14.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.202 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 54' ' ' ALA . 31.9 m -78.26 27.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 74' ' ' THR . 38.2 mt -125.86 125.68 43.23 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.744 0.307 . . . . 0.0 110.332 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.9 p -67.88 155.72 38.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.599 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.08 -40.92 67.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.189 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -55.02 -22.26 14.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.0 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.587 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.6 m-20 -68.42 3.01 1.94 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.534 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.9 OUTLIER -41.12 -65.14 0.5 Allowed Pre-proline 0 N--CA 1.462 0.159 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.501 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.0 Cg_endo -71.35 76.79 1.74 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.293 1.995 . . . . 0.0 112.246 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.587 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.3 OUTLIER -77.05 143.19 39.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.66 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.11 68.67 0.12 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.637 0.732 . . . . 0.0 110.963 178.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.748 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 20.2 m 58.75 161.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.268 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.676 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.63 -30.96 23.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.857 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.401 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 16.3 pt-20 -58.46 -46.3 86.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.448 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.66 ' HG2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -71.0 -37.54 72.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.725 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.819 HG22 HG13 ' A' ' 24' ' ' ILE . 45.5 t -62.69 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.023 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HB3' ' CD ' ' A' ' 10' ' ' ARG . . . -56.63 -48.45 77.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.066 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.414 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.3 m-20 -65.52 -45.28 84.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.839 0.352 . . . . 0.0 111.028 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.435 ' OG1' ' OE1' ' A' ' 70' ' ' GLU . 27.0 m -59.86 -44.65 94.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.624 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.454 HG22 ' CB ' ' A' ' 54' ' ' ALA . 66.2 mt -57.26 -51.52 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.399 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 14.9 m -60.33 -37.11 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 78.4 m-20 -63.31 -58.16 8.04 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.409 ' CD ' HG22 ' A' ' 57' ' ' VAL . 64.3 mttp -69.48 -38.96 77.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.427 ' HB2' ' CB ' ' A' ' 54' ' ' ALA . . . -66.75 -29.95 70.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.242 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.21 -55.88 0.42 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.236 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.5 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 19.5 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.257 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.678 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.6 p . . . . . 0 C--O 1.214 -0.788 0 N-CA-C 110.925 -0.028 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -45.29 -46.53 12.76 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.4 ' OE2' ' HD2' ' A' ' 6' ' ' LYS . 9.5 mp0 -77.74 -31.63 52.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.934 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.678 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 65.4 m-20 -65.61 -52.35 52.66 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.477 HG13 ' CG2' ' A' ' 5' ' ' VAL . 31.1 mt -68.33 -46.1 81.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.585 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.3 OUTLIER -56.89 -29.96 63.48 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.58 -43.68 96.16 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 82.7 mt-30 -63.95 -30.23 71.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.711 -0.744 . . . . 0.0 109.665 177.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.2 mt -70.5 -42.54 78.25 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.059 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.839 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 69' ' ' GLU . 10.4 mm -57.17 -52.75 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.413 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.7 86.3 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.186 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.473 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . . . -60.98 -27.88 68.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.975 0.416 . . . . 0.0 111.094 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.563 HD23 ' HB2' ' A' ' 30' ' ' LEU . 54.6 mt -85.78 -29.41 23.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.939 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.98 129.09 38.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.098 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.92 -34.49 4.17 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.836 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.587 ' N ' ' HB3' ' A' ' 33' ' ' ALA . . . -51.87 -178.05 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.843 0.354 . . . . 0.0 111.613 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.556 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -61.18 -119.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.714 ' CE2' ' HA ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -58.73 174.43 0.37 Allowed Pre-proline 0 CA--C 1.519 -0.242 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 176.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.86 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 39.3 Cg_endo -63.32 67.01 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.843 0.98 . . . . 0.0 112.292 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.777 HG13 HG23 ' A' ' 71' ' ' VAL . 24.0 mm 109.4 60.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.714 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.6 m120 -62.78 65.85 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 25' ' ' ASN . 81.5 p 56.76 156.7 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.655 ' O ' ' HB2' ' A' ' 31' ' ' MET . 52.1 Cg_exo -49.5 -34.47 33.65 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.299 1.332 . . . . 0.0 113.15 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.03 -57.1 10.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.327 0.584 . . . . 0.0 110.647 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.585 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.2 tp10 -76.0 -57.51 3.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.563 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.6 pp -49.9 -41.12 45.13 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.655 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 64.3 mtm -65.72 -33.82 76.77 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.45 -28.31 68.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.605 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.587 ' HB3' ' N ' ' A' ' 20' ' ' ALA . . . -72.6 -40.73 66.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.618 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.527 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.4 mp -35.18 145.21 0.2 Allowed Pre-proline 0 N--CA 1.467 0.407 0 CA-C-O 121.137 0.494 . . . . 0.0 112.326 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo . . . . . 0 C--N 1.347 0.48 0 C-N-CA 124.07 3.18 . . . . 0.0 114.38 -178.027 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 34' ' ' LEU . 9.9 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.873 0.368 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.454 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 6.7 m -81.0 127.82 33.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.7 m -95.55 43.71 1.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 110.368 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.458 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.134 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 32.8 mt-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -141.63 139.37 33.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.848 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 59.6 pttt -176.97 153.94 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.81 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.64 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.8 -27.22 1.94 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.659 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.9 t -67.26 -62.51 1.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.067 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -72.55 -54.32 9.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.915 0.388 . . . . 0.0 111.787 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.406 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -71.76 -45.3 62.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.812 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.91 -27.83 1.57 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.711 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -41.91 -36.69 1.13 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.795 0.807 . . . . 0.0 110.434 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.424 HG23 ' CD ' ' A' ' 78' ' ' LYS . 16.3 m -83.07 28.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.28 -1.327 . . . . 0.0 112.243 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.41 HD23 ' CG2' ' A' ' 74' ' ' THR . 36.1 mt -137.91 76.9 1.6 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.943 0.402 . . . . 0.0 110.38 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.9 p -49.08 174.92 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.247 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.02 73.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.551 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -50.69 -28.44 9.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.629 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 52.8 m-20 -75.47 3.46 9.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.338 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.678 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -43.78 -71.34 0.16 Allowed Pre-proline 0 N--CA 1.462 0.157 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.248 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 56.4 Cg_endo -68.39 77.65 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.023 1.816 . . . . 0.0 111.303 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.568 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -77.1 144.59 38.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.138 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 62.1 mttp -70.37 64.36 0.27 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.106 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.86 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 55.7 m 63.93 160.2 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.575 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.517 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.92 -27.09 11.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.893 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HA ' HD13 ' A' ' 14' ' ' ILE . 15.3 pt-20 -65.43 -38.92 91.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.969 0.414 . . . . 0.0 109.969 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 6.8 tp10 -67.73 -46.23 72.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.927 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.777 HG23 HG13 ' A' ' 24' ' ' ILE . 42.1 t -66.36 -45.65 88.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.821 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.426 ' CB ' ' HD3' ' A' ' 10' ' ' ARG . . . -55.33 -45.05 76.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.009 0.433 . . . . 0.0 110.352 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -69.82 -43.5 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.69 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.41 ' CG2' HD23 ' A' ' 58' ' ' LEU . 72.6 m -57.74 -46.93 83.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.298 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 71' ' ' VAL . 70.6 mt -58.23 -54.95 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.959 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 15.2 m -58.5 -43.93 87.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.836 0.309 . . . . 0.0 111.836 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -62.52 -54.14 44.33 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' CD ' HG23 ' A' ' 57' ' ' VAL . 98.6 mttt -72.07 -41.16 67.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 75' ' ' ILE . . . -67.04 -29.98 69.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.062 0.394 . . . . 0.0 112.062 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.49 -56.36 0.39 Allowed Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.049 -1.072 . . . . 0.0 113.223 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 14.0 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.08 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.667 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.9 p . . . . . 0 C--O 1.213 -0.844 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.466 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 0.8 OUTLIER -45.1 -46.54 11.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.6 -32.79 53.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.868 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.667 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 13.5 m-20 -64.88 -52.14 58.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.521 HG13 ' CG2' ' A' ' 5' ' ' VAL . 31.9 mt -65.4 -46.63 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 45.8 ttp180 -56.77 -28.69 61.7 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.46 -42.41 95.84 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 19.4 mt-30 -69.02 -32.44 71.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.866 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.1 mt -70.11 -45.91 74.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.266 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.3 mm -57.67 -52.23 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.698 0.285 . . . . 0.0 110.398 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.63 93.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.332 -0.937 . . . . 0.0 110.9 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.619 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . . . -64.72 -25.88 68.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.282 -0.459 . . . . 0.0 111.172 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.627 HD23 ' HB2' ' A' ' 30' ' ' LEU . 65.3 mt -83.0 -29.46 28.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.718 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.83 139.43 54.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.262 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.67 -30.85 8.88 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.888 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.587 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -51.59 -176.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.988 0.423 . . . . 0.0 111.61 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.547 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -59.83 -120.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.827 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -61.36 -169.06 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.827 ' N ' ' HD1' ' A' ' 22' ' ' PHE . 57.5 Cg_endo -71.48 62.19 2.82 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 CA-C-N 120.975 1.384 . . . . 0.0 112.178 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.782 HG13 HG22 ' A' ' 71' ' ' VAL . 48.9 mm 109.83 65.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.657 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -63.76 65.64 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 O-C-N 122.001 -0.437 . . . . 0.0 111.612 178.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.581 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 42.7 p 59.38 157.05 0.1 OUTLIER Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.583 ' O ' ' HB2' ' A' ' 31' ' ' MET . 50.7 Cg_exo -50.59 -34.36 42.66 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.331 1.354 . . . . 0.0 112.879 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -53.15 -55.43 24.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.137 0.494 . . . . 0.0 110.907 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.657 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -74.83 -57.37 3.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.627 ' HB2' HD23 ' A' ' 17' ' ' LEU . 3.8 pp -49.89 -38.46 35.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.583 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 57.3 mtm -63.5 -37.83 88.82 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.77 -26.44 66.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.166 0.508 . . . . 0.0 110.562 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.587 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -68.36 -42.99 78.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.474 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.619 ' HG ' ' HB3' ' A' ' 16' ' ' ALA . 10.0 mp -33.32 148.9 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.739 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo . . . . . 0 C--N 1.346 0.447 0 C-N-CA 123.648 2.898 . . . . 0.0 113.821 -177.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.409 HG21 ' HB3' ' A' ' 34' ' ' LEU . 2.4 t . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 120.958 0.409 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 28.1 m -83.9 125.98 32.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.996 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 63.4 m -88.84 46.26 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 0.0 110.341 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.451 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 61.8 pttt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.096 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.451 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 29.6 mt-10 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.668 0.27 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -143.94 141.69 30.36 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.053 0.454 . . . . 0.0 111.238 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HB3' ' HA ' ' A' ' 41' ' ' THR . 51.0 pttt -177.46 165.88 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.73 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.592 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -55.14 -31.98 61.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.663 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.0 t -66.58 -62.65 1.35 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 58.4 m-20 -72.21 -54.31 10.01 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.42 -44.37 58.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.63 -25.28 1.39 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.365 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 25.3 pt20 -40.6 -38.4 0.87 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.157 0.503 . . . . 0.0 111.652 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.422 ' HB ' ' HE2' ' A' ' 78' ' ' LYS . 34.3 m -65.65 -33.32 62.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.371 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.406 HD21 ' CG2' ' A' ' 74' ' ' THR . 13.2 mt -70.17 119.27 14.12 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.5 p -72.18 155.77 39.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.883 0.373 . . . . 0.0 111.468 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.82 -40.7 60.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.3 -21.2 33.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.961 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.551 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 19.6 m-20 -68.7 2.98 2.11 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.581 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.8 OUTLIER -37.78 -62.81 0.58 Allowed Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 117.953 0.342 . . . . 0.0 111.63 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.7 Cg_endo -72.08 77.63 1.95 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.378 2.052 . . . . 0.0 111.747 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -77.03 141.99 40.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.649 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.512 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.67 66.76 0.13 Allowed 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.519 0.676 . . . . 0.0 110.221 178.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.794 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 18.5 m 60.8 161.51 0.06 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.369 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.665 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.57 -31.77 25.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.645 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.434 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.9 pt-20 -58.37 -45.82 87.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.408 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -70.16 -33.69 72.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.607 -179.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.782 HG22 HG13 ' A' ' 24' ' ' ILE . 61.6 t -63.17 -44.95 99.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.919 0.39 . . . . 0.0 110.563 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.05 -50.3 73.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.067 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 56.0 m-20 -68.5 -42.04 79.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.009 0.433 . . . . 0.0 111.232 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.406 ' CG2' HD21 ' A' ' 58' ' ' LEU . 98.0 m -59.64 -49.4 77.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.797 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 71' ' ' VAL . 75.2 mt -62.07 -54.23 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.607 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 11.3 m -61.29 -44.67 98.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 4.3 m120 -59.66 -52.58 64.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HE2' ' HB ' ' A' ' 57' ' ' VAL . 48.9 mtpt -72.65 -41.06 65.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.734 0.302 . . . . 0.0 111.606 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.27 -30.08 69.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.759 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.19 -56.28 0.41 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.934 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 16.9 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.042 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.681 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p . . . . . 0 C--O 1.21 -0.974 0 N-CA-C 111.315 0.117 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 5' ' ' VAL . 86.8 tttt -44.94 -47.45 11.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -77.61 -33.48 53.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.786 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.681 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -63.69 -52.07 62.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.512 HG13 ' CG2' ' A' ' 5' ' ' VAL . 28.3 mt -64.01 -46.46 93.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.403 ' NH2' ' HE2' ' A' ' 6' ' ' LYS . 24.3 ttm180 -56.88 -28.05 61.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.92 -41.42 97.4 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.442 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 63.4 mt-30 -70.69 -31.33 68.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.633 -0.784 . . . . 0.0 110.032 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.4 -48.68 52.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.308 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.438 HD11 ' HA ' ' A' ' 69' ' ' GLU . 7.9 mm -57.27 -52.27 58.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.511 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.22 -36.47 93.27 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.911 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 12' ' ' GLN . . . -64.17 -28.45 69.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.239 -0.481 . . . . 0.0 111.247 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.625 HD23 ' HB2' ' A' ' 30' ' ' LEU . 60.8 mt -80.43 -29.45 37.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.701 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.68 133.3 53.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.067 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.58 -33.54 5.46 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.765 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.518 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -51.65 -176.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.449 . . . . 0.0 111.643 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.562 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -59.9 -123.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.759 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -58.83 -174.79 0.05 OUTLIER Pre-proline 0 N--CA 1.456 -0.127 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 176.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.808 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 52.2 Cg_endo -68.08 62.8 1.01 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 120.478 1.206 . . . . 0.0 112.326 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.838 HG13 HG21 ' A' ' 71' ' ' VAL . 49.1 mm 110.32 65.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.663 ' ND2' ' CD2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -64.67 65.99 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 122.013 -0.429 . . . . 0.0 111.478 178.027 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.506 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 27.3 p 58.43 157.2 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.553 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 50.8 Cg_exo -50.69 -34.62 44.53 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.319 1.346 . . . . 0.0 112.875 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -52.61 -55.19 24.07 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.613 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.637 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 6.0 tp10 -76.25 -57.83 3.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.625 ' HB2' HD23 ' A' ' 17' ' ' LEU . 3.8 pp -50.03 -41.85 48.34 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.532 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 28.3 ttm -66.02 -32.69 74.32 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.14 -30.39 69.51 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.394 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -68.41 -40.42 81.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.288 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.518 HD11 ' HA ' ' A' ' 31' ' ' MET . 9.0 mp -25.07 134.47 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.29 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 C--N 1.347 0.452 0 C-N-CA 123.862 3.041 . . . . 0.0 114.899 -178.029 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.424 HG23 ' HB3' ' A' ' 34' ' ' LEU . 3.8 t . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 120.777 0.322 . . . . 0.0 111.473 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.433 ' OG1' ' HD2' ' A' ' 50' ' ' LYS . 27.3 m -96.15 118.87 33.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.668 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -88.01 43.87 1.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.09 0.472 . . . . 0.0 109.975 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.444 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 19.8 ptmt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.148 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HG2' ' HB2' ' A' ' 43' ' ' LYS . 32.6 mt-10 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.682 0.277 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -140.91 132.52 27.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.936 0.398 . . . . 0.0 110.912 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.433 ' HD2' ' OG1' ' A' ' 41' ' ' THR . 21.3 ptmt -170.21 159.08 7.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.727 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.86 -29.88 3.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.951 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.9 t -72.54 -59.59 2.65 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 57.5 m-20 -72.15 -54.11 10.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -74.34 -43.97 54.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.09 -27.06 1.46 Allowed Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.363 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 18.1 pt20 -42.25 -40.14 2.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.149 0.5 . . . . 0.0 111.515 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.76 -30.39 49.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.104 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.422 HD22 ' CG2' ' A' ' 74' ' ' THR . 12.4 mt -71.32 119.85 16.05 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.5 p -75.0 155.66 37.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.355 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.64 -39.81 51.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -58.81 -21.09 55.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.618 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.4 m-20 -70.04 3.15 2.9 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.506 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.5 m-85 -40.49 -62.69 0.88 Allowed Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 118.162 0.437 . . . . 0.0 111.293 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.0 Cg_endo -71.43 74.95 2.01 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.48 2.12 . . . . 0.0 112.207 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.618 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.8 OUTLIER -76.9 139.84 40.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.167 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 38.1 mtmm -66.45 70.07 0.07 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.596 0.712 . . . . 0.0 110.671 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.808 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 37.7 m 59.33 161.15 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.284 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.656 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.55 -26.85 9.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.482 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 12.0 pt-20 -58.77 -48.99 79.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.454 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -74.87 -31.88 61.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 119.656 -0.817 . . . . 0.0 111.303 -179.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.838 HG21 HG13 ' A' ' 24' ' ' ILE . 57.2 t -61.48 -45.47 98.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.418 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.84 -46.33 90.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.108 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 9.3 t70 -62.5 -41.74 99.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.531 0.682 . . . . 0.0 110.396 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.422 ' CG2' HD22 ' A' ' 58' ' ' LEU . 85.0 m -63.19 -49.54 73.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.835 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 71' ' ' VAL . 74.7 mt -59.79 -55.17 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.072 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 9.7 m -60.9 -43.8 96.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 3.4 m120 -63.93 -50.77 67.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -74.06 -41.65 61.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 75' ' ' ILE . . . -67.11 -29.9 69.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.7 -55.79 0.36 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.064 -1.065 . . . . 0.0 113.223 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 17.5 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.237 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.65 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.3 p . . . . . 0 C--O 1.211 -0.926 0 CA-C-O 120.009 -0.043 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 13.0 tmtt? -45.11 -46.0 11.53 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.53 -34.14 54.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.857 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.65 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -63.55 -52.2 62.11 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.493 HG13 ' CG2' ' A' ' 5' ' ' VAL . 31.6 mt -65.69 -47.49 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 52.0 ttp85 -55.04 -28.8 55.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.426 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.63 -47.21 79.31 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -66.95 -28.02 67.93 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.763 -0.719 . . . . 0.0 109.986 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 9' ' ' ILE . 75.3 mt -70.43 -44.99 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.075 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.566 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 69' ' ' GLU . 11.3 mm -56.11 -49.64 74.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.05 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.69 -36.85 91.89 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.044 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.93 -27.11 69.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.25 -0.475 . . . . 0.0 111.38 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 30' ' ' LEU . 35.9 mt -85.01 -29.47 24.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.71 132.86 46.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.03 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.45 -33.97 4.88 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.519 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.572 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -52.19 -177.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.771 0.319 . . . . 0.0 111.383 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.538 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -60.79 -119.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.716 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -60.82 179.61 0.22 Allowed Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 176.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.806 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 41.4 Cg_endo -65.48 65.49 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 CA-C-N 119.921 1.008 . . . . 0.0 112.359 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.77 HG13 HG21 ' A' ' 71' ' ' VAL . 31.7 mm 107.94 61.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.59 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.6 m120 -62.98 65.75 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.554 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.1 p 57.12 156.7 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.613 ' O ' ' CB ' ' A' ' 31' ' ' MET . 53.7 Cg_exo -50.04 -33.99 36.65 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.351 1.367 . . . . 0.0 112.837 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -52.3 -56.83 12.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.308 0.575 . . . . 0.0 110.625 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.59 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.1 tp10 -76.1 -57.71 3.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.59 ' HB2' HD23 ' A' ' 17' ' ' LEU . 3.7 pp -50.2 -40.76 48.13 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.613 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 31.2 ttm -65.93 -33.61 76.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.48 -29.94 69.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.469 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -70.1 -39.62 75.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.408 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.8 mp -30.49 140.99 0.12 Allowed Pre-proline 0 N--CA 1.468 0.466 0 CA-C-O 121.108 0.48 . . . . 0.0 112.12 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 C--N 1.347 0.462 0 C-N-CA 123.859 3.04 . . . . 0.0 115.587 -177.471 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.414 HG22 ' HB3' ' A' ' 34' ' ' LEU . 6.0 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.644 0.259 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.533 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 2.0 t -108.6 121.97 46.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.073 0.464 . . . . 0.0 111.478 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 33.8 m -72.4 59.84 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.39 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 62.0 pttt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.004 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.447 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 22.1 mp0 . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.762 0.315 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.404 ' N ' ' OG1' ' A' ' 41' ' ' THR . 2.8 mm? -136.08 135.83 39.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.649 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 41' ' ' THR . 56.1 pttt -166.38 -165.26 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.058 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.506 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -78.02 -46.33 21.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.876 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.7 t -65.36 -51.62 59.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.647 0.26 . . . . 0.0 111.542 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -71.79 -51.44 22.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.441 ' HB2' ' CG2' ' A' ' 75' ' ' ILE . . . -86.03 -47.18 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.81 -26.15 1.08 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.785 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.407 ' HG3' ' N ' ' A' ' 57' ' ' VAL . 22.7 pt20 -41.57 -38.95 1.46 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.964 0.411 . . . . 0.0 111.796 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.445 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 34.1 m -65.66 -32.21 57.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.558 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.433 ' N ' HG21 ' A' ' 57' ' ' VAL . 22.4 mt -68.62 122.54 18.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.36 . . . . 0.0 110.554 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.5 p -74.74 155.81 37.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.331 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.21 -42.11 60.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.321 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.21 -20.02 38.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.169 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.671 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 28.5 m-20 -68.64 3.31 1.92 Allowed 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.554 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.7 OUTLIER -39.49 -67.46 0.28 Allowed Pre-proline 0 N--CA 1.463 0.18 0 CA-C-N 117.758 0.254 . . . . 0.0 111.466 -179.107 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.7 Cg_endo -70.43 76.39 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.311 2.007 . . . . 0.0 112.18 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.671 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -76.94 141.92 40.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.989 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.501 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 4.4 mmmp? -67.41 69.67 0.1 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.454 0.645 . . . . 0.0 110.615 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.806 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.8 m 58.5 162.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.15 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.638 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.8 -27.47 12.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.733 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 15.6 pt-20 -58.36 -49.69 76.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.555 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.501 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -73.54 -32.27 64.11 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.07 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.77 HG21 HG13 ' A' ' 24' ' ' ILE . 60.6 t -64.79 -39.65 86.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.888 0.375 . . . . 0.0 110.62 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.69 -49.54 72.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 76' ' ' VAL . 56.5 m-20 -68.46 -41.11 80.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.168 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.8 m -58.85 -51.63 69.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.513 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.441 ' CG2' ' HB2' ' A' ' 54' ' ' ALA . 75.0 mt -59.17 -53.57 46.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.316 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 11.1 m -59.82 -42.1 87.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.945 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -61.54 -53.45 56.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.679 0.276 . . . . 0.0 111.513 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HE3' ' HB ' ' A' ' 57' ' ' VAL . 27.7 mtpp -71.85 -39.68 69.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.597 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.92 69.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.812 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.34 -55.4 0.41 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.808 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 17.9 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.958 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.671 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.8 p . . . . . 0 C--O 1.213 -0.828 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 46.2 tttm -44.72 -47.05 10.7 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.798 -0.761 . . . . 0.0 108.999 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.39 -34.33 54.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.759 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.671 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 65.4 m-20 -63.03 -52.05 64.38 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.517 HG13 ' CG2' ' A' ' 5' ' ' VAL . 31.1 mt -66.23 -47.7 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 42.3 ttp180 -55.02 -28.85 55.29 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.98 -43.93 92.62 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -67.08 -30.83 70.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.746 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.0 mt -70.77 -42.64 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.781 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 69' ' ' GLU . 12.2 mm -57.82 -53.53 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.359 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.27 -37.56 92.99 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.011 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.424 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . -60.41 -30.91 69.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.072 0.463 . . . . 0.0 111.081 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 30' ' ' LEU . 46.5 mt -81.27 -29.44 34.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.513 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.82 125.25 21.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.716 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.62 -35.2 3.11 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.465 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.557 ' CB ' ' HB1' ' A' ' 33' ' ' ALA . . . -52.37 -176.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.842 0.353 . . . . 0.0 111.378 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.547 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.85 -119.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 177.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.7 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -59.66 177.44 0.27 Allowed Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.854 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 53.6 Cg_endo -65.11 65.86 0.31 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 CA-C-N 119.949 1.017 . . . . 0.0 112.372 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.765 HG13 HG22 ' A' ' 71' ' ' VAL . 26.9 mm 109.53 61.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 178.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.673 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.7 m120 -63.14 65.23 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.8 p 57.37 154.33 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.68 ' O ' ' CB ' ' A' ' 31' ' ' MET . 61.6 Cg_exo -48.21 -32.32 18.99 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.23 1.287 . . . . 0.0 112.748 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -53.0 -57.32 10.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.431 0.634 . . . . 0.0 110.591 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.582 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.1 tp10 -76.27 -57.65 3.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.2 pp -50.12 -35.15 24.58 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.68 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 30.8 ttm -66.96 -37.01 83.49 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.19 -23.98 64.9 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.659 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.557 ' HB1' ' CB ' ' A' ' 20' ' ' ALA . . . -74.0 -46.59 42.67 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.467 ' CD1' ' HA ' ' A' ' 31' ' ' MET . 5.6 mp -36.08 144.91 0.24 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 121.241 0.543 . . . . 0.0 112.404 -177.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 C--N 1.348 0.543 0 C-N-CA 124.202 3.268 . . . . 0.0 115.141 -177.528 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.454 HG22 ' HB3' ' A' ' 34' ' ' LEU . 3.9 t . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.785 0.326 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.404 ' OG1' ' NZ ' ' A' ' 50' ' ' LYS . 17.4 m -79.82 126.86 31.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.392 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.2 m -101.61 42.71 1.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.185 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . 22.5 pttp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.634 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.557 ' HA ' ' HB3' ' A' ' 43' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.488 0.661 . . . . 0.0 112.271 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.411 ' CD2' ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -143.95 133.28 23.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.721 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 60.6 pttt -169.73 -170.57 1.06 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 111.472 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.506 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -62.2 -52.4 63.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.404 ' OG ' ' HE3' ' A' ' 50' ' ' LYS . 85.3 p -72.74 -51.23 20.01 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.42 ' OD1' ' CE ' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -69.15 -49.92 52.47 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 50' ' ' LYS . . . -90.81 -45.67 8.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -54.22 -21.66 19.5 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.985 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -44.07 -31.4 0.92 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.016 0.436 . . . . 0.0 111.072 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.9 m -77.65 27.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.636 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 55' ' ' GLY . 34.6 mt -129.33 117.32 20.45 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.922 0.391 . . . . 0.0 110.637 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.445 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 72.6 p -71.84 158.26 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.615 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.73 -39.38 51.75 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.369 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -50.92 -27.28 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.035 0.445 . . . . 0.0 110.737 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.536 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 61.2 m-20 -70.73 3.68 3.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.458 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.669 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -42.12 -69.4 0.22 Allowed Pre-proline 0 C--O 1.226 -0.147 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.378 -179.244 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 51.6 Cg_endo -68.2 76.55 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.254 1.97 . . . . 0.0 111.475 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.551 ' CD1' HG21 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -77.01 142.63 39.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.137 -178.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 87.6 tttt -69.8 64.97 0.21 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.818 0.818 . . . . 0.0 111.24 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.854 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 64.8 m 64.07 161.25 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.728 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.529 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -53.38 -27.2 22.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.765 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.423 ' HA ' HD13 ' A' ' 14' ' ' ILE . 22.6 pt-20 -65.12 -39.35 92.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.17 0.509 . . . . 0.0 109.666 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' A' ' 66' ' ' LYS . 8.0 tp10 -66.23 -43.53 86.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.681 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.765 HG22 HG13 ' A' ' 24' ' ' ILE . 63.2 t -67.74 -41.1 84.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.544 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.402 ' O ' ' CG2' ' A' ' 76' ' ' VAL . . . -55.9 -44.67 78.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.08 0.467 . . . . 0.0 110.015 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.47 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.3 m-20 -72.71 -46.66 52.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.17 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.6 m -56.48 -48.78 76.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.708 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.452 HG22 ' CB ' ' A' ' 54' ' ' ALA . 68.3 mt -62.58 -54.31 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.656 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 12.9 m -60.12 -42.07 88.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 75.4 m-20 -62.65 -50.6 70.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.685 0.279 . . . . 0.0 111.483 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -72.13 -43.01 65.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.794 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . . . -67.54 -30.06 69.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.38 -56.56 0.41 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.869 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.5 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.083 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.673 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.5 p . . . . . 0 C--O 1.214 -0.806 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 5' ' ' VAL . 82.3 tttt -45.12 -43.24 9.58 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -77.72 -37.14 50.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.836 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.673 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 10.4 m-20 -62.6 -51.77 66.0 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.464 HG13 ' CG2' ' A' ' 5' ' ' VAL . 30.2 mt -63.92 -45.76 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.417 ' NH2' ' HE2' ' A' ' 6' ' ' LYS . 28.3 ttm180 -56.25 -29.95 61.76 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.4 -41.13 98.21 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -68.9 -30.12 68.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.747 -0.727 . . . . 0.0 109.755 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.1 mt -71.17 -45.6 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.829 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 69' ' ' GLU . 9.9 mm -58.2 -52.55 57.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.34 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.44 -37.47 94.49 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.351 -0.928 . . . . 0.0 110.815 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.418 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -60.62 -31.0 70.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.176 -0.512 . . . . 0.0 110.785 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.63 HD22 ' HB2' ' A' ' 30' ' ' LEU . 64.2 mt -80.87 -29.34 35.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.574 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.95 138.08 49.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.15 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.66 -33.14 6.53 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.798 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.525 ' N ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.4 -177.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.951 0.405 . . . . 0.0 111.62 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.585 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -59.81 -122.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.832 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -59.68 -171.5 0.03 OUTLIER Pre-proline 0 N--CA 1.454 -0.227 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.832 ' N ' ' HD1' ' A' ' 22' ' ' PHE . 59.3 Cg_endo -70.02 62.66 1.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 120.718 1.292 . . . . 0.0 112.012 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.748 HG13 HG23 ' A' ' 71' ' ' VAL . 49.3 mm 109.57 65.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.635 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -63.73 65.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 O-C-N 122.038 -0.414 . . . . 0.0 111.857 178.438 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.573 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 35.8 p 60.1 154.54 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.578 ' O ' ' CB ' ' A' ' 31' ' ' MET . 52.0 Cg_exo -49.57 -33.32 30.49 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.197 1.265 . . . . 0.0 112.715 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -53.99 -54.88 32.97 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.649 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.635 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 5.9 tp10 -75.2 -57.76 3.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.63 ' HB2' HD22 ' A' ' 17' ' ' LEU . 3.6 pp -50.27 -41.87 51.2 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.578 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 36.1 ttm -64.29 -32.34 73.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -70.3 -28.75 65.43 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.399 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.525 ' HB2' ' N ' ' A' ' 20' ' ' ALA . . . -71.0 -35.92 72.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.59 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.528 HD13 ' HA ' ' A' ' 31' ' ' MET . 8.8 mp -29.27 139.29 0.12 Allowed Pre-proline 0 N--CA 1.471 0.625 0 CA-C-O 121.078 0.466 . . . . 0.0 112.178 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo . . . . . 0 C--N 1.348 0.526 0 C-N-CA 124.281 3.321 . . . . 0.0 115.868 -177.338 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.448 HG22 HD21 ' A' ' 34' ' ' LEU . 8.8 t . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.751 0.31 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.429 ' OG1' ' HD2' ' A' ' 50' ' ' LYS . 29.2 m -92.72 125.1 37.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.148 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -93.41 41.31 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.478 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 60.8 pttt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.183 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.478 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 69.0 mt-10 . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.758 0.313 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -142.14 135.05 28.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.591 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HB2' ' NZ ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -171.64 -171.96 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.967 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.431 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -69.38 -50.12 49.06 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.421 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 35.4 t -66.47 -48.6 69.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.809 0.338 . . . . 0.0 111.562 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -70.32 -54.14 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . . . -94.6 -46.85 6.78 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -47.23 -26.1 3.1 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.871 -0.681 . . . . 0.0 113.047 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -43.69 -30.13 0.59 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 111.647 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.425 HG22 ' HD2' ' A' ' 78' ' ' LYS . 29.7 m -74.16 28.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.2 mt -132.67 116.37 16.55 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.4 p -70.85 155.93 40.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 111.698 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.28 -39.42 21.54 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.438 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -50.84 -27.64 7.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.941 0.401 . . . . 0.0 110.578 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.572 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.4 m-20 -71.59 3.17 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.083 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.573 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.2 OUTLIER -37.25 -53.48 2.15 Favored Pre-proline 0 N--CA 1.463 0.204 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 3.5 Cg_endo -83.27 78.47 3.19 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.87 2.38 . . . . 0.0 112.127 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' CE1' ' HB3' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -77.19 143.52 38.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.625 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 3.3 mptp? -68.64 67.14 0.13 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.565 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.817 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 34.2 m 60.53 160.98 0.05 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.19 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.617 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.47 -31.17 22.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.431 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.466 ' HA ' HD11 ' A' ' 14' ' ' ILE . 22.1 pt-20 -57.52 -46.91 83.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.371 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.464 ' CD ' ' HB2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -69.77 -35.63 75.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.5 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.748 HG23 HG13 ' A' ' 24' ' ' ILE . 61.6 t -61.9 -45.85 97.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 0.0 110.769 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.23 -49.93 72.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.986 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 76' ' ' VAL . 1.5 m-20 -68.51 -38.3 80.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.262 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 95.2 m -63.81 -51.36 65.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.0 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 71' ' ' VAL . 70.2 mt -59.3 -52.17 63.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.269 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.435 ' HB ' ' OXT' ' A' ' 81' ' ' LEU . 6.8 m -59.51 -39.91 80.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -62.36 -56.1 21.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.77 0.319 . . . . 0.0 111.702 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.425 ' HD2' HG22 ' A' ' 57' ' ' VAL . 98.6 mttt -69.46 -39.78 77.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.831 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . . . -67.08 -29.86 69.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.134 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.76 -55.43 0.42 Allowed Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.273 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.435 ' OXT' ' HB ' ' A' ' 76' ' ' VAL . 20.5 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.292 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.73 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.5 p . . . . . 0 C--O 1.213 -0.842 0 CA-C-O 120.062 -0.018 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 81.4 tttt -45.66 -51.13 12.75 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -77.87 -28.57 50.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.843 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.73 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 3.8 t70 -65.77 -52.65 49.19 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.455 HG13 ' CG2' ' A' ' 5' ' ' VAL . 15.3 mt -65.4 -42.22 92.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.518 ' NE ' ' HA ' ' A' ' 72' ' ' ALA . 3.1 tpt180 -60.25 -26.0 66.12 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.93 -44.74 94.13 Favored Glycine 0 CA--C 1.503 -0.675 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -63.43 -27.51 69.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.768 -0.716 . . . . 0.0 109.329 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.451 ' CD1' ' CZ ' ' A' ' 10' ' ' ARG . 64.3 mt -75.03 -47.3 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.721 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.7 mm -56.4 -52.2 55.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 120.749 0.309 . . . . 0.0 110.2 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.23 -37.08 94.31 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.25 -27.34 68.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.184 -0.508 . . . . 0.0 110.834 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.594 HD22 ' HB2' ' A' ' 30' ' ' LEU . 40.4 mt -80.5 -29.52 37.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.283 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.42 133.38 49.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.871 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.17 -34.03 5.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.465 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.519 ' N ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.37 -178.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.838 0.351 . . . . 0.0 111.348 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.573 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.6 m-20 -60.88 -120.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.711 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -59.44 179.8 0.18 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.805 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 50.0 Cg_endo -65.46 63.98 0.37 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 CA-C-N 119.827 0.974 . . . . 0.0 112.363 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.784 HG13 HG23 ' A' ' 71' ' ' VAL . 33.7 mm 108.65 60.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.578 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.6 m120 -62.48 65.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.552 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 61.5 p 57.64 154.42 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.584 ' O ' ' CB ' ' A' ' 31' ' ' MET . 60.2 Cg_exo -48.93 -32.44 22.99 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.305 1.336 . . . . 0.0 112.689 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -53.04 -57.38 10.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.41 0.624 . . . . 0.0 110.415 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.578 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 41.4 tp10 -76.2 -57.6 3.77 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.594 ' HB2' HD22 ' A' ' 17' ' ' LEU . 3.6 pp -50.16 -43.05 52.02 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.584 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 43.0 ttm -66.01 -31.58 72.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.2 -31.11 71.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.371 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.519 ' HB2' ' N ' ' A' ' 20' ' ' ALA . . . -69.75 -39.03 76.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.284 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.1 mp -30.0 137.33 0.17 Allowed Pre-proline 0 N--CA 1.47 0.546 0 CA-C-O 121.026 0.441 . . . . 0.0 111.831 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo . . . . . 0 C--N 1.348 0.536 0 C-N-CA 123.842 3.028 . . . . 0.0 115.754 -177.259 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.729 0.299 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.429 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 7.8 m -84.72 125.75 32.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.509 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.2 m -92.16 45.99 1.24 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.98 0.419 . . . . 0.0 110.094 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.433 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 22.2 pttp . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.083 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.433 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 26.7 mt-10 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.746 0.308 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.404 ' CD2' ' C ' ' A' ' 48' ' ' GLU . 3.1 mm? -141.38 128.98 21.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.167 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 22.5 pttp -168.47 157.88 9.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.612 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.464 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.75 -37.63 13.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.134 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.0 t -63.81 -52.48 60.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.4 ' OD2' ' HE3' ' A' ' 50' ' ' LYS . 65.2 m-20 -72.25 -50.69 25.36 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.436 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -91.91 -47.15 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.81 -29.6 2.06 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.052 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -45.55 -30.93 1.6 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.074 0.464 . . . . 0.0 111.17 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG22 ' HD2' ' A' ' 78' ' ' LYS . 34.8 m -75.11 28.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.666 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.5 mt -132.26 116.47 16.96 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.2 p -73.19 156.1 38.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.944 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.67 -37.3 12.63 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.018 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -51.0 -29.21 11.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.146 0.498 . . . . 0.0 110.187 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.585 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -72.05 3.6 4.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.556 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.552 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.1 t80 -38.99 -51.86 3.95 Favored Pre-proline 0 CA--C 1.527 0.092 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 86.5 Cg_endo -87.62 78.89 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.923 2.416 . . . . 0.0 112.061 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.585 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -77.14 140.59 40.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.971 0.415 . . . . 0.0 111.448 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.461 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 27.3 tptp -66.48 69.95 0.07 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.753 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.805 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 38.0 m 58.07 161.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.796 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.703 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.74 -30.12 21.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.935 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 10.7 pt-20 -57.41 -47.62 81.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.678 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.485 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -72.87 -37.89 67.18 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.724 -179.68 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.784 HG23 HG13 ' A' ' 24' ' ' ILE . 42.9 t -60.1 -34.56 57.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.934 0.397 . . . . 0.0 110.693 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.518 ' HA ' ' NE ' ' A' ' 10' ' ' ARG . . . -68.72 -56.03 9.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.463 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.4 m-20 -66.19 -35.09 79.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.584 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.5 m -62.58 -49.98 73.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.903 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.436 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 73.0 mt -64.12 -51.02 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG12 ' HD3' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -52.38 -38.5 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.206 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -60.63 -55.26 35.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 111.319 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HD2' HG22 ' A' ' 57' ' ' VAL . 62.0 mttp -71.91 -38.66 69.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.832 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.84 -30.11 70.2 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.2 -55.47 0.43 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 119.869 -1.158 . . . . 0.0 113.477 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.465 ' HB3' ' HG3' ' A' ' 6' ' ' LYS . 14.1 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.25 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.686 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p . . . . . 0 C--O 1.216 -0.68 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.554 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 62.9 tttp -45.33 -48.71 13.17 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.082 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -77.7 -30.1 51.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.835 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.686 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 23.0 m-20 -65.21 -52.07 57.06 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.486 HG13 ' CG2' ' A' ' 5' ' ' VAL . 23.9 mt -69.74 -48.45 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 23.2 ttp180 -56.17 -28.57 58.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.04 -44.32 91.67 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.41 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 66.2 mt-30 -66.38 -32.16 73.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.818 -0.691 . . . . 0.0 109.826 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.414 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 70.5 mt -70.58 -48.22 60.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.187 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.5 mm -53.94 -54.19 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.275 . . . . 0.0 110.8 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.7 -36.17 92.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.956 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 12' ' ' GLN . . . -63.9 -22.06 66.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.115 -0.543 . . . . 0.0 111.478 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.563 ' HB3' HD11 ' A' ' 24' ' ' ILE . 56.0 mt -90.44 -29.64 17.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.882 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 83.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.803 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 169.34 -38.48 0.2 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.384 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.533 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -51.38 -177.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.554 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -58.3 -120.52 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.683 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -58.69 175.46 0.32 Allowed Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 176.492 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.862 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 39.4 Cg_endo -63.89 65.41 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 120.853 1.036 . . . . 0.0 112.835 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.721 HG13 HG22 ' A' ' 71' ' ' VAL . 11.1 mm 109.84 61.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 177.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.575 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 3.1 m120 -65.81 64.06 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 25' ' ' ASN . 87.6 p 57.43 150.53 0.06 OUTLIER Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.864 ' O ' ' HB2' ' A' ' 31' ' ' MET . 86.9 Cg_exo -46.15 -28.5 5.54 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.09 1.86 . . . . 0.0 112.654 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -55.87 -57.31 12.61 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.563 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 5.6 tp10 -77.38 -57.37 3.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.566 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 1.4 pp -50.04 -34.36 21.24 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.68 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.864 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -77.87 -29.87 50.57 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -61.79 -28.2 69.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -81.95 -35.95 28.5 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.066 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 31' ' ' MET . 6.4 mp -33.29 130.48 0.37 Allowed Pre-proline 0 N--CA 1.467 0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 111.689 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo . . . . . 0 C--N 1.349 0.577 0 C-N-CA 123.503 2.802 . . . . 0.0 114.358 -178.379 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.4 ' CG2' HD21 ' A' ' 34' ' ' LEU . 5.2 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.83 0.348 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.5 m -101.03 95.41 6.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.722 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.4 m -72.38 57.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.9 0.381 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 8.8 ptpp? . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.267 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 43' ' ' LYS . 31.5 mt-10 . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -133.41 139.85 46.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.998 0.427 . . . . 0.0 111.648 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.437 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 56.1 pttt -177.96 -164.72 0.09 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.69 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.484 ' O ' ' CA ' ' A' ' 55' ' ' GLY . . . -77.58 -44.67 27.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.373 0.606 . . . . 0.0 111.505 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 t -59.63 -56.37 22.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.365 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -72.78 -54.33 9.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 50' ' ' LYS . . . -91.45 -43.21 9.85 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -45.62 -25.6 1.49 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.095 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -43.93 -40.16 4.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.144 0.497 . . . . 0.0 110.91 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.401 HG23 ' HD2' ' A' ' 78' ' ' LYS . 35.4 m -65.68 -32.59 58.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.157 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 55' ' ' GLY . 38.7 mt -71.36 70.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.183 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.402 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 71.7 p -47.94 156.8 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.595 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -43.63 -40.67 4.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.005 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -50.97 -27.92 8.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.886 0.374 . . . . 0.0 110.849 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.598 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 57.2 m-20 -73.33 3.45 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.62 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -40.82 -66.8 0.35 Allowed Pre-proline 0 N--CA 1.463 0.194 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.125 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 70.2 Cg_endo -72.93 75.97 2.61 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.408 2.072 . . . . 0.0 111.953 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.2 OUTLIER -77.01 142.37 39.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.357 -179.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.464 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 84.2 tttt -67.73 71.48 0.14 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.391 0.615 . . . . 0.0 110.703 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.862 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.7 m 59.31 161.37 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.003 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.541 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.73 -30.43 22.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.646 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 15.5 pt-20 -58.28 -47.63 83.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.636 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.572 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -74.38 -31.68 62.46 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.635 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.721 HG22 HG13 ' A' ' 24' ' ' ILE . 60.9 t -66.64 -51.68 53.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.409 ' O ' HG21 ' A' ' 76' ' ' VAL . . . -55.61 -42.14 74.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 109.801 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.431 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 47.5 t0 -64.52 -46.46 82.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.218 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.6 m -58.81 -47.52 84.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.949 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 69.7 mt -57.31 -49.56 79.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.507 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 15.6 m -63.4 -40.41 88.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.431 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.5 m-20 -64.63 -55.94 17.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HD2' HG23 ' A' ' 57' ' ' VAL . 97.2 mttt -70.57 -40.49 73.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . . . -67.1 -30.0 69.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.26 -56.01 0.38 Allowed Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.214 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.0 mt . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.323 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.704 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.6 p . . . . . 0 C--O 1.213 -0.846 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.9 OUTLIER -44.62 -50.47 9.75 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.608 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -77.46 -30.29 53.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.968 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.704 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 71.5 m-20 -64.41 -52.28 58.93 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.473 HG13 ' CG2' ' A' ' 5' ' ' VAL . 15.9 mt -63.75 -43.79 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.7 OUTLIER -59.26 -25.94 64.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.008 178.036 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.91 -45.15 89.78 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.419 ' OE1' ' HB3' ' A' ' 42' ' ' CYS . 75.8 mt-30 -64.3 -29.87 70.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.739 -0.731 . . . . 0.0 109.724 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.457 ' CD1' ' CZ ' ' A' ' 10' ' ' ARG . 75.7 mt -74.94 -46.15 41.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.863 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 mm -55.25 -53.09 38.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 110.397 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.4 -34.94 90.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.239 -0.981 . . . . 0.0 110.772 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.77 67.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.315 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.584 HD21 ' HB2' ' A' ' 30' ' ' LEU . 38.4 mt -83.2 -29.74 28.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 110.47 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.16 117.08 5.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.569 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.82 -36.22 1.96 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.455 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.508 ' CB ' ' HB1' ' A' ' 33' ' ' ALA . . . -53.92 -172.37 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.477 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.556 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.6 OUTLIER -62.06 -119.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.741 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -60.79 179.62 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.803 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.7 Cg_endo -65.39 66.76 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 120.778 0.986 . . . . 0.0 112.561 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.78 HG13 HG23 ' A' ' 71' ' ' VAL . 30.2 mm 108.19 61.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.581 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.7 m120 -64.39 64.76 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.6 p 58.15 155.23 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.59 ' O ' ' CB ' ' A' ' 31' ' ' MET . 64.5 Cg_exo -49.17 -32.29 24.26 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.359 1.373 . . . . 0.0 112.775 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -52.82 -57.6 9.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.502 0.668 . . . . 0.0 110.333 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.581 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 46.5 tp10 -76.5 -57.78 3.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.585 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.6 pp -50.12 -41.68 49.09 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.59 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 39.5 ttm -66.55 -32.46 73.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.3 -30.77 71.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.462 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.508 ' HB1' ' CB ' ' A' ' 20' ' ' ALA . . . -69.93 -40.77 75.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.403 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.526 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.1 mp -28.24 127.34 0.22 Allowed Pre-proline 0 N--CA 1.468 0.453 0 CA-C-O 121.061 0.458 . . . . 0.0 111.871 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 C--N 1.349 0.573 0 C-N-CA 123.513 2.809 . . . . 0.0 114.119 -178.354 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.521 -0.138 0 CA-C-O 120.852 0.358 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.412 ' CG2' ' HB3' ' A' ' 48' ' ' GLU . 28.5 m -102.73 91.33 4.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.757 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.419 ' HB3' ' OE1' ' A' ' 12' ' ' GLN . 59.3 m -70.24 57.96 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.921 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.434 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.1 pttp . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.189 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.434 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 8.9 mp0 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.945 0.403 . . . . 0.0 111.533 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.403 ' CD2' ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -144.66 135.44 24.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.661 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.405 ' HE2' ' OD2' ' A' ' 53' ' ' ASP . 57.9 pttt -171.66 -176.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.976 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.472 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -66.91 -41.78 86.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.129 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -63.87 -56.13 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 59.6 m-20 -72.28 -44.87 62.14 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.437 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -90.25 -49.76 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.95 -28.42 1.77 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.503 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 15.8 pt20 -42.85 -35.61 1.24 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.078 0.466 . . . . 0.0 111.707 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG23 ' HD2' ' A' ' 78' ' ' LYS . 24.6 m -65.53 -33.26 62.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.92 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.427 HD12 ' CZ ' ' A' ' 65' ' ' PHE . 34.8 mt -63.88 124.26 21.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 110.638 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.6 p -75.13 155.91 36.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.444 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.17 -41.42 60.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.403 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -57.28 -21.79 37.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.078 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.574 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 16.6 m-20 -69.13 3.33 2.18 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.537 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 1.3 m-85 -41.71 -66.67 0.38 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 118.055 0.389 . . . . 0.0 111.35 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 56.8 Cg_endo -69.54 74.89 1.16 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.337 2.025 . . . . 0.0 112.064 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -76.95 142.89 39.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.221 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.499 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 14.3 mmmm -68.34 70.53 0.17 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.484 0.659 . . . . 0.0 110.509 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.803 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 46.2 m 58.41 160.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.948 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.696 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.65 -27.37 11.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.803 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.454 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.2 pt-20 -58.94 -48.39 81.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.525 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -73.78 -35.29 64.93 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.065 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.78 HG23 HG13 ' A' ' 24' ' ' ILE . 49.0 t -62.23 -36.51 74.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.022 0.439 . . . . 0.0 110.431 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.484 ' HA ' ' NE ' ' A' ' 10' ' ' ARG . . . -66.11 -57.64 7.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.259 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.418 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.5 m-20 -63.88 -42.13 97.56 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.55 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.3 m -55.01 -48.35 73.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.96 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.437 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 83.1 mt -64.32 -50.49 76.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.472 HG11 ' HD3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -51.78 -38.07 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.37 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.0 m-20 -63.97 -51.86 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.19 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HD2' HG23 ' A' ' 57' ' ' VAL . 61.3 mttp -70.64 -41.97 71.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.682 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.45 -29.95 69.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.964 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.53 -54.08 0.47 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.969 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 6' ' ' LYS . 15.1 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.166 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.743 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.5 p . . . . . 0 C--O 1.217 -0.638 0 N-CA-C 111.278 0.103 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.554 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 39.2 tttm -45.3 -52.24 9.98 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -78.3 -25.94 46.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.29 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.743 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 54.8 t0 -68.03 -52.69 32.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.858 0.361 . . . . 0.0 111.882 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.494 HG13 ' CG2' ' A' ' 5' ' ' VAL . 14.4 mt -64.66 -44.49 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.783 ' HD2' HG11 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -59.62 -26.65 65.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.822 177.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.07 -42.89 99.47 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.403 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 71.0 mt-30 -64.37 -27.71 69.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.429 -0.885 . . . . 0.0 109.508 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.453 ' CD1' ' NE ' ' A' ' 10' ' ' ARG . 61.5 mt -74.89 -45.3 43.76 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.285 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.1 mm -56.84 -54.21 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.811 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.61 -36.6 93.56 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.299 -0.953 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -65.0 -24.57 67.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.131 -0.534 . . . . 0.0 111.392 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.608 HD23 ' HB2' ' A' ' 30' ' ' LEU . 48.4 mt -84.2 -29.83 26.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.831 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.67 124.14 18.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.971 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.64 -34.1 3.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.852 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.566 ' N ' ' HB2' ' A' ' 33' ' ' ALA . . . -53.23 -174.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 0.0 111.583 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.573 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 9.3 m-20 -61.45 -118.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.731 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -59.73 179.51 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 176.331 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.813 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 55.6 Cg_endo -65.99 66.3 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.901 1.0 . . . . 0.0 112.213 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.683 ' C ' ' CE1' ' A' ' 22' ' ' PHE . 42.8 mm 109.29 61.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.636 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.4 m120 -63.23 66.11 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.579 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 57.6 p 57.26 155.93 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.748 ' O ' ' HB2' ' A' ' 31' ' ' MET . 55.6 Cg_exo -49.6 -32.94 29.47 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.365 1.377 . . . . 0.0 113.054 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -53.33 -57.29 11.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.375 0.607 . . . . 0.0 110.561 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.582 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 40.6 tp10 -74.96 -57.05 4.14 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.608 ' HB2' HD23 ' A' ' 17' ' ' LEU . 3.5 pp -49.92 -42.32 48.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.748 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 27.0 mtm -64.67 -31.96 73.41 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.01 -28.66 69.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.48 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.566 ' HB2' ' N ' ' A' ' 20' ' ' ALA . . . -74.46 -38.96 62.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.2 mp -33.2 131.96 0.35 Allowed Pre-proline 0 N--CA 1.469 0.482 0 CA-C-O 121.128 0.49 . . . . 0.0 111.803 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 C--N 1.349 0.579 0 C-N-CA 124.1 3.2 . . . . 0.0 115.172 -177.633 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.231 0.109 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.463 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 19.8 m -93.77 123.17 36.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 60.0 m -91.04 45.91 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 0.0 110.609 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.463 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.171 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.463 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 35.6 mt-10 . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -138.09 139.33 39.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.128 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 59.1 pttt -178.83 157.52 0.91 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.891 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.532 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.73 -27.77 2.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.89 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 t -71.99 -61.31 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 59.9 m-20 -72.41 -54.52 9.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.441 ' CB ' HG21 ' A' ' 75' ' ' ILE . . . -73.35 -43.39 60.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.87 -22.71 3.06 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.326 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 26.5 pt20 -41.22 -40.71 1.67 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.08 0.467 . . . . 0.0 111.691 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.436 ' HB ' ' HE2' ' A' ' 78' ' ' LYS . 34.7 m -65.79 -30.64 50.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.256 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' N ' HG21 ' A' ' 57' ' ' VAL . 14.3 mt -72.2 113.58 9.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.738 0.304 . . . . 0.0 110.458 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.7 p -79.52 158.39 27.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.453 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.51 -40.16 12.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.248 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -53.06 -26.97 17.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.652 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.5 m-20 -71.08 3.16 3.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.217 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.603 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -38.87 -64.68 0.46 Allowed Pre-proline 0 N--CA 1.462 0.156 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.391 -178.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 59.3 Cg_endo -71.04 79.37 1.35 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.276 1.984 . . . . 0.0 111.444 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.484 ' CB ' HG22 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -76.82 140.09 40.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.456 -179.245 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 2.7 mppt? -67.44 62.36 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.404 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.813 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 49.4 m 64.98 161.89 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.493 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.521 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -52.01 -28.61 17.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.679 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.3 -39.2 92.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 66' ' ' LYS . 17.7 tp10 -63.52 -43.2 97.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.215 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.531 ' CG2' HG13 ' A' ' 24' ' ' ILE . 88.1 t -57.64 -46.59 86.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.807 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.491 ' O ' ' CD ' ' A' ' 10' ' ' ARG . . . -53.77 -56.13 20.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.206 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.446 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.4 m-20 -65.61 -44.3 86.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.907 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.5 m -56.53 -47.42 79.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.191 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.451 ' CG2' ' NH1' ' A' ' 10' ' ' ARG . 65.2 mt -66.31 -51.88 53.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.783 HG11 ' HD2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -56.88 -41.85 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.973 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 77.3 m-20 -63.79 -54.58 32.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HE2' ' HB ' ' A' ' 57' ' ' VAL . 43.7 mtpt -74.87 -40.83 60.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.06 -29.98 69.91 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.24 -52.41 0.48 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.515 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' HB3' ' HG3' ' A' ' 6' ' ' LYS . 15.5 mt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.354 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.663 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 2.1 p . . . . . 0 C--O 1.213 -0.82 0 CA-C-O 119.929 -0.081 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 48.9 tttp -44.89 -47.1 11.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -77.54 -33.35 54.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.905 177.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.663 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 16.4 m-20 -64.02 -52.24 60.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.504 HG13 ' CG2' ' A' ' 5' ' ' VAL . 30.2 mt -66.06 -47.09 86.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 45.6 ttp180 -55.26 -29.52 58.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.81 -44.49 96.12 Favored Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -67.57 -28.78 68.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.652 -0.774 . . . . 0.0 109.725 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 9' ' ' ILE . 71.3 mt -70.16 -43.03 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.4 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.496 HD13 ' HA ' ' A' ' 69' ' ' GLU . 13.5 mm -58.45 -48.83 84.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.004 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.16 -38.38 93.84 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.448 -0.882 . . . . 0.0 110.908 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.75 -34.02 73.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 0.0 110.694 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 30' ' ' LEU . 79.0 mt -83.9 -29.17 27.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.692 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.56 60.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.485 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.45 31.2 0.06 OUTLIER Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.994 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' CA ' ' HB3' ' A' ' 33' ' ' ALA . . . -114.45 -168.4 1.36 Allowed 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.957 0.408 . . . . 0.0 110.796 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.632 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 83.6 m-20 -59.32 -119.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.788 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -61.35 -171.16 0.04 OUTLIER Pre-proline 0 N--CA 1.454 -0.269 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 176.564 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.79 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.2 Cg_endo -70.89 64.21 2.46 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 120.72 1.293 . . . . 0.0 112.163 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.717 ' C ' ' CE1' ' A' ' 22' ' ' PHE . 50.2 mm 109.0 66.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.665 ' HB2' ' CB ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -65.42 65.85 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.881 -0.512 . . . . 0.0 111.449 178.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.601 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 51.4 p 57.48 158.97 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.716 ' O ' ' HB2' ' A' ' 31' ' ' MET . 51.5 Cg_exo -50.06 -33.33 34.43 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.344 1.362 . . . . 0.0 112.819 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -51.29 -57.32 9.16 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.64 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.665 ' CB ' ' HB2' ' A' ' 25' ' ' ASN . 45.7 tp10 -75.73 -58.53 3.23 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.614 ' HB2' HD21 ' A' ' 17' ' ' LEU . 3.5 pp -50.1 -40.16 44.92 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.716 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 29.9 ttm -63.53 -35.08 79.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.33 -30.91 69.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.303 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.516 ' HB3' ' CA ' ' A' ' 20' ' ' ALA . . . -65.34 -38.87 91.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.593 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' ' 30' ' ' LEU . 6.4 mp -39.53 134.55 1.24 Allowed Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.725 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 C--N 1.349 0.588 0 C-N-CA 123.393 2.729 . . . . 0.0 112.9 -179.275 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.431 ' CG2' ' HB3' ' A' ' 34' ' ' LEU . 6.2 t . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.373 0.13 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 3.1 t -114.99 124.21 51.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.033 0.444 . . . . 0.0 111.295 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 36.0 m -75.45 59.12 1.06 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.776 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.444 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 22.3 pttp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.679 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 55.3 mt-10 . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.724 0.297 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 2.6 mm? -127.88 130.15 48.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.63 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.609 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 19.1 ptpt -156.28 -165.87 2.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.582 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.477 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -78.61 -41.87 30.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.481 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.3 t -67.26 -55.61 13.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.709 0.29 . . . . 0.0 111.443 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -69.39 -44.4 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.793 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HB1' ' HB1' ' A' ' 79' ' ' ALA . . . -92.73 -51.63 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -53.53 -22.25 16.15 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.474 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -43.35 -31.98 0.75 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 117.114 0.457 . . . . 0.0 111.203 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -80.2 27.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.412 HD23 ' CG2' ' A' ' 74' ' ' THR . 19.1 mt -132.48 109.13 9.58 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 p -68.08 156.59 37.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.825 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.23 -37.99 17.38 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.077 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -52.56 -26.22 12.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.63 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.544 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -72.24 3.07 4.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.295 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.601 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.5 OUTLIER -39.05 -61.12 1.0 Allowed Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.334 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.87 77.08 3.16 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.483 2.122 . . . . 0.0 111.847 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -76.63 142.53 40.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.096 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.473 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 58.1 mtpt -68.68 66.7 0.13 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.377 0.608 . . . . 0.0 110.463 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.79 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 24.2 m 61.05 161.14 0.06 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.085 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.602 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.54 -30.22 19.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.499 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.496 ' HA ' HD13 ' A' ' 14' ' ' ILE . 22.1 pt-20 -59.17 -45.72 90.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.483 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.507 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -70.47 -34.39 72.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.247 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.688 HG21 HG13 ' A' ' 24' ' ' ILE . 67.2 t -63.61 -41.98 94.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.015 0.436 . . . . 0.0 110.09 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.66 -50.18 72.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.785 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.49 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 24.8 m-20 -67.8 -47.31 69.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.128 0.489 . . . . 0.0 110.746 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.412 ' CG2' HD23 ' A' ' 58' ' ' LEU . 90.8 m -54.71 -48.97 71.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.857 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.446 HD13 HG23 ' A' ' 75' ' ' ILE . 67.0 mt -60.95 -56.11 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.559 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 81' ' ' LEU . 15.7 m -58.82 -40.49 80.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 77.7 m-20 -62.88 -55.17 28.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.375 . . . . 0.0 111.715 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -72.76 -40.16 66.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.253 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.449 ' HB1' ' HB1' ' A' ' 54' ' ' ALA . . . -67.01 -29.97 69.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.66 -56.16 0.4 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.88 -1.152 . . . . 0.0 113.41 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 22.9 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.401 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.713 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p . . . . . 0 C--O 1.215 -0.748 0 CA-C-O 120.12 0.01 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 12.3 tmtt? -45.35 -51.67 10.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.9 -25.94 48.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.115 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.713 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 33.1 m-20 -67.86 -52.57 35.12 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.428 HG13 ' CG2' ' A' ' 5' ' ' VAL . 12.8 mt -65.7 -43.01 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.493 ' HD3' ' CG1' ' A' ' 76' ' ' VAL . 2.8 tpt180 -59.42 -29.07 67.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.62 -43.32 99.42 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 42' ' ' CYS . 6.4 tt0 -64.32 -29.01 70.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.334 177.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.439 ' CD1' ' CZ ' ' A' ' 10' ' ' ARG . 63.6 mt -74.37 -45.9 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.821 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 mm -56.42 -50.3 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.776 0.322 . . . . 0.0 110.329 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.47 -36.34 93.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.348 -0.93 . . . . 0.0 110.892 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 12' ' ' GLN . . . -65.07 -27.22 68.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.222 -0.489 . . . . 0.0 111.251 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.516 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 49.9 mt -84.13 -26.22 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.72 61.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.381 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.458 ' C ' ' HB3' ' A' ' 33' ' ' ALA . . . 174.14 35.02 0.04 OUTLIER Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.495 ' CB ' ' HB1' ' A' ' 33' ' ' ALA . . . -106.0 -175.97 2.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 110.99 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.571 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 53.4 m-20 -52.72 -66.97 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.742 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -116.86 -174.33 0.27 Allowed Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.819 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.7 Cg_endo -68.86 59.09 1.18 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-N 120.512 1.218 . . . . 0.0 111.987 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.754 HG13 HG23 ' A' ' 71' ' ' VAL . 24.7 mm 110.76 61.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.6 ' CB ' ' HB3' ' A' ' 29' ' ' GLU . 2.7 m120 -64.14 64.42 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.561 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.2 p 58.66 150.73 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.576 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 72.3 Cg_exo -46.77 -31.68 11.05 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.639 1.559 . . . . 0.0 112.984 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -55.54 -57.68 10.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.614 0.721 . . . . 0.0 110.338 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.6 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.0 tp10 -74.42 -57.08 4.17 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.557 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.576 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.3 pp -49.96 -36.54 28.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.571 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 55.2 mtm -64.04 -37.59 87.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.98 -24.55 65.16 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.477 0.656 . . . . 0.0 109.771 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.495 ' HB1' ' CB ' ' A' ' 20' ' ' ALA . . . -63.88 -50.83 67.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.653 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.42 ' HG ' ' HB2' ' A' ' 16' ' ' ALA . 6.1 mp -43.25 139.18 2.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.361 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 C--N 1.349 0.58 0 C-N-CA 123.842 3.028 . . . . 0.0 113.151 -179.586 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.871 0.367 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.487 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 7.3 m -82.74 115.09 21.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.433 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.464 ' HB3' ' NE2' ' A' ' 12' ' ' GLN . 32.3 m -89.2 50.56 1.96 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.018 0.437 . . . . 0.0 110.383 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.5 pttm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.975 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.447 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 51.0 mt-10 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.786 0.327 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -135.24 137.26 42.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.672 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.487 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 63.6 pttt -175.87 155.6 1.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.645 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.45 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.62 -39.39 16.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.05 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.6 t -63.53 -49.85 71.89 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.437 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.19 -53.86 11.37 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.443 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -92.23 -46.51 7.69 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.93 -29.54 2.12 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.089 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -45.27 -30.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.507 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -77.16 27.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 43.2 mt -133.18 117.24 17.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.889 0.376 . . . . 0.0 110.096 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.5 p -74.55 159.52 32.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.161 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.89 -37.58 31.94 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.085 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -50.97 -29.73 13.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.104 0.478 . . . . 0.0 110.06 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.544 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.5 m-20 -72.64 3.84 4.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.533 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.5 t80 -39.84 -51.8 5.33 Favored Pre-proline 0 C--O 1.226 -0.147 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 81.4 Cg_endo -87.74 77.31 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.832 2.355 . . . . 0.0 112.131 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.583 ' CG ' HG21 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.18 143.46 39.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.215 0.531 . . . . 0.0 111.87 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -68.28 70.8 0.17 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.742 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.819 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 21.7 m 57.04 163.66 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.203 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.89 -31.97 30.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.201 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -57.26 -49.17 76.9 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.541 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -72.49 -34.69 67.84 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.084 -179.475 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.754 HG23 HG13 ' A' ' 24' ' ' ILE . 62.1 t -65.19 -37.02 79.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.817 0.341 . . . . 0.0 111.145 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.468 ' HA ' ' NE ' ' A' ' 10' ' ' ARG . . . -65.35 -55.4 18.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.973 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.44 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.5 m-20 -66.32 -44.85 82.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.66 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.3 m -53.92 -47.65 70.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.76 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.443 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 76.8 mt -62.98 -53.13 50.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.522 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.493 ' CG1' ' HD3' ' A' ' 10' ' ' ARG . 1.8 m -53.99 -39.33 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.6 m-20 -60.07 -51.92 67.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 0.0 111.753 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -74.88 -40.11 61.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.81 -30.01 70.09 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.93 -54.81 0.4 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.553 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 8.7 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.099 -178.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.716 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.7 p . . . . . 0 C--O 1.214 -0.788 0 N-CA-C 111.161 0.059 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 12.8 tmtt? -45.34 -51.14 11.49 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -77.78 -27.97 50.39 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.066 177.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.716 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 72.6 m-20 -65.59 -52.38 52.58 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.462 HG13 ' CG2' ' A' ' 5' ' ' VAL . 16.7 mt -65.41 -43.28 94.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 1.1 tpt180 -60.16 -25.73 65.77 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.42 -45.18 87.69 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 178.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.437 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 63.7 mt-30 -64.39 -31.58 72.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.768 -0.716 . . . . 0.0 109.774 178.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.459 ' CD1' ' CZ ' ' A' ' 10' ' ' ARG . 73.6 mt -73.88 -45.24 50.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.964 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.0 mm -55.54 -53.33 37.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.784 0.326 . . . . 0.0 110.305 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.09 -34.59 88.53 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.479 ' HB2' ' HG ' ' A' ' 34' ' ' LEU . . . -65.46 -26.76 68.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.052 -0.574 . . . . 0.0 111.189 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.646 HD23 ' HB2' ' A' ' 30' ' ' LEU . 51.5 mt -80.21 -29.53 38.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.434 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.2 134.38 56.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.002 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.1 -32.25 6.06 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.898 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.573 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -52.44 -174.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.031 0.443 . . . . 0.0 111.592 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.574 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.5 m-20 -60.23 -120.31 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.788 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -62.14 -169.59 0.03 OUTLIER Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.597 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.802 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 60.3 Cg_endo -71.61 62.08 2.91 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 CA-C-N 120.888 1.353 . . . . 0.0 112.305 178.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.776 HG13 HG21 ' A' ' 71' ' ' VAL . 48.5 mm 110.59 65.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 177.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.68 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -65.68 66.26 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.976 -0.452 . . . . 0.0 111.328 178.031 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.526 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 53.9 p 59.39 156.02 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.565 ' O ' ' HB2' ' A' ' 31' ' ' MET . 64.9 Cg_exo -49.17 -33.73 28.55 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.45 1.433 . . . . 0.0 112.948 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.51 -54.46 36.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.04 0.448 . . . . 0.0 110.697 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.68 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 17.4 tp10 -75.93 -57.57 3.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.646 ' HB2' HD23 ' A' ' 17' ' ' LEU . 3.9 pp -50.03 -39.79 42.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.565 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 72.0 mtm -66.67 -32.97 74.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.51 -28.35 68.49 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 121.215 0.531 . . . . 0.0 110.253 179.018 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.573 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -70.28 -46.9 63.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.94 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 31' ' ' MET . 8.9 mp -33.73 139.39 0.27 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 112.186 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 C--N 1.346 0.419 0 C-N-CA 124.014 3.142 . . . . 0.0 114.417 -178.045 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.862 0.363 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.475 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 16.8 m -81.58 118.55 22.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.265 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 61.7 m -92.34 43.79 1.14 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.256 0.55 . . . . 0.0 109.553 178.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 23.9 pttm . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.919 -179.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.476 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 7.5 mp0 . . . . . 0 N--CA 1.461 0.114 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -141.11 140.81 34.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.094 0.473 . . . . 0.0 111.347 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 61.7 pttt -178.21 152.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.369 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.574 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.57 -30.74 3.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.005 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.3 t -69.57 -55.89 8.86 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.644 -179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 43.2 m-20 -72.41 -51.9 18.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.79 -45.57 12.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.1 -28.49 1.92 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.207 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 18.1 pt20 -43.7 -31.82 0.87 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.038 0.447 . . . . 0.0 111.329 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.8 m -77.09 27.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.667 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 43.4 mt -132.3 108.37 9.17 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.3 p -66.97 155.95 37.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.849 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.63 -37.69 13.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.229 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.67 -26.46 13.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.606 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.618 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -73.21 3.17 6.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.37 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.526 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.0 OUTLIER -41.13 -61.91 1.19 Allowed Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 117.682 0.219 . . . . 0.0 111.35 -179.337 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 63.3 Cg_endo -72.67 73.95 2.83 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.441 2.094 . . . . 0.0 111.963 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.618 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -76.77 141.58 40.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.431 -179.44 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.52 ' HB3' ' CG ' ' A' ' 70' ' ' GLU . 41.4 ttmt -67.8 69.07 0.11 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.398 0.618 . . . . 0.0 110.706 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.802 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 31.5 m 59.37 161.42 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.962 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.702 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.61 -29.81 18.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.757 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.432 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.0 pt-20 -58.63 -46.03 87.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.532 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.52 ' CG ' ' HB3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -73.96 -35.48 64.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.891 -179.562 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.776 HG21 HG13 ' A' ' 24' ' ' ILE . 45.7 t -62.87 -40.8 90.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.968 0.413 . . . . 0.0 110.417 179.433 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.423 ' HA ' ' NE ' ' A' ' 10' ' ' ARG . . . -61.73 -55.67 27.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.168 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.433 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 27.8 m-20 -64.11 -43.91 93.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.43 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.8 m -53.79 -46.95 71.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.926 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 71' ' ' VAL . 81.0 mt -64.79 -49.95 77.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.735 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.472 HG13 HH11 ' A' ' 10' ' ' ARG . 1.3 m -55.77 -38.22 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.272 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.9 m-20 -63.24 -52.78 60.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 0.0 111.396 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -72.68 -41.77 64.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.999 -179.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.3 -29.87 69.57 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.15 -54.11 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.982 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 16.0 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.193 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.719 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.4 p . . . . . 0 C--O 1.216 -0.696 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 46.9 tttm -45.67 -51.07 12.87 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.617 -0.833 . . . . 0.0 108.947 -179.325 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.78 -25.99 49.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.057 177.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.719 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 72.6 m-20 -68.18 -52.56 33.02 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.441 HG23 HD12 ' A' ' 9' ' ' ILE . 14.4 mt -66.02 -42.4 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 3.0 tpt180 -59.84 -27.18 66.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.7 177.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.02 -44.37 95.99 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 178.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.415 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 68.5 mt-30 -64.1 -27.68 69.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.439 177.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.468 ' CG2' ' NH2' ' A' ' 10' ' ' ARG . 64.4 mt -74.8 -50.25 26.32 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.86 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mm -53.77 -49.14 59.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.0 -36.67 93.79 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 178.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HB2' ' HG ' ' A' ' 34' ' ' LEU . . . -63.63 -27.99 69.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.857 179.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 30' ' ' LEU . 71.6 mt -78.8 -29.46 44.88 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.503 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.32 136.5 43.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.114 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.12 -33.5 6.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.814 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.556 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -50.8 -179.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 111.467 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.57 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 71.3 m-20 -58.25 -122.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.249 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.72 ' CG ' ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -62.66 -174.99 0.11 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 177.071 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.847 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 48.9 Cg_endo -66.55 61.78 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 CA-C-N 120.103 1.072 . . . . 0.0 112.723 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.772 HG13 ' HA ' ' A' ' 68' ' ' ALA . 36.6 mm 108.24 64.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 177.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.659 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.5 m120 -63.9 65.14 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.303 -0.248 . . . . 0.0 111.55 178.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.599 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 58.2 p 59.5 151.79 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.635 ' O ' ' HB2' ' A' ' 31' ' ' MET . 73.7 Cg_exo -46.88 -29.69 8.56 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.53 1.486 . . . . 0.0 112.642 -179.102 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.04 -57.12 13.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.511 0.672 . . . . 0.0 110.565 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.659 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 17.1 tp10 -73.39 -57.23 4.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.017 -179.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.662 ' HB2' HD21 ' A' ' 17' ' ' LEU . 3.9 pp -50.89 -38.21 48.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.635 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 61.0 mtm -67.13 -31.99 72.82 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.98 -29.69 67.96 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.65 179.266 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.556 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -71.48 -38.74 71.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.43 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 31' ' ' MET . 10.9 mp -38.37 143.77 0.41 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 121.158 0.504 . . . . 0.0 112.093 -178.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 C--N 1.35 0.608 0 C-N-CA 124.013 3.142 . . . . 0.0 114.361 -178.048 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.443 HG21 ' HB3' ' A' ' 34' ' ' LEU . 9.4 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.863 0.363 . . . . 0.0 111.337 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.474 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 10.9 m -82.38 126.37 32.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.357 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.9 m -93.61 47.63 1.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.04 0.448 . . . . 0.0 110.217 178.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.443 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.3 pttm . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.156 -179.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.443 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 26.5 mt-10 . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.761 0.315 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -138.64 137.18 36.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.183 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 61.6 pttt -177.66 157.92 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.735 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.483 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.86 -37.81 14.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.937 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.4 t -61.77 -51.96 66.16 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.376 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -72.41 -54.22 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . . . -91.51 -44.42 9.1 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.87 -28.44 1.73 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.938 -179.307 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -44.3 -31.49 1.04 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.007 0.432 . . . . 0.0 110.813 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.9 m -76.96 27.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.352 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.8 mt -134.35 92.06 2.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.913 0.387 . . . . 0.0 110.354 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.9 p -55.7 155.92 5.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.83 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.17 -36.62 8.85 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.384 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -50.81 -30.26 13.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.422 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.551 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 53.3 m-20 -72.71 3.81 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.747 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.599 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.0 t80 -38.0 -52.07 3.0 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.481 0.182 . . . . 0.0 111.396 -178.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 80.0 Cg_endo -86.39 78.42 2.09 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.681 2.254 . . . . 0.0 111.83 179.155 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.569 ' CG ' HG21 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -76.69 143.35 40.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.005 0.431 . . . . 0.0 111.741 -179.37 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.51 ' HB2' ' CD ' ' A' ' 70' ' ' GLU . 14.4 mmmm -67.17 70.68 0.1 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.634 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.847 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 47.5 m 58.73 158.74 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.69 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.772 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.83 -28.04 14.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.922 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.8 pt-20 -59.53 -47.39 85.71 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.419 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.51 ' CD ' ' HB2' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -72.04 -37.32 69.74 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.758 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.758 HG23 HG13 ' A' ' 24' ' ' ILE . 43.6 t -59.76 -36.28 65.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.98 0.419 . . . . 0.0 110.799 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.484 ' HA ' ' NE ' ' A' ' 10' ' ' ARG . . . -67.94 -57.83 5.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.442 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.404 ' HA ' ' CG2' ' A' ' 76' ' ' VAL . 1.5 m-20 -63.83 -42.29 97.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.701 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.8 m -54.01 -52.63 60.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.744 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.419 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 84.5 mt -60.03 -50.45 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.583 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.509 ' CG1' ' HD3' ' A' ' 10' ' ' ARG . 2.8 m -58.43 -39.75 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.32 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -52.96 -56.08 18.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.33 . . . . 0.0 110.936 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 80' ' ' GLY . 51.1 mtpt -75.08 -39.1 61.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.163 0.506 . . . . 0.0 110.886 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . . . -68.87 32.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -179.164 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 78' ' ' LYS . . . 88.97 -53.36 3.96 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.566 179.062 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.7 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.157 -178.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.732 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.5 p . . . . . 0 C--O 1.215 -0.753 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 40.7 tttm -44.94 -51.7 9.48 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.105 -178.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -77.84 -27.19 49.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.077 177.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.732 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 72.7 m-20 -67.22 -52.29 42.89 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.471 HG13 ' CG2' ' A' ' 5' ' ' VAL . 14.0 mt -63.81 -43.44 97.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.708 ' HD2' HG11 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -60.46 -26.48 66.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.582 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.2 -42.04 99.48 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 177.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -64.33 -28.76 69.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.362 177.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.437 ' CD1' ' CZ ' ' A' ' 10' ' ' ARG . 67.5 mt -74.38 -46.06 44.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.234 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.4 mm -56.99 -53.7 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.636 0.255 . . . . 0.0 110.525 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.47 -36.71 92.97 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HB2' ' HG ' ' A' ' 34' ' ' LEU . . . -63.94 -27.3 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.08 -0.56 . . . . 0.0 110.92 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.608 HD22 ' HB2' ' A' ' 30' ' ' LEU . 61.6 mt -79.64 -29.45 40.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.448 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.96 136.66 57.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.002 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.07 -33.11 6.35 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.774 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.556 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -50.79 -179.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.807 0.337 . . . . 0.0 111.493 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.593 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 73.1 m-20 -59.98 -121.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.739 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -58.99 177.35 0.25 Allowed Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 176.44 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.78 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 43.5 Cg_endo -64.26 67.63 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 119.897 0.999 . . . . 0.0 112.105 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.709 ' C ' ' CE1' ' A' ' 22' ' ' PHE . 44.4 mm 105.89 61.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 178.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.593 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.6 m120 -64.1 65.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 178.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 63.5 p 57.37 156.5 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.573 ' O ' ' CB ' ' A' ' 31' ' ' MET . 54.2 Cg_exo -50.43 -32.26 33.55 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.438 1.425 . . . . 0.0 112.829 -179.011 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -53.49 -57.35 10.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.452 0.644 . . . . 0.0 110.3 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.591 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -76.02 -57.98 3.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -179.272 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.608 ' HB2' HD22 ' A' ' 17' ' ' LEU . 3.8 pp -50.56 -43.72 56.39 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 30.7 ttm -65.52 -30.69 71.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.95 -29.69 66.88 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.597 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.556 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -67.76 -40.32 84.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.087 -179.414 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.1 mp -25.34 135.43 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.568 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.001 -179.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 C--N 1.349 0.566 0 C-N-CA 123.588 2.859 . . . . 0.0 115.279 -178.182 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.418 HG23 ' HB3' ' A' ' 34' ' ' LEU . 5.7 t . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.984 0.421 . . . . 0.0 111.767 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.42 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 32.2 m -100.29 121.96 42.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.902 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -92.79 46.57 1.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 110.014 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.432 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 20.8 ptmt . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.938 -179.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.432 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 38.4 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.628 0.251 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -138.5 138.95 38.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.05 0.452 . . . . 0.0 110.968 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.42 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 60.7 pttt -177.46 153.64 0.93 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.446 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.575 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.49 -29.24 2.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.809 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.401 ' HA ' ' HE2' ' A' ' 31' ' ' MET . 44.4 t -71.18 -56.06 6.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.663 0.268 . . . . 0.0 111.585 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -72.28 -54.42 9.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.35 . . . . 0.0 111.922 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.413 ' HB1' ' CG2' ' A' ' 75' ' ' ILE . . . -78.34 -48.08 16.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.936 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.39 -26.91 5.31 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.37 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -40.21 -35.97 0.46 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.555 0.693 . . . . 0.0 111.024 179.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.0 m -79.14 27.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.021 -177.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.7 mt -130.21 109.9 11.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.934 0.397 . . . . 0.0 110.057 179.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.6 p -70.81 157.24 38.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.885 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.81 -36.89 12.52 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.754 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -51.32 -29.45 15.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.163 179.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.515 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.3 m-20 -72.23 3.34 4.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.597 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.522 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.0 t80 -38.37 -51.71 3.4 Favored Pre-proline 0 C--O 1.227 -0.09 0 N-CA-C 111.308 0.114 . . . . 0.0 111.308 -178.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 87.0 Cg_endo -88.08 81.45 1.03 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.837 2.358 . . . . 0.0 112.046 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.534 ' CB ' HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -76.93 141.8 40.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.875 -179.855 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.528 ' CA ' ' HG2' ' A' ' 70' ' ' GLU . 47.6 mmtm -68.53 66.54 0.12 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.531 0.682 . . . . 0.0 110.516 179.005 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.78 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 15.4 m 61.34 160.93 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.197 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.645 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.46 -31.09 22.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.889 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.6 pt-20 -59.86 -47.01 87.47 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.331 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.528 ' HG2' ' CA ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -67.61 -33.38 74.88 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.36 -179.77 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.658 HG21 HG13 ' A' ' 24' ' ' ILE . 94.5 t -59.14 -47.08 91.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.922 0.391 . . . . 0.0 110.394 179.223 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.448 ' O ' ' CD ' ' A' ' 10' ' ' ARG . . . -56.71 -55.11 38.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.311 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.442 ' O ' HG22 ' A' ' 76' ' ' VAL . 1.5 m-20 -64.47 -36.36 83.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.585 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.4 m -65.95 -49.35 68.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.026 -179.211 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 71' ' ' VAL . 74.1 mt -59.88 -49.7 82.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.705 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.708 HG11 ' HD2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -57.49 -40.24 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.247 179.861 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -62.93 -54.7 34.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.876 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -74.06 -40.33 62.88 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.97 -29.91 69.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.12 -51.5 0.52 Allowed Glycine 0 CA--C 1.509 -0.342 0 C-N-CA 119.817 -1.182 . . . . 0.0 113.16 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.8 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.349 -178.837 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.69 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 2.1 p . . . . . 0 C--O 1.212 -0.894 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.452 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 11.2 tmtt? -45.37 -49.03 13.37 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -77.37 -30.31 53.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.043 177.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.69 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 71.9 m-20 -66.44 -52.32 47.63 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.551 HG21 ' NH2' ' A' ' 10' ' ' ARG . 17.7 mt -62.26 -51.07 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.178 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.775 HH11 HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -57.96 -25.58 61.18 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.369 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.42 -38.58 94.99 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 177.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -68.82 -35.26 76.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.383 -0.908 . . . . 0.0 110.569 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.609 HD11 ' NE ' ' A' ' 10' ' ' ARG . 11.7 mt -69.91 -43.75 79.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.4 mm -54.51 -52.46 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.717 0.294 . . . . 0.0 110.612 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.01 -37.25 94.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.935 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.52 -25.02 67.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.22 -0.49 . . . . 0.0 111.365 179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.554 HD23 ' HB2' ' A' ' 30' ' ' LEU . 33.4 mt -85.82 -29.37 23.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.978 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.64 81.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.719 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.83 -35.8 0.13 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.921 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 30' ' ' LEU . . . -53.03 -173.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.182 0.515 . . . . 0.0 111.904 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.554 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.7 OUTLIER -60.25 -119.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.018 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.735 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.97 179.79 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 177.033 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.752 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 47.9 Cg_endo -65.23 65.34 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 120.801 1.001 . . . . 0.0 112.358 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.797 HG13 HG23 ' A' ' 71' ' ' VAL . 28.6 mm 107.78 62.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 177.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.587 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.7 m120 -63.98 64.16 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.327 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 15.7 p 59.1 152.65 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.586 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 77.8 Cg_exo -48.0 -30.47 13.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.46 1.44 . . . . 0.0 112.707 -179.245 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -54.72 -57.49 11.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.492 0.663 . . . . 0.0 110.289 179.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.587 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.3 tp10 -76.11 -57.85 3.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.054 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.586 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.5 pp -50.29 -45.53 54.53 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.554 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 33.8 ttm -66.05 -29.78 70.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.56 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.08 -30.12 68.37 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.501 ' HB3' ' N ' ' A' ' 20' ' ' ALA . . . -72.73 -38.92 67.28 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 30' ' ' LEU . 7.1 mp -27.92 128.12 0.21 Allowed Pre-proline 0 N--CA 1.47 0.563 0 CA-C-O 120.949 0.404 . . . . 0.0 111.79 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 C--N 1.349 0.591 0 C-N-CA 123.569 2.846 . . . . 0.0 114.071 -178.396 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.897 0.38 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.7 m -105.92 115.8 30.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -89.46 44.03 1.18 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.098 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.539 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.3 pttp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.255 -179.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.539 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 121.288 0.566 . . . . 0.0 111.813 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -136.6 141.07 43.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.366 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HE3' ' HB3' ' A' ' 52' ' ' SER . 61.6 pttt -173.4 -168.81 0.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.937 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.535 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -65.58 -46.14 80.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.867 0.365 . . . . 0.0 111.576 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.439 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.1 t -69.99 -44.45 69.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.69 0.281 . . . . 0.0 111.495 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -67.34 -53.05 32.98 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.822 0.344 . . . . 0.0 111.906 -179.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.462 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -96.2 -44.05 7.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.468 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.64 -30.67 2.28 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.425 -178.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -46.93 -33.96 5.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.105 0.479 . . . . 0.0 110.987 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.6 -31.1 52.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.548 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.6 mt -66.66 125.39 25.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.773 0.32 . . . . 0.0 110.639 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.8 p -75.63 155.79 35.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.289 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.18 -42.09 60.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.332 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.63 -23.25 26.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.963 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.632 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 14.5 m-20 -67.89 3.16 1.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.593 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -41.03 -56.04 4.39 Favored Pre-proline 0 C--O 1.226 -0.184 0 CA-C-N 117.837 0.289 . . . . 0.0 111.673 -178.949 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 2.0 Cg_endo -80.33 76.92 4.27 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.897 2.398 . . . . 0.0 112.017 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.632 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.8 OUTLIER -77.16 142.0 39.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.488 -179.752 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 38.4 mtmm -67.89 70.5 0.14 Allowed 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.455 0.645 . . . . 0.0 110.419 178.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.752 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 28.9 m 58.43 161.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.162 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.674 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.67 -26.85 9.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.888 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.9 pt-20 -59.2 -50.46 73.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.652 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.5 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -72.65 -32.26 65.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.976 -179.418 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.797 HG23 HG13 ' A' ' 24' ' ' ILE . 57.9 t -61.98 -40.82 88.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.724 0.297 . . . . 0.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.0 -52.19 57.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.551 ' O ' HG23 ' A' ' 76' ' ' VAL . 32.1 m-20 -64.49 -37.44 87.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.011 0.434 . . . . 0.0 111.202 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.3 m -58.09 -41.93 84.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.442 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.462 HG23 ' CB ' ' A' ' 54' ' ' ALA . 63.5 mt -62.1 -53.72 44.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.134 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.775 HG12 HH11 ' A' ' 10' ' ' ARG . 2.5 m -56.94 -43.35 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 78.0 m-20 -62.6 -53.72 50.44 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -74.0 -42.41 60.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.078 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.56 -30.08 69.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.25 -55.77 0.42 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 119.936 -1.125 . . . . 0.0 113.144 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.484 ' HB2' HG11 ' A' ' 76' ' ' VAL . 21.7 mt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.405 -178.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.715 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.7 p . . . . . 0 C--O 1.213 -0.865 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 79.8 tttt -44.83 -51.08 9.88 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.362 -0.836 . . . . 0.0 109.211 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.6 -29.5 51.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.956 177.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.715 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 72.0 m-20 -64.48 -52.13 59.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.13 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.468 HG13 ' CG2' ' A' ' 5' ' ' VAL . 12.1 mt -63.16 -46.41 95.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HD3' ' CG1' ' A' ' 76' ' ' VAL . 1.8 tpt180 -57.19 -25.94 59.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.166 177.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.37 -48.34 70.11 Favored Glycine 0 CA--C 1.505 -0.531 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -62.63 -29.08 70.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.807 -0.696 . . . . 0.0 109.343 177.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.428 ' CD1' ' CZ ' ' A' ' 10' ' ' ARG . 59.7 mt -70.4 -45.53 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.801 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.1 mm -53.69 -48.54 60.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.66 -37.4 94.33 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.816 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.61 -27.81 69.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.918 0.39 . . . . 0.0 110.978 179.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.606 HD22 ' HB2' ' A' ' 30' ' ' LEU . 54.1 mt -80.69 -29.56 36.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.378 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.04 135.12 56.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.005 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.38 -33.17 5.67 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.723 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.566 ' N ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.29 -175.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.931 0.396 . . . . 0.0 111.509 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.569 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.26 -122.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.896 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.822 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -59.93 -173.42 0.05 OUTLIER Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 176.685 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.85 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 58.1 Cg_endo -69.33 61.52 1.5 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 CA-C-N 120.453 1.197 . . . . 0.0 112.592 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.769 HG13 HG23 ' A' ' 71' ' ' VAL . 43.4 mm 111.98 65.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 177.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.655 ' ND2' ' CD2' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -64.31 65.68 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.085 -0.385 . . . . 0.0 111.534 178.132 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.543 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 54.0 p 58.89 155.01 0.09 OUTLIER Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.644 ' O ' ' HB2' ' A' ' 31' ' ' MET . 54.4 Cg_exo -49.29 -33.71 29.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.236 1.291 . . . . 0.0 112.887 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.04 -56.28 17.33 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.074 0.464 . . . . 0.0 110.787 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.632 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.5 tp10 -74.54 -57.72 3.75 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.296 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.606 ' HB2' HD22 ' A' ' 17' ' ' LEU . 3.8 pp -49.79 -39.76 39.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.644 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 65.4 mtm -64.4 -34.85 79.12 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.77 -26.55 65.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.681 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.566 ' HB2' ' N ' ' A' ' 20' ' ' ALA . . . -71.09 -43.24 68.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.667 -179.318 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.536 ' HB3' HG21 ' A' ' 40' ' ' THR . 10.1 mp -37.33 138.91 0.55 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 112.274 -178.406 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 C--N 1.35 0.625 0 C-N-CA 123.869 3.046 . . . . 0.0 113.518 -178.904 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.536 HG21 ' HB3' ' A' ' 34' ' ' LEU . 7.8 t . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.656 0.265 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.498 ' HB ' ' HD3' ' A' ' 50' ' ' LYS . 2.6 t -97.91 123.31 41.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.034 0.445 . . . . 0.0 111.28 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.407 ' HB2' HG21 ' A' ' 9' ' ' ILE . 33.3 m -72.14 64.32 0.54 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.764 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.44 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 21.7 ptmt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.667 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.44 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 37.3 mt-10 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.751 0.31 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -137.7 134.5 35.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.324 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 19.6 pttm -163.73 -164.67 0.93 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' O ' ' CA ' ' A' ' 55' ' ' GLY . . . -78.1 -41.09 36.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.051 0.453 . . . . 0.0 111.317 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.418 ' HB3' ' HE2' ' A' ' 50' ' ' LYS . 39.1 t -63.87 -45.5 89.13 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.647 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.429 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 8.0 t70 -72.21 -52.79 14.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.352 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.431 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -96.34 -48.42 5.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -178.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -44.77 -28.37 1.66 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.73 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -43.89 -32.55 1.13 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.039 0.447 . . . . 0.0 111.563 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.4 m -65.51 -33.15 61.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.886 -179.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.1 mt -70.3 124.42 24.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.437 179.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.403 ' OG1' ' OD1' ' A' ' 62' ' ' ASP . 80.4 p -80.8 -176.38 5.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.897 0.38 . . . . 0.0 111.551 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.77 79.54 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.711 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -53.33 -23.99 10.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.615 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -71.04 3.2 3.58 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.543 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.2 m-85 -42.58 -64.59 0.68 Allowed Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.584 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 59.5 Cg_endo -71.01 74.94 1.79 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.436 2.091 . . . . 0.0 111.949 179.271 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.615 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.4 OUTLIER -77.04 141.61 40.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.833 -179.349 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 23.4 ttmm -67.22 70.37 0.1 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.804 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.85 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.7 m 58.19 162.35 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.164 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.631 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.69 -31.35 25.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.659 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.6 pt-20 -56.24 -48.41 76.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.589 -179.587 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.559 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -73.1 -36.99 66.88 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.974 -179.6 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.769 HG23 HG13 ' A' ' 24' ' ' ILE . 61.9 t -61.46 -34.34 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.453 ' HA ' ' NE ' ' A' ' 10' ' ' ARG . . . -68.94 -58.22 4.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.365 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -64.1 -42.32 96.95 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.99 0.424 . . . . 0.0 111.571 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.2 m -55.37 -48.09 74.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.651 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 71' ' ' VAL . 82.6 mt -63.05 -51.58 69.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.883 -179.256 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.469 ' CG1' ' HD3' ' A' ' 10' ' ' ARG . 1.5 m -54.05 -43.61 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.818 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -57.55 -49.55 75.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.748 0.309 . . . . 0.0 111.381 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -73.55 -41.11 63.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.827 -179.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.427 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . . . -67.39 -30.23 69.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.506 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.91 -55.43 0.43 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.419 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.462 ' HB3' ' HG3' ' A' ' 6' ' ' LYS . 16.8 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.174 -0.917 . . . . 0.0 111.308 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.499 -0.241 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' SER . . . . . 0.428 ' O ' ' CG ' ' A' ' -1' ' ' HIS . 47.6 t -59.74 137.62 58.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.748 0.309 . . . . 0.0 110.938 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' -2' ' ' SER . 92.5 m-70 -158.96 132.27 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.671 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt -66.07 -48.19 71.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.23 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp 61.86 128.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.911 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.8 mmm -68.72 -54.32 16.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.907 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.09 -38.06 0.85 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.466 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.68 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.8 p -66.69 -5.77 3.74 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 5' ' ' VAL . 54.1 tttm -45.05 -46.63 11.55 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.093 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -77.54 -32.88 54.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.829 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.68 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -64.86 -52.07 58.62 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.507 HG13 ' CG2' ' A' ' 5' ' ' VAL . 31.2 mt -65.48 -46.21 90.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 51.5 ttp85 -55.87 -30.53 61.68 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.49 -40.4 97.65 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.419 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 73.3 mt-30 -68.77 -31.17 70.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.688 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.6 mt -71.36 -45.82 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.068 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.199 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 69' ' ' GLU . 8.6 mm -57.87 -52.97 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.514 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.99 -36.61 93.28 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.387 -0.911 . . . . 0.0 110.941 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 12' ' ' GLN . . . -62.67 -29.79 70.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.285 -0.457 . . . . 0.0 111.103 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 30' ' ' LEU . 55.1 mt -81.26 -29.41 34.4 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.665 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.29 131.5 48.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.73 -34.74 4.62 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.716 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.528 ' N ' ' HB3' ' A' ' 33' ' ' ALA . . . -50.95 -179.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.576 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.562 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 73.0 m-20 -59.35 -120.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.704 ' CE1' ' C ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -59.92 178.53 0.24 Allowed Pre-proline 0 N--CA 1.455 -0.195 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.776 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.0 Cg_endo -65.38 65.65 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 119.799 0.964 . . . . 0.0 112.482 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.824 HG13 HG23 ' A' ' 71' ' ' VAL . 34.2 mm 107.57 61.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.585 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 3.0 m120 -64.35 65.07 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.577 ' HB3' ' CG ' ' A' ' 63' ' ' PHE . 60.6 p 57.48 156.52 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.596 ' O ' ' CB ' ' A' ' 31' ' ' MET . 54.2 Cg_exo -49.89 -32.65 30.82 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.397 1.398 . . . . 0.0 112.692 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -52.76 -57.68 9.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.35 0.595 . . . . 0.0 110.292 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.585 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.8 tp10 -76.41 -58.09 3.48 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.579 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.6 pp -50.59 -44.8 57.06 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.596 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 30.6 ttm -65.08 -31.06 72.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.37 -31.45 70.83 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.822 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.528 ' HB3' ' N ' ' A' ' 20' ' ' ALA . . . -69.84 -38.67 76.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.343 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 31' ' ' MET . 8.5 mp -26.91 129.75 0.18 Allowed Pre-proline 0 N--CA 1.47 0.54 0 CA-C-O 120.973 0.416 . . . . 0.0 111.881 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.99 -28.49 69.25 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.711 2.941 . . . . 0.0 114.274 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.729 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 6.9 t30 -72.01 -27.26 62.62 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.65 -73.42 0.41 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.898 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 84.1 Cg_endo -84.31 46.53 1.98 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.775 2.317 . . . . 0.0 112.172 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.507 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER 66.31 95.01 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.429 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.729 ' HB ' ' HB3' ' A' ' 36' ' ' ASN . 10.0 t -66.79 145.01 55.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.525 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 31.1 m -106.51 121.34 44.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 59.7 m -86.85 46.26 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.001 0.429 . . . . 0.0 110.821 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.402 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 18.7 ptpt -75.83 149.98 37.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.7 m -151.53 126.89 9.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.614 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.0 -51.59 0.95 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.742 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 47' ' ' VAL . 2.7 p30 -171.17 -40.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 0.0 110.39 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.417 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 40.3 t -66.98 139.09 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.613 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.402 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 35.3 mt-10 -125.79 132.53 52.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.36 . . . . 0.0 110.946 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -142.31 139.62 31.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.935 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 41' ' ' THR . 59.8 pttt -173.8 -176.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.719 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -66.33 -42.59 87.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.819 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.402 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.0 t -67.7 -52.38 38.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 30.0 m-20 -71.1 -49.78 40.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 50' ' ' LYS . . . -87.65 -47.01 9.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.89 -26.8 2.11 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.373 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 16.2 pt20 -41.94 -36.89 1.18 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.08 0.467 . . . . 0.0 111.774 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.4 m -65.51 -33.17 61.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.032 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 28.3 mt -68.31 124.49 23.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.642 0.258 . . . . 0.0 110.56 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.4 ' OG1' ' OD1' ' A' ' 62' ' ' ASP . 72.1 p -84.1 -173.81 4.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.797 0.332 . . . . 0.0 111.551 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.06 -44.71 91.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.568 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -55.59 -23.98 30.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 111.118 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.56 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -64.54 -9.8 21.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.577 ' CG ' ' HB3' ' A' ' 26' ' ' SER . 2.6 m-85 -39.82 -70.97 0.15 Allowed Pre-proline 0 N--CA 1.464 0.231 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 50.7 Cg_endo -67.76 74.38 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.034 1.823 . . . . 0.0 112.079 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.08 143.96 38.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.12 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.527 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 99.2 mttt -68.94 68.4 0.16 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.475 0.655 . . . . 0.0 110.56 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.776 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 25.5 m 59.51 161.48 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.979 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.646 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.67 -30.59 22.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.817 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HA ' HD11 ' A' ' 14' ' ' ILE . 11.0 pt-20 -57.67 -48.43 79.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.441 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.543 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -71.1 -33.03 69.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.875 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.824 HG23 HG13 ' A' ' 24' ' ' ILE . 92.2 t -64.83 -41.85 93.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.852 0.358 . . . . 0.0 110.857 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.35 73.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.825 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.417 ' O ' HG22 ' A' ' 76' ' ' VAL . 56.3 m-20 -68.43 -37.5 80.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.391 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.3 m -66.8 -51.95 49.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.043 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 71' ' ' VAL . 76.0 mt -58.08 -51.9 65.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.489 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 5.3 m -56.22 -39.21 58.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -61.5 -53.15 60.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.728 0.299 . . . . 0.0 111.332 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -69.24 -40.54 77.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.57 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.17 -29.77 69.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.72 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.17 -55.1 0.43 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.787 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.5 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.023 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 80.2 p -178.53 -45.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 0.0 110.821 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -61.1 -39.97 91.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.822 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt -158.34 64.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.749 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.475 ' N ' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -45.04 -42.12 8.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.081 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.45 ' HG2' ' HG2' ' A' ' 2' ' ' LYS . 95.2 mmm -117.78 -49.33 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.802 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.36 -43.3 1.29 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.675 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.695 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.9 p -69.27 -5.9 5.5 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 86.1 tttt -45.32 -48.0 13.15 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.015 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -77.59 -31.22 52.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.816 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.695 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 22.7 m-20 -65.2 -52.26 55.91 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.489 HG13 ' CG2' ' A' ' 5' ' ' VAL . 22.5 mt -66.79 -46.5 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 46.4 ttp85 -56.39 -28.07 58.18 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.19 -42.91 94.04 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 66.9 mt-30 -67.07 -32.55 73.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.876 -0.662 . . . . 0.0 109.737 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.0 mt -70.33 -43.33 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.804 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' A' ' 69' ' ' GLU . 13.3 mm -58.06 -54.09 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.244 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.54 -36.85 93.66 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . . . -60.88 -28.43 68.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.109 -0.545 . . . . 0.0 110.936 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' HB3' ' CD1' ' A' ' 24' ' ' ILE . 52.7 mt -87.6 -29.66 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.282 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.16 85.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.838 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.94 -36.0 0.19 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.17 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.513 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -52.77 -174.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 112.116 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.612 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.0 m-20 -59.96 -119.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.704 ' CE2' ' HA ' ' A' ' 25' ' ' ASN . 0.3 OUTLIER -58.52 174.21 0.37 Allowed Pre-proline 0 CA--C 1.519 -0.212 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 176.273 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.864 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 44.6 Cg_endo -63.27 66.63 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 120.916 1.077 . . . . 0.0 112.242 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.695 HG13 HG23 ' A' ' 71' ' ' VAL . 20.2 mm 109.52 59.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.704 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.5 m120 -63.37 66.75 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 25' ' ' ASN . 85.5 p 56.28 153.64 0.07 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.716 ' O ' ' HB2' ' A' ' 31' ' ' MET . 76.1 Cg_exo -47.29 -32.88 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.512 1.475 . . . . 0.0 113.176 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -53.31 -57.46 10.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.339 0.59 . . . . 0.0 110.387 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.561 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.4 tp10 -76.25 -57.52 3.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.6 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.3 pp -49.97 -42.54 49.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.716 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 62.2 mtm -68.75 -29.98 68.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.64 -31.04 70.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.899 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.513 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -74.23 -38.57 63.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.102 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.508 ' HG ' ' HB3' ' A' ' 16' ' ' ALA . 8.0 mp -34.66 140.03 0.29 Allowed Pre-proline 0 N--CA 1.466 0.341 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -47.78 -34.83 22.46 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.248 2.632 . . . . 0.0 113.225 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.489 ' CB ' ' HB ' ' A' ' 40' ' ' THR . 10.3 t30 -72.24 -25.56 61.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.333 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.6 -73.34 0.21 Allowed Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.622 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.682 ' O ' ' HB3' ' A' ' 31' ' ' MET . 71.7 Cg_endo -75.27 -42.47 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.313 2.009 . . . . 0.0 111.536 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.416 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.7 OUTLIER 168.25 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.288 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.489 ' HB ' ' CB ' ' A' ' 36' ' ' ASN . 8.9 t -54.42 134.75 45.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.188 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 23.8 m -86.64 118.17 25.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.092 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 68.4 m -92.87 44.76 1.16 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 109.776 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.502 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.1 pttp -75.62 126.06 30.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.119 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.9 m -102.94 118.56 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.16 -128.94 42.8 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.118 -1.039 . . . . 0.0 111.772 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -76.01 -38.67 57.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.895 0.379 . . . . 0.0 111.559 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 48' ' ' GLU . 37.5 t -66.78 141.45 17.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.545 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.502 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 75.6 mt-10 -132.37 130.84 41.21 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.104 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -141.0 138.53 33.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.513 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 60.8 pttt -175.14 153.64 1.64 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.641 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.66 -28.3 2.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.624 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.403 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 44.1 t -70.82 -55.5 8.38 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.311 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -72.44 -54.32 9.65 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.4 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -82.48 -42.89 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.86 -25.81 1.02 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.491 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -41.66 -36.76 1.02 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.132 0.492 . . . . 0.0 111.583 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.53 -33.41 63.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.128 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.3 mt -68.85 119.83 13.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.703 0.287 . . . . 0.0 110.231 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.412 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 76.8 p -85.44 -175.31 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.711 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.67 -43.34 84.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.298 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 3.1 p30 -51.29 -26.63 7.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.918 0.389 . . . . 0.0 110.819 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.533 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 59.4 m-20 -73.26 3.73 5.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.707 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.526 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 1.4 t80 -42.63 -52.22 10.98 Favored Pre-proline 0 C--O 1.224 -0.262 0 O-C-N 122.588 -0.07 . . . . 0.0 111.15 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 97.6 Cg_endo -89.65 78.15 0.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.194 2.596 . . . . 0.0 111.187 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.2 OUTLIER -76.9 142.8 39.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.156 -178.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 22.9 tptm -69.66 65.41 0.21 Allowed 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.122 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.864 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 49.8 m 63.63 160.0 0.09 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.638 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.58 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.97 -27.34 13.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.938 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HA ' HD11 ' A' ' 14' ' ' ILE . 11.2 pt-20 -65.36 -38.78 91.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.075 0.464 . . . . 0.0 109.832 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 7.9 tp10 -68.01 -46.42 71.3 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.94 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.695 HG23 HG13 ' A' ' 24' ' ' ILE . 47.0 t -65.11 -43.17 95.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.516 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.17 -45.47 79.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.979 0.418 . . . . 0.0 110.25 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -70.3 -40.18 74.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.095 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.8 m -63.13 -50.15 71.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.069 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.4 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 67.0 mt -61.41 -52.47 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.702 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 7.1 m -58.52 -38.64 71.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -62.33 -56.79 15.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.748 0.308 . . . . 0.0 111.676 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -69.5 -38.97 77.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.74 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.84 -29.89 69.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.009 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.42 -55.87 0.42 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.006 -1.092 . . . . 0.0 113.291 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.1 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.339 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.641 -0.184 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 47.6 t -60.5 -46.25 90.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.93 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 62.77 134.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptp -60.45 141.43 56.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.45 123.27 16.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.567 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.2 mtt -86.49 144.26 27.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.448 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.68 -18.07 29.9 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.469 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.642 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.6 p -55.75 -5.64 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 84.8 tttt -44.31 -44.15 7.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.913 0.779 . . . . 0.0 109.417 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.4 -35.58 54.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.666 177.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.642 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 48.6 m-20 -64.02 -51.83 62.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.513 HG13 ' CG2' ' A' ' 5' ' ' VAL . 37.0 mt -65.12 -45.89 92.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 50.1 ttp180 -55.34 -30.41 60.22 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.53 -41.78 97.76 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 65.0 mt-30 -66.18 -29.86 70.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.692 -0.754 . . . . 0.0 109.735 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.6 mt -70.35 -45.58 74.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.962 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.1 mm -56.74 -52.96 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.512 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.82 -37.15 92.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.073 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 12' ' ' GLN . . . -60.47 -30.53 69.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.202 -0.499 . . . . 0.0 111.172 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.682 HD21 ' HB2' ' A' ' 30' ' ' LEU . 59.5 mt -82.74 -29.45 29.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.932 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.52 132.81 54.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.049 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.13 -33.89 5.22 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.964 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.568 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -51.95 -176.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 111.567 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.571 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.1 m-20 -60.9 -121.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.712 ' CE1' ' C ' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -59.56 176.81 0.29 Allowed Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.746 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.3 Cg_endo -64.69 69.05 0.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 CA-C-N 119.773 0.954 . . . . 0.0 112.281 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.712 ' C ' ' CE1' ' A' ' 22' ' ' PHE . 51.5 mm 106.47 61.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.571 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.8 m120 -65.24 64.96 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 59.1 p 57.06 157.46 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.614 ' O ' ' CB ' ' A' ' 31' ' ' MET . 52.0 Cg_exo -50.9 -32.23 36.98 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.293 1.328 . . . . 0.0 112.86 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -52.71 -57.61 9.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.442 0.639 . . . . 0.0 110.421 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.571 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 41.8 tp10 -76.15 -58.15 3.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.682 ' HB2' HD21 ' A' ' 17' ' ' LEU . 3.9 pp -50.62 -42.95 56.67 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.614 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 30.0 ttm -63.27 -33.07 74.71 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.92 -28.32 66.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.835 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.568 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -71.16 -36.9 72.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.591 HD23 ' HA ' ' A' ' 39' ' ' ASP . 10.3 mp -27.27 137.0 0.1 Allowed Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 121.094 0.473 . . . . 0.0 112.185 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -50.15 -41.17 50.38 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.249 3.299 . . . . 0.0 115.638 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.469 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -71.9 -25.44 61.92 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.447 -0.501 . . . . 0.0 112.236 -177.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . 104.3 -66.19 0.31 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.664 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.469 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 93.0 Cg_endo -83.54 47.3 2.3 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.636 2.224 . . . . 0.0 113.009 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.591 ' HA ' HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER 64.53 93.31 0.06 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.642 0.258 . . . . 0.0 111.234 179.131 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.476 HG23 ' HB3' ' A' ' 34' ' ' LEU . 15.2 t -75.96 137.33 40.24 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.775 0.321 . . . . 0.0 111.519 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.8 m -92.55 123.9 36.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.719 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.9 m -92.04 45.53 1.22 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.974 0.416 . . . . 0.0 110.73 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -75.53 151.38 37.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.025 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.3 m -150.55 127.28 10.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.81 -59.4 0.35 Allowed Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.082 -0.508 . . . . 0.0 113.038 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -159.56 -43.36 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 110.407 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.402 HG12 HD23 ' A' ' 49' ' ' LEU . 40.5 t -66.74 137.54 24.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.683 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -124.35 131.19 53.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.988 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.402 HD23 HG12 ' A' ' 47' ' ' VAL . 3.6 mm? -141.72 133.74 27.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.605 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -165.48 -177.55 4.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.735 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.553 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -66.56 -40.52 89.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.715 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -67.01 -59.92 3.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -68.84 -54.09 17.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.758 0.313 . . . . 0.0 111.691 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.56 -50.51 25.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.74 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -49.02 -26.49 6.01 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.412 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -41.21 -43.55 2.37 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.944 0.878 . . . . 0.0 110.943 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.407 ' HB ' ' HE2' ' A' ' 78' ' ' LYS . 10.4 m -66.01 -32.64 59.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.326 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 21.1 mt -68.9 116.84 9.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.819 0.343 . . . . 0.0 110.588 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.51 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 71.8 p -71.5 155.9 40.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.196 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.16 -39.98 45.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.323 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -53.44 -25.44 16.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.595 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 61.8 m-20 -70.57 3.47 3.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.541 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -38.64 -63.65 0.56 Allowed Pre-proline 0 N--CA 1.462 0.139 0 CA-C-N 117.895 0.316 . . . . 0.0 110.958 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 73.4 Cg_endo -74.55 79.0 2.61 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.469 2.113 . . . . 0.0 111.88 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.595 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -76.83 144.29 39.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.301 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.501 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 75.2 mmtt -70.21 65.88 0.28 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.465 0.65 . . . . 0.0 110.047 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.746 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 20.2 m 61.52 160.36 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.02 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.584 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.45 -28.11 12.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.657 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 16.2 pt-20 -60.95 -48.44 81.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.376 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.501 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -67.9 -32.14 72.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.021 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.652 HG22 HG13 ' A' ' 24' ' ' ILE . 80.5 t -62.27 -41.29 90.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 110.45 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.27 -51.03 71.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.987 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.53 -39.02 85.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.258 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.8 m -65.18 -51.65 59.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.956 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.455 HD11 HG22 ' A' ' 75' ' ' ILE . 57.4 mt -57.15 -54.58 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.767 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 5.7 m -57.14 -40.04 70.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.52 -53.28 44.58 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HE2' ' HB ' ' A' ' 57' ' ' VAL . 50.2 mtpt -73.33 -39.52 65.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 111.885 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.84 -29.96 70.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.72 -55.98 0.37 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.117 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.3 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.32 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.571 -0.211 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 80.1 p -59.9 -44.96 93.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.928 0.394 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . 0.525 ' O ' ' O ' ' A' ' 1' ' ' MET . 21.2 p-80 -174.23 132.56 0.4 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.718 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' O ' ' O ' ' A' ' -1' ' ' HIS . 24.8 ptt? 49.0 122.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.951 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.468 ' NZ ' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -68.84 -55.48 11.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.832 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.5 tpp 178.27 -55.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.528 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.59 -49.79 0.43 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.748 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.704 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.6 p -74.66 -6.01 7.84 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 82.7 tttt -45.17 -47.76 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.008 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.75 -31.94 52.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.901 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.704 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -64.33 -52.17 59.75 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.502 HG13 ' CG2' ' A' ' 5' ' ' VAL . 28.9 mt -67.39 -46.18 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 48.3 ttp180 -55.45 -29.77 59.29 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.73 -43.53 93.98 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.419 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 69.3 mt-30 -66.9 -30.38 70.52 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.86 -0.67 . . . . 0.0 109.766 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.4 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 73.3 mt -70.52 -43.46 77.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.744 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.488 HD13 ' HA ' ' A' ' 69' ' ' GLU . 11.3 mm -57.61 -53.69 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.32 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.56 -36.4 92.43 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.405 -0.902 . . . . 0.0 110.855 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.457 ' HB2' ' HG ' ' A' ' 34' ' ' LEU . . . -60.55 -31.82 70.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.151 -0.524 . . . . 0.0 110.952 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.567 ' HB3' ' CD1' ' A' ' 24' ' ' ILE . 55.4 mt -82.12 -29.47 31.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.775 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.0 130.83 48.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.918 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.16 -34.37 4.48 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.879 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.555 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -52.06 -176.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.815 0.341 . . . . 0.0 111.594 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.585 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.6 m-20 -60.02 -119.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.713 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.79 178.39 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.797 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 48.9 Cg_endo -65.08 67.85 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.754 0.948 . . . . 0.0 112.131 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.799 HG13 HG22 ' A' ' 71' ' ' VAL . 44.3 mm 105.96 62.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.585 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.9 m120 -65.7 64.41 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.624 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 52.6 p 57.07 160.47 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.635 ' O ' ' HB2' ' A' ' 31' ' ' MET . 52.2 Cg_exo -52.56 -33.16 56.9 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.339 1.359 . . . . 0.0 112.971 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -52.48 -57.89 8.47 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.238 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.581 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 41.3 tp10 -76.6 -58.57 3.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.556 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.9 pp -50.65 -45.35 57.82 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.635 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 23.0 ttm -64.17 -31.49 72.7 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -70.28 -28.67 65.39 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.128 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.555 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -70.04 -37.45 75.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.725 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.551 ' HB3' HG22 ' A' ' 40' ' ' THR . 11.2 mp -31.78 145.6 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.112 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -47.54 -42.23 29.19 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.664 2.91 . . . . 0.0 113.973 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.43 ' ND2' ' N ' ' A' ' 40' ' ' THR . 0.1 OUTLIER -72.25 -18.65 61.8 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.614 -179.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . 108.66 -67.2 0.23 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.468 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 72.9 Cg_endo -79.82 -52.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.432 2.088 . . . . 0.0 113.791 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.55 ' HA ' HD23 ' A' ' 34' ' ' LEU . 12.0 p-10 -178.88 90.1 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.843 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 34' ' ' LEU . 12.9 t -71.76 136.99 47.34 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.832 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.472 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 25.4 m -91.61 125.87 36.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.972 0.415 . . . . 0.0 111.588 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.7 m -100.47 48.52 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.777 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.442 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 10.2 ptpp? -75.34 153.72 37.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.841 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.9 m -150.09 128.11 11.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.434 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.51 -131.55 47.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.26 -0.972 . . . . 0.0 111.298 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.54 26.71 3.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 0.0 110.801 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.404 ' CG1' ' CD2' ' A' ' 49' ' ' LEU . 49.1 t -127.9 145.72 34.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.141 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.442 ' HG2' ' HB2' ' A' ' 43' ' ' LYS . 23.6 mt-10 -142.06 125.1 16.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.497 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.404 ' CD2' ' CG1' ' A' ' 47' ' ' VAL . 3.7 mm? -140.64 140.57 35.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.039 0.447 . . . . 0.0 110.811 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.472 ' HD3' ' HA ' ' A' ' 41' ' ' THR . 59.5 pttt -173.54 170.81 4.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.719 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.549 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -59.65 -30.7 68.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.545 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.425 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 42.5 t -75.66 -62.05 1.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.449 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 52.4 m-20 -66.4 -51.06 60.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.406 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -78.95 -46.44 18.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.67 -26.32 1.76 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.596 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 17.2 pt20 -41.21 -38.63 1.15 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.04 0.448 . . . . 0.0 111.808 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.407 HG22 ' CD ' ' A' ' 78' ' ' LYS . 34.8 m -65.72 -30.16 49.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.408 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.407 HD12 ' CZ ' ' A' ' 65' ' ' PHE . 19.1 mt -66.91 121.67 16.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.756 0.312 . . . . 0.0 110.42 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.7 p -74.67 155.77 37.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.44 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.67 58.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.229 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.82 -23.29 29.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.544 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 15.5 m-20 -67.59 3.31 1.42 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.624 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -40.57 -55.19 4.55 Favored Pre-proline 0 C--O 1.227 -0.086 0 CA-C-N 117.77 0.259 . . . . 0.0 111.575 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 2.2 Cg_endo -82.39 78.16 3.5 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.896 2.397 . . . . 0.0 111.783 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CB ' HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -77.02 142.13 40.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.266 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.66 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.69 66.9 0.13 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.76 0.79 . . . . 0.0 110.59 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.797 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 15.5 m 61.85 159.87 0.06 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.953 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.663 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.61 -32.55 29.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.794 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' HA ' HD13 ' A' ' 14' ' ' ILE . 10.9 pt-20 -59.07 -46.1 89.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.417 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.66 ' HG2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -68.08 -33.17 74.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.19 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.799 HG22 HG13 ' A' ' 24' ' ' ILE . 72.8 t -64.77 -44.72 96.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.649 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.11 -49.53 71.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.76 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.25 -39.84 78.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.294 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.1 m -63.21 -52.62 61.53 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.406 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 58.4 mt -59.87 -52.6 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.716 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 14.1 m -57.81 -41.24 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -61.68 -51.41 68.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 111.278 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.407 ' CD ' HG22 ' A' ' 57' ' ' VAL . 66.8 mttm -71.54 -42.08 68.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.676 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.04 69.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.778 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.14 -55.7 0.44 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.664 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 19.0 mt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.337 -0.84 . . . . 0.0 110.983 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 79.8 p -78.83 51.93 1.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.662 0.267 . . . . 0.0 111.38 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -56.3 -48.39 76.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt 52.32 48.06 23.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.482 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -86.57 36.38 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.424 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.8 ptm -77.18 127.08 31.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 110.991 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.93 -139.0 6.07 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.232 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.661 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p -77.22 -6.02 8.43 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 O-C-N 123.057 -0.084 . . . . 0.0 111.11 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 12.9 tmtt? -45.09 -46.41 11.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -77.57 -33.44 54.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.84 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.661 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 14.1 m-20 -64.21 -52.32 59.42 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.506 HG13 ' CG2' ' A' ' 5' ' ' VAL . 35.3 mt -66.62 -46.56 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 40.0 ttp180 -55.0 -29.76 58.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.32 -42.46 96.11 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.411 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 70.0 mt-30 -69.06 -30.71 69.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.991 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.7 mt -71.61 -45.18 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.045 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' A' ' 69' ' ' GLU . 10.6 mm -58.3 -52.01 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.262 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.39 -37.19 93.56 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.48 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -61.52 -28.54 69.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.946 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.597 HD23 ' HB2' ' A' ' 30' ' ' LEU . 45.7 mt -83.79 -29.56 27.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.874 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.52 126.02 25.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.815 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.66 -34.99 3.3 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.72 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.537 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -52.73 -175.04 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.913 0.387 . . . . 0.0 111.588 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.549 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.6 OUTLIER -61.58 -119.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.738 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.5 OUTLIER -59.45 179.21 0.21 Allowed Pre-proline 0 N--CA 1.454 -0.266 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 176.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.758 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.3 Cg_endo -64.97 67.21 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 CA-C-N 119.688 0.924 . . . . 0.0 112.179 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.842 HG13 HG22 ' A' ' 71' ' ' VAL . 41.9 mm 107.18 62.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.593 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.8 m120 -63.65 65.37 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 69.9 p 56.28 158.68 0.07 OUTLIER Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.688 ' O ' ' HB2' ' A' ' 31' ' ' MET . 50.7 Cg_exo -51.16 -34.23 47.25 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.316 1.344 . . . . 0.0 113.032 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -51.63 -57.68 8.49 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.38 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.588 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 43.7 tp10 -76.24 -58.11 3.48 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.597 ' HB2' HD23 ' A' ' 17' ' ' LEU . 3.8 pp -50.47 -43.95 55.53 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.688 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 23.5 ttm -64.03 -32.19 73.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.96 -29.53 66.67 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.042 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.537 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -68.81 -37.98 79.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.73 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 39' ' ' ASP . 11.2 mp -31.61 145.02 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.193 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -47.55 -41.85 29.54 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.635 2.89 . . . . 0.0 113.969 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.431 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -72.14 -18.73 61.86 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.57 -179.269 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . 108.25 -66.52 0.24 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.514 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 85.0 Cg_endo -80.47 -51.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.395 2.063 . . . . 0.0 113.959 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.558 ' HA ' HD21 ' A' ' 34' ' ' LEU . 47.2 p-10 -179.48 88.44 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.537 HG21 ' HB3' ' A' ' 34' ' ' LEU . 15.0 t -71.27 137.27 48.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.823 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 27.8 m -90.71 125.78 35.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 111.597 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.3 m -100.29 50.43 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.097 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 61.6 pttt -75.24 144.22 42.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.643 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.9 m -157.14 137.4 12.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.785 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.68 50.39 64.64 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.579 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 58.89 23.35 11.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.942 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.9 t -127.71 135.34 63.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.164 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.435 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 23.5 mt-10 -120.37 131.05 54.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.033 0.444 . . . . 0.0 111.473 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.407 ' CD2' ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -142.34 136.79 30.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.427 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 41' ' ' THR . 61.2 pttt -173.68 178.77 2.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.795 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.539 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -65.61 -39.71 91.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.836 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.401 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 45.3 t -66.83 -51.55 54.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.672 0.273 . . . . 0.0 111.704 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 38.8 m-20 -72.2 -51.42 21.25 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -88.39 -45.97 9.55 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.92 -27.52 1.48 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.203 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 16.0 pt20 -43.29 -35.62 1.54 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 111.333 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.9 m -65.51 -33.0 60.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.782 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.3 119.1 10.95 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 62' ' ' ASP . 76.2 p -77.26 155.89 31.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.754 0.312 . . . . 0.0 111.073 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.33 -40.21 11.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.593 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -53.86 -26.32 24.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.166 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.635 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -70.18 3.38 2.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.511 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -39.93 -65.33 0.44 Allowed Pre-proline 0 N--CA 1.463 0.217 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.156 -179.141 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 74.1 Cg_endo -74.06 78.26 2.6 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.307 2.005 . . . . 0.0 111.855 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.635 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.8 OUTLIER -76.8 143.65 39.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.246 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.494 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 75.1 mmtt -69.57 68.38 0.24 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.464 0.65 . . . . 0.0 110.05 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.758 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 31.8 m 59.66 160.96 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.976 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.682 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.47 -25.88 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.632 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 16.5 pt-20 -59.66 -48.86 80.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.43 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.498 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -74.13 -32.18 63.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.161 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.842 HG22 HG13 ' A' ' 24' ' ' ILE . 60.2 t -61.55 -46.93 95.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.399 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.85 -44.63 91.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.874 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 35.8 t70 -62.73 -42.62 99.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.337 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.6 m -63.76 -50.68 68.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.136 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.35 -52.58 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.542 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 73' ' ' ASP . 6.8 m -58.6 -43.52 87.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 74.4 m-20 -62.1 -54.1 46.13 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.619 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -69.88 -41.01 75.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 111.6 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.03 -29.92 69.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.734 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.25 -54.61 0.46 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.891 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 76' ' ' VAL . 17.7 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.073 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 53.3 m -61.25 133.43 55.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.337 . . . . 0.0 110.88 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . 0.405 ' O ' ' HB2' ' A' ' 1' ' ' MET . 67.8 t60 -62.83 -34.79 78.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.781 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' -1' ' ' HIS . 91.0 mmm 71.67 -53.82 0.68 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.781 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -70.28 165.69 21.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.627 0.251 . . . . 0.0 110.339 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.45 ' O ' ' HG3' ' A' ' 3' ' ' MET . 45.2 tpp -165.9 42.27 0.06 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.957 0.408 . . . . 0.0 111.014 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.67 -44.2 1.98 Allowed Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.632 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.657 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p -63.2 -6.15 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 116.958 0.379 . . . . 0.0 112.01 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -44.87 -45.27 10.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -77.16 -34.39 56.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.884 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.657 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -64.49 -51.86 60.84 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.515 HG13 ' CG2' ' A' ' 5' ' ' VAL . 35.0 mt -65.94 -50.13 72.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.7 OUTLIER -56.64 -29.28 62.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.14 -41.77 99.63 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.44 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 77.3 mt-30 -69.72 -31.98 70.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.455 -0.872 . . . . 0.0 110.195 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -71.06 -46.64 66.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.563 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 mm -58.72 -52.58 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.714 0.292 . . . . 0.0 110.401 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.85 -36.36 93.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.106 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.468 ' HB2' ' HG ' ' A' ' 34' ' ' LEU . . . -67.1 -25.03 66.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.279 -0.461 . . . . 0.0 111.547 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 30' ' ' LEU . 46.1 mt -82.31 -29.41 31.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.568 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.01 132.84 54.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.857 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.2 -33.93 5.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.674 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.574 ' N ' ' HB3' ' A' ' 33' ' ' ALA . . . -51.21 -179.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.375 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.551 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.6 m-20 -58.94 -119.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.739 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -61.22 179.24 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.306 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 176.268 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.806 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 46.7 Cg_endo -65.61 65.26 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 119.889 0.996 . . . . 0.0 112.291 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.769 HG13 HG23 ' A' ' 71' ' ' VAL . 31.9 mm 107.72 60.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.61 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.6 m120 -62.82 65.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.542 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 54.7 p 58.16 153.49 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 31' ' ' MET . 67.0 Cg_exo -48.26 -32.51 19.68 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.315 1.344 . . . . 0.0 112.628 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -52.88 -57.48 10.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.51 0.671 . . . . 0.0 110.503 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.61 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.4 tp10 -75.37 -57.8 3.67 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.556 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.4 pp -50.39 -41.59 52.27 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.64 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 37.0 ttm -64.61 -32.87 74.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -73.01 -23.17 60.59 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.574 ' HB3' ' N ' ' A' ' 20' ' ' ALA . . . -72.2 -49.71 33.35 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.469 ' C ' ' O ' ' A' ' 33' ' ' ALA . 7.9 mp -24.99 135.26 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -47.46 -35.25 21.29 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.916 3.077 . . . . 0.0 113.622 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.547 ' CB ' ' HB ' ' A' ' 40' ' ' THR . 4.5 t30 -72.23 -25.66 61.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.804 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.26 -76.44 0.23 Allowed Glycine 0 CA--C 1.516 0.125 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.615 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 94.3 Cg_endo -82.25 36.45 0.62 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.582 2.188 . . . . 0.0 111.469 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.627 ' HB2' ' CG ' ' A' ' 31' ' ' MET . 1.1 t70 66.88 100.93 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.202 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.547 ' HB ' ' CB ' ' A' ' 36' ' ' ASN . 1.8 t -63.74 131.17 47.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.879 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.405 ' CG2' ' OE2' ' A' ' 48' ' ' GLU . 17.3 m -76.74 127.37 32.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.722 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 57.4 m -112.28 45.81 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.88 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 60.2 pttt -75.65 125.69 29.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.6 m -103.12 124.88 49.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.65 -54.26 0.5 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.124 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 47' ' ' VAL . 36.9 p-10 -169.46 -40.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.761 0.315 . . . . 0.0 110.854 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.413 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 61.4 t -66.73 112.09 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.797 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 87.8 tt0 -91.32 131.81 36.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.135 0.493 . . . . 0.0 111.74 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -137.69 130.31 29.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.564 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.413 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 62.4 pttt -171.7 -161.37 0.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.879 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.481 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -74.31 -47.74 32.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.408 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.7 t -69.34 -50.87 42.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -69.2 -48.74 61.24 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 50' ' ' LYS . . . -95.66 -45.74 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -47.35 -28.47 4.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.84 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -43.38 -34.13 1.2 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.207 0.527 . . . . 0.0 111.357 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.412 HG22 ' HD3' ' A' ' 78' ' ' LYS . 30.5 m -65.51 -33.2 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.918 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.9 mt -64.72 125.28 24.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 110.681 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.5 p -77.39 155.87 31.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.261 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.57 -42.63 55.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.4 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -56.1 -22.66 29.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.858 0.361 . . . . 0.0 111.075 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.601 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 15.5 m-20 -68.3 3.3 1.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.546 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -40.57 -66.3 0.38 Allowed Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 117.943 0.338 . . . . 0.0 111.532 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.2 Cg_endo -70.44 76.06 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.373 2.049 . . . . 0.0 112.09 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.601 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -77.15 141.93 39.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.502 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.568 ' HE3' ' HA ' ' A' ' 66' ' ' LYS . 1.7 tpmt? -67.32 68.51 0.08 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.702 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.806 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 47.3 m 58.73 162.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.028 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.652 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.59 -26.23 8.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.949 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 23.1 pt-20 -60.23 -49.92 75.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.551 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.534 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -71.49 -35.59 70.85 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.655 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.769 HG23 HG13 ' A' ' 24' ' ' ILE . 55.8 t -63.19 -40.8 90.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.8 -51.65 68.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.985 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -67.09 -41.57 86.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.426 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.9 m -57.59 -50.1 74.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.677 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 71' ' ' VAL . 82.4 mt -60.13 -49.04 85.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.233 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 16.6 m -63.03 -41.87 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -58.59 -55.72 31.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.412 ' HD3' HG22 ' A' ' 57' ' ' VAL . 28.2 mtpp -71.89 -38.99 69.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 111.654 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.67 -29.69 69.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.563 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.1 -53.95 0.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.817 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.4 mt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.158 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 53.6 m -60.2 -44.38 95.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -63.78 -139.89 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.491 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 ttm 60.54 -118.57 0.8 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 38.4 ttpt -94.7 30.66 1.98 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.988 0.423 . . . . 0.0 110.696 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.6 mmt 60.07 127.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.541 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.1 -23.8 76.04 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.235 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.654 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p -60.08 -5.49 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 81.7 tttt -44.34 -46.17 9.18 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.418 -0.801 . . . . 0.0 109.276 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -77.43 -34.18 54.66 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.824 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.654 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -63.77 -51.92 62.68 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.505 HG13 ' CG2' ' A' ' 5' ' ' VAL . 33.6 mt -66.69 -46.81 84.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 45.0 ttp180 -55.11 -30.14 59.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.76 -42.85 94.98 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.408 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 71.3 mt-30 -68.9 -30.01 68.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.815 -0.692 . . . . 0.0 110.063 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.4 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 70.1 mt -71.29 -44.66 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.806 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' A' ' 69' ' ' GLU . 11.3 mm -57.67 -53.11 49.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.252 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.45 -36.02 92.07 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.807 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.463 ' HB2' ' HG ' ' A' ' 34' ' ' LEU . . . -60.85 -31.69 71.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.068 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.562 HD22 ' HB2' ' A' ' 30' ' ' LEU . 48.0 mt -81.49 -29.45 33.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.552 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.06 128.31 36.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.797 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.15 -36.16 3.28 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.537 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 33' ' ' ALA . . . -52.59 -175.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.025 0.44 . . . . 0.0 111.492 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.619 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -61.56 -127.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.71 ' CD2' ' ND2' ' A' ' 25' ' ' ASN . 0.2 OUTLIER -54.23 175.49 0.16 Allowed Pre-proline 0 CA--C 1.52 -0.209 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 176.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.785 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 35.3 Cg_endo -61.92 69.17 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 CA-C-N 119.814 0.969 . . . . 0.0 112.486 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.704 HG13 HG23 ' A' ' 71' ' ' VAL . 44.2 mm 105.68 64.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 177.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.71 ' ND2' ' CD2' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -65.77 63.89 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.142 -0.349 . . . . 0.0 111.367 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.63 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 39.1 p 57.98 160.31 0.09 OUTLIER Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.59 ' O ' ' CB ' ' A' ' 31' ' ' MET . 52.7 Cg_exo -52.65 -34.01 61.76 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.335 1.356 . . . . 0.0 113.042 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.44 -57.42 9.92 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.371 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.627 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -76.35 -58.34 3.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.62 HD21 HG23 ' A' ' 24' ' ' ILE . 3.9 pp -50.33 -45.76 55.12 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.59 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 27.7 ttm -64.26 -31.37 72.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.12 -30.66 68.98 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.854 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.503 ' HB3' ' CB ' ' A' ' 20' ' ' ALA . . . -69.28 -37.79 78.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.965 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.522 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.4 mp -32.75 140.34 0.21 Allowed Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.052 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.64 -33.33 18.15 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.534 2.822 . . . . 0.0 112.896 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.504 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 14.6 t30 -72.15 -25.73 61.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.588 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . 107.54 -69.53 0.22 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.079 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 83.6 Cg_endo -80.49 -45.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.581 2.188 . . . . 0.0 112.873 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.472 ' HB3' ' SD ' ' A' ' 31' ' ' MET . 11.3 p-10 179.26 76.61 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.898 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 36' ' ' ASN . 11.3 t -54.48 135.2 46.03 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.82 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 30.8 m -93.15 115.62 28.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.795 0.331 . . . . 0.0 111.302 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 73.7 m -92.65 46.62 1.25 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 109.955 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 24.2 pttm -75.62 124.14 26.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.093 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.4 m -98.92 120.49 39.45 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.33 -128.45 41.58 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.615 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -79.86 -37.13 35.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 111.411 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 48' ' ' GLU . 38.6 t -67.22 141.79 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.584 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.487 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 70.1 mt-10 -129.57 128.7 43.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.028 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.4 ' CD2' ' CG1' ' A' ' 47' ' ' VAL . 3.7 mm? -143.24 131.23 21.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 41' ' ' THR . 21.8 pttm -165.03 172.1 13.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.429 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.57 ' HB2' ' HG3' ' A' ' 31' ' ' MET . . . -59.38 -35.94 74.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.616 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.8 t -66.44 -58.4 5.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.41 ' O ' ' NE2' ' A' ' 56' ' ' GLN . 43.9 m-20 -71.84 -54.24 10.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.429 ' HB3' ' HB1' ' A' ' 79' ' ' ALA . . . -77.58 -46.02 23.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.76 -23.41 3.43 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.58 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.43 ' HG3' HG12 ' A' ' 57' ' ' VAL . 26.2 pt20 -42.52 -32.56 0.56 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.023 0.439 . . . . 0.0 111.447 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.433 HG21 ' HD2' ' A' ' 78' ' ' LYS . 34.0 m -78.33 27.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.415 HD11 ' CE2' ' A' ' 65' ' ' PHE . 39.8 mt -127.25 115.13 18.58 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.893 0.378 . . . . 0.0 110.046 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.8 p -67.52 155.88 38.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.958 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.06 -40.38 61.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.954 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -54.93 -23.47 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.669 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.521 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 13.4 m-20 -68.53 3.07 1.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.63 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.8 OUTLIER -39.43 -65.23 0.43 Allowed Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 117.81 0.277 . . . . 0.0 111.612 -179.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.9 Cg_endo -70.71 76.35 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.367 2.044 . . . . 0.0 112.093 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.545 ' CB ' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -77.02 140.46 40.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.84 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 22.8 tptm -66.0 67.64 0.05 OUTLIER 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.429 0.633 . . . . 0.0 110.608 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.785 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 34.6 m 60.19 159.88 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.962 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.643 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.57 -29.65 17.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.563 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HA ' HD11 ' A' ' 14' ' ' ILE . 10.9 pt-20 -58.88 -47.61 84.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.297 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.499 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -68.51 -35.73 77.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.204 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.704 HG23 HG13 ' A' ' 24' ' ' ILE . 89.8 t -61.92 -44.35 98.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 110.51 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.6 -49.49 72.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.964 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.414 ' O ' HG23 ' A' ' 76' ' ' VAL . 56.5 m-20 -69.86 -41.85 74.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.992 0.425 . . . . 0.0 111.21 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.4 m -59.33 -50.98 71.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.855 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 71' ' ' VAL . 69.3 mt -61.02 -52.98 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.397 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 13.5 m -60.35 -40.38 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -60.09 -54.16 49.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 111.417 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HD2' HG21 ' A' ' 57' ' ' VAL . 63.2 mttp -71.86 -41.11 68.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.86 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.429 ' HB1' ' HB3' ' A' ' 54' ' ' ALA . . . -67.1 -29.94 69.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.834 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.77 -55.8 0.44 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.676 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.8 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.141 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 39.5 t 69.0 -56.5 0.53 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.237 0.215 . . . . 0.0 111.529 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -62.11 132.85 54.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.856 0.36 . . . . 0.0 110.98 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -63.46 144.37 57.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.055 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.549 ' O ' ' O ' ' A' ' 3' ' ' MET . 88.3 tttt -176.8 -105.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.509 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.549 ' O ' ' O ' ' A' ' 2' ' ' LYS . 25.4 ptt? 49.26 128.2 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.347 0.594 . . . . 0.0 112.132 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.25 -136.21 3.18 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.318 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.729 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.8 p -71.86 -6.43 7.61 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 O-C-N 123.047 -0.09 . . . . 0.0 111.047 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 86.3 tttt -45.76 -50.66 13.67 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -78.0 -27.77 49.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.172 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.729 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 33.8 t70 -66.96 -52.56 41.37 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.491 HG13 ' CG2' ' A' ' 5' ' ' VAL . 19.5 mt -69.6 -45.86 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 5.7 tmm_? -55.21 -31.96 61.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.09 -43.35 98.88 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 68.0 mt-30 -63.41 -29.91 71.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.673 -0.763 . . . . 0.0 109.552 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.21 -42.39 78.97 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.923 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.3 mm -57.7 -53.26 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.343 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.4 -38.06 90.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.327 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -61.77 -28.35 69.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.055 0.455 . . . . 0.0 111.28 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 30' ' ' LEU . 48.0 mt -83.45 -29.57 27.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.526 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.11 129.85 43.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.76 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.42 -33.86 4.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.668 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.586 ' N ' ' HB3' ' A' ' 33' ' ' ALA . . . -52.85 -174.29 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 111.423 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.561 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 76.8 m-20 -60.31 -119.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.734 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -60.63 -179.99 0.21 Allowed Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.748 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 41.6 Cg_endo -66.17 65.94 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 120.089 1.068 . . . . 0.0 112.336 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.819 HG13 HG22 ' A' ' 71' ' ' VAL . 50.4 mm 108.01 60.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.592 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.6 m120 -62.45 66.82 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 59.7 p 57.16 154.18 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.658 ' O ' ' CB ' ' A' ' 31' ' ' MET . 54.3 Cg_exo -48.66 -32.82 22.57 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.096 1.198 . . . . 0.0 112.65 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -52.21 -57.37 9.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.473 0.654 . . . . 0.0 110.739 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.592 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 40.2 tp10 -74.71 -57.93 3.61 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.566 ' HB2' HD21 ' A' ' 17' ' ' LEU . 3.6 pp -50.56 -40.4 52.05 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.658 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 40.1 ttm -63.88 -33.24 75.26 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -75.44 -20.49 58.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.586 ' HB3' ' N ' ' A' ' 20' ' ' ALA . . . -75.91 -42.93 47.49 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 40' ' ' THR . 6.9 mp -27.96 147.17 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -47.2 -49.86 12.12 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.051 3.168 . . . . 0.0 115.478 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -14.05 61.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.31 -69.51 0.24 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.699 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.04 43.52 1.39 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.663 2.242 . . . . 0.0 112.746 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.658 ' HB2' ' CG ' ' A' ' 31' ' ' MET . 10.1 t70 61.68 96.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.368 0.604 . . . . 0.0 111.971 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.54 HG21 ' HB3' ' A' ' 34' ' ' LEU . 5.2 t -70.2 132.7 46.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.948 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.424 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 11.8 m -76.17 124.13 26.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.963 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.6 m -90.44 44.66 1.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.528 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.441 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.5 pttm -75.73 149.27 38.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.136 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.4 m -147.21 128.47 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.773 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.79 -51.06 0.89 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.87 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 47' ' ' VAL . 2.7 p30 -171.04 -39.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 110.436 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.417 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 41.4 t -66.83 137.93 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.746 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 28.1 mt-10 -122.45 135.3 54.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.816 0.341 . . . . 0.0 110.896 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -140.83 138.01 33.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.08 0.466 . . . . 0.0 110.952 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 21.6 pttp -174.74 166.07 3.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.705 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.492 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.84 -40.47 21.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.074 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.6 t -72.01 -43.7 64.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.412 ' O ' ' NE2' ' A' ' 56' ' ' GLN . 38.2 t70 -69.14 -54.11 16.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 111.853 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.454 ' CB ' HG22 ' A' ' 75' ' ' ILE . . . -96.28 -45.77 6.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.58 -30.04 2.04 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.361 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 53' ' ' ASP . 18.7 pt20 -51.52 -28.86 14.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.202 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 54' ' ' ALA . 31.9 m -78.26 27.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 74' ' ' THR . 38.2 mt -125.86 125.68 43.23 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.744 0.307 . . . . 0.0 110.332 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.9 p -67.88 155.72 38.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.599 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.08 -40.92 67.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.189 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -55.02 -22.26 14.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.0 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.587 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.6 m-20 -68.42 3.01 1.94 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.534 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.9 OUTLIER -41.12 -65.14 0.5 Allowed Pre-proline 0 N--CA 1.462 0.159 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.501 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.0 Cg_endo -71.35 76.79 1.74 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.293 1.995 . . . . 0.0 112.246 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.587 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.3 OUTLIER -77.05 143.19 39.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.66 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.11 68.67 0.12 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.637 0.732 . . . . 0.0 110.963 178.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.748 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 20.2 m 58.75 161.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.268 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.676 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.63 -30.96 23.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.857 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.401 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 16.3 pt-20 -58.46 -46.3 86.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.448 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.66 ' HG2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -71.0 -37.54 72.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.725 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.819 HG22 HG13 ' A' ' 24' ' ' ILE . 45.5 t -62.69 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.023 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HB3' ' CD ' ' A' ' 10' ' ' ARG . . . -56.63 -48.45 77.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.066 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.414 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.3 m-20 -65.52 -45.28 84.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.839 0.352 . . . . 0.0 111.028 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.435 ' OG1' ' OE1' ' A' ' 70' ' ' GLU . 27.0 m -59.86 -44.65 94.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.624 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.454 HG22 ' CB ' ' A' ' 54' ' ' ALA . 66.2 mt -57.26 -51.52 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.399 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 14.9 m -60.33 -37.11 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 78.4 m-20 -63.31 -58.16 8.04 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.409 ' CD ' HG22 ' A' ' 57' ' ' VAL . 64.3 mttp -69.48 -38.96 77.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.427 ' HB2' ' CB ' ' A' ' 54' ' ' ALA . . . -66.75 -29.95 70.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.242 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.21 -55.88 0.42 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.236 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.5 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 19.5 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.257 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 2' ' ' LYS . 80.3 p -178.26 37.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -86.69 138.3 31.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.259 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt 64.71 58.07 1.02 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.448 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.432 ' HD3' ' HA ' ' A' ' -2' ' ' SER . 22.3 ptmt -176.26 142.43 0.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.938 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -157.42 133.11 9.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.523 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.5 -132.3 1.97 Allowed Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.872 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.678 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.6 p -70.04 -6.32 6.55 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 CA-C-N 116.677 0.238 . . . . 0.0 110.925 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -45.29 -46.53 12.76 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' OE2' ' HD2' ' A' ' 6' ' ' LYS . 9.5 mp0 -77.74 -31.63 52.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.934 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.678 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 65.4 m-20 -65.61 -52.35 52.66 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.477 HG13 ' CG2' ' A' ' 5' ' ' VAL . 31.1 mt -68.33 -46.1 81.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.585 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.3 OUTLIER -56.89 -29.96 63.48 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.58 -43.68 96.16 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 82.7 mt-30 -63.95 -30.23 71.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.711 -0.744 . . . . 0.0 109.665 177.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.2 mt -70.5 -42.54 78.25 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.059 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.839 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 69' ' ' GLU . 10.4 mm -57.17 -52.75 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.413 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.7 86.3 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.186 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.473 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . . . -60.98 -27.88 68.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.975 0.416 . . . . 0.0 111.094 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.563 HD23 ' HB2' ' A' ' 30' ' ' LEU . 54.6 mt -85.78 -29.41 23.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.939 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.98 129.09 38.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.098 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.92 -34.49 4.17 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.836 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.587 ' N ' ' HB3' ' A' ' 33' ' ' ALA . . . -51.87 -178.05 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.843 0.354 . . . . 0.0 111.613 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.556 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -61.18 -119.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.714 ' CE2' ' HA ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -58.73 174.43 0.37 Allowed Pre-proline 0 CA--C 1.519 -0.242 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 176.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.86 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 39.3 Cg_endo -63.32 67.01 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.843 0.98 . . . . 0.0 112.292 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.777 HG13 HG23 ' A' ' 71' ' ' VAL . 24.0 mm 109.4 60.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.714 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.6 m120 -62.78 65.85 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 25' ' ' ASN . 81.5 p 56.76 156.7 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.655 ' O ' ' HB2' ' A' ' 31' ' ' MET . 52.1 Cg_exo -49.5 -34.47 33.65 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.299 1.332 . . . . 0.0 113.15 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.03 -57.1 10.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.327 0.584 . . . . 0.0 110.647 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.585 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.2 tp10 -76.0 -57.51 3.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.563 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.6 pp -49.9 -41.12 45.13 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.655 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 64.3 mtm -65.72 -33.82 76.77 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.45 -28.31 68.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.605 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.587 ' HB3' ' N ' ' A' ' 20' ' ' ALA . . . -72.6 -40.73 66.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.618 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.571 HD21 ' HA ' ' A' ' 39' ' ' ASP . 10.4 mp -35.18 145.21 0.2 Allowed Pre-proline 0 N--CA 1.467 0.407 0 CA-C-O 121.137 0.494 . . . . 0.0 112.326 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -47.44 -41.96 28.74 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 124.07 3.18 . . . . 0.0 114.38 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.464 ' N ' HD21 ' A' ' 36' ' ' ASN . 0.1 OUTLIER -71.85 -16.98 62.16 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.82 -67.43 0.23 Allowed Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.94 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.601 ' O ' ' HB3' ' A' ' 31' ' ' MET . 60.7 Cg_endo -77.09 -53.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.249 1.966 . . . . 0.0 112.529 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.571 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER 172.78 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.87 0.468 . . . . 0.0 110.587 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 34' ' ' LEU . 9.9 t -68.35 135.28 51.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.873 0.368 . . . . 0.0 111.181 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.454 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 6.7 m -81.0 127.82 33.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.7 m -95.55 43.71 1.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 110.368 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.458 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -75.6 156.19 35.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.134 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.7 m -153.33 129.48 10.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.349 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.49 -52.52 0.65 Allowed Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.171 -0.537 . . . . 0.0 113.225 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -168.44 -40.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.976 0.417 . . . . 0.0 110.242 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.63 135.29 28.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.543 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 32.8 mt-10 -123.42 131.4 53.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -141.63 139.37 33.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.848 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 59.6 pttt -176.97 153.94 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.81 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.64 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.8 -27.22 1.94 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.659 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.9 t -67.26 -62.51 1.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.067 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -72.55 -54.32 9.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.915 0.388 . . . . 0.0 111.787 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.406 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -71.76 -45.3 62.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.812 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.91 -27.83 1.57 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.711 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -41.91 -36.69 1.13 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.795 0.807 . . . . 0.0 110.434 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.424 HG23 ' CD ' ' A' ' 78' ' ' LYS . 16.3 m -83.07 28.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.28 -1.327 . . . . 0.0 112.243 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.41 HD23 ' CG2' ' A' ' 74' ' ' THR . 36.1 mt -137.91 76.9 1.6 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.943 0.402 . . . . 0.0 110.38 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.9 p -49.08 174.92 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.247 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.02 73.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.551 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -50.69 -28.44 9.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.629 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 52.8 m-20 -75.47 3.46 9.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.338 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.678 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -43.78 -71.34 0.16 Allowed Pre-proline 0 N--CA 1.462 0.157 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.248 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 56.4 Cg_endo -68.39 77.65 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.023 1.816 . . . . 0.0 111.303 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.568 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -77.1 144.59 38.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.138 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 62.1 mttp -70.37 64.36 0.27 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.106 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.86 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 55.7 m 63.93 160.2 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.575 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.517 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.92 -27.09 11.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.893 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HA ' HD13 ' A' ' 14' ' ' ILE . 15.3 pt-20 -65.43 -38.92 91.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.969 0.414 . . . . 0.0 109.969 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 6.8 tp10 -67.73 -46.23 72.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.927 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.777 HG23 HG13 ' A' ' 24' ' ' ILE . 42.1 t -66.36 -45.65 88.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.821 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.426 ' CB ' ' HD3' ' A' ' 10' ' ' ARG . . . -55.33 -45.05 76.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.009 0.433 . . . . 0.0 110.352 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -69.82 -43.5 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.69 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.41 ' CG2' HD23 ' A' ' 58' ' ' LEU . 72.6 m -57.74 -46.93 83.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.298 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 71' ' ' VAL . 70.6 mt -58.23 -54.95 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.959 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 15.2 m -58.5 -43.93 87.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.836 0.309 . . . . 0.0 111.836 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -62.52 -54.14 44.33 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' CD ' HG23 ' A' ' 57' ' ' VAL . 98.6 mttt -72.07 -41.16 67.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 75' ' ' ILE . . . -67.04 -29.98 69.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.062 0.394 . . . . 0.0 112.062 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.49 -56.36 0.39 Allowed Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.049 -1.072 . . . . 0.0 113.223 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 14.0 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.08 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 47.5 t -59.9 136.15 57.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.881 0.372 . . . . 0.0 110.828 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -62.95 -41.63 99.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.944 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttm -176.02 136.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.97 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.47 ' HB3' ' NZ ' ' A' ' 2' ' ' LYS . 4.4 mmmp? -72.54 134.7 45.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.208 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.0 mtp -59.88 -45.75 91.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.898 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.54 -40.79 1.66 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.525 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.667 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.9 p -68.04 -5.86 4.7 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.466 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 0.8 OUTLIER -45.1 -46.54 11.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.6 -32.79 53.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.868 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.667 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 13.5 m-20 -64.88 -52.14 58.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.521 HG13 ' CG2' ' A' ' 5' ' ' VAL . 31.9 mt -65.4 -46.63 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 45.8 ttp180 -56.77 -28.69 61.7 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.46 -42.41 95.84 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 19.4 mt-30 -69.02 -32.44 71.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.866 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.1 mt -70.11 -45.91 74.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.266 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.3 mm -57.67 -52.23 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.698 0.285 . . . . 0.0 110.398 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.63 93.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.332 -0.937 . . . . 0.0 110.9 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.619 ' HB3' ' HG ' ' A' ' 34' ' ' LEU . . . -64.72 -25.88 68.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.282 -0.459 . . . . 0.0 111.172 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.627 HD23 ' HB2' ' A' ' 30' ' ' LEU . 65.3 mt -83.0 -29.46 28.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.718 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.83 139.43 54.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.262 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.67 -30.85 8.88 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.888 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.587 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -51.59 -176.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.988 0.423 . . . . 0.0 111.61 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.547 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -59.83 -120.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.827 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -61.36 -169.06 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.827 ' N ' ' HD1' ' A' ' 22' ' ' PHE . 57.5 Cg_endo -71.48 62.19 2.82 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 CA-C-N 120.975 1.384 . . . . 0.0 112.178 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.782 HG13 HG22 ' A' ' 71' ' ' VAL . 48.9 mm 109.83 65.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.657 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -63.76 65.64 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 O-C-N 122.001 -0.437 . . . . 0.0 111.612 178.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.581 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 42.7 p 59.38 157.05 0.1 OUTLIER Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.583 ' O ' ' HB2' ' A' ' 31' ' ' MET . 50.7 Cg_exo -50.59 -34.36 42.66 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.331 1.354 . . . . 0.0 112.879 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -53.15 -55.43 24.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.137 0.494 . . . . 0.0 110.907 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.657 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -74.83 -57.37 3.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.627 ' HB2' HD23 ' A' ' 17' ' ' LEU . 3.8 pp -49.89 -38.46 35.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.583 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 57.3 mtm -63.5 -37.83 88.82 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.77 -26.44 66.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.166 0.508 . . . . 0.0 110.562 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.587 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -68.36 -42.99 78.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.474 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.619 ' HG ' ' HB3' ' A' ' 16' ' ' ALA . 10.0 mp -33.32 148.9 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.739 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -47.22 -46.56 19.23 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.648 2.898 . . . . 0.0 113.821 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.487 HD22 ' N ' ' A' ' 40' ' ' THR . 12.3 p-10 -72.6 -26.29 61.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . 118.53 -79.19 0.3 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.545 -0.835 . . . . 0.0 112.873 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' MET . 16.8 Cg_endo -58.24 -73.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.495 2.13 . . . . 0.0 112.213 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.573 ' HA ' HD23 ' A' ' 34' ' ' LEU . 1.1 p30 -176.84 88.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.487 ' N ' HD22 ' A' ' 36' ' ' ASN . 2.4 t -62.07 136.23 57.86 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.598 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 28.1 m -83.9 125.98 32.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.996 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 63.4 m -88.84 46.26 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 0.0 110.341 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 61.8 pttt -75.69 147.43 39.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.096 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.9 m -141.78 126.98 18.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.72 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.75 -59.55 0.5 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.958 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -156.39 -42.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.807 0.337 . . . . 0.0 110.82 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 36.9 t -66.51 138.73 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.111 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.451 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 29.6 mt-10 -124.23 132.24 53.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.997 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -143.94 141.69 30.36 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.053 0.454 . . . . 0.0 111.238 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HB3' ' HA ' ' A' ' 41' ' ' THR . 51.0 pttt -177.46 165.88 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.73 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.592 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -55.14 -31.98 61.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.663 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.0 t -66.58 -62.65 1.35 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 58.4 m-20 -72.21 -54.31 10.01 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.42 -44.37 58.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.63 -25.28 1.39 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.365 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 25.3 pt20 -40.6 -38.4 0.87 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.157 0.503 . . . . 0.0 111.652 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.422 ' HB ' ' HE2' ' A' ' 78' ' ' LYS . 34.3 m -65.65 -33.32 62.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.371 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.406 HD21 ' CG2' ' A' ' 74' ' ' THR . 13.2 mt -70.17 119.27 14.12 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.5 p -72.18 155.77 39.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.883 0.373 . . . . 0.0 111.468 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.82 -40.7 60.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.3 -21.2 33.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.961 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.551 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 19.6 m-20 -68.7 2.98 2.11 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.581 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.8 OUTLIER -37.78 -62.81 0.58 Allowed Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 117.953 0.342 . . . . 0.0 111.63 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.7 Cg_endo -72.08 77.63 1.95 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.378 2.052 . . . . 0.0 111.747 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -77.03 141.99 40.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.649 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.512 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.67 66.76 0.13 Allowed 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.519 0.676 . . . . 0.0 110.221 178.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.794 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 18.5 m 60.8 161.51 0.06 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.369 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.665 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.57 -31.77 25.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.645 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.434 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.9 pt-20 -58.37 -45.82 87.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.408 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -70.16 -33.69 72.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.607 -179.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.782 HG22 HG13 ' A' ' 24' ' ' ILE . 61.6 t -63.17 -44.95 99.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.919 0.39 . . . . 0.0 110.563 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.05 -50.3 73.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.067 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 56.0 m-20 -68.5 -42.04 79.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.009 0.433 . . . . 0.0 111.232 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.406 ' CG2' HD21 ' A' ' 58' ' ' LEU . 98.0 m -59.64 -49.4 77.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.797 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 71' ' ' VAL . 75.2 mt -62.07 -54.23 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.607 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 11.3 m -61.29 -44.67 98.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 4.3 m120 -59.66 -52.58 64.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HE2' ' HB ' ' A' ' 57' ' ' VAL . 48.9 mtpt -72.65 -41.06 65.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.734 0.302 . . . . 0.0 111.606 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.27 -30.08 69.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.759 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.19 -56.28 0.41 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.934 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 16.9 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.042 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 52.4 m -86.65 43.72 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.646 0.26 . . . . 0.0 111.401 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -93.35 128.15 39.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.744 0.306 . . . . 0.0 110.92 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -104.52 -58.5 1.87 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.733 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.2 tptt 176.69 -43.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.66 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 ttt -56.29 132.79 51.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.078 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.09 -133.78 2.55 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.225 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.681 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p -71.12 -5.51 5.87 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.974 0 O-C-N 122.985 -0.127 . . . . 0.0 111.315 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 5' ' ' VAL . 86.8 tttt -44.94 -47.45 11.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -77.61 -33.48 53.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.786 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.681 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -63.69 -52.07 62.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.512 HG13 ' CG2' ' A' ' 5' ' ' VAL . 28.3 mt -64.01 -46.46 93.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' NH2' ' HE2' ' A' ' 6' ' ' LYS . 24.3 ttm180 -56.88 -28.05 61.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.92 -41.42 97.4 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.442 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 63.4 mt-30 -70.69 -31.33 68.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.633 -0.784 . . . . 0.0 110.032 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.4 -48.68 52.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.308 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.438 HD11 ' HA ' ' A' ' 69' ' ' GLU . 7.9 mm -57.27 -52.27 58.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.511 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.22 -36.47 93.27 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.911 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 12' ' ' GLN . . . -64.17 -28.45 69.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.239 -0.481 . . . . 0.0 111.247 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.625 HD23 ' HB2' ' A' ' 30' ' ' LEU . 60.8 mt -80.43 -29.45 37.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.701 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.68 133.3 53.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.067 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.58 -33.54 5.46 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.765 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.518 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -51.65 -176.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.449 . . . . 0.0 111.643 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.562 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -59.9 -123.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.759 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -58.83 -174.79 0.05 OUTLIER Pre-proline 0 N--CA 1.456 -0.127 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 176.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.808 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 52.2 Cg_endo -68.08 62.8 1.01 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 120.478 1.206 . . . . 0.0 112.326 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.838 HG13 HG21 ' A' ' 71' ' ' VAL . 49.1 mm 110.32 65.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.663 ' ND2' ' CD2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -64.67 65.99 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 122.013 -0.429 . . . . 0.0 111.478 178.027 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.506 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 27.3 p 58.43 157.2 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.553 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 50.8 Cg_exo -50.69 -34.62 44.53 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.319 1.346 . . . . 0.0 112.875 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -52.61 -55.19 24.07 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.613 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.637 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 6.0 tp10 -76.25 -57.83 3.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.625 ' HB2' HD23 ' A' ' 17' ' ' LEU . 3.8 pp -50.03 -41.85 48.34 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.532 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 28.3 ttm -66.02 -32.69 74.32 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.14 -30.39 69.51 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.394 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -68.41 -40.42 81.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.288 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.518 HD11 ' HA ' ' A' ' 31' ' ' MET . 9.0 mp -25.07 134.47 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.29 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.35 -34.84 72.52 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.862 3.041 . . . . 0.0 114.899 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.554 ' CG ' ' HB ' ' A' ' 40' ' ' THR . 15.1 p-10 -72.33 -28.24 62.93 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.28 -67.21 0.46 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.917 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.487 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 97.7 Cg_endo -83.74 43.79 1.47 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.745 2.297 . . . . 0.0 113.506 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.514 ' C ' HD22 ' A' ' 36' ' ' ASN . 1.6 m-20 62.28 93.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.554 ' HB ' ' CG ' ' A' ' 36' ' ' ASN . 3.8 t -75.4 137.57 41.11 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.473 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.433 ' OG1' ' HD2' ' A' ' 50' ' ' LYS . 27.3 m -96.15 118.87 33.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.668 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -88.01 43.87 1.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.09 0.472 . . . . 0.0 109.975 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.444 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 19.8 ptmt -75.82 132.48 40.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.148 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.0 m -111.82 114.63 27.71 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.8 -129.66 44.53 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.467 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -72.05 -37.29 69.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.008 0.432 . . . . 0.0 110.987 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.41 HG13 ' CD2' ' A' ' 49' ' ' LEU . 51.7 t -66.69 145.36 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.725 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HG2' ' HB2' ' A' ' 43' ' ' LYS . 32.6 mt-10 -141.99 128.3 19.92 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.634 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.41 ' CD2' HG13 ' A' ' 47' ' ' VAL . 3.4 mm? -140.91 132.52 27.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.936 0.398 . . . . 0.0 110.912 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.433 ' HD2' ' OG1' ' A' ' 41' ' ' THR . 21.3 ptmt -170.21 159.08 7.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.727 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.563 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.86 -29.88 3.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.951 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.9 t -72.54 -59.59 2.65 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 57.5 m-20 -72.15 -54.11 10.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -74.34 -43.97 54.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.09 -27.06 1.46 Allowed Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.363 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 18.1 pt20 -42.25 -40.14 2.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.149 0.5 . . . . 0.0 111.515 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.76 -30.39 49.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.104 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.422 HD22 ' CG2' ' A' ' 74' ' ' THR . 12.4 mt -71.32 119.85 16.05 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.5 p -75.0 155.66 37.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.355 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.64 -39.81 51.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -58.81 -21.09 55.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.618 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.4 m-20 -70.04 3.15 2.9 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.506 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.5 m-85 -40.49 -62.69 0.88 Allowed Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 118.162 0.437 . . . . 0.0 111.293 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.0 Cg_endo -71.43 74.95 2.01 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.48 2.12 . . . . 0.0 112.207 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.618 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.8 OUTLIER -76.9 139.84 40.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.167 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 38.1 mtmm -66.45 70.07 0.07 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.596 0.712 . . . . 0.0 110.671 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.808 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 37.7 m 59.33 161.15 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.284 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.656 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.55 -26.85 9.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.482 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 12.0 pt-20 -58.77 -48.99 79.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.454 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -74.87 -31.88 61.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 119.656 -0.817 . . . . 0.0 111.303 -179.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.838 HG21 HG13 ' A' ' 24' ' ' ILE . 57.2 t -61.48 -45.47 98.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.418 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.84 -46.33 90.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.108 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 9.3 t70 -62.5 -41.74 99.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.531 0.682 . . . . 0.0 110.396 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.422 ' CG2' HD22 ' A' ' 58' ' ' LEU . 85.0 m -63.19 -49.54 73.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.835 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 71' ' ' VAL . 74.7 mt -59.79 -55.17 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.072 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 9.7 m -60.9 -43.8 96.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 3.4 m120 -63.93 -50.77 67.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -74.06 -41.65 61.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 75' ' ' ILE . . . -67.11 -29.9 69.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.7 -55.79 0.36 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.064 -1.065 . . . . 0.0 113.223 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 17.5 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.237 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' SER . . . . . 0.488 ' O ' ' CG ' ' A' ' -1' ' ' HIS . 28.4 m 62.11 -137.88 0.47 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.569 -0.16 . . . . 0.0 110.569 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . 0.488 ' CG ' ' O ' ' A' ' -2' ' ' SER . 10.2 p80 47.83 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.791 0.329 . . . . 0.0 111.376 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt -71.53 126.03 28.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.29 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -75.03 -35.77 61.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.617 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 93.5 mmm 66.65 130.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.39 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.1 -138.45 5.14 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.021 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.65 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.3 p -77.1 -5.82 8.12 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 C-N-CA 121.401 -0.12 . . . . 0.0 110.957 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 13.0 tmtt? -45.11 -46.0 11.53 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.53 -34.14 54.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.857 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.65 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -63.55 -52.2 62.11 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.493 HG13 ' CG2' ' A' ' 5' ' ' VAL . 31.6 mt -65.69 -47.49 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 52.0 ttp85 -55.04 -28.8 55.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.426 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.63 -47.21 79.31 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -66.95 -28.02 67.93 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.763 -0.719 . . . . 0.0 109.986 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 9' ' ' ILE . 75.3 mt -70.43 -44.99 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.075 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.566 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 69' ' ' GLU . 11.3 mm -56.11 -49.64 74.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.05 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.69 -36.85 91.89 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.044 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.93 -27.11 69.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.25 -0.475 . . . . 0.0 111.38 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 30' ' ' LEU . 35.9 mt -85.01 -29.47 24.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.71 132.86 46.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.03 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.45 -33.97 4.88 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.519 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.572 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -52.19 -177.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.771 0.319 . . . . 0.0 111.383 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.538 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -60.79 -119.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.716 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -60.82 179.61 0.22 Allowed Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 176.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.806 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 41.4 Cg_endo -65.48 65.49 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 CA-C-N 119.921 1.008 . . . . 0.0 112.359 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.77 HG13 HG21 ' A' ' 71' ' ' VAL . 31.7 mm 107.94 61.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.59 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.6 m120 -62.98 65.75 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.554 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.1 p 57.12 156.7 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.613 ' O ' ' CB ' ' A' ' 31' ' ' MET . 53.7 Cg_exo -50.04 -33.99 36.65 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.351 1.367 . . . . 0.0 112.837 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -52.3 -56.83 12.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.308 0.575 . . . . 0.0 110.625 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.59 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.1 tp10 -76.1 -57.71 3.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.59 ' HB2' HD23 ' A' ' 17' ' ' LEU . 3.7 pp -50.2 -40.76 48.13 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.613 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 31.2 ttm -65.93 -33.61 76.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.48 -29.94 69.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.469 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -70.1 -39.62 75.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.408 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.703 HD23 ' HA ' ' A' ' 39' ' ' ASP . 10.8 mp -30.49 140.99 0.12 Allowed Pre-proline 0 N--CA 1.468 0.466 0 CA-C-O 121.108 0.48 . . . . 0.0 112.12 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.27 -50.04 15.34 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.859 3.04 . . . . 0.0 115.587 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.556 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -72.31 -26.54 61.99 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -177.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' H ' HD21 ' A' ' 36' ' ' ASN . . . 102.93 -62.18 0.46 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.936 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 93.5 Cg_endo -79.45 49.46 3.18 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.6 2.2 . . . . 0.0 113.154 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.703 ' HA ' HD23 ' A' ' 34' ' ' LEU . 2.6 p30 51.5 91.85 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.452 ' HB ' ' CG ' ' A' ' 36' ' ' ASN . 6.0 t -78.84 134.9 36.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.513 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.533 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 2.0 t -108.6 121.97 46.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.073 0.464 . . . . 0.0 111.478 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 33.8 m -72.4 59.84 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.39 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 62.0 pttt -75.19 122.54 23.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.004 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 m -98.68 87.58 3.83 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.87 -126.39 8.03 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.996 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' O ' ' OE2' ' A' ' 48' ' ' GLU . 28.5 m-20 -72.56 -43.59 63.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.3 t -70.82 137.29 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.447 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 22.1 mp0 -126.22 137.69 53.56 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.56 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.404 ' N ' ' OG1' ' A' ' 41' ' ' THR . 2.8 mm? -136.08 135.83 39.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.649 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 41' ' ' THR . 56.1 pttt -166.38 -165.26 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.058 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.506 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -78.02 -46.33 21.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.876 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.7 t -65.36 -51.62 59.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.647 0.26 . . . . 0.0 111.542 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -71.79 -51.44 22.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.441 ' HB2' ' CG2' ' A' ' 75' ' ' ILE . . . -86.03 -47.18 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.81 -26.15 1.08 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.785 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.407 ' HG3' ' N ' ' A' ' 57' ' ' VAL . 22.7 pt20 -41.57 -38.95 1.46 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.964 0.411 . . . . 0.0 111.796 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.445 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 34.1 m -65.66 -32.21 57.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.558 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.433 ' N ' HG21 ' A' ' 57' ' ' VAL . 22.4 mt -68.62 122.54 18.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.36 . . . . 0.0 110.554 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.5 p -74.74 155.81 37.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.331 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.21 -42.11 60.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.321 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.21 -20.02 38.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.169 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.671 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 28.5 m-20 -68.64 3.31 1.92 Allowed 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.554 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.7 OUTLIER -39.49 -67.46 0.28 Allowed Pre-proline 0 N--CA 1.463 0.18 0 CA-C-N 117.758 0.254 . . . . 0.0 111.466 -179.107 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.7 Cg_endo -70.43 76.39 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.311 2.007 . . . . 0.0 112.18 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.671 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -76.94 141.92 40.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.989 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.501 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 4.4 mmmp? -67.41 69.67 0.1 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.454 0.645 . . . . 0.0 110.615 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.806 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.8 m 58.5 162.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.15 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.638 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.8 -27.47 12.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.733 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 15.6 pt-20 -58.36 -49.69 76.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.555 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.501 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -73.54 -32.27 64.11 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.07 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.77 HG21 HG13 ' A' ' 24' ' ' ILE . 60.6 t -64.79 -39.65 86.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.888 0.375 . . . . 0.0 110.62 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.69 -49.54 72.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 76' ' ' VAL . 56.5 m-20 -68.46 -41.11 80.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.168 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.8 m -58.85 -51.63 69.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.513 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.441 ' CG2' ' HB2' ' A' ' 54' ' ' ALA . 75.0 mt -59.17 -53.57 46.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.316 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 11.1 m -59.82 -42.1 87.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.945 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -61.54 -53.45 56.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.679 0.276 . . . . 0.0 111.513 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.445 ' HE3' ' HB ' ' A' ' 57' ' ' VAL . 27.7 mtpp -71.85 -39.68 69.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.597 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.92 69.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.812 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.34 -55.4 0.41 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.808 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 17.9 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.958 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.524 -0.231 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 80.0 p -178.01 -47.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.854 0.359 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -65.58 -53.11 46.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 ttp 177.75 136.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.579 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' HD3' ' N ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -122.43 -50.73 1.98 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.21 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.542 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 83.3 mtp 48.35 115.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 111.523 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.19 -130.8 2.0 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.243 -0.98 . . . . 0.0 113.131 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.671 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.8 p -67.34 -5.7 4.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 46.2 tttm -44.72 -47.05 10.7 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.798 -0.761 . . . . 0.0 108.999 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.39 -34.33 54.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.759 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.671 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 65.4 m-20 -63.03 -52.05 64.38 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.517 HG13 ' CG2' ' A' ' 5' ' ' VAL . 31.1 mt -66.23 -47.7 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 42.3 ttp180 -55.02 -28.85 55.29 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.98 -43.93 92.62 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -67.08 -30.83 70.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.746 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.0 mt -70.77 -42.64 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.781 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 69' ' ' GLU . 12.2 mm -57.82 -53.53 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.359 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.27 -37.56 92.99 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.011 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.424 ' O ' ' HG ' ' A' ' 34' ' ' LEU . . . -60.41 -30.91 69.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.072 0.463 . . . . 0.0 111.081 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 30' ' ' LEU . 46.5 mt -81.27 -29.44 34.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.513 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.82 125.25 21.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.716 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.62 -35.2 3.11 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.465 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.557 ' CB ' ' HB1' ' A' ' 33' ' ' ALA . . . -52.37 -176.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.842 0.353 . . . . 0.0 111.378 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.547 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.85 -119.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 177.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.7 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -59.66 177.44 0.27 Allowed Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.854 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 53.6 Cg_endo -65.11 65.86 0.31 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 CA-C-N 119.949 1.017 . . . . 0.0 112.372 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.765 HG13 HG22 ' A' ' 71' ' ' VAL . 26.9 mm 109.53 61.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 178.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.673 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.7 m120 -63.14 65.23 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.8 p 57.37 154.33 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.68 ' O ' ' CB ' ' A' ' 31' ' ' MET . 61.6 Cg_exo -48.21 -32.32 18.99 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.23 1.287 . . . . 0.0 112.748 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -53.0 -57.32 10.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.431 0.634 . . . . 0.0 110.591 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.582 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.1 tp10 -76.27 -57.65 3.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.2 pp -50.12 -35.15 24.58 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.755 ' HG3' ' HB2' ' A' ' 39' ' ' ASP . 30.8 ttm -66.96 -37.01 83.49 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.19 -23.98 64.9 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.659 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.557 ' HB1' ' CB ' ' A' ' 20' ' ' ALA . . . -74.0 -46.59 42.67 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.562 HD22 ' HA ' ' A' ' 39' ' ' ASP . 5.6 mp -36.08 144.91 0.24 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 121.241 0.543 . . . . 0.0 112.404 -177.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -47.77 -50.36 11.8 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.202 3.268 . . . . 0.0 115.141 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 40' ' ' THR . 0.1 OUTLIER -72.27 -15.6 61.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.363 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.33 -69.28 0.24 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.674 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.35 44.82 1.59 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.688 2.259 . . . . 0.0 113.026 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.755 ' HB2' ' HG3' ' A' ' 31' ' ' MET . 10.8 t70 62.37 95.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.156 0.503 . . . . 0.0 111.729 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.454 HG22 ' HB3' ' A' ' 34' ' ' LEU . 3.9 t -65.48 133.0 50.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.096 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.404 ' OG1' ' NZ ' ' A' ' 50' ' ' LYS . 17.4 m -79.82 126.86 31.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.392 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.2 m -101.61 42.71 1.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.185 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . 22.5 pttp -75.85 149.18 37.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.634 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.6 m -142.05 136.4 30.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.023 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.39 -63.41 0.41 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.707 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -175.16 27.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.848 0.356 . . . . 0.0 111.106 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 48.7 t -128.08 125.49 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.255 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.557 ' HA ' ' HB3' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -117.42 131.1 56.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.488 0.661 . . . . 0.0 112.271 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.411 ' CD2' ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -143.95 133.28 23.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.721 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 60.6 pttt -169.73 -170.57 1.06 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 111.472 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.506 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -62.2 -52.4 63.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.404 ' OG ' ' HE3' ' A' ' 50' ' ' LYS . 85.3 p -72.74 -51.23 20.01 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.42 ' OD1' ' CE ' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -69.15 -49.92 52.47 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 50' ' ' LYS . . . -90.81 -45.67 8.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -54.22 -21.66 19.5 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.985 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -44.07 -31.4 0.92 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.016 0.436 . . . . 0.0 111.072 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.9 m -77.65 27.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.636 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 55' ' ' GLY . 34.6 mt -129.33 117.32 20.45 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.922 0.391 . . . . 0.0 110.637 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.445 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 72.6 p -71.84 158.26 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.615 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.73 -39.38 51.75 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.369 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -50.92 -27.28 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.035 0.445 . . . . 0.0 110.737 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 61.2 m-20 -70.73 3.68 3.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.458 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.669 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -42.12 -69.4 0.22 Allowed Pre-proline 0 C--O 1.226 -0.147 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.378 -179.244 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 51.6 Cg_endo -68.2 76.55 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.254 1.97 . . . . 0.0 111.475 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.551 ' CD1' HG21 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -77.01 142.63 39.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.137 -178.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 87.6 tttt -69.8 64.97 0.21 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.818 0.818 . . . . 0.0 111.24 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.854 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 64.8 m 64.07 161.25 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.728 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.529 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -53.38 -27.2 22.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.765 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.423 ' HA ' HD13 ' A' ' 14' ' ' ILE . 22.6 pt-20 -65.12 -39.35 92.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.17 0.509 . . . . 0.0 109.666 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' A' ' 66' ' ' LYS . 8.0 tp10 -66.23 -43.53 86.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.681 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.765 HG22 HG13 ' A' ' 24' ' ' ILE . 63.2 t -67.74 -41.1 84.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.544 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.402 ' O ' ' CG2' ' A' ' 76' ' ' VAL . . . -55.9 -44.67 78.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.08 0.467 . . . . 0.0 110.015 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.47 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.3 m-20 -72.71 -46.66 52.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.17 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.6 m -56.48 -48.78 76.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.708 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.452 HG22 ' CB ' ' A' ' 54' ' ' ALA . 68.3 mt -62.58 -54.31 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.656 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 12.9 m -60.12 -42.07 88.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 75.4 m-20 -62.65 -50.6 70.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.685 0.279 . . . . 0.0 111.483 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -72.13 -43.01 65.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.794 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . . . -67.54 -30.06 69.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.38 -56.56 0.41 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.869 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.5 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.083 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 47.4 t -178.23 136.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -176.79 45.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp 63.19 134.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.058 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -71.7 136.7 47.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.361 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -68.53 130.44 42.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.966 0.412 . . . . 0.0 111.142 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.15 -27.41 73.81 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.786 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.673 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.5 p -60.99 -7.12 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 5' ' ' VAL . 82.3 tttt -45.12 -43.24 9.58 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -77.72 -37.14 50.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.836 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.673 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 10.4 m-20 -62.6 -51.77 66.0 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.464 HG13 ' CG2' ' A' ' 5' ' ' VAL . 30.2 mt -63.92 -45.76 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.417 ' NH2' ' HE2' ' A' ' 6' ' ' LYS . 28.3 ttm180 -56.25 -29.95 61.76 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.4 -41.13 98.21 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -68.9 -30.12 68.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.747 -0.727 . . . . 0.0 109.755 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.1 mt -71.17 -45.6 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.829 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 69' ' ' GLU . 9.9 mm -58.2 -52.55 57.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.34 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.44 -37.47 94.49 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.351 -0.928 . . . . 0.0 110.815 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.418 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -60.62 -31.0 70.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.176 -0.512 . . . . 0.0 110.785 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.63 HD22 ' HB2' ' A' ' 30' ' ' LEU . 64.2 mt -80.87 -29.34 35.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.574 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.95 138.08 49.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.15 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.66 -33.14 6.53 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.798 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.525 ' N ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.4 -177.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.951 0.405 . . . . 0.0 111.62 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.585 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -59.81 -122.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.832 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -59.68 -171.5 0.03 OUTLIER Pre-proline 0 N--CA 1.454 -0.227 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.832 ' N ' ' HD1' ' A' ' 22' ' ' PHE . 59.3 Cg_endo -70.02 62.66 1.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 120.718 1.292 . . . . 0.0 112.012 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.748 HG13 HG23 ' A' ' 71' ' ' VAL . 49.3 mm 109.57 65.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.635 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -63.73 65.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 O-C-N 122.038 -0.414 . . . . 0.0 111.857 178.438 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.573 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 35.8 p 60.1 154.54 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.578 ' O ' ' CB ' ' A' ' 31' ' ' MET . 52.0 Cg_exo -49.57 -33.32 30.49 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.197 1.265 . . . . 0.0 112.715 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -53.99 -54.88 32.97 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.649 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.635 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 5.9 tp10 -75.2 -57.76 3.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.63 ' HB2' HD22 ' A' ' 17' ' ' LEU . 3.6 pp -50.27 -41.87 51.2 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.578 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 36.1 ttm -64.29 -32.34 73.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -70.3 -28.75 65.43 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.399 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.525 ' HB2' ' N ' ' A' ' 20' ' ' ALA . . . -71.0 -35.92 72.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.59 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.641 HD23 ' HA ' ' A' ' 39' ' ' ASP . 8.8 mp -29.27 139.29 0.12 Allowed Pre-proline 0 N--CA 1.471 0.625 0 CA-C-O 121.078 0.466 . . . . 0.0 112.178 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.9 -45.31 25.04 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.281 3.321 . . . . 0.0 115.868 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.496 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -72.15 -25.39 61.68 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.351 -177.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . 104.72 -65.74 0.3 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.733 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 84.5 Cg_endo -81.64 46.54 2.26 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.57 2.18 . . . . 0.0 113.171 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.641 ' HA ' HD23 ' A' ' 34' ' ' LEU . 0.5 OUTLIER 65.29 90.4 0.09 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.473 178.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.448 HG22 HD21 ' A' ' 34' ' ' LEU . 8.8 t -76.27 134.41 39.8 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.751 0.31 . . . . 0.0 111.176 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.429 ' OG1' ' HD2' ' A' ' 50' ' ' LYS . 29.2 m -92.72 125.1 37.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.148 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -93.41 41.31 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.478 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 60.8 pttt -75.85 129.16 36.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.183 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.0 m -106.31 118.21 36.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.13 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.53 -130.02 45.66 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.626 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 47' ' ' VAL . 41.8 p-10 -74.61 -36.66 62.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.805 0.336 . . . . 0.0 111.396 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.417 ' CG1' ' CD2' ' A' ' 49' ' ' LEU . 56.9 t -66.82 143.34 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.544 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.478 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 69.0 mt-10 -138.0 127.6 25.06 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.863 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.417 ' CD2' ' CG1' ' A' ' 47' ' ' VAL . 3.5 mm? -142.14 135.05 28.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.591 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HB2' ' NZ ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -171.64 -171.96 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.967 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.431 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -69.38 -50.12 49.06 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.421 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 35.4 t -66.47 -48.6 69.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.809 0.338 . . . . 0.0 111.562 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -70.32 -54.14 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . . . -94.6 -46.85 6.78 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -47.23 -26.1 3.1 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.871 -0.681 . . . . 0.0 113.047 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -43.69 -30.13 0.59 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 111.647 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.425 HG22 ' HD2' ' A' ' 78' ' ' LYS . 29.7 m -74.16 28.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.2 mt -132.67 116.37 16.55 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.4 p -70.85 155.93 40.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 111.698 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.28 -39.42 21.54 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.438 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -50.84 -27.64 7.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.941 0.401 . . . . 0.0 110.578 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.572 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.4 m-20 -71.59 3.17 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.083 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.573 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.2 OUTLIER -37.25 -53.48 2.15 Favored Pre-proline 0 N--CA 1.463 0.204 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 3.5 Cg_endo -83.27 78.47 3.19 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.87 2.38 . . . . 0.0 112.127 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' CE1' ' HB3' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -77.19 143.52 38.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.625 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 3.3 mptp? -68.64 67.14 0.13 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.565 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.817 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 34.2 m 60.53 160.98 0.05 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.19 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.617 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.47 -31.17 22.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.431 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.466 ' HA ' HD11 ' A' ' 14' ' ' ILE . 22.1 pt-20 -57.52 -46.91 83.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.371 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' CD ' ' HB2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -69.77 -35.63 75.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.5 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.748 HG23 HG13 ' A' ' 24' ' ' ILE . 61.6 t -61.9 -45.85 97.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 0.0 110.769 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.23 -49.93 72.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.986 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 76' ' ' VAL . 1.5 m-20 -68.51 -38.3 80.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.262 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 95.2 m -63.81 -51.36 65.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.0 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 71' ' ' VAL . 70.2 mt -59.3 -52.17 63.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.269 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.435 ' HB ' ' OXT' ' A' ' 81' ' ' LEU . 6.8 m -59.51 -39.91 80.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -62.36 -56.1 21.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.77 0.319 . . . . 0.0 111.702 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.425 ' HD2' HG22 ' A' ' 57' ' ' VAL . 98.6 mttt -69.46 -39.78 77.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.831 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . . . -67.08 -29.86 69.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.134 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.76 -55.43 0.42 Allowed Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.273 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.435 ' OXT' ' HB ' ' A' ' 76' ' ' VAL . 20.5 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.292 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 80.7 p -178.48 138.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.781 0.324 . . . . 0.0 110.834 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -173.12 127.85 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.942 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt -74.79 150.63 39.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.483 ' HB3' ' NZ ' ' A' ' 2' ' ' LYS . 6.4 ttpm? -51.25 -24.01 4.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.462 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 ttt -37.54 131.08 0.96 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.08 0.467 . . . . 0.0 111.825 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.07 -132.46 1.76 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.686 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.73 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.5 p -72.8 -6.07 7.41 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.842 0 CA-C-N 116.839 0.319 . . . . 0.0 110.965 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 81.4 tttt -45.66 -51.13 12.75 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -77.87 -28.57 50.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.843 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.73 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 3.8 t70 -65.77 -52.65 49.19 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.455 HG13 ' CG2' ' A' ' 5' ' ' VAL . 15.3 mt -65.4 -42.22 92.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.518 ' NE ' ' HA ' ' A' ' 72' ' ' ALA . 3.1 tpt180 -60.25 -26.0 66.12 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.93 -44.74 94.13 Favored Glycine 0 CA--C 1.503 -0.675 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -63.43 -27.51 69.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.768 -0.716 . . . . 0.0 109.329 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.451 ' CD1' ' CZ ' ' A' ' 10' ' ' ARG . 64.3 mt -75.03 -47.3 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.721 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.7 mm -56.4 -52.2 55.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 120.749 0.309 . . . . 0.0 110.2 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.23 -37.08 94.31 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.25 -27.34 68.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.184 -0.508 . . . . 0.0 110.834 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.594 HD22 ' HB2' ' A' ' 30' ' ' LEU . 40.4 mt -80.5 -29.52 37.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.283 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.42 133.38 49.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.871 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.17 -34.03 5.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.465 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.519 ' N ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.37 -178.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.838 0.351 . . . . 0.0 111.348 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.573 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.6 m-20 -60.88 -120.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.711 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -59.44 179.8 0.18 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.805 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 50.0 Cg_endo -65.46 63.98 0.37 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 CA-C-N 119.827 0.974 . . . . 0.0 112.363 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.784 HG13 HG23 ' A' ' 71' ' ' VAL . 33.7 mm 108.65 60.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.578 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.6 m120 -62.48 65.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.552 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 61.5 p 57.64 154.42 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.584 ' O ' ' CB ' ' A' ' 31' ' ' MET . 60.2 Cg_exo -48.93 -32.44 22.99 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.305 1.336 . . . . 0.0 112.689 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -53.04 -57.38 10.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.41 0.624 . . . . 0.0 110.415 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.578 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 41.4 tp10 -76.2 -57.6 3.77 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.594 ' HB2' HD22 ' A' ' 17' ' ' LEU . 3.6 pp -50.16 -43.05 52.02 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.584 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 43.0 ttm -66.01 -31.58 72.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.2 -31.11 71.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.371 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.519 ' HB2' ' N ' ' A' ' 20' ' ' ALA . . . -69.75 -39.03 76.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.284 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.1 mp -30.0 137.33 0.17 Allowed Pre-proline 0 N--CA 1.47 0.546 0 CA-C-O 121.026 0.441 . . . . 0.0 111.831 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.04 -49.82 13.16 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.842 3.028 . . . . 0.0 115.754 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.498 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -72.35 -25.71 61.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.426 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . 103.86 -65.18 0.35 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.255 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 88.9 Cg_endo -82.02 52.53 4.21 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.622 2.215 . . . . 0.0 112.43 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 2.6 p30 52.49 93.31 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.549 0.69 . . . . 0.0 112.517 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.435 ' N ' HD22 ' A' ' 36' ' ' ASN . 6.2 t -69.54 127.46 33.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.235 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.429 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 7.8 m -84.72 125.75 32.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.509 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.2 m -92.16 45.99 1.24 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.98 0.419 . . . . 0.0 110.094 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.433 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 22.2 pttp -75.44 145.29 41.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.083 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.4 m -137.62 127.69 25.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.896 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.29 -51.41 0.8 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.024 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -169.57 -40.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.976 0.417 . . . . 0.0 110.44 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.402 HG12 HD23 ' A' ' 49' ' ' LEU . 38.3 t -66.76 134.72 29.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.768 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.433 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 26.7 mt-10 -117.99 135.58 54.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.746 0.308 . . . . 0.0 111.045 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.404 ' CD2' ' C ' ' A' ' 48' ' ' GLU . 3.1 mm? -141.38 128.98 21.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.167 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 22.5 pttp -168.47 157.88 9.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.612 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.464 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.75 -37.63 13.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.134 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.0 t -63.81 -52.48 60.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.4 ' OD2' ' HE3' ' A' ' 50' ' ' LYS . 65.2 m-20 -72.25 -50.69 25.36 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.436 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -91.91 -47.15 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.81 -29.6 2.06 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.052 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -45.55 -30.93 1.6 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.074 0.464 . . . . 0.0 111.17 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG22 ' HD2' ' A' ' 78' ' ' LYS . 34.8 m -75.11 28.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.666 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 38.5 mt -132.26 116.47 16.96 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.2 p -73.19 156.1 38.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.944 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.67 -37.3 12.63 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.018 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -51.0 -29.21 11.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.146 0.498 . . . . 0.0 110.187 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.585 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -72.05 3.6 4.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.556 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.552 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.1 t80 -38.99 -51.86 3.95 Favored Pre-proline 0 CA--C 1.527 0.092 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 86.5 Cg_endo -87.62 78.89 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.923 2.416 . . . . 0.0 112.061 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.585 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -77.14 140.59 40.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.971 0.415 . . . . 0.0 111.448 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.461 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 27.3 tptp -66.48 69.95 0.07 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.753 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.805 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 38.0 m 58.07 161.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.796 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.703 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.74 -30.12 21.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.935 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 10.7 pt-20 -57.41 -47.62 81.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.678 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.485 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -72.87 -37.89 67.18 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.724 -179.68 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.784 HG23 HG13 ' A' ' 24' ' ' ILE . 42.9 t -60.1 -34.56 57.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.934 0.397 . . . . 0.0 110.693 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.518 ' HA ' ' NE ' ' A' ' 10' ' ' ARG . . . -68.72 -56.03 9.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.463 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.4 m-20 -66.19 -35.09 79.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.584 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.5 m -62.58 -49.98 73.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.903 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.436 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 73.0 mt -64.12 -51.02 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.456 HG12 ' HD3' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -52.38 -38.5 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.206 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -60.63 -55.26 35.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 111.319 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HD2' HG22 ' A' ' 57' ' ' VAL . 62.0 mttp -71.91 -38.66 69.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.832 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.84 -30.11 70.2 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.2 -55.47 0.43 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 119.869 -1.158 . . . . 0.0 113.477 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.465 ' HB3' ' HG3' ' A' ' 6' ' ' LYS . 14.1 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.25 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 52.8 m -60.1 -43.98 95.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.856 0.36 . . . . 0.0 110.932 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -64.72 133.91 53.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.961 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt 62.56 130.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.98 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' HG2' ' CD2' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -95.87 42.8 1.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.274 0.559 . . . . 0.0 111.532 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.2 mtp 50.26 31.69 5.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.436 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 43.99 31.87 2.17 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.042 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.686 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p -77.14 -5.59 7.81 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.554 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 62.9 tttp -45.33 -48.71 13.17 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.082 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -77.7 -30.1 51.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.835 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.686 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 23.0 m-20 -65.21 -52.07 57.06 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.486 HG13 ' CG2' ' A' ' 5' ' ' VAL . 23.9 mt -69.74 -48.45 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 23.2 ttp180 -56.17 -28.57 58.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.04 -44.32 91.67 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.41 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 66.2 mt-30 -66.38 -32.16 73.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.818 -0.691 . . . . 0.0 109.826 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.414 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 70.5 mt -70.58 -48.22 60.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.187 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.5 mm -53.94 -54.19 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.275 . . . . 0.0 110.8 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.7 -36.17 92.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.956 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 12' ' ' GLN . . . -63.9 -22.06 66.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.115 -0.543 . . . . 0.0 111.478 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.563 ' HB3' HD11 ' A' ' 24' ' ' ILE . 56.0 mt -90.44 -29.64 17.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.882 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 83.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.803 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 169.34 -38.48 0.2 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.384 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.533 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -51.38 -177.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.554 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -58.3 -120.52 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.683 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -58.69 175.46 0.32 Allowed Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 176.492 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.862 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 39.4 Cg_endo -63.89 65.41 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 120.853 1.036 . . . . 0.0 112.835 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.721 HG13 HG22 ' A' ' 71' ' ' VAL . 11.1 mm 109.84 61.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 177.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.575 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 3.1 m120 -65.81 64.06 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 25' ' ' ASN . 87.6 p 57.43 150.53 0.06 OUTLIER Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.864 ' O ' ' HB2' ' A' ' 31' ' ' MET . 86.9 Cg_exo -46.15 -28.5 5.54 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.09 1.86 . . . . 0.0 112.654 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -55.87 -57.31 12.61 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.563 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 5.6 tp10 -77.38 -57.37 3.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.566 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 1.4 pp -50.04 -34.36 21.24 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.68 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.864 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -77.87 -29.87 50.57 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -61.79 -28.2 69.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -81.95 -35.95 28.5 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.066 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.549 HD23 ' HA ' ' A' ' 39' ' ' ASP . 6.4 mp -33.29 130.48 0.37 Allowed Pre-proline 0 N--CA 1.467 0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 111.689 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.45 -33.08 45.48 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.503 2.802 . . . . 0.0 114.358 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.664 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 7.2 t30 -72.11 -27.46 62.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.9 -74.16 0.39 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.489 -0.863 . . . . 0.0 113.015 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 78.2 Cg_endo -83.43 43.87 1.52 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.724 2.282 . . . . 0.0 112.502 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.549 ' HA ' HD23 ' A' ' 34' ' ' LEU . 0.9 OUTLIER 68.81 97.97 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.272 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 36' ' ' ASN . 5.2 t -69.49 137.74 52.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.352 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.5 m -101.03 95.41 6.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.722 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.4 m -72.38 57.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.9 0.381 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 8.8 ptpp? -75.65 150.34 37.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.267 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.3 m -157.05 130.05 7.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.576 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 46' ' ' ASP . . . 58.43 49.55 75.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.298 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 11.4 m-20 79.04 -42.07 0.29 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.465 0.306 . . . . 0.0 111.578 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.9 t -66.55 139.0 21.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.863 0.364 . . . . 0.0 111.095 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 43' ' ' LYS . 31.5 mt-10 -127.27 133.08 50.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.298 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -133.41 139.85 46.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.998 0.427 . . . . 0.0 111.648 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 56.1 pttt -177.96 -164.72 0.09 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.69 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.484 ' O ' ' CA ' ' A' ' 55' ' ' GLY . . . -77.58 -44.67 27.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.373 0.606 . . . . 0.0 111.505 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 t -59.63 -56.37 22.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.365 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -72.78 -54.33 9.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 50' ' ' LYS . . . -91.45 -43.21 9.85 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -45.62 -25.6 1.49 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.095 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -43.93 -40.16 4.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.144 0.497 . . . . 0.0 110.91 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.401 HG23 ' HD2' ' A' ' 78' ' ' LYS . 35.4 m -65.68 -32.59 58.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.157 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 55' ' ' GLY . 38.7 mt -71.36 70.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.183 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.402 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 71.7 p -47.94 156.8 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.595 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -43.63 -40.67 4.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.005 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -50.97 -27.92 8.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.886 0.374 . . . . 0.0 110.849 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.598 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 57.2 m-20 -73.33 3.45 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.62 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -40.82 -66.8 0.35 Allowed Pre-proline 0 N--CA 1.463 0.194 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.125 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 70.2 Cg_endo -72.93 75.97 2.61 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.408 2.072 . . . . 0.0 111.953 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.2 OUTLIER -77.01 142.37 39.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.357 -179.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.464 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 84.2 tttt -67.73 71.48 0.14 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.391 0.615 . . . . 0.0 110.703 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.862 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.7 m 59.31 161.37 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.003 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.541 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.73 -30.43 22.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.646 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 15.5 pt-20 -58.28 -47.63 83.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.636 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.572 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -74.38 -31.68 62.46 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.635 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.721 HG22 HG13 ' A' ' 24' ' ' ILE . 60.9 t -66.64 -51.68 53.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.409 ' O ' HG21 ' A' ' 76' ' ' VAL . . . -55.61 -42.14 74.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 109.801 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.431 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 47.5 t0 -64.52 -46.46 82.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.218 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.6 m -58.81 -47.52 84.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.949 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 79' ' ' ALA . 69.7 mt -57.31 -49.56 79.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.507 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 15.6 m -63.4 -40.41 88.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.431 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.5 m-20 -64.63 -55.94 17.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HD2' HG23 ' A' ' 57' ' ' VAL . 97.2 mttt -70.57 -40.49 73.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . . . -67.1 -30.0 69.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.26 -56.01 0.38 Allowed Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.214 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.0 mt . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.323 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 51.9 m -60.55 132.9 55.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.726 0.298 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -74.36 -143.3 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.49 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm 60.11 33.74 21.21 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.79 0.329 . . . . 0.0 111.088 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -90.6 143.45 26.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.19 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.8 mtm -128.8 -61.2 1.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.601 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.06 -33.35 0.43 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.535 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.704 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.6 p -61.36 -5.11 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.846 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.9 OUTLIER -44.62 -50.47 9.75 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.608 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -77.46 -30.29 53.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.968 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.704 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 71.5 m-20 -64.41 -52.28 58.93 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.473 HG13 ' CG2' ' A' ' 5' ' ' VAL . 15.9 mt -63.75 -43.79 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.7 OUTLIER -59.26 -25.94 64.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.008 178.036 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.91 -45.15 89.78 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.419 ' OE1' ' HB3' ' A' ' 42' ' ' CYS . 75.8 mt-30 -64.3 -29.87 70.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.739 -0.731 . . . . 0.0 109.724 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.457 ' CD1' ' CZ ' ' A' ' 10' ' ' ARG . 75.7 mt -74.94 -46.15 41.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.863 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 mm -55.25 -53.09 38.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 110.397 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.4 -34.94 90.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.239 -0.981 . . . . 0.0 110.772 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.77 67.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.315 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.584 HD21 ' HB2' ' A' ' 30' ' ' LEU . 38.4 mt -83.2 -29.74 28.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 110.47 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.16 117.08 5.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.569 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.82 -36.22 1.96 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.455 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.508 ' CB ' ' HB1' ' A' ' 33' ' ' ALA . . . -53.92 -172.37 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.477 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.556 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.6 OUTLIER -62.06 -119.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.741 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -60.79 179.62 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.803 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.7 Cg_endo -65.39 66.76 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 120.778 0.986 . . . . 0.0 112.561 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.78 HG13 HG23 ' A' ' 71' ' ' VAL . 30.2 mm 108.19 61.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.581 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.7 m120 -64.39 64.76 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.6 p 58.15 155.23 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.59 ' O ' ' CB ' ' A' ' 31' ' ' MET . 64.5 Cg_exo -49.17 -32.29 24.26 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.359 1.373 . . . . 0.0 112.775 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -52.82 -57.6 9.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.502 0.668 . . . . 0.0 110.333 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.581 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 46.5 tp10 -76.5 -57.78 3.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.585 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.6 pp -50.12 -41.68 49.09 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.59 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 39.5 ttm -66.55 -32.46 73.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.3 -30.77 71.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.462 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.508 ' HB1' ' CB ' ' A' ' 20' ' ' ALA . . . -69.93 -40.77 75.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.403 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.526 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.1 mp -28.24 127.34 0.22 Allowed Pre-proline 0 N--CA 1.468 0.453 0 CA-C-O 121.061 0.458 . . . . 0.0 111.871 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.7 -30.76 57.67 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.513 2.809 . . . . 0.0 114.119 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.575 ' CB ' ' HB ' ' A' ' 40' ' ' THR . 11.2 t30 -72.2 -27.49 62.58 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.06 -75.68 0.45 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.829 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 98.6 Cg_endo -82.18 52.65 4.23 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.542 2.161 . . . . 0.0 111.666 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 38' ' ' PRO . 7.6 p-10 50.61 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.682 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.575 ' HB ' ' CB ' ' A' ' 36' ' ' ASN . 3.2 t -58.98 136.21 57.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.183 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.412 ' CG2' ' HB3' ' A' ' 48' ' ' GLU . 28.5 m -102.73 91.33 4.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.757 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.419 ' HB3' ' OE1' ' A' ' 12' ' ' GLN . 59.3 m -70.24 57.96 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.921 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.434 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.1 pttp -75.74 129.99 37.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.189 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.9 p -81.99 87.74 6.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.51 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.12 -57.78 0.41 Allowed Glycine 0 CA--C 1.519 0.281 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.148 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -130.87 -46.39 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.781 0.324 . . . . 0.0 110.573 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.7 t -66.93 130.62 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.524 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.434 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 8.9 mp0 -114.95 133.85 55.66 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.945 0.403 . . . . 0.0 111.533 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.403 ' CD2' ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -144.66 135.44 24.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.661 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.405 ' HE2' ' OD2' ' A' ' 53' ' ' ASP . 57.9 pttt -171.66 -176.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.976 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.472 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -66.91 -41.78 86.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.129 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -63.87 -56.13 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 59.6 m-20 -72.28 -44.87 62.14 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.437 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -90.25 -49.76 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.95 -28.42 1.77 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.503 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 15.8 pt20 -42.85 -35.61 1.24 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.078 0.466 . . . . 0.0 111.707 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG23 ' HD2' ' A' ' 78' ' ' LYS . 24.6 m -65.53 -33.26 62.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.92 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.427 HD12 ' CZ ' ' A' ' 65' ' ' PHE . 34.8 mt -63.88 124.26 21.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 110.638 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.6 p -75.13 155.91 36.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.444 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.17 -41.42 60.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.403 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -57.28 -21.79 37.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.078 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.574 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 16.6 m-20 -69.13 3.33 2.18 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.537 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 1.3 m-85 -41.71 -66.67 0.38 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 118.055 0.389 . . . . 0.0 111.35 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 56.8 Cg_endo -69.54 74.89 1.16 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.337 2.025 . . . . 0.0 112.064 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.5 OUTLIER -76.95 142.89 39.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.221 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.499 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 14.3 mmmm -68.34 70.53 0.17 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.484 0.659 . . . . 0.0 110.509 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.803 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 46.2 m 58.41 160.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.948 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.696 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.65 -27.37 11.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.803 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.454 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.2 pt-20 -58.94 -48.39 81.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.525 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -73.78 -35.29 64.93 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.065 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.78 HG23 HG13 ' A' ' 24' ' ' ILE . 49.0 t -62.23 -36.51 74.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.022 0.439 . . . . 0.0 110.431 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.484 ' HA ' ' NE ' ' A' ' 10' ' ' ARG . . . -66.11 -57.64 7.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.259 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.418 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.5 m-20 -63.88 -42.13 97.56 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.55 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.3 m -55.01 -48.35 73.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.96 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.437 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 83.1 mt -64.32 -50.49 76.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.472 HG11 ' HD3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -51.78 -38.07 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.37 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.0 m-20 -63.97 -51.86 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.19 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HD2' HG23 ' A' ' 57' ' ' VAL . 61.3 mttp -70.64 -41.97 71.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.682 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.45 -29.95 69.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.964 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.53 -54.08 0.47 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.969 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 6' ' ' LYS . 15.1 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.166 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 48.0 t -178.47 -44.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.791 0.329 . . . . 0.0 110.951 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -59.79 130.62 47.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.07 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttp 179.39 -46.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.543 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 3' ' ' MET . 59.8 tttm -178.54 120.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.365 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.533 ' CE ' ' HA ' ' A' ' 3' ' ' MET . 0.2 OUTLIER -152.52 134.29 14.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.0 -140.09 5.63 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.421 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.743 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.5 p -77.16 -5.36 7.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 N-CA-C 111.278 0.103 . . . . 0.0 111.278 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.554 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 39.2 tttm -45.3 -52.24 9.98 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -78.3 -25.94 46.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.29 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.743 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 54.8 t0 -68.03 -52.69 32.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.858 0.361 . . . . 0.0 111.882 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.494 HG13 ' CG2' ' A' ' 5' ' ' VAL . 14.4 mt -64.66 -44.49 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.783 ' HD2' HG11 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -59.62 -26.65 65.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.822 177.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.07 -42.89 99.47 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.403 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 71.0 mt-30 -64.37 -27.71 69.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.429 -0.885 . . . . 0.0 109.508 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.453 ' CD1' ' NE ' ' A' ' 10' ' ' ARG . 61.5 mt -74.89 -45.3 43.76 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.285 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.1 mm -56.84 -54.21 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.811 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.61 -36.6 93.56 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.299 -0.953 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -65.0 -24.57 67.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.131 -0.534 . . . . 0.0 111.392 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.608 HD23 ' HB2' ' A' ' 30' ' ' LEU . 48.4 mt -84.2 -29.83 26.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.831 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.67 124.14 18.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.971 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.64 -34.1 3.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.852 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.566 ' N ' ' HB2' ' A' ' 33' ' ' ALA . . . -53.23 -174.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 0.0 111.583 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.573 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 9.3 m-20 -61.45 -118.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.731 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -59.73 179.51 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 176.331 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.813 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 55.6 Cg_endo -65.99 66.3 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.901 1.0 . . . . 0.0 112.213 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.683 ' C ' ' CE1' ' A' ' 22' ' ' PHE . 42.8 mm 109.29 61.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.636 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.4 m120 -63.23 66.11 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.579 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 57.6 p 57.26 155.93 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.748 ' O ' ' HB2' ' A' ' 31' ' ' MET . 55.6 Cg_exo -49.6 -32.94 29.47 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.365 1.377 . . . . 0.0 113.054 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -53.33 -57.29 11.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.375 0.607 . . . . 0.0 110.561 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.582 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 40.6 tp10 -74.96 -57.05 4.14 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.608 ' HB2' HD23 ' A' ' 17' ' ' LEU . 3.5 pp -49.92 -42.32 48.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.748 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 27.0 mtm -64.67 -31.96 73.41 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.01 -28.66 69.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.48 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.566 ' HB2' ' N ' ' A' ' 20' ' ' ALA . . . -74.46 -38.96 62.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.585 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.2 mp -33.2 131.96 0.35 Allowed Pre-proline 0 N--CA 1.469 0.482 0 CA-C-O 121.128 0.49 . . . . 0.0 111.803 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.27 -34.93 72.26 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 124.1 3.2 . . . . 0.0 115.172 -177.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.505 HD22 ' C ' ' A' ' 39' ' ' ASP . 15.3 p-10 -72.0 -27.24 62.61 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.35 -69.31 0.27 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.496 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.453 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 94.8 Cg_endo -81.4 38.25 0.74 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.655 2.236 . . . . 0.0 112.978 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.541 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.6 OUTLIER 61.6 95.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.3 0.571 . . . . 0.0 112.071 179.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.439 ' N ' ' OD1' ' A' ' 36' ' ' ASN . 2.7 t -64.34 138.35 58.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.249 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.463 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 19.8 m -93.77 123.17 36.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 60.0 m -91.04 45.91 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 0.0 110.609 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.463 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -75.67 155.06 36.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.171 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.4 m -150.65 128.63 11.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.294 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.45 -53.5 0.65 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.091 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -167.51 -41.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.978 0.418 . . . . 0.0 110.172 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.5 t -66.79 130.62 32.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.586 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.463 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 35.6 mt-10 -115.9 132.55 56.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -138.09 139.33 39.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.128 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 59.1 pttt -178.83 157.52 0.91 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.891 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.532 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.73 -27.77 2.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.89 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 t -71.99 -61.31 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 59.9 m-20 -72.41 -54.52 9.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.441 ' CB ' HG21 ' A' ' 75' ' ' ILE . . . -73.35 -43.39 60.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.87 -22.71 3.06 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.326 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 26.5 pt20 -41.22 -40.71 1.67 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.08 0.467 . . . . 0.0 111.691 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.436 ' HB ' ' HE2' ' A' ' 78' ' ' LYS . 34.7 m -65.79 -30.64 50.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.256 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' N ' HG21 ' A' ' 57' ' ' VAL . 14.3 mt -72.2 113.58 9.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.738 0.304 . . . . 0.0 110.458 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.7 p -79.52 158.39 27.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.453 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.51 -40.16 12.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.248 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -53.06 -26.97 17.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.652 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.5 m-20 -71.08 3.16 3.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.217 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.603 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -38.87 -64.68 0.46 Allowed Pre-proline 0 N--CA 1.462 0.156 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.391 -178.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 59.3 Cg_endo -71.04 79.37 1.35 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.276 1.984 . . . . 0.0 111.444 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.484 ' CB ' HG22 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -76.82 140.09 40.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.456 -179.245 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 2.7 mppt? -67.44 62.36 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.404 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.813 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 49.4 m 64.98 161.89 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.493 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.521 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -52.01 -28.61 17.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.679 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -65.3 -39.2 92.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 66' ' ' LYS . 17.7 tp10 -63.52 -43.2 97.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.215 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.531 ' CG2' HG13 ' A' ' 24' ' ' ILE . 88.1 t -57.64 -46.59 86.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.807 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.491 ' O ' ' CD ' ' A' ' 10' ' ' ARG . . . -53.77 -56.13 20.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.206 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.446 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.4 m-20 -65.61 -44.3 86.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.907 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.5 m -56.53 -47.42 79.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.191 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.451 ' CG2' ' NH1' ' A' ' 10' ' ' ARG . 65.2 mt -66.31 -51.88 53.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.783 HG11 ' HD2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -56.88 -41.85 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.973 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 77.3 m-20 -63.79 -54.58 32.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HE2' ' HB ' ' A' ' 57' ' ' VAL . 43.7 mtpt -74.87 -40.83 60.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.06 -29.98 69.91 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.24 -52.41 0.48 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.515 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' HB3' ' HG3' ' A' ' 6' ' ' LYS . 15.5 mt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.354 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 58.2 m -167.06 137.38 3.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.9 0.381 . . . . 0.0 110.812 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.39 -31.68 69.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.705 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.51 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 10.6 mmt 63.06 143.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.827 0.346 . . . . 0.0 110.831 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.434 ' HD2' ' HD2' ' A' ' 6' ' ' LYS . 20.2 ttmm -165.87 138.04 3.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.109 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.6 mtt -159.19 33.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.48 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.13 -122.78 2.15 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.867 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.663 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 2.1 p -77.32 -5.75 8.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 CA-C-N 115.833 -0.184 . . . . 0.0 111.189 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 48.9 tttp -44.89 -47.1 11.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -77.54 -33.35 54.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.905 177.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.663 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 16.4 m-20 -64.02 -52.24 60.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.504 HG13 ' CG2' ' A' ' 5' ' ' VAL . 30.2 mt -66.06 -47.09 86.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 45.6 ttp180 -55.26 -29.52 58.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.81 -44.49 96.12 Favored Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -67.57 -28.78 68.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.652 -0.774 . . . . 0.0 109.725 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 9' ' ' ILE . 71.3 mt -70.16 -43.03 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.4 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.496 HD13 ' HA ' ' A' ' 69' ' ' GLU . 13.5 mm -58.45 -48.83 84.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.004 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.16 -38.38 93.84 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.448 -0.882 . . . . 0.0 110.908 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.75 -34.02 73.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 0.0 110.694 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 30' ' ' LEU . 79.0 mt -83.9 -29.17 27.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.692 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.56 60.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.485 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.45 31.2 0.06 OUTLIER Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.994 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' CA ' ' HB3' ' A' ' 33' ' ' ALA . . . -114.45 -168.4 1.36 Allowed 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.957 0.408 . . . . 0.0 110.796 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.632 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 83.6 m-20 -59.32 -119.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.788 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -61.35 -171.16 0.04 OUTLIER Pre-proline 0 N--CA 1.454 -0.269 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 176.564 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.79 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.2 Cg_endo -70.89 64.21 2.46 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 120.72 1.293 . . . . 0.0 112.163 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.717 ' C ' ' CE1' ' A' ' 22' ' ' PHE . 50.2 mm 109.0 66.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.665 ' HB2' ' CB ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -65.42 65.85 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.881 -0.512 . . . . 0.0 111.449 178.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.601 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 51.4 p 57.48 158.97 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.716 ' O ' ' HB2' ' A' ' 31' ' ' MET . 51.5 Cg_exo -50.06 -33.33 34.43 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.344 1.362 . . . . 0.0 112.819 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -51.29 -57.32 9.16 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.64 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.665 ' CB ' ' HB2' ' A' ' 25' ' ' ASN . 45.7 tp10 -75.73 -58.53 3.23 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.614 ' HB2' HD21 ' A' ' 17' ' ' LEU . 3.5 pp -50.1 -40.16 44.92 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.716 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 29.9 ttm -63.53 -35.08 79.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.33 -30.91 69.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.303 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.516 ' HB3' ' CA ' ' A' ' 20' ' ' ALA . . . -65.34 -38.87 91.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.593 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' ' 30' ' ' LEU . 6.4 mp -39.53 134.55 1.24 Allowed Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.725 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -47.7 -29.8 11.59 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.393 2.729 . . . . 0.0 112.9 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.619 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 18.5 t30 -72.01 -26.36 62.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.528 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . 103.9 -64.65 0.36 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.958 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 60.4 Cg_endo -83.93 -38.64 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.754 2.302 . . . . 0.0 113.722 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.599 ' HB3' ' SD ' ' A' ' 31' ' ' MET . 53.5 p-10 174.21 71.12 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.619 ' HB ' ' HB3' ' A' ' 36' ' ' ASN . 6.2 t -59.22 140.71 55.69 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.661 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 3.1 t -114.99 124.21 51.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.033 0.444 . . . . 0.0 111.295 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 36.0 m -75.45 59.12 1.06 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.776 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.444 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 22.3 pttp -75.17 140.5 43.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.679 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.6 m -132.46 124.47 28.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.258 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.506 ' O ' ' OD1' ' A' ' 46' ' ' ASP . . . 67.09 -69.71 0.2 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.705 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 45' ' ' GLY . 67.8 m-20 -140.98 -46.04 0.39 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.766 0.317 . . . . 0.0 111.475 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.79 130.23 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.938 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.444 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 55.3 mt-10 -113.14 133.24 55.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.379 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 2.6 mm? -127.88 130.15 48.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.63 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.609 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 19.1 ptpt -156.28 -165.87 2.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.582 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.477 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -78.61 -41.87 30.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.481 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.3 t -67.26 -55.61 13.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.709 0.29 . . . . 0.0 111.443 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -69.39 -44.4 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.793 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HB1' ' HB1' ' A' ' 79' ' ' ALA . . . -92.73 -51.63 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -53.53 -22.25 16.15 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.474 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -43.35 -31.98 0.75 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 117.114 0.457 . . . . 0.0 111.203 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -80.2 27.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.412 HD23 ' CG2' ' A' ' 74' ' ' THR . 19.1 mt -132.48 109.13 9.58 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 p -68.08 156.59 37.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.825 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.23 -37.99 17.38 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.077 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -52.56 -26.22 12.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.63 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.544 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -72.24 3.07 4.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.295 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.601 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.5 OUTLIER -39.05 -61.12 1.0 Allowed Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.334 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.87 77.08 3.16 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.483 2.122 . . . . 0.0 111.847 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -76.63 142.53 40.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.096 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.473 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 58.1 mtpt -68.68 66.7 0.13 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.377 0.608 . . . . 0.0 110.463 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.79 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 24.2 m 61.05 161.14 0.06 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.085 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.602 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.54 -30.22 19.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.499 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.496 ' HA ' HD13 ' A' ' 14' ' ' ILE . 22.1 pt-20 -59.17 -45.72 90.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.483 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.507 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -70.47 -34.39 72.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.247 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.688 HG21 HG13 ' A' ' 24' ' ' ILE . 67.2 t -63.61 -41.98 94.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.015 0.436 . . . . 0.0 110.09 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.66 -50.18 72.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.785 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.49 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 24.8 m-20 -67.8 -47.31 69.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.128 0.489 . . . . 0.0 110.746 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.412 ' CG2' HD23 ' A' ' 58' ' ' LEU . 90.8 m -54.71 -48.97 71.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.857 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.446 HD13 HG23 ' A' ' 75' ' ' ILE . 67.0 mt -60.95 -56.11 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.559 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 81' ' ' LEU . 15.7 m -58.82 -40.49 80.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 77.7 m-20 -62.88 -55.17 28.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.375 . . . . 0.0 111.715 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -72.76 -40.16 66.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.253 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.449 ' HB1' ' HB1' ' A' ' 54' ' ' ALA . . . -67.01 -29.97 69.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.66 -56.16 0.4 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.88 -1.152 . . . . 0.0 113.41 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.434 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 22.9 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.401 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.6 -0.2 . . . . 0.0 112.6 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 47.5 t -60.91 131.6 51.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 110.943 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -67.45 138.88 56.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.987 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mtp 63.02 45.63 5.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.173 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 3' ' ' MET . 77.2 tttt -60.98 -63.19 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.656 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.422 ' O ' ' O ' ' A' ' 2' ' ' LYS . 26.5 mmt 57.46 132.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.448 0.642 . . . . 0.0 112.003 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.62 -144.71 10.22 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.049 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.713 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p -77.4 -5.63 7.93 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 C-N-CA 121.533 -0.067 . . . . 0.0 111.012 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 12.3 tmtt? -45.35 -51.67 10.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.9 -25.94 48.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.115 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.713 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 33.1 m-20 -67.86 -52.57 35.12 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.428 HG13 ' CG2' ' A' ' 5' ' ' VAL . 12.8 mt -65.7 -43.01 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.493 ' HD3' ' CG1' ' A' ' 76' ' ' VAL . 2.8 tpt180 -59.42 -29.07 67.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.62 -43.32 99.42 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 42' ' ' CYS . 6.4 tt0 -64.32 -29.01 70.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.334 177.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.439 ' CD1' ' CZ ' ' A' ' 10' ' ' ARG . 63.6 mt -74.37 -45.9 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.821 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 mm -56.42 -50.3 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.776 0.322 . . . . 0.0 110.329 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.47 -36.34 93.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.348 -0.93 . . . . 0.0 110.892 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 12' ' ' GLN . . . -65.07 -27.22 68.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.222 -0.489 . . . . 0.0 111.251 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.516 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 49.9 mt -84.13 -26.22 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.72 61.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.381 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.458 ' C ' ' HB3' ' A' ' 33' ' ' ALA . . . 174.14 35.02 0.04 OUTLIER Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.495 ' CB ' ' HB1' ' A' ' 33' ' ' ALA . . . -106.0 -175.97 2.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 110.99 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.571 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 53.4 m-20 -52.72 -66.97 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.742 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -116.86 -174.33 0.27 Allowed Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.819 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.7 Cg_endo -68.86 59.09 1.18 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-N 120.512 1.218 . . . . 0.0 111.987 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.754 HG13 HG23 ' A' ' 71' ' ' VAL . 24.7 mm 110.76 61.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.6 ' CB ' ' HB3' ' A' ' 29' ' ' GLU . 2.7 m120 -64.14 64.42 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.561 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.2 p 58.66 150.73 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.576 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 72.3 Cg_exo -46.77 -31.68 11.05 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.639 1.559 . . . . 0.0 112.984 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -55.54 -57.68 10.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.614 0.721 . . . . 0.0 110.338 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.6 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.0 tp10 -74.42 -57.08 4.17 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.557 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.576 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.3 pp -49.96 -36.54 28.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.571 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 55.2 mtm -64.04 -37.59 87.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.98 -24.55 65.16 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.477 0.656 . . . . 0.0 109.771 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.495 ' HB1' ' CB ' ' A' ' 20' ' ' ALA . . . -63.88 -50.83 67.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.653 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.42 ' HG ' ' HB2' ' A' ' 16' ' ' ALA . 6.1 mp -43.25 139.18 2.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.361 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -47.95 -32.74 18.55 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.842 3.028 . . . . 0.0 113.151 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.541 ' CB ' ' HB ' ' A' ' 40' ' ' THR . 4.9 t30 -72.16 -25.49 61.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.864 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.01 -76.69 0.24 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.884 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD2' ' ND2' ' A' ' 36' ' ' ASN . 95.7 Cg_endo -83.23 35.89 0.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.419 2.079 . . . . 0.0 112.053 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.534 ' CB ' ' HG2' ' A' ' 31' ' ' MET . 13.8 t70 65.66 99.81 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.479 0.656 . . . . 0.0 111.822 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.541 ' HB ' ' CB ' ' A' ' 36' ' ' ASN . 2.7 t -64.95 141.44 58.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.905 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.487 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 7.3 m -82.74 115.09 21.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.433 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.464 ' HB3' ' NE2' ' A' ' 12' ' ' GLN . 32.3 m -89.2 50.56 1.96 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.018 0.437 . . . . 0.0 110.383 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.5 pttm -75.41 147.63 39.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.975 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.2 m -137.63 127.84 26.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.031 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.57 -58.39 0.47 Allowed Glycine 0 CA--C 1.519 0.344 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.046 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -159.47 -42.17 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 110.728 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.1 t -66.43 134.59 29.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.985 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.447 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 51.0 mt-10 -119.04 134.09 55.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.861 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -135.24 137.26 42.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.672 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.487 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 63.6 pttt -175.87 155.6 1.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.645 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.45 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.62 -39.39 16.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.05 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.6 t -63.53 -49.85 71.89 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.437 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.19 -53.86 11.37 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.443 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -92.23 -46.51 7.69 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.93 -29.54 2.12 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.089 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -45.27 -30.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.507 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -77.16 27.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 43.2 mt -133.18 117.24 17.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.889 0.376 . . . . 0.0 110.096 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.5 p -74.55 159.52 32.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.161 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.89 -37.58 31.94 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.085 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -50.97 -29.73 13.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.104 0.478 . . . . 0.0 110.06 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.544 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.5 m-20 -72.64 3.84 4.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.533 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.5 t80 -39.84 -51.8 5.33 Favored Pre-proline 0 C--O 1.226 -0.147 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 81.4 Cg_endo -87.74 77.31 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.832 2.355 . . . . 0.0 112.131 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.583 ' CG ' HG21 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.18 143.46 39.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.215 0.531 . . . . 0.0 111.87 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -68.28 70.8 0.17 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.742 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.819 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 21.7 m 57.04 163.66 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.203 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.89 -31.97 30.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.201 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -57.26 -49.17 76.9 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.541 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -72.49 -34.69 67.84 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.084 -179.475 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.754 HG23 HG13 ' A' ' 24' ' ' ILE . 62.1 t -65.19 -37.02 79.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.817 0.341 . . . . 0.0 111.145 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.468 ' HA ' ' NE ' ' A' ' 10' ' ' ARG . . . -65.35 -55.4 18.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.973 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.44 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.5 m-20 -66.32 -44.85 82.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.66 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.3 m -53.92 -47.65 70.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.76 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.443 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 76.8 mt -62.98 -53.13 50.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.522 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.493 ' CG1' ' HD3' ' A' ' 10' ' ' ARG . 1.8 m -53.99 -39.33 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.6 m-20 -60.07 -51.92 67.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 0.0 111.753 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -74.88 -40.11 61.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.81 -30.01 70.09 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.93 -54.81 0.4 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.553 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 8.7 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.099 -178.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 60.8 m -167.3 137.06 2.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.818 0.342 . . . . 0.0 110.797 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 63.54 -121.66 0.54 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.293 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt 60.6 44.06 12.01 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 122.115 -0.366 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -178.97 134.66 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 ttt -177.7 134.23 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.977 0.418 . . . . 0.0 111.021 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.89 -137.79 3.87 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.142 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.716 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.7 p -75.51 -5.36 7.09 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 O-C-N 122.967 -0.137 . . . . 0.0 111.161 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 12.8 tmtt? -45.34 -51.14 11.49 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -77.78 -27.97 50.39 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.066 177.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.716 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 72.6 m-20 -65.59 -52.38 52.58 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.462 HG13 ' CG2' ' A' ' 5' ' ' VAL . 16.7 mt -65.41 -43.28 94.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 1.1 tpt180 -60.16 -25.73 65.77 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.42 -45.18 87.69 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 178.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.437 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 63.7 mt-30 -64.39 -31.58 72.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.768 -0.716 . . . . 0.0 109.774 178.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.459 ' CD1' ' CZ ' ' A' ' 10' ' ' ARG . 73.6 mt -73.88 -45.24 50.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.964 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.0 mm -55.54 -53.33 37.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.784 0.326 . . . . 0.0 110.305 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.09 -34.59 88.53 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.479 ' HB2' ' HG ' ' A' ' 34' ' ' LEU . . . -65.46 -26.76 68.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.052 -0.574 . . . . 0.0 111.189 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.646 HD23 ' HB2' ' A' ' 30' ' ' LEU . 51.5 mt -80.21 -29.53 38.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.434 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.2 134.38 56.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.002 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.1 -32.25 6.06 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.898 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.573 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -52.44 -174.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.031 0.443 . . . . 0.0 111.592 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.574 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.5 m-20 -60.23 -120.31 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.788 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -62.14 -169.59 0.03 OUTLIER Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.597 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.802 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 60.3 Cg_endo -71.61 62.08 2.91 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 CA-C-N 120.888 1.353 . . . . 0.0 112.305 178.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.776 HG13 HG21 ' A' ' 71' ' ' VAL . 48.5 mm 110.59 65.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 177.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.68 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -65.68 66.26 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.976 -0.452 . . . . 0.0 111.328 178.031 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.526 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 53.9 p 59.39 156.02 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.565 ' O ' ' HB2' ' A' ' 31' ' ' MET . 64.9 Cg_exo -49.17 -33.73 28.55 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.45 1.433 . . . . 0.0 112.948 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.51 -54.46 36.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.04 0.448 . . . . 0.0 110.697 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.68 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 17.4 tp10 -75.93 -57.57 3.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.646 ' HB2' HD23 ' A' ' 17' ' ' LEU . 3.9 pp -50.03 -39.79 42.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.565 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 72.0 mtm -66.67 -32.97 74.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.51 -28.35 68.49 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 121.215 0.531 . . . . 0.0 110.253 179.018 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.573 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -70.28 -46.9 63.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.94 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.602 HD23 ' HA ' ' A' ' 39' ' ' ASP . 8.9 mp -33.73 139.39 0.27 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 112.186 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -47.62 -42.95 29.1 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 124.014 3.142 . . . . 0.0 114.417 -178.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.462 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 15.7 p-10 -72.58 -27.39 62.16 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.62 -70.54 0.25 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.797 -0.715 . . . . 0.0 112.061 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 88.8 Cg_endo -80.22 49.5 3.23 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.746 2.298 . . . . 0.0 112.533 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.602 ' HA ' HD23 ' A' ' 34' ' ' LEU . 2.3 p30 49.25 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.431 ' N ' HD22 ' A' ' 36' ' ' ASN . 1.7 t -56.89 134.06 55.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.149 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.475 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 16.8 m -81.58 118.55 22.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.265 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 61.7 m -92.34 43.79 1.14 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.256 0.55 . . . . 0.0 109.553 178.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.476 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 23.9 pttm -75.54 143.57 42.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.919 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.0 m -133.87 122.3 23.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.544 178.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.28 -132.45 30.4 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.185 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -79.24 -26.91 42.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.412 HG12 HD23 ' A' ' 49' ' ' LEU . 33.1 t -85.24 138.48 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.476 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 7.5 mp0 -126.77 135.11 50.63 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.293 179.24 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.412 HD23 HG12 ' A' ' 47' ' ' VAL . 3.6 mm? -141.11 140.81 34.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.094 0.473 . . . . 0.0 111.347 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 61.7 pttt -178.21 152.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.369 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.574 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.57 -30.74 3.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.005 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.3 t -69.57 -55.89 8.86 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.644 -179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 43.2 m-20 -72.41 -51.9 18.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.79 -45.57 12.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.1 -28.49 1.92 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.207 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 18.1 pt20 -43.7 -31.82 0.87 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.038 0.447 . . . . 0.0 111.329 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.8 m -77.09 27.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.667 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 43.4 mt -132.3 108.37 9.17 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.3 p -66.97 155.95 37.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.849 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.63 -37.69 13.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.229 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.67 -26.46 13.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.606 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.618 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -73.21 3.17 6.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.37 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.526 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.0 OUTLIER -41.13 -61.91 1.19 Allowed Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 117.682 0.219 . . . . 0.0 111.35 -179.337 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 63.3 Cg_endo -72.67 73.95 2.83 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.441 2.094 . . . . 0.0 111.963 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.618 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -76.77 141.58 40.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.431 -179.44 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.52 ' HB3' ' CG ' ' A' ' 70' ' ' GLU . 41.4 ttmt -67.8 69.07 0.11 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.398 0.618 . . . . 0.0 110.706 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.802 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 31.5 m 59.37 161.42 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.962 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.702 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.61 -29.81 18.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.757 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.432 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.0 pt-20 -58.63 -46.03 87.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.532 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.52 ' CG ' ' HB3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -73.96 -35.48 64.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.891 -179.562 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.776 HG21 HG13 ' A' ' 24' ' ' ILE . 45.7 t -62.87 -40.8 90.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.968 0.413 . . . . 0.0 110.417 179.433 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.423 ' HA ' ' NE ' ' A' ' 10' ' ' ARG . . . -61.73 -55.67 27.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.168 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.433 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 27.8 m-20 -64.11 -43.91 93.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.43 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.8 m -53.79 -46.95 71.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.926 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 71' ' ' VAL . 81.0 mt -64.79 -49.95 77.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.735 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.472 HG13 HH11 ' A' ' 10' ' ' ARG . 1.3 m -55.77 -38.22 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.272 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.9 m-20 -63.24 -52.78 60.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 0.0 111.396 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -72.68 -41.77 64.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.999 -179.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.3 -29.87 69.57 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.15 -54.11 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.982 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 16.0 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.193 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 112.434 -0.267 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 53.7 m 60.52 54.25 3.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -51.42 130.4 27.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.179 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mmm -67.32 -33.66 75.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.143 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' HE2' ' CB ' ' A' ' 6' ' ' LYS . 28.3 tptp -144.22 141.21 29.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.466 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 3' ' ' MET . 49.5 ttp -160.07 38.58 0.18 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.806 0.336 . . . . 0.0 111.351 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.4 -38.65 1.02 Allowed Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.823 -0.703 . . . . 0.0 114.385 178.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.719 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.4 p -58.63 -6.21 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 CA-C-N 117.452 0.626 . . . . 0.0 112.276 -178.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 46.9 tttm -45.67 -51.07 12.87 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.617 -0.833 . . . . 0.0 108.947 -179.325 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.78 -25.99 49.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.057 177.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.719 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 72.6 m-20 -68.18 -52.56 33.02 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.441 HG23 HD12 ' A' ' 9' ' ' ILE . 14.4 mt -66.02 -42.4 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 3.0 tpt180 -59.84 -27.18 66.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.7 177.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.02 -44.37 95.99 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 178.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.415 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 68.5 mt-30 -64.1 -27.68 69.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.439 177.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.468 ' CG2' ' NH2' ' A' ' 10' ' ' ARG . 64.4 mt -74.8 -50.25 26.32 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.86 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mm -53.77 -49.14 59.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.0 -36.67 93.79 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 178.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HB2' ' HG ' ' A' ' 34' ' ' LEU . . . -63.63 -27.99 69.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.857 179.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 30' ' ' LEU . 71.6 mt -78.8 -29.46 44.88 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.503 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.32 136.5 43.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.114 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.12 -33.5 6.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.814 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.556 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -50.8 -179.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 111.467 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.57 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 71.3 m-20 -58.25 -122.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.249 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.72 ' CG ' ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -62.66 -174.99 0.11 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 177.071 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.847 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 48.9 Cg_endo -66.55 61.78 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 CA-C-N 120.103 1.072 . . . . 0.0 112.723 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.772 HG13 ' HA ' ' A' ' 68' ' ' ALA . 36.6 mm 108.24 64.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 177.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.659 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.5 m120 -63.9 65.14 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.303 -0.248 . . . . 0.0 111.55 178.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.599 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 58.2 p 59.5 151.79 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.635 ' O ' ' HB2' ' A' ' 31' ' ' MET . 73.7 Cg_exo -46.88 -29.69 8.56 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.53 1.486 . . . . 0.0 112.642 -179.102 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.04 -57.12 13.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.511 0.672 . . . . 0.0 110.565 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.659 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 17.1 tp10 -73.39 -57.23 4.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.017 -179.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.662 ' HB2' HD21 ' A' ' 17' ' ' LEU . 3.9 pp -50.89 -38.21 48.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.635 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 61.0 mtm -67.13 -31.99 72.82 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.98 -29.69 67.96 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.65 179.266 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.556 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -71.48 -38.74 71.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.43 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.569 HD22 ' HA ' ' A' ' 39' ' ' ASP . 10.9 mp -38.37 143.77 0.41 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 121.158 0.504 . . . . 0.0 112.093 -178.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -47.68 -40.35 30.88 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 124.013 3.142 . . . . 0.0 114.361 -178.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.435 ' N ' HD21 ' A' ' 36' ' ' ASN . 0.1 OUTLIER -71.84 -16.66 62.16 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.845 -178.904 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.11 -67.28 0.23 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.286 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.579 ' O ' ' HB3' ' A' ' 31' ' ' MET . 64.0 Cg_endo -77.88 -54.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.209 1.939 . . . . 0.0 112.644 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.569 ' HA ' HD22 ' A' ' 34' ' ' LEU . 4.5 p-10 174.53 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.893 0.477 . . . . 0.0 110.293 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.443 HG21 ' HB3' ' A' ' 34' ' ' LEU . 9.4 t -71.17 135.2 47.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.863 0.363 . . . . 0.0 111.337 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.474 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 10.9 m -82.38 126.37 32.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.357 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.9 m -93.61 47.63 1.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.04 0.448 . . . . 0.0 110.217 178.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.3 pttm -75.26 145.48 41.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.156 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.0 m -137.28 127.33 25.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.935 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.64 -58.3 0.49 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.971 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -159.48 -42.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 110.72 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.8 t -66.7 133.26 31.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.892 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.443 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 26.5 mt-10 -116.01 135.06 54.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.866 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -138.64 137.18 36.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.183 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 61.6 pttt -177.66 157.92 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.735 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.86 -37.81 14.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.937 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.4 t -61.77 -51.96 66.16 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.376 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -72.41 -54.22 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . . . -91.51 -44.42 9.1 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.87 -28.44 1.73 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.938 -179.307 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -44.3 -31.49 1.04 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.007 0.432 . . . . 0.0 110.813 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.9 m -76.96 27.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.352 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.8 mt -134.35 92.06 2.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.913 0.387 . . . . 0.0 110.354 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.9 p -55.7 155.92 5.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.83 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.17 -36.62 8.85 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.384 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -50.81 -30.26 13.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.422 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.551 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 53.3 m-20 -72.71 3.81 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.747 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.599 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.0 t80 -38.0 -52.07 3.0 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.481 0.182 . . . . 0.0 111.396 -178.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 80.0 Cg_endo -86.39 78.42 2.09 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.681 2.254 . . . . 0.0 111.83 179.155 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' CG ' HG21 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -76.69 143.35 40.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.005 0.431 . . . . 0.0 111.741 -179.37 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.51 ' HB2' ' CD ' ' A' ' 70' ' ' GLU . 14.4 mmmm -67.17 70.68 0.1 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.634 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.847 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 47.5 m 58.73 158.74 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.69 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.772 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.83 -28.04 14.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.922 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.8 pt-20 -59.53 -47.39 85.71 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.419 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.51 ' CD ' ' HB2' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -72.04 -37.32 69.74 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.758 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.758 HG23 HG13 ' A' ' 24' ' ' ILE . 43.6 t -59.76 -36.28 65.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.98 0.419 . . . . 0.0 110.799 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.484 ' HA ' ' NE ' ' A' ' 10' ' ' ARG . . . -67.94 -57.83 5.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.442 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.404 ' HA ' ' CG2' ' A' ' 76' ' ' VAL . 1.5 m-20 -63.83 -42.29 97.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.701 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.8 m -54.01 -52.63 60.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.744 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.419 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 84.5 mt -60.03 -50.45 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.583 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.509 ' CG1' ' HD3' ' A' ' 10' ' ' ARG . 2.8 m -58.43 -39.75 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.32 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -52.96 -56.08 18.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.33 . . . . 0.0 110.936 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 80' ' ' GLY . 51.1 mtpt -75.08 -39.1 61.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.163 0.506 . . . . 0.0 110.886 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . . . -68.87 32.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -179.164 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 78' ' ' LYS . . . 88.97 -53.36 3.96 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.566 179.062 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.7 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.157 -178.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 84.0 p 52.18 40.55 29.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.815 0.341 . . . . 0.0 111.121 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.33 -14.73 63.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.404 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt -57.64 136.23 56.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.884 0.373 . . . . 0.0 111.175 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -123.24 132.08 53.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.583 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.9 mtt -63.78 125.03 23.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.952 0.406 . . . . 0.0 111.053 -179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.19 -34.32 51.91 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.362 179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.732 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.5 p -65.24 -5.17 2.33 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 40.7 tttm -44.94 -51.7 9.48 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.105 -178.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -77.84 -27.19 49.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.077 177.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.732 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 72.7 m-20 -67.22 -52.29 42.89 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.471 HG13 ' CG2' ' A' ' 5' ' ' VAL . 14.0 mt -63.81 -43.44 97.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.708 ' HD2' HG11 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -60.46 -26.48 66.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.582 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.2 -42.04 99.48 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 177.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -64.33 -28.76 69.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.362 177.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.437 ' CD1' ' CZ ' ' A' ' 10' ' ' ARG . 67.5 mt -74.38 -46.06 44.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.234 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.4 mm -56.99 -53.7 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.636 0.255 . . . . 0.0 110.525 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.47 -36.71 92.97 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HB2' ' HG ' ' A' ' 34' ' ' LEU . . . -63.94 -27.3 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.08 -0.56 . . . . 0.0 110.92 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.608 HD22 ' HB2' ' A' ' 30' ' ' LEU . 61.6 mt -79.64 -29.45 40.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.448 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.96 136.66 57.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.002 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.07 -33.11 6.35 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.774 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.556 ' N ' ' HB1' ' A' ' 33' ' ' ALA . . . -50.79 -179.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.807 0.337 . . . . 0.0 111.493 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.593 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 73.1 m-20 -59.98 -121.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.739 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -58.99 177.35 0.25 Allowed Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 176.44 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.78 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 43.5 Cg_endo -64.26 67.63 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 119.897 0.999 . . . . 0.0 112.105 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.709 ' C ' ' CE1' ' A' ' 22' ' ' PHE . 44.4 mm 105.89 61.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 178.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.593 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.6 m120 -64.1 65.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 178.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 63.5 p 57.37 156.5 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.573 ' O ' ' CB ' ' A' ' 31' ' ' MET . 54.2 Cg_exo -50.43 -32.26 33.55 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.438 1.425 . . . . 0.0 112.829 -179.011 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -53.49 -57.35 10.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.452 0.644 . . . . 0.0 110.3 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.591 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -76.02 -57.98 3.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -179.272 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.608 ' HB2' HD22 ' A' ' 17' ' ' LEU . 3.8 pp -50.56 -43.72 56.39 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 30.7 ttm -65.52 -30.69 71.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.95 -29.69 66.88 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.597 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.556 ' HB1' ' N ' ' A' ' 20' ' ' ALA . . . -67.76 -40.32 84.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.087 -179.414 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' A' ' 39' ' ' ASP . 10.1 mp -25.34 135.43 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.568 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.001 -179.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.13 26.23 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.588 2.859 . . . . 0.0 115.279 -178.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.479 HD22 ' C ' ' A' ' 39' ' ' ASP . 13.2 p-10 -129.48 -27.46 2.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 118.351 0.523 . . . . 0.0 111.927 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.45 -71.34 0.28 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.732 -179.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.405 ' CD ' ' O ' ' A' ' 36' ' ' ASN . 85.2 Cg_endo -83.86 41.37 1.03 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.699 2.266 . . . . 0.0 113.515 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.542 ' HA ' HD22 ' A' ' 34' ' ' LEU . 1.2 m-20 61.74 94.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 178.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.468 ' HB ' ' CG ' ' A' ' 36' ' ' ASN . 5.7 t -70.05 141.62 52.82 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.767 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.42 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 32.2 m -100.29 121.96 42.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.902 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -92.79 46.57 1.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 110.014 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.432 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 20.8 ptmt -75.53 125.72 29.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.938 -179.168 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.7 m -107.62 120.39 42.08 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.68 -127.36 39.04 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.136 -1.031 . . . . 0.0 111.536 -178.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -79.67 -40.2 29.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.743 0.306 . . . . 0.0 111.436 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 48' ' ' GLU . 28.5 t -68.5 141.48 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.636 -179.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.432 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 38.4 mt-10 -125.84 134.11 51.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.8 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -138.5 138.95 38.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.05 0.452 . . . . 0.0 110.968 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.42 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 60.7 pttt -177.46 153.64 0.93 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.446 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.575 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.49 -29.24 2.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.809 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.401 ' HA ' ' HE2' ' A' ' 31' ' ' MET . 44.4 t -71.18 -56.06 6.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.663 0.268 . . . . 0.0 111.585 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -72.28 -54.42 9.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.35 . . . . 0.0 111.922 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.413 ' HB1' ' CG2' ' A' ' 75' ' ' ILE . . . -78.34 -48.08 16.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.936 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.39 -26.91 5.31 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.37 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -40.21 -35.97 0.46 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.555 0.693 . . . . 0.0 111.024 179.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.0 m -79.14 27.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.021 -177.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.7 mt -130.21 109.9 11.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.934 0.397 . . . . 0.0 110.057 179.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.6 p -70.81 157.24 38.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.885 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.81 -36.89 12.52 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.754 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -51.32 -29.45 15.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.163 179.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.515 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.3 m-20 -72.23 3.34 4.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.597 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.522 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.0 t80 -38.37 -51.71 3.4 Favored Pre-proline 0 C--O 1.227 -0.09 0 N-CA-C 111.308 0.114 . . . . 0.0 111.308 -178.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 87.0 Cg_endo -88.08 81.45 1.03 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.837 2.358 . . . . 0.0 112.046 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.534 ' CB ' HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -76.93 141.8 40.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.875 -179.855 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.528 ' CA ' ' HG2' ' A' ' 70' ' ' GLU . 47.6 mmtm -68.53 66.54 0.12 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.531 0.682 . . . . 0.0 110.516 179.005 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.78 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 15.4 m 61.34 160.93 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.197 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.645 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.46 -31.09 22.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.889 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.6 pt-20 -59.86 -47.01 87.47 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.331 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.528 ' HG2' ' CA ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -67.61 -33.38 74.88 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.36 -179.77 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.658 HG21 HG13 ' A' ' 24' ' ' ILE . 94.5 t -59.14 -47.08 91.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.922 0.391 . . . . 0.0 110.394 179.223 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.448 ' O ' ' CD ' ' A' ' 10' ' ' ARG . . . -56.71 -55.11 38.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.311 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.442 ' O ' HG22 ' A' ' 76' ' ' VAL . 1.5 m-20 -64.47 -36.36 83.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.585 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.4 m -65.95 -49.35 68.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.026 -179.211 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 71' ' ' VAL . 74.1 mt -59.88 -49.7 82.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.705 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.708 HG11 ' HD2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -57.49 -40.24 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.247 179.861 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -62.93 -54.7 34.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.876 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -74.06 -40.33 62.88 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.97 -29.91 69.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.12 -51.5 0.52 Allowed Glycine 0 CA--C 1.509 -0.342 0 C-N-CA 119.817 -1.182 . . . . 0.0 113.16 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.8 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.349 -178.837 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 51.6 m 60.13 46.82 10.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.906 0.384 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -176.11 -44.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt -79.21 50.29 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.475 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt 69.29 -120.84 0.14 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.7 mtt -87.5 -35.11 18.38 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 122.035 -0.416 . . . . 0.0 110.804 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.99 -43.52 2.85 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.861 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.69 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 2.1 p -69.89 -6.08 6.11 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.894 0 CA-C-N 116.734 0.267 . . . . 0.0 111.411 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 11.2 tmtt? -45.37 -49.03 13.37 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -77.37 -30.31 53.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.043 177.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.69 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 71.9 m-20 -66.44 -52.32 47.63 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.551 HG21 ' NH2' ' A' ' 10' ' ' ARG . 17.7 mt -62.26 -51.07 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.178 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.775 HH11 HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -57.96 -25.58 61.18 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.369 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.42 -38.58 94.99 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 177.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -68.82 -35.26 76.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.383 -0.908 . . . . 0.0 110.569 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.609 HD11 ' NE ' ' A' ' 10' ' ' ARG . 11.7 mt -69.91 -43.75 79.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.4 mm -54.51 -52.46 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.717 0.294 . . . . 0.0 110.612 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.01 -37.25 94.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.935 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.52 -25.02 67.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.22 -0.49 . . . . 0.0 111.365 179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.554 HD23 ' HB2' ' A' ' 30' ' ' LEU . 33.4 mt -85.82 -29.37 23.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.978 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.64 81.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.719 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.83 -35.8 0.13 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.921 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 30' ' ' LEU . . . -53.03 -173.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.182 0.515 . . . . 0.0 111.904 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.554 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.7 OUTLIER -60.25 -119.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.018 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.735 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.97 179.79 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 177.033 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.752 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 47.9 Cg_endo -65.23 65.34 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 120.801 1.001 . . . . 0.0 112.358 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.797 HG13 HG23 ' A' ' 71' ' ' VAL . 28.6 mm 107.78 62.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 177.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.587 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.7 m120 -63.98 64.16 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.327 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 15.7 p 59.1 152.65 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.586 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 77.8 Cg_exo -48.0 -30.47 13.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.46 1.44 . . . . 0.0 112.707 -179.245 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -54.72 -57.49 11.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.492 0.663 . . . . 0.0 110.289 179.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.587 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.3 tp10 -76.11 -57.85 3.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.054 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.586 ' HG ' ' HA ' ' A' ' 27' ' ' PRO . 3.5 pp -50.29 -45.53 54.53 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.554 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 33.8 ttm -66.05 -29.78 70.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.56 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.08 -30.12 68.37 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.501 ' HB3' ' N ' ' A' ' 20' ' ' ALA . . . -72.73 -38.92 67.28 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 30' ' ' LEU . 7.1 mp -27.92 128.12 0.21 Allowed Pre-proline 0 N--CA 1.47 0.563 0 CA-C-O 120.949 0.404 . . . . 0.0 111.79 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.98 -25.32 69.62 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.569 2.846 . . . . 0.0 114.071 -178.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.616 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 9.1 t30 -72.04 -27.43 62.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.06 -74.23 0.45 Allowed Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.925 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 80.7 Cg_endo -84.5 47.14 2.09 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.833 2.355 . . . . 0.0 112.512 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.466 ' HA ' HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER 64.68 95.28 0.05 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.553 179.451 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 36' ' ' ASN . 6.6 t -65.31 141.15 58.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.22 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.7 m -105.92 115.8 30.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -89.46 44.03 1.18 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.098 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.539 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.3 pttp -79.68 124.05 28.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.255 -179.043 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 61.2 m -101.38 122.13 43.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.15 -129.48 37.77 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.174 -1.013 . . . . 0.0 111.762 -178.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 47' ' ' VAL . 40.6 p-10 -78.97 -38.88 35.8 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.413 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 49.0 t -66.97 142.38 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.637 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.539 ' HA ' ' CB ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -137.48 124.94 22.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.288 0.566 . . . . 0.0 111.813 179.615 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -136.6 141.07 43.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.366 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HE3' ' HB3' ' A' ' 52' ' ' SER . 61.6 pttt -173.4 -168.81 0.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.937 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.535 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -65.58 -46.14 80.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.867 0.365 . . . . 0.0 111.576 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.439 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.1 t -69.99 -44.45 69.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.69 0.281 . . . . 0.0 111.495 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -67.34 -53.05 32.98 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.822 0.344 . . . . 0.0 111.906 -179.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.462 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -96.2 -44.05 7.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.468 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.64 -30.67 2.28 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.425 -178.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -46.93 -33.96 5.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.105 0.479 . . . . 0.0 110.987 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.6 -31.1 52.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.548 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.6 mt -66.66 125.39 25.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.773 0.32 . . . . 0.0 110.639 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.8 p -75.63 155.79 35.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.289 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.18 -42.09 60.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.332 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.63 -23.25 26.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.963 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.632 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 14.5 m-20 -67.89 3.16 1.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.593 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -41.03 -56.04 4.39 Favored Pre-proline 0 C--O 1.226 -0.184 0 CA-C-N 117.837 0.289 . . . . 0.0 111.673 -178.949 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 2.0 Cg_endo -80.33 76.92 4.27 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.897 2.398 . . . . 0.0 112.017 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.632 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.8 OUTLIER -77.16 142.0 39.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.488 -179.752 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 38.4 mtmm -67.89 70.5 0.14 Allowed 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.455 0.645 . . . . 0.0 110.419 178.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.752 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 28.9 m 58.43 161.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.162 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.674 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.67 -26.85 9.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.888 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.9 pt-20 -59.2 -50.46 73.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.652 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.5 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -72.65 -32.26 65.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.976 -179.418 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.797 HG23 HG13 ' A' ' 24' ' ' ILE . 57.9 t -61.98 -40.82 88.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.724 0.297 . . . . 0.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.0 -52.19 57.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.551 ' O ' HG23 ' A' ' 76' ' ' VAL . 32.1 m-20 -64.49 -37.44 87.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.011 0.434 . . . . 0.0 111.202 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.3 m -58.09 -41.93 84.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.442 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.462 HG23 ' CB ' ' A' ' 54' ' ' ALA . 63.5 mt -62.1 -53.72 44.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.134 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.775 HG12 HH11 ' A' ' 10' ' ' ARG . 2.5 m -56.94 -43.35 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 78.0 m-20 -62.6 -53.72 50.44 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -74.0 -42.41 60.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.078 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.56 -30.08 69.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.25 -55.77 0.42 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 119.936 -1.125 . . . . 0.0 113.144 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.484 ' HB2' HG11 ' A' ' 76' ' ' VAL . 21.7 mt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.405 -178.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 53.4 m -61.28 136.65 58.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 111.002 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -175.76 -57.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.7 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt -85.55 135.94 33.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.533 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.523 ' HB3' ' NZ ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -175.38 134.41 0.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.012 -179.84 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.416 ' N ' ' HD2' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -176.9 125.11 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.049 179.731 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.16 -114.98 0.62 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.852 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.715 ' HA ' ' HB2' ' A' ' 8' ' ' ASP . 1.7 p -62.19 -5.19 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.559 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 79.8 tttt -44.83 -51.08 9.88 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.362 -0.836 . . . . 0.0 109.211 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.6 -29.5 51.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.956 177.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.715 ' HB2' ' HA ' ' A' ' 5' ' ' VAL . 72.0 m-20 -64.48 -52.13 59.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.13 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.468 HG13 ' CG2' ' A' ' 5' ' ' VAL . 12.1 mt -63.16 -46.41 95.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HD3' ' CG1' ' A' ' 76' ' ' VAL . 1.8 tpt180 -57.19 -25.94 59.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.166 177.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.37 -48.34 70.11 Favored Glycine 0 CA--C 1.505 -0.531 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -62.63 -29.08 70.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.807 -0.696 . . . . 0.0 109.343 177.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.428 ' CD1' ' CZ ' ' A' ' 10' ' ' ARG . 59.7 mt -70.4 -45.53 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.801 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.1 mm -53.69 -48.54 60.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.66 -37.4 94.33 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.816 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.61 -27.81 69.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.918 0.39 . . . . 0.0 110.978 179.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.606 HD22 ' HB2' ' A' ' 30' ' ' LEU . 54.1 mt -80.69 -29.56 36.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.378 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.04 135.12 56.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.005 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.38 -33.17 5.67 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.723 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.566 ' N ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.29 -175.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.931 0.396 . . . . 0.0 111.509 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.569 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.26 -122.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.896 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.822 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -59.93 -173.42 0.05 OUTLIER Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 176.685 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.85 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 58.1 Cg_endo -69.33 61.52 1.5 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 CA-C-N 120.453 1.197 . . . . 0.0 112.592 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.769 HG13 HG23 ' A' ' 71' ' ' VAL . 43.4 mm 111.98 65.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 177.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.655 ' ND2' ' CD2' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -64.31 65.68 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.085 -0.385 . . . . 0.0 111.534 178.132 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.543 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 54.0 p 58.89 155.01 0.09 OUTLIER Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.644 ' O ' ' HB2' ' A' ' 31' ' ' MET . 54.4 Cg_exo -49.29 -33.71 29.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.236 1.291 . . . . 0.0 112.887 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.04 -56.28 17.33 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.074 0.464 . . . . 0.0 110.787 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.632 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.5 tp10 -74.54 -57.72 3.75 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.296 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.606 ' HB2' HD22 ' A' ' 17' ' ' LEU . 3.8 pp -49.79 -39.76 39.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.644 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 65.4 mtm -64.4 -34.85 79.12 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.77 -26.55 65.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.681 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.566 ' HB2' ' N ' ' A' ' 20' ' ' ALA . . . -71.09 -43.24 68.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.667 -179.318 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.536 ' HB3' HG21 ' A' ' 40' ' ' THR . 10.1 mp -37.33 138.91 0.55 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 112.274 -178.406 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -47.86 -31.61 15.68 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.869 3.046 . . . . 0.0 113.518 -178.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.571 ' CB ' ' HB ' ' A' ' 40' ' ' THR . 7.7 t30 -72.16 -25.31 61.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.49 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.63 -73.49 0.21 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.566 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.587 ' O ' ' HB3' ' A' ' 31' ' ' MET . 59.6 Cg_endo -73.69 -54.54 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.967 1.778 . . . . 0.0 111.712 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.498 ' HA ' HD23 ' A' ' 34' ' ' LEU . 6.1 p-10 171.25 98.74 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.247 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.571 ' HB ' ' CB ' ' A' ' 36' ' ' ASN . 7.8 t -80.54 133.29 35.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.656 0.265 . . . . 0.0 110.884 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.498 ' HB ' ' HD3' ' A' ' 50' ' ' LYS . 2.6 t -97.91 123.31 41.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.034 0.445 . . . . 0.0 111.28 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.407 ' HB2' HG21 ' A' ' 9' ' ' ILE . 33.3 m -72.14 64.32 0.54 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.764 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.44 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 21.7 ptmt -74.97 148.53 39.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.667 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.0 m -155.56 129.55 8.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.303 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 46' ' ' ASP . . . 60.7 48.65 85.16 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.237 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 9.0 t70 79.97 -39.55 0.19 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 122.6 0.36 . . . . 0.0 111.94 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.51 134.87 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.789 0.328 . . . . 0.0 111.351 -179.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.44 ' HG2' ' CB ' ' A' ' 43' ' ' LYS . 37.3 mt-10 -127.27 133.03 50.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.369 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -137.7 134.5 35.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.324 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 19.6 pttm -163.73 -164.67 0.93 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' O ' ' CA ' ' A' ' 55' ' ' GLY . . . -78.1 -41.09 36.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.051 0.453 . . . . 0.0 111.317 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.418 ' HB3' ' HE2' ' A' ' 50' ' ' LYS . 39.1 t -63.87 -45.5 89.13 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.647 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.429 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 8.0 t70 -72.21 -52.79 14.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.352 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.431 ' CB ' ' CG2' ' A' ' 75' ' ' ILE . . . -96.34 -48.42 5.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -178.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -44.77 -28.37 1.66 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.73 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -43.89 -32.55 1.13 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.039 0.447 . . . . 0.0 111.563 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.4 m -65.51 -33.15 61.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.886 -179.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.1 mt -70.3 124.42 24.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.437 179.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.403 ' OG1' ' OD1' ' A' ' 62' ' ' ASP . 80.4 p -80.8 -176.38 5.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.897 0.38 . . . . 0.0 111.551 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.77 79.54 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.711 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -53.33 -23.99 10.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.615 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -71.04 3.2 3.58 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.543 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.2 m-85 -42.58 -64.59 0.68 Allowed Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.584 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 59.5 Cg_endo -71.01 74.94 1.79 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.436 2.091 . . . . 0.0 111.949 179.271 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.615 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.4 OUTLIER -77.04 141.61 40.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.833 -179.349 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 23.4 ttmm -67.22 70.37 0.1 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.804 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.85 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.7 m 58.19 162.35 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.164 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.631 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.69 -31.35 25.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.659 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.6 pt-20 -56.24 -48.41 76.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.589 -179.587 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.559 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -73.1 -36.99 66.88 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.974 -179.6 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.769 HG23 HG13 ' A' ' 24' ' ' ILE . 61.9 t -61.46 -34.34 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.453 ' HA ' ' NE ' ' A' ' 10' ' ' ARG . . . -68.94 -58.22 4.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.365 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -64.1 -42.32 96.95 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.99 0.424 . . . . 0.0 111.571 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.2 m -55.37 -48.09 74.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.651 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 71' ' ' VAL . 82.6 mt -63.05 -51.58 69.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.883 -179.256 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.469 ' CG1' ' HD3' ' A' ' 10' ' ' ARG . 1.5 m -54.05 -43.61 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.818 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -57.55 -49.55 75.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.748 0.309 . . . . 0.0 111.381 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -73.55 -41.11 63.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.827 -179.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.427 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . . . -67.39 -30.23 69.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.506 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.91 -55.43 0.43 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.419 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.462 ' HB3' ' HG3' ' A' ' 6' ' ' LYS . 16.8 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.174 -0.917 . . . . 0.0 111.308 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.8 p . . . . . 0 C--O 1.215 -0.74 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HA ' HD13 ' A' ' 81' ' ' LEU . 54.1 tttm -45.05 -46.63 11.55 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.093 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -77.54 -32.88 54.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.829 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.706 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -64.86 -52.07 58.62 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.52 HG13 ' CG2' ' A' ' 5' ' ' VAL . 31.2 mt -65.48 -46.21 90.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.727 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 51.5 ttp85 -55.87 -30.53 61.68 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.49 -40.4 97.65 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 73.3 mt-30 -68.77 -31.17 70.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.688 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.6 mt -71.36 -45.82 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.068 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.199 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.6 mm -57.87 -52.97 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.514 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.99 -36.61 93.28 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.387 -0.911 . . . . 0.0 110.941 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -62.67 -29.79 70.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.285 -0.457 . . . . 0.0 111.103 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.001 HD22 HD12 ' A' ' 24' ' ' ILE . 55.1 mt -81.26 -29.41 34.4 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.665 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.29 131.5 48.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.73 -34.74 4.62 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.716 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.74 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.95 -179.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.576 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 73.0 m-20 -59.35 -120.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.733 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -59.92 178.53 0.24 Allowed Pre-proline 0 N--CA 1.455 -0.195 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.6 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.78 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.0 Cg_endo -65.38 65.65 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 119.799 0.964 . . . . 0.0 112.482 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.001 HD12 HD22 ' A' ' 17' ' ' LEU . 34.2 mm 107.57 61.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.606 ' HA ' ' CZ ' ' A' ' 22' ' ' PHE . 3.0 m120 -64.35 65.07 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.596 ' HB3' ' CG ' ' A' ' 63' ' ' PHE . 60.6 p 57.48 156.52 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.631 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 54.2 Cg_exo -49.89 -32.65 30.82 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.397 1.398 . . . . 0.0 112.692 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -52.76 -57.68 9.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.35 0.595 . . . . 0.0 110.292 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.601 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.8 tp10 -76.41 -58.09 3.48 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.853 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.59 -44.8 57.06 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.842 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 30.6 ttm -65.08 -31.06 72.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -68.37 -31.45 70.83 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.822 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -69.84 -38.67 76.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.343 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 31' ' ' MET . 8.5 mp -26.91 129.75 0.18 Allowed Pre-proline 0 N--CA 1.47 0.54 0 CA-C-O 120.973 0.416 . . . . 0.0 111.881 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 12.2 Cg_endo . . . . . 0 C--N 1.351 0.659 0 C-N-CA 123.711 2.941 . . . . 0.0 114.274 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.626 HG22 HD23 ' A' ' 34' ' ' LEU . 10.0 t . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.776 0.322 . . . . 0.0 111.525 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.47 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 31.1 m -106.51 121.34 44.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.484 ' CB ' HG23 ' A' ' 9' ' ' ILE . 59.7 m -86.85 46.26 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.001 0.429 . . . . 0.0 110.821 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.405 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 18.7 ptpt . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.892 ' C ' HD22 ' A' ' 49' ' ' LEU . 35.3 mt-10 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.857 0.36 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.892 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.5 mm? -142.31 139.62 31.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.935 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 41' ' ' THR . 59.8 pttt -173.8 -176.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.719 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.842 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -66.33 -42.59 87.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.819 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.405 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.0 t -67.7 -52.38 38.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.467 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 30.0 m-20 -71.1 -49.78 40.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -87.65 -47.01 9.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.89 -26.8 2.11 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.373 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -41.94 -36.89 1.18 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.08 0.467 . . . . 0.0 111.774 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 54' ' ' ALA . 33.4 m -65.51 -33.17 61.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.032 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.649 HD13 ' CE2' ' A' ' 65' ' ' PHE . 28.3 mt -68.31 124.49 23.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.642 0.258 . . . . 0.0 110.56 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.1 p -84.1 -173.81 4.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.797 0.332 . . . . 0.0 111.551 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.06 -44.71 91.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.568 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -55.59 -23.98 30.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 111.118 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -64.54 -9.8 21.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.596 ' CG ' ' HB3' ' A' ' 26' ' ' SER . 2.6 m-85 -39.82 -70.97 0.15 Allowed Pre-proline 0 N--CA 1.464 0.231 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 50.7 Cg_endo -67.76 74.38 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.034 1.823 . . . . 0.0 112.079 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.821 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.08 143.96 38.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.12 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 99.2 mttt -68.94 68.4 0.16 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.475 0.655 . . . . 0.0 110.56 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.78 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 25.5 m 59.51 161.48 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.979 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.656 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.67 -30.59 22.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.817 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.0 pt-20 -57.67 -48.43 79.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.441 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.554 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -71.1 -33.03 69.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.875 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.969 HG21 HG21 ' A' ' 24' ' ' ILE . 92.2 t -64.83 -41.85 93.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.852 0.358 . . . . 0.0 110.857 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.82 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -60.49 -50.35 73.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.825 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -68.43 -37.5 80.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.391 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.3 m -66.8 -51.95 49.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.043 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 71' ' ' VAL . 76.0 mt -58.08 -51.9 65.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.489 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 72' ' ' ALA . 5.3 m -56.22 -39.21 58.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -61.5 -53.15 60.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.728 0.299 . . . . 0.0 111.332 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HB2' HG21 ' A' ' 57' ' ' VAL . 63.1 mttp -69.24 -40.54 77.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.57 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.644 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.17 -29.77 69.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.72 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.17 -55.1 0.43 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.787 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.5 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.023 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.733 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.9 p . . . . . 0 C--O 1.214 -0.799 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 86.1 tttt -45.32 -48.0 13.15 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.015 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -77.59 -31.22 52.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.816 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.733 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 22.7 m-20 -65.2 -52.26 55.91 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 5' ' ' VAL . 22.5 mt -66.79 -46.5 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.763 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 46.4 ttp85 -56.39 -28.07 58.18 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.19 -42.91 94.04 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 66.9 mt-30 -67.07 -32.55 73.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.876 -0.662 . . . . 0.0 109.737 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.0 mt -70.33 -43.33 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.804 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 14' ' ' ILE . 13.3 mm -58.06 -54.09 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.244 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.54 -36.85 93.66 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.692 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -60.88 -28.43 68.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.109 -0.545 . . . . 0.0 110.936 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.068 HD22 HD12 ' A' ' 24' ' ' ILE . 52.7 mt -87.6 -29.66 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.282 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.16 85.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.838 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.94 -36.0 0.19 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.17 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.747 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.77 -174.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 112.116 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.644 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.0 m-20 -59.96 -119.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.721 ' CE2' ' HA ' ' A' ' 25' ' ' ASN . 0.3 OUTLIER -58.52 174.21 0.37 Allowed Pre-proline 0 CA--C 1.519 -0.212 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 176.273 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.874 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 44.6 Cg_endo -63.27 66.63 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 120.916 1.077 . . . . 0.0 112.242 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.068 HD12 HD22 ' A' ' 17' ' ' LEU . 20.2 mm 109.52 59.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.721 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.5 m120 -63.37 66.75 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 25' ' ' ASN . 85.5 p 56.28 153.64 0.07 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.716 ' O ' ' HB2' ' A' ' 31' ' ' MET . 76.1 Cg_exo -47.29 -32.88 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.512 1.475 . . . . 0.0 113.176 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -53.31 -57.46 10.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.339 0.59 . . . . 0.0 110.387 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.4 tp10 -76.25 -57.52 3.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.964 HD13 HD21 ' A' ' 17' ' ' LEU . 3.3 pp -49.97 -42.54 49.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.716 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 62.2 mtm -68.75 -29.98 68.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.64 -31.04 70.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.899 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.747 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -74.23 -38.57 63.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.102 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 16' ' ' ALA . 8.0 mp -34.66 140.03 0.29 Allowed Pre-proline 0 N--CA 1.466 0.341 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo . . . . . 0 C--N 1.349 0.56 0 C-N-CA 123.248 2.632 . . . . 0.0 113.225 -178.956 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.428 ' N ' HD23 ' A' ' 34' ' ' LEU . 8.9 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.762 0.315 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.535 HG23 ' HD3' ' A' ' 50' ' ' LYS . 23.8 m -86.64 118.17 25.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.092 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 68.4 m -92.87 44.76 1.16 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 109.776 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.1 pttp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.119 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.876 ' C ' HD22 ' A' ' 49' ' ' LEU . 75.6 mt-10 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.778 0.323 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.876 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -141.0 138.53 33.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.513 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.535 ' HD3' HG23 ' A' ' 41' ' ' THR . 60.8 pttt -175.14 153.64 1.64 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.665 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.66 -28.3 2.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.624 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.403 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 44.1 t -70.82 -55.5 8.38 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.311 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -72.44 -54.32 9.65 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -82.48 -42.89 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.86 -25.81 1.02 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.491 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -41.66 -36.76 1.02 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.132 0.492 . . . . 0.0 111.583 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 54' ' ' ALA . 32.9 m -65.53 -33.41 63.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.128 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.699 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 30.3 mt -68.85 119.83 13.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.703 0.287 . . . . 0.0 110.231 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.412 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 76.8 p -85.44 -175.31 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.711 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.67 -43.34 84.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.298 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.447 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 3.1 p30 -51.29 -26.63 7.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.918 0.389 . . . . 0.0 110.819 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 59.4 m-20 -73.26 3.73 5.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.707 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.53 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 1.4 t80 -42.63 -52.22 10.98 Favored Pre-proline 0 C--O 1.224 -0.262 0 O-C-N 122.588 -0.07 . . . . 0.0 111.15 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 97.6 Cg_endo -89.65 78.15 0.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.194 2.596 . . . . 0.0 111.187 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.744 ' CG ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -76.9 142.8 39.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.156 -178.483 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 22.9 tptm -69.66 65.41 0.21 Allowed 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.122 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.874 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 49.8 m 63.63 160.0 0.09 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.638 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.603 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.97 -27.34 13.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.938 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.36 -38.78 91.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.075 0.464 . . . . 0.0 109.832 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 7.9 tp10 -68.01 -46.42 71.3 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.94 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.027 ' CG2' HG21 ' A' ' 24' ' ' ILE . 47.0 t -65.11 -43.17 95.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.516 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -56.17 -45.47 79.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.979 0.418 . . . . 0.0 110.25 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -70.3 -40.18 74.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.095 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.436 HG23 ' NZ ' ' A' ' 78' ' ' LYS . 61.8 m -63.13 -50.15 71.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.069 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.532 HG23 ' CB ' ' A' ' 54' ' ' ALA . 67.0 mt -61.41 -52.47 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.702 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 72' ' ' ALA . 7.1 m -58.52 -38.64 71.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -62.33 -56.79 15.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.748 0.308 . . . . 0.0 111.676 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' NZ ' HG23 ' A' ' 74' ' ' THR . 61.8 mttp -69.5 -38.97 77.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.74 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.716 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.84 -29.89 69.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.009 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.42 -55.87 0.42 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.006 -1.092 . . . . 0.0 113.291 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.1 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.339 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.689 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.6 p . . . . . 0 C--O 1.211 -0.968 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.65 ' HA ' HD13 ' A' ' 81' ' ' LEU . 84.8 tttt -44.31 -44.15 7.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.913 0.779 . . . . 0.0 109.417 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.4 -35.58 54.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.666 177.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.689 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 48.6 m-20 -64.02 -51.83 62.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.529 HG13 ' CG2' ' A' ' 5' ' ' VAL . 37.0 mt -65.12 -45.89 92.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.842 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 50.1 ttp180 -55.34 -30.41 60.22 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.53 -41.78 97.76 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.535 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 65.0 mt-30 -66.18 -29.86 70.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.692 -0.754 . . . . 0.0 109.735 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 10' ' ' ARG . 63.6 mt -70.35 -45.58 74.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.962 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 69' ' ' GLU . 9.1 mm -56.74 -52.96 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.512 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.82 -37.15 92.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.073 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.47 -30.53 69.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.202 -0.499 . . . . 0.0 111.172 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.048 HD22 HD12 ' A' ' 24' ' ' ILE . 59.5 mt -82.74 -29.45 29.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.932 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.52 132.81 54.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.049 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.13 -33.89 5.22 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.964 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.7 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.95 -176.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 111.567 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.601 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.1 m-20 -60.9 -121.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.713 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.56 176.81 0.29 Allowed Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.376 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.773 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.3 Cg_endo -64.69 69.05 0.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 CA-C-N 119.773 0.954 . . . . 0.0 112.281 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.048 HD12 HD22 ' A' ' 17' ' ' LEU . 51.5 mm 106.47 61.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.601 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.8 m120 -65.24 64.96 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.569 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 59.1 p 57.06 157.46 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.614 ' O ' ' CB ' ' A' ' 31' ' ' MET . 52.0 Cg_exo -50.9 -32.23 36.98 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.293 1.328 . . . . 0.0 112.86 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -52.71 -57.61 9.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.442 0.639 . . . . 0.0 110.421 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.594 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 41.8 tp10 -76.15 -58.15 3.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.824 HD22 HG23 ' A' ' 24' ' ' ILE . 3.9 pp -50.62 -42.95 56.67 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.822 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 30.0 ttm -63.27 -33.07 74.71 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -68.92 -28.32 66.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.835 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.7 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -71.16 -36.9 72.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.3 mp -27.27 137.0 0.1 Allowed Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 121.094 0.473 . . . . 0.0 112.185 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo . . . . . 0 C--N 1.35 0.606 0 C-N-CA 124.249 3.299 . . . . 0.0 115.638 -177.292 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.534 HG22 HD23 ' A' ' 34' ' ' LEU . 15.2 t . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.775 0.321 . . . . 0.0 111.519 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.645 HG21 ' CE ' ' A' ' 43' ' ' LYS . 47.8 m -92.55 123.9 36.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.719 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.9 m -92.04 45.53 1.22 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.974 0.416 . . . . 0.0 110.73 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.645 ' CE ' HG21 ' A' ' 41' ' ' THR . 18.6 ptpt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.025 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.882 ' C ' HD22 ' A' ' 49' ' ' LEU . 22.7 mt-10 . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.81 0.338 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -141.72 133.74 27.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.605 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.769 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 21.1 ptmt -165.48 -177.55 4.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.735 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.822 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -66.56 -40.52 89.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.715 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -67.01 -59.92 3.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.401 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 57.9 m-20 -68.84 -54.09 17.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.758 0.313 . . . . 0.0 111.691 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.946 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -72.56 -50.51 25.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.74 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -49.02 -26.49 6.01 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.412 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -41.21 -43.55 2.37 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.944 0.878 . . . . 0.0 110.943 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 54' ' ' ALA . 10.4 m -66.01 -32.64 59.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.326 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.682 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 21.1 mt -68.9 116.84 9.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.819 0.343 . . . . 0.0 110.588 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.51 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 71.8 p -71.5 155.9 40.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.196 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.16 -39.98 45.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.323 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -53.44 -25.44 16.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.615 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 61.8 m-20 -70.57 3.47 3.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.569 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.4 OUTLIER -38.64 -63.65 0.56 Allowed Pre-proline 0 N--CA 1.462 0.139 0 CA-C-N 117.895 0.316 . . . . 0.0 110.958 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 73.4 Cg_endo -74.55 79.0 2.61 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.469 2.113 . . . . 0.0 111.88 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.755 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -76.83 144.29 39.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.301 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.51 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 75.2 mmtt -70.21 65.88 0.28 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.465 0.65 . . . . 0.0 110.047 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.773 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 20.2 m 61.52 160.36 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.02 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.587 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.45 -28.11 12.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.657 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HA ' HD11 ' A' ' 14' ' ' ILE . 16.2 pt-20 -60.95 -48.44 81.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.376 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.518 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -67.9 -32.14 72.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.021 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 24' ' ' ILE . 80.5 t -62.27 -41.29 90.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 110.45 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.842 ' HB1' ' CG ' ' A' ' 10' ' ' ARG . . . -60.27 -51.03 71.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.987 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.53 -39.02 85.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.258 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.8 m -65.18 -51.65 59.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.956 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.946 HG23 ' HB1' ' A' ' 54' ' ' ALA . 57.4 mt -57.15 -54.58 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.767 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 72' ' ' ALA . 5.7 m -57.14 -40.04 70.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -65.52 -53.28 44.58 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HB2' HG21 ' A' ' 57' ' ' VAL . 50.2 mtpt -73.33 -39.52 65.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 111.885 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.433 ' HB1' HD12 ' A' ' 49' ' ' LEU . . . -66.84 -29.96 70.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.72 -55.98 0.37 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.117 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.65 HD13 ' HA ' ' A' ' 6' ' ' LYS . 20.3 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.32 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.718 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.6 p . . . . . 0 C--O 1.215 -0.742 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 82.7 tttt -45.17 -47.76 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.008 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.75 -31.94 52.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.901 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.718 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -64.33 -52.17 59.75 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.807 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 5' ' ' VAL . 28.9 mt -67.39 -46.18 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.823 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 48.3 ttp180 -55.45 -29.77 59.29 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.73 -43.53 93.98 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 69.3 mt-30 -66.9 -30.38 70.52 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.86 -0.67 . . . . 0.0 109.766 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 10' ' ' ARG . 73.3 mt -70.52 -43.46 77.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.744 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 69' ' ' GLU . 11.3 mm -57.61 -53.69 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.32 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.56 -36.4 92.43 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.405 -0.902 . . . . 0.0 110.855 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -60.55 -31.82 70.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.151 -0.524 . . . . 0.0 110.952 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.065 HD22 HD12 ' A' ' 24' ' ' ILE . 55.4 mt -82.12 -29.47 31.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.775 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.0 130.83 48.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.918 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.16 -34.37 4.48 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.879 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.7 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.06 -176.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.815 0.341 . . . . 0.0 111.594 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.614 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.6 m-20 -60.02 -119.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.745 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.79 178.39 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.81 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 48.9 Cg_endo -65.08 67.85 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.754 0.948 . . . . 0.0 112.131 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.065 HD12 HD22 ' A' ' 17' ' ' LEU . 44.3 mm 105.96 62.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.614 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.9 m120 -65.7 64.41 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.657 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 52.6 p 57.07 160.47 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.657 ' O ' ' HB2' ' A' ' 31' ' ' MET . 52.2 Cg_exo -52.56 -33.16 56.9 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.339 1.359 . . . . 0.0 112.971 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -52.48 -57.89 8.47 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.238 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.612 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 41.3 tp10 -76.6 -58.57 3.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.906 HD22 HG23 ' A' ' 24' ' ' ILE . 3.9 pp -50.65 -45.35 57.82 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.815 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 23.0 ttm -64.17 -31.49 72.7 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -70.28 -28.67 65.39 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.128 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.7 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -70.04 -37.45 75.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.725 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 31' ' ' MET . 11.2 mp -31.78 145.6 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.112 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.544 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.5 Cg_endo . . . . . 0 C--N 1.348 0.549 0 C-N-CA 123.664 2.91 . . . . 0.0 113.973 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.629 HG22 HD23 ' A' ' 34' ' ' LEU . 12.9 t . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.685 0.279 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.489 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 25.4 m -91.61 125.87 36.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.972 0.415 . . . . 0.0 111.588 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.7 m -100.47 48.52 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.777 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.48 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 10.2 ptpp? . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.841 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.887 ' C ' HD22 ' A' ' 49' ' ' LEU . 23.6 mt-10 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.68 0.276 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.887 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.7 mm? -140.64 140.57 35.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.039 0.447 . . . . 0.0 110.811 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.509 ' HG3' ' H ' ' A' ' 53' ' ' ASP . 59.5 pttt -173.54 170.81 4.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.719 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.815 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -59.65 -30.7 68.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.545 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 42.5 t -75.66 -62.05 1.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.509 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 52.4 m-20 -66.4 -51.06 60.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.598 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -78.95 -46.44 18.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.67 -26.32 1.76 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.596 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 17.2 pt20 -41.21 -38.63 1.15 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.04 0.448 . . . . 0.0 111.808 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.8 m -65.72 -30.16 49.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.408 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.678 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 19.1 mt -66.91 121.67 16.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.756 0.312 . . . . 0.0 110.42 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.7 p -74.67 155.77 37.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.44 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.67 58.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.229 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.82 -23.29 29.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.563 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 15.5 m-20 -67.59 3.31 1.42 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.657 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -40.57 -55.19 4.55 Favored Pre-proline 0 C--O 1.227 -0.086 0 CA-C-N 117.77 0.259 . . . . 0.0 111.575 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 2.2 Cg_endo -82.39 78.16 3.5 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.896 2.397 . . . . 0.0 111.783 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.911 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.02 142.13 40.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.266 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.666 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.69 66.9 0.13 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.76 0.79 . . . . 0.0 110.59 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.81 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 15.5 m 61.85 159.87 0.06 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.953 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.668 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.61 -32.55 29.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.794 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.445 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 10.9 pt-20 -59.07 -46.1 89.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.417 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.666 ' HG2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -68.08 -33.17 74.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.19 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.949 HG21 HG21 ' A' ' 24' ' ' ILE . 72.8 t -64.77 -44.72 96.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.649 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.826 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -55.11 -49.53 71.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.76 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.25 -39.84 78.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.294 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.1 m -63.21 -52.62 61.53 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.48 HG23 ' HB1' ' A' ' 54' ' ' ALA . 58.4 mt -59.87 -52.6 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.716 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 72' ' ' ALA . 14.1 m -57.81 -41.24 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -61.68 -51.41 68.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 111.278 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HB2' HG21 ' A' ' 57' ' ' VAL . 66.8 mttm -71.54 -42.08 68.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.676 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.519 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.42 -30.04 69.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.778 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.14 -55.7 0.44 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.664 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 19.0 mt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.337 -0.84 . . . . 0.0 110.983 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.705 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p . . . . . 0 C--O 1.215 -0.758 0 CA-C-O 119.993 -0.051 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.547 ' HE2' HG21 ' A' ' 76' ' ' VAL . 12.9 tmtt? -45.09 -46.41 11.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -77.57 -33.44 54.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.84 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.705 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 14.1 m-20 -64.21 -52.32 59.42 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.531 HG13 HG22 ' A' ' 5' ' ' VAL . 35.3 mt -66.62 -46.56 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.783 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 40.0 ttp180 -55.0 -29.76 58.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.32 -42.46 96.11 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.539 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 70.0 mt-30 -69.06 -30.71 69.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.991 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.7 mt -71.61 -45.18 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.045 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 14' ' ' ILE . 10.6 mm -58.3 -52.01 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.262 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.39 -37.19 93.56 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.557 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -61.52 -28.54 69.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.946 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.05 HD22 HD12 ' A' ' 24' ' ' ILE . 45.7 mt -83.79 -29.56 27.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.874 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.52 126.02 25.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.815 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.66 -34.99 3.3 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.72 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.673 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.73 -175.04 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.913 0.387 . . . . 0.0 111.588 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.573 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -61.58 -119.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.773 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.5 OUTLIER -59.45 179.21 0.21 Allowed Pre-proline 0 N--CA 1.454 -0.266 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 176.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.792 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.3 Cg_endo -64.97 67.21 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 CA-C-N 119.688 0.924 . . . . 0.0 112.179 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.05 HD12 HD22 ' A' ' 17' ' ' LEU . 41.9 mm 107.18 62.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.608 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.8 m120 -63.65 65.37 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 69.9 p 56.28 158.68 0.07 OUTLIER Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.71 ' O ' ' HB2' ' A' ' 31' ' ' MET . 50.7 Cg_exo -51.16 -34.23 47.25 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.316 1.344 . . . . 0.0 113.032 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -51.63 -57.68 8.49 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.38 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 43.7 tp10 -76.24 -58.11 3.48 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.853 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -50.47 -43.95 55.53 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.87 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 23.5 ttm -64.03 -32.19 73.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.96 -29.53 66.67 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.042 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.673 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -68.81 -37.98 79.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.73 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 31' ' ' MET . 11.2 mp -31.61 145.02 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.193 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.529 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.5 Cg_endo . . . . . 0 C--N 1.348 0.505 0 C-N-CA 123.635 2.89 . . . . 0.0 113.969 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.608 HG22 HD23 ' A' ' 34' ' ' LEU . 15.0 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.665 0.269 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 27.8 m -90.71 125.78 35.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 111.597 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.3 m -100.29 50.43 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.097 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.443 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 61.6 pttt . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.643 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.9 ' C ' HD22 ' A' ' 49' ' ' LEU . 23.5 mt-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.033 0.444 . . . . 0.0 111.473 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.9 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -142.34 136.79 30.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.427 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HG3' ' H ' ' A' ' 53' ' ' ASP . 61.2 pttt -173.68 178.77 2.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.795 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.87 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -65.61 -39.71 91.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.836 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.3 t -66.83 -51.55 54.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.672 0.273 . . . . 0.0 111.704 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.474 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 38.8 m-20 -72.2 -51.42 21.25 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.676 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -88.39 -45.97 9.55 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.92 -27.52 1.48 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.203 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 16.0 pt20 -43.29 -35.62 1.54 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 111.333 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 54' ' ' ALA . 32.9 m -65.51 -33.0 60.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.782 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.715 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 17.0 mt -66.3 119.1 10.95 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.2 p -77.26 155.89 31.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.754 0.312 . . . . 0.0 111.073 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.33 -40.21 11.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.593 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -53.86 -26.32 24.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.166 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.661 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -70.18 3.38 2.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -39.93 -65.33 0.44 Allowed Pre-proline 0 N--CA 1.463 0.217 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.156 -179.141 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 74.1 Cg_endo -74.06 78.26 2.6 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.307 2.005 . . . . 0.0 111.855 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.915 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -76.8 143.65 39.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.246 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.502 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 75.1 mmtt -69.57 68.38 0.24 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.464 0.65 . . . . 0.0 110.05 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.792 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 31.8 m 59.66 160.96 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.976 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.691 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.47 -25.88 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.632 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 16.5 pt-20 -59.66 -48.86 80.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.43 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.517 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -74.13 -32.18 63.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.161 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.015 HG21 HG21 ' A' ' 24' ' ' ILE . 60.2 t -61.55 -46.93 95.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.399 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.835 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -58.85 -44.63 91.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.874 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -62.73 -42.62 99.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.337 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.414 HG22 HD21 ' A' ' 58' ' ' LEU . 88.6 m -63.76 -50.68 68.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.136 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.676 HG23 ' CB ' ' A' ' 54' ' ' ALA . 71.9 mt -58.35 -52.58 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.542 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 72' ' ' ALA . 6.8 m -58.6 -43.52 87.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -62.1 -54.1 46.13 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.619 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -69.88 -41.01 75.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 111.6 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.636 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.03 -29.92 69.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.734 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.25 -54.61 0.46 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.891 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 17.7 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.073 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.704 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p . . . . . 0 C--O 1.214 -0.791 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -44.87 -45.27 10.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -77.16 -34.39 56.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.884 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.704 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -64.49 -51.86 60.84 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.63 HD13 HD23 ' A' ' 49' ' ' LEU . 35.0 mt -65.94 -50.13 72.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.927 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -56.64 -29.28 62.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.14 -41.77 99.63 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 77.3 mt-30 -69.72 -31.98 70.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.455 -0.872 . . . . 0.0 110.195 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -71.06 -46.64 66.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.563 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 14' ' ' ILE . 5.1 mm -58.72 -52.58 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.714 0.292 . . . . 0.0 110.401 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.85 -36.36 93.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.106 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -67.1 -25.03 66.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.279 -0.461 . . . . 0.0 111.547 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.077 HD22 HD12 ' A' ' 24' ' ' ILE . 46.1 mt -82.31 -29.41 31.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.568 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.01 132.84 54.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.857 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.2 -33.93 5.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.674 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.668 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.21 -179.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.375 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.584 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.6 m-20 -58.94 -119.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.735 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -61.22 179.24 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.306 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 176.268 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.811 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 46.7 Cg_endo -65.61 65.26 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 119.889 0.996 . . . . 0.0 112.291 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.077 HD12 HD22 ' A' ' 17' ' ' LEU . 31.9 mm 107.72 60.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.62 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.6 m120 -62.82 65.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.572 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 54.7 p 58.16 153.49 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 31' ' ' MET . 67.0 Cg_exo -48.26 -32.51 19.68 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.315 1.344 . . . . 0.0 112.628 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -52.88 -57.48 10.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.51 0.671 . . . . 0.0 110.503 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.62 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.4 tp10 -75.37 -57.8 3.67 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.878 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.4 pp -50.39 -41.59 52.27 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.64 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 37.0 ttm -64.61 -32.87 74.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -73.01 -23.17 60.59 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.668 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -72.2 -49.71 33.35 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.649 HD12 ' H ' ' A' ' 34' ' ' LEU . 7.9 mp -24.99 135.26 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 C--N 1.349 0.583 0 C-N-CA 123.916 3.077 . . . . 0.0 113.622 -178.5 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.448 HG22 HD23 ' A' ' 34' ' ' LEU . 1.8 t . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.743 0.306 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.414 HG23 ' OE2' ' A' ' 48' ' ' GLU . 17.3 m -76.74 127.37 32.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.722 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.401 ' HB3' ' OE1' ' A' ' 12' ' ' GLN . 57.4 m -112.28 45.81 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.88 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 60.2 pttt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.859 ' C ' HD22 ' A' ' 49' ' ' LEU . 87.8 tt0 . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 121.135 0.493 . . . . 0.0 111.74 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.859 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.1 mm? -137.69 130.31 29.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.564 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 52' ' ' SER . 62.4 pttt -171.7 -161.37 0.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.879 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.476 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -74.31 -47.74 32.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.425 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.7 t -69.34 -50.87 42.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -69.2 -48.74 61.24 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.701 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -95.66 -45.74 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -47.35 -28.47 4.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.84 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -43.38 -34.13 1.2 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.207 0.527 . . . . 0.0 111.357 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 54' ' ' ALA . 30.5 m -65.51 -33.2 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.918 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.755 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 30.9 mt -64.72 125.28 24.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 110.681 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.5 p -77.39 155.87 31.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.261 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.57 -42.63 55.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.4 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -56.1 -22.66 29.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.858 0.361 . . . . 0.0 111.075 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.625 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 15.5 m-20 -68.3 3.3 1.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.572 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.7 OUTLIER -40.57 -66.3 0.38 Allowed Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 117.943 0.338 . . . . 0.0 111.532 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.2 Cg_endo -70.44 76.06 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.373 2.049 . . . . 0.0 112.09 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.907 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.15 141.93 39.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.502 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.61 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 1.7 tpmt? -67.32 68.51 0.08 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.702 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.811 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 47.3 m 58.73 162.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.028 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.667 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.59 -26.23 8.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.949 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 23.1 pt-20 -60.23 -49.92 75.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.551 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.54 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -71.49 -35.59 70.85 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.655 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.983 ' CG2' HG21 ' A' ' 24' ' ' ILE . 55.8 t -63.19 -40.8 90.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.927 ' HB1' ' HG2' ' A' ' 10' ' ' ARG . . . -60.8 -51.65 68.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.985 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -67.09 -41.57 86.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.426 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.9 m -57.59 -50.1 74.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.677 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.571 HG23 ' CB ' ' A' ' 54' ' ' ALA . 82.4 mt -60.13 -49.04 85.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.233 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 16.6 m -63.03 -41.87 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -58.59 -55.72 31.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HE3' ' HB ' ' A' ' 57' ' ' VAL . 28.2 mtpp -71.89 -38.99 69.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 111.654 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.619 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.67 -29.69 69.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.563 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.1 -53.95 0.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.817 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.4 mt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.158 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p . . . . . 0 C--O 1.214 -0.785 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 81.7 tttt -44.34 -46.17 9.18 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.418 -0.801 . . . . 0.0 109.276 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -77.43 -34.18 54.66 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.824 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.702 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -63.77 -51.92 62.68 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.517 HG13 ' CG2' ' A' ' 5' ' ' VAL . 33.6 mt -66.69 -46.81 84.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.732 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 45.0 ttp180 -55.11 -30.14 59.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.76 -42.85 94.98 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.551 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 71.3 mt-30 -68.9 -30.01 68.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.815 -0.692 . . . . 0.0 110.063 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.1 mt -71.29 -44.66 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.806 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 14' ' ' ILE . 11.3 mm -57.67 -53.11 49.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.252 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.45 -36.02 92.07 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.807 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.85 -31.69 71.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.068 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.006 HD22 HD12 ' A' ' 24' ' ' ILE . 48.0 mt -81.49 -29.45 33.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.552 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.06 128.31 36.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.797 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.15 -36.16 3.28 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.537 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.648 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.59 -175.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.025 0.44 . . . . 0.0 111.492 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.649 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -61.56 -127.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.731 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -54.23 175.49 0.16 Allowed Pre-proline 0 CA--C 1.52 -0.209 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 176.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.819 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 35.3 Cg_endo -61.92 69.17 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 CA-C-N 119.814 0.969 . . . . 0.0 112.486 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.011 HG21 HG21 ' A' ' 71' ' ' VAL . 44.2 mm 105.68 64.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 177.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.649 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 4.4 m-20 -65.77 63.89 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.142 -0.349 . . . . 0.0 111.367 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.659 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 39.1 p 57.98 160.31 0.09 OUTLIER Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.6 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 52.7 Cg_exo -52.65 -34.01 61.76 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.335 1.356 . . . . 0.0 113.042 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.44 -57.42 9.92 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.371 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.647 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -76.35 -58.34 3.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.916 HD22 HG23 ' A' ' 24' ' ' ILE . 3.9 pp -50.33 -45.76 55.12 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.791 ' N ' HD12 ' A' ' 30' ' ' LEU . 27.7 ttm -64.26 -31.37 72.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -69.12 -30.66 68.98 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.854 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.648 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -69.28 -37.79 78.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.965 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.778 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.4 mp -32.75 140.34 0.21 Allowed Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.052 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo . . . . . 0 C--N 1.349 0.575 0 C-N-CA 123.534 2.822 . . . . 0.0 112.896 -179.23 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.704 HG22 HD23 ' A' ' 34' ' ' LEU . 11.3 t . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 120.515 0.198 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 30.8 m -93.15 115.62 28.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.795 0.331 . . . . 0.0 111.302 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 73.7 m -92.65 46.62 1.25 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 109.955 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.495 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 24.2 pttm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.093 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.86 ' C ' HD22 ' A' ' 49' ' ' LEU . 70.1 mt-10 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.722 0.296 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.86 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.7 mm? -143.24 131.23 21.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HG3' ' H ' ' A' ' 53' ' ' ASP . 21.8 pttm -165.03 172.1 13.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.429 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.567 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -59.38 -35.94 74.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.616 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.8 t -66.44 -58.4 5.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 43.9 m-20 -71.84 -54.24 10.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.674 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -77.58 -46.02 23.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.76 -23.41 3.43 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.58 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.41 ' NE2' ' O ' ' A' ' 53' ' ' ASP . 26.2 pt20 -42.52 -32.56 0.56 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.023 0.439 . . . . 0.0 111.447 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.0 m -78.33 27.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.587 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 39.8 mt -127.25 115.13 18.58 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.893 0.378 . . . . 0.0 110.046 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.8 p -67.52 155.88 38.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.958 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.06 -40.38 61.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.954 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -54.93 -23.47 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.669 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.541 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 13.4 m-20 -68.53 3.07 1.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.659 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.8 OUTLIER -39.43 -65.23 0.43 Allowed Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 117.81 0.277 . . . . 0.0 111.612 -179.056 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.9 Cg_endo -70.71 76.35 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.367 2.044 . . . . 0.0 112.093 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.853 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.02 140.46 40.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.84 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 22.8 tptm -66.0 67.64 0.05 OUTLIER 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.429 0.633 . . . . 0.0 110.608 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.819 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 34.6 m 60.19 159.88 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.962 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.643 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.57 -29.65 17.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.563 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 10.9 pt-20 -58.88 -47.61 84.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.297 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.509 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -68.51 -35.73 77.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.204 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.011 HG21 HG21 ' A' ' 24' ' ' ILE . 89.8 t -61.92 -44.35 98.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 110.51 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -55.6 -49.49 72.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -69.86 -41.85 74.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.992 0.425 . . . . 0.0 111.21 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.409 HG23 ' NZ ' ' A' ' 78' ' ' LYS . 86.4 m -59.33 -50.98 71.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.855 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.438 HG23 ' CB ' ' A' ' 54' ' ' ALA . 69.3 mt -61.02 -52.98 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.397 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 72' ' ' ALA . 13.5 m -60.35 -40.38 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -60.09 -54.16 49.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 111.417 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.562 ' HB2' HG21 ' A' ' 57' ' ' VAL . 63.2 mttp -71.86 -41.11 68.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.86 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.674 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.1 -29.94 69.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.834 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.77 -55.8 0.44 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.676 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.8 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.141 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.749 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.8 p . . . . . 0 C--O 1.216 -0.709 0 CA-C-O 120.027 -0.035 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 86.3 tttt -45.76 -50.66 13.67 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -78.0 -27.77 49.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.172 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.749 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 33.8 t70 -66.96 -52.56 41.37 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.542 HG13 HG22 ' A' ' 5' ' ' VAL . 19.5 mt -69.6 -45.86 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.678 ' CD ' ' HB1' ' A' ' 72' ' ' ALA . 5.7 tmm_? -55.21 -31.96 61.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.09 -43.35 98.88 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 68.0 mt-30 -63.41 -29.91 71.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.673 -0.763 . . . . 0.0 109.552 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 10' ' ' ARG . 61.9 mt -70.21 -42.39 78.97 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 69' ' ' GLU . 8.3 mm -57.7 -53.26 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.343 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.4 -38.06 90.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.327 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -61.77 -28.35 69.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.055 0.455 . . . . 0.0 111.28 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.024 HD22 HD12 ' A' ' 24' ' ' ILE . 48.0 mt -83.45 -29.57 27.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.526 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.11 129.85 43.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.76 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.42 -33.86 4.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.668 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.664 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.85 -174.29 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 111.423 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.593 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 76.8 m-20 -60.31 -119.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.733 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -60.63 -179.99 0.21 Allowed Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.295 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 41.6 Cg_endo -66.17 65.94 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 120.089 1.068 . . . . 0.0 112.336 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.024 HD12 HD22 ' A' ' 17' ' ' LEU . 50.4 mm 108.01 60.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.611 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.6 m120 -62.45 66.82 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.561 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 59.7 p 57.16 154.18 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.658 ' O ' ' CB ' ' A' ' 31' ' ' MET . 54.3 Cg_exo -48.66 -32.82 22.57 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.096 1.198 . . . . 0.0 112.65 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -52.21 -57.37 9.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.473 0.654 . . . . 0.0 110.739 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.611 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 40.2 tp10 -74.71 -57.93 3.61 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.895 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.56 -40.4 52.05 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.658 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 40.1 ttm -63.88 -33.24 75.26 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -75.44 -20.49 58.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.664 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -75.91 -42.93 47.49 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 30' ' ' LEU . 6.9 mp -27.96 147.17 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo . . . . . 0 C--N 1.348 0.55 0 C-N-CA 124.051 3.168 . . . . 0.0 115.478 -177.288 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 34' ' ' LEU . 5.2 t . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.769 0.319 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.438 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 11.8 m -76.17 124.13 26.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.963 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.6 m -90.44 44.66 1.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.528 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.5 pttm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.136 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.866 ' C ' HD22 ' A' ' 49' ' ' LEU . 28.1 mt-10 . . . . . 0 N--CA 1.461 0.082 0 CA-C-O 120.816 0.341 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.866 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.5 mm? -140.83 138.01 33.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.08 0.466 . . . . 0.0 110.952 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 21.6 pttp -174.74 166.07 3.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.705 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.491 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.84 -40.47 21.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.074 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.6 t -72.01 -43.7 64.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.412 ' O ' ' NE2' ' A' ' 56' ' ' GLN . 38.2 t70 -69.14 -54.11 16.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 111.853 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.986 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -96.28 -45.77 6.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.58 -30.04 2.04 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.361 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 53' ' ' ASP . 18.7 pt20 -51.52 -28.86 14.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.202 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.986 HG22 ' O ' ' A' ' 54' ' ' ALA . 31.9 m -78.26 27.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.516 HD13 ' CE2' ' A' ' 65' ' ' PHE . 38.2 mt -125.86 125.68 43.23 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.744 0.307 . . . . 0.0 110.332 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.9 p -67.88 155.72 38.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.599 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.08 -40.92 67.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.189 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -55.02 -22.26 14.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.0 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.607 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.6 m-20 -68.42 3.01 1.94 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.9 OUTLIER -41.12 -65.14 0.5 Allowed Pre-proline 0 N--CA 1.462 0.159 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.501 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.0 Cg_endo -71.35 76.79 1.74 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.293 1.995 . . . . 0.0 112.246 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.964 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.05 143.19 39.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.671 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.11 68.67 0.12 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.637 0.732 . . . . 0.0 110.963 178.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.771 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 20.2 m 58.75 161.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.268 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.686 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.63 -30.96 23.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.857 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.621 ' HA ' HD11 ' A' ' 14' ' ' ILE . 16.3 pt-20 -58.46 -46.3 86.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.448 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.671 ' HG2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -71.0 -37.54 72.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.725 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.006 HG21 HG21 ' A' ' 24' ' ' ILE . 45.5 t -62.69 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.023 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.678 ' HB1' ' CD ' ' A' ' 10' ' ' ARG . . . -56.63 -48.45 77.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.066 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.411 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 1.3 m-20 -65.52 -45.28 84.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.839 0.352 . . . . 0.0 111.028 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.435 ' OG1' ' OE1' ' A' ' 70' ' ' GLU . 27.0 m -59.86 -44.65 94.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.624 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.784 HG23 ' CB ' ' A' ' 54' ' ' ALA . 66.2 mt -57.26 -51.52 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.399 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 14.9 m -60.33 -37.11 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -63.31 -58.16 8.04 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HB2' HG21 ' A' ' 57' ' ' VAL . 64.3 mttp -69.48 -38.96 77.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.621 ' HB2' ' CB ' ' A' ' 54' ' ' ALA . . . -66.75 -29.95 70.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.242 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.21 -55.88 0.42 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.236 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.534 HD13 ' HA ' ' A' ' 6' ' ' LYS . 19.5 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.257 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.727 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.6 p . . . . . 0 C--O 1.214 -0.788 0 N-CA-C 110.925 -0.028 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -45.29 -46.53 12.76 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.407 ' OE2' ' HD2' ' A' ' 6' ' ' LYS . 9.5 mp0 -77.74 -31.63 52.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.934 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.727 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 65.4 m-20 -65.61 -52.35 52.66 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.507 HG13 HG22 ' A' ' 5' ' ' VAL . 31.1 mt -68.33 -46.1 81.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.599 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.3 OUTLIER -56.89 -29.96 63.48 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.142 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.58 -43.68 96.16 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 82.7 mt-30 -63.95 -30.23 71.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.711 -0.744 . . . . 0.0 109.665 177.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 10' ' ' ARG . 63.2 mt -70.5 -42.54 78.25 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.059 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.839 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' A' ' 69' ' ' GLU . 10.4 mm -57.17 -52.75 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.413 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.7 86.3 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.186 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -60.98 -27.88 68.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.975 0.416 . . . . 0.0 111.094 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.092 HD22 HD12 ' A' ' 24' ' ' ILE . 54.6 mt -85.78 -29.41 23.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.939 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.98 129.09 38.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.098 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.92 -34.49 4.17 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.836 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.702 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.87 -178.05 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.843 0.354 . . . . 0.0 111.613 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -61.18 -119.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.728 ' CE2' ' HA ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -58.73 174.43 0.37 Allowed Pre-proline 0 CA--C 1.519 -0.242 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 176.102 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.889 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 39.3 Cg_endo -63.32 67.01 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.843 0.98 . . . . 0.0 112.292 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.092 HD12 HD22 ' A' ' 17' ' ' LEU . 24.0 mm 109.4 60.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.728 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.6 m120 -62.78 65.85 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 25' ' ' ASN . 81.5 p 56.76 156.7 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.656 ' O ' ' HB2' ' A' ' 31' ' ' MET . 52.1 Cg_exo -49.5 -34.47 33.65 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.299 1.332 . . . . 0.0 113.15 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.03 -57.1 10.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.327 0.584 . . . . 0.0 110.647 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.604 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.2 tp10 -76.0 -57.51 3.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.901 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -49.9 -41.12 45.13 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.873 ' HA ' HD13 ' A' ' 34' ' ' LEU . 64.3 mtm -65.72 -33.82 76.77 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.45 -28.31 68.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.605 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.702 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -72.6 -40.73 66.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.618 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.873 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.4 mp -35.18 145.21 0.2 Allowed Pre-proline 0 N--CA 1.467 0.407 0 CA-C-O 121.137 0.494 . . . . 0.0 112.326 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.536 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.2 Cg_endo . . . . . 0 C--N 1.347 0.48 0 C-N-CA 124.07 3.18 . . . . 0.0 114.38 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.563 HG22 HD23 ' A' ' 34' ' ' LEU . 9.9 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.873 0.368 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.467 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 6.7 m -81.0 127.82 33.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.7 m -95.55 43.71 1.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 110.368 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.461 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.134 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.878 ' C ' HD22 ' A' ' 49' ' ' LEU . 32.8 mt-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.878 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.7 mm? -141.63 139.37 33.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.848 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.467 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 59.6 pttt -176.97 153.94 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.81 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.768 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.8 -27.22 1.94 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.659 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.9 t -67.26 -62.51 1.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.067 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -72.55 -54.32 9.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.915 0.388 . . . . 0.0 111.787 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.898 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -71.76 -45.3 62.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.812 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.91 -27.83 1.57 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.711 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -41.91 -36.69 1.13 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.795 0.807 . . . . 0.0 110.434 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 54' ' ' ALA . 16.3 m -83.07 28.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.28 -1.327 . . . . 0.0 112.243 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 57' ' ' VAL . 36.1 mt -137.91 76.9 1.6 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.943 0.402 . . . . 0.0 110.38 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.9 p -49.08 174.92 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.247 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.02 73.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.551 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -50.69 -28.44 9.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.629 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.472 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 52.8 m-20 -75.47 3.46 9.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.338 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.685 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -43.78 -71.34 0.16 Allowed Pre-proline 0 N--CA 1.462 0.157 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.248 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 56.4 Cg_endo -68.39 77.65 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.023 1.816 . . . . 0.0 111.303 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.755 ' CG ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -77.1 144.59 38.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.138 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 62.1 mttp -70.37 64.36 0.27 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.106 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.889 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 55.7 m 63.93 160.2 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.575 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.541 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.92 -27.09 11.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.893 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.471 ' HA ' HD11 ' A' ' 14' ' ' ILE . 15.3 pt-20 -65.43 -38.92 91.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.969 0.414 . . . . 0.0 109.969 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 6.8 tp10 -67.73 -46.23 72.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.927 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.001 ' CG2' HG21 ' A' ' 24' ' ' ILE . 42.1 t -66.36 -45.65 88.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.821 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.564 ' HB1' ' CD ' ' A' ' 10' ' ' ARG . . . -55.33 -45.05 76.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.009 0.433 . . . . 0.0 110.352 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -69.82 -43.5 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.69 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.467 HG22 HD21 ' A' ' 58' ' ' LEU . 72.6 m -57.74 -46.93 83.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.298 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.875 HG23 ' CB ' ' A' ' 54' ' ' ALA . 70.6 mt -58.23 -54.95 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.959 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.53 HG21 ' HE3' ' A' ' 6' ' ' LYS . 15.2 m -58.5 -43.93 87.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.836 0.309 . . . . 0.0 111.836 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -62.52 -54.14 44.33 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.425 ' CB ' HG21 ' A' ' 57' ' ' VAL . 98.6 mttt -72.07 -41.16 67.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.42 ' HB1' ' CD1' ' A' ' 49' ' ' LEU . . . -67.04 -29.98 69.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.062 0.394 . . . . 0.0 112.062 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.49 -56.36 0.39 Allowed Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.049 -1.072 . . . . 0.0 113.223 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 14.0 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.08 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.9 p . . . . . 0 C--O 1.213 -0.844 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.484 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 0.8 OUTLIER -45.1 -46.54 11.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.834 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.6 -32.79 53.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.868 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.706 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 13.5 m-20 -64.88 -52.14 58.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.542 HG13 HG22 ' A' ' 5' ' ' VAL . 31.9 mt -65.4 -46.63 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.826 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 45.8 ttp180 -56.77 -28.69 61.7 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.46 -42.41 95.84 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 67.8 mt-30 -69.02 -32.44 71.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.866 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.1 mt -70.11 -45.91 74.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.266 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 14' ' ' ILE . 5.3 mm -57.67 -52.23 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.698 0.285 . . . . 0.0 110.398 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.63 93.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.332 -0.937 . . . . 0.0 110.9 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.719 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -64.72 -25.88 68.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.282 -0.459 . . . . 0.0 111.172 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.008 HD22 HD12 ' A' ' 24' ' ' ILE . 65.3 mt -83.0 -29.46 28.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.718 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.83 139.43 54.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.262 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.67 -30.85 8.88 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.888 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.674 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.59 -176.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.988 0.423 . . . . 0.0 111.61 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.575 ' CB ' ' ND2' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -59.83 -120.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.825 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -61.36 -169.06 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.825 ' N ' ' HD1' ' A' ' 22' ' ' PHE . 57.5 Cg_endo -71.48 62.19 2.82 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 CA-C-N 120.975 1.384 . . . . 0.0 112.178 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.064 HG21 HG21 ' A' ' 71' ' ' VAL . 48.9 mm 109.83 65.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.671 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 7.3 m-20 -63.76 65.64 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 O-C-N 122.001 -0.437 . . . . 0.0 111.612 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.609 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 42.7 p 59.38 157.05 0.1 OUTLIER Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.604 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 50.7 Cg_exo -50.59 -34.36 42.66 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.331 1.354 . . . . 0.0 112.879 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -53.15 -55.43 24.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.137 0.494 . . . . 0.0 110.907 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.671 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -74.83 -57.37 3.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.907 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -49.89 -38.46 35.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.792 ' HA ' HD13 ' A' ' 34' ' ' LEU . 57.3 mtm -63.5 -37.83 88.82 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.77 -26.44 66.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.166 0.508 . . . . 0.0 110.562 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.674 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -68.36 -42.99 78.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.474 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.792 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.0 mp -33.32 148.9 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.739 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo . . . . . 0 C--N 1.346 0.447 0 C-N-CA 123.648 2.898 . . . . 0.0 113.821 -177.979 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.642 HG22 HD23 ' A' ' 34' ' ' LEU . 2.4 t . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 120.958 0.409 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.445 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 28.1 m -83.9 125.98 32.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.996 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.494 ' HB2' HG23 ' A' ' 9' ' ' ILE . 63.4 m -88.84 46.26 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 0.0 110.341 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.455 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 61.8 pttt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.096 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.874 ' C ' HD22 ' A' ' 49' ' ' LEU . 29.6 mt-10 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.668 0.27 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.874 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -143.94 141.69 30.36 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.053 0.454 . . . . 0.0 111.238 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 41' ' ' THR . 51.0 pttt -177.46 165.88 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.73 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.724 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -55.14 -31.98 61.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.663 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.0 t -66.58 -62.65 1.35 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 58.4 m-20 -72.21 -54.31 10.01 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.506 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -73.42 -44.37 58.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.63 -25.28 1.39 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.365 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 25.3 pt20 -40.6 -38.4 0.87 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.157 0.503 . . . . 0.0 111.652 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.3 m -65.65 -33.32 62.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.371 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 13.2 mt -70.17 119.27 14.12 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.5 p -72.18 155.77 39.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.883 0.373 . . . . 0.0 111.468 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.82 -40.7 60.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.3 -21.2 33.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.961 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.573 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 19.6 m-20 -68.7 2.98 2.11 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.609 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.8 OUTLIER -37.78 -62.81 0.58 Allowed Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 117.953 0.342 . . . . 0.0 111.63 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.7 Cg_endo -72.08 77.63 1.95 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.378 2.052 . . . . 0.0 111.747 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.919 ' CD2' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -77.03 141.99 40.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.649 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.67 66.76 0.13 Allowed 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.519 0.676 . . . . 0.0 110.221 178.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.802 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 18.5 m 60.8 161.51 0.06 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.369 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.672 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.57 -31.77 25.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.645 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.9 pt-20 -58.37 -45.82 87.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.408 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -70.16 -33.69 72.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.607 -179.718 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.064 HG21 HG21 ' A' ' 24' ' ' ILE . 61.6 t -63.17 -44.95 99.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.919 0.39 . . . . 0.0 110.563 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.865 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -57.05 -50.3 73.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.067 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 56.0 m-20 -68.5 -42.04 79.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.009 0.433 . . . . 0.0 111.232 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.474 HG22 HD21 ' A' ' 58' ' ' LEU . 98.0 m -59.64 -49.4 77.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.797 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.49 HG23 ' HB1' ' A' ' 54' ' ' ALA . 75.2 mt -62.07 -54.23 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.607 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.865 HG22 ' O ' ' A' ' 72' ' ' ALA . 11.3 m -61.29 -44.67 98.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 4.3 m120 -59.66 -52.58 64.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.43 ' HE2' ' HB ' ' A' ' 57' ' ' VAL . 48.9 mtpt -72.65 -41.06 65.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.734 0.302 . . . . 0.0 111.606 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.27 -30.08 69.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.759 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.19 -56.28 0.41 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.934 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 16.9 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.042 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.703 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p . . . . . 0 C--O 1.21 -0.974 0 N-CA-C 111.315 0.117 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HE2' ' NH2' ' A' ' 10' ' ' ARG . 86.8 tttt -44.94 -47.45 11.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -77.61 -33.48 53.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.786 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.703 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -63.69 -52.07 62.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.527 HG13 ' CG2' ' A' ' 5' ' ' VAL . 28.3 mt -64.01 -46.46 93.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.794 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 24.3 ttm180 -56.88 -28.05 61.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.92 -41.42 97.4 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 63.4 mt-30 -70.69 -31.33 68.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.633 -0.784 . . . . 0.0 110.032 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.4 -48.68 52.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.308 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.466 ' HA ' HD13 ' A' ' 14' ' ' ILE . 7.9 mm -57.27 -52.27 58.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.511 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.22 -36.47 93.27 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.911 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -64.17 -28.45 69.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.239 -0.481 . . . . 0.0 111.247 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.048 HD22 HD12 ' A' ' 24' ' ' ILE . 60.8 mt -80.43 -29.45 37.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.701 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.68 133.3 53.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.067 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.58 -33.54 5.46 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.765 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.706 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.65 -176.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.449 . . . . 0.0 111.643 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -59.9 -123.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.143 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.775 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -58.83 -174.79 0.05 OUTLIER Pre-proline 0 N--CA 1.456 -0.127 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 176.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.844 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 52.2 Cg_endo -68.08 62.8 1.01 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 120.478 1.206 . . . . 0.0 112.326 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.048 HD12 HD22 ' A' ' 17' ' ' LEU . 49.1 mm 110.32 65.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.655 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 6.3 m-20 -64.67 65.99 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 122.013 -0.429 . . . . 0.0 111.478 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.541 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 27.3 p 58.43 157.2 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.602 ' HG3' HD12 ' A' ' 58' ' ' LEU . 50.8 Cg_exo -50.69 -34.62 44.53 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.319 1.346 . . . . 0.0 112.875 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -52.61 -55.19 24.07 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.613 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.655 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 6.0 tp10 -76.25 -57.83 3.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.933 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -50.03 -41.85 48.34 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.749 ' N ' HD12 ' A' ' 30' ' ' LEU . 28.3 ttm -66.02 -32.69 74.32 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.14 -30.39 69.51 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.394 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -68.41 -40.42 81.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.288 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.0 mp -25.07 134.47 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.29 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 C--N 1.347 0.452 0 C-N-CA 123.862 3.041 . . . . 0.0 114.899 -178.029 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.52 HG22 HD23 ' A' ' 34' ' ' LEU . 3.8 t . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 120.777 0.322 . . . . 0.0 111.473 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.45 ' OG1' ' HD2' ' A' ' 50' ' ' LYS . 27.3 m -96.15 118.87 33.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.668 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -88.01 43.87 1.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.09 0.472 . . . . 0.0 109.975 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 19.8 ptmt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.148 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.883 ' C ' HD22 ' A' ' 49' ' ' LEU . 32.6 mt-10 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.682 0.277 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.883 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -140.91 132.52 27.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.936 0.398 . . . . 0.0 110.912 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HD2' ' OG1' ' A' ' 41' ' ' THR . 21.3 ptmt -170.21 159.08 7.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.727 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.86 -29.88 3.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.951 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.9 t -72.54 -59.59 2.65 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 57.5 m-20 -72.15 -54.11 10.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.79 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -74.34 -43.97 54.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.09 -27.06 1.46 Allowed Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.363 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 18.1 pt20 -42.25 -40.14 2.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.149 0.5 . . . . 0.0 111.515 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.751 HG22 ' O ' ' A' ' 54' ' ' ALA . 28.0 m -65.76 -30.39 49.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.104 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.691 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 12.4 mt -71.32 119.85 16.05 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.5 p -75.0 155.66 37.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.355 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.64 -39.81 51.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -58.81 -21.09 55.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.642 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.4 m-20 -70.04 3.15 2.9 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.5 m-85 -40.49 -62.69 0.88 Allowed Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 118.162 0.437 . . . . 0.0 111.293 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.0 Cg_endo -71.43 74.95 2.01 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.48 2.12 . . . . 0.0 112.207 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.881 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -76.9 139.84 40.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.167 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.486 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 38.1 mtmm -66.45 70.07 0.07 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.596 0.712 . . . . 0.0 110.671 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.844 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 37.7 m 59.33 161.15 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.284 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.67 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.55 -26.85 9.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.482 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.515 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 12.0 pt-20 -58.77 -48.99 79.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.454 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.499 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -74.87 -31.88 61.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 119.656 -0.817 . . . . 0.0 111.303 -179.387 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.971 HG21 HG21 ' A' ' 24' ' ' ILE . 57.2 t -61.48 -45.47 98.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.418 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.889 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -60.84 -46.33 90.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.108 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 9.3 t70 -62.5 -41.74 99.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.531 0.682 . . . . 0.0 110.396 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.471 HG22 HD21 ' A' ' 58' ' ' LEU . 85.0 m -63.19 -49.54 73.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.835 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.79 HG23 ' CB ' ' A' ' 54' ' ' ALA . 74.7 mt -59.79 -55.17 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.072 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 72' ' ' ALA . 9.7 m -60.9 -43.8 96.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 3.4 m120 -63.93 -50.77 67.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HB2' HG21 ' A' ' 57' ' ' VAL . 99.7 mttt -74.06 -41.65 61.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.536 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.11 -29.9 69.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.7 -55.79 0.36 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.064 -1.065 . . . . 0.0 113.223 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 17.5 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.237 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.7 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.3 p . . . . . 0 C--O 1.211 -0.926 0 CA-C-O 120.009 -0.043 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 13.0 tmtt? -45.11 -46.0 11.53 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.53 -34.14 54.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.857 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.7 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -63.55 -52.2 62.11 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.811 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.73 HG23 ' HB2' ' A' ' 42' ' ' CYS . 31.6 mt -65.69 -47.49 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.802 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 52.0 ttp85 -55.04 -28.8 55.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.426 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.63 -47.21 79.31 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -66.95 -28.02 67.93 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.763 -0.719 . . . . 0.0 109.986 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 9' ' ' ILE . 75.3 mt -70.43 -44.99 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.075 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.566 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.46 HD13 ' HA ' ' A' ' 14' ' ' ILE . 11.3 mm -56.11 -49.64 74.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.05 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.69 -36.85 91.89 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.044 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.93 -27.11 69.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.25 -0.475 . . . . 0.0 111.38 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.025 HD22 HD12 ' A' ' 24' ' ' ILE . 35.9 mt -85.01 -29.47 24.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.71 132.86 46.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.03 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.45 -33.97 4.88 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.519 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.715 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.19 -177.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.771 0.319 . . . . 0.0 111.383 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.55 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.79 -119.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.749 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -60.82 179.61 0.22 Allowed Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 176.536 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.816 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 41.4 Cg_endo -65.48 65.49 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 CA-C-N 119.921 1.008 . . . . 0.0 112.359 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.025 HD12 HD22 ' A' ' 17' ' ' LEU . 31.7 mm 107.94 61.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.611 ' HA ' ' CZ ' ' A' ' 22' ' ' PHE . 2.6 m120 -62.98 65.75 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.588 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.1 p 57.12 156.7 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.613 ' O ' ' CB ' ' A' ' 31' ' ' MET . 53.7 Cg_exo -50.04 -33.99 36.65 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.351 1.367 . . . . 0.0 112.837 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -52.3 -56.83 12.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.308 0.575 . . . . 0.0 110.625 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.603 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.1 tp10 -76.1 -57.71 3.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.9 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.7 pp -50.2 -40.76 48.13 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.75 ' HA ' HD13 ' A' ' 34' ' ' LEU . 31.2 ttm -65.93 -33.61 76.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.48 -29.94 69.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.469 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.715 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -70.1 -39.62 75.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.408 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.75 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.8 mp -30.49 140.99 0.12 Allowed Pre-proline 0 N--CA 1.468 0.466 0 CA-C-O 121.108 0.48 . . . . 0.0 112.12 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 C--N 1.347 0.462 0 C-N-CA 123.859 3.04 . . . . 0.0 115.587 -177.471 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.474 ' N ' HD23 ' A' ' 34' ' ' LEU . 6.0 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.644 0.259 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.565 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 2.0 t -108.6 121.97 46.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.073 0.464 . . . . 0.0 111.478 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.73 ' HB2' HG23 ' A' ' 9' ' ' ILE . 33.8 m -72.4 59.84 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.39 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.467 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 62.0 pttt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.004 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.865 ' C ' HD22 ' A' ' 49' ' ' LEU . 22.1 mp0 . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.762 0.315 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.865 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.8 mm? -136.08 135.83 39.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.649 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.749 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 56.1 pttt -166.38 -165.26 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.058 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.506 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -78.02 -46.33 21.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.876 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.7 t -65.36 -51.62 59.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.647 0.26 . . . . 0.0 111.542 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.44 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 46.4 m-20 -71.79 -51.44 22.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 50' ' ' LYS . . . -86.03 -47.18 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.81 -26.15 1.08 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.785 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.419 ' HG3' ' N ' ' A' ' 57' ' ' VAL . 22.7 pt20 -41.57 -38.95 1.46 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.964 0.411 . . . . 0.0 111.796 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.1 m -65.66 -32.21 57.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.558 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.71 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 22.4 mt -68.62 122.54 18.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.36 . . . . 0.0 110.554 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.5 p -74.74 155.81 37.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.331 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.21 -42.11 60.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.321 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.21 -20.02 38.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.169 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.693 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 28.5 m-20 -68.64 3.31 1.92 Allowed 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.588 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.7 OUTLIER -39.49 -67.46 0.28 Allowed Pre-proline 0 N--CA 1.463 0.18 0 CA-C-N 117.758 0.254 . . . . 0.0 111.466 -179.107 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.7 Cg_endo -70.43 76.39 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.311 2.007 . . . . 0.0 112.18 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.858 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -76.94 141.92 40.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.989 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.507 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 4.4 mmmp? -67.41 69.67 0.1 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.454 0.645 . . . . 0.0 110.615 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.816 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.8 m 58.5 162.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.15 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.651 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.8 -27.47 12.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.733 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.494 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 15.6 pt-20 -58.36 -49.69 76.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.555 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.507 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -73.54 -32.27 64.11 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.07 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.972 HG21 HG21 ' A' ' 24' ' ' ILE . 60.6 t -64.79 -39.65 86.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.888 0.375 . . . . 0.0 110.62 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.802 ' HB1' ' CG ' ' A' ' 10' ' ' ARG . . . -63.69 -49.54 72.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -68.46 -41.11 80.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.168 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.8 m -58.85 -51.63 69.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.513 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.651 HG23 ' HB1' ' A' ' 54' ' ' ALA . 75.0 mt -59.17 -53.57 46.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.316 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 72' ' ' ALA . 11.1 m -59.82 -42.1 87.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.945 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -61.54 -53.45 56.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.679 0.276 . . . . 0.0 111.513 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.478 ' HE3' ' HB ' ' A' ' 57' ' ' VAL . 27.7 mtpp -71.85 -39.68 69.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.597 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.92 69.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.812 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.34 -55.4 0.41 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.808 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 17.9 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.958 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.8 p . . . . . 0 C--O 1.213 -0.828 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 46.2 tttm -44.72 -47.05 10.7 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.798 -0.761 . . . . 0.0 108.999 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.39 -34.33 54.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.759 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.706 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 65.4 m-20 -63.03 -52.05 64.38 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.534 HG13 HG22 ' A' ' 5' ' ' VAL . 31.1 mt -66.23 -47.7 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.838 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 42.3 ttp180 -55.02 -28.85 55.29 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.98 -43.93 92.62 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 68.7 mt-30 -67.08 -30.83 70.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.746 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 9' ' ' ILE . 68.0 mt -70.77 -42.64 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.781 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.2 mm -57.82 -53.53 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.359 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.27 -37.56 92.99 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.011 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.41 -30.91 69.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.072 0.463 . . . . 0.0 111.081 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.103 HD22 HD12 ' A' ' 24' ' ' ILE . 46.5 mt -81.27 -29.44 34.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.513 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.82 125.25 21.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.716 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.62 -35.2 3.11 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.465 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.655 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.37 -176.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.842 0.353 . . . . 0.0 111.378 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.577 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.85 -119.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 177.589 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.729 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -59.66 177.44 0.27 Allowed Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.182 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.877 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 53.6 Cg_endo -65.11 65.86 0.31 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 CA-C-N 119.949 1.017 . . . . 0.0 112.372 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.103 HD12 HD22 ' A' ' 17' ' ' LEU . 26.9 mm 109.53 61.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 178.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.696 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.7 m120 -63.14 65.23 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.589 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.8 p 57.37 154.33 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.68 ' O ' ' CB ' ' A' ' 31' ' ' MET . 61.6 Cg_exo -48.21 -32.32 18.99 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.23 1.287 . . . . 0.0 112.748 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -53.0 -57.32 10.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.431 0.634 . . . . 0.0 110.591 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.6 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.1 tp10 -76.27 -57.65 3.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.901 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.2 pp -50.12 -35.15 24.58 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.68 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 30.8 ttm -66.96 -37.01 83.49 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.19 -23.98 64.9 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.659 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.655 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -74.0 -46.59 42.67 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 30' ' ' LEU . 5.6 mp -36.08 144.91 0.24 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 121.241 0.543 . . . . 0.0 112.404 -177.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.8 Cg_endo . . . . . 0 C--N 1.348 0.543 0 C-N-CA 124.202 3.268 . . . . 0.0 115.141 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.553 HG22 HD23 ' A' ' 34' ' ' LEU . 3.9 t . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.785 0.326 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 m -79.82 126.86 31.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.392 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.2 m -101.61 42.71 1.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.185 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.572 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . 22.5 pttp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.634 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.908 ' C ' HD22 ' A' ' 49' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.488 0.661 . . . . 0.0 112.271 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.908 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -143.95 133.28 23.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.721 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 60.6 pttt -169.73 -170.57 1.06 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 111.472 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.505 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -62.2 -52.4 63.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.414 ' OG ' ' HE3' ' A' ' 50' ' ' LYS . 85.3 p -72.74 -51.23 20.01 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.42 ' OD1' ' CE ' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -69.15 -49.92 52.47 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.717 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -90.81 -45.67 8.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -54.22 -21.66 19.5 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.985 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -44.07 -31.4 0.92 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.016 0.436 . . . . 0.0 111.072 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.9 m -77.65 27.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.636 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.536 HD21 HG22 ' A' ' 74' ' ' THR . 34.6 mt -129.33 117.32 20.45 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.922 0.391 . . . . 0.0 110.637 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.445 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 72.6 p -71.84 158.26 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.615 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.73 -39.38 51.75 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.369 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -50.92 -27.28 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.035 0.445 . . . . 0.0 110.737 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.555 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 61.2 m-20 -70.73 3.68 3.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.458 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.676 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -42.12 -69.4 0.22 Allowed Pre-proline 0 C--O 1.226 -0.147 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.378 -179.244 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 51.6 Cg_endo -68.2 76.55 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.254 1.97 . . . . 0.0 111.475 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.2 OUTLIER -77.01 142.63 39.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.137 -178.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 87.6 tttt -69.8 64.97 0.21 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.818 0.818 . . . . 0.0 111.24 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.877 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 64.8 m 64.07 161.25 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.728 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.553 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -53.38 -27.2 22.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.765 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -65.12 -39.35 92.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.17 0.509 . . . . 0.0 109.666 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 8.0 tp10 -66.23 -43.53 86.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.681 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.986 ' CG2' HG21 ' A' ' 24' ' ' ILE . 63.2 t -67.74 -41.1 84.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.544 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.857 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -55.9 -44.67 78.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.08 0.467 . . . . 0.0 110.015 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.71 -46.66 52.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.17 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.536 HG22 HD21 ' A' ' 58' ' ' LEU . 62.6 m -56.48 -48.78 76.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.708 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.477 HG23 ' CB ' ' A' ' 54' ' ' ALA . 68.3 mt -62.58 -54.31 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.656 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 72' ' ' ALA . 12.9 m -60.12 -42.07 88.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -62.65 -50.6 70.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.685 0.279 . . . . 0.0 111.483 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HB2' HG21 ' A' ' 57' ' ' VAL . 67.7 mttm -72.13 -43.01 65.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.794 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.542 ' HB1' HD12 ' A' ' 49' ' ' LEU . . . -67.54 -30.06 69.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.38 -56.56 0.41 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.869 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.5 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.083 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.713 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.5 p . . . . . 0 C--O 1.214 -0.806 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HE2' ' NH2' ' A' ' 10' ' ' ARG . 82.3 tttt -45.12 -43.24 9.58 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -77.72 -37.14 50.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.836 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.713 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 10.4 m-20 -62.6 -51.77 66.0 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.484 HG13 HG22 ' A' ' 5' ' ' VAL . 30.2 mt -63.92 -45.76 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.756 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 28.3 ttm180 -56.25 -29.95 61.76 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.4 -41.13 98.21 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 68.1 mt-30 -68.9 -30.12 68.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.747 -0.727 . . . . 0.0 109.755 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 10' ' ' ARG . 70.1 mt -71.17 -45.6 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.829 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 14' ' ' ILE . 9.9 mm -58.2 -52.55 57.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.34 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.44 -37.47 94.49 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.351 -0.928 . . . . 0.0 110.815 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.62 -31.0 70.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.176 -0.512 . . . . 0.0 110.785 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.026 HD22 HD12 ' A' ' 24' ' ' ILE . 64.2 mt -80.87 -29.34 35.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.574 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.95 138.08 49.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.15 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.66 -33.14 6.53 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.798 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.717 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.4 -177.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.951 0.405 . . . . 0.0 111.62 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.606 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -59.81 -122.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.389 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.83 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -59.68 -171.5 0.03 OUTLIER Pre-proline 0 N--CA 1.454 -0.227 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.052 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.835 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.3 Cg_endo -70.02 62.66 1.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 120.718 1.292 . . . . 0.0 112.012 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.052 HG21 HG21 ' A' ' 71' ' ' VAL . 49.3 mm 109.57 65.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.647 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 5.8 m-20 -63.73 65.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 O-C-N 122.038 -0.414 . . . . 0.0 111.857 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.603 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 35.8 p 60.1 154.54 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.606 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 52.0 Cg_exo -49.57 -33.32 30.49 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.197 1.265 . . . . 0.0 112.715 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -53.99 -54.88 32.97 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.649 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.647 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 5.9 tp10 -75.2 -57.76 3.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.915 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.27 -41.87 51.2 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.758 ' N ' HD12 ' A' ' 30' ' ' LEU . 36.1 ttm -64.29 -32.34 73.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -70.3 -28.75 65.43 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.399 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -71.0 -35.92 72.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.59 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.712 ' HB3' HG22 ' A' ' 40' ' ' THR . 8.8 mp -29.27 139.29 0.12 Allowed Pre-proline 0 N--CA 1.471 0.625 0 CA-C-O 121.078 0.466 . . . . 0.0 112.178 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo . . . . . 0 C--N 1.348 0.526 0 C-N-CA 124.281 3.321 . . . . 0.0 115.868 -177.338 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.712 HG22 ' HB3' ' A' ' 34' ' ' LEU . 8.8 t . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.751 0.31 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.458 ' OG1' ' HD2' ' A' ' 50' ' ' LYS . 29.2 m -92.72 125.1 37.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.148 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -93.41 41.31 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 60.8 pttt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.183 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.882 ' C ' HD22 ' A' ' 49' ' ' LEU . 69.0 mt-10 . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.758 0.313 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.5 mm? -142.14 135.05 28.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.591 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.53 ' NZ ' ' HB2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -171.64 -171.96 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.967 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.425 ' O ' ' CA ' ' A' ' 55' ' ' GLY . . . -69.38 -50.12 49.06 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.472 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 35.4 t -66.47 -48.6 69.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.809 0.338 . . . . 0.0 111.562 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.439 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 28.8 m-20 -70.32 -54.14 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.744 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -94.6 -46.85 6.78 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -47.23 -26.1 3.1 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.871 -0.681 . . . . 0.0 113.047 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -43.69 -30.13 0.59 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 111.647 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 54' ' ' ALA . 29.7 m -74.16 28.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.773 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 22.2 mt -132.67 116.37 16.55 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.4 p -70.85 155.93 40.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 111.698 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.28 -39.42 21.54 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.438 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -50.84 -27.64 7.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.941 0.401 . . . . 0.0 110.578 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.593 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.4 m-20 -71.59 3.17 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.083 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.603 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.2 OUTLIER -37.25 -53.48 2.15 Favored Pre-proline 0 N--CA 1.463 0.204 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.435 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 3.5 Cg_endo -83.27 78.47 3.19 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.87 2.38 . . . . 0.0 112.127 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.881 ' CD2' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.19 143.52 38.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.625 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 3.3 mptp? -68.64 67.14 0.13 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.565 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.835 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 34.2 m 60.53 160.98 0.05 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.19 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.621 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.47 -31.17 22.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.431 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.499 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 22.1 pt-20 -57.52 -46.91 83.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.371 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.487 ' HG3' ' HD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -69.77 -35.63 75.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.5 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.052 HG21 HG21 ' A' ' 24' ' ' ILE . 61.6 t -61.9 -45.85 97.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 0.0 110.769 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.846 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -56.23 -49.93 72.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.986 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.51 -38.3 80.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.262 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 95.2 m -63.81 -51.36 65.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.0 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.427 HG23 ' CB ' ' A' ' 54' ' ' ALA . 70.2 mt -59.3 -52.17 63.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.269 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 72' ' ' ALA . 6.8 m -59.51 -39.91 80.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -62.36 -56.1 21.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.77 0.319 . . . . 0.0 111.702 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.549 ' HB2' HG21 ' A' ' 57' ' ' VAL . 98.6 mttt -69.46 -39.78 77.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.831 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.744 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.08 -29.86 69.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.134 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.76 -55.43 0.42 Allowed Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.273 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.5 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.292 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.745 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.5 p . . . . . 0 C--O 1.213 -0.842 0 CA-C-O 120.062 -0.018 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.579 ' HA ' HD13 ' A' ' 81' ' ' LEU . 81.4 tttt -45.66 -51.13 12.75 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -77.87 -28.57 50.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.843 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.745 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 3.8 t70 -65.77 -52.65 49.19 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.505 HG13 HG22 ' A' ' 5' ' ' VAL . 15.3 mt -65.4 -42.22 92.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.903 ' NH2' HG21 ' A' ' 13' ' ' ILE . 3.1 tpt180 -60.25 -26.0 66.12 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.93 -44.74 94.13 Favored Glycine 0 CA--C 1.503 -0.675 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 77.5 mt-30 -63.43 -27.51 69.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.768 -0.716 . . . . 0.0 109.329 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.903 HG21 ' NH2' ' A' ' 10' ' ' ARG . 64.3 mt -75.03 -47.3 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.721 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.455 ' HA ' HD13 ' A' ' 14' ' ' ILE . 4.7 mm -56.4 -52.2 55.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 120.749 0.309 . . . . 0.0 110.2 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.23 -37.08 94.31 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -62.25 -27.34 68.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.184 -0.508 . . . . 0.0 110.834 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.055 HD22 HD12 ' A' ' 24' ' ' ILE . 40.4 mt -80.5 -29.52 37.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.283 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.42 133.38 49.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.871 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.17 -34.03 5.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.465 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.694 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.37 -178.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.838 0.351 . . . . 0.0 111.348 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.605 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.6 m-20 -60.88 -120.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.746 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -59.44 179.8 0.18 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.739 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.816 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 50.0 Cg_endo -65.46 63.98 0.37 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 CA-C-N 119.827 0.974 . . . . 0.0 112.363 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.055 HD12 HD22 ' A' ' 17' ' ' LEU . 33.7 mm 108.65 60.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.605 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.6 m120 -62.48 65.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.584 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 61.5 p 57.64 154.42 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.635 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 60.2 Cg_exo -48.93 -32.44 22.99 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.305 1.336 . . . . 0.0 112.689 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -53.04 -57.38 10.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.41 0.624 . . . . 0.0 110.415 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.593 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 41.4 tp10 -76.2 -57.6 3.77 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.892 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.16 -43.05 52.02 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.735 ' HA ' HD13 ' A' ' 34' ' ' LEU . 43.0 ttm -66.01 -31.58 72.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -67.2 -31.11 71.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.371 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.694 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -69.75 -39.03 76.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.284 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.1 mp -30.0 137.33 0.17 Allowed Pre-proline 0 N--CA 1.47 0.546 0 CA-C-O 121.026 0.441 . . . . 0.0 111.831 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo . . . . . 0 C--N 1.348 0.536 0 C-N-CA 123.842 3.028 . . . . 0.0 115.754 -177.259 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.729 0.299 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 7.8 m -84.72 125.75 32.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.509 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.2 m -92.16 45.99 1.24 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.98 0.419 . . . . 0.0 110.094 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.439 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 22.2 pttp . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.083 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.903 ' C ' HD22 ' A' ' 49' ' ' LEU . 26.7 mt-10 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.746 0.308 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.903 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.1 mm? -141.38 128.98 21.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.167 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 22.5 pttp -168.47 157.88 9.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.612 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.461 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.75 -37.63 13.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.134 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.0 t -63.81 -52.48 60.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -72.25 -50.69 25.36 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.892 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -91.91 -47.15 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.81 -29.6 2.06 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.052 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -45.55 -30.93 1.6 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.074 0.464 . . . . 0.0 111.17 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.8 m -75.11 28.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.666 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.576 HD13 ' CE2' ' A' ' 65' ' ' PHE . 38.5 mt -132.26 116.47 16.96 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.2 p -73.19 156.1 38.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.944 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.67 -37.3 12.63 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.018 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -51.0 -29.21 11.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.146 0.498 . . . . 0.0 110.187 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.605 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -72.05 3.6 4.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.556 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.584 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.1 t80 -38.99 -51.86 3.95 Favored Pre-proline 0 CA--C 1.527 0.092 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 86.5 Cg_endo -87.62 78.89 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.923 2.416 . . . . 0.0 112.061 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.944 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.14 140.59 40.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.971 0.415 . . . . 0.0 111.448 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 27.3 tptp -66.48 69.95 0.07 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.753 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.816 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 38.0 m 58.07 161.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.796 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.715 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.74 -30.12 21.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.935 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 10.7 pt-20 -57.41 -47.62 81.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.678 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -72.87 -37.89 67.18 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.724 -179.68 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.982 ' CG2' HG21 ' A' ' 24' ' ' ILE . 42.9 t -60.1 -34.56 57.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.934 0.397 . . . . 0.0 110.693 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.752 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -68.72 -56.03 9.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.463 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.4 m-20 -66.19 -35.09 79.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.584 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.5 m -62.58 -49.98 73.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.903 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.676 HD12 HH22 ' A' ' 10' ' ' ARG . 73.0 mt -64.12 -51.02 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -52.38 -38.5 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.206 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -60.63 -55.26 35.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 111.319 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB2' HG21 ' A' ' 57' ' ' VAL . 62.0 mttp -71.91 -38.66 69.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.832 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.738 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.84 -30.11 70.2 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.2 -55.47 0.43 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 119.869 -1.158 . . . . 0.0 113.477 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.643 HD12 HG12 ' A' ' 76' ' ' VAL . 14.1 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.25 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.73 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p . . . . . 0 C--O 1.216 -0.68 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 62.9 tttp -45.33 -48.71 13.17 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.082 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -77.7 -30.1 51.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.835 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.73 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 23.0 m-20 -65.21 -52.07 57.06 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.883 HD13 HD23 ' A' ' 49' ' ' LEU . 23.9 mt -69.74 -48.45 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.779 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 23.2 ttp180 -56.17 -28.57 58.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.04 -44.32 91.67 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.52 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 66.2 mt-30 -66.38 -32.16 73.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.818 -0.691 . . . . 0.0 109.826 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 70.5 mt -70.58 -48.22 60.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.187 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 69' ' ' GLU . 7.5 mm -53.94 -54.19 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.275 . . . . 0.0 110.8 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.7 -36.17 92.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.956 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -63.9 -22.06 66.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.115 -0.543 . . . . 0.0 111.478 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.043 HD22 HD12 ' A' ' 24' ' ' ILE . 56.0 mt -90.44 -29.64 17.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.882 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 83.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.803 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 169.34 -38.48 0.2 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.384 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.749 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.38 -177.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.555 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -58.3 -120.52 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.71 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -58.69 175.46 0.32 Allowed Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 176.492 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.899 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 39.4 Cg_endo -63.89 65.41 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 120.853 1.036 . . . . 0.0 112.835 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.128 HG23 HD22 ' A' ' 30' ' ' LEU . 11.1 mm 109.84 61.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 177.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.587 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 3.1 m120 -65.81 64.06 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.668 ' C ' HD23 ' A' ' 30' ' ' LEU . 87.6 p 57.43 150.53 0.06 OUTLIER Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.88 ' O ' ' HB2' ' A' ' 31' ' ' MET . 86.9 Cg_exo -46.15 -28.5 5.54 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.09 1.86 . . . . 0.0 112.654 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -55.87 -57.31 12.61 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.579 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 5.6 tp10 -77.38 -57.37 3.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.128 HD22 HG23 ' A' ' 24' ' ' ILE . 1.4 pp -50.04 -34.36 21.24 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.68 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.88 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -77.87 -29.87 50.57 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.735 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -61.79 -28.2 69.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.749 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -81.95 -35.95 28.5 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.066 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 31' ' ' MET . 6.4 mp -33.29 130.48 0.37 Allowed Pre-proline 0 N--CA 1.467 0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 111.689 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo . . . . . 0 C--N 1.349 0.577 0 C-N-CA 123.503 2.802 . . . . 0.0 114.358 -178.379 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.569 HG22 HD23 ' A' ' 34' ' ' LEU . 5.2 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.83 0.348 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.5 m -101.03 95.41 6.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.722 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.4 m -72.38 57.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.9 0.381 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 8.8 ptpp? . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.267 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.829 ' C ' HD22 ' A' ' 49' ' ' LEU . 31.5 mt-10 . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.883 HD23 HD13 ' A' ' 9' ' ' ILE . 2.4 mm? -133.41 139.85 46.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.998 0.427 . . . . 0.0 111.648 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 56.1 pttt -177.96 -164.72 0.09 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.69 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.758 ' HB1' ' HB3' ' A' ' 27' ' ' PRO . . . -77.58 -44.67 27.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.373 0.606 . . . . 0.0 111.505 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.404 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 23.2 t -59.63 -56.37 22.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.365 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.424 ' OD2' ' HE2' ' A' ' 50' ' ' LYS . 58.7 m-20 -72.78 -54.33 9.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.76 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -91.45 -43.21 9.85 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -45.62 -25.6 1.49 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.095 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -43.93 -40.16 4.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.144 0.497 . . . . 0.0 110.91 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 54' ' ' ALA . 35.4 m -65.68 -32.59 58.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.157 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.762 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 38.7 mt -71.36 70.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.183 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.402 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 71.7 p -47.94 156.8 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.595 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -43.63 -40.67 4.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.005 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -50.97 -27.92 8.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.886 0.374 . . . . 0.0 110.849 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.618 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 57.2 m-20 -73.33 3.45 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.625 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -40.82 -66.8 0.35 Allowed Pre-proline 0 N--CA 1.463 0.194 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.125 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 70.2 Cg_endo -72.93 75.97 2.61 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.408 2.072 . . . . 0.0 111.953 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.969 ' CG ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -77.01 142.37 39.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.357 -179.504 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.494 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 84.2 tttt -67.73 71.48 0.14 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.391 0.615 . . . . 0.0 110.703 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.899 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.7 m 59.31 161.37 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.003 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.73 -30.43 22.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.646 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.484 ' HA ' HD11 ' A' ' 14' ' ' ILE . 15.5 pt-20 -58.28 -47.63 83.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.636 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.571 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -74.38 -31.68 62.46 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.635 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.972 ' CG2' HG21 ' A' ' 24' ' ' ILE . 60.9 t -66.64 -51.68 53.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.779 ' HB1' ' HG2' ' A' ' 10' ' ' ARG . . . -55.61 -42.14 74.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 109.801 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.431 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 47.5 t0 -64.52 -46.46 82.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.218 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.47 HG22 HD21 ' A' ' 58' ' ' LEU . 98.6 m -58.81 -47.52 84.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.949 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 69.7 mt -57.31 -49.56 79.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.507 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 15.6 m -63.4 -40.41 88.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.431 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.5 m-20 -64.63 -55.94 17.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.57 -40.49 73.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.608 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.1 -30.0 69.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.26 -56.01 0.38 Allowed Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.214 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.0 mt . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.323 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.72 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.6 p . . . . . 0 C--O 1.213 -0.846 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.733 ' HE3' HG21 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -44.62 -50.47 9.75 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.608 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -77.46 -30.29 53.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.968 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.72 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 71.5 m-20 -64.41 -52.28 58.93 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.487 HG13 ' CG2' ' A' ' 5' ' ' VAL . 15.9 mt -63.75 -43.79 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.898 ' NH2' HG21 ' A' ' 13' ' ' ILE . 0.7 OUTLIER -59.26 -25.94 64.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.008 178.036 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.91 -45.15 89.78 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' A' ' 42' ' ' CYS . 75.8 mt-30 -64.3 -29.87 70.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.739 -0.731 . . . . 0.0 109.724 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.898 HG21 ' NH2' ' A' ' 10' ' ' ARG . 75.7 mt -74.94 -46.15 41.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.863 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.454 ' HA ' HD13 ' A' ' 14' ' ' ILE . 5.1 mm -55.25 -53.09 38.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 110.397 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.4 -34.94 90.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.239 -0.981 . . . . 0.0 110.772 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.77 67.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.315 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.077 HD22 HD12 ' A' ' 24' ' ' ILE . 38.4 mt -83.2 -29.74 28.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 110.47 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.16 117.08 5.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.569 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.82 -36.22 1.96 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.455 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.674 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -53.92 -172.37 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.477 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.571 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -62.06 -119.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.793 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.776 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -60.79 179.62 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.815 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.7 Cg_endo -65.39 66.76 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 120.778 0.986 . . . . 0.0 112.561 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.077 HD12 HD22 ' A' ' 17' ' ' LEU . 30.2 mm 108.19 61.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 22' ' ' PHE . 2.7 m120 -64.39 64.76 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.6 p 58.15 155.23 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.641 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 64.5 Cg_exo -49.17 -32.29 24.26 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.359 1.373 . . . . 0.0 112.775 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -52.82 -57.6 9.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.502 0.668 . . . . 0.0 110.333 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.591 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 46.5 tp10 -76.5 -57.78 3.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.871 HD22 HG23 ' A' ' 24' ' ' ILE . 3.6 pp -50.12 -41.68 49.09 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.729 ' HA ' HD13 ' A' ' 34' ' ' LEU . 39.5 ttm -66.55 -32.46 73.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.3 -30.77 71.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.462 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.674 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -69.93 -40.77 75.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.403 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.729 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.1 mp -28.24 127.34 0.22 Allowed Pre-proline 0 N--CA 1.468 0.453 0 CA-C-O 121.061 0.458 . . . . 0.0 111.871 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 C--N 1.349 0.573 0 C-N-CA 123.513 2.809 . . . . 0.0 114.119 -178.354 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.521 -0.138 0 CA-C-O 120.852 0.358 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.419 ' CG2' ' HB3' ' A' ' 48' ' ' GLU . 28.5 m -102.73 91.33 4.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.757 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.424 ' HB3' ' OE1' ' A' ' 12' ' ' GLN . 59.3 m -70.24 57.96 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.921 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.44 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.1 pttp . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.189 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.888 ' C ' HD22 ' A' ' 49' ' ' LEU . 8.9 mp0 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.945 0.403 . . . . 0.0 111.533 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.888 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -144.66 135.44 24.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.661 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.571 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 57.9 pttt -171.66 -176.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.976 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.472 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -66.91 -41.78 86.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.129 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -63.87 -56.13 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.435 ' OD2' ' HE2' ' A' ' 50' ' ' LYS . 59.6 m-20 -72.28 -44.87 62.14 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.613 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -90.25 -49.76 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.95 -28.42 1.77 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.503 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 15.8 pt20 -42.85 -35.61 1.24 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.078 0.466 . . . . 0.0 111.707 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 54' ' ' ALA . 24.6 m -65.53 -33.26 62.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.92 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.678 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 34.8 mt -63.88 124.26 21.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 110.638 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.6 p -75.13 155.91 36.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.444 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.17 -41.42 60.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.403 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -57.28 -21.79 37.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.078 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.599 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 16.6 m-20 -69.13 3.33 2.18 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.3 m-85 -41.71 -66.67 0.38 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 118.055 0.389 . . . . 0.0 111.35 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 56.8 Cg_endo -69.54 74.89 1.16 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.337 2.025 . . . . 0.0 112.064 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.913 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -76.95 142.89 39.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.221 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.505 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 14.3 mmmm -68.34 70.53 0.17 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.484 0.659 . . . . 0.0 110.509 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.815 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 46.2 m 58.41 160.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.948 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.704 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.65 -27.37 11.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.803 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.2 pt-20 -58.94 -48.39 81.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.525 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.505 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -73.78 -35.29 64.93 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.065 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.977 ' CG2' HG21 ' A' ' 24' ' ' ILE . 49.0 t -62.23 -36.51 74.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.022 0.439 . . . . 0.0 110.431 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.865 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -66.11 -57.64 7.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.259 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 m-20 -63.88 -42.13 97.56 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.55 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.3 m -55.01 -48.35 73.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.96 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.613 HG23 ' HB1' ' A' ' 54' ' ' ALA . 83.1 mt -64.32 -50.49 76.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.733 HG21 ' HE3' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -51.78 -38.07 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.37 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -63.97 -51.86 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.19 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.439 ' HB2' HG21 ' A' ' 57' ' ' VAL . 61.3 mttp -70.64 -41.97 71.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.682 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.504 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.45 -29.95 69.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.964 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.53 -54.08 0.47 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.969 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 6' ' ' LYS . 15.1 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.166 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.758 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.5 p . . . . . 0 C--O 1.217 -0.638 0 N-CA-C 111.278 0.103 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 39.2 tttm -45.3 -52.24 9.98 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -78.3 -25.94 46.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.29 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.758 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 54.8 t0 -68.03 -52.69 32.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.858 0.361 . . . . 0.0 111.882 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.511 HG13 HG22 ' A' ' 5' ' ' VAL . 14.4 mt -64.66 -44.49 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.85 ' HD2' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -59.62 -26.65 65.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.822 177.724 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.07 -42.89 99.47 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 71.0 mt-30 -64.37 -27.71 69.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.429 -0.885 . . . . 0.0 109.508 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.808 HD12 ' NE ' ' A' ' 10' ' ' ARG . 61.5 mt -74.89 -45.3 43.76 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.285 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.588 HD11 ' HB2' ' A' ' 72' ' ' ALA . 15.1 mm -56.84 -54.21 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.811 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.61 -36.6 93.56 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.299 -0.953 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -65.0 -24.57 67.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.131 -0.534 . . . . 0.0 111.392 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.078 HD22 HD12 ' A' ' 24' ' ' ILE . 48.4 mt -84.2 -29.83 26.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.831 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.67 124.14 18.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.971 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.64 -34.1 3.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.852 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.714 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -53.23 -174.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 0.0 111.583 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.604 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 9.3 m-20 -61.45 -118.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.753 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -59.73 179.51 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 176.331 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.813 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 55.6 Cg_endo -65.99 66.3 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.901 1.0 . . . . 0.0 112.213 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.078 HD12 HD22 ' A' ' 17' ' ' LEU . 42.8 mm 109.29 61.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.652 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.4 m120 -63.23 66.11 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.61 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 57.6 p 57.26 155.93 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.756 ' O ' ' HB2' ' A' ' 31' ' ' MET . 55.6 Cg_exo -49.6 -32.94 29.47 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.365 1.377 . . . . 0.0 113.054 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -53.33 -57.29 11.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.375 0.607 . . . . 0.0 110.561 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.598 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 40.6 tp10 -74.96 -57.05 4.14 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.899 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.5 pp -49.92 -42.32 48.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.776 ' HA ' HD13 ' A' ' 34' ' ' LEU . 27.0 mtm -64.67 -31.96 73.41 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -66.01 -28.66 69.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.48 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -74.46 -38.96 62.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.776 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.2 mp -33.2 131.96 0.35 Allowed Pre-proline 0 N--CA 1.469 0.482 0 CA-C-O 121.128 0.49 . . . . 0.0 111.803 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 C--N 1.349 0.579 0 C-N-CA 124.1 3.2 . . . . 0.0 115.172 -177.633 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.514 HG22 HD23 ' A' ' 34' ' ' LEU . 2.7 t . . . . . 0 C--O 1.231 0.109 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.473 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 19.8 m -93.77 123.17 36.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.404 ' CB ' HG23 ' A' ' 9' ' ' ILE . 60.0 m -91.04 45.91 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 0.0 110.609 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.468 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.171 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.885 ' C ' HD22 ' A' ' 49' ' ' LEU . 35.6 mt-10 . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.885 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -138.09 139.33 39.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.128 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.473 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 59.1 pttt -178.83 157.52 0.91 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.891 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.583 ' HB3' ' CG ' ' A' ' 31' ' ' MET . . . -47.73 -27.77 2.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.89 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 t -71.99 -61.31 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 59.9 m-20 -72.41 -54.52 9.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.697 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -73.35 -43.39 60.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.87 -22.71 3.06 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.326 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 26.5 pt20 -41.22 -40.71 1.67 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.08 0.467 . . . . 0.0 111.691 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.7 m -65.79 -30.64 50.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.256 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.609 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 14.3 mt -72.2 113.58 9.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.738 0.304 . . . . 0.0 110.458 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.7 p -79.52 158.39 27.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.453 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.51 -40.16 12.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.248 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -53.06 -26.97 17.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.652 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.5 m-20 -71.08 3.16 3.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.217 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.61 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -38.87 -64.68 0.46 Allowed Pre-proline 0 N--CA 1.462 0.156 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.391 -178.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 59.3 Cg_endo -71.04 79.37 1.35 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.276 1.984 . . . . 0.0 111.444 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.609 ' CZ ' HD13 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -76.82 140.09 40.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.456 -179.245 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 2.7 mppt? -67.44 62.36 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.404 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.813 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 49.4 m 64.98 161.89 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.493 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.537 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -52.01 -28.61 17.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.679 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 15.5 pt-20 -65.3 -39.2 92.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' HG3' ' CD2' ' A' ' 65' ' ' PHE . 17.7 tp10 -63.52 -43.2 97.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.215 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.799 ' CG2' HG21 ' A' ' 24' ' ' ILE . 88.1 t -57.64 -46.59 86.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.807 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.839 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -53.77 -56.13 20.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.206 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.61 -44.3 86.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.907 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.5 m -56.53 -47.42 79.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.191 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.706 HG22 HH12 ' A' ' 10' ' ' ARG . 65.2 mt -66.31 -51.88 53.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.85 HG13 ' HD2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -56.88 -41.85 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.973 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -63.79 -54.58 32.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HB2' HG21 ' A' ' 57' ' ' VAL . 43.7 mtpt -74.87 -40.83 60.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 75' ' ' ILE . . . -67.06 -29.98 69.91 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.24 -52.41 0.48 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.515 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.59 ' HB2' HG12 ' A' ' 76' ' ' VAL . 15.5 mt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.354 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.705 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.1 p . . . . . 0 C--O 1.213 -0.82 0 CA-C-O 119.929 -0.081 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 48.9 tttp -44.89 -47.1 11.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -77.54 -33.35 54.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.905 177.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.705 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 16.4 m-20 -64.02 -52.24 60.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.717 HG23 ' HB2' ' A' ' 42' ' ' CYS . 30.2 mt -66.06 -47.09 86.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.871 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 45.6 ttp180 -55.26 -29.52 58.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.81 -44.49 96.12 Favored Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -67.57 -28.78 68.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.652 -0.774 . . . . 0.0 109.725 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 10' ' ' ARG . 71.3 mt -70.16 -43.03 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.4 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 69' ' ' GLU . 13.5 mm -58.45 -48.83 84.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.004 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.16 -38.38 93.84 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.448 -0.882 . . . . 0.0 110.908 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.585 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -60.75 -34.02 73.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 0.0 110.694 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.013 HD22 HD12 ' A' ' 24' ' ' ILE . 79.0 mt -83.9 -29.17 27.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.692 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.56 60.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.485 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.551 ' C ' ' HB1' ' A' ' 33' ' ' ALA . . . 179.45 31.2 0.06 OUTLIER Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.994 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 33' ' ' ALA . . . -114.45 -168.4 1.36 Allowed 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.957 0.408 . . . . 0.0 110.796 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.66 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 83.6 m-20 -59.32 -119.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.805 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -61.35 -171.16 0.04 OUTLIER Pre-proline 0 N--CA 1.454 -0.269 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 176.564 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.806 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.2 Cg_endo -70.89 64.21 2.46 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 120.72 1.293 . . . . 0.0 112.163 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.013 HD12 HD22 ' A' ' 17' ' ' LEU . 50.2 mm 109.0 66.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.674 ' HB2' ' CB ' ' A' ' 29' ' ' GLU . 7.3 m-20 -65.42 65.85 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.881 -0.512 . . . . 0.0 111.449 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.633 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 51.4 p 57.48 158.97 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.737 ' O ' ' HB2' ' A' ' 31' ' ' MET . 51.5 Cg_exo -50.06 -33.33 34.43 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.344 1.362 . . . . 0.0 112.819 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -51.29 -57.32 9.16 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.64 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.674 ' CB ' ' HB2' ' A' ' 25' ' ' ASN . 45.7 tp10 -75.73 -58.53 3.23 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.807 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.5 pp -50.1 -40.16 44.92 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.771 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 29.9 ttm -63.53 -35.08 79.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.33 -30.91 69.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.303 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . . . -65.34 -38.87 91.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.593 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.785 ' CG ' HG22 ' A' ' 40' ' ' THR . 6.4 mp -39.53 134.55 1.24 Allowed Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.725 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 C--N 1.349 0.588 0 C-N-CA 123.393 2.729 . . . . 0.0 112.9 -179.275 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.785 HG22 ' CG ' ' A' ' 34' ' ' LEU . 6.2 t . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.373 0.13 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 3.1 t -114.99 124.21 51.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.033 0.444 . . . . 0.0 111.295 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.717 ' HB2' HG23 ' A' ' 9' ' ' ILE . 36.0 m -75.45 59.12 1.06 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.776 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.449 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 22.3 pttp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.679 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.803 ' C ' HD22 ' A' ' 49' ' ' LEU . 55.3 mt-10 . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.724 0.297 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.803 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.6 mm? -127.88 130.15 48.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.63 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.824 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 19.1 ptpt -156.28 -165.87 2.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.582 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.771 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -78.61 -41.87 30.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.481 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.3 t -67.26 -55.61 13.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.709 0.29 . . . . 0.0 111.443 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 35.6 m-20 -69.39 -44.4 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.793 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 50' ' ' LYS . . . -92.73 -51.63 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -53.53 -22.25 16.15 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.474 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -43.35 -31.98 0.75 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 117.114 0.457 . . . . 0.0 111.203 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 54' ' ' ALA . 35.3 m -80.2 27.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.653 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 19.1 mt -132.48 109.13 9.58 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 p -68.08 156.59 37.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.825 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.23 -37.99 17.38 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.077 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -52.56 -26.22 12.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.63 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.565 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -72.24 3.07 4.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.295 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.633 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.5 OUTLIER -39.05 -61.12 1.0 Allowed Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.334 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.87 77.08 3.16 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.483 2.122 . . . . 0.0 111.847 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.882 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -76.63 142.53 40.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.096 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 58.1 mtpt -68.68 66.7 0.13 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.377 0.608 . . . . 0.0 110.463 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.806 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 24.2 m 61.05 161.14 0.06 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.085 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.602 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.54 -30.22 19.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.499 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 22.1 pt-20 -59.17 -45.72 90.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.483 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.533 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -70.47 -34.39 72.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.247 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.982 HG21 HG21 ' A' ' 24' ' ' ILE . 67.2 t -63.61 -41.98 94.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.015 0.436 . . . . 0.0 110.09 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.871 ' HB1' ' HG2' ' A' ' 10' ' ' ARG . . . -56.66 -50.18 72.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.785 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -67.8 -47.31 69.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.128 0.489 . . . . 0.0 110.746 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.429 HG22 HD21 ' A' ' 58' ' ' LEU . 90.8 m -54.71 -48.97 71.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.857 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.813 HG23 ' HB1' ' A' ' 54' ' ' ALA . 67.0 mt -60.95 -56.11 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.559 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 72' ' ' ALA . 15.7 m -58.82 -40.49 80.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -62.88 -55.17 28.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.375 . . . . 0.0 111.715 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' CB ' HG21 ' A' ' 57' ' ' VAL . 67.3 mttm -72.76 -40.16 66.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.253 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.01 -29.97 69.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.66 -56.16 0.4 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.88 -1.152 . . . . 0.0 113.41 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.448 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 22.9 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.401 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.734 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p . . . . . 0 C--O 1.215 -0.748 0 CA-C-O 120.12 0.01 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.654 ' HE2' HG21 ' A' ' 76' ' ' VAL . 12.3 tmtt? -45.35 -51.67 10.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.9 -25.94 48.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.115 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.734 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 33.1 m-20 -67.86 -52.57 35.12 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.455 HG13 HG22 ' A' ' 5' ' ' VAL . 12.8 mt -65.7 -43.01 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.888 ' NH2' HG21 ' A' ' 13' ' ' ILE . 2.8 tpt180 -59.42 -29.07 67.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.62 -43.32 99.42 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -64.32 -29.01 70.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.334 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.888 HG21 ' NH2' ' A' ' 10' ' ' ARG . 63.6 mt -74.37 -45.9 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.821 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.452 ' HA ' HD13 ' A' ' 14' ' ' ILE . 4.6 mm -56.42 -50.3 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.776 0.322 . . . . 0.0 110.329 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.47 -36.34 93.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.348 -0.93 . . . . 0.0 110.892 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HB1' HD23 ' A' ' 34' ' ' LEU . . . -65.07 -27.22 68.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.222 -0.489 . . . . 0.0 111.251 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.013 HD22 ' CD1' ' A' ' 24' ' ' ILE . 49.9 mt -84.13 -26.22 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.72 61.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.381 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 174.14 35.02 0.04 OUTLIER Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.826 ' HB2' ' HB2' ' A' ' 33' ' ' ALA . . . -106.0 -175.97 2.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 110.99 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.594 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 53.4 m-20 -52.72 -66.97 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.758 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -116.86 -174.33 0.27 Allowed Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.519 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.825 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.7 Cg_endo -68.86 59.09 1.18 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-N 120.512 1.218 . . . . 0.0 111.987 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.013 ' CD1' HD22 ' A' ' 17' ' ' LEU . 24.7 mm 110.76 61.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.645 ' CB ' ' HB3' ' A' ' 29' ' ' GLU . 2.7 m120 -64.14 64.42 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.595 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.2 p 58.66 150.73 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.634 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 72.3 Cg_exo -46.77 -31.68 11.05 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.639 1.559 . . . . 0.0 112.984 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -55.54 -57.68 10.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.614 0.721 . . . . 0.0 110.338 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.645 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.0 tp10 -74.42 -57.08 4.17 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.557 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.982 HD13 HD21 ' A' ' 17' ' ' LEU . 3.3 pp -49.96 -36.54 28.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.663 ' HG2' ' HB3' ' A' ' 51' ' ' ALA . 55.2 mtm -64.04 -37.59 87.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.98 -24.55 65.16 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.477 0.656 . . . . 0.0 109.771 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.826 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . . . -63.88 -50.83 67.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.653 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 30' ' ' LEU . 6.1 mp -43.25 139.18 2.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.361 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 C--N 1.349 0.58 0 C-N-CA 123.842 3.028 . . . . 0.0 113.151 -179.586 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.483 HG22 HD23 ' A' ' 34' ' ' LEU . 2.7 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.871 0.367 . . . . 0.0 111.905 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.511 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 7.3 m -82.74 115.09 21.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.433 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.401 ' O ' HG23 ' A' ' 9' ' ' ILE . 32.3 m -89.2 50.56 1.96 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.018 0.437 . . . . 0.0 110.383 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.452 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.5 pttm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.975 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.846 ' C ' HD22 ' A' ' 49' ' ' LEU . 51.0 mt-10 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.786 0.327 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.846 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.9 mm? -135.24 137.26 42.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.672 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 63.6 pttt -175.87 155.6 1.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.645 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.663 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.62 -39.39 16.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.05 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.6 t -63.53 -49.85 71.89 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.437 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.19 -53.86 11.37 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.781 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -92.23 -46.51 7.69 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.93 -29.54 2.12 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.089 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -45.27 -30.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.507 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 54' ' ' ALA . 33.2 m -77.16 27.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.649 HD13 ' CE2' ' A' ' 65' ' ' PHE . 43.2 mt -133.18 117.24 17.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.889 0.376 . . . . 0.0 110.096 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.5 p -74.55 159.52 32.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.161 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.89 -37.58 31.94 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.085 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -50.97 -29.73 13.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.104 0.478 . . . . 0.0 110.06 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.56 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.5 m-20 -72.64 3.84 4.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.533 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.595 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.5 t80 -39.84 -51.8 5.33 Favored Pre-proline 0 C--O 1.226 -0.147 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 81.4 Cg_endo -87.74 77.31 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.832 2.355 . . . . 0.0 112.131 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.891 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.18 143.46 39.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.215 0.531 . . . . 0.0 111.87 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -68.28 70.8 0.17 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.742 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.825 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 21.7 m 57.04 163.66 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.203 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.597 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.89 -31.97 30.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.201 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -57.26 -49.17 76.9 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.547 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -72.49 -34.69 67.84 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.084 -179.475 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.001 ' CG2' HG21 ' A' ' 24' ' ' ILE . 62.1 t -65.19 -37.02 79.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.817 0.341 . . . . 0.0 111.145 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.664 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -65.35 -55.4 18.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.973 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 m-20 -66.32 -44.85 82.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.66 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.3 m -53.92 -47.65 70.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.76 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.564 HD12 HH22 ' A' ' 10' ' ' ARG . 76.8 mt -62.98 -53.13 50.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.522 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.71 HG13 ' HD3' ' A' ' 10' ' ' ARG . 1.8 m -53.99 -39.33 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -60.07 -51.92 67.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 0.0 111.753 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.505 ' HB2' HG21 ' A' ' 57' ' ' VAL . 47.7 mtpt -74.88 -40.11 61.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.757 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.81 -30.01 70.09 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.93 -54.81 0.4 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.553 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.678 HD12 HG12 ' A' ' 76' ' ' VAL . 8.7 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.099 -178.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.741 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.7 p . . . . . 0 C--O 1.214 -0.788 0 N-CA-C 111.161 0.059 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.691 ' HE2' HG21 ' A' ' 76' ' ' VAL . 12.8 tmtt? -45.34 -51.14 11.49 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.638 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -77.78 -27.97 50.39 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.066 177.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.741 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.6 m-20 -65.59 -52.38 52.58 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.479 HG13 HG22 ' A' ' 5' ' ' VAL . 16.7 mt -65.41 -43.28 94.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.893 ' NH2' HG21 ' A' ' 13' ' ' ILE . 1.1 tpt180 -60.16 -25.73 65.77 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.786 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.42 -45.18 87.69 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 178.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -64.39 -31.58 72.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.768 -0.716 . . . . 0.0 109.774 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.893 HG21 ' NH2' ' A' ' 10' ' ' ARG . 73.6 mt -73.88 -45.24 50.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.964 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HA ' HD13 ' A' ' 14' ' ' ILE . 4.0 mm -55.54 -53.33 37.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.784 0.326 . . . . 0.0 110.305 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.09 -34.59 88.53 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.739 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -65.46 -26.76 68.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.052 -0.574 . . . . 0.0 111.189 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.0 HD22 HD12 ' A' ' 24' ' ' ILE . 51.5 mt -80.21 -29.53 38.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.434 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.2 134.38 56.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.002 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.1 -32.25 6.06 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.898 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.714 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.44 -174.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.031 0.443 . . . . 0.0 111.592 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.601 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.5 m-20 -60.23 -120.31 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.806 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -62.14 -169.59 0.03 OUTLIER Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.597 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.828 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 60.3 Cg_endo -71.61 62.08 2.91 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 CA-C-N 120.888 1.353 . . . . 0.0 112.305 178.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.0 HD12 HD22 ' A' ' 17' ' ' LEU . 48.5 mm 110.59 65.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 177.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.713 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 8.3 m-20 -65.68 66.26 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.976 -0.452 . . . . 0.0 111.328 178.031 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.551 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 53.9 p 59.39 156.02 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.057 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.603 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 64.9 Cg_exo -49.17 -33.73 28.55 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.45 1.433 . . . . 0.0 112.948 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.51 -54.46 36.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.04 0.448 . . . . 0.0 110.697 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.713 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 17.4 tp10 -75.93 -57.57 3.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.918 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.9 pp -50.03 -39.79 42.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.817 ' HA ' HD13 ' A' ' 34' ' ' LEU . 72.0 mtm -66.67 -32.97 74.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.423 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.51 -28.35 68.49 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 121.215 0.531 . . . . 0.0 110.253 179.018 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -70.28 -46.9 63.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.94 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.817 HD13 ' HA ' ' A' ' 31' ' ' MET . 8.9 mp -33.73 139.39 0.27 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 112.186 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 C--N 1.346 0.419 0 C-N-CA 124.014 3.142 . . . . 0.0 114.417 -178.045 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.682 HG22 HD23 ' A' ' 34' ' ' LEU . 1.7 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.862 0.363 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.499 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 16.8 m -81.58 118.55 22.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.265 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 61.7 m -92.34 43.79 1.14 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.256 0.55 . . . . 0.0 109.553 178.66 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.492 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 23.9 pttm . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.919 -179.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.882 ' C ' HD22 ' A' ' 49' ' ' LEU . 7.5 mp0 . . . . . 0 N--CA 1.461 0.114 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -141.11 140.81 34.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.094 0.473 . . . . 0.0 111.347 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 61.7 pttt -178.21 152.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.369 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.616 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.57 -30.74 3.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.005 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.3 t -69.57 -55.89 8.86 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.644 -179.698 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 43.2 m-20 -72.41 -51.9 18.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.798 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -84.79 -45.57 12.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.1 -28.49 1.92 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.207 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 18.1 pt20 -43.7 -31.82 0.87 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.038 0.447 . . . . 0.0 111.329 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.8 m -77.09 27.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.667 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.563 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 43.4 mt -132.3 108.37 9.17 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.236 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.3 p -66.97 155.95 37.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.849 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.63 -37.69 13.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.229 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.67 -26.46 13.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.606 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.641 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -73.21 3.17 6.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.37 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.551 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.0 OUTLIER -41.13 -61.91 1.19 Allowed Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 117.682 0.219 . . . . 0.0 111.35 -179.337 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 63.3 Cg_endo -72.67 73.95 2.83 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.441 2.094 . . . . 0.0 111.963 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.907 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -76.77 141.58 40.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.431 -179.44 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HB3' ' CG ' ' A' ' 70' ' ' GLU . 41.4 ttmt -67.8 69.07 0.11 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.398 0.618 . . . . 0.0 110.706 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.828 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 31.5 m 59.37 161.42 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.962 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.712 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.61 -29.81 18.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.757 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.469 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.0 pt-20 -58.63 -46.03 87.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.532 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.533 ' CG ' ' HB3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -73.96 -35.48 64.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.891 -179.562 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.962 HG21 HG21 ' A' ' 24' ' ' ILE . 45.7 t -62.87 -40.8 90.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.968 0.413 . . . . 0.0 110.417 179.433 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.836 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -61.73 -55.67 27.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.168 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.498 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.8 m-20 -64.11 -43.91 93.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.43 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.8 m -53.79 -46.95 71.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.926 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.553 HD12 ' NH2' ' A' ' 10' ' ' ARG . 81.0 mt -64.79 -49.95 77.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.735 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.691 HG21 ' HE2' ' A' ' 6' ' ' LYS . 1.3 m -55.77 -38.22 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.272 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -63.24 -52.78 60.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 0.0 111.396 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HB2' HG21 ' A' ' 57' ' ' VAL . 95.9 mttt -72.68 -41.77 64.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.999 -179.116 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.637 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.3 -29.87 69.57 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.15 -54.11 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.982 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.476 HD12 HG12 ' A' ' 76' ' ' VAL . 16.0 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.193 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.751 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.4 p . . . . . 0 C--O 1.216 -0.696 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.579 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 46.9 tttm -45.67 -51.07 12.87 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.617 -0.833 . . . . 0.0 108.947 -179.325 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.78 -25.99 49.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.057 177.758 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.751 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.6 m-20 -68.18 -52.56 33.02 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.543 HD13 HD23 ' A' ' 49' ' ' LEU . 14.4 mt -66.02 -42.4 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.519 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.935 ' NH2' HG21 ' A' ' 13' ' ' ILE . 3.0 tpt180 -59.84 -27.18 66.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.7 177.407 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.02 -44.37 95.99 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 178.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -64.1 -27.68 69.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.439 177.622 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.935 HG21 ' NH2' ' A' ' 10' ' ' ARG . 64.4 mt -74.8 -50.25 26.32 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.86 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 14' ' ' ILE . 3.0 mm -53.77 -49.14 59.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.0 -36.67 93.79 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 178.083 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.839 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -63.63 -27.99 69.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.857 179.034 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.965 HD22 HD12 ' A' ' 24' ' ' ILE . 71.6 mt -78.8 -29.46 44.88 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.503 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.32 136.5 43.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.114 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.12 -33.5 6.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.814 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.741 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.8 -179.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 111.467 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.593 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 71.3 m-20 -58.25 -122.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.249 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.726 ' CG ' ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -62.66 -174.99 0.11 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 177.071 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.881 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 48.9 Cg_endo -66.55 61.78 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 CA-C-N 120.103 1.072 . . . . 0.0 112.723 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.998 HG21 HG21 ' A' ' 71' ' ' VAL . 36.6 mm 108.24 64.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 177.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.674 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.5 m120 -63.9 65.14 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.303 -0.248 . . . . 0.0 111.55 178.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.629 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 58.2 p 59.5 151.79 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.636 ' O ' ' HB2' ' A' ' 31' ' ' MET . 73.7 Cg_exo -46.88 -29.69 8.56 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.53 1.486 . . . . 0.0 112.642 -179.102 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.04 -57.12 13.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.511 0.672 . . . . 0.0 110.565 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.674 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 17.1 tp10 -73.39 -57.23 4.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.017 -179.004 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.929 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.9 pp -50.89 -38.21 48.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.636 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 61.0 mtm -67.13 -31.99 72.82 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.271 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.98 -29.69 67.96 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.65 179.266 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.741 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -71.48 -38.74 71.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.43 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.839 ' HG ' ' HB1' ' A' ' 16' ' ' ALA . 10.9 mp -38.37 143.77 0.41 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 121.158 0.504 . . . . 0.0 112.093 -178.614 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 C--N 1.35 0.608 0 C-N-CA 124.013 3.142 . . . . 0.0 114.361 -178.048 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.557 HG22 HD23 ' A' ' 34' ' ' LEU . 9.4 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.863 0.363 . . . . 0.0 111.337 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.481 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 10.9 m -82.38 126.37 32.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.357 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.9 m -93.61 47.63 1.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.04 0.448 . . . . 0.0 110.217 178.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.3 pttm . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.156 -179.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.867 ' C ' HD22 ' A' ' 49' ' ' LEU . 26.5 mt-10 . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.761 0.315 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.867 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.9 mm? -138.64 137.18 36.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.183 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.481 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 61.6 pttt -177.66 157.92 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.735 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HB3' ' CG ' ' A' ' 31' ' ' MET . . . -47.86 -37.81 14.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.937 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.4 t -61.77 -51.96 66.16 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.376 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -72.41 -54.22 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.438 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.894 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -91.51 -44.42 9.1 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.538 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.87 -28.44 1.73 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.938 -179.307 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -44.3 -31.49 1.04 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.007 0.432 . . . . 0.0 110.813 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 54' ' ' ALA . 35.9 m -76.96 27.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.352 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.696 HD23 ' O ' ' A' ' 57' ' ' VAL . 30.8 mt -134.35 92.06 2.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.913 0.387 . . . . 0.0 110.354 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.9 p -55.7 155.92 5.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.83 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.17 -36.62 8.85 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.384 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -50.81 -30.26 13.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.422 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.572 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 53.3 m-20 -72.71 3.81 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.747 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.629 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.0 t80 -38.0 -52.07 3.0 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.481 0.182 . . . . 0.0 111.396 -178.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 80.0 Cg_endo -86.39 78.42 2.09 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.681 2.254 . . . . 0.0 111.83 179.155 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.964 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -76.69 143.35 40.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.005 0.431 . . . . 0.0 111.741 -179.37 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.509 ' HB2' ' CD ' ' A' ' 70' ' ' GLU . 14.4 mmmm -67.17 70.68 0.1 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.634 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.881 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 47.5 m 58.73 158.74 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.69 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.794 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.83 -28.04 14.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.922 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.452 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.8 pt-20 -59.53 -47.39 85.71 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.419 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.509 ' CD ' ' HB2' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -72.04 -37.32 69.74 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.758 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.998 HG21 HG21 ' A' ' 24' ' ' ILE . 43.6 t -59.76 -36.28 65.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.98 0.419 . . . . 0.0 110.799 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -67.94 -57.83 5.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.442 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 m-20 -63.83 -42.29 97.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.701 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.8 m -54.01 -52.63 60.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.744 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.645 HD12 HH22 ' A' ' 10' ' ' ARG . 84.5 mt -60.03 -50.45 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.583 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.72 HG13 ' HD3' ' A' ' 10' ' ' ARG . 2.8 m -58.43 -39.75 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.32 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -52.96 -56.08 18.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.33 . . . . 0.0 110.936 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.405 ' NZ ' ' HB ' ' A' ' 57' ' ' VAL . 51.1 mtpt -75.08 -39.1 61.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.163 0.506 . . . . 0.0 110.886 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.663 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -68.87 32.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -179.164 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.97 -53.36 3.96 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.566 179.062 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.7 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.157 -178.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.742 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.5 p . . . . . 0 C--O 1.215 -0.753 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 40.7 tttm -44.94 -51.7 9.48 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.105 -178.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -77.84 -27.19 49.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.077 177.685 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.742 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.7 m-20 -67.22 -52.29 42.89 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.482 HG13 ' CG2' ' A' ' 5' ' ' VAL . 14.0 mt -63.81 -43.44 97.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.546 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.94 ' HD2' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -60.46 -26.48 66.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.582 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.2 -42.04 99.48 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 177.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 84.2 mt-30 -64.33 -28.76 69.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.362 177.48 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.824 HD12 ' NE ' ' A' ' 10' ' ' ARG . 67.5 mt -74.38 -46.06 44.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.234 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 72' ' ' ALA . 9.4 mm -56.99 -53.7 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.636 0.255 . . . . 0.0 110.525 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.47 -36.71 92.97 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.628 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -63.94 -27.3 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.08 -0.56 . . . . 0.0 110.92 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.015 HD22 HD12 ' A' ' 24' ' ' ILE . 61.6 mt -79.64 -29.45 40.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.448 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.96 136.66 57.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.002 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.07 -33.11 6.35 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.774 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.698 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.79 -179.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.807 0.337 . . . . 0.0 111.493 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.623 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 73.1 m-20 -59.98 -121.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.739 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -58.99 177.35 0.25 Allowed Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 176.44 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.792 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 43.5 Cg_endo -64.26 67.63 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 119.897 0.999 . . . . 0.0 112.105 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.015 HD12 HD22 ' A' ' 17' ' ' LEU . 44.4 mm 105.89 61.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 178.249 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.623 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.6 m120 -64.1 65.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 178.561 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.559 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 63.5 p 57.37 156.5 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.608 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 54.2 Cg_exo -50.43 -32.26 33.55 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.438 1.425 . . . . 0.0 112.829 -179.011 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -53.49 -57.35 10.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.452 0.644 . . . . 0.0 110.3 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -76.02 -57.98 3.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -179.272 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.861 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -50.56 -43.72 56.39 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.738 ' N ' HD12 ' A' ' 30' ' ' LEU . 30.7 ttm -65.52 -30.69 71.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.534 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.95 -29.69 66.88 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.597 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.698 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -67.76 -40.32 84.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.087 -179.414 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.733 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.1 mp -25.34 135.43 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.568 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.001 -179.086 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 C--N 1.349 0.566 0 C-N-CA 123.588 2.859 . . . . 0.0 115.279 -178.182 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.651 HG22 HD23 ' A' ' 34' ' ' LEU . 5.7 t . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.984 0.421 . . . . 0.0 111.767 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.54 HG23 ' HD3' ' A' ' 50' ' ' LYS . 32.2 m -100.29 121.96 42.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.902 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -92.79 46.57 1.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 110.014 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.441 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 20.8 ptmt . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.938 -179.168 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.866 ' C ' HD22 ' A' ' 49' ' ' LEU . 38.4 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.628 0.251 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.866 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.3 mm? -138.5 138.95 38.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.05 0.452 . . . . 0.0 110.968 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.54 ' HD3' HG23 ' A' ' 41' ' ' THR . 60.7 pttt -177.46 153.64 0.93 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.446 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.576 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.49 -29.24 2.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.809 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.417 ' HA ' ' HE1' ' A' ' 31' ' ' MET . 44.4 t -71.18 -56.06 6.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.663 0.268 . . . . 0.0 111.585 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -72.28 -54.42 9.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.35 . . . . 0.0 111.922 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.692 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -78.34 -48.08 16.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.936 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.39 -26.91 5.31 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.37 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -40.21 -35.97 0.46 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.555 0.693 . . . . 0.0 111.024 179.354 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 54' ' ' ALA . 11.0 m -79.14 27.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.021 -177.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.576 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 32.7 mt -130.21 109.9 11.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.934 0.397 . . . . 0.0 110.057 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.6 p -70.81 157.24 38.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.885 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.81 -36.89 12.52 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.754 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -51.32 -29.45 15.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.163 179.197 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.536 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.3 m-20 -72.23 3.34 4.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.597 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.559 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.0 t80 -38.37 -51.71 3.4 Favored Pre-proline 0 C--O 1.227 -0.09 0 N-CA-C 111.308 0.114 . . . . 0.0 111.308 -178.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 87.0 Cg_endo -88.08 81.45 1.03 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.837 2.358 . . . . 0.0 112.046 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.748 ' CD2' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -76.93 141.8 40.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.875 -179.855 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.535 ' CA ' ' HG2' ' A' ' 70' ' ' GLU . 47.6 mmtm -68.53 66.54 0.12 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.531 0.682 . . . . 0.0 110.516 179.005 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.792 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 15.4 m 61.34 160.93 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.197 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.652 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.46 -31.09 22.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.889 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.6 pt-20 -59.86 -47.01 87.47 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.331 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.535 ' HG2' ' CA ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -67.61 -33.38 74.88 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.36 -179.77 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.827 ' CG2' HG21 ' A' ' 24' ' ' ILE . 94.5 t -59.14 -47.08 91.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.922 0.391 . . . . 0.0 110.394 179.223 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.756 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -56.71 -55.11 38.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.311 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.47 -36.36 83.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.585 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.4 m -65.95 -49.35 68.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.026 -179.211 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.743 HG22 HH12 ' A' ' 10' ' ' ARG . 74.1 mt -59.88 -49.7 82.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.705 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.94 HG13 ' HD2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -57.49 -40.24 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.247 179.861 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -62.93 -54.7 34.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.876 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.512 ' HB2' HG21 ' A' ' 57' ' ' VAL . 96.5 mttt -74.06 -40.33 62.88 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.97 -29.91 69.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.186 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.12 -51.5 0.52 Allowed Glycine 0 CA--C 1.509 -0.342 0 C-N-CA 119.817 -1.182 . . . . 0.0 113.16 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.591 HD12 HG12 ' A' ' 76' ' ' VAL . 16.8 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.349 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.728 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.1 p . . . . . 0 C--O 1.212 -0.894 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.886 ' HE2' HG21 ' A' ' 76' ' ' VAL . 11.2 tmtt? -45.37 -49.03 13.37 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.28 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -77.37 -30.31 53.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.043 177.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.728 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 71.9 m-20 -66.44 -52.32 47.63 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.568 HG22 ' NH2' ' A' ' 10' ' ' ARG . 17.7 mt -62.26 -51.07 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.178 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.936 ' CD ' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -57.96 -25.58 61.18 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.369 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.42 -38.58 94.99 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 177.192 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -68.82 -35.26 76.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.383 -0.908 . . . . 0.0 110.569 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.594 HD11 ' NH2' ' A' ' 10' ' ' ARG . 11.7 mt -69.91 -43.75 79.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.442 ' HA ' HD13 ' A' ' 14' ' ' ILE . 13.4 mm -54.51 -52.46 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.717 0.294 . . . . 0.0 110.612 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.01 -37.25 94.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.935 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.52 -25.02 67.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.22 -0.49 . . . . 0.0 111.365 179.373 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.069 HD22 HD12 ' A' ' 24' ' ' ILE . 33.4 mt -85.82 -29.37 23.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.978 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.64 81.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.719 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.83 -35.8 0.13 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.921 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.717 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -53.03 -173.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.182 0.515 . . . . 0.0 111.904 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.588 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.7 OUTLIER -60.25 -119.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.018 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.771 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.97 179.79 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 177.033 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HD2' ' HB2' ' A' ' 22' ' ' PHE . 47.9 Cg_endo -65.23 65.34 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 120.801 1.001 . . . . 0.0 112.358 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.069 HD12 HD22 ' A' ' 17' ' ' LEU . 28.6 mm 107.78 62.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 177.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.601 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.7 m120 -63.98 64.16 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.327 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 15.7 p 59.1 152.65 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.43 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.647 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 77.8 Cg_exo -48.0 -30.47 13.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.46 1.44 . . . . 0.0 112.707 -179.245 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -54.72 -57.49 11.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.492 0.663 . . . . 0.0 110.289 179.062 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.601 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.3 tp10 -76.11 -57.85 3.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.054 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.861 HD13 HD21 ' A' ' 17' ' ' LEU . 3.5 pp -50.29 -45.53 54.53 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.694 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.679 ' N ' HD12 ' A' ' 30' ' ' LEU . 33.8 ttm -66.05 -29.78 70.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.56 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -69.08 -30.12 68.37 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -72.73 -38.92 67.28 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.61 HD23 HG22 ' A' ' 40' ' ' THR . 7.1 mp -27.92 128.12 0.21 Allowed Pre-proline 0 N--CA 1.47 0.563 0 CA-C-O 120.949 0.404 . . . . 0.0 111.79 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 C--N 1.349 0.591 0 C-N-CA 123.569 2.846 . . . . 0.0 114.071 -178.396 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.61 HG22 HD23 ' A' ' 34' ' ' LEU . 6.6 t . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.897 0.38 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.7 m -105.92 115.8 30.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -89.46 44.03 1.18 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.098 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.3 pttp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.255 -179.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.825 ' C ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 121.288 0.566 . . . . 0.0 111.813 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.825 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.8 mm? -136.6 141.07 43.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.366 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HE3' ' HB3' ' A' ' 52' ' ' SER . 61.6 pttt -173.4 -168.81 0.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.937 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.534 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -65.58 -46.14 80.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.867 0.365 . . . . 0.0 111.576 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.456 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.1 t -69.99 -44.45 69.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.69 0.281 . . . . 0.0 111.495 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -67.34 -53.05 32.98 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.822 0.344 . . . . 0.0 111.906 -179.534 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.905 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -96.2 -44.05 7.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.468 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.64 -30.67 2.28 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.425 -178.757 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -46.93 -33.96 5.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.105 0.479 . . . . 0.0 110.987 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 54' ' ' ALA . 29.1 m -65.6 -31.1 52.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.548 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.708 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 22.6 mt -66.66 125.39 25.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.773 0.32 . . . . 0.0 110.639 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.8 p -75.63 155.79 35.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.289 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.18 -42.09 60.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.332 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.63 -23.25 26.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.963 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.654 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 14.5 m-20 -67.89 3.16 1.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.6 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -41.03 -56.04 4.39 Favored Pre-proline 0 C--O 1.226 -0.184 0 CA-C-N 117.837 0.289 . . . . 0.0 111.673 -178.949 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 2.0 Cg_endo -80.33 76.92 4.27 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.897 2.398 . . . . 0.0 112.017 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.869 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -77.16 142.0 39.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.488 -179.752 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.504 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 38.4 mtmm -67.89 70.5 0.14 Allowed 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.455 0.645 . . . . 0.0 110.419 178.866 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.756 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 28.9 m 58.43 161.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.162 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.681 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.67 -26.85 9.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.888 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.9 pt-20 -59.2 -50.46 73.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.652 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.504 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -72.65 -32.26 65.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.976 -179.418 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.005 HG21 HG21 ' A' ' 24' ' ' ILE . 57.9 t -61.98 -40.82 88.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.724 0.297 . . . . 0.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.689 ' HB1' ' CG ' ' A' ' 10' ' ' ARG . . . -65.0 -52.19 57.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 76' ' ' VAL . 32.1 m-20 -64.49 -37.44 87.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.011 0.434 . . . . 0.0 111.202 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.404 HG22 HD21 ' A' ' 58' ' ' LEU . 53.3 m -58.09 -41.93 84.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.442 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.905 HG23 ' CB ' ' A' ' 54' ' ' ALA . 63.5 mt -62.1 -53.72 44.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.134 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.936 HG13 ' CD ' ' A' ' 10' ' ' ARG . 2.5 m -56.94 -43.35 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -62.6 -53.72 50.44 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.476 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -74.0 -42.41 60.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.078 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.579 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.56 -30.08 69.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.568 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.25 -55.77 0.42 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 119.936 -1.125 . . . . 0.0 113.144 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.547 HD12 HG12 ' A' ' 76' ' ' VAL . 21.7 mt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.405 -178.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.729 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.7 p . . . . . 0 C--O 1.213 -0.865 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 79.8 tttt -44.83 -51.08 9.88 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.362 -0.836 . . . . 0.0 109.211 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.6 -29.5 51.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.956 177.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.729 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.0 m-20 -64.48 -52.13 59.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.13 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.606 HG23 ' HB2' ' A' ' 42' ' ' CYS . 12.1 mt -63.16 -46.41 95.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.886 ' NH2' HG21 ' A' ' 13' ' ' ILE . 1.8 tpt180 -57.19 -25.94 59.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.166 177.851 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.37 -48.34 70.11 Favored Glycine 0 CA--C 1.505 -0.531 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -62.63 -29.08 70.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.807 -0.696 . . . . 0.0 109.343 177.602 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.886 HG21 ' NH2' ' A' ' 10' ' ' ARG . 59.7 mt -70.4 -45.53 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.801 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HA ' HD13 ' A' ' 14' ' ' ILE . 7.1 mm -53.69 -48.54 60.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.66 -37.4 94.33 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.816 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.638 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -62.61 -27.81 69.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.918 0.39 . . . . 0.0 110.978 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.024 HD22 HD12 ' A' ' 24' ' ' ILE . 54.1 mt -80.69 -29.56 36.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.378 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.04 135.12 56.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.005 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.38 -33.17 5.67 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.723 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.686 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.29 -175.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.931 0.396 . . . . 0.0 111.509 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.26 -122.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.896 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.82 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -59.93 -173.42 0.05 OUTLIER Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 176.685 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.855 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 58.1 Cg_endo -69.33 61.52 1.5 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 CA-C-N 120.453 1.197 . . . . 0.0 112.592 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.024 HD12 HD22 ' A' ' 17' ' ' LEU . 43.4 mm 111.98 65.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 177.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.645 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 5.8 m-20 -64.31 65.68 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.085 -0.385 . . . . 0.0 111.534 178.132 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.571 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 54.0 p 58.89 155.01 0.09 OUTLIER Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 31' ' ' MET . 54.4 Cg_exo -49.29 -33.71 29.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.236 1.291 . . . . 0.0 112.887 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.04 -56.28 17.33 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.074 0.464 . . . . 0.0 110.787 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.645 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.5 tp10 -74.54 -57.72 3.75 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.296 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.938 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -49.79 -39.76 39.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.675 ' HA ' HD13 ' A' ' 34' ' ' LEU . 65.4 mtm -64.4 -34.85 79.12 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.767 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.77 -26.55 65.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.681 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.686 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -71.09 -43.24 68.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.667 -179.318 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.675 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.1 mp -37.33 138.91 0.55 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 112.274 -178.406 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 C--N 1.35 0.625 0 C-N-CA 123.869 3.046 . . . . 0.0 113.518 -178.904 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 34' ' ' LEU . 7.8 t . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.656 0.265 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 2.6 t -97.91 123.31 41.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.034 0.445 . . . . 0.0 111.28 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.606 ' HB2' HG23 ' A' ' 9' ' ' ILE . 33.3 m -72.14 64.32 0.54 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.764 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 21.7 ptmt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.667 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.843 ' C ' HD22 ' A' ' 49' ' ' LEU . 37.3 mt-10 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.751 0.31 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.843 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.8 mm? -137.7 134.5 35.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.324 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 41' ' ' THR . 19.6 pttm -163.73 -164.67 0.93 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.613 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -78.1 -41.09 36.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.051 0.453 . . . . 0.0 111.317 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.439 ' HB3' ' HE2' ' A' ' 50' ' ' LYS . 39.1 t -63.87 -45.5 89.13 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.647 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.485 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 8.0 t70 -72.21 -52.79 14.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.352 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.851 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -96.34 -48.42 5.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -178.653 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -44.77 -28.37 1.66 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.73 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -43.89 -32.55 1.13 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.039 0.447 . . . . 0.0 111.563 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 54' ' ' ALA . 30.4 m -65.51 -33.15 61.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.886 -179.188 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.668 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 29.1 mt -70.3 124.42 24.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.437 179.486 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -80.8 -176.38 5.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.897 0.38 . . . . 0.0 111.551 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.77 79.54 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.711 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -53.33 -23.99 10.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.638 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -71.04 3.2 3.58 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.571 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.2 m-85 -42.58 -64.59 0.68 Allowed Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.584 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 59.5 Cg_endo -71.01 74.94 1.79 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.436 2.091 . . . . 0.0 111.949 179.271 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.874 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -77.04 141.61 40.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.833 -179.349 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.483 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 23.4 ttmm -67.22 70.37 0.1 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.804 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.855 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.7 m 58.19 162.35 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.164 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.645 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.69 -31.35 25.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.659 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.6 pt-20 -56.24 -48.41 76.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.589 -179.587 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.569 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -73.1 -36.99 66.88 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.974 -179.6 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.972 ' CG2' HG21 ' A' ' 24' ' ' ILE . 61.9 t -61.46 -34.34 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.821 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -68.94 -58.22 4.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.365 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 76' ' ' VAL . 31.7 m-20 -64.1 -42.32 96.95 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.99 0.424 . . . . 0.0 111.571 -179.545 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.2 m -55.37 -48.09 74.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.651 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.496 HD12 ' NH2' ' A' ' 10' ' ' ARG . 82.6 mt -63.05 -51.58 69.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.883 -179.256 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.708 HG13 ' HD3' ' A' ' 10' ' ' ARG . 1.5 m -54.05 -43.61 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.818 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -57.55 -49.55 75.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.748 0.309 . . . . 0.0 111.381 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HB2' HG21 ' A' ' 57' ' ' VAL . 66.9 mttm -73.55 -41.11 63.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.827 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.851 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.39 -30.23 69.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.506 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.91 -55.43 0.43 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.419 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.549 HD12 HG12 ' A' ' 76' ' ' VAL . 16.8 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.174 -0.917 . . . . 0.0 111.308 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.499 -0.241 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' SER . . . . . 0.428 ' O ' ' CG ' ' A' ' -1' ' ' HIS . 47.6 t -59.74 137.62 58.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.748 0.309 . . . . 0.0 110.938 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -1' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' -2' ' ' SER . 92.5 m-70 -158.96 132.27 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.671 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt -66.07 -48.19 71.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.23 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp 61.86 128.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.911 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.8 mmm -68.72 -54.32 16.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.907 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.09 -38.06 0.85 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.466 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.8 p -66.69 -5.77 3.74 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HA ' HD13 ' A' ' 81' ' ' LEU . 54.1 tttm -45.05 -46.63 11.55 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.093 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -77.54 -32.88 54.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.829 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.706 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -64.86 -52.07 58.62 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.52 HG13 ' CG2' ' A' ' 5' ' ' VAL . 31.2 mt -65.48 -46.21 90.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.727 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 51.5 ttp85 -55.87 -30.53 61.68 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.49 -40.4 97.65 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 73.3 mt-30 -68.77 -31.17 70.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.688 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.6 mt -71.36 -45.82 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.068 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.199 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.6 mm -57.87 -52.97 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.514 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.99 -36.61 93.28 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.387 -0.911 . . . . 0.0 110.941 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -62.67 -29.79 70.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.285 -0.457 . . . . 0.0 111.103 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.001 HD22 HD12 ' A' ' 24' ' ' ILE . 55.1 mt -81.26 -29.41 34.4 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.665 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.29 131.5 48.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.73 -34.74 4.62 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.716 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.74 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.95 -179.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.576 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 73.0 m-20 -59.35 -120.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.733 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -59.92 178.53 0.24 Allowed Pre-proline 0 N--CA 1.455 -0.195 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.78 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.0 Cg_endo -65.38 65.65 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 119.799 0.964 . . . . 0.0 112.482 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.001 HD12 HD22 ' A' ' 17' ' ' LEU . 34.2 mm 107.57 61.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.606 ' HA ' ' CZ ' ' A' ' 22' ' ' PHE . 3.0 m120 -64.35 65.07 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.596 ' HB3' ' CG ' ' A' ' 63' ' ' PHE . 60.6 p 57.48 156.52 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.631 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 54.2 Cg_exo -49.89 -32.65 30.82 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.397 1.398 . . . . 0.0 112.692 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -52.76 -57.68 9.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.35 0.595 . . . . 0.0 110.292 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.601 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.8 tp10 -76.41 -58.09 3.48 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.853 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.59 -44.8 57.06 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.842 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 30.6 ttm -65.08 -31.06 72.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -68.37 -31.45 70.83 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.822 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -69.84 -38.67 76.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.343 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 31' ' ' MET . 8.5 mp -26.91 129.75 0.18 Allowed Pre-proline 0 N--CA 1.47 0.54 0 CA-C-O 120.973 0.416 . . . . 0.0 111.881 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 12.2 Cg_endo -55.99 -28.49 69.25 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.711 2.941 . . . . 0.0 114.274 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.78 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 5.4 t-20 -72.01 -27.26 62.62 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.65 -73.42 0.41 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.898 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 84.1 Cg_endo -84.31 46.53 1.98 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.775 2.317 . . . . 0.0 112.172 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.31 95.01 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.429 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.78 ' HB ' ' HB3' ' A' ' 36' ' ' ASN . 10.0 t -66.79 145.01 55.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.525 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.47 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 31.1 m -106.51 121.34 44.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.484 ' CB ' HG23 ' A' ' 9' ' ' ILE . 59.7 m -86.85 46.26 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.001 0.429 . . . . 0.0 110.821 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 18.7 ptpt -75.83 149.98 37.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.7 m -151.53 126.89 9.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.614 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.0 -51.59 0.95 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.742 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.438 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.7 p30 -171.17 -40.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 0.0 110.39 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.729 HG12 ' CD2' ' A' ' 49' ' ' LEU . 40.3 t -66.98 139.09 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.613 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.892 ' C ' HD22 ' A' ' 49' ' ' LEU . 35.3 mt-10 -125.79 132.53 52.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.36 . . . . 0.0 110.946 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.892 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.5 mm? -142.31 139.62 31.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.935 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 41' ' ' THR . 59.8 pttt -173.8 -176.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.719 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.842 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -66.33 -42.59 87.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.819 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.405 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.0 t -67.7 -52.38 38.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.467 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 30.0 m-20 -71.1 -49.78 40.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -87.65 -47.01 9.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.89 -26.8 2.11 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.373 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -41.94 -36.89 1.18 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.08 0.467 . . . . 0.0 111.774 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 54' ' ' ALA . 33.4 m -65.51 -33.17 61.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.032 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.649 HD13 ' CE2' ' A' ' 65' ' ' PHE . 28.3 mt -68.31 124.49 23.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.642 0.258 . . . . 0.0 110.56 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.1 p -84.1 -173.81 4.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.797 0.332 . . . . 0.0 111.551 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.06 -44.71 91.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.568 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -55.59 -23.98 30.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 111.118 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -64.54 -9.8 21.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.596 ' CG ' ' HB3' ' A' ' 26' ' ' SER . 2.6 m-85 -39.82 -70.97 0.15 Allowed Pre-proline 0 N--CA 1.464 0.231 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 50.7 Cg_endo -67.76 74.38 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.034 1.823 . . . . 0.0 112.079 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.821 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.08 143.96 38.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.12 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 99.2 mttt -68.94 68.4 0.16 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.475 0.655 . . . . 0.0 110.56 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.78 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 25.5 m 59.51 161.48 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.979 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.656 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.67 -30.59 22.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.817 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.0 pt-20 -57.67 -48.43 79.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.441 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.554 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -71.1 -33.03 69.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.875 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.969 HG21 HG21 ' A' ' 24' ' ' ILE . 92.2 t -64.83 -41.85 93.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.852 0.358 . . . . 0.0 110.857 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.82 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -60.49 -50.35 73.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.825 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -68.43 -37.5 80.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.391 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.3 m -66.8 -51.95 49.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.043 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 71' ' ' VAL . 76.0 mt -58.08 -51.9 65.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.489 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 72' ' ' ALA . 5.3 m -56.22 -39.21 58.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -61.5 -53.15 60.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.728 0.299 . . . . 0.0 111.332 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HB2' HG21 ' A' ' 57' ' ' VAL . 63.1 mttp -69.24 -40.54 77.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.57 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.644 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.17 -29.77 69.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.72 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.17 -55.1 0.43 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.787 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.5 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.023 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 80.2 p -178.53 -45.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 0.0 110.821 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -61.1 -39.97 91.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.822 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt -158.34 64.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.749 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.478 ' HG2' ' HG2' ' A' ' 3' ' ' MET . 0.0 OUTLIER -45.04 -42.12 8.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.081 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.478 ' HG2' ' HG2' ' A' ' 2' ' ' LYS . 95.2 mmm -117.78 -49.33 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.802 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.36 -43.3 1.29 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.675 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.733 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.9 p -69.27 -5.9 5.5 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 86.1 tttt -45.32 -48.0 13.15 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.015 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -77.59 -31.22 52.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.816 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.733 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 22.7 m-20 -65.2 -52.26 55.91 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 5' ' ' VAL . 22.5 mt -66.79 -46.5 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.763 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 46.4 ttp85 -56.39 -28.07 58.18 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.19 -42.91 94.04 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 66.9 mt-30 -67.07 -32.55 73.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.876 -0.662 . . . . 0.0 109.737 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.0 mt -70.33 -43.33 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.804 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 14' ' ' ILE . 13.3 mm -58.06 -54.09 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.244 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.54 -36.85 93.66 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.692 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -60.88 -28.43 68.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.109 -0.545 . . . . 0.0 110.936 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.068 HD22 HD12 ' A' ' 24' ' ' ILE . 52.7 mt -87.6 -29.66 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.282 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.16 85.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.838 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.94 -36.0 0.19 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.17 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.747 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.77 -174.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 112.116 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.644 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.0 m-20 -59.96 -119.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.721 ' CE2' ' HA ' ' A' ' 25' ' ' ASN . 0.3 OUTLIER -58.52 174.21 0.37 Allowed Pre-proline 0 CA--C 1.519 -0.212 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 176.273 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.874 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 44.6 Cg_endo -63.27 66.63 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 120.916 1.077 . . . . 0.0 112.242 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.068 HD12 HD22 ' A' ' 17' ' ' LEU . 20.2 mm 109.52 59.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.721 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.5 m120 -63.37 66.75 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 25' ' ' ASN . 85.5 p 56.28 153.64 0.07 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.716 ' O ' ' HB2' ' A' ' 31' ' ' MET . 76.1 Cg_exo -47.29 -32.88 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.512 1.475 . . . . 0.0 113.176 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -53.31 -57.46 10.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.339 0.59 . . . . 0.0 110.387 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.4 tp10 -76.25 -57.52 3.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.964 HD13 HD21 ' A' ' 17' ' ' LEU . 3.3 pp -49.97 -42.54 49.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.716 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 62.2 mtm -68.75 -29.98 68.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.64 -31.04 70.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.899 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.747 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -74.23 -38.57 63.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.102 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 16' ' ' ALA . 8.0 mp -34.66 140.03 0.29 Allowed Pre-proline 0 N--CA 1.466 0.341 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -47.78 -34.83 22.46 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.248 2.632 . . . . 0.0 113.225 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.504 ' CB ' ' HB ' ' A' ' 40' ' ' THR . 5.9 t-20 -72.24 -25.56 61.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.333 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.6 -73.34 0.21 Allowed Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.622 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.706 ' O ' ' HB3' ' A' ' 31' ' ' MET . 71.7 Cg_endo -75.27 -42.47 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.313 2.009 . . . . 0.0 111.536 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.532 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.7 OUTLIER 168.25 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.288 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.504 ' HB ' ' CB ' ' A' ' 36' ' ' ASN . 8.9 t -54.42 134.75 45.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.188 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.535 HG23 ' HD3' ' A' ' 50' ' ' LYS . 23.8 m -86.64 118.17 25.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.092 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 68.4 m -92.87 44.76 1.16 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 109.776 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.1 pttp -75.62 126.06 30.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.119 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.9 m -102.94 118.56 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.16 -128.94 42.8 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.118 -1.039 . . . . 0.0 111.772 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -76.01 -38.67 57.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.895 0.379 . . . . 0.0 111.559 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.694 HG12 ' CD2' ' A' ' 49' ' ' LEU . 37.5 t -66.78 141.45 17.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.545 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.876 ' C ' HD22 ' A' ' 49' ' ' LEU . 75.6 mt-10 -132.37 130.84 41.21 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.104 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.876 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -141.0 138.53 33.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.513 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.535 ' HD3' HG23 ' A' ' 41' ' ' THR . 60.8 pttt -175.14 153.64 1.64 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.665 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.66 -28.3 2.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.624 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.403 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 44.1 t -70.82 -55.5 8.38 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.311 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -72.44 -54.32 9.65 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -82.48 -42.89 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.86 -25.81 1.02 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.491 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -41.66 -36.76 1.02 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.132 0.492 . . . . 0.0 111.583 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 54' ' ' ALA . 32.9 m -65.53 -33.41 63.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.128 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.699 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 30.3 mt -68.85 119.83 13.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.703 0.287 . . . . 0.0 110.231 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.412 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 76.8 p -85.44 -175.31 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.711 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.67 -43.34 84.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.298 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.447 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 3.1 p30 -51.29 -26.63 7.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.918 0.389 . . . . 0.0 110.819 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 59.4 m-20 -73.26 3.73 5.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.707 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.53 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 1.4 t80 -42.63 -52.22 10.98 Favored Pre-proline 0 C--O 1.224 -0.262 0 O-C-N 122.588 -0.07 . . . . 0.0 111.15 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 97.6 Cg_endo -89.65 78.15 0.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.194 2.596 . . . . 0.0 111.187 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.744 ' CG ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -76.9 142.8 39.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.156 -178.483 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 22.9 tptm -69.66 65.41 0.21 Allowed 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.122 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.874 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 49.8 m 63.63 160.0 0.09 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.638 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.603 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.97 -27.34 13.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.938 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.36 -38.78 91.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.075 0.464 . . . . 0.0 109.832 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 7.9 tp10 -68.01 -46.42 71.3 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.94 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.027 ' CG2' HG21 ' A' ' 24' ' ' ILE . 47.0 t -65.11 -43.17 95.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.516 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -56.17 -45.47 79.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.979 0.418 . . . . 0.0 110.25 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -70.3 -40.18 74.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.095 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.436 HG23 ' NZ ' ' A' ' 78' ' ' LYS . 61.8 m -63.13 -50.15 71.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.069 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.532 HG23 ' CB ' ' A' ' 54' ' ' ALA . 67.0 mt -61.41 -52.47 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.702 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 72' ' ' ALA . 7.1 m -58.52 -38.64 71.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -62.33 -56.79 15.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.748 0.308 . . . . 0.0 111.676 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' NZ ' HG23 ' A' ' 74' ' ' THR . 61.8 mttp -69.5 -38.97 77.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.74 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.716 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.84 -29.89 69.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.009 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.42 -55.87 0.42 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.006 -1.092 . . . . 0.0 113.291 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.1 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.339 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.641 -0.184 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 47.6 t -60.5 -46.25 90.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.93 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 39.2 m80 62.77 134.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptp -60.45 141.43 56.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.45 123.27 16.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.567 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.2 mtt -86.49 144.26 27.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.448 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.68 -18.07 29.9 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.469 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.689 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.6 p -55.75 -5.64 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.65 ' HA ' HD13 ' A' ' 81' ' ' LEU . 84.8 tttt -44.31 -44.15 7.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.913 0.779 . . . . 0.0 109.417 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.4 -35.58 54.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.666 177.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.689 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 48.6 m-20 -64.02 -51.83 62.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.529 HG13 ' CG2' ' A' ' 5' ' ' VAL . 37.0 mt -65.12 -45.89 92.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.842 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 50.1 ttp180 -55.34 -30.41 60.22 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.53 -41.78 97.76 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.535 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 65.0 mt-30 -66.18 -29.86 70.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.692 -0.754 . . . . 0.0 109.735 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 10' ' ' ARG . 63.6 mt -70.35 -45.58 74.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.962 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 69' ' ' GLU . 9.1 mm -56.74 -52.96 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.512 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.82 -37.15 92.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.073 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.47 -30.53 69.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.202 -0.499 . . . . 0.0 111.172 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.048 HD22 HD12 ' A' ' 24' ' ' ILE . 59.5 mt -82.74 -29.45 29.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.932 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.52 132.81 54.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.049 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.13 -33.89 5.22 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.964 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.7 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.95 -176.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 111.567 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.601 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.1 m-20 -60.9 -121.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.713 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.56 176.81 0.29 Allowed Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.773 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.3 Cg_endo -64.69 69.05 0.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 CA-C-N 119.773 0.954 . . . . 0.0 112.281 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.048 HD12 HD22 ' A' ' 17' ' ' LEU . 51.5 mm 106.47 61.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.601 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.8 m120 -65.24 64.96 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.569 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 59.1 p 57.06 157.46 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.614 ' O ' ' CB ' ' A' ' 31' ' ' MET . 52.0 Cg_exo -50.9 -32.23 36.98 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.293 1.328 . . . . 0.0 112.86 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -52.71 -57.61 9.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.442 0.639 . . . . 0.0 110.421 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.594 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 41.8 tp10 -76.15 -58.15 3.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.824 HD22 HG23 ' A' ' 24' ' ' ILE . 3.9 pp -50.62 -42.95 56.67 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.822 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 30.0 ttm -63.27 -33.07 74.71 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -68.92 -28.32 66.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.835 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.7 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -71.16 -36.9 72.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.3 mp -27.27 137.0 0.1 Allowed Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 121.094 0.473 . . . . 0.0 112.185 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -50.15 -41.17 50.38 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.249 3.299 . . . . 0.0 115.638 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.502 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 18.8 p-10 -71.9 -25.44 61.92 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.447 -0.501 . . . . 0.0 112.236 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.3 -66.19 0.31 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.664 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 93.0 Cg_endo -83.54 47.3 2.3 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.636 2.224 . . . . 0.0 113.009 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.454 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.7 OUTLIER 64.53 93.31 0.06 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.642 0.258 . . . . 0.0 111.234 179.131 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.534 HG22 HD23 ' A' ' 34' ' ' LEU . 15.2 t -75.96 137.33 40.24 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.775 0.321 . . . . 0.0 111.519 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.645 HG21 ' CE ' ' A' ' 43' ' ' LYS . 47.8 m -92.55 123.9 36.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.719 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.9 m -92.04 45.53 1.22 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.974 0.416 . . . . 0.0 110.73 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.645 ' CE ' HG21 ' A' ' 41' ' ' THR . 18.6 ptpt -75.53 151.38 37.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.025 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.3 m -150.55 127.28 10.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.81 -59.4 0.35 Allowed Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.082 -0.508 . . . . 0.0 113.038 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -159.56 -43.36 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 110.407 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.749 HG12 ' CD2' ' A' ' 49' ' ' LEU . 40.5 t -66.74 137.54 24.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.683 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.882 ' C ' HD22 ' A' ' 49' ' ' LEU . 22.7 mt-10 -124.35 131.19 53.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.988 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -141.72 133.74 27.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.605 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.769 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 21.1 ptmt -165.48 -177.55 4.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.735 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.822 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -66.56 -40.52 89.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.715 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -67.01 -59.92 3.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.401 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 57.9 m-20 -68.84 -54.09 17.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.758 0.313 . . . . 0.0 111.691 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.946 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -72.56 -50.51 25.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.74 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -49.02 -26.49 6.01 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.412 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -41.21 -43.55 2.37 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.944 0.878 . . . . 0.0 110.943 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 54' ' ' ALA . 10.4 m -66.01 -32.64 59.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.326 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.682 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 21.1 mt -68.9 116.84 9.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.819 0.343 . . . . 0.0 110.588 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.51 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 71.8 p -71.5 155.9 40.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.196 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.16 -39.98 45.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.323 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -53.44 -25.44 16.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.615 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 61.8 m-20 -70.57 3.47 3.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.569 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.4 OUTLIER -38.64 -63.65 0.56 Allowed Pre-proline 0 N--CA 1.462 0.139 0 CA-C-N 117.895 0.316 . . . . 0.0 110.958 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 73.4 Cg_endo -74.55 79.0 2.61 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.469 2.113 . . . . 0.0 111.88 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.755 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -76.83 144.29 39.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.301 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.51 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 75.2 mmtt -70.21 65.88 0.28 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.465 0.65 . . . . 0.0 110.047 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.773 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 20.2 m 61.52 160.36 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.02 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.587 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.45 -28.11 12.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.657 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HA ' HD11 ' A' ' 14' ' ' ILE . 16.2 pt-20 -60.95 -48.44 81.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.376 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.518 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -67.9 -32.14 72.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.021 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 24' ' ' ILE . 80.5 t -62.27 -41.29 90.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 110.45 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.842 ' HB1' ' CG ' ' A' ' 10' ' ' ARG . . . -60.27 -51.03 71.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.987 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.53 -39.02 85.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.258 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.8 m -65.18 -51.65 59.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.956 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.946 HG23 ' HB1' ' A' ' 54' ' ' ALA . 57.4 mt -57.15 -54.58 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.767 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 72' ' ' ALA . 5.7 m -57.14 -40.04 70.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -65.52 -53.28 44.58 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HB2' HG21 ' A' ' 57' ' ' VAL . 50.2 mtpt -73.33 -39.52 65.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 111.885 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.433 ' HB1' HD12 ' A' ' 49' ' ' LEU . . . -66.84 -29.96 70.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.72 -55.98 0.37 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.117 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.65 HD13 ' HA ' ' A' ' 6' ' ' LYS . 20.3 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.32 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.571 -0.211 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 80.1 p -59.9 -44.96 93.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.928 0.394 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' HIS . . . . . 0.525 ' O ' ' O ' ' A' ' 1' ' ' MET . 21.2 p-80 -174.23 132.56 0.4 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.718 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.525 ' O ' ' O ' ' A' ' -1' ' ' HIS . 24.8 ptt? 49.0 122.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.951 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.463 ' NZ ' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -68.84 -55.48 11.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.832 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.5 tpp 178.27 -55.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.528 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.59 -49.79 0.43 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.748 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.718 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.6 p -74.66 -6.01 7.84 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 82.7 tttt -45.17 -47.76 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.008 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.75 -31.94 52.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.901 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.718 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -64.33 -52.17 59.75 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 5' ' ' VAL . 28.9 mt -67.39 -46.18 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.823 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 48.3 ttp180 -55.45 -29.77 59.29 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.73 -43.53 93.98 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 69.3 mt-30 -66.9 -30.38 70.52 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.86 -0.67 . . . . 0.0 109.766 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 10' ' ' ARG . 73.3 mt -70.52 -43.46 77.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.744 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 69' ' ' GLU . 11.3 mm -57.61 -53.69 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.32 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.56 -36.4 92.43 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.405 -0.902 . . . . 0.0 110.855 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -60.55 -31.82 70.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.151 -0.524 . . . . 0.0 110.952 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.065 HD22 HD12 ' A' ' 24' ' ' ILE . 55.4 mt -82.12 -29.47 31.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.775 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.0 130.83 48.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.918 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.16 -34.37 4.48 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.879 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.7 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.06 -176.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.815 0.341 . . . . 0.0 111.594 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.614 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.6 m-20 -60.02 -119.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.745 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.79 178.39 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.81 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 48.9 Cg_endo -65.08 67.85 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.754 0.948 . . . . 0.0 112.131 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.065 HD12 HD22 ' A' ' 17' ' ' LEU . 44.3 mm 105.96 62.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.614 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.9 m120 -65.7 64.41 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.657 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 52.6 p 57.07 160.47 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.657 ' O ' ' HB2' ' A' ' 31' ' ' MET . 52.2 Cg_exo -52.56 -33.16 56.9 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.339 1.359 . . . . 0.0 112.971 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -52.48 -57.89 8.47 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.238 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.612 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 41.3 tp10 -76.6 -58.57 3.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.906 HD22 HG23 ' A' ' 24' ' ' ILE . 3.9 pp -50.65 -45.35 57.82 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.815 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 23.0 ttm -64.17 -31.49 72.7 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -70.28 -28.67 65.39 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.128 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.7 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -70.04 -37.45 75.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.725 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 31' ' ' MET . 11.2 mp -31.78 145.6 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.112 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.544 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.5 Cg_endo -47.54 -42.23 29.19 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.664 2.91 . . . . 0.0 113.973 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.452 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -72.25 -18.65 61.8 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.614 -179.159 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.45 ' N ' HD22 ' A' ' 36' ' ' ASN . . . 108.66 -67.2 0.23 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.468 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.452 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 72.9 Cg_endo -79.82 -52.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.432 2.088 . . . . 0.0 113.791 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.559 ' HA ' HD22 ' A' ' 34' ' ' LEU . 12.0 p-10 -178.88 90.1 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.843 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.629 HG22 HD23 ' A' ' 34' ' ' LEU . 12.9 t -71.76 136.99 47.34 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.832 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.489 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 25.4 m -91.61 125.87 36.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.972 0.415 . . . . 0.0 111.588 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.7 m -100.47 48.52 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.777 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.48 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 10.2 ptpp? -75.34 153.72 37.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.841 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.9 m -150.09 128.11 11.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.434 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.51 -131.55 47.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.26 -0.972 . . . . 0.0 111.298 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.54 26.71 3.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 0.0 110.801 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.6 HG12 ' CD2' ' A' ' 49' ' ' LEU . 49.1 t -127.9 145.72 34.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.141 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.887 ' C ' HD22 ' A' ' 49' ' ' LEU . 23.6 mt-10 -142.06 125.1 16.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.497 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.887 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.7 mm? -140.64 140.57 35.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.039 0.447 . . . . 0.0 110.811 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.509 ' HG3' ' H ' ' A' ' 53' ' ' ASP . 59.5 pttt -173.54 170.81 4.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.719 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.815 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -59.65 -30.7 68.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.545 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 42.5 t -75.66 -62.05 1.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.509 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 52.4 m-20 -66.4 -51.06 60.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.598 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -78.95 -46.44 18.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.67 -26.32 1.76 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.596 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 17.2 pt20 -41.21 -38.63 1.15 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.04 0.448 . . . . 0.0 111.808 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.8 m -65.72 -30.16 49.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.408 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.678 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 19.1 mt -66.91 121.67 16.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.756 0.312 . . . . 0.0 110.42 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.7 p -74.67 155.77 37.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.44 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.67 58.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.229 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.82 -23.29 29.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.563 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 15.5 m-20 -67.59 3.31 1.42 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.657 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -40.57 -55.19 4.55 Favored Pre-proline 0 C--O 1.227 -0.086 0 CA-C-N 117.77 0.259 . . . . 0.0 111.575 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 2.2 Cg_endo -82.39 78.16 3.5 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.896 2.397 . . . . 0.0 111.783 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.911 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.02 142.13 40.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.266 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.666 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.69 66.9 0.13 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.76 0.79 . . . . 0.0 110.59 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.81 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 15.5 m 61.85 159.87 0.06 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.953 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.668 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.61 -32.55 29.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.794 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.445 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 10.9 pt-20 -59.07 -46.1 89.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.417 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.666 ' HG2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -68.08 -33.17 74.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.19 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.949 HG21 HG21 ' A' ' 24' ' ' ILE . 72.8 t -64.77 -44.72 96.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.649 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.826 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -55.11 -49.53 71.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.76 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.25 -39.84 78.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.294 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.1 m -63.21 -52.62 61.53 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.48 HG23 ' HB1' ' A' ' 54' ' ' ALA . 58.4 mt -59.87 -52.6 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.716 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 72' ' ' ALA . 14.1 m -57.81 -41.24 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -61.68 -51.41 68.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 111.278 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HB2' HG21 ' A' ' 57' ' ' VAL . 66.8 mttm -71.54 -42.08 68.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.676 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.519 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.42 -30.04 69.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.778 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.14 -55.7 0.44 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.664 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 19.0 mt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.337 -0.84 . . . . 0.0 110.983 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 79.8 p -78.83 51.93 1.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.662 0.267 . . . . 0.0 111.38 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -56.3 -48.39 76.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt 52.32 48.06 23.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.482 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -86.57 36.38 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.424 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.8 ptm -77.18 127.08 31.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 110.991 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.93 -139.0 6.07 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.232 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.705 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p -77.22 -6.02 8.43 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 O-C-N 123.057 -0.084 . . . . 0.0 111.11 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.547 ' HE2' HG21 ' A' ' 76' ' ' VAL . 12.9 tmtt? -45.09 -46.41 11.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -77.57 -33.44 54.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.84 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.705 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 14.1 m-20 -64.21 -52.32 59.42 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.531 HG13 HG22 ' A' ' 5' ' ' VAL . 35.3 mt -66.62 -46.56 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.783 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 40.0 ttp180 -55.0 -29.76 58.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.32 -42.46 96.11 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.539 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 70.0 mt-30 -69.06 -30.71 69.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.991 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.7 mt -71.61 -45.18 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.045 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 14' ' ' ILE . 10.6 mm -58.3 -52.01 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.262 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.39 -37.19 93.56 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.557 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -61.52 -28.54 69.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.946 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.05 HD22 HD12 ' A' ' 24' ' ' ILE . 45.7 mt -83.79 -29.56 27.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.874 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.52 126.02 25.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.815 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.66 -34.99 3.3 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.72 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.673 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.73 -175.04 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.913 0.387 . . . . 0.0 111.588 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.573 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -61.58 -119.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.773 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.5 OUTLIER -59.45 179.21 0.21 Allowed Pre-proline 0 N--CA 1.454 -0.266 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 176.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.792 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.3 Cg_endo -64.97 67.21 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 CA-C-N 119.688 0.924 . . . . 0.0 112.179 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.05 HD12 HD22 ' A' ' 17' ' ' LEU . 41.9 mm 107.18 62.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.608 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.8 m120 -63.65 65.37 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 69.9 p 56.28 158.68 0.07 OUTLIER Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.71 ' O ' ' HB2' ' A' ' 31' ' ' MET . 50.7 Cg_exo -51.16 -34.23 47.25 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.316 1.344 . . . . 0.0 113.032 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -51.63 -57.68 8.49 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.38 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 43.7 tp10 -76.24 -58.11 3.48 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.853 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -50.47 -43.95 55.53 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.87 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 23.5 ttm -64.03 -32.19 73.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.96 -29.53 66.67 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.042 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.673 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -68.81 -37.98 79.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.73 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 31' ' ' MET . 11.2 mp -31.61 145.02 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.193 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.529 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.5 Cg_endo -47.55 -41.85 29.54 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.635 2.89 . . . . 0.0 113.969 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.461 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -72.14 -18.73 61.86 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.57 -179.269 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' N ' HD22 ' A' ' 36' ' ' ASN . . . 108.25 -66.52 0.24 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.514 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 85.0 Cg_endo -80.47 -51.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.395 2.063 . . . . 0.0 113.959 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.569 ' HA ' HD22 ' A' ' 34' ' ' LEU . 47.2 p-10 -179.48 88.44 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.608 HG22 HD23 ' A' ' 34' ' ' LEU . 15.0 t -71.27 137.27 48.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.823 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 27.8 m -90.71 125.78 35.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 111.597 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.3 m -100.29 50.43 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.097 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 61.6 pttt -75.24 144.22 42.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.643 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 47' ' ' VAL . 49.9 m -157.14 137.4 12.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.785 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 47' ' ' VAL . . . 62.68 50.39 64.64 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.579 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 58.89 23.35 11.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.942 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.758 HG12 ' CD2' ' A' ' 49' ' ' LEU . 39.9 t -127.71 135.34 63.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.164 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.9 ' C ' HD22 ' A' ' 49' ' ' LEU . 23.5 mt-10 -120.37 131.05 54.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.033 0.444 . . . . 0.0 111.473 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.9 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -142.34 136.79 30.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.427 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HG3' ' H ' ' A' ' 53' ' ' ASP . 61.2 pttt -173.68 178.77 2.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.795 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.87 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -65.61 -39.71 91.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.836 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.3 t -66.83 -51.55 54.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.672 0.273 . . . . 0.0 111.704 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.474 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 38.8 m-20 -72.2 -51.42 21.25 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.676 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -88.39 -45.97 9.55 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.92 -27.52 1.48 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.203 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 16.0 pt20 -43.29 -35.62 1.54 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 111.333 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 54' ' ' ALA . 32.9 m -65.51 -33.0 60.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.782 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.715 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 17.0 mt -66.3 119.1 10.95 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.2 p -77.26 155.89 31.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.754 0.312 . . . . 0.0 111.073 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.33 -40.21 11.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.593 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -53.86 -26.32 24.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.166 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.661 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -70.18 3.38 2.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -39.93 -65.33 0.44 Allowed Pre-proline 0 N--CA 1.463 0.217 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.156 -179.141 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 74.1 Cg_endo -74.06 78.26 2.6 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.307 2.005 . . . . 0.0 111.855 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.915 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -76.8 143.65 39.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.246 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.502 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 75.1 mmtt -69.57 68.38 0.24 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.464 0.65 . . . . 0.0 110.05 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.792 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 31.8 m 59.66 160.96 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.976 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.691 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.47 -25.88 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.632 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 16.5 pt-20 -59.66 -48.86 80.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.43 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.517 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -74.13 -32.18 63.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.161 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.015 HG21 HG21 ' A' ' 24' ' ' ILE . 60.2 t -61.55 -46.93 95.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.399 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.835 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -58.85 -44.63 91.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.874 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -62.73 -42.62 99.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.337 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.414 HG22 HD21 ' A' ' 58' ' ' LEU . 88.6 m -63.76 -50.68 68.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.136 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.676 HG23 ' CB ' ' A' ' 54' ' ' ALA . 71.9 mt -58.35 -52.58 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.542 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 72' ' ' ALA . 6.8 m -58.6 -43.52 87.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -62.1 -54.1 46.13 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.619 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -69.88 -41.01 75.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 111.6 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.636 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.03 -29.92 69.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.734 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.25 -54.61 0.46 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.891 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 17.7 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.073 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 53.3 m -61.25 133.43 55.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.337 . . . . 0.0 110.88 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 1' ' ' MET . 67.8 t60 -62.83 -34.79 78.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.781 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' -1' ' ' HIS . 91.0 mmm 71.67 -53.82 0.68 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.781 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.625 ' HA ' HD23 ' A' ' 81' ' ' LEU . 54.8 mtpt -70.28 165.69 21.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.627 0.251 . . . . 0.0 110.339 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.447 ' O ' ' HG3' ' A' ' 3' ' ' MET . 45.2 tpp -165.9 42.27 0.06 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.957 0.408 . . . . 0.0 111.014 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.67 -44.2 1.98 Allowed Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.632 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.704 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p -63.2 -6.15 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 116.958 0.379 . . . . 0.0 112.01 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -44.87 -45.27 10.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -77.16 -34.39 56.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.884 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.704 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -64.49 -51.86 60.84 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.63 HD13 HD23 ' A' ' 49' ' ' LEU . 35.0 mt -65.94 -50.13 72.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.927 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -56.64 -29.28 62.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.14 -41.77 99.63 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 77.3 mt-30 -69.72 -31.98 70.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.455 -0.872 . . . . 0.0 110.195 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -71.06 -46.64 66.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.563 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 14' ' ' ILE . 5.1 mm -58.72 -52.58 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.714 0.292 . . . . 0.0 110.401 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.85 -36.36 93.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.106 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -67.1 -25.03 66.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.279 -0.461 . . . . 0.0 111.547 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.077 HD22 HD12 ' A' ' 24' ' ' ILE . 46.1 mt -82.31 -29.41 31.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.568 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.01 132.84 54.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.857 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.2 -33.93 5.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.674 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.668 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.21 -179.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.375 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.584 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.6 m-20 -58.94 -119.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.735 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -61.22 179.24 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.306 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 176.268 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.811 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 46.7 Cg_endo -65.61 65.26 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 119.889 0.996 . . . . 0.0 112.291 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.077 HD12 HD22 ' A' ' 17' ' ' LEU . 31.9 mm 107.72 60.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.62 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.6 m120 -62.82 65.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.572 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 54.7 p 58.16 153.49 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 31' ' ' MET . 67.0 Cg_exo -48.26 -32.51 19.68 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.315 1.344 . . . . 0.0 112.628 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -52.88 -57.48 10.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.51 0.671 . . . . 0.0 110.503 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.62 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.4 tp10 -75.37 -57.8 3.67 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.878 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.4 pp -50.39 -41.59 52.27 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.667 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 37.0 ttm -64.61 -32.87 74.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -73.01 -23.17 60.59 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.668 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -72.2 -49.71 33.35 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.687 HD22 ' HA ' ' A' ' 39' ' ' ASP . 7.9 mp -24.99 135.26 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -47.46 -35.25 21.29 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.916 3.077 . . . . 0.0 113.622 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.561 ' CB ' ' HB ' ' A' ' 40' ' ' THR . 3.6 t-20 -72.23 -25.66 61.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.804 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.26 -76.44 0.23 Allowed Glycine 0 CA--C 1.516 0.125 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.615 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 94.3 Cg_endo -82.25 36.45 0.62 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.582 2.188 . . . . 0.0 111.469 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.687 ' HA ' HD22 ' A' ' 34' ' ' LEU . 1.1 t70 66.88 100.93 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.202 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.561 ' HB ' ' CB ' ' A' ' 36' ' ' ASN . 1.8 t -63.74 131.17 47.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.879 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.414 HG23 ' OE2' ' A' ' 48' ' ' GLU . 17.3 m -76.74 127.37 32.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.722 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.401 ' HB3' ' OE1' ' A' ' 12' ' ' GLN . 57.4 m -112.28 45.81 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.88 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 60.2 pttt -75.65 125.69 29.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.6 m -103.12 124.88 49.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.65 -54.26 0.5 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.124 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 47' ' ' VAL . 36.9 p-10 -169.46 -40.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.761 0.315 . . . . 0.0 110.854 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.034 HG12 HD21 ' A' ' 49' ' ' LEU . 61.4 t -66.73 112.09 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.797 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.859 ' C ' HD22 ' A' ' 49' ' ' LEU . 87.8 tt0 -91.32 131.81 36.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.135 0.493 . . . . 0.0 111.74 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.034 HD21 HG12 ' A' ' 47' ' ' VAL . 2.1 mm? -137.69 130.31 29.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.564 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 52' ' ' SER . 62.4 pttt -171.7 -161.37 0.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.879 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.476 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -74.31 -47.74 32.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.425 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.7 t -69.34 -50.87 42.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -69.2 -48.74 61.24 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.701 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -95.66 -45.74 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -47.35 -28.47 4.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.84 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -43.38 -34.13 1.2 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.207 0.527 . . . . 0.0 111.357 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 54' ' ' ALA . 30.5 m -65.51 -33.2 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.918 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.755 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 30.9 mt -64.72 125.28 24.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 110.681 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.5 p -77.39 155.87 31.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.261 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.57 -42.63 55.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.4 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -56.1 -22.66 29.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.858 0.361 . . . . 0.0 111.075 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.625 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 15.5 m-20 -68.3 3.3 1.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.572 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.7 OUTLIER -40.57 -66.3 0.38 Allowed Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 117.943 0.338 . . . . 0.0 111.532 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.2 Cg_endo -70.44 76.06 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.373 2.049 . . . . 0.0 112.09 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.907 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.15 141.93 39.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.502 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.61 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 1.7 tpmt? -67.32 68.51 0.08 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.702 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.811 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 47.3 m 58.73 162.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.028 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.667 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.59 -26.23 8.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.949 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 23.1 pt-20 -60.23 -49.92 75.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.551 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.54 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -71.49 -35.59 70.85 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.655 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.983 ' CG2' HG21 ' A' ' 24' ' ' ILE . 55.8 t -63.19 -40.8 90.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.927 ' HB1' ' HG2' ' A' ' 10' ' ' ARG . . . -60.8 -51.65 68.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.985 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -67.09 -41.57 86.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.426 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.9 m -57.59 -50.1 74.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.677 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.571 HG23 ' CB ' ' A' ' 54' ' ' ALA . 82.4 mt -60.13 -49.04 85.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.233 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 16.6 m -63.03 -41.87 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -58.59 -55.72 31.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HE3' ' HB ' ' A' ' 57' ' ' VAL . 28.2 mtpp -71.89 -38.99 69.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 111.654 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.619 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.67 -29.69 69.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.563 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.1 -53.95 0.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.817 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 2' ' ' LYS . 18.4 mt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.158 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 53.6 m -60.2 -44.38 95.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -63.78 -139.89 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.491 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 ttm 60.54 -118.57 0.8 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 38.4 ttpt -94.7 30.66 1.98 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.988 0.423 . . . . 0.0 110.696 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.6 mmt 60.07 127.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.541 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.1 -23.8 76.04 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.235 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p -60.08 -5.49 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 81.7 tttt -44.34 -46.17 9.18 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.418 -0.801 . . . . 0.0 109.276 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -77.43 -34.18 54.66 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.824 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.702 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -63.77 -51.92 62.68 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.517 HG13 ' CG2' ' A' ' 5' ' ' VAL . 33.6 mt -66.69 -46.81 84.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.732 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 45.0 ttp180 -55.11 -30.14 59.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.76 -42.85 94.98 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.551 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 71.3 mt-30 -68.9 -30.01 68.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.815 -0.692 . . . . 0.0 110.063 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.1 mt -71.29 -44.66 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.806 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 14' ' ' ILE . 11.3 mm -57.67 -53.11 49.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.252 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.45 -36.02 92.07 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.807 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.85 -31.69 71.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.068 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.006 HD22 HD12 ' A' ' 24' ' ' ILE . 48.0 mt -81.49 -29.45 33.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.552 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.06 128.31 36.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.797 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.15 -36.16 3.28 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.537 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.648 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.59 -175.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.025 0.44 . . . . 0.0 111.492 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.649 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -61.56 -127.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.731 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -54.23 175.49 0.16 Allowed Pre-proline 0 CA--C 1.52 -0.209 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 176.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.819 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 35.3 Cg_endo -61.92 69.17 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 CA-C-N 119.814 0.969 . . . . 0.0 112.486 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.011 HG21 HG21 ' A' ' 71' ' ' VAL . 44.2 mm 105.68 64.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 177.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.649 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 4.4 m-20 -65.77 63.89 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.142 -0.349 . . . . 0.0 111.367 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.659 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 39.1 p 57.98 160.31 0.09 OUTLIER Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.6 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 52.7 Cg_exo -52.65 -34.01 61.76 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.335 1.356 . . . . 0.0 113.042 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.44 -57.42 9.92 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.371 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.647 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -76.35 -58.34 3.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.916 HD22 HG23 ' A' ' 24' ' ' ILE . 3.9 pp -50.33 -45.76 55.12 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.791 ' N ' HD12 ' A' ' 30' ' ' LEU . 27.7 ttm -64.26 -31.37 72.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -69.12 -30.66 68.98 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.854 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.648 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -69.28 -37.79 78.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.965 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.778 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.4 mp -32.75 140.34 0.21 Allowed Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.052 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.64 -33.33 18.15 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.534 2.822 . . . . 0.0 112.896 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.552 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 6.8 t-20 -72.15 -25.73 61.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.588 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . 107.54 -69.53 0.22 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.079 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 83.6 Cg_endo -80.49 -45.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.581 2.188 . . . . 0.0 112.873 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.5 ' HA ' HD22 ' A' ' 34' ' ' LEU . 11.3 p-10 179.26 76.61 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.898 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.704 HG22 HD23 ' A' ' 34' ' ' LEU . 11.3 t -54.48 135.2 46.03 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.82 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 30.8 m -93.15 115.62 28.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.795 0.331 . . . . 0.0 111.302 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 73.7 m -92.65 46.62 1.25 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 109.955 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.495 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 24.2 pttm -75.62 124.14 26.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.093 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.4 m -98.92 120.49 39.45 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.33 -128.45 41.58 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.615 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -79.86 -37.13 35.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 111.411 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.707 HG12 ' CD2' ' A' ' 49' ' ' LEU . 38.6 t -67.22 141.79 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.584 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.86 ' C ' HD22 ' A' ' 49' ' ' LEU . 70.1 mt-10 -129.57 128.7 43.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.028 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.86 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.7 mm? -143.24 131.23 21.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HG3' ' H ' ' A' ' 53' ' ' ASP . 21.8 pttm -165.03 172.1 13.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.429 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.567 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -59.38 -35.94 74.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.616 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.8 t -66.44 -58.4 5.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 43.9 m-20 -71.84 -54.24 10.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.674 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -77.58 -46.02 23.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.76 -23.41 3.43 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.58 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.41 ' NE2' ' O ' ' A' ' 53' ' ' ASP . 26.2 pt20 -42.52 -32.56 0.56 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.023 0.439 . . . . 0.0 111.447 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.0 m -78.33 27.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.587 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 39.8 mt -127.25 115.13 18.58 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.893 0.378 . . . . 0.0 110.046 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.8 p -67.52 155.88 38.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.958 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.06 -40.38 61.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.954 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -54.93 -23.47 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.669 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.541 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 13.4 m-20 -68.53 3.07 1.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.659 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.8 OUTLIER -39.43 -65.23 0.43 Allowed Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 117.81 0.277 . . . . 0.0 111.612 -179.056 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.9 Cg_endo -70.71 76.35 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.367 2.044 . . . . 0.0 112.093 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.853 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.02 140.46 40.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.84 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 22.8 tptm -66.0 67.64 0.05 OUTLIER 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.429 0.633 . . . . 0.0 110.608 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.819 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 34.6 m 60.19 159.88 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.962 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.643 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.57 -29.65 17.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.563 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 10.9 pt-20 -58.88 -47.61 84.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.297 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.509 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -68.51 -35.73 77.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.204 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.011 HG21 HG21 ' A' ' 24' ' ' ILE . 89.8 t -61.92 -44.35 98.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 110.51 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -55.6 -49.49 72.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -69.86 -41.85 74.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.992 0.425 . . . . 0.0 111.21 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.409 HG23 ' NZ ' ' A' ' 78' ' ' LYS . 86.4 m -59.33 -50.98 71.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.855 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.438 HG23 ' CB ' ' A' ' 54' ' ' ALA . 69.3 mt -61.02 -52.98 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.397 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 72' ' ' ALA . 13.5 m -60.35 -40.38 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -60.09 -54.16 49.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 111.417 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.562 ' HB2' HG21 ' A' ' 57' ' ' VAL . 63.2 mttp -71.86 -41.11 68.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.86 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.674 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.1 -29.94 69.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.834 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.77 -55.8 0.44 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.676 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.8 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.141 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 39.5 t 69.0 -56.5 0.53 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.237 0.215 . . . . 0.0 111.529 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -62.11 132.85 54.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.856 0.36 . . . . 0.0 110.98 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -63.46 144.37 57.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.055 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.549 ' O ' ' O ' ' A' ' 3' ' ' MET . 88.3 tttt -176.8 -105.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.509 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.549 ' O ' ' O ' ' A' ' 2' ' ' LYS . 25.4 ptt? 49.26 128.2 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.347 0.594 . . . . 0.0 112.132 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.25 -136.21 3.18 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.318 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.749 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.8 p -71.86 -6.43 7.61 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 O-C-N 123.047 -0.09 . . . . 0.0 111.047 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 86.3 tttt -45.76 -50.66 13.67 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -78.0 -27.77 49.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.172 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.749 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 33.8 t70 -66.96 -52.56 41.37 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.542 HG13 HG22 ' A' ' 5' ' ' VAL . 19.5 mt -69.6 -45.86 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.678 ' CD ' ' HB1' ' A' ' 72' ' ' ALA . 5.7 tmm_? -55.21 -31.96 61.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.09 -43.35 98.88 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 68.0 mt-30 -63.41 -29.91 71.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.673 -0.763 . . . . 0.0 109.552 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 10' ' ' ARG . 61.9 mt -70.21 -42.39 78.97 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 69' ' ' GLU . 8.3 mm -57.7 -53.26 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.343 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.4 -38.06 90.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.327 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -61.77 -28.35 69.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.055 0.455 . . . . 0.0 111.28 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.024 HD22 HD12 ' A' ' 24' ' ' ILE . 48.0 mt -83.45 -29.57 27.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.526 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.11 129.85 43.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.76 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.42 -33.86 4.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.668 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.664 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.85 -174.29 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 111.423 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.593 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 76.8 m-20 -60.31 -119.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.733 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -60.63 -179.99 0.21 Allowed Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.295 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 41.6 Cg_endo -66.17 65.94 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 120.089 1.068 . . . . 0.0 112.336 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.024 HD12 HD22 ' A' ' 17' ' ' LEU . 50.4 mm 108.01 60.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.611 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.6 m120 -62.45 66.82 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.561 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 59.7 p 57.16 154.18 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.658 ' O ' ' CB ' ' A' ' 31' ' ' MET . 54.3 Cg_exo -48.66 -32.82 22.57 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.096 1.198 . . . . 0.0 112.65 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -52.21 -57.37 9.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.473 0.654 . . . . 0.0 110.739 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.611 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 40.2 tp10 -74.71 -57.93 3.61 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.895 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.56 -40.4 52.05 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.696 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 40.1 ttm -63.88 -33.24 75.26 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -75.44 -20.49 58.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.664 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -75.91 -42.93 47.49 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 30' ' ' LEU . 6.9 mp -27.96 147.17 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -47.2 -49.86 12.12 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.051 3.168 . . . . 0.0 115.478 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.422 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 32.6 p-10 -72.3 -14.05 61.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.31 -69.51 0.24 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.699 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 84.5 Cg_endo -84.04 43.52 1.39 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.663 2.242 . . . . 0.0 112.746 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.696 ' HB2' ' CG ' ' A' ' 31' ' ' MET . 10.1 t70 61.68 96.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.368 0.604 . . . . 0.0 111.971 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 34' ' ' LEU . 5.2 t -70.2 132.7 46.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.948 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.438 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 11.8 m -76.17 124.13 26.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.963 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.6 m -90.44 44.66 1.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.528 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.5 pttm -75.73 149.27 38.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.136 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.4 m -147.21 128.47 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.773 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.79 -51.06 0.89 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.87 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.424 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.7 p30 -171.04 -39.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 110.436 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.7 HG12 ' CD2' ' A' ' 49' ' ' LEU . 41.4 t -66.83 137.93 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.746 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.866 ' C ' HD22 ' A' ' 49' ' ' LEU . 28.1 mt-10 -122.45 135.3 54.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.816 0.341 . . . . 0.0 110.896 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.866 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.5 mm? -140.83 138.01 33.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.08 0.466 . . . . 0.0 110.952 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 21.6 pttp -174.74 166.07 3.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.705 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.491 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.84 -40.47 21.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.074 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.6 t -72.01 -43.7 64.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.412 ' O ' ' NE2' ' A' ' 56' ' ' GLN . 38.2 t70 -69.14 -54.11 16.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 111.853 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.986 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -96.28 -45.77 6.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.58 -30.04 2.04 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.361 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 53' ' ' ASP . 18.7 pt20 -51.52 -28.86 14.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.202 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.986 HG22 ' O ' ' A' ' 54' ' ' ALA . 31.9 m -78.26 27.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.516 HD13 ' CE2' ' A' ' 65' ' ' PHE . 38.2 mt -125.86 125.68 43.23 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.744 0.307 . . . . 0.0 110.332 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.9 p -67.88 155.72 38.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.599 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.08 -40.92 67.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.189 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -55.02 -22.26 14.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.0 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.607 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.6 m-20 -68.42 3.01 1.94 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.9 OUTLIER -41.12 -65.14 0.5 Allowed Pre-proline 0 N--CA 1.462 0.159 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.501 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.0 Cg_endo -71.35 76.79 1.74 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.293 1.995 . . . . 0.0 112.246 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.964 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.05 143.19 39.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.671 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.11 68.67 0.12 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.637 0.732 . . . . 0.0 110.963 178.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.771 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 20.2 m 58.75 161.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.268 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.686 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.63 -30.96 23.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.857 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.621 ' HA ' HD11 ' A' ' 14' ' ' ILE . 16.3 pt-20 -58.46 -46.3 86.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.448 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.671 ' HG2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -71.0 -37.54 72.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.725 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.006 HG21 HG21 ' A' ' 24' ' ' ILE . 45.5 t -62.69 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.023 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.678 ' HB1' ' CD ' ' A' ' 10' ' ' ARG . . . -56.63 -48.45 77.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.066 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.411 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 1.3 m-20 -65.52 -45.28 84.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.839 0.352 . . . . 0.0 111.028 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.435 ' OG1' ' OE1' ' A' ' 70' ' ' GLU . 27.0 m -59.86 -44.65 94.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.624 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.784 HG23 ' CB ' ' A' ' 54' ' ' ALA . 66.2 mt -57.26 -51.52 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.399 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 14.9 m -60.33 -37.11 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -63.31 -58.16 8.04 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HB2' HG21 ' A' ' 57' ' ' VAL . 64.3 mttp -69.48 -38.96 77.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.621 ' HB2' ' CB ' ' A' ' 54' ' ' ALA . . . -66.75 -29.95 70.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.242 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.21 -55.88 0.42 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.236 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.534 HD13 ' HA ' ' A' ' 6' ' ' LYS . 19.5 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.257 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 2' ' ' LYS . 80.3 p -178.26 37.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -86.69 138.3 31.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.259 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt 64.71 58.07 1.02 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.448 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' -2' ' ' SER . 22.3 ptmt -176.26 142.43 0.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.938 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -157.42 133.11 9.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.523 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.5 -132.3 1.97 Allowed Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.872 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.727 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.6 p -70.04 -6.32 6.55 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 CA-C-N 116.677 0.238 . . . . 0.0 110.925 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -45.29 -46.53 12.76 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.407 ' OE2' ' HD2' ' A' ' 6' ' ' LYS . 9.5 mp0 -77.74 -31.63 52.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.934 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.727 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 65.4 m-20 -65.61 -52.35 52.66 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.507 HG13 HG22 ' A' ' 5' ' ' VAL . 31.1 mt -68.33 -46.1 81.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.599 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.3 OUTLIER -56.89 -29.96 63.48 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.142 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.58 -43.68 96.16 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 82.7 mt-30 -63.95 -30.23 71.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.711 -0.744 . . . . 0.0 109.665 177.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 10' ' ' ARG . 63.2 mt -70.5 -42.54 78.25 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.059 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.839 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' A' ' 69' ' ' GLU . 10.4 mm -57.17 -52.75 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.413 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.7 86.3 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.186 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -60.98 -27.88 68.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.975 0.416 . . . . 0.0 111.094 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.092 HD22 HD12 ' A' ' 24' ' ' ILE . 54.6 mt -85.78 -29.41 23.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.939 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.98 129.09 38.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.098 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.92 -34.49 4.17 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.836 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.702 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.87 -178.05 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.843 0.354 . . . . 0.0 111.613 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -61.18 -119.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.728 ' CE2' ' HA ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -58.73 174.43 0.37 Allowed Pre-proline 0 CA--C 1.519 -0.242 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 176.102 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.889 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 39.3 Cg_endo -63.32 67.01 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.843 0.98 . . . . 0.0 112.292 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.092 HD12 HD22 ' A' ' 17' ' ' LEU . 24.0 mm 109.4 60.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.728 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.6 m120 -62.78 65.85 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 25' ' ' ASN . 81.5 p 56.76 156.7 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.656 ' O ' ' HB2' ' A' ' 31' ' ' MET . 52.1 Cg_exo -49.5 -34.47 33.65 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.299 1.332 . . . . 0.0 113.15 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.03 -57.1 10.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.327 0.584 . . . . 0.0 110.647 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.604 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.2 tp10 -76.0 -57.51 3.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.901 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -49.9 -41.12 45.13 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.873 ' HA ' HD13 ' A' ' 34' ' ' LEU . 64.3 mtm -65.72 -33.82 76.77 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.45 -28.31 68.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.605 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.702 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -72.6 -40.73 66.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.618 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.873 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.4 mp -35.18 145.21 0.2 Allowed Pre-proline 0 N--CA 1.467 0.407 0 CA-C-O 121.137 0.494 . . . . 0.0 112.326 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.536 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.2 Cg_endo -47.44 -41.96 28.74 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 124.07 3.18 . . . . 0.0 114.38 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.466 HD22 ' N ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -71.85 -16.98 62.16 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' N ' HD22 ' A' ' 36' ' ' ASN . . . 109.82 -67.43 0.23 Allowed Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.94 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.616 ' O ' ' HB3' ' A' ' 31' ' ' MET . 60.7 Cg_endo -77.09 -53.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.249 1.966 . . . . 0.0 112.529 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.649 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER 172.78 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.87 0.468 . . . . 0.0 110.587 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.563 HG22 HD23 ' A' ' 34' ' ' LEU . 9.9 t -68.35 135.28 51.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.873 0.368 . . . . 0.0 111.181 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.467 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 6.7 m -81.0 127.82 33.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.7 m -95.55 43.71 1.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 110.368 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.461 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -75.6 156.19 35.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.134 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.7 m -153.33 129.48 10.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.349 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.49 -52.52 0.65 Allowed Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.171 -0.537 . . . . 0.0 113.225 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -168.44 -40.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.976 0.417 . . . . 0.0 110.242 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.733 HG12 ' CD2' ' A' ' 49' ' ' LEU . 41.5 t -66.63 135.29 28.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.543 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.878 ' C ' HD22 ' A' ' 49' ' ' LEU . 32.8 mt-10 -123.42 131.4 53.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.878 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.7 mm? -141.63 139.37 33.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.848 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.467 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 59.6 pttt -176.97 153.94 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.81 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.768 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.8 -27.22 1.94 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.659 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.9 t -67.26 -62.51 1.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.067 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -72.55 -54.32 9.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.915 0.388 . . . . 0.0 111.787 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.898 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -71.76 -45.3 62.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.812 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.91 -27.83 1.57 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.711 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -41.91 -36.69 1.13 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.795 0.807 . . . . 0.0 110.434 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 54' ' ' ALA . 16.3 m -83.07 28.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.28 -1.327 . . . . 0.0 112.243 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 57' ' ' VAL . 36.1 mt -137.91 76.9 1.6 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.943 0.402 . . . . 0.0 110.38 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.9 p -49.08 174.92 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.247 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.02 73.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.551 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -50.69 -28.44 9.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.629 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.472 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 52.8 m-20 -75.47 3.46 9.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.338 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.685 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -43.78 -71.34 0.16 Allowed Pre-proline 0 N--CA 1.462 0.157 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.248 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 56.4 Cg_endo -68.39 77.65 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.023 1.816 . . . . 0.0 111.303 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.755 ' CG ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -77.1 144.59 38.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.138 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 62.1 mttp -70.37 64.36 0.27 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.106 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.889 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 55.7 m 63.93 160.2 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.575 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.541 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.92 -27.09 11.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.893 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.471 ' HA ' HD11 ' A' ' 14' ' ' ILE . 15.3 pt-20 -65.43 -38.92 91.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.969 0.414 . . . . 0.0 109.969 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 6.8 tp10 -67.73 -46.23 72.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.927 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.001 ' CG2' HG21 ' A' ' 24' ' ' ILE . 42.1 t -66.36 -45.65 88.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.821 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.564 ' HB1' ' CD ' ' A' ' 10' ' ' ARG . . . -55.33 -45.05 76.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.009 0.433 . . . . 0.0 110.352 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -69.82 -43.5 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.69 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.467 HG22 HD21 ' A' ' 58' ' ' LEU . 72.6 m -57.74 -46.93 83.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.298 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.875 HG23 ' CB ' ' A' ' 54' ' ' ALA . 70.6 mt -58.23 -54.95 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.959 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.53 HG21 ' HE3' ' A' ' 6' ' ' LYS . 15.2 m -58.5 -43.93 87.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.836 0.309 . . . . 0.0 111.836 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -62.52 -54.14 44.33 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.425 ' CB ' HG21 ' A' ' 57' ' ' VAL . 98.6 mttt -72.07 -41.16 67.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.42 ' HB1' ' CD1' ' A' ' 49' ' ' LEU . . . -67.04 -29.98 69.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.062 0.394 . . . . 0.0 112.062 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.49 -56.36 0.39 Allowed Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.049 -1.072 . . . . 0.0 113.223 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 14.0 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.08 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 47.5 t -59.9 136.15 57.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.881 0.372 . . . . 0.0 110.828 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -62.95 -41.63 99.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.944 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttm -176.02 136.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.97 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.468 ' HB3' ' NZ ' ' A' ' 2' ' ' LYS . 4.4 mmmp? -72.54 134.7 45.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.208 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.0 mtp -59.88 -45.75 91.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.898 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.54 -40.79 1.66 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.525 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.9 p -68.04 -5.86 4.7 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.484 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 0.8 OUTLIER -45.1 -46.54 11.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.834 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.6 -32.79 53.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.868 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.706 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 13.5 m-20 -64.88 -52.14 58.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.542 HG13 HG22 ' A' ' 5' ' ' VAL . 31.9 mt -65.4 -46.63 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.826 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 45.8 ttp180 -56.77 -28.69 61.7 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.46 -42.41 95.84 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 67.8 mt-30 -69.02 -32.44 71.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.866 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.1 mt -70.11 -45.91 74.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.266 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 14' ' ' ILE . 5.3 mm -57.67 -52.23 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.698 0.285 . . . . 0.0 110.398 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.63 93.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.332 -0.937 . . . . 0.0 110.9 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.719 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -64.72 -25.88 68.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.282 -0.459 . . . . 0.0 111.172 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.008 HD22 HD12 ' A' ' 24' ' ' ILE . 65.3 mt -83.0 -29.46 28.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.718 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.83 139.43 54.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.262 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.67 -30.85 8.88 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.888 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.674 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.59 -176.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.988 0.423 . . . . 0.0 111.61 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.575 ' CB ' ' ND2' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -59.83 -120.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.825 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -61.36 -169.06 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.825 ' N ' ' HD1' ' A' ' 22' ' ' PHE . 57.5 Cg_endo -71.48 62.19 2.82 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 CA-C-N 120.975 1.384 . . . . 0.0 112.178 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.064 HG21 HG21 ' A' ' 71' ' ' VAL . 48.9 mm 109.83 65.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.671 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 7.3 m-20 -63.76 65.64 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 O-C-N 122.001 -0.437 . . . . 0.0 111.612 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.609 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 42.7 p 59.38 157.05 0.1 OUTLIER Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.604 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 50.7 Cg_exo -50.59 -34.36 42.66 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.331 1.354 . . . . 0.0 112.879 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -53.15 -55.43 24.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.137 0.494 . . . . 0.0 110.907 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.671 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -74.83 -57.37 3.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.907 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -49.89 -38.46 35.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.792 ' HA ' HD13 ' A' ' 34' ' ' LEU . 57.3 mtm -63.5 -37.83 88.82 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.77 -26.44 66.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.166 0.508 . . . . 0.0 110.562 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.674 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -68.36 -42.99 78.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.474 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.792 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.0 mp -33.32 148.9 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.739 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -47.22 -46.56 19.23 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.648 2.898 . . . . 0.0 113.821 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.492 ' OD1' ' HB ' ' A' ' 40' ' ' THR . 12.3 p-10 -72.6 -26.29 61.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . 118.53 -79.19 0.3 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.545 -0.835 . . . . 0.0 112.873 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' MET . 16.8 Cg_endo -58.24 -73.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.495 2.13 . . . . 0.0 112.213 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.638 ' HA ' HD22 ' A' ' 34' ' ' LEU . 1.1 p30 -176.84 88.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.642 HG22 HD23 ' A' ' 34' ' ' LEU . 2.4 t -62.07 136.23 57.86 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.598 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.445 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 28.1 m -83.9 125.98 32.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.996 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.494 ' HB2' HG23 ' A' ' 9' ' ' ILE . 63.4 m -88.84 46.26 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 0.0 110.341 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.455 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 61.8 pttt -75.69 147.43 39.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.096 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.9 m -141.78 126.98 18.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.72 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.75 -59.55 0.5 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.958 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -156.39 -42.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.807 0.337 . . . . 0.0 110.82 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.725 HG12 ' CD2' ' A' ' 49' ' ' LEU . 36.9 t -66.51 138.73 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.111 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.874 ' C ' HD22 ' A' ' 49' ' ' LEU . 29.6 mt-10 -124.23 132.24 53.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.997 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.874 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -143.94 141.69 30.36 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.053 0.454 . . . . 0.0 111.238 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 41' ' ' THR . 51.0 pttt -177.46 165.88 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.73 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.724 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -55.14 -31.98 61.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.663 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.0 t -66.58 -62.65 1.35 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 58.4 m-20 -72.21 -54.31 10.01 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.506 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -73.42 -44.37 58.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.63 -25.28 1.39 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.365 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 25.3 pt20 -40.6 -38.4 0.87 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.157 0.503 . . . . 0.0 111.652 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.3 m -65.65 -33.32 62.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.371 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 13.2 mt -70.17 119.27 14.12 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.5 p -72.18 155.77 39.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.883 0.373 . . . . 0.0 111.468 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.82 -40.7 60.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.3 -21.2 33.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.961 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.573 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 19.6 m-20 -68.7 2.98 2.11 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.609 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.8 OUTLIER -37.78 -62.81 0.58 Allowed Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 117.953 0.342 . . . . 0.0 111.63 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.7 Cg_endo -72.08 77.63 1.95 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.378 2.052 . . . . 0.0 111.747 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.919 ' CD2' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -77.03 141.99 40.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.649 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.67 66.76 0.13 Allowed 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.519 0.676 . . . . 0.0 110.221 178.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.802 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 18.5 m 60.8 161.51 0.06 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.369 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.672 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.57 -31.77 25.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.645 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.9 pt-20 -58.37 -45.82 87.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.408 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -70.16 -33.69 72.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.607 -179.718 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.064 HG21 HG21 ' A' ' 24' ' ' ILE . 61.6 t -63.17 -44.95 99.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.919 0.39 . . . . 0.0 110.563 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.865 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -57.05 -50.3 73.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.067 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 56.0 m-20 -68.5 -42.04 79.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.009 0.433 . . . . 0.0 111.232 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.474 HG22 HD21 ' A' ' 58' ' ' LEU . 98.0 m -59.64 -49.4 77.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.797 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.49 HG23 ' HB1' ' A' ' 54' ' ' ALA . 75.2 mt -62.07 -54.23 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.607 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.865 HG22 ' O ' ' A' ' 72' ' ' ALA . 11.3 m -61.29 -44.67 98.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 4.3 m120 -59.66 -52.58 64.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.43 ' HE2' ' HB ' ' A' ' 57' ' ' VAL . 48.9 mtpt -72.65 -41.06 65.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.734 0.302 . . . . 0.0 111.606 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.27 -30.08 69.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.759 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.19 -56.28 0.41 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.934 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 16.9 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.042 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 52.4 m -86.65 43.72 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.646 0.26 . . . . 0.0 111.401 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -93.35 128.15 39.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.744 0.306 . . . . 0.0 110.92 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 1.8 mpt? -104.52 -58.5 1.87 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.733 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 1' ' ' MET . 56.2 tptt 176.69 -43.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.66 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 ttt -56.29 132.79 51.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.078 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.09 -133.78 2.55 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.225 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.703 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p -71.12 -5.51 5.87 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.974 0 O-C-N 122.985 -0.127 . . . . 0.0 111.315 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HE2' ' NH2' ' A' ' 10' ' ' ARG . 86.8 tttt -44.94 -47.45 11.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -77.61 -33.48 53.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.786 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.703 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -63.69 -52.07 62.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.527 HG13 ' CG2' ' A' ' 5' ' ' VAL . 28.3 mt -64.01 -46.46 93.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.794 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 24.3 ttm180 -56.88 -28.05 61.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.92 -41.42 97.4 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 63.4 mt-30 -70.69 -31.33 68.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.633 -0.784 . . . . 0.0 110.032 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.4 -48.68 52.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.308 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.466 ' HA ' HD13 ' A' ' 14' ' ' ILE . 7.9 mm -57.27 -52.27 58.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.511 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.22 -36.47 93.27 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.911 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -64.17 -28.45 69.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.239 -0.481 . . . . 0.0 111.247 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.048 HD22 HD12 ' A' ' 24' ' ' ILE . 60.8 mt -80.43 -29.45 37.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.701 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.68 133.3 53.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.067 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.58 -33.54 5.46 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.765 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.706 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.65 -176.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.449 . . . . 0.0 111.643 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -59.9 -123.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.143 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.775 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -58.83 -174.79 0.05 OUTLIER Pre-proline 0 N--CA 1.456 -0.127 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 176.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.844 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 52.2 Cg_endo -68.08 62.8 1.01 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 120.478 1.206 . . . . 0.0 112.326 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.048 HD12 HD22 ' A' ' 17' ' ' LEU . 49.1 mm 110.32 65.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.655 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 6.3 m-20 -64.67 65.99 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 122.013 -0.429 . . . . 0.0 111.478 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.541 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 27.3 p 58.43 157.2 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.602 ' HG3' HD12 ' A' ' 58' ' ' LEU . 50.8 Cg_exo -50.69 -34.62 44.53 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.319 1.346 . . . . 0.0 112.875 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -52.61 -55.19 24.07 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.613 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.655 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 6.0 tp10 -76.25 -57.83 3.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.933 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -50.03 -41.85 48.34 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.749 ' N ' HD12 ' A' ' 30' ' ' LEU . 28.3 ttm -66.02 -32.69 74.32 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.14 -30.39 69.51 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.394 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -68.41 -40.42 81.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.288 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.0 mp -25.07 134.47 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.29 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.35 -34.84 72.52 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.862 3.041 . . . . 0.0 114.899 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.577 ' CG ' ' HB ' ' A' ' 40' ' ' THR . 15.1 p-10 -72.33 -28.24 62.93 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.28 -67.21 0.46 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.917 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 97.7 Cg_endo -83.74 43.79 1.47 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.745 2.297 . . . . 0.0 113.506 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.568 ' C ' HD21 ' A' ' 36' ' ' ASN . 1.6 m-20 62.28 93.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.577 ' HB ' ' CG ' ' A' ' 36' ' ' ASN . 3.8 t -75.4 137.57 41.11 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.473 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.45 ' OG1' ' HD2' ' A' ' 50' ' ' LYS . 27.3 m -96.15 118.87 33.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.668 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -88.01 43.87 1.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.09 0.472 . . . . 0.0 109.975 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 19.8 ptmt -75.82 132.48 40.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.148 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.0 m -111.82 114.63 27.71 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.8 -129.66 44.53 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.467 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -72.05 -37.29 69.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.008 0.432 . . . . 0.0 110.987 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.615 HG12 ' CD2' ' A' ' 49' ' ' LEU . 51.7 t -66.69 145.36 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.725 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.883 ' C ' HD22 ' A' ' 49' ' ' LEU . 32.6 mt-10 -141.99 128.3 19.92 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.634 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.883 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -140.91 132.52 27.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.936 0.398 . . . . 0.0 110.912 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HD2' ' OG1' ' A' ' 41' ' ' THR . 21.3 ptmt -170.21 159.08 7.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.727 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.86 -29.88 3.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.951 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.9 t -72.54 -59.59 2.65 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 57.5 m-20 -72.15 -54.11 10.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.79 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -74.34 -43.97 54.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.09 -27.06 1.46 Allowed Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.363 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 18.1 pt20 -42.25 -40.14 2.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.149 0.5 . . . . 0.0 111.515 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.751 HG22 ' O ' ' A' ' 54' ' ' ALA . 28.0 m -65.76 -30.39 49.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.104 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.691 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 12.4 mt -71.32 119.85 16.05 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.5 p -75.0 155.66 37.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.355 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.64 -39.81 51.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -58.81 -21.09 55.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.642 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.4 m-20 -70.04 3.15 2.9 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.5 m-85 -40.49 -62.69 0.88 Allowed Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 118.162 0.437 . . . . 0.0 111.293 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.0 Cg_endo -71.43 74.95 2.01 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.48 2.12 . . . . 0.0 112.207 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.881 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -76.9 139.84 40.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.167 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.486 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 38.1 mtmm -66.45 70.07 0.07 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.596 0.712 . . . . 0.0 110.671 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.844 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 37.7 m 59.33 161.15 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.284 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.67 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.55 -26.85 9.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.482 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.515 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 12.0 pt-20 -58.77 -48.99 79.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.454 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.499 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -74.87 -31.88 61.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 119.656 -0.817 . . . . 0.0 111.303 -179.387 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.971 HG21 HG21 ' A' ' 24' ' ' ILE . 57.2 t -61.48 -45.47 98.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.418 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.889 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -60.84 -46.33 90.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.108 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 9.3 t70 -62.5 -41.74 99.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.531 0.682 . . . . 0.0 110.396 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.471 HG22 HD21 ' A' ' 58' ' ' LEU . 85.0 m -63.19 -49.54 73.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.835 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.79 HG23 ' CB ' ' A' ' 54' ' ' ALA . 74.7 mt -59.79 -55.17 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.072 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 72' ' ' ALA . 9.7 m -60.9 -43.8 96.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 3.4 m120 -63.93 -50.77 67.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HB2' HG21 ' A' ' 57' ' ' VAL . 99.7 mttt -74.06 -41.65 61.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.536 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.11 -29.9 69.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.7 -55.79 0.36 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.064 -1.065 . . . . 0.0 113.223 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 17.5 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.237 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' SER . . . . . 0.488 ' O ' ' CG ' ' A' ' -1' ' ' HIS . 28.4 m 62.11 -137.88 0.47 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.569 -0.16 . . . . 0.0 110.569 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' -1' ' ' HIS . . . . . 0.488 ' CG ' ' O ' ' A' ' -2' ' ' SER . 10.2 p80 47.83 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.791 0.329 . . . . 0.0 111.376 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt -71.53 126.03 28.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.29 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.52 ' HZ1' HD23 ' A' ' 81' ' ' LEU . 61.7 pttt -75.03 -35.77 61.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.617 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 93.5 mmm 66.65 130.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.39 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.1 -138.45 5.14 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.021 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.7 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.3 p -77.1 -5.82 8.12 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 C-N-CA 121.401 -0.12 . . . . 0.0 110.957 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 13.0 tmtt? -45.11 -46.0 11.53 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.53 -34.14 54.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.857 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.7 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -63.55 -52.2 62.11 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.811 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.73 HG23 ' HB2' ' A' ' 42' ' ' CYS . 31.6 mt -65.69 -47.49 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.802 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 52.0 ttp85 -55.04 -28.8 55.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.426 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.63 -47.21 79.31 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -66.95 -28.02 67.93 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.763 -0.719 . . . . 0.0 109.986 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 9' ' ' ILE . 75.3 mt -70.43 -44.99 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.075 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.566 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.46 HD13 ' HA ' ' A' ' 14' ' ' ILE . 11.3 mm -56.11 -49.64 74.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.05 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.69 -36.85 91.89 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.044 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.93 -27.11 69.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.25 -0.475 . . . . 0.0 111.38 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.025 HD22 HD12 ' A' ' 24' ' ' ILE . 35.9 mt -85.01 -29.47 24.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.71 132.86 46.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.03 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.45 -33.97 4.88 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.519 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.715 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.19 -177.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.771 0.319 . . . . 0.0 111.383 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.55 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.79 -119.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.749 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -60.82 179.61 0.22 Allowed Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 176.536 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.816 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 41.4 Cg_endo -65.48 65.49 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 CA-C-N 119.921 1.008 . . . . 0.0 112.359 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.025 HD12 HD22 ' A' ' 17' ' ' LEU . 31.7 mm 107.94 61.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.611 ' HA ' ' CZ ' ' A' ' 22' ' ' PHE . 2.6 m120 -62.98 65.75 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.588 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.1 p 57.12 156.7 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.613 ' O ' ' CB ' ' A' ' 31' ' ' MET . 53.7 Cg_exo -50.04 -33.99 36.65 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.351 1.367 . . . . 0.0 112.837 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -52.3 -56.83 12.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.308 0.575 . . . . 0.0 110.625 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.603 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.1 tp10 -76.1 -57.71 3.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.9 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.7 pp -50.2 -40.76 48.13 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.75 ' HA ' HD13 ' A' ' 34' ' ' LEU . 31.2 ttm -65.93 -33.61 76.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.48 -29.94 69.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.469 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.715 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -70.1 -39.62 75.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.408 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.75 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.8 mp -30.49 140.99 0.12 Allowed Pre-proline 0 N--CA 1.468 0.466 0 CA-C-O 121.108 0.48 . . . . 0.0 112.12 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.27 -50.04 15.34 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.859 3.04 . . . . 0.0 115.587 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.596 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 33.6 p-10 -72.31 -26.54 61.99 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -177.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.93 -62.18 0.46 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.936 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.596 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 93.5 Cg_endo -79.45 49.46 3.18 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.6 2.2 . . . . 0.0 113.154 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 2.6 p30 51.5 91.85 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.539 ' H ' HD23 ' A' ' 34' ' ' LEU . 6.0 t -78.84 134.9 36.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.513 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.565 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 2.0 t -108.6 121.97 46.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.073 0.464 . . . . 0.0 111.478 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.73 ' HB2' HG23 ' A' ' 9' ' ' ILE . 33.8 m -72.4 59.84 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.39 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.467 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 62.0 pttt -75.19 122.54 23.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.004 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 m -98.68 87.58 3.83 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.87 -126.39 8.03 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.996 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' O ' ' OE2' ' A' ' 48' ' ' GLU . 28.5 m-20 -72.56 -43.59 63.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.655 HG12 ' CD2' ' A' ' 49' ' ' LEU . 58.3 t -70.82 137.29 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.865 ' C ' HD22 ' A' ' 49' ' ' LEU . 22.1 mp0 -126.22 137.69 53.56 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.56 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.865 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.8 mm? -136.08 135.83 39.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.649 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.749 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 56.1 pttt -166.38 -165.26 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.058 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.506 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -78.02 -46.33 21.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.876 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.7 t -65.36 -51.62 59.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.647 0.26 . . . . 0.0 111.542 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.44 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 46.4 m-20 -71.79 -51.44 22.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 50' ' ' LYS . . . -86.03 -47.18 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.81 -26.15 1.08 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.785 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.419 ' HG3' ' N ' ' A' ' 57' ' ' VAL . 22.7 pt20 -41.57 -38.95 1.46 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.964 0.411 . . . . 0.0 111.796 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.1 m -65.66 -32.21 57.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.558 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.71 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 22.4 mt -68.62 122.54 18.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.36 . . . . 0.0 110.554 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.5 p -74.74 155.81 37.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.331 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.21 -42.11 60.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.321 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.21 -20.02 38.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.169 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.693 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 28.5 m-20 -68.64 3.31 1.92 Allowed 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.588 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.7 OUTLIER -39.49 -67.46 0.28 Allowed Pre-proline 0 N--CA 1.463 0.18 0 CA-C-N 117.758 0.254 . . . . 0.0 111.466 -179.107 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.7 Cg_endo -70.43 76.39 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.311 2.007 . . . . 0.0 112.18 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.858 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -76.94 141.92 40.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.989 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.507 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 4.4 mmmp? -67.41 69.67 0.1 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.454 0.645 . . . . 0.0 110.615 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.816 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.8 m 58.5 162.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.15 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.651 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.8 -27.47 12.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.733 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.494 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 15.6 pt-20 -58.36 -49.69 76.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.555 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.507 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -73.54 -32.27 64.11 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.07 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.972 HG21 HG21 ' A' ' 24' ' ' ILE . 60.6 t -64.79 -39.65 86.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.888 0.375 . . . . 0.0 110.62 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.802 ' HB1' ' CG ' ' A' ' 10' ' ' ARG . . . -63.69 -49.54 72.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -68.46 -41.11 80.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.168 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.8 m -58.85 -51.63 69.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.513 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.651 HG23 ' HB1' ' A' ' 54' ' ' ALA . 75.0 mt -59.17 -53.57 46.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.316 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 72' ' ' ALA . 11.1 m -59.82 -42.1 87.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.945 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -61.54 -53.45 56.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.679 0.276 . . . . 0.0 111.513 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.478 ' HE3' ' HB ' ' A' ' 57' ' ' VAL . 27.7 mtpp -71.85 -39.68 69.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.597 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.92 69.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.812 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.34 -55.4 0.41 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.808 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 17.9 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.958 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.524 -0.231 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 80.0 p -178.01 -47.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.854 0.359 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -65.58 -53.11 46.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 ttp 177.75 136.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.579 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -122.43 -50.73 1.98 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.21 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.556 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 83.3 mtp 48.35 115.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 111.523 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.19 -130.8 2.0 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.243 -0.98 . . . . 0.0 113.131 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.8 p -67.34 -5.7 4.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 46.2 tttm -44.72 -47.05 10.7 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.798 -0.761 . . . . 0.0 108.999 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.39 -34.33 54.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.759 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.706 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 65.4 m-20 -63.03 -52.05 64.38 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.534 HG13 HG22 ' A' ' 5' ' ' VAL . 31.1 mt -66.23 -47.7 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.838 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 42.3 ttp180 -55.02 -28.85 55.29 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.98 -43.93 92.62 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 68.7 mt-30 -67.08 -30.83 70.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.746 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 9' ' ' ILE . 68.0 mt -70.77 -42.64 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.781 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.2 mm -57.82 -53.53 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.359 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.27 -37.56 92.99 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.011 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.41 -30.91 69.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.072 0.463 . . . . 0.0 111.081 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.103 HD22 HD12 ' A' ' 24' ' ' ILE . 46.5 mt -81.27 -29.44 34.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.513 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.82 125.25 21.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.716 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.62 -35.2 3.11 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.465 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.655 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.37 -176.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.842 0.353 . . . . 0.0 111.378 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.577 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.85 -119.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 177.589 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.729 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -59.66 177.44 0.27 Allowed Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.182 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.877 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 53.6 Cg_endo -65.11 65.86 0.31 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 CA-C-N 119.949 1.017 . . . . 0.0 112.372 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.103 HD12 HD22 ' A' ' 17' ' ' LEU . 26.9 mm 109.53 61.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 178.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.696 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.7 m120 -63.14 65.23 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.589 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.8 p 57.37 154.33 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.68 ' O ' ' CB ' ' A' ' 31' ' ' MET . 61.6 Cg_exo -48.21 -32.32 18.99 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.23 1.287 . . . . 0.0 112.748 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -53.0 -57.32 10.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.431 0.634 . . . . 0.0 110.591 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.6 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.1 tp10 -76.27 -57.65 3.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.901 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.2 pp -50.12 -35.15 24.58 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.805 ' HG3' ' HB2' ' A' ' 39' ' ' ASP . 30.8 ttm -66.96 -37.01 83.49 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.19 -23.98 64.9 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.659 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.655 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -74.0 -46.59 42.67 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 30' ' ' LEU . 5.6 mp -36.08 144.91 0.24 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 121.241 0.543 . . . . 0.0 112.404 -177.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.8 Cg_endo -47.77 -50.36 11.8 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.202 3.268 . . . . 0.0 115.141 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.49 ' ND2' ' HA ' ' A' ' 40' ' ' THR . 30.9 p-10 -72.27 -15.6 61.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.33 -69.28 0.24 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.674 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 86.6 Cg_endo -84.35 44.82 1.59 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.688 2.259 . . . . 0.0 113.026 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.805 ' HB2' ' HG3' ' A' ' 31' ' ' MET . 10.8 t70 62.37 95.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.156 0.503 . . . . 0.0 111.729 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.553 HG22 HD23 ' A' ' 34' ' ' LEU . 3.9 t -65.48 133.0 50.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.096 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 m -79.82 126.86 31.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.392 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.2 m -101.61 42.71 1.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.185 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.572 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . 22.5 pttp -75.85 149.18 37.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.634 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.6 m -142.05 136.4 30.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.023 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.39 -63.41 0.41 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.707 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -175.16 27.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.848 0.356 . . . . 0.0 111.106 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.729 HG12 ' CD2' ' A' ' 49' ' ' LEU . 48.7 t -128.08 125.49 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.255 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.908 ' C ' HD22 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -117.42 131.1 56.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.488 0.661 . . . . 0.0 112.271 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.908 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -143.95 133.28 23.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.721 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 60.6 pttt -169.73 -170.57 1.06 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 111.472 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.505 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -62.2 -52.4 63.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.414 ' OG ' ' HE3' ' A' ' 50' ' ' LYS . 85.3 p -72.74 -51.23 20.01 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.42 ' OD1' ' CE ' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -69.15 -49.92 52.47 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.717 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -90.81 -45.67 8.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -54.22 -21.66 19.5 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.985 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -44.07 -31.4 0.92 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.016 0.436 . . . . 0.0 111.072 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.9 m -77.65 27.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.636 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.536 HD21 HG22 ' A' ' 74' ' ' THR . 34.6 mt -129.33 117.32 20.45 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.922 0.391 . . . . 0.0 110.637 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.445 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 72.6 p -71.84 158.26 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.615 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.73 -39.38 51.75 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.369 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -50.92 -27.28 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.035 0.445 . . . . 0.0 110.737 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.555 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 61.2 m-20 -70.73 3.68 3.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.458 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.676 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -42.12 -69.4 0.22 Allowed Pre-proline 0 C--O 1.226 -0.147 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.378 -179.244 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 51.6 Cg_endo -68.2 76.55 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.254 1.97 . . . . 0.0 111.475 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.2 OUTLIER -77.01 142.63 39.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.137 -178.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 87.6 tttt -69.8 64.97 0.21 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.818 0.818 . . . . 0.0 111.24 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.877 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 64.8 m 64.07 161.25 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.728 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.553 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -53.38 -27.2 22.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.765 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -65.12 -39.35 92.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.17 0.509 . . . . 0.0 109.666 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 8.0 tp10 -66.23 -43.53 86.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.681 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.986 ' CG2' HG21 ' A' ' 24' ' ' ILE . 63.2 t -67.74 -41.1 84.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.544 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.857 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -55.9 -44.67 78.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.08 0.467 . . . . 0.0 110.015 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.71 -46.66 52.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.17 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.536 HG22 HD21 ' A' ' 58' ' ' LEU . 62.6 m -56.48 -48.78 76.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.708 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.477 HG23 ' CB ' ' A' ' 54' ' ' ALA . 68.3 mt -62.58 -54.31 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.656 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 72' ' ' ALA . 12.9 m -60.12 -42.07 88.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -62.65 -50.6 70.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.685 0.279 . . . . 0.0 111.483 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HB2' HG21 ' A' ' 57' ' ' VAL . 67.7 mttm -72.13 -43.01 65.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.794 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.542 ' HB1' HD12 ' A' ' 49' ' ' LEU . . . -67.54 -30.06 69.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.38 -56.56 0.41 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.869 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.5 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.083 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 47.4 t -178.23 136.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -176.79 45.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp 63.19 134.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.058 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -71.7 136.7 47.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.361 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -68.53 130.44 42.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.966 0.412 . . . . 0.0 111.142 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.15 -27.41 73.81 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.786 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.713 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.5 p -60.99 -7.12 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HE2' ' NH2' ' A' ' 10' ' ' ARG . 82.3 tttt -45.12 -43.24 9.58 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -77.72 -37.14 50.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.836 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.713 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 10.4 m-20 -62.6 -51.77 66.0 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.484 HG13 HG22 ' A' ' 5' ' ' VAL . 30.2 mt -63.92 -45.76 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.756 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 28.3 ttm180 -56.25 -29.95 61.76 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.4 -41.13 98.21 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 68.1 mt-30 -68.9 -30.12 68.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.747 -0.727 . . . . 0.0 109.755 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 10' ' ' ARG . 70.1 mt -71.17 -45.6 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.829 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 14' ' ' ILE . 9.9 mm -58.2 -52.55 57.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.34 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.44 -37.47 94.49 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.351 -0.928 . . . . 0.0 110.815 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.62 -31.0 70.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.176 -0.512 . . . . 0.0 110.785 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.026 HD22 HD12 ' A' ' 24' ' ' ILE . 64.2 mt -80.87 -29.34 35.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.574 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.95 138.08 49.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.15 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.66 -33.14 6.53 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.798 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.717 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.4 -177.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.951 0.405 . . . . 0.0 111.62 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.606 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -59.81 -122.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.389 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.83 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -59.68 -171.5 0.03 OUTLIER Pre-proline 0 N--CA 1.454 -0.227 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.052 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.835 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.3 Cg_endo -70.02 62.66 1.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 120.718 1.292 . . . . 0.0 112.012 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.052 HG21 HG21 ' A' ' 71' ' ' VAL . 49.3 mm 109.57 65.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.647 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 5.8 m-20 -63.73 65.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 O-C-N 122.038 -0.414 . . . . 0.0 111.857 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.603 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 35.8 p 60.1 154.54 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.606 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 52.0 Cg_exo -49.57 -33.32 30.49 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.197 1.265 . . . . 0.0 112.715 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -53.99 -54.88 32.97 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.649 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.647 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 5.9 tp10 -75.2 -57.76 3.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.915 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.27 -41.87 51.2 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.758 ' N ' HD12 ' A' ' 30' ' ' LEU . 36.1 ttm -64.29 -32.34 73.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -70.3 -28.75 65.43 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.399 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -71.0 -35.92 72.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.59 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.712 ' HB3' HG22 ' A' ' 40' ' ' THR . 8.8 mp -29.27 139.29 0.12 Allowed Pre-proline 0 N--CA 1.471 0.625 0 CA-C-O 121.078 0.466 . . . . 0.0 112.178 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.9 -45.31 25.04 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.281 3.321 . . . . 0.0 115.868 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.53 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 18.1 p-10 -72.15 -25.39 61.68 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.351 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.72 -65.74 0.3 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.733 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 84.5 Cg_endo -81.64 46.54 2.26 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.57 2.18 . . . . 0.0 113.171 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.435 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER 65.29 90.4 0.09 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.473 178.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.712 HG22 ' HB3' ' A' ' 34' ' ' LEU . 8.8 t -76.27 134.41 39.8 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.751 0.31 . . . . 0.0 111.176 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.458 ' OG1' ' HD2' ' A' ' 50' ' ' LYS . 29.2 m -92.72 125.1 37.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.148 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -93.41 41.31 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 60.8 pttt -75.85 129.16 36.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.183 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.0 m -106.31 118.21 36.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.13 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.53 -130.02 45.66 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.626 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' OD1' HG23 ' A' ' 47' ' ' VAL . 41.8 p-10 -74.61 -36.66 62.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.805 0.336 . . . . 0.0 111.396 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.637 HG12 ' CD2' ' A' ' 49' ' ' LEU . 56.9 t -66.82 143.34 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.544 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.882 ' C ' HD22 ' A' ' 49' ' ' LEU . 69.0 mt-10 -138.0 127.6 25.06 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.863 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.5 mm? -142.14 135.05 28.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.591 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.53 ' NZ ' ' HB2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -171.64 -171.96 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.967 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.425 ' O ' ' CA ' ' A' ' 55' ' ' GLY . . . -69.38 -50.12 49.06 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.472 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 35.4 t -66.47 -48.6 69.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.809 0.338 . . . . 0.0 111.562 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.439 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 28.8 m-20 -70.32 -54.14 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.744 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -94.6 -46.85 6.78 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -47.23 -26.1 3.1 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.871 -0.681 . . . . 0.0 113.047 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -43.69 -30.13 0.59 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 111.647 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 54' ' ' ALA . 29.7 m -74.16 28.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.773 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 22.2 mt -132.67 116.37 16.55 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.4 p -70.85 155.93 40.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 111.698 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.28 -39.42 21.54 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.438 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -50.84 -27.64 7.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.941 0.401 . . . . 0.0 110.578 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.593 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.4 m-20 -71.59 3.17 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.083 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.603 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.2 OUTLIER -37.25 -53.48 2.15 Favored Pre-proline 0 N--CA 1.463 0.204 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.435 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 3.5 Cg_endo -83.27 78.47 3.19 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.87 2.38 . . . . 0.0 112.127 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.881 ' CD2' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.19 143.52 38.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.625 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 3.3 mptp? -68.64 67.14 0.13 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.565 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.835 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 34.2 m 60.53 160.98 0.05 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.19 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.621 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.47 -31.17 22.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.431 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.499 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 22.1 pt-20 -57.52 -46.91 83.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.371 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.487 ' HG3' ' HD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -69.77 -35.63 75.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.5 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.052 HG21 HG21 ' A' ' 24' ' ' ILE . 61.6 t -61.9 -45.85 97.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 0.0 110.769 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.846 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -56.23 -49.93 72.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.986 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.51 -38.3 80.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.262 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 95.2 m -63.81 -51.36 65.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.0 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.427 HG23 ' CB ' ' A' ' 54' ' ' ALA . 70.2 mt -59.3 -52.17 63.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.269 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 72' ' ' ALA . 6.8 m -59.51 -39.91 80.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -62.36 -56.1 21.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.77 0.319 . . . . 0.0 111.702 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.549 ' HB2' HG21 ' A' ' 57' ' ' VAL . 98.6 mttt -69.46 -39.78 77.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.831 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.744 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.08 -29.86 69.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.134 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.76 -55.43 0.42 Allowed Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.273 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.5 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.292 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 80.7 p -178.48 138.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.781 0.324 . . . . 0.0 110.834 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -173.12 127.85 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.942 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt -74.79 150.63 39.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.493 ' HB3' ' NZ ' ' A' ' 2' ' ' LYS . 6.4 ttpm? -51.25 -24.01 4.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.462 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 ttt -37.54 131.08 0.96 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.08 0.467 . . . . 0.0 111.825 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.07 -132.46 1.76 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.686 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.745 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.5 p -72.8 -6.07 7.41 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.842 0 CA-C-N 116.839 0.319 . . . . 0.0 110.965 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.579 ' HA ' HD13 ' A' ' 81' ' ' LEU . 81.4 tttt -45.66 -51.13 12.75 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -77.87 -28.57 50.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.843 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.745 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 3.8 t70 -65.77 -52.65 49.19 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.505 HG13 HG22 ' A' ' 5' ' ' VAL . 15.3 mt -65.4 -42.22 92.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.903 ' NH2' HG21 ' A' ' 13' ' ' ILE . 3.1 tpt180 -60.25 -26.0 66.12 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.93 -44.74 94.13 Favored Glycine 0 CA--C 1.503 -0.675 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 77.5 mt-30 -63.43 -27.51 69.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.768 -0.716 . . . . 0.0 109.329 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.903 HG21 ' NH2' ' A' ' 10' ' ' ARG . 64.3 mt -75.03 -47.3 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.721 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.455 ' HA ' HD13 ' A' ' 14' ' ' ILE . 4.7 mm -56.4 -52.2 55.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 120.749 0.309 . . . . 0.0 110.2 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.23 -37.08 94.31 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -62.25 -27.34 68.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.184 -0.508 . . . . 0.0 110.834 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.055 HD22 HD12 ' A' ' 24' ' ' ILE . 40.4 mt -80.5 -29.52 37.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.283 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.42 133.38 49.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.871 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.17 -34.03 5.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.465 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.694 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.37 -178.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.838 0.351 . . . . 0.0 111.348 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.605 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.6 m-20 -60.88 -120.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.746 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -59.44 179.8 0.18 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.739 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.816 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 50.0 Cg_endo -65.46 63.98 0.37 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 CA-C-N 119.827 0.974 . . . . 0.0 112.363 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.055 HD12 HD22 ' A' ' 17' ' ' LEU . 33.7 mm 108.65 60.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.605 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.6 m120 -62.48 65.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.584 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 61.5 p 57.64 154.42 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.635 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 60.2 Cg_exo -48.93 -32.44 22.99 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.305 1.336 . . . . 0.0 112.689 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -53.04 -57.38 10.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.41 0.624 . . . . 0.0 110.415 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.593 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 41.4 tp10 -76.2 -57.6 3.77 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.892 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.16 -43.05 52.02 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.735 ' HA ' HD13 ' A' ' 34' ' ' LEU . 43.0 ttm -66.01 -31.58 72.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -67.2 -31.11 71.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.371 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.694 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -69.75 -39.03 76.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.284 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.1 mp -30.0 137.33 0.17 Allowed Pre-proline 0 N--CA 1.47 0.546 0 CA-C-O 121.026 0.441 . . . . 0.0 111.831 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.04 -49.82 13.16 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.842 3.028 . . . . 0.0 115.754 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.534 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 27.4 p-10 -72.35 -25.71 61.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.86 -65.18 0.35 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.255 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.534 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 88.9 Cg_endo -82.02 52.53 4.21 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.622 2.215 . . . . 0.0 112.43 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 2.6 p30 52.49 93.31 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.549 0.69 . . . . 0.0 112.517 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.2 t -69.54 127.46 33.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.235 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 7.8 m -84.72 125.75 32.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.509 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.2 m -92.16 45.99 1.24 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.98 0.419 . . . . 0.0 110.094 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.439 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 22.2 pttp -75.44 145.29 41.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.083 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.4 m -137.62 127.69 25.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.896 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.29 -51.41 0.8 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.024 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -169.57 -40.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.976 0.417 . . . . 0.0 110.44 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.703 HG12 ' CD2' ' A' ' 49' ' ' LEU . 38.3 t -66.76 134.72 29.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.768 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.903 ' C ' HD22 ' A' ' 49' ' ' LEU . 26.7 mt-10 -117.99 135.58 54.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.746 0.308 . . . . 0.0 111.045 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.903 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.1 mm? -141.38 128.98 21.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.167 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 22.5 pttp -168.47 157.88 9.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.612 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.461 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.75 -37.63 13.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.134 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.0 t -63.81 -52.48 60.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -72.25 -50.69 25.36 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.892 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -91.91 -47.15 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.81 -29.6 2.06 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.052 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -45.55 -30.93 1.6 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.074 0.464 . . . . 0.0 111.17 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.8 m -75.11 28.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.666 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.576 HD13 ' CE2' ' A' ' 65' ' ' PHE . 38.5 mt -132.26 116.47 16.96 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.2 p -73.19 156.1 38.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.944 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.67 -37.3 12.63 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.018 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -51.0 -29.21 11.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.146 0.498 . . . . 0.0 110.187 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.605 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -72.05 3.6 4.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.556 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.584 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.1 t80 -38.99 -51.86 3.95 Favored Pre-proline 0 CA--C 1.527 0.092 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 86.5 Cg_endo -87.62 78.89 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.923 2.416 . . . . 0.0 112.061 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.944 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.14 140.59 40.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.971 0.415 . . . . 0.0 111.448 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 27.3 tptp -66.48 69.95 0.07 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.753 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.816 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 38.0 m 58.07 161.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.796 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.715 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.74 -30.12 21.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.935 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 10.7 pt-20 -57.41 -47.62 81.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.678 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -72.87 -37.89 67.18 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.724 -179.68 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.982 ' CG2' HG21 ' A' ' 24' ' ' ILE . 42.9 t -60.1 -34.56 57.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.934 0.397 . . . . 0.0 110.693 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.752 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -68.72 -56.03 9.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.463 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.4 m-20 -66.19 -35.09 79.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.584 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.5 m -62.58 -49.98 73.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.903 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.676 HD12 HH22 ' A' ' 10' ' ' ARG . 73.0 mt -64.12 -51.02 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -52.38 -38.5 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.206 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -60.63 -55.26 35.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 111.319 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB2' HG21 ' A' ' 57' ' ' VAL . 62.0 mttp -71.91 -38.66 69.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.832 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.738 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.84 -30.11 70.2 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.2 -55.47 0.43 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 119.869 -1.158 . . . . 0.0 113.477 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.643 HD12 HG12 ' A' ' 76' ' ' VAL . 14.1 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.25 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 52.8 m -60.1 -43.98 95.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.856 0.36 . . . . 0.0 110.932 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -64.72 133.91 53.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.961 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt 62.56 130.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.98 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' HG2' ' CD2' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -95.87 42.8 1.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.274 0.559 . . . . 0.0 111.532 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.2 mtp 50.26 31.69 5.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.436 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 43.99 31.87 2.17 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.042 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.73 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p -77.14 -5.59 7.81 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 62.9 tttp -45.33 -48.71 13.17 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.082 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -77.7 -30.1 51.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.835 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.73 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 23.0 m-20 -65.21 -52.07 57.06 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.883 HD13 HD23 ' A' ' 49' ' ' LEU . 23.9 mt -69.74 -48.45 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.779 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 23.2 ttp180 -56.17 -28.57 58.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.04 -44.32 91.67 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.52 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 66.2 mt-30 -66.38 -32.16 73.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.818 -0.691 . . . . 0.0 109.826 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 70.5 mt -70.58 -48.22 60.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.187 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 69' ' ' GLU . 7.5 mm -53.94 -54.19 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.275 . . . . 0.0 110.8 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.7 -36.17 92.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.956 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -63.9 -22.06 66.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.115 -0.543 . . . . 0.0 111.478 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.043 HD22 HD12 ' A' ' 24' ' ' ILE . 56.0 mt -90.44 -29.64 17.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.882 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 83.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.803 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 169.34 -38.48 0.2 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.384 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.749 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.38 -177.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.555 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -58.3 -120.52 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.71 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -58.69 175.46 0.32 Allowed Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 176.492 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.899 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 39.4 Cg_endo -63.89 65.41 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 120.853 1.036 . . . . 0.0 112.835 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.128 HG23 HD22 ' A' ' 30' ' ' LEU . 11.1 mm 109.84 61.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 177.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.587 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 3.1 m120 -65.81 64.06 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.668 ' C ' HD23 ' A' ' 30' ' ' LEU . 87.6 p 57.43 150.53 0.06 OUTLIER Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.88 ' O ' ' HB2' ' A' ' 31' ' ' MET . 86.9 Cg_exo -46.15 -28.5 5.54 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.09 1.86 . . . . 0.0 112.654 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -55.87 -57.31 12.61 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.579 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 5.6 tp10 -77.38 -57.37 3.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.128 HD22 HG23 ' A' ' 24' ' ' ILE . 1.4 pp -50.04 -34.36 21.24 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.68 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.88 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -77.87 -29.87 50.57 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -61.79 -28.2 69.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.749 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -81.95 -35.95 28.5 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.066 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 31' ' ' MET . 6.4 mp -33.29 130.48 0.37 Allowed Pre-proline 0 N--CA 1.467 0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 111.689 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.45 -33.08 45.48 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.503 2.802 . . . . 0.0 114.358 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.714 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 5.5 t-20 -72.11 -27.46 62.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.9 -74.16 0.39 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.489 -0.863 . . . . 0.0 113.015 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 78.2 Cg_endo -83.43 43.87 1.52 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.724 2.282 . . . . 0.0 112.502 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.81 97.97 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.272 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.714 ' HB ' ' HB3' ' A' ' 36' ' ' ASN . 5.2 t -69.49 137.74 52.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.352 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.5 m -101.03 95.41 6.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.722 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.4 m -72.38 57.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.9 0.381 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 8.8 ptpp? -75.65 150.34 37.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.267 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.3 m -157.05 130.05 7.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.576 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 46' ' ' ASP . . . 58.43 49.55 75.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.298 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 11.4 m-20 79.04 -42.07 0.29 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.465 0.306 . . . . 0.0 111.578 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.715 HG12 HD21 ' A' ' 49' ' ' LEU . 40.9 t -66.55 139.0 21.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.863 0.364 . . . . 0.0 111.095 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.829 ' C ' HD22 ' A' ' 49' ' ' LEU . 31.5 mt-10 -127.27 133.08 50.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.298 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.883 HD23 HD13 ' A' ' 9' ' ' ILE . 2.4 mm? -133.41 139.85 46.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.998 0.427 . . . . 0.0 111.648 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 56.1 pttt -177.96 -164.72 0.09 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.69 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.758 ' HB1' ' HB3' ' A' ' 27' ' ' PRO . . . -77.58 -44.67 27.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.373 0.606 . . . . 0.0 111.505 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.404 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 23.2 t -59.63 -56.37 22.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.365 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' OD2' ' HE2' ' A' ' 50' ' ' LYS . 58.7 m-20 -72.78 -54.33 9.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.76 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -91.45 -43.21 9.85 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -45.62 -25.6 1.49 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.095 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -43.93 -40.16 4.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.144 0.497 . . . . 0.0 110.91 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 54' ' ' ALA . 35.4 m -65.68 -32.59 58.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.157 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.762 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 38.7 mt -71.36 70.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.183 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.402 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 71.7 p -47.94 156.8 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.595 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -43.63 -40.67 4.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.005 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -50.97 -27.92 8.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.886 0.374 . . . . 0.0 110.849 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.618 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 57.2 m-20 -73.33 3.45 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.625 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -40.82 -66.8 0.35 Allowed Pre-proline 0 N--CA 1.463 0.194 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.125 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 70.2 Cg_endo -72.93 75.97 2.61 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.408 2.072 . . . . 0.0 111.953 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.969 ' CG ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -77.01 142.37 39.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.357 -179.504 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.494 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 84.2 tttt -67.73 71.48 0.14 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.391 0.615 . . . . 0.0 110.703 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.899 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.7 m 59.31 161.37 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.003 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.73 -30.43 22.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.646 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.484 ' HA ' HD11 ' A' ' 14' ' ' ILE . 15.5 pt-20 -58.28 -47.63 83.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.636 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.571 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -74.38 -31.68 62.46 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.635 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.972 ' CG2' HG21 ' A' ' 24' ' ' ILE . 60.9 t -66.64 -51.68 53.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.779 ' HB1' ' HG2' ' A' ' 10' ' ' ARG . . . -55.61 -42.14 74.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 109.801 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.431 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 47.5 t0 -64.52 -46.46 82.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.218 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.47 HG22 HD21 ' A' ' 58' ' ' LEU . 98.6 m -58.81 -47.52 84.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.949 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 69.7 mt -57.31 -49.56 79.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.507 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 15.6 m -63.4 -40.41 88.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.431 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.5 m-20 -64.63 -55.94 17.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.57 -40.49 73.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.608 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.1 -30.0 69.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.26 -56.01 0.38 Allowed Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.214 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.0 mt . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.323 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 51.9 m -60.55 132.9 55.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.726 0.298 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -74.36 -143.3 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.49 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm 60.11 33.74 21.21 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.79 0.329 . . . . 0.0 111.088 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -90.6 143.45 26.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.19 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.8 mtm -128.8 -61.2 1.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.601 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.06 -33.35 0.43 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.535 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.72 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.6 p -61.36 -5.11 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.846 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.733 ' HE3' HG21 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -44.62 -50.47 9.75 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.608 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -77.46 -30.29 53.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.968 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.72 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 71.5 m-20 -64.41 -52.28 58.93 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.672 HD11 ' HB3' ' A' ' 44' ' ' SER . 15.9 mt -63.75 -43.79 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.898 ' NH2' HG21 ' A' ' 13' ' ' ILE . 0.7 OUTLIER -59.26 -25.94 64.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.008 178.036 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.91 -45.15 89.78 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' A' ' 42' ' ' CYS . 75.8 mt-30 -64.3 -29.87 70.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.739 -0.731 . . . . 0.0 109.724 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.898 HG21 ' NH2' ' A' ' 10' ' ' ARG . 75.7 mt -74.94 -46.15 41.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.863 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.454 ' HA ' HD13 ' A' ' 14' ' ' ILE . 5.1 mm -55.25 -53.09 38.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 110.397 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.4 -34.94 90.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.239 -0.981 . . . . 0.0 110.772 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.77 67.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.315 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.077 HD22 HD12 ' A' ' 24' ' ' ILE . 38.4 mt -83.2 -29.74 28.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 110.47 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.16 117.08 5.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.569 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.82 -36.22 1.96 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.455 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.674 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -53.92 -172.37 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.477 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.571 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -62.06 -119.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.776 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -60.79 179.62 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.815 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.7 Cg_endo -65.39 66.76 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 120.778 0.986 . . . . 0.0 112.561 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.077 HD12 HD22 ' A' ' 17' ' ' LEU . 30.2 mm 108.19 61.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 22' ' ' PHE . 2.7 m120 -64.39 64.76 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.6 p 58.15 155.23 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.641 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 64.5 Cg_exo -49.17 -32.29 24.26 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.359 1.373 . . . . 0.0 112.775 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -52.82 -57.6 9.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.502 0.668 . . . . 0.0 110.333 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.591 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 46.5 tp10 -76.5 -57.78 3.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.871 HD22 HG23 ' A' ' 24' ' ' ILE . 3.6 pp -50.12 -41.68 49.09 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.729 ' HA ' HD13 ' A' ' 34' ' ' LEU . 39.5 ttm -66.55 -32.46 73.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.3 -30.77 71.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.462 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.674 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -69.93 -40.77 75.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.403 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.729 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.1 mp -28.24 127.34 0.22 Allowed Pre-proline 0 N--CA 1.468 0.453 0 CA-C-O 121.061 0.458 . . . . 0.0 111.871 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.7 -30.76 57.67 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.513 2.809 . . . . 0.0 114.119 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.618 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 7.5 t-20 -72.2 -27.49 62.58 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.06 -75.68 0.45 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.829 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 98.6 Cg_endo -82.18 52.65 4.23 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.542 2.161 . . . . 0.0 111.666 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 38' ' ' PRO . 7.6 p-10 50.61 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.682 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.594 ' HB ' ' CB ' ' A' ' 36' ' ' ASN . 3.2 t -58.98 136.21 57.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.183 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.419 ' CG2' ' HB3' ' A' ' 48' ' ' GLU . 28.5 m -102.73 91.33 4.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.757 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.424 ' HB3' ' OE1' ' A' ' 12' ' ' GLN . 59.3 m -70.24 57.96 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.921 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.44 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.1 pttp -75.74 129.99 37.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.189 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.672 ' HB3' HD11 ' A' ' 9' ' ' ILE . 43.9 p -81.99 87.74 6.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.51 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.12 -57.78 0.41 Allowed Glycine 0 CA--C 1.519 0.281 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.148 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -130.87 -46.39 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.781 0.324 . . . . 0.0 110.573 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.755 HG12 ' CD2' ' A' ' 49' ' ' LEU . 44.7 t -66.93 130.62 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.524 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.888 ' C ' HD22 ' A' ' 49' ' ' LEU . 8.9 mp0 -114.95 133.85 55.66 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.945 0.403 . . . . 0.0 111.533 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.888 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -144.66 135.44 24.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.661 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.571 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 57.9 pttt -171.66 -176.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.976 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.472 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -66.91 -41.78 86.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.129 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -63.87 -56.13 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.435 ' OD2' ' HE2' ' A' ' 50' ' ' LYS . 59.6 m-20 -72.28 -44.87 62.14 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.613 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -90.25 -49.76 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.95 -28.42 1.77 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.503 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 15.8 pt20 -42.85 -35.61 1.24 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.078 0.466 . . . . 0.0 111.707 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 54' ' ' ALA . 24.6 m -65.53 -33.26 62.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.92 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.678 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 34.8 mt -63.88 124.26 21.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 110.638 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.6 p -75.13 155.91 36.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.444 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.17 -41.42 60.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.403 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -57.28 -21.79 37.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.078 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.599 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 16.6 m-20 -69.13 3.33 2.18 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.3 m-85 -41.71 -66.67 0.38 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 118.055 0.389 . . . . 0.0 111.35 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 56.8 Cg_endo -69.54 74.89 1.16 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.337 2.025 . . . . 0.0 112.064 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.913 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -76.95 142.89 39.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.221 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.505 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 14.3 mmmm -68.34 70.53 0.17 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.484 0.659 . . . . 0.0 110.509 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.815 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 46.2 m 58.41 160.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.948 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.704 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.65 -27.37 11.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.803 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.2 pt-20 -58.94 -48.39 81.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.525 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.505 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -73.78 -35.29 64.93 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.065 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.977 ' CG2' HG21 ' A' ' 24' ' ' ILE . 49.0 t -62.23 -36.51 74.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.022 0.439 . . . . 0.0 110.431 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.865 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -66.11 -57.64 7.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.259 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 m-20 -63.88 -42.13 97.56 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.55 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.3 m -55.01 -48.35 73.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.96 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.613 HG23 ' HB1' ' A' ' 54' ' ' ALA . 83.1 mt -64.32 -50.49 76.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.733 HG21 ' HE3' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -51.78 -38.07 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.37 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -63.97 -51.86 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.19 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.439 ' HB2' HG21 ' A' ' 57' ' ' VAL . 61.3 mttp -70.64 -41.97 71.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.682 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.504 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.45 -29.95 69.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.964 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.53 -54.08 0.47 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.969 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 6' ' ' LYS . 15.1 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.166 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 48.0 t -178.47 -44.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.791 0.329 . . . . 0.0 110.951 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -59.79 130.62 47.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.07 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttp 179.39 -46.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.543 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 3' ' ' MET . 59.8 tttm -178.54 120.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.365 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.544 ' CE ' ' HA ' ' A' ' 3' ' ' MET . 0.2 OUTLIER -152.52 134.29 14.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.771 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.0 -140.09 5.63 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.421 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.758 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.5 p -77.16 -5.36 7.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 N-CA-C 111.278 0.103 . . . . 0.0 111.278 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 39.2 tttm -45.3 -52.24 9.98 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -78.3 -25.94 46.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.29 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.758 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 54.8 t0 -68.03 -52.69 32.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.858 0.361 . . . . 0.0 111.882 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.511 HG13 HG22 ' A' ' 5' ' ' VAL . 14.4 mt -64.66 -44.49 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.85 ' HD2' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -59.62 -26.65 65.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.822 177.724 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.07 -42.89 99.47 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 71.0 mt-30 -64.37 -27.71 69.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.429 -0.885 . . . . 0.0 109.508 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.808 HD12 ' NE ' ' A' ' 10' ' ' ARG . 61.5 mt -74.89 -45.3 43.76 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.285 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.588 HD11 ' HB2' ' A' ' 72' ' ' ALA . 15.1 mm -56.84 -54.21 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.811 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.61 -36.6 93.56 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.299 -0.953 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -65.0 -24.57 67.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.131 -0.534 . . . . 0.0 111.392 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.078 HD22 HD12 ' A' ' 24' ' ' ILE . 48.4 mt -84.2 -29.83 26.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.831 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.67 124.14 18.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.971 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.64 -34.1 3.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.852 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.714 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -53.23 -174.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 0.0 111.583 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.604 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 9.3 m-20 -61.45 -118.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.753 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -59.73 179.51 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 176.331 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.813 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 55.6 Cg_endo -65.99 66.3 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.901 1.0 . . . . 0.0 112.213 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.078 HD12 HD22 ' A' ' 17' ' ' LEU . 42.8 mm 109.29 61.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.652 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.4 m120 -63.23 66.11 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.61 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 57.6 p 57.26 155.93 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.756 ' O ' ' HB2' ' A' ' 31' ' ' MET . 55.6 Cg_exo -49.6 -32.94 29.47 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.365 1.377 . . . . 0.0 113.054 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -53.33 -57.29 11.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.375 0.607 . . . . 0.0 110.561 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.598 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 40.6 tp10 -74.96 -57.05 4.14 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.899 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.5 pp -49.92 -42.32 48.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.776 ' HA ' HD13 ' A' ' 34' ' ' LEU . 27.0 mtm -64.67 -31.96 73.41 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -66.01 -28.66 69.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.48 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -74.46 -38.96 62.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.776 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.2 mp -33.2 131.96 0.35 Allowed Pre-proline 0 N--CA 1.469 0.482 0 CA-C-O 121.128 0.49 . . . . 0.0 111.803 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.27 -34.93 72.26 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 124.1 3.2 . . . . 0.0 115.172 -177.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.548 HD21 ' C ' ' A' ' 39' ' ' ASP . 15.3 p-10 -72.0 -27.24 62.61 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.35 -69.31 0.27 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.496 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 94.8 Cg_endo -81.4 38.25 0.74 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.655 2.236 . . . . 0.0 112.978 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.548 ' C ' HD21 ' A' ' 36' ' ' ASN . 0.6 OUTLIER 61.6 95.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.3 0.571 . . . . 0.0 112.071 179.293 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.514 HG22 HD23 ' A' ' 34' ' ' LEU . 2.7 t -64.34 138.35 58.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.249 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.473 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 19.8 m -93.77 123.17 36.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.404 ' CB ' HG23 ' A' ' 9' ' ' ILE . 60.0 m -91.04 45.91 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 0.0 110.609 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.468 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -75.67 155.06 36.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.171 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.4 m -150.65 128.63 11.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.294 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.45 -53.5 0.65 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.091 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -167.51 -41.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.978 0.418 . . . . 0.0 110.172 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.762 HG12 ' CD2' ' A' ' 49' ' ' LEU . 38.5 t -66.79 130.62 32.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.586 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.885 ' C ' HD22 ' A' ' 49' ' ' LEU . 35.6 mt-10 -115.9 132.55 56.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.885 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -138.09 139.33 39.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.128 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.473 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 59.1 pttt -178.83 157.52 0.91 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.891 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.583 ' HB3' ' CG ' ' A' ' 31' ' ' MET . . . -47.73 -27.77 2.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.89 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 t -71.99 -61.31 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 59.9 m-20 -72.41 -54.52 9.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.697 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -73.35 -43.39 60.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.87 -22.71 3.06 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.326 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 26.5 pt20 -41.22 -40.71 1.67 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.08 0.467 . . . . 0.0 111.691 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.7 m -65.79 -30.64 50.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.256 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.609 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 14.3 mt -72.2 113.58 9.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.738 0.304 . . . . 0.0 110.458 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.7 p -79.52 158.39 27.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.453 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.51 -40.16 12.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.248 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -53.06 -26.97 17.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.652 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.5 m-20 -71.08 3.16 3.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.217 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.61 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -38.87 -64.68 0.46 Allowed Pre-proline 0 N--CA 1.462 0.156 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.391 -178.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 59.3 Cg_endo -71.04 79.37 1.35 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.276 1.984 . . . . 0.0 111.444 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.609 ' CZ ' HD13 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -76.82 140.09 40.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.456 -179.245 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 2.7 mppt? -67.44 62.36 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.404 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.813 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 49.4 m 64.98 161.89 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.493 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.537 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -52.01 -28.61 17.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.679 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 15.5 pt-20 -65.3 -39.2 92.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' HG3' ' CD2' ' A' ' 65' ' ' PHE . 17.7 tp10 -63.52 -43.2 97.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.215 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.799 ' CG2' HG21 ' A' ' 24' ' ' ILE . 88.1 t -57.64 -46.59 86.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.807 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.839 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -53.77 -56.13 20.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.206 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.61 -44.3 86.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.907 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.5 m -56.53 -47.42 79.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.191 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.706 HG22 HH12 ' A' ' 10' ' ' ARG . 65.2 mt -66.31 -51.88 53.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.85 HG13 ' HD2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -56.88 -41.85 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.973 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -63.79 -54.58 32.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HB2' HG21 ' A' ' 57' ' ' VAL . 43.7 mtpt -74.87 -40.83 60.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 75' ' ' ILE . . . -67.06 -29.98 69.91 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.24 -52.41 0.48 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.515 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.59 ' HB2' HG12 ' A' ' 76' ' ' VAL . 15.5 mt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.354 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' SER . . . . . 0.423 ' HB3' ' HE3' ' A' ' 1' ' ' MET . 58.2 m -167.06 137.38 3.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.9 0.381 . . . . 0.0 110.812 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -31.68 69.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.705 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 10.6 mmt 63.06 143.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.827 0.346 . . . . 0.0 110.831 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.459 ' HE3' ' HA ' ' A' ' 81' ' ' LEU . 20.2 ttmm -165.87 138.04 3.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.109 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.6 mtt -159.19 33.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.48 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.13 -122.78 2.15 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.867 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.705 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.1 p -77.32 -5.75 8.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 CA-C-N 115.833 -0.184 . . . . 0.0 111.189 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 48.9 tttp -44.89 -47.1 11.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -77.54 -33.35 54.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.905 177.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.705 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 16.4 m-20 -64.02 -52.24 60.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.717 HG23 ' HB2' ' A' ' 42' ' ' CYS . 30.2 mt -66.06 -47.09 86.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.871 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 45.6 ttp180 -55.26 -29.52 58.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.81 -44.49 96.12 Favored Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -67.57 -28.78 68.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.652 -0.774 . . . . 0.0 109.725 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 10' ' ' ARG . 71.3 mt -70.16 -43.03 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.4 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 69' ' ' GLU . 13.5 mm -58.45 -48.83 84.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.004 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.16 -38.38 93.84 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.448 -0.882 . . . . 0.0 110.908 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.585 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -60.75 -34.02 73.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 0.0 110.694 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.013 HD22 HD12 ' A' ' 24' ' ' ILE . 79.0 mt -83.9 -29.17 27.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.692 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.56 60.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.485 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.551 ' C ' ' HB1' ' A' ' 33' ' ' ALA . . . 179.45 31.2 0.06 OUTLIER Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.994 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 33' ' ' ALA . . . -114.45 -168.4 1.36 Allowed 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.957 0.408 . . . . 0.0 110.796 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.66 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 83.6 m-20 -59.32 -119.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.805 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -61.35 -171.16 0.04 OUTLIER Pre-proline 0 N--CA 1.454 -0.269 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 176.564 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.806 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.2 Cg_endo -70.89 64.21 2.46 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 120.72 1.293 . . . . 0.0 112.163 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.013 HD12 HD22 ' A' ' 17' ' ' LEU . 50.2 mm 109.0 66.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.674 ' HB2' ' CB ' ' A' ' 29' ' ' GLU . 7.3 m-20 -65.42 65.85 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.881 -0.512 . . . . 0.0 111.449 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.633 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 51.4 p 57.48 158.97 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.737 ' O ' ' HB2' ' A' ' 31' ' ' MET . 51.5 Cg_exo -50.06 -33.33 34.43 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.344 1.362 . . . . 0.0 112.819 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -51.29 -57.32 9.16 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.64 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.674 ' CB ' ' HB2' ' A' ' 25' ' ' ASN . 45.7 tp10 -75.73 -58.53 3.23 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.807 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.5 pp -50.1 -40.16 44.92 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.771 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 29.9 ttm -63.53 -35.08 79.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.33 -30.91 69.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.303 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . . . -65.34 -38.87 91.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.593 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.785 ' CG ' HG22 ' A' ' 40' ' ' THR . 6.4 mp -39.53 134.55 1.24 Allowed Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.725 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -47.7 -29.8 11.59 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.393 2.729 . . . . 0.0 112.9 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.671 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 7.4 t-20 -72.01 -26.36 62.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.528 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . 103.9 -64.65 0.36 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.958 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 60.4 Cg_endo -83.93 -38.64 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.754 2.302 . . . . 0.0 113.722 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.622 ' HB3' ' SD ' ' A' ' 31' ' ' MET . 53.5 p-10 174.21 71.12 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.785 HG22 ' CG ' ' A' ' 34' ' ' LEU . 6.2 t -59.22 140.71 55.69 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.661 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 3.1 t -114.99 124.21 51.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.033 0.444 . . . . 0.0 111.295 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.717 ' HB2' HG23 ' A' ' 9' ' ' ILE . 36.0 m -75.45 59.12 1.06 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.776 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.449 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 22.3 pttp -75.17 140.5 43.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.679 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.6 m -132.46 124.47 28.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.258 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.506 ' O ' ' OD1' ' A' ' 46' ' ' ASP . . . 67.09 -69.71 0.2 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.705 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 45' ' ' GLY . 67.8 m-20 -140.98 -46.04 0.39 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.766 0.317 . . . . 0.0 111.475 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.716 HG12 HD21 ' A' ' 49' ' ' LEU . 48.2 t -66.79 130.23 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.938 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.803 ' C ' HD22 ' A' ' 49' ' ' LEU . 55.3 mt-10 -113.14 133.24 55.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.379 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.803 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.6 mm? -127.88 130.15 48.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.63 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.824 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 19.1 ptpt -156.28 -165.87 2.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.582 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.771 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -78.61 -41.87 30.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.481 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.3 t -67.26 -55.61 13.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.709 0.29 . . . . 0.0 111.443 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 35.6 m-20 -69.39 -44.4 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.793 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 50' ' ' LYS . . . -92.73 -51.63 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -53.53 -22.25 16.15 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.474 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -43.35 -31.98 0.75 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 117.114 0.457 . . . . 0.0 111.203 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 54' ' ' ALA . 35.3 m -80.2 27.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.653 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 19.1 mt -132.48 109.13 9.58 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 p -68.08 156.59 37.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.825 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.23 -37.99 17.38 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.077 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -52.56 -26.22 12.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.63 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.565 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -72.24 3.07 4.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.295 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.633 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.5 OUTLIER -39.05 -61.12 1.0 Allowed Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.334 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.87 77.08 3.16 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.483 2.122 . . . . 0.0 111.847 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.882 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -76.63 142.53 40.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.096 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 58.1 mtpt -68.68 66.7 0.13 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.377 0.608 . . . . 0.0 110.463 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.806 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 24.2 m 61.05 161.14 0.06 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.085 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.602 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.54 -30.22 19.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.499 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 22.1 pt-20 -59.17 -45.72 90.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.483 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.533 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -70.47 -34.39 72.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.247 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.982 HG21 HG21 ' A' ' 24' ' ' ILE . 67.2 t -63.61 -41.98 94.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.015 0.436 . . . . 0.0 110.09 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.871 ' HB1' ' HG2' ' A' ' 10' ' ' ARG . . . -56.66 -50.18 72.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.785 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -67.8 -47.31 69.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.128 0.489 . . . . 0.0 110.746 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.429 HG22 HD21 ' A' ' 58' ' ' LEU . 90.8 m -54.71 -48.97 71.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.857 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.813 HG23 ' HB1' ' A' ' 54' ' ' ALA . 67.0 mt -60.95 -56.11 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.559 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 72' ' ' ALA . 15.7 m -58.82 -40.49 80.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -62.88 -55.17 28.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.375 . . . . 0.0 111.715 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' CB ' HG21 ' A' ' 57' ' ' VAL . 67.3 mttm -72.76 -40.16 66.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.253 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.01 -29.97 69.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.66 -56.16 0.4 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.88 -1.152 . . . . 0.0 113.41 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.459 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 22.9 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.401 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.6 -0.2 . . . . 0.0 112.6 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 47.5 t -60.91 131.6 51.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 110.943 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -67.45 138.88 56.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.987 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mtp 63.02 45.63 5.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.173 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 3' ' ' MET . 77.2 tttt -60.98 -63.19 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.656 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.422 ' O ' ' O ' ' A' ' 2' ' ' LYS . 26.5 mmt 57.46 132.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.448 0.642 . . . . 0.0 112.003 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.62 -144.71 10.22 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.049 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.734 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p -77.4 -5.63 7.93 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 C-N-CA 121.533 -0.067 . . . . 0.0 111.012 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.654 ' HE2' HG21 ' A' ' 76' ' ' VAL . 12.3 tmtt? -45.35 -51.67 10.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.9 -25.94 48.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.115 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.734 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 33.1 m-20 -67.86 -52.57 35.12 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.455 HG13 HG22 ' A' ' 5' ' ' VAL . 12.8 mt -65.7 -43.01 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.888 ' NH2' HG21 ' A' ' 13' ' ' ILE . 2.8 tpt180 -59.42 -29.07 67.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.62 -43.32 99.42 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -64.32 -29.01 70.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.334 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.888 HG21 ' NH2' ' A' ' 10' ' ' ARG . 63.6 mt -74.37 -45.9 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.821 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.452 ' HA ' HD13 ' A' ' 14' ' ' ILE . 4.6 mm -56.42 -50.3 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.776 0.322 . . . . 0.0 110.329 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.47 -36.34 93.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.348 -0.93 . . . . 0.0 110.892 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HB1' HD23 ' A' ' 34' ' ' LEU . . . -65.07 -27.22 68.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.222 -0.489 . . . . 0.0 111.251 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.013 HD22 ' CD1' ' A' ' 24' ' ' ILE . 49.9 mt -84.13 -26.22 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.72 61.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.381 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 174.14 35.02 0.04 OUTLIER Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.826 ' HB2' ' HB2' ' A' ' 33' ' ' ALA . . . -106.0 -175.97 2.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 110.99 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.594 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 53.4 m-20 -52.72 -66.97 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.758 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -116.86 -174.33 0.27 Allowed Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.519 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.825 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.7 Cg_endo -68.86 59.09 1.18 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-N 120.512 1.218 . . . . 0.0 111.987 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.013 ' CD1' HD22 ' A' ' 17' ' ' LEU . 24.7 mm 110.76 61.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.645 ' CB ' ' HB3' ' A' ' 29' ' ' GLU . 2.7 m120 -64.14 64.42 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.595 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.2 p 58.66 150.73 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.634 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 72.3 Cg_exo -46.77 -31.68 11.05 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.639 1.559 . . . . 0.0 112.984 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -55.54 -57.68 10.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.614 0.721 . . . . 0.0 110.338 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.645 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.0 tp10 -74.42 -57.08 4.17 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.557 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.982 HD13 HD21 ' A' ' 17' ' ' LEU . 3.3 pp -49.96 -36.54 28.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.663 ' HG2' ' HB3' ' A' ' 51' ' ' ALA . 55.2 mtm -64.04 -37.59 87.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.98 -24.55 65.16 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.477 0.656 . . . . 0.0 109.771 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.826 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . . . -63.88 -50.83 67.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.653 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 30' ' ' LEU . 6.1 mp -43.25 139.18 2.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.361 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -47.95 -32.74 18.55 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.842 3.028 . . . . 0.0 113.151 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.558 ' CB ' ' HB ' ' A' ' 40' ' ' THR . 4.0 t-20 -72.16 -25.49 61.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.864 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.01 -76.69 0.24 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.884 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 95.7 Cg_endo -83.23 35.89 0.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.419 2.079 . . . . 0.0 112.053 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.534 ' HB2' ' HG2' ' A' ' 31' ' ' MET . 13.8 t70 65.66 99.81 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.479 0.656 . . . . 0.0 111.822 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.558 ' HB ' ' CB ' ' A' ' 36' ' ' ASN . 2.7 t -64.95 141.44 58.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.905 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.511 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 7.3 m -82.74 115.09 21.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.433 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.401 ' O ' HG23 ' A' ' 9' ' ' ILE . 32.3 m -89.2 50.56 1.96 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.018 0.437 . . . . 0.0 110.383 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.452 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.5 pttm -75.41 147.63 39.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.975 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.2 m -137.63 127.84 26.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.031 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.57 -58.39 0.47 Allowed Glycine 0 CA--C 1.519 0.344 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.046 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -159.47 -42.17 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 110.728 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.727 HG12 HD21 ' A' ' 49' ' ' LEU . 45.1 t -66.43 134.59 29.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.985 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.846 ' C ' HD22 ' A' ' 49' ' ' LEU . 51.0 mt-10 -119.04 134.09 55.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.861 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.846 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.9 mm? -135.24 137.26 42.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.672 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 63.6 pttt -175.87 155.6 1.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.645 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.663 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.62 -39.39 16.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.05 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.6 t -63.53 -49.85 71.89 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.437 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.19 -53.86 11.37 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.781 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -92.23 -46.51 7.69 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.93 -29.54 2.12 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.089 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -45.27 -30.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.507 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 54' ' ' ALA . 33.2 m -77.16 27.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.649 HD13 ' CE2' ' A' ' 65' ' ' PHE . 43.2 mt -133.18 117.24 17.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.889 0.376 . . . . 0.0 110.096 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.5 p -74.55 159.52 32.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.161 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.89 -37.58 31.94 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.085 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -50.97 -29.73 13.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.104 0.478 . . . . 0.0 110.06 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.56 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.5 m-20 -72.64 3.84 4.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.533 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.595 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.5 t80 -39.84 -51.8 5.33 Favored Pre-proline 0 C--O 1.226 -0.147 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 81.4 Cg_endo -87.74 77.31 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.832 2.355 . . . . 0.0 112.131 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.891 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.18 143.46 39.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.215 0.531 . . . . 0.0 111.87 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -68.28 70.8 0.17 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.742 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.825 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 21.7 m 57.04 163.66 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.203 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.597 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.89 -31.97 30.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.201 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -57.26 -49.17 76.9 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.547 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -72.49 -34.69 67.84 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.084 -179.475 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.001 ' CG2' HG21 ' A' ' 24' ' ' ILE . 62.1 t -65.19 -37.02 79.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.817 0.341 . . . . 0.0 111.145 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.664 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -65.35 -55.4 18.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.973 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 m-20 -66.32 -44.85 82.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.66 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.3 m -53.92 -47.65 70.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.76 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.564 HD12 HH22 ' A' ' 10' ' ' ARG . 76.8 mt -62.98 -53.13 50.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.522 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.71 HG13 ' HD3' ' A' ' 10' ' ' ARG . 1.8 m -53.99 -39.33 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -60.07 -51.92 67.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 0.0 111.753 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.505 ' HB2' HG21 ' A' ' 57' ' ' VAL . 47.7 mtpt -74.88 -40.11 61.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.757 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.81 -30.01 70.09 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.93 -54.81 0.4 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.553 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.678 HD12 HG12 ' A' ' 76' ' ' VAL . 8.7 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.099 -178.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 60.8 m -167.3 137.06 2.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.818 0.342 . . . . 0.0 110.797 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 63.54 -121.66 0.54 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.293 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt 60.6 44.06 12.01 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 122.115 -0.366 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -178.97 134.66 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 ttt -177.7 134.23 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.977 0.418 . . . . 0.0 111.021 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.89 -137.79 3.87 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.142 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.741 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.7 p -75.51 -5.36 7.09 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 O-C-N 122.967 -0.137 . . . . 0.0 111.161 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.691 ' HE2' HG21 ' A' ' 76' ' ' VAL . 12.8 tmtt? -45.34 -51.14 11.49 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.638 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -77.78 -27.97 50.39 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.066 177.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.741 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.6 m-20 -65.59 -52.38 52.58 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.479 HG13 HG22 ' A' ' 5' ' ' VAL . 16.7 mt -65.41 -43.28 94.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.893 ' NH2' HG21 ' A' ' 13' ' ' ILE . 1.1 tpt180 -60.16 -25.73 65.77 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.42 -45.18 87.69 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 178.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -64.39 -31.58 72.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.768 -0.716 . . . . 0.0 109.774 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.893 HG21 ' NH2' ' A' ' 10' ' ' ARG . 73.6 mt -73.88 -45.24 50.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.964 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HA ' HD13 ' A' ' 14' ' ' ILE . 4.0 mm -55.54 -53.33 37.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.784 0.326 . . . . 0.0 110.305 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.09 -34.59 88.53 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.739 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -65.46 -26.76 68.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.052 -0.574 . . . . 0.0 111.189 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.0 HD22 HD12 ' A' ' 24' ' ' ILE . 51.5 mt -80.21 -29.53 38.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.434 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.2 134.38 56.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.002 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.1 -32.25 6.06 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.898 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.714 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.44 -174.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.031 0.443 . . . . 0.0 111.592 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.601 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.5 m-20 -60.23 -120.31 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.806 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -62.14 -169.59 0.03 OUTLIER Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.597 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.828 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 60.3 Cg_endo -71.61 62.08 2.91 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 CA-C-N 120.888 1.353 . . . . 0.0 112.305 178.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.0 HD12 HD22 ' A' ' 17' ' ' LEU . 48.5 mm 110.59 65.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 177.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.713 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 8.3 m-20 -65.68 66.26 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.976 -0.452 . . . . 0.0 111.328 178.031 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.551 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 53.9 p 59.39 156.02 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.057 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.603 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 64.9 Cg_exo -49.17 -33.73 28.55 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.45 1.433 . . . . 0.0 112.948 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.51 -54.46 36.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.04 0.448 . . . . 0.0 110.697 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.713 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 17.4 tp10 -75.93 -57.57 3.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.918 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.9 pp -50.03 -39.79 42.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.817 ' HA ' HD13 ' A' ' 34' ' ' LEU . 72.0 mtm -66.67 -32.97 74.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.423 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.51 -28.35 68.49 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 121.215 0.531 . . . . 0.0 110.253 179.018 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -70.28 -46.9 63.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.94 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.817 HD13 ' HA ' ' A' ' 31' ' ' MET . 8.9 mp -33.73 139.39 0.27 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 112.186 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -47.62 -42.95 29.1 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 124.014 3.142 . . . . 0.0 114.417 -178.045 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.492 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 15.7 p-10 -72.58 -27.39 62.16 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.486 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.62 -70.54 0.25 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.797 -0.715 . . . . 0.0 112.061 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.492 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 88.8 Cg_endo -80.22 49.5 3.23 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.746 2.298 . . . . 0.0 112.533 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.67 ' HA ' HD22 ' A' ' 34' ' ' LEU . 2.3 p30 49.25 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.682 HG22 HD23 ' A' ' 34' ' ' LEU . 1.7 t -56.89 134.06 55.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.149 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.499 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 16.8 m -81.58 118.55 22.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.265 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 61.7 m -92.34 43.79 1.14 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.256 0.55 . . . . 0.0 109.553 178.66 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.492 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 23.9 pttm -75.54 143.57 42.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.919 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.0 m -133.87 122.3 23.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.544 178.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.28 -132.45 30.4 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.185 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -79.24 -26.91 42.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.738 HG12 ' CD2' ' A' ' 49' ' ' LEU . 33.1 t -85.24 138.48 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.882 ' C ' HD22 ' A' ' 49' ' ' LEU . 7.5 mp0 -126.77 135.11 50.63 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.293 179.24 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -141.11 140.81 34.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.094 0.473 . . . . 0.0 111.347 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 61.7 pttt -178.21 152.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.369 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.616 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.57 -30.74 3.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.005 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.3 t -69.57 -55.89 8.86 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.644 -179.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 43.2 m-20 -72.41 -51.9 18.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.798 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -84.79 -45.57 12.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.1 -28.49 1.92 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.207 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 18.1 pt20 -43.7 -31.82 0.87 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.038 0.447 . . . . 0.0 111.329 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.8 m -77.09 27.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.667 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.563 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 43.4 mt -132.3 108.37 9.17 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.236 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.3 p -66.97 155.95 37.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.849 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.63 -37.69 13.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.229 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.67 -26.46 13.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.606 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.641 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -73.21 3.17 6.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.37 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.551 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.0 OUTLIER -41.13 -61.91 1.19 Allowed Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 117.682 0.219 . . . . 0.0 111.35 -179.337 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 63.3 Cg_endo -72.67 73.95 2.83 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.441 2.094 . . . . 0.0 111.963 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.907 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -76.77 141.58 40.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.431 -179.44 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HB3' ' CG ' ' A' ' 70' ' ' GLU . 41.4 ttmt -67.8 69.07 0.11 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.398 0.618 . . . . 0.0 110.706 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.828 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 31.5 m 59.37 161.42 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.962 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.712 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.61 -29.81 18.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.757 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.469 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.0 pt-20 -58.63 -46.03 87.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.532 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.533 ' CG ' ' HB3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -73.96 -35.48 64.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.891 -179.562 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.962 HG21 HG21 ' A' ' 24' ' ' ILE . 45.7 t -62.87 -40.8 90.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.968 0.413 . . . . 0.0 110.417 179.433 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.836 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -61.73 -55.67 27.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.168 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.498 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.8 m-20 -64.11 -43.91 93.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.43 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.8 m -53.79 -46.95 71.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.926 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.553 HD12 ' NH2' ' A' ' 10' ' ' ARG . 81.0 mt -64.79 -49.95 77.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.735 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.691 HG21 ' HE2' ' A' ' 6' ' ' LYS . 1.3 m -55.77 -38.22 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.272 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -63.24 -52.78 60.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 0.0 111.396 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HB2' HG21 ' A' ' 57' ' ' VAL . 95.9 mttt -72.68 -41.77 64.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.999 -179.116 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.637 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.3 -29.87 69.57 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.15 -54.11 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.982 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.476 HD12 HG12 ' A' ' 76' ' ' VAL . 16.0 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.193 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 112.434 -0.267 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 53.7 m 60.52 54.25 3.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -51.42 130.4 27.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.179 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mmm -67.32 -33.66 75.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.143 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.413 ' HE2' ' CB ' ' A' ' 6' ' ' LYS . 28.3 tptp -144.22 141.21 29.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.466 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.475 ' O ' ' HG2' ' A' ' 3' ' ' MET . 49.5 ttp -160.07 38.58 0.18 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.806 0.336 . . . . 0.0 111.351 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.4 -38.65 1.02 Allowed Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.823 -0.703 . . . . 0.0 114.385 178.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.751 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.4 p -58.63 -6.21 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 CA-C-N 117.452 0.626 . . . . 0.0 112.276 -178.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.579 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 46.9 tttm -45.67 -51.07 12.87 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.617 -0.833 . . . . 0.0 108.947 -179.325 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.78 -25.99 49.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.057 177.758 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.751 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.6 m-20 -68.18 -52.56 33.02 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.543 HD13 HD23 ' A' ' 49' ' ' LEU . 14.4 mt -66.02 -42.4 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.519 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.935 ' NH2' HG21 ' A' ' 13' ' ' ILE . 3.0 tpt180 -59.84 -27.18 66.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.7 177.407 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.02 -44.37 95.99 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 178.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -64.1 -27.68 69.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.439 177.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.935 HG21 ' NH2' ' A' ' 10' ' ' ARG . 64.4 mt -74.8 -50.25 26.32 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.86 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 14' ' ' ILE . 3.0 mm -53.77 -49.14 59.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.0 -36.67 93.79 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 178.083 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.839 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -63.63 -27.99 69.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.857 179.034 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.965 HD22 HD12 ' A' ' 24' ' ' ILE . 71.6 mt -78.8 -29.46 44.88 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.503 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.32 136.5 43.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.114 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.12 -33.5 6.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.814 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.741 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.8 -179.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 111.467 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.593 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 71.3 m-20 -58.25 -122.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.249 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.726 ' CG ' ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -62.66 -174.99 0.11 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 177.071 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.881 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 48.9 Cg_endo -66.55 61.78 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 CA-C-N 120.103 1.072 . . . . 0.0 112.723 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.998 HG21 HG21 ' A' ' 71' ' ' VAL . 36.6 mm 108.24 64.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 177.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.674 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.5 m120 -63.9 65.14 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.303 -0.248 . . . . 0.0 111.55 178.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.629 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 58.2 p 59.5 151.79 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.636 ' O ' ' HB2' ' A' ' 31' ' ' MET . 73.7 Cg_exo -46.88 -29.69 8.56 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.53 1.486 . . . . 0.0 112.642 -179.102 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.04 -57.12 13.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.511 0.672 . . . . 0.0 110.565 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.674 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 17.1 tp10 -73.39 -57.23 4.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.017 -179.004 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.929 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.9 pp -50.89 -38.21 48.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.636 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 61.0 mtm -67.13 -31.99 72.82 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.271 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.98 -29.69 67.96 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.65 179.266 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.741 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -71.48 -38.74 71.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.43 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.839 ' HG ' ' HB1' ' A' ' 16' ' ' ALA . 10.9 mp -38.37 143.77 0.41 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 121.158 0.504 . . . . 0.0 112.093 -178.614 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -47.68 -40.35 30.88 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 124.013 3.142 . . . . 0.0 114.361 -178.048 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.461 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -71.84 -16.66 62.16 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.845 -178.904 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' N ' HD22 ' A' ' 36' ' ' ASN . . . 108.11 -67.28 0.23 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.286 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.596 ' O ' ' HB3' ' A' ' 31' ' ' MET . 64.0 Cg_endo -77.88 -54.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.209 1.939 . . . . 0.0 112.644 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.504 ' HA ' HD22 ' A' ' 34' ' ' LEU . 4.5 p-10 174.53 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.893 0.477 . . . . 0.0 110.293 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.557 HG22 HD23 ' A' ' 34' ' ' LEU . 9.4 t -71.17 135.2 47.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.863 0.363 . . . . 0.0 111.337 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.481 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 10.9 m -82.38 126.37 32.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.357 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.9 m -93.61 47.63 1.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.04 0.448 . . . . 0.0 110.217 178.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.3 pttm -75.26 145.48 41.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.156 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.0 m -137.28 127.33 25.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.935 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.64 -58.3 0.49 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.971 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -159.48 -42.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 110.72 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.769 HG12 HD21 ' A' ' 49' ' ' LEU . 38.8 t -66.7 133.26 31.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.892 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.867 ' C ' HD22 ' A' ' 49' ' ' LEU . 26.5 mt-10 -116.01 135.06 54.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.866 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.867 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.9 mm? -138.64 137.18 36.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.183 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.481 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 61.6 pttt -177.66 157.92 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.735 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HB3' ' CG ' ' A' ' 31' ' ' MET . . . -47.86 -37.81 14.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.937 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.4 t -61.77 -51.96 66.16 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.376 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -72.41 -54.22 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.438 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.894 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -91.51 -44.42 9.1 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.538 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.87 -28.44 1.73 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.938 -179.307 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -44.3 -31.49 1.04 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.007 0.432 . . . . 0.0 110.813 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 54' ' ' ALA . 35.9 m -76.96 27.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.352 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.696 HD23 ' O ' ' A' ' 57' ' ' VAL . 30.8 mt -134.35 92.06 2.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.913 0.387 . . . . 0.0 110.354 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.9 p -55.7 155.92 5.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.83 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.17 -36.62 8.85 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.384 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -50.81 -30.26 13.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.422 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.572 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 53.3 m-20 -72.71 3.81 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.747 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.629 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.0 t80 -38.0 -52.07 3.0 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.481 0.182 . . . . 0.0 111.396 -178.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 80.0 Cg_endo -86.39 78.42 2.09 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.681 2.254 . . . . 0.0 111.83 179.155 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.964 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -76.69 143.35 40.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.005 0.431 . . . . 0.0 111.741 -179.37 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.509 ' HB2' ' CD ' ' A' ' 70' ' ' GLU . 14.4 mmmm -67.17 70.68 0.1 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.634 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.881 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 47.5 m 58.73 158.74 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.69 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.794 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.83 -28.04 14.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.922 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.452 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.8 pt-20 -59.53 -47.39 85.71 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.419 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.509 ' CD ' ' HB2' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -72.04 -37.32 69.74 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.758 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.998 HG21 HG21 ' A' ' 24' ' ' ILE . 43.6 t -59.76 -36.28 65.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.98 0.419 . . . . 0.0 110.799 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -67.94 -57.83 5.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.442 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 m-20 -63.83 -42.29 97.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.701 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.8 m -54.01 -52.63 60.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.744 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.645 HD12 HH22 ' A' ' 10' ' ' ARG . 84.5 mt -60.03 -50.45 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.583 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.72 HG13 ' HD3' ' A' ' 10' ' ' ARG . 2.8 m -58.43 -39.75 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.32 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -52.96 -56.08 18.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.33 . . . . 0.0 110.936 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.405 ' NZ ' ' HB ' ' A' ' 57' ' ' VAL . 51.1 mtpt -75.08 -39.1 61.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.163 0.506 . . . . 0.0 110.886 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.663 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -68.87 32.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -179.164 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.97 -53.36 3.96 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.566 179.062 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.7 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.157 -178.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 84.0 p 52.18 40.55 29.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.815 0.341 . . . . 0.0 111.121 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -14.73 63.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.404 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt -57.64 136.23 56.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.884 0.373 . . . . 0.0 111.175 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -123.24 132.08 53.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.583 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.9 mtt -63.78 125.03 23.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.952 0.406 . . . . 0.0 111.053 -179.745 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.19 -34.32 51.91 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.362 179.601 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.742 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.5 p -65.24 -5.17 2.33 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 40.7 tttm -44.94 -51.7 9.48 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.105 -178.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -77.84 -27.19 49.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.077 177.685 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.742 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.7 m-20 -67.22 -52.29 42.89 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.791 HD11 ' HB2' ' A' ' 44' ' ' SER . 14.0 mt -63.81 -43.44 97.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.94 ' HD2' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -60.46 -26.48 66.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.582 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.2 -42.04 99.48 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 177.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 84.2 mt-30 -64.33 -28.76 69.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.362 177.48 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.824 HD12 ' NE ' ' A' ' 10' ' ' ARG . 67.5 mt -74.38 -46.06 44.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.234 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 72' ' ' ALA . 9.4 mm -56.99 -53.7 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.636 0.255 . . . . 0.0 110.525 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.47 -36.71 92.97 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.628 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -63.94 -27.3 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.08 -0.56 . . . . 0.0 110.92 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.015 HD22 HD12 ' A' ' 24' ' ' ILE . 61.6 mt -79.64 -29.45 40.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.448 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.96 136.66 57.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.002 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.07 -33.11 6.35 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.774 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.698 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.79 -179.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.807 0.337 . . . . 0.0 111.493 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.623 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 73.1 m-20 -59.98 -121.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.739 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -58.99 177.35 0.25 Allowed Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 176.44 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.792 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 43.5 Cg_endo -64.26 67.63 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 119.897 0.999 . . . . 0.0 112.105 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.015 HD12 HD22 ' A' ' 17' ' ' LEU . 44.4 mm 105.89 61.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 178.249 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.623 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.6 m120 -64.1 65.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 178.561 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.559 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 63.5 p 57.37 156.5 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.608 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 54.2 Cg_exo -50.43 -32.26 33.55 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.438 1.425 . . . . 0.0 112.829 -179.011 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -53.49 -57.35 10.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.452 0.644 . . . . 0.0 110.3 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -76.02 -57.98 3.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -179.272 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.861 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -50.56 -43.72 56.39 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.738 ' N ' HD12 ' A' ' 30' ' ' LEU . 30.7 ttm -65.52 -30.69 71.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.534 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.95 -29.69 66.88 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.597 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.698 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -67.76 -40.32 84.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.087 -179.414 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.733 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.1 mp -25.34 135.43 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.568 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.001 -179.086 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.13 26.23 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.588 2.859 . . . . 0.0 115.279 -178.182 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.52 HD21 ' C ' ' A' ' 39' ' ' ASP . 13.2 p-10 -129.48 -27.46 2.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 118.351 0.523 . . . . 0.0 111.927 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.45 -71.34 0.28 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.732 -179.437 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 85.2 Cg_endo -83.86 41.37 1.03 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.699 2.266 . . . . 0.0 113.515 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.52 ' C ' HD21 ' A' ' 36' ' ' ASN . 1.2 m-20 61.74 94.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 178.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.651 HG22 HD23 ' A' ' 34' ' ' LEU . 5.7 t -70.05 141.62 52.82 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.767 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.54 HG23 ' HD3' ' A' ' 50' ' ' LYS . 32.2 m -100.29 121.96 42.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.902 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -92.79 46.57 1.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 110.014 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.441 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 20.8 ptmt -75.53 125.72 29.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.938 -179.168 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.791 ' HB2' HD11 ' A' ' 9' ' ' ILE . 64.7 m -107.62 120.39 42.08 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.197 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.68 -127.36 39.04 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.136 -1.031 . . . . 0.0 111.536 -178.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -79.67 -40.2 29.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.743 0.306 . . . . 0.0 111.436 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.676 HG12 ' CD2' ' A' ' 49' ' ' LEU . 28.5 t -68.5 141.48 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.636 -179.202 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.866 ' C ' HD22 ' A' ' 49' ' ' LEU . 38.4 mt-10 -125.84 134.11 51.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.8 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.866 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.3 mm? -138.5 138.95 38.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.05 0.452 . . . . 0.0 110.968 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.54 ' HD3' HG23 ' A' ' 41' ' ' THR . 60.7 pttt -177.46 153.64 0.93 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.446 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.576 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.49 -29.24 2.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.809 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.417 ' HA ' ' HE1' ' A' ' 31' ' ' MET . 44.4 t -71.18 -56.06 6.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.663 0.268 . . . . 0.0 111.585 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -72.28 -54.42 9.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.35 . . . . 0.0 111.922 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.692 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -78.34 -48.08 16.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.936 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.39 -26.91 5.31 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.37 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -40.21 -35.97 0.46 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.555 0.693 . . . . 0.0 111.024 179.354 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 54' ' ' ALA . 11.0 m -79.14 27.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.021 -177.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.576 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 32.7 mt -130.21 109.9 11.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.934 0.397 . . . . 0.0 110.057 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.6 p -70.81 157.24 38.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.885 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.81 -36.89 12.52 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.754 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -51.32 -29.45 15.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.163 179.197 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.3 m-20 -72.23 3.34 4.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.597 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.559 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.0 t80 -38.37 -51.71 3.4 Favored Pre-proline 0 C--O 1.227 -0.09 0 N-CA-C 111.308 0.114 . . . . 0.0 111.308 -178.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 87.0 Cg_endo -88.08 81.45 1.03 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.837 2.358 . . . . 0.0 112.046 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.748 ' CD2' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -76.93 141.8 40.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.875 -179.855 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.535 ' CA ' ' HG2' ' A' ' 70' ' ' GLU . 47.6 mmtm -68.53 66.54 0.12 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.531 0.682 . . . . 0.0 110.516 179.005 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.792 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 15.4 m 61.34 160.93 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.197 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.652 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.46 -31.09 22.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.889 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.6 pt-20 -59.86 -47.01 87.47 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.331 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.535 ' HG2' ' CA ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -67.61 -33.38 74.88 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.36 -179.77 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.827 ' CG2' HG21 ' A' ' 24' ' ' ILE . 94.5 t -59.14 -47.08 91.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.922 0.391 . . . . 0.0 110.394 179.223 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.756 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -56.71 -55.11 38.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.311 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.47 -36.36 83.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.585 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.4 m -65.95 -49.35 68.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.026 -179.211 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.743 HG22 HH12 ' A' ' 10' ' ' ARG . 74.1 mt -59.88 -49.7 82.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.705 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.94 HG13 ' HD2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -57.49 -40.24 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.247 179.861 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -62.93 -54.7 34.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.876 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.512 ' HB2' HG21 ' A' ' 57' ' ' VAL . 96.5 mttt -74.06 -40.33 62.88 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.97 -29.91 69.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.186 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.12 -51.5 0.52 Allowed Glycine 0 CA--C 1.509 -0.342 0 C-N-CA 119.817 -1.182 . . . . 0.0 113.16 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.591 HD12 HG12 ' A' ' 76' ' ' VAL . 16.8 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.349 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 51.6 m 60.13 46.82 10.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.906 0.384 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -176.11 -44.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt -79.21 50.29 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.475 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt 69.29 -120.84 0.14 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.7 mtt -87.5 -35.11 18.38 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 122.035 -0.416 . . . . 0.0 110.804 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.99 -43.52 2.85 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.861 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.728 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.1 p -69.89 -6.08 6.11 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.894 0 CA-C-N 116.734 0.267 . . . . 0.0 111.411 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.886 ' HE2' HG21 ' A' ' 76' ' ' VAL . 11.2 tmtt? -45.37 -49.03 13.37 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.28 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -77.37 -30.31 53.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.043 177.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.728 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 71.9 m-20 -66.44 -52.32 47.63 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.568 HG22 ' NH2' ' A' ' 10' ' ' ARG . 17.7 mt -62.26 -51.07 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.178 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.936 ' CD ' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -57.96 -25.58 61.18 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.369 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.42 -38.58 94.99 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 177.192 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -68.82 -35.26 76.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.383 -0.908 . . . . 0.0 110.569 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.594 HD11 ' NH2' ' A' ' 10' ' ' ARG . 11.7 mt -69.91 -43.75 79.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.442 ' HA ' HD13 ' A' ' 14' ' ' ILE . 13.4 mm -54.51 -52.46 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.717 0.294 . . . . 0.0 110.612 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.01 -37.25 94.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.935 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.52 -25.02 67.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.22 -0.49 . . . . 0.0 111.365 179.373 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.069 HD22 HD12 ' A' ' 24' ' ' ILE . 33.4 mt -85.82 -29.37 23.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.978 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.64 81.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.719 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.83 -35.8 0.13 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.921 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.717 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -53.03 -173.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.182 0.515 . . . . 0.0 111.904 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.588 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.7 OUTLIER -60.25 -119.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.018 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.771 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.97 179.79 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 177.033 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HD2' ' HB2' ' A' ' 22' ' ' PHE . 47.9 Cg_endo -65.23 65.34 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 120.801 1.001 . . . . 0.0 112.358 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.069 HD12 HD22 ' A' ' 17' ' ' LEU . 28.6 mm 107.78 62.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 177.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.601 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.7 m120 -63.98 64.16 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.327 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 15.7 p 59.1 152.65 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.43 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.647 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 77.8 Cg_exo -48.0 -30.47 13.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.46 1.44 . . . . 0.0 112.707 -179.245 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -54.72 -57.49 11.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.492 0.663 . . . . 0.0 110.289 179.062 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.601 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.3 tp10 -76.11 -57.85 3.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.054 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.861 HD13 HD21 ' A' ' 17' ' ' LEU . 3.5 pp -50.29 -45.53 54.53 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.694 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.679 ' N ' HD12 ' A' ' 30' ' ' LEU . 33.8 ttm -66.05 -29.78 70.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.56 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -69.08 -30.12 68.37 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -72.73 -38.92 67.28 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.61 HD23 HG22 ' A' ' 40' ' ' THR . 7.1 mp -27.92 128.12 0.21 Allowed Pre-proline 0 N--CA 1.47 0.563 0 CA-C-O 120.949 0.404 . . . . 0.0 111.79 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.98 -25.32 69.62 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.569 2.846 . . . . 0.0 114.071 -178.396 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.663 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 6.8 t-20 -72.04 -27.43 62.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.06 -74.23 0.45 Allowed Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.925 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 80.7 Cg_endo -84.5 47.14 2.09 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.833 2.355 . . . . 0.0 112.512 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.68 95.28 0.05 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.553 179.451 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' ' 36' ' ' ASN . 6.6 t -65.31 141.15 58.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.22 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.7 m -105.92 115.8 30.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -89.46 44.03 1.18 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.098 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.3 pttp -79.68 124.05 28.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.255 -179.043 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 61.2 m -101.38 122.13 43.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.249 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.15 -129.48 37.77 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.174 -1.013 . . . . 0.0 111.762 -178.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 47' ' ' VAL . 40.6 p-10 -78.97 -38.88 35.8 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.521 HG12 ' CD2' ' A' ' 49' ' ' LEU . 49.0 t -66.97 142.38 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.637 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.825 ' C ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -137.48 124.94 22.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.288 0.566 . . . . 0.0 111.813 179.615 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.825 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.8 mm? -136.6 141.07 43.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.366 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HE3' ' HB3' ' A' ' 52' ' ' SER . 61.6 pttt -173.4 -168.81 0.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.937 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.534 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -65.58 -46.14 80.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.867 0.365 . . . . 0.0 111.576 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.456 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.1 t -69.99 -44.45 69.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.69 0.281 . . . . 0.0 111.495 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -67.34 -53.05 32.98 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.822 0.344 . . . . 0.0 111.906 -179.534 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.905 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -96.2 -44.05 7.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.468 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.64 -30.67 2.28 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.425 -178.757 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -46.93 -33.96 5.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.105 0.479 . . . . 0.0 110.987 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 54' ' ' ALA . 29.1 m -65.6 -31.1 52.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.548 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.708 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 22.6 mt -66.66 125.39 25.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.773 0.32 . . . . 0.0 110.639 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.8 p -75.63 155.79 35.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.289 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.18 -42.09 60.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.332 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.63 -23.25 26.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.963 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.654 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 14.5 m-20 -67.89 3.16 1.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.6 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -41.03 -56.04 4.39 Favored Pre-proline 0 C--O 1.226 -0.184 0 CA-C-N 117.837 0.289 . . . . 0.0 111.673 -178.949 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 2.0 Cg_endo -80.33 76.92 4.27 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.897 2.398 . . . . 0.0 112.017 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.869 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -77.16 142.0 39.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.488 -179.752 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.504 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 38.4 mtmm -67.89 70.5 0.14 Allowed 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.455 0.645 . . . . 0.0 110.419 178.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.756 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 28.9 m 58.43 161.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.162 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.681 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.67 -26.85 9.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.888 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.9 pt-20 -59.2 -50.46 73.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.652 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.504 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -72.65 -32.26 65.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.976 -179.418 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.005 HG21 HG21 ' A' ' 24' ' ' ILE . 57.9 t -61.98 -40.82 88.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.724 0.297 . . . . 0.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.689 ' HB1' ' CG ' ' A' ' 10' ' ' ARG . . . -65.0 -52.19 57.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 76' ' ' VAL . 32.1 m-20 -64.49 -37.44 87.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.011 0.434 . . . . 0.0 111.202 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.404 HG22 HD21 ' A' ' 58' ' ' LEU . 53.3 m -58.09 -41.93 84.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.442 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.905 HG23 ' CB ' ' A' ' 54' ' ' ALA . 63.5 mt -62.1 -53.72 44.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.134 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.936 HG13 ' CD ' ' A' ' 10' ' ' ARG . 2.5 m -56.94 -43.35 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -62.6 -53.72 50.44 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.476 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -74.0 -42.41 60.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.078 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.579 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.56 -30.08 69.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.568 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.25 -55.77 0.42 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 119.936 -1.125 . . . . 0.0 113.144 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.547 HD12 HG12 ' A' ' 76' ' ' VAL . 21.7 mt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.405 -178.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 53.4 m -61.28 136.65 58.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 111.002 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -175.76 -57.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.7 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt -85.55 135.94 33.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.533 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.527 ' HB3' ' NZ ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -175.38 134.41 0.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.012 -179.84 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.428 ' N ' ' HD2' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -176.9 125.11 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.049 179.731 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.16 -114.98 0.62 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.852 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.729 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.7 p -62.19 -5.19 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.559 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 79.8 tttt -44.83 -51.08 9.88 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.362 -0.836 . . . . 0.0 109.211 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.6 -29.5 51.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.956 177.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.729 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.0 m-20 -64.48 -52.13 59.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.13 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.606 HG23 ' HB2' ' A' ' 42' ' ' CYS . 12.1 mt -63.16 -46.41 95.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.886 ' NH2' HG21 ' A' ' 13' ' ' ILE . 1.8 tpt180 -57.19 -25.94 59.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.166 177.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.37 -48.34 70.11 Favored Glycine 0 CA--C 1.505 -0.531 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -62.63 -29.08 70.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.807 -0.696 . . . . 0.0 109.343 177.602 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.886 HG21 ' NH2' ' A' ' 10' ' ' ARG . 59.7 mt -70.4 -45.53 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.801 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HA ' HD13 ' A' ' 14' ' ' ILE . 7.1 mm -53.69 -48.54 60.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.66 -37.4 94.33 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.816 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.638 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -62.61 -27.81 69.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.918 0.39 . . . . 0.0 110.978 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.024 HD22 HD12 ' A' ' 24' ' ' ILE . 54.1 mt -80.69 -29.56 36.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.378 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.04 135.12 56.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.005 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.38 -33.17 5.67 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.723 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.686 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.29 -175.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.931 0.396 . . . . 0.0 111.509 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.26 -122.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.896 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.82 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -59.93 -173.42 0.05 OUTLIER Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 176.685 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.855 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 58.1 Cg_endo -69.33 61.52 1.5 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 CA-C-N 120.453 1.197 . . . . 0.0 112.592 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.024 HD12 HD22 ' A' ' 17' ' ' LEU . 43.4 mm 111.98 65.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 177.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.645 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 5.8 m-20 -64.31 65.68 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.085 -0.385 . . . . 0.0 111.534 178.132 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.571 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 54.0 p 58.89 155.01 0.09 OUTLIER Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 31' ' ' MET . 54.4 Cg_exo -49.29 -33.71 29.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.236 1.291 . . . . 0.0 112.887 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.04 -56.28 17.33 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.074 0.464 . . . . 0.0 110.787 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.645 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.5 tp10 -74.54 -57.72 3.75 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.296 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.938 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -49.79 -39.76 39.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.675 ' HA ' HD13 ' A' ' 34' ' ' LEU . 65.4 mtm -64.4 -34.85 79.12 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.767 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.77 -26.55 65.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.681 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.686 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -71.09 -43.24 68.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.667 -179.318 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.675 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.1 mp -37.33 138.91 0.55 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 112.274 -178.406 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -47.86 -31.61 15.68 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.869 3.046 . . . . 0.0 113.518 -178.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.593 ' CB ' ' HB ' ' A' ' 40' ' ' THR . 4.4 t-20 -72.16 -25.31 61.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.49 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.63 -73.49 0.21 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.566 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.602 ' O ' ' HB3' ' A' ' 31' ' ' MET . 59.6 Cg_endo -73.69 -54.54 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.967 1.778 . . . . 0.0 111.712 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.45 ' HA ' HD22 ' A' ' 34' ' ' LEU . 6.1 p-10 171.25 98.74 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.247 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.593 ' HB ' ' CB ' ' A' ' 36' ' ' ASN . 7.8 t -80.54 133.29 35.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.656 0.265 . . . . 0.0 110.884 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 2.6 t -97.91 123.31 41.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.034 0.445 . . . . 0.0 111.28 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.606 ' HB2' HG23 ' A' ' 9' ' ' ILE . 33.3 m -72.14 64.32 0.54 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.764 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 21.7 ptmt -74.97 148.53 39.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.667 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.0 m -155.56 129.55 8.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.303 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 46' ' ' ASP . . . 60.7 48.65 85.16 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.237 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 9.0 t70 79.97 -39.55 0.19 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 122.6 0.36 . . . . 0.0 111.94 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.685 HG12 ' CD2' ' A' ' 49' ' ' LEU . 44.5 t -66.51 134.87 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.789 0.328 . . . . 0.0 111.351 -179.626 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.843 ' C ' HD22 ' A' ' 49' ' ' LEU . 37.3 mt-10 -127.27 133.03 50.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.369 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.843 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.8 mm? -137.7 134.5 35.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.324 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 41' ' ' THR . 19.6 pttm -163.73 -164.67 0.93 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.613 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -78.1 -41.09 36.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.051 0.453 . . . . 0.0 111.317 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.439 ' HB3' ' HE2' ' A' ' 50' ' ' LYS . 39.1 t -63.87 -45.5 89.13 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.647 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.485 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 8.0 t70 -72.21 -52.79 14.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.352 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.851 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -96.34 -48.42 5.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -178.653 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -44.77 -28.37 1.66 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.73 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -43.89 -32.55 1.13 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.039 0.447 . . . . 0.0 111.563 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 54' ' ' ALA . 30.4 m -65.51 -33.15 61.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.886 -179.188 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.668 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 29.1 mt -70.3 124.42 24.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.437 179.486 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -80.8 -176.38 5.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.897 0.38 . . . . 0.0 111.551 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.77 79.54 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.711 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -53.33 -23.99 10.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.638 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -71.04 3.2 3.58 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.571 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.2 m-85 -42.58 -64.59 0.68 Allowed Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.584 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 59.5 Cg_endo -71.01 74.94 1.79 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.436 2.091 . . . . 0.0 111.949 179.271 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.874 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -77.04 141.61 40.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.833 -179.349 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.483 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 23.4 ttmm -67.22 70.37 0.1 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.804 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.855 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.7 m 58.19 162.35 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.164 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.645 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.69 -31.35 25.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.659 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.6 pt-20 -56.24 -48.41 76.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.589 -179.587 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.569 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -73.1 -36.99 66.88 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.974 -179.6 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.972 ' CG2' HG21 ' A' ' 24' ' ' ILE . 61.9 t -61.46 -34.34 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.821 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -68.94 -58.22 4.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.365 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 76' ' ' VAL . 31.7 m-20 -64.1 -42.32 96.95 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.99 0.424 . . . . 0.0 111.571 -179.545 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.2 m -55.37 -48.09 74.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.651 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.496 HD12 ' NH2' ' A' ' 10' ' ' ARG . 82.6 mt -63.05 -51.58 69.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.883 -179.256 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.708 HG13 ' HD3' ' A' ' 10' ' ' ARG . 1.5 m -54.05 -43.61 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.818 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -57.55 -49.55 75.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.748 0.309 . . . . 0.0 111.381 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HB2' HG21 ' A' ' 57' ' ' VAL . 66.9 mttm -73.55 -41.11 63.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.827 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.851 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.39 -30.23 69.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.506 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.91 -55.43 0.43 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.419 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.549 HD12 HG12 ' A' ' 76' ' ' VAL . 16.8 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.174 -0.917 . . . . 0.0 111.308 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.8 p . . . . . 0 C--O 1.215 -0.74 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HA ' HD13 ' A' ' 81' ' ' LEU . 54.1 tttm -45.05 -46.63 11.55 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.093 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -77.54 -32.88 54.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.829 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.706 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -64.86 -52.07 58.62 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.52 HG13 ' CG2' ' A' ' 5' ' ' VAL . 31.2 mt -65.48 -46.21 90.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.727 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 51.5 ttp85 -55.87 -30.53 61.68 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.49 -40.4 97.65 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 73.3 mt-30 -68.77 -31.17 70.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.688 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.6 mt -71.36 -45.82 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.068 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.199 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.6 mm -57.87 -52.97 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.514 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.99 -36.61 93.28 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.387 -0.911 . . . . 0.0 110.941 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -62.67 -29.79 70.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.285 -0.457 . . . . 0.0 111.103 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.001 HD22 HD12 ' A' ' 24' ' ' ILE . 55.1 mt -81.26 -29.41 34.4 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.665 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.29 131.5 48.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.73 -34.74 4.62 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.716 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.74 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.95 -179.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.576 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 73.0 m-20 -59.35 -120.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.733 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -59.92 178.53 0.24 Allowed Pre-proline 0 N--CA 1.455 -0.195 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.78 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.0 Cg_endo -65.38 65.65 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 119.799 0.964 . . . . 0.0 112.482 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.001 HD12 HD22 ' A' ' 17' ' ' LEU . 34.2 mm 107.57 61.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.606 ' HA ' ' CZ ' ' A' ' 22' ' ' PHE . 3.0 m120 -64.35 65.07 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.596 ' HB3' ' CG ' ' A' ' 63' ' ' PHE . 60.6 p 57.48 156.52 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.631 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 54.2 Cg_exo -49.89 -32.65 30.82 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.397 1.398 . . . . 0.0 112.692 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -52.76 -57.68 9.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.35 0.595 . . . . 0.0 110.292 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.601 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.8 tp10 -76.41 -58.09 3.48 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.853 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.59 -44.8 57.06 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.842 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 30.6 ttm -65.08 -31.06 72.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -68.37 -31.45 70.83 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.822 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -69.84 -38.67 76.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.343 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 31' ' ' MET . 8.5 mp -26.91 129.75 0.18 Allowed Pre-proline 0 N--CA 1.47 0.54 0 CA-C-O 120.973 0.416 . . . . 0.0 111.881 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 12.2 Cg_endo . . . . . 0 C--N 1.351 0.659 0 C-N-CA 123.711 2.941 . . . . 0.0 114.274 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.626 HG22 HD23 ' A' ' 34' ' ' LEU . 10.0 t . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.776 0.322 . . . . 0.0 111.525 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.47 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 31.1 m -106.51 121.34 44.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.484 ' CB ' HG23 ' A' ' 9' ' ' ILE . 59.7 m -86.85 46.26 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.001 0.429 . . . . 0.0 110.821 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.405 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 18.7 ptpt . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.892 ' C ' HD22 ' A' ' 49' ' ' LEU . 35.3 mt-10 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.857 0.36 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.892 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.5 mm? -142.31 139.62 31.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.935 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 41' ' ' THR . 59.8 pttt -173.8 -176.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.719 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.842 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -66.33 -42.59 87.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.819 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.405 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.0 t -67.7 -52.38 38.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.467 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 30.0 m-20 -71.1 -49.78 40.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -87.65 -47.01 9.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.89 -26.8 2.11 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.373 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -41.94 -36.89 1.18 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.08 0.467 . . . . 0.0 111.774 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 54' ' ' ALA . 33.4 m -65.51 -33.17 61.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.032 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.649 HD13 ' CE2' ' A' ' 65' ' ' PHE . 28.3 mt -68.31 124.49 23.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.642 0.258 . . . . 0.0 110.56 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.1 p -84.1 -173.81 4.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.797 0.332 . . . . 0.0 111.551 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.06 -44.71 91.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.568 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -55.59 -23.98 30.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 111.118 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -64.54 -9.8 21.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.596 ' CG ' ' HB3' ' A' ' 26' ' ' SER . 2.6 m-85 -39.82 -70.97 0.15 Allowed Pre-proline 0 N--CA 1.464 0.231 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 50.7 Cg_endo -67.76 74.38 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.034 1.823 . . . . 0.0 112.079 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.821 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.08 143.96 38.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.12 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 99.2 mttt -68.94 68.4 0.16 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.475 0.655 . . . . 0.0 110.56 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.78 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 25.5 m 59.51 161.48 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.979 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.656 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.67 -30.59 22.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.817 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.0 pt-20 -57.67 -48.43 79.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.441 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.554 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -71.1 -33.03 69.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.875 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.969 HG21 HG21 ' A' ' 24' ' ' ILE . 92.2 t -64.83 -41.85 93.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.852 0.358 . . . . 0.0 110.857 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.82 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -60.49 -50.35 73.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.825 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -68.43 -37.5 80.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.391 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.3 m -66.8 -51.95 49.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.043 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 71' ' ' VAL . 76.0 mt -58.08 -51.9 65.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.489 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 72' ' ' ALA . 5.3 m -56.22 -39.21 58.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -61.5 -53.15 60.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.728 0.299 . . . . 0.0 111.332 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HB2' HG21 ' A' ' 57' ' ' VAL . 63.1 mttp -69.24 -40.54 77.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.57 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.644 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.17 -29.77 69.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.72 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.17 -55.1 0.43 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.787 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.5 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.023 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.733 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.9 p . . . . . 0 C--O 1.214 -0.799 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 86.1 tttt -45.32 -48.0 13.15 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.015 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -77.59 -31.22 52.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.816 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.733 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 22.7 m-20 -65.2 -52.26 55.91 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 5' ' ' VAL . 22.5 mt -66.79 -46.5 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.763 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 46.4 ttp85 -56.39 -28.07 58.18 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.19 -42.91 94.04 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 66.9 mt-30 -67.07 -32.55 73.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.876 -0.662 . . . . 0.0 109.737 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.0 mt -70.33 -43.33 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.804 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 14' ' ' ILE . 13.3 mm -58.06 -54.09 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.244 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.54 -36.85 93.66 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.692 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -60.88 -28.43 68.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.109 -0.545 . . . . 0.0 110.936 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.068 HD22 HD12 ' A' ' 24' ' ' ILE . 52.7 mt -87.6 -29.66 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.282 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.16 85.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.838 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.94 -36.0 0.19 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.17 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.747 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.77 -174.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 112.116 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.644 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.0 m-20 -59.96 -119.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.721 ' CE2' ' HA ' ' A' ' 25' ' ' ASN . 0.3 OUTLIER -58.52 174.21 0.37 Allowed Pre-proline 0 CA--C 1.519 -0.212 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 176.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.874 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 44.6 Cg_endo -63.27 66.63 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 120.916 1.077 . . . . 0.0 112.242 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.068 HD12 HD22 ' A' ' 17' ' ' LEU . 20.2 mm 109.52 59.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.721 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.5 m120 -63.37 66.75 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 25' ' ' ASN . 85.5 p 56.28 153.64 0.07 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.716 ' O ' ' HB2' ' A' ' 31' ' ' MET . 76.1 Cg_exo -47.29 -32.88 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.512 1.475 . . . . 0.0 113.176 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -53.31 -57.46 10.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.339 0.59 . . . . 0.0 110.387 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.4 tp10 -76.25 -57.52 3.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.964 HD13 HD21 ' A' ' 17' ' ' LEU . 3.3 pp -49.97 -42.54 49.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.716 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 62.2 mtm -68.75 -29.98 68.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.64 -31.04 70.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.899 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.747 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -74.23 -38.57 63.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.102 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 16' ' ' ALA . 8.0 mp -34.66 140.03 0.29 Allowed Pre-proline 0 N--CA 1.466 0.341 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo . . . . . 0 C--N 1.349 0.56 0 C-N-CA 123.248 2.632 . . . . 0.0 113.225 -178.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.428 ' N ' HD23 ' A' ' 34' ' ' LEU . 8.9 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.762 0.315 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.535 HG23 ' HD3' ' A' ' 50' ' ' LYS . 23.8 m -86.64 118.17 25.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.092 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 68.4 m -92.87 44.76 1.16 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 109.776 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.1 pttp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.119 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.876 ' C ' HD22 ' A' ' 49' ' ' LEU . 75.6 mt-10 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.778 0.323 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.876 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -141.0 138.53 33.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.513 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.535 ' HD3' HG23 ' A' ' 41' ' ' THR . 60.8 pttt -175.14 153.64 1.64 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.665 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.66 -28.3 2.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.624 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.403 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 44.1 t -70.82 -55.5 8.38 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.311 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -72.44 -54.32 9.65 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -82.48 -42.89 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.86 -25.81 1.02 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.491 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -41.66 -36.76 1.02 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.132 0.492 . . . . 0.0 111.583 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 54' ' ' ALA . 32.9 m -65.53 -33.41 63.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.128 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.699 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 30.3 mt -68.85 119.83 13.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.703 0.287 . . . . 0.0 110.231 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.412 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 76.8 p -85.44 -175.31 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.711 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.67 -43.34 84.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.298 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.447 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 3.1 p30 -51.29 -26.63 7.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.918 0.389 . . . . 0.0 110.819 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 59.4 m-20 -73.26 3.73 5.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.707 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.53 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 1.4 t80 -42.63 -52.22 10.98 Favored Pre-proline 0 C--O 1.224 -0.262 0 O-C-N 122.588 -0.07 . . . . 0.0 111.15 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 97.6 Cg_endo -89.65 78.15 0.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.194 2.596 . . . . 0.0 111.187 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.744 ' CG ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -76.9 142.8 39.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.156 -178.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 22.9 tptm -69.66 65.41 0.21 Allowed 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.122 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.874 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 49.8 m 63.63 160.0 0.09 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.638 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.603 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.97 -27.34 13.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.938 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.36 -38.78 91.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.075 0.464 . . . . 0.0 109.832 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 7.9 tp10 -68.01 -46.42 71.3 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.94 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.027 ' CG2' HG21 ' A' ' 24' ' ' ILE . 47.0 t -65.11 -43.17 95.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.516 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -56.17 -45.47 79.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.979 0.418 . . . . 0.0 110.25 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -70.3 -40.18 74.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.095 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.436 HG23 ' NZ ' ' A' ' 78' ' ' LYS . 61.8 m -63.13 -50.15 71.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.069 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.532 HG23 ' CB ' ' A' ' 54' ' ' ALA . 67.0 mt -61.41 -52.47 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.702 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 72' ' ' ALA . 7.1 m -58.52 -38.64 71.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -62.33 -56.79 15.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.748 0.308 . . . . 0.0 111.676 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' NZ ' HG23 ' A' ' 74' ' ' THR . 61.8 mttp -69.5 -38.97 77.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.74 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.716 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.84 -29.89 69.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.009 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.42 -55.87 0.42 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.006 -1.092 . . . . 0.0 113.291 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.1 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.339 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.689 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.6 p . . . . . 0 C--O 1.211 -0.968 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.65 ' HA ' HD13 ' A' ' 81' ' ' LEU . 84.8 tttt -44.31 -44.15 7.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.913 0.779 . . . . 0.0 109.417 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.4 -35.58 54.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.666 177.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.689 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 48.6 m-20 -64.02 -51.83 62.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.529 HG13 ' CG2' ' A' ' 5' ' ' VAL . 37.0 mt -65.12 -45.89 92.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.842 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 50.1 ttp180 -55.34 -30.41 60.22 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.53 -41.78 97.76 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.535 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 65.0 mt-30 -66.18 -29.86 70.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.692 -0.754 . . . . 0.0 109.735 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 10' ' ' ARG . 63.6 mt -70.35 -45.58 74.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.962 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 69' ' ' GLU . 9.1 mm -56.74 -52.96 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.512 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.82 -37.15 92.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.073 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.47 -30.53 69.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.202 -0.499 . . . . 0.0 111.172 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.048 HD22 HD12 ' A' ' 24' ' ' ILE . 59.5 mt -82.74 -29.45 29.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.932 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.52 132.81 54.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.049 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.13 -33.89 5.22 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.964 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.7 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.95 -176.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 111.567 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.601 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.1 m-20 -60.9 -121.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.713 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.56 176.81 0.29 Allowed Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.773 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.3 Cg_endo -64.69 69.05 0.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 CA-C-N 119.773 0.954 . . . . 0.0 112.281 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.048 HD12 HD22 ' A' ' 17' ' ' LEU . 51.5 mm 106.47 61.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.601 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.8 m120 -65.24 64.96 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.569 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 59.1 p 57.06 157.46 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.614 ' O ' ' CB ' ' A' ' 31' ' ' MET . 52.0 Cg_exo -50.9 -32.23 36.98 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.293 1.328 . . . . 0.0 112.86 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -52.71 -57.61 9.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.442 0.639 . . . . 0.0 110.421 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.594 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 41.8 tp10 -76.15 -58.15 3.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.824 HD22 HG23 ' A' ' 24' ' ' ILE . 3.9 pp -50.62 -42.95 56.67 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.822 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 30.0 ttm -63.27 -33.07 74.71 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -68.92 -28.32 66.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.835 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.7 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -71.16 -36.9 72.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.3 mp -27.27 137.0 0.1 Allowed Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 121.094 0.473 . . . . 0.0 112.185 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo . . . . . 0 C--N 1.35 0.606 0 C-N-CA 124.249 3.299 . . . . 0.0 115.638 -177.292 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.534 HG22 HD23 ' A' ' 34' ' ' LEU . 15.2 t . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.775 0.321 . . . . 0.0 111.519 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.645 HG21 ' CE ' ' A' ' 43' ' ' LYS . 47.8 m -92.55 123.9 36.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.719 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.9 m -92.04 45.53 1.22 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.974 0.416 . . . . 0.0 110.73 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.645 ' CE ' HG21 ' A' ' 41' ' ' THR . 18.6 ptpt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.025 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.882 ' C ' HD22 ' A' ' 49' ' ' LEU . 22.7 mt-10 . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.81 0.338 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -141.72 133.74 27.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.605 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.769 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 21.1 ptmt -165.48 -177.55 4.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.735 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.822 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -66.56 -40.52 89.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.715 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -67.01 -59.92 3.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.401 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 57.9 m-20 -68.84 -54.09 17.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.758 0.313 . . . . 0.0 111.691 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.946 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -72.56 -50.51 25.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.74 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -49.02 -26.49 6.01 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.412 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -41.21 -43.55 2.37 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.944 0.878 . . . . 0.0 110.943 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 54' ' ' ALA . 10.4 m -66.01 -32.64 59.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.326 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.682 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 21.1 mt -68.9 116.84 9.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.819 0.343 . . . . 0.0 110.588 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.51 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 71.8 p -71.5 155.9 40.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.196 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.16 -39.98 45.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.323 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -53.44 -25.44 16.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.615 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 61.8 m-20 -70.57 3.47 3.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.569 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.4 OUTLIER -38.64 -63.65 0.56 Allowed Pre-proline 0 N--CA 1.462 0.139 0 CA-C-N 117.895 0.316 . . . . 0.0 110.958 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 73.4 Cg_endo -74.55 79.0 2.61 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.469 2.113 . . . . 0.0 111.88 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.755 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -76.83 144.29 39.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.301 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.51 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 75.2 mmtt -70.21 65.88 0.28 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.465 0.65 . . . . 0.0 110.047 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.773 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 20.2 m 61.52 160.36 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.02 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.587 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.45 -28.11 12.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.657 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HA ' HD11 ' A' ' 14' ' ' ILE . 16.2 pt-20 -60.95 -48.44 81.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.376 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.518 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -67.9 -32.14 72.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.021 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 24' ' ' ILE . 80.5 t -62.27 -41.29 90.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 110.45 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.842 ' HB1' ' CG ' ' A' ' 10' ' ' ARG . . . -60.27 -51.03 71.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.987 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.53 -39.02 85.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.258 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.8 m -65.18 -51.65 59.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.956 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.946 HG23 ' HB1' ' A' ' 54' ' ' ALA . 57.4 mt -57.15 -54.58 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.767 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 72' ' ' ALA . 5.7 m -57.14 -40.04 70.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.52 -53.28 44.58 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HB2' HG21 ' A' ' 57' ' ' VAL . 50.2 mtpt -73.33 -39.52 65.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 111.885 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.433 ' HB1' HD12 ' A' ' 49' ' ' LEU . . . -66.84 -29.96 70.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.72 -55.98 0.37 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.117 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.65 HD13 ' HA ' ' A' ' 6' ' ' LYS . 20.3 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.32 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.718 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.6 p . . . . . 0 C--O 1.215 -0.742 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 82.7 tttt -45.17 -47.76 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.008 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.75 -31.94 52.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.901 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.718 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -64.33 -52.17 59.75 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 5' ' ' VAL . 28.9 mt -67.39 -46.18 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.823 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 48.3 ttp180 -55.45 -29.77 59.29 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.73 -43.53 93.98 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 69.3 mt-30 -66.9 -30.38 70.52 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.86 -0.67 . . . . 0.0 109.766 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 10' ' ' ARG . 73.3 mt -70.52 -43.46 77.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.744 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 69' ' ' GLU . 11.3 mm -57.61 -53.69 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.32 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.56 -36.4 92.43 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.405 -0.902 . . . . 0.0 110.855 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -60.55 -31.82 70.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.151 -0.524 . . . . 0.0 110.952 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.065 HD22 HD12 ' A' ' 24' ' ' ILE . 55.4 mt -82.12 -29.47 31.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.775 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.0 130.83 48.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.918 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.16 -34.37 4.48 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.879 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.7 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.06 -176.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.815 0.341 . . . . 0.0 111.594 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.614 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.6 m-20 -60.02 -119.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.745 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.79 178.39 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.81 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 48.9 Cg_endo -65.08 67.85 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.754 0.948 . . . . 0.0 112.131 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.065 HD12 HD22 ' A' ' 17' ' ' LEU . 44.3 mm 105.96 62.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.614 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.9 m120 -65.7 64.41 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.657 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 52.6 p 57.07 160.47 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.657 ' O ' ' HB2' ' A' ' 31' ' ' MET . 52.2 Cg_exo -52.56 -33.16 56.9 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.339 1.359 . . . . 0.0 112.971 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -52.48 -57.89 8.47 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.238 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.612 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 41.3 tp10 -76.6 -58.57 3.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.906 HD22 HG23 ' A' ' 24' ' ' ILE . 3.9 pp -50.65 -45.35 57.82 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.815 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 23.0 ttm -64.17 -31.49 72.7 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -70.28 -28.67 65.39 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.128 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.7 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -70.04 -37.45 75.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.725 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 31' ' ' MET . 11.2 mp -31.78 145.6 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.112 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.544 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.5 Cg_endo . . . . . 0 C--N 1.348 0.549 0 C-N-CA 123.664 2.91 . . . . 0.0 113.973 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.629 HG22 HD23 ' A' ' 34' ' ' LEU . 12.9 t . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.685 0.279 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.489 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 25.4 m -91.61 125.87 36.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.972 0.415 . . . . 0.0 111.588 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.7 m -100.47 48.52 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.777 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.48 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 10.2 ptpp? . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.841 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.887 ' C ' HD22 ' A' ' 49' ' ' LEU . 23.6 mt-10 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.68 0.276 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.887 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.7 mm? -140.64 140.57 35.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.039 0.447 . . . . 0.0 110.811 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.509 ' HG3' ' H ' ' A' ' 53' ' ' ASP . 59.5 pttt -173.54 170.81 4.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.719 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.815 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -59.65 -30.7 68.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.545 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 42.5 t -75.66 -62.05 1.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.509 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 52.4 m-20 -66.4 -51.06 60.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.598 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -78.95 -46.44 18.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.67 -26.32 1.76 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.596 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 17.2 pt20 -41.21 -38.63 1.15 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.04 0.448 . . . . 0.0 111.808 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.8 m -65.72 -30.16 49.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.408 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.678 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 19.1 mt -66.91 121.67 16.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.756 0.312 . . . . 0.0 110.42 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.7 p -74.67 155.77 37.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.44 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.67 58.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.229 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.82 -23.29 29.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.563 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 15.5 m-20 -67.59 3.31 1.42 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.657 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -40.57 -55.19 4.55 Favored Pre-proline 0 C--O 1.227 -0.086 0 CA-C-N 117.77 0.259 . . . . 0.0 111.575 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 2.2 Cg_endo -82.39 78.16 3.5 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.896 2.397 . . . . 0.0 111.783 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.911 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.02 142.13 40.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.266 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.666 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.69 66.9 0.13 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.76 0.79 . . . . 0.0 110.59 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.81 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 15.5 m 61.85 159.87 0.06 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.953 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.668 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.61 -32.55 29.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.794 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.445 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 10.9 pt-20 -59.07 -46.1 89.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.417 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.666 ' HG2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -68.08 -33.17 74.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.19 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.949 HG21 HG21 ' A' ' 24' ' ' ILE . 72.8 t -64.77 -44.72 96.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.649 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.826 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -55.11 -49.53 71.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.76 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.25 -39.84 78.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.294 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.1 m -63.21 -52.62 61.53 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.48 HG23 ' HB1' ' A' ' 54' ' ' ALA . 58.4 mt -59.87 -52.6 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.716 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 72' ' ' ALA . 14.1 m -57.81 -41.24 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -61.68 -51.41 68.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 111.278 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HB2' HG21 ' A' ' 57' ' ' VAL . 66.8 mttm -71.54 -42.08 68.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.676 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.519 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.42 -30.04 69.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.778 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.14 -55.7 0.44 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.664 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 19.0 mt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.337 -0.84 . . . . 0.0 110.983 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.705 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p . . . . . 0 C--O 1.215 -0.758 0 CA-C-O 119.993 -0.051 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.547 ' HE2' HG21 ' A' ' 76' ' ' VAL . 12.9 tmtt? -45.09 -46.41 11.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -77.57 -33.44 54.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.84 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.705 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 14.1 m-20 -64.21 -52.32 59.42 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.531 HG13 HG22 ' A' ' 5' ' ' VAL . 35.3 mt -66.62 -46.56 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.783 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 40.0 ttp180 -55.0 -29.76 58.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.32 -42.46 96.11 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.539 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 70.0 mt-30 -69.06 -30.71 69.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.991 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.7 mt -71.61 -45.18 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.045 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 14' ' ' ILE . 10.6 mm -58.3 -52.01 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.262 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.39 -37.19 93.56 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.557 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -61.52 -28.54 69.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.946 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.05 HD22 HD12 ' A' ' 24' ' ' ILE . 45.7 mt -83.79 -29.56 27.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.874 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.52 126.02 25.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.815 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.66 -34.99 3.3 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.72 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.673 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.73 -175.04 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.913 0.387 . . . . 0.0 111.588 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.573 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -61.58 -119.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.773 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.5 OUTLIER -59.45 179.21 0.21 Allowed Pre-proline 0 N--CA 1.454 -0.266 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 176.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.792 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.3 Cg_endo -64.97 67.21 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 CA-C-N 119.688 0.924 . . . . 0.0 112.179 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.05 HD12 HD22 ' A' ' 17' ' ' LEU . 41.9 mm 107.18 62.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.608 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.8 m120 -63.65 65.37 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 69.9 p 56.28 158.68 0.07 OUTLIER Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.71 ' O ' ' HB2' ' A' ' 31' ' ' MET . 50.7 Cg_exo -51.16 -34.23 47.25 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.316 1.344 . . . . 0.0 113.032 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -51.63 -57.68 8.49 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.38 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 43.7 tp10 -76.24 -58.11 3.48 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.853 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -50.47 -43.95 55.53 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.87 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 23.5 ttm -64.03 -32.19 73.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.96 -29.53 66.67 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.042 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.673 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -68.81 -37.98 79.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.73 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 31' ' ' MET . 11.2 mp -31.61 145.02 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.193 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.529 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.5 Cg_endo . . . . . 0 C--N 1.348 0.505 0 C-N-CA 123.635 2.89 . . . . 0.0 113.969 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.608 HG22 HD23 ' A' ' 34' ' ' LEU . 15.0 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.665 0.269 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 27.8 m -90.71 125.78 35.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 111.597 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.3 m -100.29 50.43 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.097 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.443 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 61.6 pttt . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.643 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.9 ' C ' HD22 ' A' ' 49' ' ' LEU . 23.5 mt-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.033 0.444 . . . . 0.0 111.473 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.9 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -142.34 136.79 30.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.427 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HG3' ' H ' ' A' ' 53' ' ' ASP . 61.2 pttt -173.68 178.77 2.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.795 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.87 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -65.61 -39.71 91.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.836 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.3 t -66.83 -51.55 54.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.672 0.273 . . . . 0.0 111.704 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.474 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 38.8 m-20 -72.2 -51.42 21.25 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.676 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -88.39 -45.97 9.55 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.92 -27.52 1.48 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.203 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 16.0 pt20 -43.29 -35.62 1.54 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 111.333 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 54' ' ' ALA . 32.9 m -65.51 -33.0 60.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.782 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.715 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 17.0 mt -66.3 119.1 10.95 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.2 p -77.26 155.89 31.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.754 0.312 . . . . 0.0 111.073 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.33 -40.21 11.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.593 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -53.86 -26.32 24.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.166 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.661 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -70.18 3.38 2.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -39.93 -65.33 0.44 Allowed Pre-proline 0 N--CA 1.463 0.217 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.156 -179.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 74.1 Cg_endo -74.06 78.26 2.6 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.307 2.005 . . . . 0.0 111.855 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.915 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -76.8 143.65 39.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.246 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.502 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 75.1 mmtt -69.57 68.38 0.24 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.464 0.65 . . . . 0.0 110.05 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.792 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 31.8 m 59.66 160.96 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.976 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.691 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.47 -25.88 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.632 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 16.5 pt-20 -59.66 -48.86 80.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.43 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.517 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -74.13 -32.18 63.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.161 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.015 HG21 HG21 ' A' ' 24' ' ' ILE . 60.2 t -61.55 -46.93 95.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.399 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.835 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -58.85 -44.63 91.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.874 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 35.8 t70 -62.73 -42.62 99.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.337 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.414 HG22 HD21 ' A' ' 58' ' ' LEU . 88.6 m -63.76 -50.68 68.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.136 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.676 HG23 ' CB ' ' A' ' 54' ' ' ALA . 71.9 mt -58.35 -52.58 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.542 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 72' ' ' ALA . 6.8 m -58.6 -43.52 87.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 74.4 m-20 -62.1 -54.1 46.13 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.619 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -69.88 -41.01 75.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 111.6 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.636 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.03 -29.92 69.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.734 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.25 -54.61 0.46 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.891 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 17.7 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.073 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.704 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p . . . . . 0 C--O 1.214 -0.791 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -44.87 -45.27 10.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -77.16 -34.39 56.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.884 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.704 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -64.49 -51.86 60.84 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.63 HD13 HD23 ' A' ' 49' ' ' LEU . 35.0 mt -65.94 -50.13 72.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.927 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -56.64 -29.28 62.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.14 -41.77 99.63 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 77.3 mt-30 -69.72 -31.98 70.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.455 -0.872 . . . . 0.0 110.195 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -71.06 -46.64 66.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.563 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 14' ' ' ILE . 5.1 mm -58.72 -52.58 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.714 0.292 . . . . 0.0 110.401 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.85 -36.36 93.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.106 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -67.1 -25.03 66.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.279 -0.461 . . . . 0.0 111.547 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.077 HD22 HD12 ' A' ' 24' ' ' ILE . 46.1 mt -82.31 -29.41 31.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.568 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.01 132.84 54.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.857 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.2 -33.93 5.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.674 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.668 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.21 -179.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.375 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.584 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.6 m-20 -58.94 -119.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.735 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -61.22 179.24 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.306 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 176.268 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.811 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 46.7 Cg_endo -65.61 65.26 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 119.889 0.996 . . . . 0.0 112.291 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.077 HD12 HD22 ' A' ' 17' ' ' LEU . 31.9 mm 107.72 60.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.62 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.6 m120 -62.82 65.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.572 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 54.7 p 58.16 153.49 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 31' ' ' MET . 67.0 Cg_exo -48.26 -32.51 19.68 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.315 1.344 . . . . 0.0 112.628 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -52.88 -57.48 10.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.51 0.671 . . . . 0.0 110.503 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.62 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.4 tp10 -75.37 -57.8 3.67 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.878 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.4 pp -50.39 -41.59 52.27 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.64 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 37.0 ttm -64.61 -32.87 74.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -73.01 -23.17 60.59 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.668 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -72.2 -49.71 33.35 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.649 HD12 ' H ' ' A' ' 34' ' ' LEU . 7.9 mp -24.99 135.26 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 C--N 1.349 0.583 0 C-N-CA 123.916 3.077 . . . . 0.0 113.622 -178.5 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.448 HG22 HD23 ' A' ' 34' ' ' LEU . 1.8 t . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.743 0.306 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.414 HG23 ' OE2' ' A' ' 48' ' ' GLU . 17.3 m -76.74 127.37 32.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.722 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.401 ' HB3' ' OE1' ' A' ' 12' ' ' GLN . 57.4 m -112.28 45.81 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.88 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 60.2 pttt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.859 ' C ' HD22 ' A' ' 49' ' ' LEU . 87.8 tt0 . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 121.135 0.493 . . . . 0.0 111.74 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.859 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.1 mm? -137.69 130.31 29.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.564 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 52' ' ' SER . 62.4 pttt -171.7 -161.37 0.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.879 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.476 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -74.31 -47.74 32.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.425 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.7 t -69.34 -50.87 42.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -69.2 -48.74 61.24 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.701 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -95.66 -45.74 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -47.35 -28.47 4.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.84 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -43.38 -34.13 1.2 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.207 0.527 . . . . 0.0 111.357 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 54' ' ' ALA . 30.5 m -65.51 -33.2 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.918 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.755 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 30.9 mt -64.72 125.28 24.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 110.681 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.5 p -77.39 155.87 31.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.261 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.57 -42.63 55.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.4 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -56.1 -22.66 29.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.858 0.361 . . . . 0.0 111.075 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.625 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 15.5 m-20 -68.3 3.3 1.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.572 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.7 OUTLIER -40.57 -66.3 0.38 Allowed Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 117.943 0.338 . . . . 0.0 111.532 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.2 Cg_endo -70.44 76.06 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.373 2.049 . . . . 0.0 112.09 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.907 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.15 141.93 39.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.502 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.61 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 1.7 tpmt? -67.32 68.51 0.08 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.702 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.811 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 47.3 m 58.73 162.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.028 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.667 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.59 -26.23 8.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.949 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 23.1 pt-20 -60.23 -49.92 75.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.551 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.54 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -71.49 -35.59 70.85 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.655 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.983 ' CG2' HG21 ' A' ' 24' ' ' ILE . 55.8 t -63.19 -40.8 90.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.927 ' HB1' ' HG2' ' A' ' 10' ' ' ARG . . . -60.8 -51.65 68.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.985 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -67.09 -41.57 86.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.426 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.9 m -57.59 -50.1 74.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.677 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.571 HG23 ' CB ' ' A' ' 54' ' ' ALA . 82.4 mt -60.13 -49.04 85.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.233 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 16.6 m -63.03 -41.87 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -58.59 -55.72 31.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HE3' ' HB ' ' A' ' 57' ' ' VAL . 28.2 mtpp -71.89 -38.99 69.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 111.654 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.619 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.67 -29.69 69.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.563 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.1 -53.95 0.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.817 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.4 mt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.158 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p . . . . . 0 C--O 1.214 -0.785 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 81.7 tttt -44.34 -46.17 9.18 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.418 -0.801 . . . . 0.0 109.276 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -77.43 -34.18 54.66 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.824 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.702 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -63.77 -51.92 62.68 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.517 HG13 ' CG2' ' A' ' 5' ' ' VAL . 33.6 mt -66.69 -46.81 84.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.732 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 45.0 ttp180 -55.11 -30.14 59.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.76 -42.85 94.98 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.551 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 71.3 mt-30 -68.9 -30.01 68.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.815 -0.692 . . . . 0.0 110.063 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.1 mt -71.29 -44.66 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.806 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 14' ' ' ILE . 11.3 mm -57.67 -53.11 49.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.252 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.45 -36.02 92.07 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.807 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.85 -31.69 71.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.068 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.006 HD22 HD12 ' A' ' 24' ' ' ILE . 48.0 mt -81.49 -29.45 33.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.552 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.06 128.31 36.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.797 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.15 -36.16 3.28 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.537 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.648 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.59 -175.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.025 0.44 . . . . 0.0 111.492 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.649 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -61.56 -127.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.731 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -54.23 175.49 0.16 Allowed Pre-proline 0 CA--C 1.52 -0.209 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 176.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.819 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 35.3 Cg_endo -61.92 69.17 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 CA-C-N 119.814 0.969 . . . . 0.0 112.486 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.011 HG21 HG21 ' A' ' 71' ' ' VAL . 44.2 mm 105.68 64.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 177.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.71 ' ND2' ' CD2' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -65.77 63.89 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.142 -0.349 . . . . 0.0 111.367 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.659 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 39.1 p 57.98 160.31 0.09 OUTLIER Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.6 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 52.7 Cg_exo -52.65 -34.01 61.76 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.335 1.356 . . . . 0.0 113.042 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.44 -57.42 9.92 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.371 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.647 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -76.35 -58.34 3.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.916 HD22 HG23 ' A' ' 24' ' ' ILE . 3.9 pp -50.33 -45.76 55.12 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.791 ' N ' HD12 ' A' ' 30' ' ' LEU . 27.7 ttm -64.26 -31.37 72.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -69.12 -30.66 68.98 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.854 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.648 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -69.28 -37.79 78.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.965 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.778 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.4 mp -32.75 140.34 0.21 Allowed Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.052 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo . . . . . 0 C--N 1.349 0.575 0 C-N-CA 123.534 2.822 . . . . 0.0 112.896 -179.23 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.704 HG22 HD23 ' A' ' 34' ' ' LEU . 11.3 t . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 120.515 0.198 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 30.8 m -93.15 115.62 28.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.795 0.331 . . . . 0.0 111.302 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 73.7 m -92.65 46.62 1.25 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 109.955 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.495 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 24.2 pttm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.093 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.86 ' C ' HD22 ' A' ' 49' ' ' LEU . 70.1 mt-10 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.722 0.296 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.86 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.7 mm? -143.24 131.23 21.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HG3' ' H ' ' A' ' 53' ' ' ASP . 21.8 pttm -165.03 172.1 13.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.429 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.567 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -59.38 -35.94 74.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.616 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.8 t -66.44 -58.4 5.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 43.9 m-20 -71.84 -54.24 10.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.674 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -77.58 -46.02 23.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.76 -23.41 3.43 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.58 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.41 ' NE2' ' O ' ' A' ' 53' ' ' ASP . 26.2 pt20 -42.52 -32.56 0.56 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.023 0.439 . . . . 0.0 111.447 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.0 m -78.33 27.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.587 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 39.8 mt -127.25 115.13 18.58 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.893 0.378 . . . . 0.0 110.046 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.8 p -67.52 155.88 38.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.958 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.06 -40.38 61.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.954 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -54.93 -23.47 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.669 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.541 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 13.4 m-20 -68.53 3.07 1.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.659 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.8 OUTLIER -39.43 -65.23 0.43 Allowed Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 117.81 0.277 . . . . 0.0 111.612 -179.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.9 Cg_endo -70.71 76.35 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.367 2.044 . . . . 0.0 112.093 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.853 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.02 140.46 40.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.84 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 22.8 tptm -66.0 67.64 0.05 OUTLIER 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.429 0.633 . . . . 0.0 110.608 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.819 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 34.6 m 60.19 159.88 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.962 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.643 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.57 -29.65 17.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.563 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 10.9 pt-20 -58.88 -47.61 84.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.297 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.509 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -68.51 -35.73 77.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.204 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.011 HG21 HG21 ' A' ' 24' ' ' ILE . 89.8 t -61.92 -44.35 98.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 110.51 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -55.6 -49.49 72.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -69.86 -41.85 74.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.992 0.425 . . . . 0.0 111.21 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.409 HG23 ' NZ ' ' A' ' 78' ' ' LYS . 86.4 m -59.33 -50.98 71.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.855 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.438 HG23 ' CB ' ' A' ' 54' ' ' ALA . 69.3 mt -61.02 -52.98 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.397 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 72' ' ' ALA . 13.5 m -60.35 -40.38 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -60.09 -54.16 49.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 111.417 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.562 ' HB2' HG21 ' A' ' 57' ' ' VAL . 63.2 mttp -71.86 -41.11 68.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.86 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.674 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.1 -29.94 69.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.834 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.77 -55.8 0.44 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.676 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.8 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.141 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.749 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.8 p . . . . . 0 C--O 1.216 -0.709 0 CA-C-O 120.027 -0.035 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 86.3 tttt -45.76 -50.66 13.67 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -78.0 -27.77 49.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.172 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.749 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 33.8 t70 -66.96 -52.56 41.37 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.542 HG13 HG22 ' A' ' 5' ' ' VAL . 19.5 mt -69.6 -45.86 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.678 ' CD ' ' HB1' ' A' ' 72' ' ' ALA . 5.7 tmm_? -55.21 -31.96 61.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.09 -43.35 98.88 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 68.0 mt-30 -63.41 -29.91 71.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.673 -0.763 . . . . 0.0 109.552 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 10' ' ' ARG . 61.9 mt -70.21 -42.39 78.97 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 69' ' ' GLU . 8.3 mm -57.7 -53.26 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.343 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.4 -38.06 90.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.327 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -61.77 -28.35 69.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.055 0.455 . . . . 0.0 111.28 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.024 HD22 HD12 ' A' ' 24' ' ' ILE . 48.0 mt -83.45 -29.57 27.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.526 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.11 129.85 43.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.76 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.42 -33.86 4.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.668 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.664 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.85 -174.29 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 111.423 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.593 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 76.8 m-20 -60.31 -119.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.733 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -60.63 -179.99 0.21 Allowed Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 41.6 Cg_endo -66.17 65.94 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 120.089 1.068 . . . . 0.0 112.336 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.024 HD12 HD22 ' A' ' 17' ' ' LEU . 50.4 mm 108.01 60.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.611 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.6 m120 -62.45 66.82 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.561 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 59.7 p 57.16 154.18 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.658 ' O ' ' CB ' ' A' ' 31' ' ' MET . 54.3 Cg_exo -48.66 -32.82 22.57 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.096 1.198 . . . . 0.0 112.65 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -52.21 -57.37 9.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.473 0.654 . . . . 0.0 110.739 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.611 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 40.2 tp10 -74.71 -57.93 3.61 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.895 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.56 -40.4 52.05 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.658 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 40.1 ttm -63.88 -33.24 75.26 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -75.44 -20.49 58.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.664 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -75.91 -42.93 47.49 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 30' ' ' LEU . 6.9 mp -27.96 147.17 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo . . . . . 0 C--N 1.348 0.55 0 C-N-CA 124.051 3.168 . . . . 0.0 115.478 -177.288 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 34' ' ' LEU . 5.2 t . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.769 0.319 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.438 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 11.8 m -76.17 124.13 26.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.963 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.6 m -90.44 44.66 1.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.528 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.5 pttm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.136 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.866 ' C ' HD22 ' A' ' 49' ' ' LEU . 28.1 mt-10 . . . . . 0 N--CA 1.461 0.082 0 CA-C-O 120.816 0.341 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.866 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.5 mm? -140.83 138.01 33.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.08 0.466 . . . . 0.0 110.952 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 21.6 pttp -174.74 166.07 3.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.705 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.491 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.84 -40.47 21.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.074 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.6 t -72.01 -43.7 64.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.412 ' O ' ' NE2' ' A' ' 56' ' ' GLN . 38.2 t70 -69.14 -54.11 16.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 111.853 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.986 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -96.28 -45.77 6.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.58 -30.04 2.04 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.361 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 53' ' ' ASP . 18.7 pt20 -51.52 -28.86 14.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.202 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.986 HG22 ' O ' ' A' ' 54' ' ' ALA . 31.9 m -78.26 27.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.516 HD13 ' CE2' ' A' ' 65' ' ' PHE . 38.2 mt -125.86 125.68 43.23 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.744 0.307 . . . . 0.0 110.332 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.9 p -67.88 155.72 38.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.599 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.08 -40.92 67.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.189 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -55.02 -22.26 14.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.0 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.607 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.6 m-20 -68.42 3.01 1.94 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.9 OUTLIER -41.12 -65.14 0.5 Allowed Pre-proline 0 N--CA 1.462 0.159 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.501 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.0 Cg_endo -71.35 76.79 1.74 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.293 1.995 . . . . 0.0 112.246 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.964 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.05 143.19 39.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.671 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.11 68.67 0.12 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.637 0.732 . . . . 0.0 110.963 178.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.771 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 20.2 m 58.75 161.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.268 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.686 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.63 -30.96 23.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.857 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.621 ' HA ' HD11 ' A' ' 14' ' ' ILE . 16.3 pt-20 -58.46 -46.3 86.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.448 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.671 ' HG2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -71.0 -37.54 72.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.725 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.006 HG21 HG21 ' A' ' 24' ' ' ILE . 45.5 t -62.69 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.023 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.678 ' HB1' ' CD ' ' A' ' 10' ' ' ARG . . . -56.63 -48.45 77.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.066 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.414 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.3 m-20 -65.52 -45.28 84.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.839 0.352 . . . . 0.0 111.028 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.435 ' OG1' ' OE1' ' A' ' 70' ' ' GLU . 27.0 m -59.86 -44.65 94.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.624 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.784 HG23 ' CB ' ' A' ' 54' ' ' ALA . 66.2 mt -57.26 -51.52 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.399 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 14.9 m -60.33 -37.11 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 78.4 m-20 -63.31 -58.16 8.04 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HB2' HG21 ' A' ' 57' ' ' VAL . 64.3 mttp -69.48 -38.96 77.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.621 ' HB2' ' CB ' ' A' ' 54' ' ' ALA . . . -66.75 -29.95 70.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.242 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.21 -55.88 0.42 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.236 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.534 HD13 ' HA ' ' A' ' 6' ' ' LYS . 19.5 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.257 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.727 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.6 p . . . . . 0 C--O 1.214 -0.788 0 N-CA-C 110.925 -0.028 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -45.29 -46.53 12.76 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.407 ' OE2' ' HD2' ' A' ' 6' ' ' LYS . 9.5 mp0 -77.74 -31.63 52.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.934 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.727 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 65.4 m-20 -65.61 -52.35 52.66 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.507 HG13 HG22 ' A' ' 5' ' ' VAL . 31.1 mt -68.33 -46.1 81.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.599 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.3 OUTLIER -56.89 -29.96 63.48 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.58 -43.68 96.16 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 82.7 mt-30 -63.95 -30.23 71.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.711 -0.744 . . . . 0.0 109.665 177.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 10' ' ' ARG . 63.2 mt -70.5 -42.54 78.25 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.059 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.839 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' A' ' 69' ' ' GLU . 10.4 mm -57.17 -52.75 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.413 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.7 86.3 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.186 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -60.98 -27.88 68.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.975 0.416 . . . . 0.0 111.094 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.092 HD22 HD12 ' A' ' 24' ' ' ILE . 54.6 mt -85.78 -29.41 23.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.939 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.98 129.09 38.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.098 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.92 -34.49 4.17 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.836 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.702 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.87 -178.05 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.843 0.354 . . . . 0.0 111.613 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -61.18 -119.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.728 ' CE2' ' HA ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -58.73 174.43 0.37 Allowed Pre-proline 0 CA--C 1.519 -0.242 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 176.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.889 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 39.3 Cg_endo -63.32 67.01 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.843 0.98 . . . . 0.0 112.292 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.092 HD12 HD22 ' A' ' 17' ' ' LEU . 24.0 mm 109.4 60.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.728 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.6 m120 -62.78 65.85 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 25' ' ' ASN . 81.5 p 56.76 156.7 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.656 ' O ' ' HB2' ' A' ' 31' ' ' MET . 52.1 Cg_exo -49.5 -34.47 33.65 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.299 1.332 . . . . 0.0 113.15 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.03 -57.1 10.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.327 0.584 . . . . 0.0 110.647 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.604 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.2 tp10 -76.0 -57.51 3.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.901 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -49.9 -41.12 45.13 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.873 ' HA ' HD13 ' A' ' 34' ' ' LEU . 64.3 mtm -65.72 -33.82 76.77 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.45 -28.31 68.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.605 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.702 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -72.6 -40.73 66.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.618 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.873 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.4 mp -35.18 145.21 0.2 Allowed Pre-proline 0 N--CA 1.467 0.407 0 CA-C-O 121.137 0.494 . . . . 0.0 112.326 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.536 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.2 Cg_endo . . . . . 0 C--N 1.347 0.48 0 C-N-CA 124.07 3.18 . . . . 0.0 114.38 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.563 HG22 HD23 ' A' ' 34' ' ' LEU . 9.9 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.873 0.368 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.467 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 6.7 m -81.0 127.82 33.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.7 m -95.55 43.71 1.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 110.368 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.461 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.134 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.878 ' C ' HD22 ' A' ' 49' ' ' LEU . 32.8 mt-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.878 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.7 mm? -141.63 139.37 33.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.848 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.467 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 59.6 pttt -176.97 153.94 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.81 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.768 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.8 -27.22 1.94 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.659 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.9 t -67.26 -62.51 1.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.067 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -72.55 -54.32 9.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.915 0.388 . . . . 0.0 111.787 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.898 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -71.76 -45.3 62.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.812 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.91 -27.83 1.57 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.711 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -41.91 -36.69 1.13 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.795 0.807 . . . . 0.0 110.434 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 54' ' ' ALA . 16.3 m -83.07 28.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.28 -1.327 . . . . 0.0 112.243 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 57' ' ' VAL . 36.1 mt -137.91 76.9 1.6 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.943 0.402 . . . . 0.0 110.38 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.9 p -49.08 174.92 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.247 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.02 73.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.551 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -50.69 -28.44 9.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.629 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.472 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 52.8 m-20 -75.47 3.46 9.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.338 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.685 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -43.78 -71.34 0.16 Allowed Pre-proline 0 N--CA 1.462 0.157 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.248 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 56.4 Cg_endo -68.39 77.65 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.023 1.816 . . . . 0.0 111.303 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.755 ' CG ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -77.1 144.59 38.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.138 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 62.1 mttp -70.37 64.36 0.27 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.106 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.889 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 55.7 m 63.93 160.2 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.575 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.541 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.92 -27.09 11.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.893 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.471 ' HA ' HD11 ' A' ' 14' ' ' ILE . 15.3 pt-20 -65.43 -38.92 91.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.969 0.414 . . . . 0.0 109.969 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 6.8 tp10 -67.73 -46.23 72.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.927 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.001 ' CG2' HG21 ' A' ' 24' ' ' ILE . 42.1 t -66.36 -45.65 88.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.821 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.564 ' HB1' ' CD ' ' A' ' 10' ' ' ARG . . . -55.33 -45.05 76.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.009 0.433 . . . . 0.0 110.352 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -69.82 -43.5 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.69 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.467 HG22 HD21 ' A' ' 58' ' ' LEU . 72.6 m -57.74 -46.93 83.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.298 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.875 HG23 ' CB ' ' A' ' 54' ' ' ALA . 70.6 mt -58.23 -54.95 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.959 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.53 HG21 ' HE3' ' A' ' 6' ' ' LYS . 15.2 m -58.5 -43.93 87.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.836 0.309 . . . . 0.0 111.836 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -62.52 -54.14 44.33 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.425 ' CB ' HG21 ' A' ' 57' ' ' VAL . 98.6 mttt -72.07 -41.16 67.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.42 ' HB1' ' CD1' ' A' ' 49' ' ' LEU . . . -67.04 -29.98 69.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.062 0.394 . . . . 0.0 112.062 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.49 -56.36 0.39 Allowed Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.049 -1.072 . . . . 0.0 113.223 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 14.0 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.08 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.9 p . . . . . 0 C--O 1.213 -0.844 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.484 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 0.8 OUTLIER -45.1 -46.54 11.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.6 -32.79 53.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.868 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.706 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 13.5 m-20 -64.88 -52.14 58.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.542 HG13 HG22 ' A' ' 5' ' ' VAL . 31.9 mt -65.4 -46.63 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.826 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 45.8 ttp180 -56.77 -28.69 61.7 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.46 -42.41 95.84 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 19.4 mt-30 -69.02 -32.44 71.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.866 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.1 mt -70.11 -45.91 74.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.266 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 14' ' ' ILE . 5.3 mm -57.67 -52.23 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.698 0.285 . . . . 0.0 110.398 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.63 93.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.332 -0.937 . . . . 0.0 110.9 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.719 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -64.72 -25.88 68.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.282 -0.459 . . . . 0.0 111.172 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.008 HD22 HD12 ' A' ' 24' ' ' ILE . 65.3 mt -83.0 -29.46 28.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.718 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.83 139.43 54.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.262 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.67 -30.85 8.88 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.888 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.674 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.59 -176.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.988 0.423 . . . . 0.0 111.61 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.569 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -59.83 -120.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.825 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -61.36 -169.06 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.825 ' N ' ' HD1' ' A' ' 22' ' ' PHE . 57.5 Cg_endo -71.48 62.19 2.82 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 CA-C-N 120.975 1.384 . . . . 0.0 112.178 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.064 HG21 HG21 ' A' ' 71' ' ' VAL . 48.9 mm 109.83 65.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.671 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -63.76 65.64 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 O-C-N 122.001 -0.437 . . . . 0.0 111.612 178.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.609 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 42.7 p 59.38 157.05 0.1 OUTLIER Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.604 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 50.7 Cg_exo -50.59 -34.36 42.66 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.331 1.354 . . . . 0.0 112.879 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -53.15 -55.43 24.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.137 0.494 . . . . 0.0 110.907 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.671 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -74.83 -57.37 3.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.907 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -49.89 -38.46 35.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.792 ' HA ' HD13 ' A' ' 34' ' ' LEU . 57.3 mtm -63.5 -37.83 88.82 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.77 -26.44 66.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.166 0.508 . . . . 0.0 110.562 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.674 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -68.36 -42.99 78.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.474 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.792 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.0 mp -33.32 148.9 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.739 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo . . . . . 0 C--N 1.346 0.447 0 C-N-CA 123.648 2.898 . . . . 0.0 113.821 -177.979 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.642 HG22 HD23 ' A' ' 34' ' ' LEU . 2.4 t . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 120.958 0.409 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.445 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 28.1 m -83.9 125.98 32.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.996 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.494 ' HB2' HG23 ' A' ' 9' ' ' ILE . 63.4 m -88.84 46.26 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 0.0 110.341 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.455 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 61.8 pttt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.096 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.874 ' C ' HD22 ' A' ' 49' ' ' LEU . 29.6 mt-10 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.668 0.27 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.874 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -143.94 141.69 30.36 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.053 0.454 . . . . 0.0 111.238 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 41' ' ' THR . 51.0 pttt -177.46 165.88 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.73 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.724 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -55.14 -31.98 61.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.663 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.0 t -66.58 -62.65 1.35 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 58.4 m-20 -72.21 -54.31 10.01 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.506 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -73.42 -44.37 58.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.63 -25.28 1.39 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.365 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 25.3 pt20 -40.6 -38.4 0.87 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.157 0.503 . . . . 0.0 111.652 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.3 m -65.65 -33.32 62.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.371 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 13.2 mt -70.17 119.27 14.12 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.5 p -72.18 155.77 39.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.883 0.373 . . . . 0.0 111.468 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.82 -40.7 60.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.3 -21.2 33.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.961 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.573 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 19.6 m-20 -68.7 2.98 2.11 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.609 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.8 OUTLIER -37.78 -62.81 0.58 Allowed Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 117.953 0.342 . . . . 0.0 111.63 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.7 Cg_endo -72.08 77.63 1.95 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.378 2.052 . . . . 0.0 111.747 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.919 ' CD2' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -77.03 141.99 40.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.649 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.67 66.76 0.13 Allowed 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.519 0.676 . . . . 0.0 110.221 178.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.802 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 18.5 m 60.8 161.51 0.06 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.369 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.672 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.57 -31.77 25.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.645 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.9 pt-20 -58.37 -45.82 87.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.408 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -70.16 -33.69 72.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.607 -179.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.064 HG21 HG21 ' A' ' 24' ' ' ILE . 61.6 t -63.17 -44.95 99.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.919 0.39 . . . . 0.0 110.563 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.865 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -57.05 -50.3 73.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.067 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 56.0 m-20 -68.5 -42.04 79.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.009 0.433 . . . . 0.0 111.232 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.474 HG22 HD21 ' A' ' 58' ' ' LEU . 98.0 m -59.64 -49.4 77.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.797 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.49 HG23 ' HB1' ' A' ' 54' ' ' ALA . 75.2 mt -62.07 -54.23 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.607 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.865 HG22 ' O ' ' A' ' 72' ' ' ALA . 11.3 m -61.29 -44.67 98.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 4.3 m120 -59.66 -52.58 64.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.43 ' HE2' ' HB ' ' A' ' 57' ' ' VAL . 48.9 mtpt -72.65 -41.06 65.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.734 0.302 . . . . 0.0 111.606 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.27 -30.08 69.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.759 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.19 -56.28 0.41 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.934 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 16.9 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.042 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.703 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p . . . . . 0 C--O 1.21 -0.974 0 N-CA-C 111.315 0.117 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HE2' ' NH2' ' A' ' 10' ' ' ARG . 86.8 tttt -44.94 -47.45 11.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -77.61 -33.48 53.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.786 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.703 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -63.69 -52.07 62.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.527 HG13 ' CG2' ' A' ' 5' ' ' VAL . 28.3 mt -64.01 -46.46 93.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.794 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 24.3 ttm180 -56.88 -28.05 61.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.92 -41.42 97.4 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 63.4 mt-30 -70.69 -31.33 68.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.633 -0.784 . . . . 0.0 110.032 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.4 -48.68 52.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.308 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.466 ' HA ' HD13 ' A' ' 14' ' ' ILE . 7.9 mm -57.27 -52.27 58.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.511 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.22 -36.47 93.27 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.911 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -64.17 -28.45 69.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.239 -0.481 . . . . 0.0 111.247 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.048 HD22 HD12 ' A' ' 24' ' ' ILE . 60.8 mt -80.43 -29.45 37.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.701 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.68 133.3 53.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.067 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.58 -33.54 5.46 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.765 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.706 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.65 -176.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.449 . . . . 0.0 111.643 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -59.9 -123.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.775 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -58.83 -174.79 0.05 OUTLIER Pre-proline 0 N--CA 1.456 -0.127 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 176.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.844 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 52.2 Cg_endo -68.08 62.8 1.01 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 120.478 1.206 . . . . 0.0 112.326 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.048 HD12 HD22 ' A' ' 17' ' ' LEU . 49.1 mm 110.32 65.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.663 ' ND2' ' CD2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -64.67 65.99 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 122.013 -0.429 . . . . 0.0 111.478 178.027 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.541 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 27.3 p 58.43 157.2 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.602 ' HG3' HD12 ' A' ' 58' ' ' LEU . 50.8 Cg_exo -50.69 -34.62 44.53 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.319 1.346 . . . . 0.0 112.875 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -52.61 -55.19 24.07 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.613 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.655 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 6.0 tp10 -76.25 -57.83 3.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.933 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -50.03 -41.85 48.34 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.749 ' N ' HD12 ' A' ' 30' ' ' LEU . 28.3 ttm -66.02 -32.69 74.32 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.14 -30.39 69.51 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.394 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -68.41 -40.42 81.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.288 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.0 mp -25.07 134.47 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.29 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo . . . . . 0 C--N 1.347 0.452 0 C-N-CA 123.862 3.041 . . . . 0.0 114.899 -178.029 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.52 HG22 HD23 ' A' ' 34' ' ' LEU . 3.8 t . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 120.777 0.322 . . . . 0.0 111.473 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.45 ' OG1' ' HD2' ' A' ' 50' ' ' LYS . 27.3 m -96.15 118.87 33.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.668 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -88.01 43.87 1.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.09 0.472 . . . . 0.0 109.975 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 19.8 ptmt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.148 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.883 ' C ' HD22 ' A' ' 49' ' ' LEU . 32.6 mt-10 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.682 0.277 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.883 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -140.91 132.52 27.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.936 0.398 . . . . 0.0 110.912 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HD2' ' OG1' ' A' ' 41' ' ' THR . 21.3 ptmt -170.21 159.08 7.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.727 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.86 -29.88 3.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.951 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.9 t -72.54 -59.59 2.65 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 57.5 m-20 -72.15 -54.11 10.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.79 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -74.34 -43.97 54.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.09 -27.06 1.46 Allowed Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.363 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 18.1 pt20 -42.25 -40.14 2.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.149 0.5 . . . . 0.0 111.515 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.751 HG22 ' O ' ' A' ' 54' ' ' ALA . 28.0 m -65.76 -30.39 49.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.104 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.691 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 12.4 mt -71.32 119.85 16.05 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.5 p -75.0 155.66 37.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.355 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.64 -39.81 51.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -58.81 -21.09 55.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.642 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.4 m-20 -70.04 3.15 2.9 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.5 m-85 -40.49 -62.69 0.88 Allowed Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 118.162 0.437 . . . . 0.0 111.293 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.0 Cg_endo -71.43 74.95 2.01 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.48 2.12 . . . . 0.0 112.207 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.881 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -76.9 139.84 40.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.167 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.486 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 38.1 mtmm -66.45 70.07 0.07 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.596 0.712 . . . . 0.0 110.671 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.844 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 37.7 m 59.33 161.15 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.284 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.67 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.55 -26.85 9.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.482 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.515 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 12.0 pt-20 -58.77 -48.99 79.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.454 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.499 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -74.87 -31.88 61.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 119.656 -0.817 . . . . 0.0 111.303 -179.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.971 HG21 HG21 ' A' ' 24' ' ' ILE . 57.2 t -61.48 -45.47 98.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.418 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.889 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -60.84 -46.33 90.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.108 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 9.3 t70 -62.5 -41.74 99.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.531 0.682 . . . . 0.0 110.396 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.471 HG22 HD21 ' A' ' 58' ' ' LEU . 85.0 m -63.19 -49.54 73.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.835 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.79 HG23 ' CB ' ' A' ' 54' ' ' ALA . 74.7 mt -59.79 -55.17 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.072 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 72' ' ' ALA . 9.7 m -60.9 -43.8 96.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 3.4 m120 -63.93 -50.77 67.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HB2' HG21 ' A' ' 57' ' ' VAL . 99.7 mttt -74.06 -41.65 61.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.536 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.11 -29.9 69.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.7 -55.79 0.36 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.064 -1.065 . . . . 0.0 113.223 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 17.5 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.237 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.7 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.3 p . . . . . 0 C--O 1.211 -0.926 0 CA-C-O 120.009 -0.043 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 13.0 tmtt? -45.11 -46.0 11.53 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.53 -34.14 54.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.857 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.7 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -63.55 -52.2 62.11 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.73 HG23 ' HB2' ' A' ' 42' ' ' CYS . 31.6 mt -65.69 -47.49 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.802 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 52.0 ttp85 -55.04 -28.8 55.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.426 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.63 -47.21 79.31 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -66.95 -28.02 67.93 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.763 -0.719 . . . . 0.0 109.986 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 9' ' ' ILE . 75.3 mt -70.43 -44.99 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.075 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.566 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.46 HD13 ' HA ' ' A' ' 14' ' ' ILE . 11.3 mm -56.11 -49.64 74.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.05 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.69 -36.85 91.89 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.044 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.93 -27.11 69.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.25 -0.475 . . . . 0.0 111.38 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.025 HD22 HD12 ' A' ' 24' ' ' ILE . 35.9 mt -85.01 -29.47 24.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.71 132.86 46.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.03 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.45 -33.97 4.88 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.519 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.715 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.19 -177.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.771 0.319 . . . . 0.0 111.383 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.55 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.79 -119.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.749 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -60.82 179.61 0.22 Allowed Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 176.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.816 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 41.4 Cg_endo -65.48 65.49 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 CA-C-N 119.921 1.008 . . . . 0.0 112.359 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.025 HD12 HD22 ' A' ' 17' ' ' LEU . 31.7 mm 107.94 61.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.611 ' HA ' ' CZ ' ' A' ' 22' ' ' PHE . 2.6 m120 -62.98 65.75 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.588 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.1 p 57.12 156.7 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.613 ' O ' ' CB ' ' A' ' 31' ' ' MET . 53.7 Cg_exo -50.04 -33.99 36.65 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.351 1.367 . . . . 0.0 112.837 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -52.3 -56.83 12.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.308 0.575 . . . . 0.0 110.625 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.603 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.1 tp10 -76.1 -57.71 3.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.9 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.7 pp -50.2 -40.76 48.13 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.75 ' HA ' HD13 ' A' ' 34' ' ' LEU . 31.2 ttm -65.93 -33.61 76.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.48 -29.94 69.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.469 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.715 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -70.1 -39.62 75.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.408 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.75 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.8 mp -30.49 140.99 0.12 Allowed Pre-proline 0 N--CA 1.468 0.466 0 CA-C-O 121.108 0.48 . . . . 0.0 112.12 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 C--N 1.347 0.462 0 C-N-CA 123.859 3.04 . . . . 0.0 115.587 -177.471 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.474 ' N ' HD23 ' A' ' 34' ' ' LEU . 6.0 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.644 0.259 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.565 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 2.0 t -108.6 121.97 46.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.073 0.464 . . . . 0.0 111.478 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.73 ' HB2' HG23 ' A' ' 9' ' ' ILE . 33.8 m -72.4 59.84 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.39 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.467 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 62.0 pttt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.004 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.865 ' C ' HD22 ' A' ' 49' ' ' LEU . 22.1 mp0 . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.762 0.315 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.865 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.8 mm? -136.08 135.83 39.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.649 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.749 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 56.1 pttt -166.38 -165.26 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.058 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.506 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -78.02 -46.33 21.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.876 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.7 t -65.36 -51.62 59.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.647 0.26 . . . . 0.0 111.542 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.44 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 46.4 m-20 -71.79 -51.44 22.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 50' ' ' LYS . . . -86.03 -47.18 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.81 -26.15 1.08 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.785 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.419 ' HG3' ' N ' ' A' ' 57' ' ' VAL . 22.7 pt20 -41.57 -38.95 1.46 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.964 0.411 . . . . 0.0 111.796 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.1 m -65.66 -32.21 57.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.558 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.71 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 22.4 mt -68.62 122.54 18.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.36 . . . . 0.0 110.554 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.5 p -74.74 155.81 37.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.331 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.21 -42.11 60.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.321 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.21 -20.02 38.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.169 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.693 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 28.5 m-20 -68.64 3.31 1.92 Allowed 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.588 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.7 OUTLIER -39.49 -67.46 0.28 Allowed Pre-proline 0 N--CA 1.463 0.18 0 CA-C-N 117.758 0.254 . . . . 0.0 111.466 -179.107 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.7 Cg_endo -70.43 76.39 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.311 2.007 . . . . 0.0 112.18 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.858 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -76.94 141.92 40.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.989 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.507 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 4.4 mmmp? -67.41 69.67 0.1 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.454 0.645 . . . . 0.0 110.615 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.816 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.8 m 58.5 162.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.15 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.651 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.8 -27.47 12.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.733 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.494 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 15.6 pt-20 -58.36 -49.69 76.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.555 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.507 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -73.54 -32.27 64.11 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.07 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.972 HG21 HG21 ' A' ' 24' ' ' ILE . 60.6 t -64.79 -39.65 86.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.888 0.375 . . . . 0.0 110.62 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.802 ' HB1' ' CG ' ' A' ' 10' ' ' ARG . . . -63.69 -49.54 72.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -68.46 -41.11 80.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.168 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.8 m -58.85 -51.63 69.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.513 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.651 HG23 ' HB1' ' A' ' 54' ' ' ALA . 75.0 mt -59.17 -53.57 46.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.316 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 72' ' ' ALA . 11.1 m -59.82 -42.1 87.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.945 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -61.54 -53.45 56.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.679 0.276 . . . . 0.0 111.513 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.478 ' HE3' ' HB ' ' A' ' 57' ' ' VAL . 27.7 mtpp -71.85 -39.68 69.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.597 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.92 69.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.812 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.34 -55.4 0.41 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.808 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 17.9 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.958 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.8 p . . . . . 0 C--O 1.213 -0.828 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 46.2 tttm -44.72 -47.05 10.7 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.798 -0.761 . . . . 0.0 108.999 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.39 -34.33 54.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.759 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.706 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 65.4 m-20 -63.03 -52.05 64.38 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.534 HG13 HG22 ' A' ' 5' ' ' VAL . 31.1 mt -66.23 -47.7 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.838 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 42.3 ttp180 -55.02 -28.85 55.29 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.98 -43.93 92.62 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 68.7 mt-30 -67.08 -30.83 70.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.746 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 9' ' ' ILE . 68.0 mt -70.77 -42.64 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.781 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.2 mm -57.82 -53.53 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.359 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.27 -37.56 92.99 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.011 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.41 -30.91 69.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.072 0.463 . . . . 0.0 111.081 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.103 HD22 HD12 ' A' ' 24' ' ' ILE . 46.5 mt -81.27 -29.44 34.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.513 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.82 125.25 21.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.716 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.62 -35.2 3.11 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.465 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.655 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.37 -176.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.842 0.353 . . . . 0.0 111.378 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.577 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.85 -119.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 177.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.729 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -59.66 177.44 0.27 Allowed Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.877 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 53.6 Cg_endo -65.11 65.86 0.31 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 CA-C-N 119.949 1.017 . . . . 0.0 112.372 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.103 HD12 HD22 ' A' ' 17' ' ' LEU . 26.9 mm 109.53 61.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 178.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.696 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.7 m120 -63.14 65.23 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.589 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.8 p 57.37 154.33 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.68 ' O ' ' CB ' ' A' ' 31' ' ' MET . 61.6 Cg_exo -48.21 -32.32 18.99 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.23 1.287 . . . . 0.0 112.748 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -53.0 -57.32 10.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.431 0.634 . . . . 0.0 110.591 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.6 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.1 tp10 -76.27 -57.65 3.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.901 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.2 pp -50.12 -35.15 24.58 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.68 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 30.8 ttm -66.96 -37.01 83.49 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.19 -23.98 64.9 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.659 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.655 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -74.0 -46.59 42.67 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 30' ' ' LEU . 5.6 mp -36.08 144.91 0.24 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 121.241 0.543 . . . . 0.0 112.404 -177.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.8 Cg_endo . . . . . 0 C--N 1.348 0.543 0 C-N-CA 124.202 3.268 . . . . 0.0 115.141 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.553 HG22 HD23 ' A' ' 34' ' ' LEU . 3.9 t . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.785 0.326 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 m -79.82 126.86 31.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.392 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.2 m -101.61 42.71 1.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.185 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.572 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . 22.5 pttp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.634 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.908 ' C ' HD22 ' A' ' 49' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.488 0.661 . . . . 0.0 112.271 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.908 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -143.95 133.28 23.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.721 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 60.6 pttt -169.73 -170.57 1.06 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 111.472 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.505 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -62.2 -52.4 63.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.414 ' OG ' ' HE3' ' A' ' 50' ' ' LYS . 85.3 p -72.74 -51.23 20.01 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.42 ' OD1' ' CE ' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -69.15 -49.92 52.47 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.717 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -90.81 -45.67 8.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -54.22 -21.66 19.5 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.985 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -44.07 -31.4 0.92 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.016 0.436 . . . . 0.0 111.072 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.9 m -77.65 27.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.636 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.536 HD21 HG22 ' A' ' 74' ' ' THR . 34.6 mt -129.33 117.32 20.45 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.922 0.391 . . . . 0.0 110.637 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.445 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 72.6 p -71.84 158.26 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.615 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.73 -39.38 51.75 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.369 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -50.92 -27.28 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.035 0.445 . . . . 0.0 110.737 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.555 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 61.2 m-20 -70.73 3.68 3.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.458 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.676 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -42.12 -69.4 0.22 Allowed Pre-proline 0 C--O 1.226 -0.147 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.378 -179.244 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 51.6 Cg_endo -68.2 76.55 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.254 1.97 . . . . 0.0 111.475 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.2 OUTLIER -77.01 142.63 39.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.137 -178.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 87.6 tttt -69.8 64.97 0.21 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.818 0.818 . . . . 0.0 111.24 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.877 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 64.8 m 64.07 161.25 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.728 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.553 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -53.38 -27.2 22.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.765 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -65.12 -39.35 92.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.17 0.509 . . . . 0.0 109.666 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 8.0 tp10 -66.23 -43.53 86.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.681 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.986 ' CG2' HG21 ' A' ' 24' ' ' ILE . 63.2 t -67.74 -41.1 84.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.544 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.857 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -55.9 -44.67 78.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.08 0.467 . . . . 0.0 110.015 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.47 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.3 m-20 -72.71 -46.66 52.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.17 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.536 HG22 HD21 ' A' ' 58' ' ' LEU . 62.6 m -56.48 -48.78 76.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.708 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.477 HG23 ' CB ' ' A' ' 54' ' ' ALA . 68.3 mt -62.58 -54.31 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.656 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 72' ' ' ALA . 12.9 m -60.12 -42.07 88.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 75.4 m-20 -62.65 -50.6 70.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.685 0.279 . . . . 0.0 111.483 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HB2' HG21 ' A' ' 57' ' ' VAL . 67.7 mttm -72.13 -43.01 65.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.794 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.542 ' HB1' HD12 ' A' ' 49' ' ' LEU . . . -67.54 -30.06 69.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.38 -56.56 0.41 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.869 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.5 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.083 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.713 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.5 p . . . . . 0 C--O 1.214 -0.806 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HE2' ' NH2' ' A' ' 10' ' ' ARG . 82.3 tttt -45.12 -43.24 9.58 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -77.72 -37.14 50.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.836 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.713 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 10.4 m-20 -62.6 -51.77 66.0 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.484 HG13 HG22 ' A' ' 5' ' ' VAL . 30.2 mt -63.92 -45.76 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.756 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 28.3 ttm180 -56.25 -29.95 61.76 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.4 -41.13 98.21 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 68.1 mt-30 -68.9 -30.12 68.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.747 -0.727 . . . . 0.0 109.755 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 10' ' ' ARG . 70.1 mt -71.17 -45.6 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.829 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 14' ' ' ILE . 9.9 mm -58.2 -52.55 57.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.34 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.44 -37.47 94.49 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.351 -0.928 . . . . 0.0 110.815 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.62 -31.0 70.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.176 -0.512 . . . . 0.0 110.785 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.026 HD22 HD12 ' A' ' 24' ' ' ILE . 64.2 mt -80.87 -29.34 35.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.574 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.95 138.08 49.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.15 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.66 -33.14 6.53 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.798 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.717 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.4 -177.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.951 0.405 . . . . 0.0 111.62 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.606 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -59.81 -122.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.389 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.83 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -59.68 -171.5 0.03 OUTLIER Pre-proline 0 N--CA 1.454 -0.227 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.835 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.3 Cg_endo -70.02 62.66 1.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 120.718 1.292 . . . . 0.0 112.012 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.052 HG21 HG21 ' A' ' 71' ' ' VAL . 49.3 mm 109.57 65.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.647 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -63.73 65.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 O-C-N 122.038 -0.414 . . . . 0.0 111.857 178.438 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.603 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 35.8 p 60.1 154.54 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.606 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 52.0 Cg_exo -49.57 -33.32 30.49 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.197 1.265 . . . . 0.0 112.715 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -53.99 -54.88 32.97 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.649 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.647 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 5.9 tp10 -75.2 -57.76 3.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.915 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.27 -41.87 51.2 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.758 ' N ' HD12 ' A' ' 30' ' ' LEU . 36.1 ttm -64.29 -32.34 73.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -70.3 -28.75 65.43 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.399 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -71.0 -35.92 72.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.59 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.712 ' HB3' HG22 ' A' ' 40' ' ' THR . 8.8 mp -29.27 139.29 0.12 Allowed Pre-proline 0 N--CA 1.471 0.625 0 CA-C-O 121.078 0.466 . . . . 0.0 112.178 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo . . . . . 0 C--N 1.348 0.526 0 C-N-CA 124.281 3.321 . . . . 0.0 115.868 -177.338 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.712 HG22 ' HB3' ' A' ' 34' ' ' LEU . 8.8 t . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.751 0.31 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.458 ' OG1' ' HD2' ' A' ' 50' ' ' LYS . 29.2 m -92.72 125.1 37.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.148 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -93.41 41.31 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 60.8 pttt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.183 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.882 ' C ' HD22 ' A' ' 49' ' ' LEU . 69.0 mt-10 . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.758 0.313 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.5 mm? -142.14 135.05 28.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.591 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.53 ' NZ ' ' HB2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -171.64 -171.96 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.967 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.425 ' O ' ' CA ' ' A' ' 55' ' ' GLY . . . -69.38 -50.12 49.06 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.472 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 35.4 t -66.47 -48.6 69.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.809 0.338 . . . . 0.0 111.562 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.439 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 28.8 m-20 -70.32 -54.14 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.744 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -94.6 -46.85 6.78 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -47.23 -26.1 3.1 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.871 -0.681 . . . . 0.0 113.047 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -43.69 -30.13 0.59 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 111.647 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 54' ' ' ALA . 29.7 m -74.16 28.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.773 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 22.2 mt -132.67 116.37 16.55 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.4 p -70.85 155.93 40.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 111.698 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.28 -39.42 21.54 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.438 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -50.84 -27.64 7.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.941 0.401 . . . . 0.0 110.578 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.593 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.4 m-20 -71.59 3.17 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.083 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.603 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.2 OUTLIER -37.25 -53.48 2.15 Favored Pre-proline 0 N--CA 1.463 0.204 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.435 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 3.5 Cg_endo -83.27 78.47 3.19 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.87 2.38 . . . . 0.0 112.127 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.881 ' CD2' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.19 143.52 38.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.625 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 3.3 mptp? -68.64 67.14 0.13 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.565 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.835 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 34.2 m 60.53 160.98 0.05 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.19 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.621 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.47 -31.17 22.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.431 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.499 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 22.1 pt-20 -57.52 -46.91 83.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.371 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.487 ' HG3' ' HD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -69.77 -35.63 75.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.5 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.052 HG21 HG21 ' A' ' 24' ' ' ILE . 61.6 t -61.9 -45.85 97.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 0.0 110.769 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.846 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -56.23 -49.93 72.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.986 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.51 -38.3 80.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.262 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 95.2 m -63.81 -51.36 65.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.0 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.427 HG23 ' CB ' ' A' ' 54' ' ' ALA . 70.2 mt -59.3 -52.17 63.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.269 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 72' ' ' ALA . 6.8 m -59.51 -39.91 80.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -62.36 -56.1 21.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.77 0.319 . . . . 0.0 111.702 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.549 ' HB2' HG21 ' A' ' 57' ' ' VAL . 98.6 mttt -69.46 -39.78 77.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.831 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.744 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.08 -29.86 69.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.134 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.76 -55.43 0.42 Allowed Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.273 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.5 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.292 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.745 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.5 p . . . . . 0 C--O 1.213 -0.842 0 CA-C-O 120.062 -0.018 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.579 ' HA ' HD13 ' A' ' 81' ' ' LEU . 81.4 tttt -45.66 -51.13 12.75 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -77.87 -28.57 50.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.843 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.745 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 3.8 t70 -65.77 -52.65 49.19 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.505 HG13 HG22 ' A' ' 5' ' ' VAL . 15.3 mt -65.4 -42.22 92.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.903 ' NH2' HG21 ' A' ' 13' ' ' ILE . 3.1 tpt180 -60.25 -26.0 66.12 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.93 -44.74 94.13 Favored Glycine 0 CA--C 1.503 -0.675 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 23.3 mt-30 -63.43 -27.51 69.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.768 -0.716 . . . . 0.0 109.329 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.903 HG21 ' NH2' ' A' ' 10' ' ' ARG . 64.3 mt -75.03 -47.3 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.721 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.455 ' HA ' HD13 ' A' ' 14' ' ' ILE . 4.7 mm -56.4 -52.2 55.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 120.749 0.309 . . . . 0.0 110.2 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.23 -37.08 94.31 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -62.25 -27.34 68.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.184 -0.508 . . . . 0.0 110.834 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.055 HD22 HD12 ' A' ' 24' ' ' ILE . 40.4 mt -80.5 -29.52 37.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.283 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.42 133.38 49.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.871 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.17 -34.03 5.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.465 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.694 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.37 -178.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.838 0.351 . . . . 0.0 111.348 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.605 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.6 m-20 -60.88 -120.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.746 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -59.44 179.8 0.18 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.816 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 50.0 Cg_endo -65.46 63.98 0.37 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 CA-C-N 119.827 0.974 . . . . 0.0 112.363 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.055 HD12 HD22 ' A' ' 17' ' ' LEU . 33.7 mm 108.65 60.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.605 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.6 m120 -62.48 65.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.584 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 61.5 p 57.64 154.42 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.635 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 60.2 Cg_exo -48.93 -32.44 22.99 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.305 1.336 . . . . 0.0 112.689 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -53.04 -57.38 10.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.41 0.624 . . . . 0.0 110.415 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.593 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 41.4 tp10 -76.2 -57.6 3.77 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.892 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.16 -43.05 52.02 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.735 ' HA ' HD13 ' A' ' 34' ' ' LEU . 43.0 ttm -66.01 -31.58 72.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -67.2 -31.11 71.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.371 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.694 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -69.75 -39.03 76.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.284 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.1 mp -30.0 137.33 0.17 Allowed Pre-proline 0 N--CA 1.47 0.546 0 CA-C-O 121.026 0.441 . . . . 0.0 111.831 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo . . . . . 0 C--N 1.348 0.536 0 C-N-CA 123.842 3.028 . . . . 0.0 115.754 -177.259 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.729 0.299 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 7.8 m -84.72 125.75 32.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.509 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.2 m -92.16 45.99 1.24 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.98 0.419 . . . . 0.0 110.094 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.439 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 22.2 pttp . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.083 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.903 ' C ' HD22 ' A' ' 49' ' ' LEU . 26.7 mt-10 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.746 0.308 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.903 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.1 mm? -141.38 128.98 21.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.167 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 22.5 pttp -168.47 157.88 9.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.612 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.461 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.75 -37.63 13.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.134 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.0 t -63.81 -52.48 60.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -72.25 -50.69 25.36 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.892 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -91.91 -47.15 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.81 -29.6 2.06 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.052 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -45.55 -30.93 1.6 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.074 0.464 . . . . 0.0 111.17 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.8 m -75.11 28.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.666 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.576 HD13 ' CE2' ' A' ' 65' ' ' PHE . 38.5 mt -132.26 116.47 16.96 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.2 p -73.19 156.1 38.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.944 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.67 -37.3 12.63 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.018 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -51.0 -29.21 11.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.146 0.498 . . . . 0.0 110.187 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.605 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -72.05 3.6 4.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.556 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.584 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.1 t80 -38.99 -51.86 3.95 Favored Pre-proline 0 CA--C 1.527 0.092 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 86.5 Cg_endo -87.62 78.89 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.923 2.416 . . . . 0.0 112.061 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.944 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.14 140.59 40.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.971 0.415 . . . . 0.0 111.448 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 27.3 tptp -66.48 69.95 0.07 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.753 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.816 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 38.0 m 58.07 161.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.796 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.715 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.74 -30.12 21.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.935 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 10.7 pt-20 -57.41 -47.62 81.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.678 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -72.87 -37.89 67.18 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.724 -179.68 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.982 ' CG2' HG21 ' A' ' 24' ' ' ILE . 42.9 t -60.1 -34.56 57.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.934 0.397 . . . . 0.0 110.693 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.752 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -68.72 -56.03 9.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.463 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.4 m-20 -66.19 -35.09 79.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.584 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.5 m -62.58 -49.98 73.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.903 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.676 HD12 HH22 ' A' ' 10' ' ' ARG . 73.0 mt -64.12 -51.02 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -52.38 -38.5 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.206 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -60.63 -55.26 35.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 111.319 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB2' HG21 ' A' ' 57' ' ' VAL . 62.0 mttp -71.91 -38.66 69.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.832 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.738 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.84 -30.11 70.2 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.2 -55.47 0.43 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 119.869 -1.158 . . . . 0.0 113.477 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.643 HD12 HG12 ' A' ' 76' ' ' VAL . 14.1 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.25 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.73 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p . . . . . 0 C--O 1.216 -0.68 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 62.9 tttp -45.33 -48.71 13.17 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.082 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -77.7 -30.1 51.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.835 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.73 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 23.0 m-20 -65.21 -52.07 57.06 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.883 HD13 HD23 ' A' ' 49' ' ' LEU . 23.9 mt -69.74 -48.45 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.779 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 23.2 ttp180 -56.17 -28.57 58.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.04 -44.32 91.67 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.52 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 66.2 mt-30 -66.38 -32.16 73.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.818 -0.691 . . . . 0.0 109.826 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 70.5 mt -70.58 -48.22 60.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.187 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 69' ' ' GLU . 7.5 mm -53.94 -54.19 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.275 . . . . 0.0 110.8 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.7 -36.17 92.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.956 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -63.9 -22.06 66.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.115 -0.543 . . . . 0.0 111.478 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.043 HD22 HD12 ' A' ' 24' ' ' ILE . 56.0 mt -90.44 -29.64 17.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.882 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 83.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.803 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 169.34 -38.48 0.2 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.384 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.749 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.38 -177.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.555 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -58.3 -120.52 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.71 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -58.69 175.46 0.32 Allowed Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 176.492 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.899 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 39.4 Cg_endo -63.89 65.41 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 120.853 1.036 . . . . 0.0 112.835 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.128 HG23 HD22 ' A' ' 30' ' ' LEU . 11.1 mm 109.84 61.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 177.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.587 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 3.1 m120 -65.81 64.06 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.668 ' C ' HD23 ' A' ' 30' ' ' LEU . 87.6 p 57.43 150.53 0.06 OUTLIER Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.88 ' O ' ' HB2' ' A' ' 31' ' ' MET . 86.9 Cg_exo -46.15 -28.5 5.54 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.09 1.86 . . . . 0.0 112.654 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -55.87 -57.31 12.61 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.579 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 5.6 tp10 -77.38 -57.37 3.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.128 HD22 HG23 ' A' ' 24' ' ' ILE . 1.4 pp -50.04 -34.36 21.24 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.68 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.88 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -77.87 -29.87 50.57 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -61.79 -28.2 69.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.749 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -81.95 -35.95 28.5 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.066 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 31' ' ' MET . 6.4 mp -33.29 130.48 0.37 Allowed Pre-proline 0 N--CA 1.467 0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 111.689 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo . . . . . 0 C--N 1.349 0.577 0 C-N-CA 123.503 2.802 . . . . 0.0 114.358 -178.379 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.569 HG22 HD23 ' A' ' 34' ' ' LEU . 5.2 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.83 0.348 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.5 m -101.03 95.41 6.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.722 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.4 m -72.38 57.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.9 0.381 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 8.8 ptpp? . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.267 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.829 ' C ' HD22 ' A' ' 49' ' ' LEU . 31.5 mt-10 . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.883 HD23 HD13 ' A' ' 9' ' ' ILE . 2.4 mm? -133.41 139.85 46.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.998 0.427 . . . . 0.0 111.648 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 56.1 pttt -177.96 -164.72 0.09 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.69 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.758 ' HB1' ' HB3' ' A' ' 27' ' ' PRO . . . -77.58 -44.67 27.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.373 0.606 . . . . 0.0 111.505 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.404 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 23.2 t -59.63 -56.37 22.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.365 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.424 ' OD2' ' HE2' ' A' ' 50' ' ' LYS . 58.7 m-20 -72.78 -54.33 9.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.76 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -91.45 -43.21 9.85 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -45.62 -25.6 1.49 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.095 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -43.93 -40.16 4.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.144 0.497 . . . . 0.0 110.91 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 54' ' ' ALA . 35.4 m -65.68 -32.59 58.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.157 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.762 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 38.7 mt -71.36 70.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.183 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.402 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 71.7 p -47.94 156.8 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.595 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -43.63 -40.67 4.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.005 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -50.97 -27.92 8.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.886 0.374 . . . . 0.0 110.849 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.618 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 57.2 m-20 -73.33 3.45 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.625 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -40.82 -66.8 0.35 Allowed Pre-proline 0 N--CA 1.463 0.194 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.125 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 70.2 Cg_endo -72.93 75.97 2.61 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.408 2.072 . . . . 0.0 111.953 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.969 ' CG ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -77.01 142.37 39.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.357 -179.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.494 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 84.2 tttt -67.73 71.48 0.14 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.391 0.615 . . . . 0.0 110.703 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.899 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.7 m 59.31 161.37 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.003 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.73 -30.43 22.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.646 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.484 ' HA ' HD11 ' A' ' 14' ' ' ILE . 15.5 pt-20 -58.28 -47.63 83.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.636 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.571 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -74.38 -31.68 62.46 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.635 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.972 ' CG2' HG21 ' A' ' 24' ' ' ILE . 60.9 t -66.64 -51.68 53.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.779 ' HB1' ' HG2' ' A' ' 10' ' ' ARG . . . -55.61 -42.14 74.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 109.801 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.431 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 47.5 t0 -64.52 -46.46 82.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.218 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.47 HG22 HD21 ' A' ' 58' ' ' LEU . 98.6 m -58.81 -47.52 84.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.949 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 69.7 mt -57.31 -49.56 79.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.507 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 15.6 m -63.4 -40.41 88.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.431 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.5 m-20 -64.63 -55.94 17.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.57 -40.49 73.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.608 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.1 -30.0 69.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.26 -56.01 0.38 Allowed Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.214 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.0 mt . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.323 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.72 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.6 p . . . . . 0 C--O 1.213 -0.846 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.733 ' HE3' HG21 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -44.62 -50.47 9.75 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -77.46 -30.29 53.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.968 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.72 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 71.5 m-20 -64.41 -52.28 58.93 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.487 HG13 ' CG2' ' A' ' 5' ' ' VAL . 15.9 mt -63.75 -43.79 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.898 ' NH2' HG21 ' A' ' 13' ' ' ILE . 0.7 OUTLIER -59.26 -25.94 64.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.008 178.036 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.91 -45.15 89.78 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' A' ' 42' ' ' CYS . 75.8 mt-30 -64.3 -29.87 70.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.739 -0.731 . . . . 0.0 109.724 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.898 HG21 ' NH2' ' A' ' 10' ' ' ARG . 75.7 mt -74.94 -46.15 41.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.863 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.454 ' HA ' HD13 ' A' ' 14' ' ' ILE . 5.1 mm -55.25 -53.09 38.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 110.397 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.4 -34.94 90.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.239 -0.981 . . . . 0.0 110.772 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.77 67.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.315 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.077 HD22 HD12 ' A' ' 24' ' ' ILE . 38.4 mt -83.2 -29.74 28.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 110.47 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.16 117.08 5.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.569 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.82 -36.22 1.96 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.455 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.674 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -53.92 -172.37 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.477 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.571 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -62.06 -119.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.776 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -60.79 179.62 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.815 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.7 Cg_endo -65.39 66.76 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 120.778 0.986 . . . . 0.0 112.561 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.077 HD12 HD22 ' A' ' 17' ' ' LEU . 30.2 mm 108.19 61.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 22' ' ' PHE . 2.7 m120 -64.39 64.76 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.6 p 58.15 155.23 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.641 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 64.5 Cg_exo -49.17 -32.29 24.26 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.359 1.373 . . . . 0.0 112.775 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -52.82 -57.6 9.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.502 0.668 . . . . 0.0 110.333 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.591 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 46.5 tp10 -76.5 -57.78 3.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.871 HD22 HG23 ' A' ' 24' ' ' ILE . 3.6 pp -50.12 -41.68 49.09 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.729 ' HA ' HD13 ' A' ' 34' ' ' LEU . 39.5 ttm -66.55 -32.46 73.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.3 -30.77 71.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.462 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.674 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -69.93 -40.77 75.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.403 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.729 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.1 mp -28.24 127.34 0.22 Allowed Pre-proline 0 N--CA 1.468 0.453 0 CA-C-O 121.061 0.458 . . . . 0.0 111.871 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 C--N 1.349 0.573 0 C-N-CA 123.513 2.809 . . . . 0.0 114.119 -178.354 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.521 -0.138 0 CA-C-O 120.852 0.358 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.419 ' CG2' ' HB3' ' A' ' 48' ' ' GLU . 28.5 m -102.73 91.33 4.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.757 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.424 ' HB3' ' OE1' ' A' ' 12' ' ' GLN . 59.3 m -70.24 57.96 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.921 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.44 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.1 pttp . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.189 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.888 ' C ' HD22 ' A' ' 49' ' ' LEU . 8.9 mp0 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.945 0.403 . . . . 0.0 111.533 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.888 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -144.66 135.44 24.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.661 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.571 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 57.9 pttt -171.66 -176.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.976 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.472 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -66.91 -41.78 86.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.129 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -63.87 -56.13 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.435 ' OD2' ' HE2' ' A' ' 50' ' ' LYS . 59.6 m-20 -72.28 -44.87 62.14 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.613 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -90.25 -49.76 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.95 -28.42 1.77 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.503 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 15.8 pt20 -42.85 -35.61 1.24 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.078 0.466 . . . . 0.0 111.707 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 54' ' ' ALA . 24.6 m -65.53 -33.26 62.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.92 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.678 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 34.8 mt -63.88 124.26 21.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 110.638 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.6 p -75.13 155.91 36.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.444 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.17 -41.42 60.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.403 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -57.28 -21.79 37.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.078 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.599 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 16.6 m-20 -69.13 3.33 2.18 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.3 m-85 -41.71 -66.67 0.38 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 118.055 0.389 . . . . 0.0 111.35 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 56.8 Cg_endo -69.54 74.89 1.16 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.337 2.025 . . . . 0.0 112.064 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.913 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -76.95 142.89 39.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.221 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.505 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 14.3 mmmm -68.34 70.53 0.17 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.484 0.659 . . . . 0.0 110.509 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.815 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 46.2 m 58.41 160.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.948 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.704 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.65 -27.37 11.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.803 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.2 pt-20 -58.94 -48.39 81.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.525 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.505 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -73.78 -35.29 64.93 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.065 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.977 ' CG2' HG21 ' A' ' 24' ' ' ILE . 49.0 t -62.23 -36.51 74.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.022 0.439 . . . . 0.0 110.431 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.865 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -66.11 -57.64 7.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.259 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 m-20 -63.88 -42.13 97.56 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.55 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.3 m -55.01 -48.35 73.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.96 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.613 HG23 ' HB1' ' A' ' 54' ' ' ALA . 83.1 mt -64.32 -50.49 76.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.733 HG21 ' HE3' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -51.78 -38.07 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.37 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.0 m-20 -63.97 -51.86 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.19 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.439 ' HB2' HG21 ' A' ' 57' ' ' VAL . 61.3 mttp -70.64 -41.97 71.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.682 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.504 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.45 -29.95 69.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.964 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.53 -54.08 0.47 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.969 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 6' ' ' LYS . 15.1 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.166 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.758 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.5 p . . . . . 0 C--O 1.217 -0.638 0 N-CA-C 111.278 0.103 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 39.2 tttm -45.3 -52.24 9.98 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -78.3 -25.94 46.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.29 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.758 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 54.8 t0 -68.03 -52.69 32.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.858 0.361 . . . . 0.0 111.882 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.511 HG13 HG22 ' A' ' 5' ' ' VAL . 14.4 mt -64.66 -44.49 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.85 ' HD2' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -59.62 -26.65 65.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.822 177.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.07 -42.89 99.47 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 71.0 mt-30 -64.37 -27.71 69.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.429 -0.885 . . . . 0.0 109.508 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.808 HD12 ' NE ' ' A' ' 10' ' ' ARG . 61.5 mt -74.89 -45.3 43.76 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.285 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.588 HD11 ' HB2' ' A' ' 72' ' ' ALA . 15.1 mm -56.84 -54.21 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.811 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.61 -36.6 93.56 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.299 -0.953 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -65.0 -24.57 67.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.131 -0.534 . . . . 0.0 111.392 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.078 HD22 HD12 ' A' ' 24' ' ' ILE . 48.4 mt -84.2 -29.83 26.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.831 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.67 124.14 18.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.971 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.64 -34.1 3.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.852 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.714 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -53.23 -174.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 0.0 111.583 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.604 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 9.3 m-20 -61.45 -118.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.753 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -59.73 179.51 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 176.331 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.813 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 55.6 Cg_endo -65.99 66.3 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.901 1.0 . . . . 0.0 112.213 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.078 HD12 HD22 ' A' ' 17' ' ' LEU . 42.8 mm 109.29 61.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.652 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.4 m120 -63.23 66.11 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.61 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 57.6 p 57.26 155.93 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.756 ' O ' ' HB2' ' A' ' 31' ' ' MET . 55.6 Cg_exo -49.6 -32.94 29.47 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.365 1.377 . . . . 0.0 113.054 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -53.33 -57.29 11.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.375 0.607 . . . . 0.0 110.561 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.598 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 40.6 tp10 -74.96 -57.05 4.14 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.899 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.5 pp -49.92 -42.32 48.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.776 ' HA ' HD13 ' A' ' 34' ' ' LEU . 27.0 mtm -64.67 -31.96 73.41 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -66.01 -28.66 69.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.48 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -74.46 -38.96 62.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.776 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.2 mp -33.2 131.96 0.35 Allowed Pre-proline 0 N--CA 1.469 0.482 0 CA-C-O 121.128 0.49 . . . . 0.0 111.803 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 C--N 1.349 0.579 0 C-N-CA 124.1 3.2 . . . . 0.0 115.172 -177.633 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.514 HG22 HD23 ' A' ' 34' ' ' LEU . 2.7 t . . . . . 0 C--O 1.231 0.109 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.473 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 19.8 m -93.77 123.17 36.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.404 ' CB ' HG23 ' A' ' 9' ' ' ILE . 60.0 m -91.04 45.91 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 0.0 110.609 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.468 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.171 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.885 ' C ' HD22 ' A' ' 49' ' ' LEU . 35.6 mt-10 . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.885 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -138.09 139.33 39.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.128 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.473 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 59.1 pttt -178.83 157.52 0.91 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.891 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.583 ' HB3' ' CG ' ' A' ' 31' ' ' MET . . . -47.73 -27.77 2.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.89 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 t -71.99 -61.31 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 59.9 m-20 -72.41 -54.52 9.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.697 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -73.35 -43.39 60.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.87 -22.71 3.06 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.326 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 26.5 pt20 -41.22 -40.71 1.67 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.08 0.467 . . . . 0.0 111.691 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.7 m -65.79 -30.64 50.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.256 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.609 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 14.3 mt -72.2 113.58 9.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.738 0.304 . . . . 0.0 110.458 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.7 p -79.52 158.39 27.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.453 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.51 -40.16 12.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.248 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -53.06 -26.97 17.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.652 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.5 m-20 -71.08 3.16 3.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.217 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.61 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -38.87 -64.68 0.46 Allowed Pre-proline 0 N--CA 1.462 0.156 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.391 -178.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 59.3 Cg_endo -71.04 79.37 1.35 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.276 1.984 . . . . 0.0 111.444 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.609 ' CZ ' HD13 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -76.82 140.09 40.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.456 -179.245 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 2.7 mppt? -67.44 62.36 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.404 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.813 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 49.4 m 64.98 161.89 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.493 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.537 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -52.01 -28.61 17.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.679 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 15.5 pt-20 -65.3 -39.2 92.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' HG3' ' CD2' ' A' ' 65' ' ' PHE . 17.7 tp10 -63.52 -43.2 97.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.215 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.799 ' CG2' HG21 ' A' ' 24' ' ' ILE . 88.1 t -57.64 -46.59 86.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.807 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.839 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -53.77 -56.13 20.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.206 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.446 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.4 m-20 -65.61 -44.3 86.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.907 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.5 m -56.53 -47.42 79.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.191 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.706 HG22 HH12 ' A' ' 10' ' ' ARG . 65.2 mt -66.31 -51.88 53.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.85 HG13 ' HD2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -56.88 -41.85 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.973 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 77.3 m-20 -63.79 -54.58 32.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HB2' HG21 ' A' ' 57' ' ' VAL . 43.7 mtpt -74.87 -40.83 60.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 75' ' ' ILE . . . -67.06 -29.98 69.91 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.24 -52.41 0.48 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.515 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.59 ' HB2' HG12 ' A' ' 76' ' ' VAL . 15.5 mt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.354 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.705 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.1 p . . . . . 0 C--O 1.213 -0.82 0 CA-C-O 119.929 -0.081 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 48.9 tttp -44.89 -47.1 11.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -77.54 -33.35 54.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.905 177.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.705 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 16.4 m-20 -64.02 -52.24 60.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.717 HG23 ' HB2' ' A' ' 42' ' ' CYS . 30.2 mt -66.06 -47.09 86.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.871 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 45.6 ttp180 -55.26 -29.52 58.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.81 -44.49 96.12 Favored Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -67.57 -28.78 68.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.652 -0.774 . . . . 0.0 109.725 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 10' ' ' ARG . 71.3 mt -70.16 -43.03 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.4 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 69' ' ' GLU . 13.5 mm -58.45 -48.83 84.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.004 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.16 -38.38 93.84 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.448 -0.882 . . . . 0.0 110.908 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.585 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -60.75 -34.02 73.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 0.0 110.694 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.013 HD22 HD12 ' A' ' 24' ' ' ILE . 79.0 mt -83.9 -29.17 27.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.692 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.56 60.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.485 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.551 ' C ' ' HB1' ' A' ' 33' ' ' ALA . . . 179.45 31.2 0.06 OUTLIER Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.994 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 33' ' ' ALA . . . -114.45 -168.4 1.36 Allowed 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.957 0.408 . . . . 0.0 110.796 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.66 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 83.6 m-20 -59.32 -119.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.805 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -61.35 -171.16 0.04 OUTLIER Pre-proline 0 N--CA 1.454 -0.269 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 176.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.806 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.2 Cg_endo -70.89 64.21 2.46 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 120.72 1.293 . . . . 0.0 112.163 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.013 HD12 HD22 ' A' ' 17' ' ' LEU . 50.2 mm 109.0 66.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.674 ' HB2' ' CB ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -65.42 65.85 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.881 -0.512 . . . . 0.0 111.449 178.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.633 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 51.4 p 57.48 158.97 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.737 ' O ' ' HB2' ' A' ' 31' ' ' MET . 51.5 Cg_exo -50.06 -33.33 34.43 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.344 1.362 . . . . 0.0 112.819 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -51.29 -57.32 9.16 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.64 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.674 ' CB ' ' HB2' ' A' ' 25' ' ' ASN . 45.7 tp10 -75.73 -58.53 3.23 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.807 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.5 pp -50.1 -40.16 44.92 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.771 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 29.9 ttm -63.53 -35.08 79.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.33 -30.91 69.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.303 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . . . -65.34 -38.87 91.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.593 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.785 ' CG ' HG22 ' A' ' 40' ' ' THR . 6.4 mp -39.53 134.55 1.24 Allowed Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.725 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 C--N 1.349 0.588 0 C-N-CA 123.393 2.729 . . . . 0.0 112.9 -179.275 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.785 HG22 ' CG ' ' A' ' 34' ' ' LEU . 6.2 t . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.373 0.13 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 3.1 t -114.99 124.21 51.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.033 0.444 . . . . 0.0 111.295 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.717 ' HB2' HG23 ' A' ' 9' ' ' ILE . 36.0 m -75.45 59.12 1.06 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.776 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.449 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 22.3 pttp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.679 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.803 ' C ' HD22 ' A' ' 49' ' ' LEU . 55.3 mt-10 . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.724 0.297 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.803 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.6 mm? -127.88 130.15 48.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.63 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.824 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 19.1 ptpt -156.28 -165.87 2.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.582 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.771 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -78.61 -41.87 30.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.481 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.3 t -67.26 -55.61 13.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.709 0.29 . . . . 0.0 111.443 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 35.6 m-20 -69.39 -44.4 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.793 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 50' ' ' LYS . . . -92.73 -51.63 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -53.53 -22.25 16.15 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.474 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -43.35 -31.98 0.75 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 117.114 0.457 . . . . 0.0 111.203 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 54' ' ' ALA . 35.3 m -80.2 27.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.653 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 19.1 mt -132.48 109.13 9.58 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 p -68.08 156.59 37.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.825 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.23 -37.99 17.38 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.077 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -52.56 -26.22 12.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.63 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.565 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -72.24 3.07 4.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.295 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.633 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.5 OUTLIER -39.05 -61.12 1.0 Allowed Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.334 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.87 77.08 3.16 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.483 2.122 . . . . 0.0 111.847 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.882 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -76.63 142.53 40.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.096 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 58.1 mtpt -68.68 66.7 0.13 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.377 0.608 . . . . 0.0 110.463 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.806 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 24.2 m 61.05 161.14 0.06 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.085 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.602 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.54 -30.22 19.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.499 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 22.1 pt-20 -59.17 -45.72 90.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.483 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.533 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -70.47 -34.39 72.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.247 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.982 HG21 HG21 ' A' ' 24' ' ' ILE . 67.2 t -63.61 -41.98 94.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.015 0.436 . . . . 0.0 110.09 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.871 ' HB1' ' HG2' ' A' ' 10' ' ' ARG . . . -56.66 -50.18 72.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.785 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.49 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 24.8 m-20 -67.8 -47.31 69.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.128 0.489 . . . . 0.0 110.746 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.429 HG22 HD21 ' A' ' 58' ' ' LEU . 90.8 m -54.71 -48.97 71.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.857 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.813 HG23 ' HB1' ' A' ' 54' ' ' ALA . 67.0 mt -60.95 -56.11 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.559 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 72' ' ' ALA . 15.7 m -58.82 -40.49 80.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 77.7 m-20 -62.88 -55.17 28.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.375 . . . . 0.0 111.715 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' CB ' HG21 ' A' ' 57' ' ' VAL . 67.3 mttm -72.76 -40.16 66.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.253 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.01 -29.97 69.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.66 -56.16 0.4 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.88 -1.152 . . . . 0.0 113.41 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.448 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 22.9 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.401 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.734 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p . . . . . 0 C--O 1.215 -0.748 0 CA-C-O 120.12 0.01 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.654 ' HE2' HG21 ' A' ' 76' ' ' VAL . 12.3 tmtt? -45.35 -51.67 10.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.9 -25.94 48.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.115 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.734 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 33.1 m-20 -67.86 -52.57 35.12 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.455 HG13 HG22 ' A' ' 5' ' ' VAL . 12.8 mt -65.7 -43.01 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.888 ' NH2' HG21 ' A' ' 13' ' ' ILE . 2.8 tpt180 -59.42 -29.07 67.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.62 -43.32 99.42 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.46 ' NE2' ' HB3' ' A' ' 42' ' ' CYS . 6.4 tt0 -64.32 -29.01 70.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.334 177.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.888 HG21 ' NH2' ' A' ' 10' ' ' ARG . 63.6 mt -74.37 -45.9 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.821 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.452 ' HA ' HD13 ' A' ' 14' ' ' ILE . 4.6 mm -56.42 -50.3 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.776 0.322 . . . . 0.0 110.329 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.47 -36.34 93.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.348 -0.93 . . . . 0.0 110.892 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HB1' HD23 ' A' ' 34' ' ' LEU . . . -65.07 -27.22 68.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.222 -0.489 . . . . 0.0 111.251 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.013 HD22 ' CD1' ' A' ' 24' ' ' ILE . 49.9 mt -84.13 -26.22 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.72 61.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.381 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 174.14 35.02 0.04 OUTLIER Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.826 ' HB2' ' HB2' ' A' ' 33' ' ' ALA . . . -106.0 -175.97 2.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 110.99 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.594 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 53.4 m-20 -52.72 -66.97 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.758 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -116.86 -174.33 0.27 Allowed Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.825 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.7 Cg_endo -68.86 59.09 1.18 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-N 120.512 1.218 . . . . 0.0 111.987 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.013 ' CD1' HD22 ' A' ' 17' ' ' LEU . 24.7 mm 110.76 61.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.645 ' CB ' ' HB3' ' A' ' 29' ' ' GLU . 2.7 m120 -64.14 64.42 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.595 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.2 p 58.66 150.73 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.634 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 72.3 Cg_exo -46.77 -31.68 11.05 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.639 1.559 . . . . 0.0 112.984 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -55.54 -57.68 10.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.614 0.721 . . . . 0.0 110.338 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.645 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.0 tp10 -74.42 -57.08 4.17 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.557 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.982 HD13 HD21 ' A' ' 17' ' ' LEU . 3.3 pp -49.96 -36.54 28.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.663 ' HG2' ' HB3' ' A' ' 51' ' ' ALA . 55.2 mtm -64.04 -37.59 87.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.98 -24.55 65.16 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.477 0.656 . . . . 0.0 109.771 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.826 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . . . -63.88 -50.83 67.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.653 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 30' ' ' LEU . 6.1 mp -43.25 139.18 2.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.361 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 C--N 1.349 0.58 0 C-N-CA 123.842 3.028 . . . . 0.0 113.151 -179.586 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.483 HG22 HD23 ' A' ' 34' ' ' LEU . 2.7 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.871 0.367 . . . . 0.0 111.905 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.511 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 7.3 m -82.74 115.09 21.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.433 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.46 ' HB3' ' NE2' ' A' ' 12' ' ' GLN . 32.3 m -89.2 50.56 1.96 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.018 0.437 . . . . 0.0 110.383 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.452 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.5 pttm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.975 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.846 ' C ' HD22 ' A' ' 49' ' ' LEU . 51.0 mt-10 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.786 0.327 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.846 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.9 mm? -135.24 137.26 42.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.672 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 63.6 pttt -175.87 155.6 1.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.645 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.663 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.62 -39.39 16.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.05 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.6 t -63.53 -49.85 71.89 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.437 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.19 -53.86 11.37 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.781 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -92.23 -46.51 7.69 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.93 -29.54 2.12 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.089 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -45.27 -30.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.507 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 54' ' ' ALA . 33.2 m -77.16 27.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.649 HD13 ' CE2' ' A' ' 65' ' ' PHE . 43.2 mt -133.18 117.24 17.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.889 0.376 . . . . 0.0 110.096 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.5 p -74.55 159.52 32.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.161 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.89 -37.58 31.94 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.085 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -50.97 -29.73 13.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.104 0.478 . . . . 0.0 110.06 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.56 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.5 m-20 -72.64 3.84 4.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.533 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.595 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.5 t80 -39.84 -51.8 5.33 Favored Pre-proline 0 C--O 1.226 -0.147 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 81.4 Cg_endo -87.74 77.31 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.832 2.355 . . . . 0.0 112.131 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.891 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.18 143.46 39.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.215 0.531 . . . . 0.0 111.87 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -68.28 70.8 0.17 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.742 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.825 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 21.7 m 57.04 163.66 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.203 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.597 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.89 -31.97 30.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.201 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -57.26 -49.17 76.9 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.547 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -72.49 -34.69 67.84 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.084 -179.475 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.001 ' CG2' HG21 ' A' ' 24' ' ' ILE . 62.1 t -65.19 -37.02 79.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.817 0.341 . . . . 0.0 111.145 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.664 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -65.35 -55.4 18.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.973 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 m-20 -66.32 -44.85 82.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.66 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.3 m -53.92 -47.65 70.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.76 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.564 HD12 HH22 ' A' ' 10' ' ' ARG . 76.8 mt -62.98 -53.13 50.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.522 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.71 HG13 ' HD3' ' A' ' 10' ' ' ARG . 1.8 m -53.99 -39.33 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.6 m-20 -60.07 -51.92 67.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 0.0 111.753 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.505 ' HB2' HG21 ' A' ' 57' ' ' VAL . 47.7 mtpt -74.88 -40.11 61.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.757 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.81 -30.01 70.09 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.93 -54.81 0.4 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.553 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.678 HD12 HG12 ' A' ' 76' ' ' VAL . 8.7 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.099 -178.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.741 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.7 p . . . . . 0 C--O 1.214 -0.788 0 N-CA-C 111.161 0.059 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.691 ' HE2' HG21 ' A' ' 76' ' ' VAL . 12.8 tmtt? -45.34 -51.14 11.49 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -77.78 -27.97 50.39 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.066 177.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.741 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.6 m-20 -65.59 -52.38 52.58 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.479 HG13 HG22 ' A' ' 5' ' ' VAL . 16.7 mt -65.41 -43.28 94.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.893 ' NH2' HG21 ' A' ' 13' ' ' ILE . 1.1 tpt180 -60.16 -25.73 65.77 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.42 -45.18 87.69 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 178.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -64.39 -31.58 72.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.768 -0.716 . . . . 0.0 109.774 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.893 HG21 ' NH2' ' A' ' 10' ' ' ARG . 73.6 mt -73.88 -45.24 50.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.964 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HA ' HD13 ' A' ' 14' ' ' ILE . 4.0 mm -55.54 -53.33 37.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.784 0.326 . . . . 0.0 110.305 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.09 -34.59 88.53 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.739 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -65.46 -26.76 68.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.052 -0.574 . . . . 0.0 111.189 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.0 HD22 HD12 ' A' ' 24' ' ' ILE . 51.5 mt -80.21 -29.53 38.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.434 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.2 134.38 56.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.002 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.1 -32.25 6.06 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.898 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.714 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.44 -174.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.031 0.443 . . . . 0.0 111.592 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.601 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.5 m-20 -60.23 -120.31 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.806 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -62.14 -169.59 0.03 OUTLIER Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.597 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.828 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 60.3 Cg_endo -71.61 62.08 2.91 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 CA-C-N 120.888 1.353 . . . . 0.0 112.305 178.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.0 HD12 HD22 ' A' ' 17' ' ' LEU . 48.5 mm 110.59 65.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 177.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.713 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -65.68 66.26 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.976 -0.452 . . . . 0.0 111.328 178.031 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.551 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 53.9 p 59.39 156.02 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.603 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 64.9 Cg_exo -49.17 -33.73 28.55 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.45 1.433 . . . . 0.0 112.948 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.51 -54.46 36.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.04 0.448 . . . . 0.0 110.697 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.713 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 17.4 tp10 -75.93 -57.57 3.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.918 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.9 pp -50.03 -39.79 42.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.817 ' HA ' HD13 ' A' ' 34' ' ' LEU . 72.0 mtm -66.67 -32.97 74.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.51 -28.35 68.49 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 121.215 0.531 . . . . 0.0 110.253 179.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -70.28 -46.9 63.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.94 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.817 HD13 ' HA ' ' A' ' 31' ' ' MET . 8.9 mp -33.73 139.39 0.27 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 112.186 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 C--N 1.346 0.419 0 C-N-CA 124.014 3.142 . . . . 0.0 114.417 -178.045 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.682 HG22 HD23 ' A' ' 34' ' ' LEU . 1.7 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.862 0.363 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.499 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 16.8 m -81.58 118.55 22.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.265 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 61.7 m -92.34 43.79 1.14 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.256 0.55 . . . . 0.0 109.553 178.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.492 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 23.9 pttm . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.919 -179.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.882 ' C ' HD22 ' A' ' 49' ' ' LEU . 7.5 mp0 . . . . . 0 N--CA 1.461 0.114 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -141.11 140.81 34.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.094 0.473 . . . . 0.0 111.347 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 61.7 pttt -178.21 152.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.369 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.616 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.57 -30.74 3.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.005 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.3 t -69.57 -55.89 8.86 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.644 -179.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 43.2 m-20 -72.41 -51.9 18.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.798 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -84.79 -45.57 12.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.1 -28.49 1.92 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.207 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 18.1 pt20 -43.7 -31.82 0.87 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.038 0.447 . . . . 0.0 111.329 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.8 m -77.09 27.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.667 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.563 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 43.4 mt -132.3 108.37 9.17 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.236 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.3 p -66.97 155.95 37.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.849 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.63 -37.69 13.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.229 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.67 -26.46 13.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.606 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.641 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -73.21 3.17 6.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.37 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.551 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.0 OUTLIER -41.13 -61.91 1.19 Allowed Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 117.682 0.219 . . . . 0.0 111.35 -179.337 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 63.3 Cg_endo -72.67 73.95 2.83 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.441 2.094 . . . . 0.0 111.963 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.907 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -76.77 141.58 40.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.431 -179.44 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HB3' ' CG ' ' A' ' 70' ' ' GLU . 41.4 ttmt -67.8 69.07 0.11 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.398 0.618 . . . . 0.0 110.706 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.828 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 31.5 m 59.37 161.42 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.962 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.712 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.61 -29.81 18.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.757 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.469 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.0 pt-20 -58.63 -46.03 87.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.532 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.533 ' CG ' ' HB3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -73.96 -35.48 64.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.891 -179.562 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.962 HG21 HG21 ' A' ' 24' ' ' ILE . 45.7 t -62.87 -40.8 90.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.968 0.413 . . . . 0.0 110.417 179.433 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.836 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -61.73 -55.67 27.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.168 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.498 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.8 m-20 -64.11 -43.91 93.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.43 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.8 m -53.79 -46.95 71.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.926 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.553 HD12 ' NH2' ' A' ' 10' ' ' ARG . 81.0 mt -64.79 -49.95 77.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.735 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.691 HG21 ' HE2' ' A' ' 6' ' ' LYS . 1.3 m -55.77 -38.22 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.272 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.9 m-20 -63.24 -52.78 60.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 0.0 111.396 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HB2' HG21 ' A' ' 57' ' ' VAL . 95.9 mttt -72.68 -41.77 64.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.999 -179.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.637 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.3 -29.87 69.57 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.15 -54.11 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.982 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.476 HD12 HG12 ' A' ' 76' ' ' VAL . 16.0 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.193 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.751 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.4 p . . . . . 0 C--O 1.216 -0.696 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.579 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 46.9 tttm -45.67 -51.07 12.87 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.617 -0.833 . . . . 0.0 108.947 -179.325 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.78 -25.99 49.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.057 177.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.751 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.6 m-20 -68.18 -52.56 33.02 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.543 HD13 HD23 ' A' ' 49' ' ' LEU . 14.4 mt -66.02 -42.4 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.935 ' NH2' HG21 ' A' ' 13' ' ' ILE . 3.0 tpt180 -59.84 -27.18 66.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.7 177.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.02 -44.37 95.99 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 178.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -64.1 -27.68 69.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.439 177.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.935 HG21 ' NH2' ' A' ' 10' ' ' ARG . 64.4 mt -74.8 -50.25 26.32 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.86 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 14' ' ' ILE . 3.0 mm -53.77 -49.14 59.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.0 -36.67 93.79 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 178.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.839 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -63.63 -27.99 69.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.857 179.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.965 HD22 HD12 ' A' ' 24' ' ' ILE . 71.6 mt -78.8 -29.46 44.88 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.503 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.32 136.5 43.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.114 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.12 -33.5 6.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.814 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.741 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.8 -179.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 111.467 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.593 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 71.3 m-20 -58.25 -122.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.249 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.726 ' CG ' ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -62.66 -174.99 0.11 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 177.071 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.881 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 48.9 Cg_endo -66.55 61.78 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 CA-C-N 120.103 1.072 . . . . 0.0 112.723 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.998 HG21 HG21 ' A' ' 71' ' ' VAL . 36.6 mm 108.24 64.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 177.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.674 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.5 m120 -63.9 65.14 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.303 -0.248 . . . . 0.0 111.55 178.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.629 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 58.2 p 59.5 151.79 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.636 ' O ' ' HB2' ' A' ' 31' ' ' MET . 73.7 Cg_exo -46.88 -29.69 8.56 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.53 1.486 . . . . 0.0 112.642 -179.102 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.04 -57.12 13.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.511 0.672 . . . . 0.0 110.565 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.674 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 17.1 tp10 -73.39 -57.23 4.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.017 -179.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.929 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.9 pp -50.89 -38.21 48.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.636 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 61.0 mtm -67.13 -31.99 72.82 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.98 -29.69 67.96 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.65 179.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.741 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -71.48 -38.74 71.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.43 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.839 ' HG ' ' HB1' ' A' ' 16' ' ' ALA . 10.9 mp -38.37 143.77 0.41 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 121.158 0.504 . . . . 0.0 112.093 -178.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 C--N 1.35 0.608 0 C-N-CA 124.013 3.142 . . . . 0.0 114.361 -178.048 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.557 HG22 HD23 ' A' ' 34' ' ' LEU . 9.4 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.863 0.363 . . . . 0.0 111.337 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.481 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 10.9 m -82.38 126.37 32.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.357 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.9 m -93.61 47.63 1.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.04 0.448 . . . . 0.0 110.217 178.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.3 pttm . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.156 -179.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.867 ' C ' HD22 ' A' ' 49' ' ' LEU . 26.5 mt-10 . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.761 0.315 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.867 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.9 mm? -138.64 137.18 36.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.183 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.481 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 61.6 pttt -177.66 157.92 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.735 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HB3' ' CG ' ' A' ' 31' ' ' MET . . . -47.86 -37.81 14.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.937 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.4 t -61.77 -51.96 66.16 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.376 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -72.41 -54.22 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.894 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -91.51 -44.42 9.1 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.87 -28.44 1.73 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.938 -179.307 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -44.3 -31.49 1.04 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.007 0.432 . . . . 0.0 110.813 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 54' ' ' ALA . 35.9 m -76.96 27.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.352 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.696 HD23 ' O ' ' A' ' 57' ' ' VAL . 30.8 mt -134.35 92.06 2.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.913 0.387 . . . . 0.0 110.354 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.9 p -55.7 155.92 5.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.83 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.17 -36.62 8.85 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.384 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -50.81 -30.26 13.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.422 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.572 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 53.3 m-20 -72.71 3.81 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.747 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.629 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.0 t80 -38.0 -52.07 3.0 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.481 0.182 . . . . 0.0 111.396 -178.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 80.0 Cg_endo -86.39 78.42 2.09 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.681 2.254 . . . . 0.0 111.83 179.155 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.964 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -76.69 143.35 40.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.005 0.431 . . . . 0.0 111.741 -179.37 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.509 ' HB2' ' CD ' ' A' ' 70' ' ' GLU . 14.4 mmmm -67.17 70.68 0.1 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.634 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.881 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 47.5 m 58.73 158.74 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.69 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.794 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.83 -28.04 14.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.922 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.452 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.8 pt-20 -59.53 -47.39 85.71 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.419 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.509 ' CD ' ' HB2' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -72.04 -37.32 69.74 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.758 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.998 HG21 HG21 ' A' ' 24' ' ' ILE . 43.6 t -59.76 -36.28 65.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.98 0.419 . . . . 0.0 110.799 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -67.94 -57.83 5.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.442 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 m-20 -63.83 -42.29 97.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.701 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.8 m -54.01 -52.63 60.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.744 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.645 HD12 HH22 ' A' ' 10' ' ' ARG . 84.5 mt -60.03 -50.45 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.583 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.72 HG13 ' HD3' ' A' ' 10' ' ' ARG . 2.8 m -58.43 -39.75 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.32 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -52.96 -56.08 18.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.33 . . . . 0.0 110.936 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.405 ' NZ ' ' HB ' ' A' ' 57' ' ' VAL . 51.1 mtpt -75.08 -39.1 61.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.163 0.506 . . . . 0.0 110.886 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.663 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -68.87 32.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -179.164 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.97 -53.36 3.96 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.566 179.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.7 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.157 -178.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.742 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.5 p . . . . . 0 C--O 1.215 -0.753 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 40.7 tttm -44.94 -51.7 9.48 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.105 -178.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -77.84 -27.19 49.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.077 177.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.742 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.7 m-20 -67.22 -52.29 42.89 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.482 HG13 ' CG2' ' A' ' 5' ' ' VAL . 14.0 mt -63.81 -43.44 97.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.94 ' HD2' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -60.46 -26.48 66.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.582 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.2 -42.04 99.48 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 177.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 84.2 mt-30 -64.33 -28.76 69.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.362 177.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.824 HD12 ' NE ' ' A' ' 10' ' ' ARG . 67.5 mt -74.38 -46.06 44.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.234 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 72' ' ' ALA . 9.4 mm -56.99 -53.7 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.636 0.255 . . . . 0.0 110.525 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.47 -36.71 92.97 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.628 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -63.94 -27.3 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.08 -0.56 . . . . 0.0 110.92 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.015 HD22 HD12 ' A' ' 24' ' ' ILE . 61.6 mt -79.64 -29.45 40.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.448 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.96 136.66 57.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.002 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.07 -33.11 6.35 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.774 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.698 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.79 -179.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.807 0.337 . . . . 0.0 111.493 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.623 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 73.1 m-20 -59.98 -121.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.739 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -58.99 177.35 0.25 Allowed Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 176.44 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.792 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 43.5 Cg_endo -64.26 67.63 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 119.897 0.999 . . . . 0.0 112.105 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.015 HD12 HD22 ' A' ' 17' ' ' LEU . 44.4 mm 105.89 61.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 178.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.623 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.6 m120 -64.1 65.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 178.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.559 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 63.5 p 57.37 156.5 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.608 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 54.2 Cg_exo -50.43 -32.26 33.55 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.438 1.425 . . . . 0.0 112.829 -179.011 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -53.49 -57.35 10.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.452 0.644 . . . . 0.0 110.3 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.605 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -76.02 -57.98 3.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -179.272 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.861 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -50.56 -43.72 56.39 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.738 ' N ' HD12 ' A' ' 30' ' ' LEU . 30.7 ttm -65.52 -30.69 71.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.95 -29.69 66.88 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.597 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.698 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -67.76 -40.32 84.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.087 -179.414 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.733 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.1 mp -25.34 135.43 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.568 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.001 -179.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 C--N 1.349 0.566 0 C-N-CA 123.588 2.859 . . . . 0.0 115.279 -178.182 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.651 HG22 HD23 ' A' ' 34' ' ' LEU . 5.7 t . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.984 0.421 . . . . 0.0 111.767 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.54 HG23 ' HD3' ' A' ' 50' ' ' LYS . 32.2 m -100.29 121.96 42.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.902 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -92.79 46.57 1.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 110.014 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.441 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 20.8 ptmt . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.938 -179.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.866 ' C ' HD22 ' A' ' 49' ' ' LEU . 38.4 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.628 0.251 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.866 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.3 mm? -138.5 138.95 38.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.05 0.452 . . . . 0.0 110.968 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.54 ' HD3' HG23 ' A' ' 41' ' ' THR . 60.7 pttt -177.46 153.64 0.93 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.446 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.576 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.49 -29.24 2.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.809 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.417 ' HA ' ' HE1' ' A' ' 31' ' ' MET . 44.4 t -71.18 -56.06 6.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.663 0.268 . . . . 0.0 111.585 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -72.28 -54.42 9.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.35 . . . . 0.0 111.922 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.692 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -78.34 -48.08 16.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.936 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.39 -26.91 5.31 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.37 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -40.21 -35.97 0.46 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.555 0.693 . . . . 0.0 111.024 179.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 54' ' ' ALA . 11.0 m -79.14 27.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.021 -177.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.576 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 32.7 mt -130.21 109.9 11.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.934 0.397 . . . . 0.0 110.057 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.6 p -70.81 157.24 38.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.885 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.81 -36.89 12.52 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.754 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -51.32 -29.45 15.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.163 179.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.536 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.3 m-20 -72.23 3.34 4.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.597 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.559 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.0 t80 -38.37 -51.71 3.4 Favored Pre-proline 0 C--O 1.227 -0.09 0 N-CA-C 111.308 0.114 . . . . 0.0 111.308 -178.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 87.0 Cg_endo -88.08 81.45 1.03 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.837 2.358 . . . . 0.0 112.046 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.748 ' CD2' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -76.93 141.8 40.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.875 -179.855 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.535 ' CA ' ' HG2' ' A' ' 70' ' ' GLU . 47.6 mmtm -68.53 66.54 0.12 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.531 0.682 . . . . 0.0 110.516 179.005 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.792 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 15.4 m 61.34 160.93 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.197 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.652 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.46 -31.09 22.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.889 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.6 pt-20 -59.86 -47.01 87.47 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.331 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.535 ' HG2' ' CA ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -67.61 -33.38 74.88 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.36 -179.77 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.827 ' CG2' HG21 ' A' ' 24' ' ' ILE . 94.5 t -59.14 -47.08 91.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.922 0.391 . . . . 0.0 110.394 179.223 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.756 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -56.71 -55.11 38.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.311 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.47 -36.36 83.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.585 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.4 m -65.95 -49.35 68.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.026 -179.211 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.743 HG22 HH12 ' A' ' 10' ' ' ARG . 74.1 mt -59.88 -49.7 82.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.705 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.94 HG13 ' HD2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -57.49 -40.24 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.247 179.861 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -62.93 -54.7 34.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.876 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.512 ' HB2' HG21 ' A' ' 57' ' ' VAL . 96.5 mttt -74.06 -40.33 62.88 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.97 -29.91 69.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.186 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.12 -51.5 0.52 Allowed Glycine 0 CA--C 1.509 -0.342 0 C-N-CA 119.817 -1.182 . . . . 0.0 113.16 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.591 HD12 HG12 ' A' ' 76' ' ' VAL . 16.8 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.349 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.728 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.1 p . . . . . 0 C--O 1.212 -0.894 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.886 ' HE2' HG21 ' A' ' 76' ' ' VAL . 11.2 tmtt? -45.37 -49.03 13.37 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -77.37 -30.31 53.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.043 177.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.728 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 71.9 m-20 -66.44 -52.32 47.63 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.568 HG22 ' NH2' ' A' ' 10' ' ' ARG . 17.7 mt -62.26 -51.07 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.178 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.936 ' CD ' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -57.96 -25.58 61.18 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.369 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.42 -38.58 94.99 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 177.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -68.82 -35.26 76.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.383 -0.908 . . . . 0.0 110.569 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.594 HD11 ' NH2' ' A' ' 10' ' ' ARG . 11.7 mt -69.91 -43.75 79.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.442 ' HA ' HD13 ' A' ' 14' ' ' ILE . 13.4 mm -54.51 -52.46 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.717 0.294 . . . . 0.0 110.612 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.01 -37.25 94.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.935 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.52 -25.02 67.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.22 -0.49 . . . . 0.0 111.365 179.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.069 HD22 HD12 ' A' ' 24' ' ' ILE . 33.4 mt -85.82 -29.37 23.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.978 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.64 81.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.719 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.83 -35.8 0.13 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.921 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.717 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -53.03 -173.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.182 0.515 . . . . 0.0 111.904 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.588 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.7 OUTLIER -60.25 -119.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.018 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.771 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.97 179.79 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 177.033 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HD2' ' HB2' ' A' ' 22' ' ' PHE . 47.9 Cg_endo -65.23 65.34 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 120.801 1.001 . . . . 0.0 112.358 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.069 HD12 HD22 ' A' ' 17' ' ' LEU . 28.6 mm 107.78 62.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 177.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.601 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.7 m120 -63.98 64.16 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 15.7 p 59.1 152.65 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.647 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 77.8 Cg_exo -48.0 -30.47 13.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.46 1.44 . . . . 0.0 112.707 -179.245 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -54.72 -57.49 11.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.492 0.663 . . . . 0.0 110.289 179.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.601 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.3 tp10 -76.11 -57.85 3.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.054 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.861 HD13 HD21 ' A' ' 17' ' ' LEU . 3.5 pp -50.29 -45.53 54.53 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.679 ' N ' HD12 ' A' ' 30' ' ' LEU . 33.8 ttm -66.05 -29.78 70.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -69.08 -30.12 68.37 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -72.73 -38.92 67.28 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.61 HD23 HG22 ' A' ' 40' ' ' THR . 7.1 mp -27.92 128.12 0.21 Allowed Pre-proline 0 N--CA 1.47 0.563 0 CA-C-O 120.949 0.404 . . . . 0.0 111.79 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 C--N 1.349 0.591 0 C-N-CA 123.569 2.846 . . . . 0.0 114.071 -178.396 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.61 HG22 HD23 ' A' ' 34' ' ' LEU . 6.6 t . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.897 0.38 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.7 m -105.92 115.8 30.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -89.46 44.03 1.18 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.098 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.3 pttp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.255 -179.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.825 ' C ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 121.288 0.566 . . . . 0.0 111.813 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.825 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.8 mm? -136.6 141.07 43.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.366 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HE3' ' HB3' ' A' ' 52' ' ' SER . 61.6 pttt -173.4 -168.81 0.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.937 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.534 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -65.58 -46.14 80.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.867 0.365 . . . . 0.0 111.576 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.456 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.1 t -69.99 -44.45 69.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.69 0.281 . . . . 0.0 111.495 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -67.34 -53.05 32.98 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.822 0.344 . . . . 0.0 111.906 -179.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.905 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -96.2 -44.05 7.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.64 -30.67 2.28 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.425 -178.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -46.93 -33.96 5.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.105 0.479 . . . . 0.0 110.987 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 54' ' ' ALA . 29.1 m -65.6 -31.1 52.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.548 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.708 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 22.6 mt -66.66 125.39 25.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.773 0.32 . . . . 0.0 110.639 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.8 p -75.63 155.79 35.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.289 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.18 -42.09 60.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.332 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.63 -23.25 26.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.963 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.654 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 14.5 m-20 -67.89 3.16 1.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.6 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -41.03 -56.04 4.39 Favored Pre-proline 0 C--O 1.226 -0.184 0 CA-C-N 117.837 0.289 . . . . 0.0 111.673 -178.949 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 2.0 Cg_endo -80.33 76.92 4.27 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.897 2.398 . . . . 0.0 112.017 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.869 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -77.16 142.0 39.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.488 -179.752 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.504 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 38.4 mtmm -67.89 70.5 0.14 Allowed 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.455 0.645 . . . . 0.0 110.419 178.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.756 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 28.9 m 58.43 161.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.162 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.681 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.67 -26.85 9.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.888 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.9 pt-20 -59.2 -50.46 73.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.652 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.504 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -72.65 -32.26 65.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.976 -179.418 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.005 HG21 HG21 ' A' ' 24' ' ' ILE . 57.9 t -61.98 -40.82 88.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.724 0.297 . . . . 0.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.689 ' HB1' ' CG ' ' A' ' 10' ' ' ARG . . . -65.0 -52.19 57.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 76' ' ' VAL . 32.1 m-20 -64.49 -37.44 87.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.011 0.434 . . . . 0.0 111.202 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.404 HG22 HD21 ' A' ' 58' ' ' LEU . 53.3 m -58.09 -41.93 84.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.442 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.905 HG23 ' CB ' ' A' ' 54' ' ' ALA . 63.5 mt -62.1 -53.72 44.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.134 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.936 HG13 ' CD ' ' A' ' 10' ' ' ARG . 2.5 m -56.94 -43.35 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 78.0 m-20 -62.6 -53.72 50.44 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -74.0 -42.41 60.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.078 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.579 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.56 -30.08 69.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.25 -55.77 0.42 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 119.936 -1.125 . . . . 0.0 113.144 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.547 HD12 HG12 ' A' ' 76' ' ' VAL . 21.7 mt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.405 -178.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.729 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.7 p . . . . . 0 C--O 1.213 -0.865 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 79.8 tttt -44.83 -51.08 9.88 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.362 -0.836 . . . . 0.0 109.211 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.6 -29.5 51.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.956 177.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.729 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.0 m-20 -64.48 -52.13 59.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.13 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.606 HG23 ' HB2' ' A' ' 42' ' ' CYS . 12.1 mt -63.16 -46.41 95.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.886 ' NH2' HG21 ' A' ' 13' ' ' ILE . 1.8 tpt180 -57.19 -25.94 59.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.166 177.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.37 -48.34 70.11 Favored Glycine 0 CA--C 1.505 -0.531 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -62.63 -29.08 70.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.807 -0.696 . . . . 0.0 109.343 177.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.886 HG21 ' NH2' ' A' ' 10' ' ' ARG . 59.7 mt -70.4 -45.53 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.801 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HA ' HD13 ' A' ' 14' ' ' ILE . 7.1 mm -53.69 -48.54 60.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.66 -37.4 94.33 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.816 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.638 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -62.61 -27.81 69.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.918 0.39 . . . . 0.0 110.978 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.024 HD22 HD12 ' A' ' 24' ' ' ILE . 54.1 mt -80.69 -29.56 36.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.378 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.04 135.12 56.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.005 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.38 -33.17 5.67 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.723 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.686 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.29 -175.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.931 0.396 . . . . 0.0 111.509 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.26 -122.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.896 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.82 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -59.93 -173.42 0.05 OUTLIER Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 176.685 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.855 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 58.1 Cg_endo -69.33 61.52 1.5 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 CA-C-N 120.453 1.197 . . . . 0.0 112.592 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.024 HD12 HD22 ' A' ' 17' ' ' LEU . 43.4 mm 111.98 65.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 177.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.655 ' ND2' ' CD2' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -64.31 65.68 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.085 -0.385 . . . . 0.0 111.534 178.132 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.571 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 54.0 p 58.89 155.01 0.09 OUTLIER Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 31' ' ' MET . 54.4 Cg_exo -49.29 -33.71 29.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.236 1.291 . . . . 0.0 112.887 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.04 -56.28 17.33 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.074 0.464 . . . . 0.0 110.787 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.645 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.5 tp10 -74.54 -57.72 3.75 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.296 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.938 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -49.79 -39.76 39.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.675 ' HA ' HD13 ' A' ' 34' ' ' LEU . 65.4 mtm -64.4 -34.85 79.12 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.77 -26.55 65.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.681 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.686 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -71.09 -43.24 68.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.667 -179.318 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.675 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.1 mp -37.33 138.91 0.55 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 112.274 -178.406 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 C--N 1.35 0.625 0 C-N-CA 123.869 3.046 . . . . 0.0 113.518 -178.904 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 34' ' ' LEU . 7.8 t . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.656 0.265 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 2.6 t -97.91 123.31 41.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.034 0.445 . . . . 0.0 111.28 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.606 ' HB2' HG23 ' A' ' 9' ' ' ILE . 33.3 m -72.14 64.32 0.54 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.764 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 21.7 ptmt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.667 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.843 ' C ' HD22 ' A' ' 49' ' ' LEU . 37.3 mt-10 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.751 0.31 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.843 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.8 mm? -137.7 134.5 35.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.324 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 41' ' ' THR . 19.6 pttm -163.73 -164.67 0.93 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.613 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -78.1 -41.09 36.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.051 0.453 . . . . 0.0 111.317 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.439 ' HB3' ' HE2' ' A' ' 50' ' ' LYS . 39.1 t -63.87 -45.5 89.13 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.647 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.485 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 8.0 t70 -72.21 -52.79 14.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.352 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.851 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -96.34 -48.42 5.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -178.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -44.77 -28.37 1.66 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.73 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -43.89 -32.55 1.13 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.039 0.447 . . . . 0.0 111.563 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 54' ' ' ALA . 30.4 m -65.51 -33.15 61.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.886 -179.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.668 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 29.1 mt -70.3 124.42 24.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.437 179.486 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -80.8 -176.38 5.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.897 0.38 . . . . 0.0 111.551 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.77 79.54 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.711 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -53.33 -23.99 10.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.638 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -71.04 3.2 3.58 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.571 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.2 m-85 -42.58 -64.59 0.68 Allowed Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.584 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 59.5 Cg_endo -71.01 74.94 1.79 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.436 2.091 . . . . 0.0 111.949 179.271 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.874 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -77.04 141.61 40.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.833 -179.349 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.483 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 23.4 ttmm -67.22 70.37 0.1 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.804 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.855 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.7 m 58.19 162.35 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.164 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.645 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.69 -31.35 25.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.659 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.6 pt-20 -56.24 -48.41 76.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.589 -179.587 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.569 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -73.1 -36.99 66.88 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.974 -179.6 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.972 ' CG2' HG21 ' A' ' 24' ' ' ILE . 61.9 t -61.46 -34.34 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.821 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -68.94 -58.22 4.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.365 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 76' ' ' VAL . 31.7 m-20 -64.1 -42.32 96.95 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.99 0.424 . . . . 0.0 111.571 -179.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.2 m -55.37 -48.09 74.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.651 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.496 HD12 ' NH2' ' A' ' 10' ' ' ARG . 82.6 mt -63.05 -51.58 69.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.883 -179.256 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.708 HG13 ' HD3' ' A' ' 10' ' ' ARG . 1.5 m -54.05 -43.61 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.818 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -57.55 -49.55 75.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.748 0.309 . . . . 0.0 111.381 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HB2' HG21 ' A' ' 57' ' ' VAL . 66.9 mttm -73.55 -41.11 63.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.827 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.851 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.39 -30.23 69.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.506 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.91 -55.43 0.43 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.419 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.549 HD12 HG12 ' A' ' 76' ' ' VAL . 16.8 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.174 -0.917 . . . . 0.0 111.308 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.499 -0.241 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . 0.428 ' O ' ' CG ' ' A' ' -1' ' ' HIS . 47.6 t -59.74 137.62 58.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.748 0.309 . . . . 0.0 110.938 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' -2' ' ' SER . 92.5 m-70 -158.96 132.27 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.671 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt -66.07 -48.19 71.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.23 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp 61.86 128.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.911 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.8 mmm -68.72 -54.32 16.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.907 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.09 -38.06 0.85 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.466 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.8 p -66.69 -5.77 3.74 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HA ' HD13 ' A' ' 81' ' ' LEU . 54.1 tttm -45.05 -46.63 11.55 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.093 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -77.54 -32.88 54.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.829 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.706 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -64.86 -52.07 58.62 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.52 HG13 ' CG2' ' A' ' 5' ' ' VAL . 31.2 mt -65.48 -46.21 90.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.727 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 51.5 ttp85 -55.87 -30.53 61.68 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.49 -40.4 97.65 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 73.3 mt-30 -68.77 -31.17 70.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.688 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.6 mt -71.36 -45.82 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.068 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.199 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.6 mm -57.87 -52.97 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.514 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.99 -36.61 93.28 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.387 -0.911 . . . . 0.0 110.941 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -62.67 -29.79 70.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.285 -0.457 . . . . 0.0 111.103 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.001 HD22 HD12 ' A' ' 24' ' ' ILE . 55.1 mt -81.26 -29.41 34.4 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.665 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.29 131.5 48.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.73 -34.74 4.62 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.716 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.74 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.95 -179.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.829 0.347 . . . . 0.0 111.576 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 73.0 m-20 -59.35 -120.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.733 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -59.92 178.53 0.24 Allowed Pre-proline 0 N--CA 1.455 -0.195 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.78 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.0 Cg_endo -65.38 65.65 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 119.799 0.964 . . . . 0.0 112.482 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.001 HD12 HD22 ' A' ' 17' ' ' LEU . 34.2 mm 107.57 61.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.606 ' HA ' ' CZ ' ' A' ' 22' ' ' PHE . 3.0 m120 -64.35 65.07 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.596 ' HB3' ' CG ' ' A' ' 63' ' ' PHE . 60.6 p 57.48 156.52 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.631 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 54.2 Cg_exo -49.89 -32.65 30.82 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.397 1.398 . . . . 0.0 112.692 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -52.76 -57.68 9.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.35 0.595 . . . . 0.0 110.292 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.601 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.8 tp10 -76.41 -58.09 3.48 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.853 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.59 -44.8 57.06 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.842 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 30.6 ttm -65.08 -31.06 72.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -68.37 -31.45 70.83 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.822 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -69.84 -38.67 76.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.343 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 31' ' ' MET . 8.5 mp -26.91 129.75 0.18 Allowed Pre-proline 0 N--CA 1.47 0.54 0 CA-C-O 120.973 0.416 . . . . 0.0 111.881 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 12.2 Cg_endo -55.99 -28.49 69.25 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.711 2.941 . . . . 0.0 114.274 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.78 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 6.9 t30 -72.01 -27.26 62.62 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.65 -73.42 0.41 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.898 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 84.1 Cg_endo -84.31 46.53 1.98 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.775 2.317 . . . . 0.0 112.172 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.31 95.01 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.429 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.78 ' HB ' ' HB3' ' A' ' 36' ' ' ASN . 10.0 t -66.79 145.01 55.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.525 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.47 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 31.1 m -106.51 121.34 44.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.486 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.484 ' CB ' HG23 ' A' ' 9' ' ' ILE . 59.7 m -86.85 46.26 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.001 0.429 . . . . 0.0 110.821 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 18.7 ptpt -75.83 149.98 37.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.7 m -151.53 126.89 9.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.614 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.0 -51.59 0.95 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.742 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.438 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.7 p30 -171.17 -40.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 0.0 110.39 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.729 HG12 ' CD2' ' A' ' 49' ' ' LEU . 40.3 t -66.98 139.09 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.613 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.892 ' C ' HD22 ' A' ' 49' ' ' LEU . 35.3 mt-10 -125.79 132.53 52.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.36 . . . . 0.0 110.946 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.892 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.5 mm? -142.31 139.62 31.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.935 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 41' ' ' THR . 59.8 pttt -173.8 -176.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.719 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.842 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -66.33 -42.59 87.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.819 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.405 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.0 t -67.7 -52.38 38.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.467 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 30.0 m-20 -71.1 -49.78 40.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -87.65 -47.01 9.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.89 -26.8 2.11 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.373 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -41.94 -36.89 1.18 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.08 0.467 . . . . 0.0 111.774 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 54' ' ' ALA . 33.4 m -65.51 -33.17 61.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.032 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.649 HD13 ' CE2' ' A' ' 65' ' ' PHE . 28.3 mt -68.31 124.49 23.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.642 0.258 . . . . 0.0 110.56 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.1 p -84.1 -173.81 4.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.797 0.332 . . . . 0.0 111.551 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.06 -44.71 91.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.568 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -55.59 -23.98 30.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 111.118 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.578 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -64.54 -9.8 21.53 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.596 ' CG ' ' HB3' ' A' ' 26' ' ' SER . 2.6 m-85 -39.82 -70.97 0.15 Allowed Pre-proline 0 N--CA 1.464 0.231 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 50.7 Cg_endo -67.76 74.38 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.034 1.823 . . . . 0.0 112.079 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.821 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.08 143.96 38.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.12 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 99.2 mttt -68.94 68.4 0.16 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.475 0.655 . . . . 0.0 110.56 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.78 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 25.5 m 59.51 161.48 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.979 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.656 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.67 -30.59 22.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.817 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.0 pt-20 -57.67 -48.43 79.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.441 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.554 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -71.1 -33.03 69.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.875 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.969 HG21 HG21 ' A' ' 24' ' ' ILE . 92.2 t -64.83 -41.85 93.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.852 0.358 . . . . 0.0 110.857 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.82 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -60.49 -50.35 73.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.825 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -68.43 -37.5 80.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.391 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.3 m -66.8 -51.95 49.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.043 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 71' ' ' VAL . 76.0 mt -58.08 -51.9 65.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.489 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 72' ' ' ALA . 5.3 m -56.22 -39.21 58.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -61.5 -53.15 60.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.728 0.299 . . . . 0.0 111.332 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HB2' HG21 ' A' ' 57' ' ' VAL . 63.1 mttp -69.24 -40.54 77.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.57 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.644 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.17 -29.77 69.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.72 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.17 -55.1 0.43 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.787 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.5 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.023 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 80.2 p -178.53 -45.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 0.0 110.821 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -61.1 -39.97 91.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.822 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt -158.34 64.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.749 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.478 ' HG2' ' HG2' ' A' ' 3' ' ' MET . 0.0 OUTLIER -45.04 -42.12 8.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.081 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.478 ' HG2' ' HG2' ' A' ' 2' ' ' LYS . 95.2 mmm -117.78 -49.33 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.802 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.36 -43.3 1.29 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.675 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.733 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.9 p -69.27 -5.9 5.5 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 86.1 tttt -45.32 -48.0 13.15 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.015 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -77.59 -31.22 52.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.816 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.733 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 22.7 m-20 -65.2 -52.26 55.91 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 5' ' ' VAL . 22.5 mt -66.79 -46.5 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.763 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 46.4 ttp85 -56.39 -28.07 58.18 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.19 -42.91 94.04 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 66.9 mt-30 -67.07 -32.55 73.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.876 -0.662 . . . . 0.0 109.737 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.0 mt -70.33 -43.33 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.804 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 14' ' ' ILE . 13.3 mm -58.06 -54.09 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.244 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.54 -36.85 93.66 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.692 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -60.88 -28.43 68.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.109 -0.545 . . . . 0.0 110.936 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.068 HD22 HD12 ' A' ' 24' ' ' ILE . 52.7 mt -87.6 -29.66 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.282 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.16 85.25 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.838 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.94 -36.0 0.19 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.17 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.747 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.77 -174.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.076 0.465 . . . . 0.0 112.116 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.644 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.0 m-20 -59.96 -119.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.721 ' CE2' ' HA ' ' A' ' 25' ' ' ASN . 0.3 OUTLIER -58.52 174.21 0.37 Allowed Pre-proline 0 CA--C 1.519 -0.212 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 176.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.874 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 44.6 Cg_endo -63.27 66.63 0.16 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 120.916 1.077 . . . . 0.0 112.242 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.068 HD12 HD22 ' A' ' 17' ' ' LEU . 20.2 mm 109.52 59.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.721 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.5 m120 -63.37 66.75 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 25' ' ' ASN . 85.5 p 56.28 153.64 0.07 OUTLIER Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.716 ' O ' ' HB2' ' A' ' 31' ' ' MET . 76.1 Cg_exo -47.29 -32.88 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.512 1.475 . . . . 0.0 113.176 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -53.31 -57.46 10.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.339 0.59 . . . . 0.0 110.387 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.4 tp10 -76.25 -57.52 3.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.964 HD13 HD21 ' A' ' 17' ' ' LEU . 3.3 pp -49.97 -42.54 49.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.716 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 62.2 mtm -68.75 -29.98 68.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.64 -31.04 70.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.899 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.747 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -74.23 -38.57 63.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.102 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 16' ' ' ALA . 8.0 mp -34.66 140.03 0.29 Allowed Pre-proline 0 N--CA 1.466 0.341 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -47.78 -34.83 22.46 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.248 2.632 . . . . 0.0 113.225 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.504 ' CB ' ' HB ' ' A' ' 40' ' ' THR . 10.3 t30 -72.24 -25.56 61.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.333 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.6 -73.34 0.21 Allowed Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.622 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.706 ' O ' ' HB3' ' A' ' 31' ' ' MET . 71.7 Cg_endo -75.27 -42.47 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.313 2.009 . . . . 0.0 111.536 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.532 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.7 OUTLIER 168.25 86.92 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.288 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.504 ' HB ' ' CB ' ' A' ' 36' ' ' ASN . 8.9 t -54.42 134.75 45.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.188 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.535 HG23 ' HD3' ' A' ' 50' ' ' LYS . 23.8 m -86.64 118.17 25.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.092 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 68.4 m -92.87 44.76 1.16 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.184 0.516 . . . . 0.0 109.776 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.1 pttp -75.62 126.06 30.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.119 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.9 m -102.94 118.56 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.16 -128.94 42.8 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.118 -1.039 . . . . 0.0 111.772 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -76.01 -38.67 57.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.895 0.379 . . . . 0.0 111.559 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.694 HG12 ' CD2' ' A' ' 49' ' ' LEU . 37.5 t -66.78 141.45 17.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.545 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.876 ' C ' HD22 ' A' ' 49' ' ' LEU . 75.6 mt-10 -132.37 130.84 41.21 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.104 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.876 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -141.0 138.53 33.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.513 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.535 ' HD3' HG23 ' A' ' 41' ' ' THR . 60.8 pttt -175.14 153.64 1.64 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.665 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.66 -28.3 2.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.624 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.403 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 44.1 t -70.82 -55.5 8.38 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.311 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -72.44 -54.32 9.65 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.716 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -82.48 -42.89 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.86 -25.81 1.02 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.491 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -41.66 -36.76 1.02 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.132 0.492 . . . . 0.0 111.583 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 54' ' ' ALA . 32.9 m -65.53 -33.41 63.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.128 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.699 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 30.3 mt -68.85 119.83 13.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.703 0.287 . . . . 0.0 110.231 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.412 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 76.8 p -85.44 -175.31 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.711 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.67 -43.34 84.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.298 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.447 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 3.1 p30 -51.29 -26.63 7.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.918 0.389 . . . . 0.0 110.819 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 59.4 m-20 -73.26 3.73 5.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.707 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.53 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 1.4 t80 -42.63 -52.22 10.98 Favored Pre-proline 0 C--O 1.224 -0.262 0 O-C-N 122.588 -0.07 . . . . 0.0 111.15 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 97.6 Cg_endo -89.65 78.15 0.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.194 2.596 . . . . 0.0 111.187 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.744 ' CG ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -76.9 142.8 39.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.156 -178.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 22.9 tptm -69.66 65.41 0.21 Allowed 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.122 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.874 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 49.8 m 63.63 160.0 0.09 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.638 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.603 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.97 -27.34 13.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.938 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.36 -38.78 91.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.075 0.464 . . . . 0.0 109.832 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 7.9 tp10 -68.01 -46.42 71.3 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.94 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.027 ' CG2' HG21 ' A' ' 24' ' ' ILE . 47.0 t -65.11 -43.17 95.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.516 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -56.17 -45.47 79.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.979 0.418 . . . . 0.0 110.25 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -70.3 -40.18 74.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.095 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.436 HG23 ' NZ ' ' A' ' 78' ' ' LYS . 61.8 m -63.13 -50.15 71.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.069 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.532 HG23 ' CB ' ' A' ' 54' ' ' ALA . 67.0 mt -61.41 -52.47 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.702 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 72' ' ' ALA . 7.1 m -58.52 -38.64 71.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -62.33 -56.79 15.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.748 0.308 . . . . 0.0 111.676 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' NZ ' HG23 ' A' ' 74' ' ' THR . 61.8 mttp -69.5 -38.97 77.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.74 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.716 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.84 -29.89 69.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.009 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.42 -55.87 0.42 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.006 -1.092 . . . . 0.0 113.291 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.1 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.339 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.641 -0.184 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 47.6 t -60.5 -46.25 90.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.93 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 62.77 134.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptp -60.45 141.43 56.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.45 123.27 16.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.567 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.2 mtt -86.49 144.26 27.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.448 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.68 -18.07 29.9 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.469 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.689 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.6 p -55.75 -5.64 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.65 ' HA ' HD13 ' A' ' 81' ' ' LEU . 84.8 tttt -44.31 -44.15 7.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.913 0.779 . . . . 0.0 109.417 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.4 -35.58 54.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.666 177.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.689 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 48.6 m-20 -64.02 -51.83 62.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.529 HG13 ' CG2' ' A' ' 5' ' ' VAL . 37.0 mt -65.12 -45.89 92.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.842 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 50.1 ttp180 -55.34 -30.41 60.22 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.53 -41.78 97.76 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.535 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 65.0 mt-30 -66.18 -29.86 70.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.692 -0.754 . . . . 0.0 109.735 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 10' ' ' ARG . 63.6 mt -70.35 -45.58 74.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.962 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 69' ' ' GLU . 9.1 mm -56.74 -52.96 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.512 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.82 -37.15 92.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.073 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.47 -30.53 69.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.202 -0.499 . . . . 0.0 111.172 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.048 HD22 HD12 ' A' ' 24' ' ' ILE . 59.5 mt -82.74 -29.45 29.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.932 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.52 132.81 54.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.049 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.13 -33.89 5.22 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.964 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.7 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.95 -176.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 111.567 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.601 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.1 m-20 -60.9 -121.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.713 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.56 176.81 0.29 Allowed Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.773 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.3 Cg_endo -64.69 69.05 0.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 CA-C-N 119.773 0.954 . . . . 0.0 112.281 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.048 HD12 HD22 ' A' ' 17' ' ' LEU . 51.5 mm 106.47 61.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.601 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.8 m120 -65.24 64.96 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.569 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 59.1 p 57.06 157.46 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.614 ' O ' ' CB ' ' A' ' 31' ' ' MET . 52.0 Cg_exo -50.9 -32.23 36.98 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.293 1.328 . . . . 0.0 112.86 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -52.71 -57.61 9.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.442 0.639 . . . . 0.0 110.421 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.594 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 41.8 tp10 -76.15 -58.15 3.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.824 HD22 HG23 ' A' ' 24' ' ' ILE . 3.9 pp -50.62 -42.95 56.67 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.822 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 30.0 ttm -63.27 -33.07 74.71 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -68.92 -28.32 66.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.835 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.7 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -71.16 -36.9 72.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.3 mp -27.27 137.0 0.1 Allowed Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 121.094 0.473 . . . . 0.0 112.185 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -50.15 -41.17 50.38 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.249 3.299 . . . . 0.0 115.638 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.502 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -71.9 -25.44 61.92 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.447 -0.501 . . . . 0.0 112.236 -177.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . 104.3 -66.19 0.31 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.664 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 93.0 Cg_endo -83.54 47.3 2.3 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.636 2.224 . . . . 0.0 113.009 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.454 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.7 OUTLIER 64.53 93.31 0.06 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.642 0.258 . . . . 0.0 111.234 179.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.534 HG22 HD23 ' A' ' 34' ' ' LEU . 15.2 t -75.96 137.33 40.24 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.775 0.321 . . . . 0.0 111.519 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.645 HG21 ' CE ' ' A' ' 43' ' ' LYS . 47.8 m -92.55 123.9 36.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.719 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.9 m -92.04 45.53 1.22 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.974 0.416 . . . . 0.0 110.73 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.645 ' CE ' HG21 ' A' ' 41' ' ' THR . 18.6 ptpt -75.53 151.38 37.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.025 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.3 m -150.55 127.28 10.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.136 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.81 -59.4 0.35 Allowed Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.082 -0.508 . . . . 0.0 113.038 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -159.56 -43.36 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 110.407 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.749 HG12 ' CD2' ' A' ' 49' ' ' LEU . 40.5 t -66.74 137.54 24.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.683 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.882 ' C ' HD22 ' A' ' 49' ' ' LEU . 22.7 mt-10 -124.35 131.19 53.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.988 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -141.72 133.74 27.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.605 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.769 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 21.1 ptmt -165.48 -177.55 4.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.735 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.822 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -66.56 -40.52 89.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.715 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.1 t -67.01 -59.92 3.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.401 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 57.9 m-20 -68.84 -54.09 17.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.758 0.313 . . . . 0.0 111.691 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.946 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -72.56 -50.51 25.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.74 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -49.02 -26.49 6.01 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.412 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -41.21 -43.55 2.37 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.944 0.878 . . . . 0.0 110.943 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 54' ' ' ALA . 10.4 m -66.01 -32.64 59.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.326 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.682 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 21.1 mt -68.9 116.84 9.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.819 0.343 . . . . 0.0 110.588 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.51 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 71.8 p -71.5 155.9 40.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.196 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.16 -39.98 45.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.323 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -53.44 -25.44 16.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.615 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 61.8 m-20 -70.57 3.47 3.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.569 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.4 OUTLIER -38.64 -63.65 0.56 Allowed Pre-proline 0 N--CA 1.462 0.139 0 CA-C-N 117.895 0.316 . . . . 0.0 110.958 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 73.4 Cg_endo -74.55 79.0 2.61 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.469 2.113 . . . . 0.0 111.88 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.755 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -76.83 144.29 39.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.301 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.51 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 75.2 mmtt -70.21 65.88 0.28 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.465 0.65 . . . . 0.0 110.047 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.773 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 20.2 m 61.52 160.36 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.02 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.587 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.45 -28.11 12.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.657 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HA ' HD11 ' A' ' 14' ' ' ILE . 16.2 pt-20 -60.95 -48.44 81.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.376 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.518 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -67.9 -32.14 72.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.021 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 24' ' ' ILE . 80.5 t -62.27 -41.29 90.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.878 0.371 . . . . 0.0 110.45 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.842 ' HB1' ' CG ' ' A' ' 10' ' ' ARG . . . -60.27 -51.03 71.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.987 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.53 -39.02 85.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.258 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.8 m -65.18 -51.65 59.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.956 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.946 HG23 ' HB1' ' A' ' 54' ' ' ALA . 57.4 mt -57.15 -54.58 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.767 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.829 HG22 ' O ' ' A' ' 72' ' ' ALA . 5.7 m -57.14 -40.04 70.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -65.52 -53.28 44.58 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HB2' HG21 ' A' ' 57' ' ' VAL . 50.2 mtpt -73.33 -39.52 65.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 111.885 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.433 ' HB1' HD12 ' A' ' 49' ' ' LEU . . . -66.84 -29.96 70.02 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.72 -55.98 0.37 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.117 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.65 HD13 ' HA ' ' A' ' 6' ' ' LYS . 20.3 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.32 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.571 -0.211 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 80.1 p -59.9 -44.96 93.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.928 0.394 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . 0.525 ' O ' ' O ' ' A' ' 1' ' ' MET . 21.2 p-80 -174.23 132.56 0.4 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.718 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.525 ' O ' ' O ' ' A' ' -1' ' ' HIS . 24.8 ptt? 49.0 122.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.951 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.463 ' NZ ' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -68.84 -55.48 11.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.832 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.5 tpp 178.27 -55.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.528 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.59 -49.79 0.43 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.748 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.718 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.6 p -74.66 -6.01 7.84 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 82.7 tttt -45.17 -47.76 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.008 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.75 -31.94 52.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.901 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.718 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -64.33 -52.17 59.75 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 5' ' ' VAL . 28.9 mt -67.39 -46.18 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.823 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 48.3 ttp180 -55.45 -29.77 59.29 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.73 -43.53 93.98 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 69.3 mt-30 -66.9 -30.38 70.52 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.86 -0.67 . . . . 0.0 109.766 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 10' ' ' ARG . 73.3 mt -70.52 -43.46 77.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.744 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 69' ' ' GLU . 11.3 mm -57.61 -53.69 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.32 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.56 -36.4 92.43 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.405 -0.902 . . . . 0.0 110.855 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -60.55 -31.82 70.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.151 -0.524 . . . . 0.0 110.952 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.065 HD22 HD12 ' A' ' 24' ' ' ILE . 55.4 mt -82.12 -29.47 31.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.775 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.0 130.83 48.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.918 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.16 -34.37 4.48 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.879 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.7 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.06 -176.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.815 0.341 . . . . 0.0 111.594 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.614 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.6 m-20 -60.02 -119.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.745 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.79 178.39 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.81 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 48.9 Cg_endo -65.08 67.85 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.754 0.948 . . . . 0.0 112.131 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.065 HD12 HD22 ' A' ' 17' ' ' LEU . 44.3 mm 105.96 62.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.614 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.9 m120 -65.7 64.41 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.657 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 52.6 p 57.07 160.47 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.657 ' O ' ' HB2' ' A' ' 31' ' ' MET . 52.2 Cg_exo -52.56 -33.16 56.9 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.339 1.359 . . . . 0.0 112.971 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -52.48 -57.89 8.47 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.238 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.612 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 41.3 tp10 -76.6 -58.57 3.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.906 HD22 HG23 ' A' ' 24' ' ' ILE . 3.9 pp -50.65 -45.35 57.82 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.815 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 23.0 ttm -64.17 -31.49 72.7 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -70.28 -28.67 65.39 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.128 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.7 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -70.04 -37.45 75.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.725 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 31' ' ' MET . 11.2 mp -31.78 145.6 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.112 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.544 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.5 Cg_endo -47.54 -42.23 29.19 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.664 2.91 . . . . 0.0 113.973 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.452 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -72.25 -18.65 61.8 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.614 -179.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.45 ' N ' HD22 ' A' ' 36' ' ' ASN . . . 108.66 -67.2 0.23 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.468 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.452 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 72.9 Cg_endo -79.82 -52.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.432 2.088 . . . . 0.0 113.791 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.559 ' HA ' HD22 ' A' ' 34' ' ' LEU . 12.0 p-10 -178.88 90.1 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.843 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.629 HG22 HD23 ' A' ' 34' ' ' LEU . 12.9 t -71.76 136.99 47.34 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.832 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.489 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 25.4 m -91.61 125.87 36.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.972 0.415 . . . . 0.0 111.588 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.7 m -100.47 48.52 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.777 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.48 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 10.2 ptpp? -75.34 153.72 37.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.841 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.9 m -150.09 128.11 11.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.434 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.51 -131.55 47.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.26 -0.972 . . . . 0.0 111.298 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -94.54 26.71 3.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 0.0 110.801 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.6 HG12 ' CD2' ' A' ' 49' ' ' LEU . 49.1 t -127.9 145.72 34.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.141 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.887 ' C ' HD22 ' A' ' 49' ' ' LEU . 23.6 mt-10 -142.06 125.1 16.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.497 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.887 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.7 mm? -140.64 140.57 35.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.039 0.447 . . . . 0.0 110.811 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.509 ' HG3' ' H ' ' A' ' 53' ' ' ASP . 59.5 pttt -173.54 170.81 4.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.719 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.815 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -59.65 -30.7 68.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.545 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 42.5 t -75.66 -62.05 1.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.509 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 52.4 m-20 -66.4 -51.06 60.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.598 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -78.95 -46.44 18.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.67 -26.32 1.76 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.596 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 17.2 pt20 -41.21 -38.63 1.15 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.04 0.448 . . . . 0.0 111.808 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.8 m -65.72 -30.16 49.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.408 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.678 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 19.1 mt -66.91 121.67 16.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.756 0.312 . . . . 0.0 110.42 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.7 p -74.67 155.77 37.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.44 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.67 58.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.229 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.82 -23.29 29.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.563 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 15.5 m-20 -67.59 3.31 1.42 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.657 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -40.57 -55.19 4.55 Favored Pre-proline 0 C--O 1.227 -0.086 0 CA-C-N 117.77 0.259 . . . . 0.0 111.575 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 2.2 Cg_endo -82.39 78.16 3.5 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.896 2.397 . . . . 0.0 111.783 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.911 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.02 142.13 40.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.266 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.666 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.69 66.9 0.13 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.76 0.79 . . . . 0.0 110.59 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.81 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 15.5 m 61.85 159.87 0.06 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.953 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.668 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.61 -32.55 29.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.794 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.445 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 10.9 pt-20 -59.07 -46.1 89.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.417 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.666 ' HG2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -68.08 -33.17 74.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.19 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.949 HG21 HG21 ' A' ' 24' ' ' ILE . 72.8 t -64.77 -44.72 96.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.649 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.826 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -55.11 -49.53 71.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.76 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.25 -39.84 78.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.294 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.1 m -63.21 -52.62 61.53 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.48 HG23 ' HB1' ' A' ' 54' ' ' ALA . 58.4 mt -59.87 -52.6 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.716 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 72' ' ' ALA . 14.1 m -57.81 -41.24 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -61.68 -51.41 68.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 111.278 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HB2' HG21 ' A' ' 57' ' ' VAL . 66.8 mttm -71.54 -42.08 68.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.676 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.519 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.42 -30.04 69.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.778 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.14 -55.7 0.44 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.664 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 19.0 mt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.337 -0.84 . . . . 0.0 110.983 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 79.8 p -78.83 51.93 1.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.662 0.267 . . . . 0.0 111.38 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -56.3 -48.39 76.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt 52.32 48.06 23.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.482 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -86.57 36.38 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.424 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.8 ptm -77.18 127.08 31.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 110.991 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.93 -139.0 6.07 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.232 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.705 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p -77.22 -6.02 8.43 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 O-C-N 123.057 -0.084 . . . . 0.0 111.11 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.547 ' HE2' HG21 ' A' ' 76' ' ' VAL . 12.9 tmtt? -45.09 -46.41 11.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -77.57 -33.44 54.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.84 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.705 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 14.1 m-20 -64.21 -52.32 59.42 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.531 HG13 HG22 ' A' ' 5' ' ' VAL . 35.3 mt -66.62 -46.56 85.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.783 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 40.0 ttp180 -55.0 -29.76 58.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.32 -42.46 96.11 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.539 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 70.0 mt-30 -69.06 -30.71 69.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.809 -0.696 . . . . 0.0 109.991 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.7 mt -71.61 -45.18 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.045 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 14' ' ' ILE . 10.6 mm -58.3 -52.01 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.262 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.39 -37.19 93.56 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.557 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -61.52 -28.54 69.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.156 -0.522 . . . . 0.0 110.946 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.05 HD22 HD12 ' A' ' 24' ' ' ILE . 45.7 mt -83.79 -29.56 27.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.874 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.52 126.02 25.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.815 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.66 -34.99 3.3 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.72 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.673 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.73 -175.04 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.913 0.387 . . . . 0.0 111.588 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.573 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -61.58 -119.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.773 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.5 OUTLIER -59.45 179.21 0.21 Allowed Pre-proline 0 N--CA 1.454 -0.266 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 176.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.792 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.3 Cg_endo -64.97 67.21 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 CA-C-N 119.688 0.924 . . . . 0.0 112.179 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.05 HD12 HD22 ' A' ' 17' ' ' LEU . 41.9 mm 107.18 62.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.608 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.8 m120 -63.65 65.37 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 69.9 p 56.28 158.68 0.07 OUTLIER Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.71 ' O ' ' HB2' ' A' ' 31' ' ' MET . 50.7 Cg_exo -51.16 -34.23 47.25 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.316 1.344 . . . . 0.0 113.032 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -51.63 -57.68 8.49 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.38 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 43.7 tp10 -76.24 -58.11 3.48 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.853 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -50.47 -43.95 55.53 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.87 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 23.5 ttm -64.03 -32.19 73.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.96 -29.53 66.67 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.042 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.673 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -68.81 -37.98 79.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.73 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 31' ' ' MET . 11.2 mp -31.61 145.02 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.193 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.529 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.5 Cg_endo -47.55 -41.85 29.54 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.635 2.89 . . . . 0.0 113.969 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.461 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -72.14 -18.73 61.86 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.57 -179.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' N ' HD22 ' A' ' 36' ' ' ASN . . . 108.25 -66.52 0.24 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.514 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 85.0 Cg_endo -80.47 -51.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.395 2.063 . . . . 0.0 113.959 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.569 ' HA ' HD22 ' A' ' 34' ' ' LEU . 47.2 p-10 -179.48 88.44 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.608 HG22 HD23 ' A' ' 34' ' ' LEU . 15.0 t -71.27 137.27 48.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.823 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 27.8 m -90.71 125.78 35.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 111.597 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.3 m -100.29 50.43 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.097 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 61.6 pttt -75.24 144.22 42.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.643 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 47' ' ' VAL . 49.9 m -157.14 137.4 12.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.785 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 47' ' ' VAL . . . 62.68 50.39 64.64 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.579 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 58.89 23.35 11.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.942 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.758 HG12 ' CD2' ' A' ' 49' ' ' LEU . 39.9 t -127.71 135.34 63.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.164 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.9 ' C ' HD22 ' A' ' 49' ' ' LEU . 23.5 mt-10 -120.37 131.05 54.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.033 0.444 . . . . 0.0 111.473 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.9 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -142.34 136.79 30.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.427 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HG3' ' H ' ' A' ' 53' ' ' ASP . 61.2 pttt -173.68 178.77 2.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.795 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.87 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -65.61 -39.71 91.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.836 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.3 t -66.83 -51.55 54.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.672 0.273 . . . . 0.0 111.704 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.474 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 38.8 m-20 -72.2 -51.42 21.25 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.676 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -88.39 -45.97 9.55 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.92 -27.52 1.48 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.203 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 16.0 pt20 -43.29 -35.62 1.54 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 111.333 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 54' ' ' ALA . 32.9 m -65.51 -33.0 60.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.782 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.715 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 17.0 mt -66.3 119.1 10.95 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.2 p -77.26 155.89 31.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.754 0.312 . . . . 0.0 111.073 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.33 -40.21 11.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.593 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -53.86 -26.32 24.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.166 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.661 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -70.18 3.38 2.85 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.549 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -39.93 -65.33 0.44 Allowed Pre-proline 0 N--CA 1.463 0.217 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.156 -179.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 74.1 Cg_endo -74.06 78.26 2.6 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.307 2.005 . . . . 0.0 111.855 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.915 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -76.8 143.65 39.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.246 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.502 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 75.1 mmtt -69.57 68.38 0.24 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.464 0.65 . . . . 0.0 110.05 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.792 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 31.8 m 59.66 160.96 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.976 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.691 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.47 -25.88 7.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.632 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 16.5 pt-20 -59.66 -48.86 80.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.43 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.517 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -74.13 -32.18 63.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.161 -179.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.015 HG21 HG21 ' A' ' 24' ' ' ILE . 60.2 t -61.55 -46.93 95.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.399 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.835 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -58.85 -44.63 91.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.874 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 35.8 t70 -62.73 -42.62 99.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.337 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.414 HG22 HD21 ' A' ' 58' ' ' LEU . 88.6 m -63.76 -50.68 68.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.136 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.676 HG23 ' CB ' ' A' ' 54' ' ' ALA . 71.9 mt -58.35 -52.58 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.542 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 72' ' ' ALA . 6.8 m -58.6 -43.52 87.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 74.4 m-20 -62.1 -54.1 46.13 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.619 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -69.88 -41.01 75.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 111.6 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.636 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.03 -29.92 69.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.734 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.25 -54.61 0.46 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.891 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 17.7 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.073 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 53.3 m -61.25 133.43 55.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.337 . . . . 0.0 110.88 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 1' ' ' MET . 67.8 t60 -62.83 -34.79 78.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.781 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' -1' ' ' HIS . 91.0 mmm 71.67 -53.82 0.68 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.781 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.625 ' HA ' HD23 ' A' ' 81' ' ' LEU . 54.8 mtpt -70.28 165.69 21.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.627 0.251 . . . . 0.0 110.339 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.447 ' O ' ' HG3' ' A' ' 3' ' ' MET . 45.2 tpp -165.9 42.27 0.06 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.957 0.408 . . . . 0.0 111.014 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.67 -44.2 1.98 Allowed Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.632 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.704 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p -63.2 -6.15 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 116.958 0.379 . . . . 0.0 112.01 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -44.87 -45.27 10.17 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -77.16 -34.39 56.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.884 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.704 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -64.49 -51.86 60.84 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.63 HD13 HD23 ' A' ' 49' ' ' LEU . 35.0 mt -65.94 -50.13 72.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.927 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -56.64 -29.28 62.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.14 -41.77 99.63 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 77.3 mt-30 -69.72 -31.98 70.3 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.455 -0.872 . . . . 0.0 110.195 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -71.06 -46.64 66.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.563 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 14' ' ' ILE . 5.1 mm -58.72 -52.58 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.714 0.292 . . . . 0.0 110.401 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.85 -36.36 93.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.106 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -67.1 -25.03 66.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.279 -0.461 . . . . 0.0 111.547 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.077 HD22 HD12 ' A' ' 24' ' ' ILE . 46.1 mt -82.31 -29.41 31.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.568 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.01 132.84 54.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.857 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.2 -33.93 5.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.674 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.668 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.21 -179.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.811 0.338 . . . . 0.0 111.375 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.584 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.6 m-20 -58.94 -119.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.735 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -61.22 179.24 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.306 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 176.268 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.811 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 46.7 Cg_endo -65.61 65.26 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 119.889 0.996 . . . . 0.0 112.291 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.077 HD12 HD22 ' A' ' 17' ' ' LEU . 31.9 mm 107.72 60.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.62 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.6 m120 -62.82 65.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.572 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 54.7 p 58.16 153.49 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 31' ' ' MET . 67.0 Cg_exo -48.26 -32.51 19.68 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.315 1.344 . . . . 0.0 112.628 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -52.88 -57.48 10.11 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.51 0.671 . . . . 0.0 110.503 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.62 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.4 tp10 -75.37 -57.8 3.67 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.878 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.4 pp -50.39 -41.59 52.27 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.667 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 37.0 ttm -64.61 -32.87 74.72 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -73.01 -23.17 60.59 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.668 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -72.2 -49.71 33.35 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.687 HD22 ' HA ' ' A' ' 39' ' ' ASP . 7.9 mp -24.99 135.26 0.08 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -47.46 -35.25 21.29 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.916 3.077 . . . . 0.0 113.622 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.561 ' CB ' ' HB ' ' A' ' 40' ' ' THR . 4.5 t30 -72.23 -25.66 61.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.804 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.26 -76.44 0.23 Allowed Glycine 0 CA--C 1.516 0.125 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.615 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 94.3 Cg_endo -82.25 36.45 0.62 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.582 2.188 . . . . 0.0 111.469 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.687 ' HA ' HD22 ' A' ' 34' ' ' LEU . 1.1 t70 66.88 100.93 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.202 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.561 ' HB ' ' CB ' ' A' ' 36' ' ' ASN . 1.8 t -63.74 131.17 47.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.879 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.414 HG23 ' OE2' ' A' ' 48' ' ' GLU . 17.3 m -76.74 127.37 32.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.722 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.401 ' HB3' ' OE1' ' A' ' 12' ' ' GLN . 57.4 m -112.28 45.81 1.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.88 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 60.2 pttt -75.65 125.69 29.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.6 m -103.12 124.88 49.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.65 -54.26 0.5 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.124 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 47' ' ' VAL . 36.9 p-10 -169.46 -40.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.761 0.315 . . . . 0.0 110.854 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.034 HG12 HD21 ' A' ' 49' ' ' LEU . 61.4 t -66.73 112.09 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.797 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.859 ' C ' HD22 ' A' ' 49' ' ' LEU . 87.8 tt0 -91.32 131.81 36.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.135 0.493 . . . . 0.0 111.74 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.034 HD21 HG12 ' A' ' 47' ' ' VAL . 2.1 mm? -137.69 130.31 29.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.564 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 52' ' ' SER . 62.4 pttt -171.7 -161.37 0.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.879 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.476 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -74.31 -47.74 32.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.425 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.7 t -69.34 -50.87 42.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -69.2 -48.74 61.24 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.701 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -95.66 -45.74 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -47.35 -28.47 4.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.84 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -43.38 -34.13 1.2 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.207 0.527 . . . . 0.0 111.357 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 54' ' ' ALA . 30.5 m -65.51 -33.2 62.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.918 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.755 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 30.9 mt -64.72 125.28 24.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 110.681 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.5 p -77.39 155.87 31.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.261 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.57 -42.63 55.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.4 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -56.1 -22.66 29.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.858 0.361 . . . . 0.0 111.075 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.625 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 15.5 m-20 -68.3 3.3 1.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.572 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.7 OUTLIER -40.57 -66.3 0.38 Allowed Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 117.943 0.338 . . . . 0.0 111.532 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.2 Cg_endo -70.44 76.06 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.373 2.049 . . . . 0.0 112.09 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.907 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.15 141.93 39.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.502 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.61 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 1.7 tpmt? -67.32 68.51 0.08 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.702 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.811 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 47.3 m 58.73 162.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.028 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.667 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.59 -26.23 8.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.949 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 23.1 pt-20 -60.23 -49.92 75.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.551 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.54 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -71.49 -35.59 70.85 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.655 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.983 ' CG2' HG21 ' A' ' 24' ' ' ILE . 55.8 t -63.19 -40.8 90.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.927 ' HB1' ' HG2' ' A' ' 10' ' ' ARG . . . -60.8 -51.65 68.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.985 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -67.09 -41.57 86.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.426 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.9 m -57.59 -50.1 74.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.677 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.571 HG23 ' CB ' ' A' ' 54' ' ' ALA . 82.4 mt -60.13 -49.04 85.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.233 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 16.6 m -63.03 -41.87 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -58.59 -55.72 31.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HE3' ' HB ' ' A' ' 57' ' ' VAL . 28.2 mtpp -71.89 -38.99 69.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 111.654 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.619 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.67 -29.69 69.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.563 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.1 -53.95 0.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.817 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 2' ' ' LYS . 18.4 mt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.158 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 53.6 m -60.2 -44.38 95.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -63.78 -139.89 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.491 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 ttm 60.54 -118.57 0.8 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 38.4 ttpt -94.7 30.66 1.98 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.988 0.423 . . . . 0.0 110.696 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.6 mmt 60.07 127.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.541 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.1 -23.8 76.04 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.235 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p -60.08 -5.49 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 81.7 tttt -44.34 -46.17 9.18 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.418 -0.801 . . . . 0.0 109.276 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -77.43 -34.18 54.66 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.824 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.702 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -63.77 -51.92 62.68 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.517 HG13 ' CG2' ' A' ' 5' ' ' VAL . 33.6 mt -66.69 -46.81 84.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.732 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 45.0 ttp180 -55.11 -30.14 59.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.76 -42.85 94.98 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.551 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 71.3 mt-30 -68.9 -30.01 68.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.815 -0.692 . . . . 0.0 110.063 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.1 mt -71.29 -44.66 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.806 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 14' ' ' ILE . 11.3 mm -57.67 -53.11 49.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.252 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.45 -36.02 92.07 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.807 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.85 -31.69 71.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.068 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.006 HD22 HD12 ' A' ' 24' ' ' ILE . 48.0 mt -81.49 -29.45 33.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.552 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.06 128.31 36.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.797 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.15 -36.16 3.28 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.537 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.648 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.59 -175.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.025 0.44 . . . . 0.0 111.492 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.649 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -61.56 -127.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.731 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -54.23 175.49 0.16 Allowed Pre-proline 0 CA--C 1.52 -0.209 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 176.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.819 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 35.3 Cg_endo -61.92 69.17 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 CA-C-N 119.814 0.969 . . . . 0.0 112.486 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.011 HG21 HG21 ' A' ' 71' ' ' VAL . 44.2 mm 105.68 64.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 177.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.71 ' ND2' ' CD2' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -65.77 63.89 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.142 -0.349 . . . . 0.0 111.367 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.659 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 39.1 p 57.98 160.31 0.09 OUTLIER Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.6 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 52.7 Cg_exo -52.65 -34.01 61.76 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.335 1.356 . . . . 0.0 113.042 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.44 -57.42 9.92 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.371 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.647 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -76.35 -58.34 3.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.916 HD22 HG23 ' A' ' 24' ' ' ILE . 3.9 pp -50.33 -45.76 55.12 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.791 ' N ' HD12 ' A' ' 30' ' ' LEU . 27.7 ttm -64.26 -31.37 72.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -69.12 -30.66 68.98 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.854 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.648 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -69.28 -37.79 78.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.965 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.778 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.4 mp -32.75 140.34 0.21 Allowed Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.052 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.64 -33.33 18.15 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.534 2.822 . . . . 0.0 112.896 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.552 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 14.6 t30 -72.15 -25.73 61.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.588 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . 107.54 -69.53 0.22 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.079 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 83.6 Cg_endo -80.49 -45.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.581 2.188 . . . . 0.0 112.873 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.5 ' HA ' HD22 ' A' ' 34' ' ' LEU . 11.3 p-10 179.26 76.61 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.898 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.704 HG22 HD23 ' A' ' 34' ' ' LEU . 11.3 t -54.48 135.2 46.03 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.82 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 30.8 m -93.15 115.62 28.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.795 0.331 . . . . 0.0 111.302 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 73.7 m -92.65 46.62 1.25 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 109.955 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.495 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 24.2 pttm -75.62 124.14 26.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.093 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.4 m -98.92 120.49 39.45 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.33 -128.45 41.58 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.615 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -79.86 -37.13 35.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.823 0.344 . . . . 0.0 111.411 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.707 HG12 ' CD2' ' A' ' 49' ' ' LEU . 38.6 t -67.22 141.79 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.584 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.86 ' C ' HD22 ' A' ' 49' ' ' LEU . 70.1 mt-10 -129.57 128.7 43.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.028 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.86 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.7 mm? -143.24 131.23 21.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HG3' ' H ' ' A' ' 53' ' ' ASP . 21.8 pttm -165.03 172.1 13.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.429 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.567 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -59.38 -35.94 74.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.616 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.8 t -66.44 -58.4 5.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 43.9 m-20 -71.84 -54.24 10.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.674 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -77.58 -46.02 23.47 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.76 -23.41 3.43 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.58 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.41 ' NE2' ' O ' ' A' ' 53' ' ' ASP . 26.2 pt20 -42.52 -32.56 0.56 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.023 0.439 . . . . 0.0 111.447 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.0 m -78.33 27.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.587 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 39.8 mt -127.25 115.13 18.58 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.893 0.378 . . . . 0.0 110.046 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.8 p -67.52 155.88 38.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.958 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.06 -40.38 61.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.954 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -54.93 -23.47 19.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.669 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.541 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 13.4 m-20 -68.53 3.07 1.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.659 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.8 OUTLIER -39.43 -65.23 0.43 Allowed Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 117.81 0.277 . . . . 0.0 111.612 -179.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.9 Cg_endo -70.71 76.35 1.52 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.367 2.044 . . . . 0.0 112.093 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.853 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.02 140.46 40.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.84 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 22.8 tptm -66.0 67.64 0.05 OUTLIER 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.429 0.633 . . . . 0.0 110.608 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.819 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 34.6 m 60.19 159.88 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.962 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.643 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.57 -29.65 17.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.563 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 10.9 pt-20 -58.88 -47.61 84.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.297 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.509 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -68.51 -35.73 77.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.204 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.011 HG21 HG21 ' A' ' 24' ' ' ILE . 89.8 t -61.92 -44.35 98.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 110.51 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.837 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -55.6 -49.49 72.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -69.86 -41.85 74.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.992 0.425 . . . . 0.0 111.21 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.409 HG23 ' NZ ' ' A' ' 78' ' ' LYS . 86.4 m -59.33 -50.98 71.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.855 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.438 HG23 ' CB ' ' A' ' 54' ' ' ALA . 69.3 mt -61.02 -52.98 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.397 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 72' ' ' ALA . 13.5 m -60.35 -40.38 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -60.09 -54.16 49.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 111.417 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.562 ' HB2' HG21 ' A' ' 57' ' ' VAL . 63.2 mttp -71.86 -41.11 68.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.86 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.674 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.1 -29.94 69.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.834 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.77 -55.8 0.44 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.676 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.8 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.141 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 39.5 t 69.0 -56.5 0.53 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.237 0.215 . . . . 0.0 111.529 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -62.11 132.85 54.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.856 0.36 . . . . 0.0 110.98 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -63.46 144.37 57.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.055 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.549 ' O ' ' O ' ' A' ' 3' ' ' MET . 88.3 tttt -176.8 -105.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.509 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.549 ' O ' ' O ' ' A' ' 2' ' ' LYS . 25.4 ptt? 49.26 128.2 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.347 0.594 . . . . 0.0 112.132 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.25 -136.21 3.18 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.318 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.749 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.8 p -71.86 -6.43 7.61 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 O-C-N 123.047 -0.09 . . . . 0.0 111.047 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 86.3 tttt -45.76 -50.66 13.67 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -78.0 -27.77 49.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.172 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.749 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 33.8 t70 -66.96 -52.56 41.37 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.542 HG13 HG22 ' A' ' 5' ' ' VAL . 19.5 mt -69.6 -45.86 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.678 ' CD ' ' HB1' ' A' ' 72' ' ' ALA . 5.7 tmm_? -55.21 -31.96 61.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.09 -43.35 98.88 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 68.0 mt-30 -63.41 -29.91 71.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.673 -0.763 . . . . 0.0 109.552 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 10' ' ' ARG . 61.9 mt -70.21 -42.39 78.97 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 69' ' ' GLU . 8.3 mm -57.7 -53.26 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.343 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.4 -38.06 90.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.327 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -61.77 -28.35 69.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.055 0.455 . . . . 0.0 111.28 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.024 HD22 HD12 ' A' ' 24' ' ' ILE . 48.0 mt -83.45 -29.57 27.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.526 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.11 129.85 43.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.76 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.42 -33.86 4.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.668 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.664 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.85 -174.29 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 111.423 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.593 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 76.8 m-20 -60.31 -119.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.733 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -60.63 -179.99 0.21 Allowed Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 41.6 Cg_endo -66.17 65.94 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 120.089 1.068 . . . . 0.0 112.336 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.024 HD12 HD22 ' A' ' 17' ' ' LEU . 50.4 mm 108.01 60.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.611 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.6 m120 -62.45 66.82 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.561 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 59.7 p 57.16 154.18 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.658 ' O ' ' CB ' ' A' ' 31' ' ' MET . 54.3 Cg_exo -48.66 -32.82 22.57 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.096 1.198 . . . . 0.0 112.65 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -52.21 -57.37 9.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.473 0.654 . . . . 0.0 110.739 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.611 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 40.2 tp10 -74.71 -57.93 3.61 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.895 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.56 -40.4 52.05 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.696 ' CG ' ' HB2' ' A' ' 39' ' ' ASP . 40.1 ttm -63.88 -33.24 75.26 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -75.44 -20.49 58.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.664 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -75.91 -42.93 47.49 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 30' ' ' LEU . 6.9 mp -27.96 147.17 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -47.2 -49.86 12.12 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.051 3.168 . . . . 0.0 115.478 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.459 HD21 ' N ' ' A' ' 40' ' ' THR . 0.1 OUTLIER -72.3 -14.05 61.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.453 ' N ' HD22 ' A' ' 36' ' ' ASN . . . 105.31 -69.51 0.24 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.699 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 84.5 Cg_endo -84.04 43.52 1.39 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.663 2.242 . . . . 0.0 112.746 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.696 ' HB2' ' CG ' ' A' ' 31' ' ' MET . 10.1 t70 61.68 96.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.368 0.604 . . . . 0.0 111.971 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 34' ' ' LEU . 5.2 t -70.2 132.7 46.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.948 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.438 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 11.8 m -76.17 124.13 26.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.963 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.6 m -90.44 44.66 1.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.528 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.5 pttm -75.73 149.27 38.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.136 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.4 m -147.21 128.47 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.773 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.79 -51.06 0.89 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.87 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.424 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.7 p30 -171.04 -39.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.846 0.355 . . . . 0.0 110.436 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.7 HG12 ' CD2' ' A' ' 49' ' ' LEU . 41.4 t -66.83 137.93 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.746 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.866 ' C ' HD22 ' A' ' 49' ' ' LEU . 28.1 mt-10 -122.45 135.3 54.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.816 0.341 . . . . 0.0 110.896 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.866 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.5 mm? -140.83 138.01 33.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.08 0.466 . . . . 0.0 110.952 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 21.6 pttp -174.74 166.07 3.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.705 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.491 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.84 -40.47 21.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.074 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.6 t -72.01 -43.7 64.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.412 ' O ' ' NE2' ' A' ' 56' ' ' GLN . 38.2 t70 -69.14 -54.11 16.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 0.0 111.853 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.986 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -96.28 -45.77 6.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.58 -30.04 2.04 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.361 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 53' ' ' ASP . 18.7 pt20 -51.52 -28.86 14.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.202 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.986 HG22 ' O ' ' A' ' 54' ' ' ALA . 31.9 m -78.26 27.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.516 HD13 ' CE2' ' A' ' 65' ' ' PHE . 38.2 mt -125.86 125.68 43.23 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.744 0.307 . . . . 0.0 110.332 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.9 p -67.88 155.72 38.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.599 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.08 -40.92 67.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.189 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -55.02 -22.26 14.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.0 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.607 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.6 m-20 -68.42 3.01 1.94 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.9 OUTLIER -41.12 -65.14 0.5 Allowed Pre-proline 0 N--CA 1.462 0.159 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.501 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.0 Cg_endo -71.35 76.79 1.74 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.293 1.995 . . . . 0.0 112.246 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.964 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.05 143.19 39.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 -179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.671 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.11 68.67 0.12 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.637 0.732 . . . . 0.0 110.963 178.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.771 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 20.2 m 58.75 161.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.268 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.686 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.63 -30.96 23.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.857 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.621 ' HA ' HD11 ' A' ' 14' ' ' ILE . 16.3 pt-20 -58.46 -46.3 86.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.448 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.671 ' HG2' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -71.0 -37.54 72.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.725 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.006 HG21 HG21 ' A' ' 24' ' ' ILE . 45.5 t -62.69 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.023 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.678 ' HB1' ' CD ' ' A' ' 10' ' ' ARG . . . -56.63 -48.45 77.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.066 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.414 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.3 m-20 -65.52 -45.28 84.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.839 0.352 . . . . 0.0 111.028 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.435 ' OG1' ' OE1' ' A' ' 70' ' ' GLU . 27.0 m -59.86 -44.65 94.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.624 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.784 HG23 ' CB ' ' A' ' 54' ' ' ALA . 66.2 mt -57.26 -51.52 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.399 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 14.9 m -60.33 -37.11 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 78.4 m-20 -63.31 -58.16 8.04 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HB2' HG21 ' A' ' 57' ' ' VAL . 64.3 mttp -69.48 -38.96 77.92 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.621 ' HB2' ' CB ' ' A' ' 54' ' ' ALA . . . -66.75 -29.95 70.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.242 -178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.21 -55.88 0.42 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 119.944 -1.122 . . . . 0.0 113.236 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.534 HD13 ' HA ' ' A' ' 6' ' ' LYS . 19.5 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.257 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 2' ' ' LYS . 80.3 p -178.26 37.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -86.69 138.3 31.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.259 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt 64.71 58.07 1.02 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.448 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' -2' ' ' SER . 22.3 ptmt -176.26 142.43 0.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.938 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -157.42 133.11 9.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.523 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.5 -132.3 1.97 Allowed Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.872 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.727 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.6 p -70.04 -6.32 6.55 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 CA-C-N 116.677 0.238 . . . . 0.0 110.925 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -45.29 -46.53 12.76 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.407 ' OE2' ' HD2' ' A' ' 6' ' ' LYS . 9.5 mp0 -77.74 -31.63 52.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.934 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.727 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 65.4 m-20 -65.61 -52.35 52.66 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.507 HG13 HG22 ' A' ' 5' ' ' VAL . 31.1 mt -68.33 -46.1 81.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.599 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 0.3 OUTLIER -56.89 -29.96 63.48 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.58 -43.68 96.16 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 82.7 mt-30 -63.95 -30.23 71.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.711 -0.744 . . . . 0.0 109.665 177.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 10' ' ' ARG . 63.2 mt -70.5 -42.54 78.25 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.059 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.839 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' A' ' 69' ' ' GLU . 10.4 mm -57.17 -52.75 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.413 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.37 -37.7 86.3 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.186 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -60.98 -27.88 68.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.975 0.416 . . . . 0.0 111.094 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.092 HD22 HD12 ' A' ' 24' ' ' ILE . 54.6 mt -85.78 -29.41 23.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.939 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.98 129.09 38.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.098 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.92 -34.49 4.17 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.836 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.702 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.87 -178.05 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.843 0.354 . . . . 0.0 111.613 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -61.18 -119.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.728 ' CE2' ' HA ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -58.73 174.43 0.37 Allowed Pre-proline 0 CA--C 1.519 -0.242 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 176.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.889 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 39.3 Cg_endo -63.32 67.01 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.843 0.98 . . . . 0.0 112.292 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.092 HD12 HD22 ' A' ' 17' ' ' LEU . 24.0 mm 109.4 60.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.728 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.6 m120 -62.78 65.85 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 25' ' ' ASN . 81.5 p 56.76 156.7 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.656 ' O ' ' HB2' ' A' ' 31' ' ' MET . 52.1 Cg_exo -49.5 -34.47 33.65 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.299 1.332 . . . . 0.0 113.15 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.03 -57.1 10.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.327 0.584 . . . . 0.0 110.647 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.604 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.2 tp10 -76.0 -57.51 3.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.901 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -49.9 -41.12 45.13 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.873 ' HA ' HD13 ' A' ' 34' ' ' LEU . 64.3 mtm -65.72 -33.82 76.77 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.45 -28.31 68.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.605 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.702 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -72.6 -40.73 66.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.618 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.873 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.4 mp -35.18 145.21 0.2 Allowed Pre-proline 0 N--CA 1.467 0.407 0 CA-C-O 121.137 0.494 . . . . 0.0 112.326 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.536 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.2 Cg_endo -47.44 -41.96 28.74 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 124.07 3.18 . . . . 0.0 114.38 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.466 HD22 ' N ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -71.85 -16.98 62.16 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' N ' HD22 ' A' ' 36' ' ' ASN . . . 109.82 -67.43 0.23 Allowed Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.94 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.616 ' O ' ' HB3' ' A' ' 31' ' ' MET . 60.7 Cg_endo -77.09 -53.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.249 1.966 . . . . 0.0 112.529 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.649 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER 172.78 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.87 0.468 . . . . 0.0 110.587 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.563 HG22 HD23 ' A' ' 34' ' ' LEU . 9.9 t -68.35 135.28 51.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.873 0.368 . . . . 0.0 111.181 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.467 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 6.7 m -81.0 127.82 33.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.7 m -95.55 43.71 1.09 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 110.368 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.461 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -75.6 156.19 35.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.134 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.7 m -153.33 129.48 10.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.349 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.49 -52.52 0.65 Allowed Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.171 -0.537 . . . . 0.0 113.225 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -168.44 -40.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.976 0.417 . . . . 0.0 110.242 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.733 HG12 ' CD2' ' A' ' 49' ' ' LEU . 41.5 t -66.63 135.29 28.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.543 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.878 ' C ' HD22 ' A' ' 49' ' ' LEU . 32.8 mt-10 -123.42 131.4 53.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.878 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.7 mm? -141.63 139.37 33.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.848 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.467 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 59.6 pttt -176.97 153.94 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.81 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.768 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.8 -27.22 1.94 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.659 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.9 t -67.26 -62.51 1.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.067 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -72.55 -54.32 9.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.915 0.388 . . . . 0.0 111.787 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.898 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -71.76 -45.3 62.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.812 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.65 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.91 -27.83 1.57 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.711 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -41.91 -36.69 1.13 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.795 0.807 . . . . 0.0 110.434 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 54' ' ' ALA . 16.3 m -83.07 28.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.28 -1.327 . . . . 0.0 112.243 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 57' ' ' VAL . 36.1 mt -137.91 76.9 1.6 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.943 0.402 . . . . 0.0 110.38 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.9 p -49.08 174.92 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.247 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.02 73.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.551 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -50.69 -28.44 9.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.013 0.435 . . . . 0.0 110.629 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.472 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 52.8 m-20 -75.47 3.46 9.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.338 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.685 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -43.78 -71.34 0.16 Allowed Pre-proline 0 N--CA 1.462 0.157 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.248 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 56.4 Cg_endo -68.39 77.65 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.023 1.816 . . . . 0.0 111.303 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.755 ' CG ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -77.1 144.59 38.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.138 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 62.1 mttp -70.37 64.36 0.27 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.106 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.889 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 55.7 m 63.93 160.2 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.575 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.541 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.92 -27.09 11.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.893 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.471 ' HA ' HD11 ' A' ' 14' ' ' ILE . 15.3 pt-20 -65.43 -38.92 91.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.969 0.414 . . . . 0.0 109.969 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.511 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 6.8 tp10 -67.73 -46.23 72.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.927 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.001 ' CG2' HG21 ' A' ' 24' ' ' ILE . 42.1 t -66.36 -45.65 88.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.821 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.564 ' HB1' ' CD ' ' A' ' 10' ' ' ARG . . . -55.33 -45.05 76.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.009 0.433 . . . . 0.0 110.352 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -69.82 -43.5 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.69 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.467 HG22 HD21 ' A' ' 58' ' ' LEU . 72.6 m -57.74 -46.93 83.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.298 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.875 HG23 ' CB ' ' A' ' 54' ' ' ALA . 70.6 mt -58.23 -54.95 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.959 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.53 HG21 ' HE3' ' A' ' 6' ' ' LYS . 15.2 m -58.5 -43.93 87.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.836 0.309 . . . . 0.0 111.836 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -62.52 -54.14 44.33 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.425 ' CB ' HG21 ' A' ' 57' ' ' VAL . 98.6 mttt -72.07 -41.16 67.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.42 ' HB1' ' CD1' ' A' ' 49' ' ' LEU . . . -67.04 -29.98 69.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.062 0.394 . . . . 0.0 112.062 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.49 -56.36 0.39 Allowed Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.049 -1.072 . . . . 0.0 113.223 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 14.0 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.08 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 47.5 t -59.9 136.15 57.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.881 0.372 . . . . 0.0 110.828 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -62.95 -41.63 99.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.944 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttm -176.02 136.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.97 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.468 ' HB3' ' NZ ' ' A' ' 2' ' ' LYS . 4.4 mmmp? -72.54 134.7 45.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.208 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.0 mtp -59.88 -45.75 91.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.898 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.54 -40.79 1.66 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.525 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.9 p -68.04 -5.86 4.7 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.484 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 0.8 OUTLIER -45.1 -46.54 11.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.6 -32.79 53.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.868 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.706 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 13.5 m-20 -64.88 -52.14 58.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.542 HG13 HG22 ' A' ' 5' ' ' VAL . 31.9 mt -65.4 -46.63 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.826 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 45.8 ttp180 -56.77 -28.69 61.7 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.46 -42.41 95.84 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 19.4 mt-30 -69.02 -32.44 71.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.866 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.1 mt -70.11 -45.91 74.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.266 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 14' ' ' ILE . 5.3 mm -57.67 -52.23 60.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.698 0.285 . . . . 0.0 110.398 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.63 93.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.332 -0.937 . . . . 0.0 110.9 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.719 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -64.72 -25.88 68.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.282 -0.459 . . . . 0.0 111.172 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.008 HD22 HD12 ' A' ' 24' ' ' ILE . 65.3 mt -83.0 -29.46 28.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.718 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.83 139.43 54.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.262 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.67 -30.85 8.88 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.888 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.674 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.59 -176.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.988 0.423 . . . . 0.0 111.61 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.569 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -59.83 -120.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.825 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -61.36 -169.06 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.825 ' N ' ' HD1' ' A' ' 22' ' ' PHE . 57.5 Cg_endo -71.48 62.19 2.82 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 CA-C-N 120.975 1.384 . . . . 0.0 112.178 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.064 HG21 HG21 ' A' ' 71' ' ' VAL . 48.9 mm 109.83 65.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.671 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -63.76 65.64 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 O-C-N 122.001 -0.437 . . . . 0.0 111.612 178.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.609 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 42.7 p 59.38 157.05 0.1 OUTLIER Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.604 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 50.7 Cg_exo -50.59 -34.36 42.66 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.331 1.354 . . . . 0.0 112.879 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -53.15 -55.43 24.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.137 0.494 . . . . 0.0 110.907 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.671 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -74.83 -57.37 3.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.907 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -49.89 -38.46 35.86 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.792 ' HA ' HD13 ' A' ' 34' ' ' LEU . 57.3 mtm -63.5 -37.83 88.82 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.77 -26.44 66.97 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.166 0.508 . . . . 0.0 110.562 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.674 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -68.36 -42.99 78.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.474 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.792 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.0 mp -33.32 148.9 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.739 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -47.22 -46.56 19.23 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.648 2.898 . . . . 0.0 113.821 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.492 ' OD1' ' HB ' ' A' ' 40' ' ' THR . 12.3 p-10 -72.6 -26.29 61.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . 118.53 -79.19 0.3 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.545 -0.835 . . . . 0.0 112.873 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' MET . 16.8 Cg_endo -58.24 -73.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.495 2.13 . . . . 0.0 112.213 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.638 ' HA ' HD22 ' A' ' 34' ' ' LEU . 1.1 p30 -176.84 88.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.642 HG22 HD23 ' A' ' 34' ' ' LEU . 2.4 t -62.07 136.23 57.86 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.598 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.445 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 28.1 m -83.9 125.98 32.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.996 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.494 ' HB2' HG23 ' A' ' 9' ' ' ILE . 63.4 m -88.84 46.26 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 0.0 110.341 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.455 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 61.8 pttt -75.69 147.43 39.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.096 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.9 m -141.78 126.98 18.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.72 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.75 -59.55 0.5 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.958 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -156.39 -42.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.807 0.337 . . . . 0.0 110.82 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.725 HG12 ' CD2' ' A' ' 49' ' ' LEU . 36.9 t -66.51 138.73 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.111 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.874 ' C ' HD22 ' A' ' 49' ' ' LEU . 29.6 mt-10 -124.23 132.24 53.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.997 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.874 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -143.94 141.69 30.36 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.053 0.454 . . . . 0.0 111.238 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 41' ' ' THR . 51.0 pttt -177.46 165.88 2.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.73 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.724 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -55.14 -31.98 61.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.663 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.0 t -66.58 -62.65 1.35 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 58.4 m-20 -72.21 -54.31 10.01 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.506 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -73.42 -44.37 58.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.63 -25.28 1.39 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.365 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 25.3 pt20 -40.6 -38.4 0.87 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.157 0.503 . . . . 0.0 111.652 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.3 m -65.65 -33.32 62.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.371 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 13.2 mt -70.17 119.27 14.12 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.5 p -72.18 155.77 39.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.883 0.373 . . . . 0.0 111.468 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.82 -40.7 60.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.3 -21.2 33.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.961 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.573 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 19.6 m-20 -68.7 2.98 2.11 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.609 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.8 OUTLIER -37.78 -62.81 0.58 Allowed Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 117.953 0.342 . . . . 0.0 111.63 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.7 Cg_endo -72.08 77.63 1.95 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.378 2.052 . . . . 0.0 111.747 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.919 ' CD2' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -77.03 141.99 40.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.649 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -68.67 66.76 0.13 Allowed 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.519 0.676 . . . . 0.0 110.221 178.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.802 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 18.5 m 60.8 161.51 0.06 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.369 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.672 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.57 -31.77 25.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.645 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.9 pt-20 -58.37 -45.82 87.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.408 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -70.16 -33.69 72.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.607 -179.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.064 HG21 HG21 ' A' ' 24' ' ' ILE . 61.6 t -63.17 -44.95 99.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.919 0.39 . . . . 0.0 110.563 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.865 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -57.05 -50.3 73.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.067 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 56.0 m-20 -68.5 -42.04 79.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.009 0.433 . . . . 0.0 111.232 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.474 HG22 HD21 ' A' ' 58' ' ' LEU . 98.0 m -59.64 -49.4 77.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.797 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.49 HG23 ' HB1' ' A' ' 54' ' ' ALA . 75.2 mt -62.07 -54.23 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.607 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.865 HG22 ' O ' ' A' ' 72' ' ' ALA . 11.3 m -61.29 -44.67 98.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 4.3 m120 -59.66 -52.58 64.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.43 ' HE2' ' HB ' ' A' ' 57' ' ' VAL . 48.9 mtpt -72.65 -41.06 65.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.734 0.302 . . . . 0.0 111.606 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.27 -30.08 69.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.759 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.19 -56.28 0.41 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.934 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 16.9 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.042 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 52.4 m -86.65 43.72 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.646 0.26 . . . . 0.0 111.401 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -93.35 128.15 39.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.744 0.306 . . . . 0.0 110.92 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 1.8 mpt? -104.52 -58.5 1.87 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.733 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 1' ' ' MET . 56.2 tptt 176.69 -43.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.66 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 ttt -56.29 132.79 51.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.078 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.09 -133.78 2.55 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.225 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.703 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p -71.12 -5.51 5.87 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.974 0 O-C-N 122.985 -0.127 . . . . 0.0 111.315 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' HE2' ' NH2' ' A' ' 10' ' ' ARG . 86.8 tttt -44.94 -47.45 11.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -77.61 -33.48 53.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.786 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.703 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -63.69 -52.07 62.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.527 HG13 ' CG2' ' A' ' 5' ' ' VAL . 28.3 mt -64.01 -46.46 93.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.794 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 24.3 ttm180 -56.88 -28.05 61.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.92 -41.42 97.4 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 63.4 mt-30 -70.69 -31.33 68.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.633 -0.784 . . . . 0.0 110.032 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.4 -48.68 52.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.308 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.466 ' HA ' HD13 ' A' ' 14' ' ' ILE . 7.9 mm -57.27 -52.27 58.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.511 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.22 -36.47 93.27 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.911 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -64.17 -28.45 69.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.239 -0.481 . . . . 0.0 111.247 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.048 HD22 HD12 ' A' ' 24' ' ' ILE . 60.8 mt -80.43 -29.45 37.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.701 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.68 133.3 53.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.067 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.58 -33.54 5.46 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.765 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.706 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.65 -176.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.044 0.449 . . . . 0.0 111.643 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -59.9 -123.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.775 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -58.83 -174.79 0.05 OUTLIER Pre-proline 0 N--CA 1.456 -0.127 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 176.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.844 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 52.2 Cg_endo -68.08 62.8 1.01 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 120.478 1.206 . . . . 0.0 112.326 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.048 HD12 HD22 ' A' ' 17' ' ' LEU . 49.1 mm 110.32 65.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.663 ' ND2' ' CD2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -64.67 65.99 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 122.013 -0.429 . . . . 0.0 111.478 178.027 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.541 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 27.3 p 58.43 157.2 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.602 ' HG3' HD12 ' A' ' 58' ' ' LEU . 50.8 Cg_exo -50.69 -34.62 44.53 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.319 1.346 . . . . 0.0 112.875 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -52.61 -55.19 24.07 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.613 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.655 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 6.0 tp10 -76.25 -57.83 3.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.933 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -50.03 -41.85 48.34 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.749 ' N ' HD12 ' A' ' 30' ' ' LEU . 28.3 ttm -66.02 -32.69 74.32 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.14 -30.39 69.51 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.394 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -68.41 -40.42 81.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.288 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.0 mp -25.07 134.47 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.29 -178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.35 -34.84 72.52 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.862 3.041 . . . . 0.0 114.899 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.577 ' CG ' ' HB ' ' A' ' 40' ' ' THR . 15.1 p-10 -72.33 -28.24 62.93 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.28 -67.21 0.46 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.917 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 97.7 Cg_endo -83.74 43.79 1.47 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.745 2.297 . . . . 0.0 113.506 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.568 ' C ' HD21 ' A' ' 36' ' ' ASN . 1.6 m-20 62.28 93.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.577 ' HB ' ' CG ' ' A' ' 36' ' ' ASN . 3.8 t -75.4 137.57 41.11 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.473 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.45 ' OG1' ' HD2' ' A' ' 50' ' ' LYS . 27.3 m -96.15 118.87 33.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.668 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -88.01 43.87 1.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.09 0.472 . . . . 0.0 109.975 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 19.8 ptmt -75.82 132.48 40.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.148 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.0 m -111.82 114.63 27.71 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.8 -129.66 44.53 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.467 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -72.05 -37.29 69.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.008 0.432 . . . . 0.0 110.987 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.615 HG12 ' CD2' ' A' ' 49' ' ' LEU . 51.7 t -66.69 145.36 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.725 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.883 ' C ' HD22 ' A' ' 49' ' ' LEU . 32.6 mt-10 -141.99 128.3 19.92 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.634 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.883 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -140.91 132.52 27.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.936 0.398 . . . . 0.0 110.912 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HD2' ' OG1' ' A' ' 41' ' ' THR . 21.3 ptmt -170.21 159.08 7.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.727 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.86 -29.88 3.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.951 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.9 t -72.54 -59.59 2.65 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 57.5 m-20 -72.15 -54.11 10.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.79 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -74.34 -43.97 54.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.09 -27.06 1.46 Allowed Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.363 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 18.1 pt20 -42.25 -40.14 2.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.149 0.5 . . . . 0.0 111.515 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.751 HG22 ' O ' ' A' ' 54' ' ' ALA . 28.0 m -65.76 -30.39 49.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.104 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.691 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 12.4 mt -71.32 119.85 16.05 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.5 p -75.0 155.66 37.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.355 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.64 -39.81 51.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -58.81 -21.09 55.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.642 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 17.4 m-20 -70.04 3.15 2.9 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.5 m-85 -40.49 -62.69 0.88 Allowed Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 118.162 0.437 . . . . 0.0 111.293 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 60.0 Cg_endo -71.43 74.95 2.01 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.48 2.12 . . . . 0.0 112.207 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.881 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -76.9 139.84 40.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.167 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.486 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 38.1 mtmm -66.45 70.07 0.07 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.596 0.712 . . . . 0.0 110.671 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.844 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 37.7 m 59.33 161.15 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.284 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.67 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.55 -26.85 9.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.482 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.515 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 12.0 pt-20 -58.77 -48.99 79.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.454 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.499 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -74.87 -31.88 61.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 119.656 -0.817 . . . . 0.0 111.303 -179.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.971 HG21 HG21 ' A' ' 24' ' ' ILE . 57.2 t -61.48 -45.47 98.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.418 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.889 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -60.84 -46.33 90.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.108 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 77' ' ' ASN . 9.3 t70 -62.5 -41.74 99.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.531 0.682 . . . . 0.0 110.396 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.471 HG22 HD21 ' A' ' 58' ' ' LEU . 85.0 m -63.19 -49.54 73.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.835 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.79 HG23 ' CB ' ' A' ' 54' ' ' ALA . 74.7 mt -59.79 -55.17 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.072 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 72' ' ' ALA . 9.7 m -60.9 -43.8 96.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 3.4 m120 -63.93 -50.77 67.36 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HB2' HG21 ' A' ' 57' ' ' VAL . 99.7 mttt -74.06 -41.65 61.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.536 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.11 -29.9 69.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.7 -55.79 0.36 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.064 -1.065 . . . . 0.0 113.223 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 17.5 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.396 -0.811 . . . . 0.0 111.237 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . 0.488 ' O ' ' CG ' ' A' ' -1' ' ' HIS . 28.4 m 62.11 -137.88 0.47 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.569 -0.16 . . . . 0.0 110.569 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . 0.488 ' CG ' ' O ' ' A' ' -2' ' ' SER . 10.2 p80 47.83 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.791 0.329 . . . . 0.0 111.376 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt -71.53 126.03 28.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.29 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.52 ' HZ1' HD23 ' A' ' 81' ' ' LEU . 61.7 pttt -75.03 -35.77 61.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.617 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 93.5 mmm 66.65 130.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.39 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.1 -138.45 5.14 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.021 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.7 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.3 p -77.1 -5.82 8.12 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 C-N-CA 121.401 -0.12 . . . . 0.0 110.957 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 13.0 tmtt? -45.11 -46.0 11.53 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.53 -34.14 54.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.857 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.7 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -63.55 -52.2 62.11 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.73 HG23 ' HB2' ' A' ' 42' ' ' CYS . 31.6 mt -65.69 -47.49 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.802 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 52.0 ttp85 -55.04 -28.8 55.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.426 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.63 -47.21 79.31 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -66.95 -28.02 67.93 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.763 -0.719 . . . . 0.0 109.986 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 9' ' ' ILE . 75.3 mt -70.43 -44.99 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.075 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.566 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.46 HD13 ' HA ' ' A' ' 14' ' ' ILE . 11.3 mm -56.11 -49.64 74.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.05 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.69 -36.85 91.89 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.044 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.93 -27.11 69.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.25 -0.475 . . . . 0.0 111.38 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.025 HD22 HD12 ' A' ' 24' ' ' ILE . 35.9 mt -85.01 -29.47 24.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.71 132.86 46.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.03 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.45 -33.97 4.88 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.519 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.715 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.19 -177.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.771 0.319 . . . . 0.0 111.383 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.55 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.79 -119.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.749 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -60.82 179.61 0.22 Allowed Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 176.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.816 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 41.4 Cg_endo -65.48 65.49 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 CA-C-N 119.921 1.008 . . . . 0.0 112.359 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.025 HD12 HD22 ' A' ' 17' ' ' LEU . 31.7 mm 107.94 61.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.611 ' HA ' ' CZ ' ' A' ' 22' ' ' PHE . 2.6 m120 -62.98 65.75 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.588 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.1 p 57.12 156.7 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.613 ' O ' ' CB ' ' A' ' 31' ' ' MET . 53.7 Cg_exo -50.04 -33.99 36.65 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.351 1.367 . . . . 0.0 112.837 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -52.3 -56.83 12.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.308 0.575 . . . . 0.0 110.625 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.603 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.1 tp10 -76.1 -57.71 3.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.9 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.7 pp -50.2 -40.76 48.13 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.75 ' HA ' HD13 ' A' ' 34' ' ' LEU . 31.2 ttm -65.93 -33.61 76.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.48 -29.94 69.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.469 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.715 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -70.1 -39.62 75.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.408 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.75 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.8 mp -30.49 140.99 0.12 Allowed Pre-proline 0 N--CA 1.468 0.466 0 CA-C-O 121.108 0.48 . . . . 0.0 112.12 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.27 -50.04 15.34 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.859 3.04 . . . . 0.0 115.587 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.596 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -72.31 -26.54 61.99 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -177.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.442 ' H ' HD22 ' A' ' 36' ' ' ASN . . . 102.93 -62.18 0.46 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.936 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.596 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 93.5 Cg_endo -79.45 49.46 3.18 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.6 2.2 . . . . 0.0 113.154 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 2.6 p30 51.5 91.85 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.539 ' H ' HD23 ' A' ' 34' ' ' LEU . 6.0 t -78.84 134.9 36.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.513 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.565 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 2.0 t -108.6 121.97 46.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.073 0.464 . . . . 0.0 111.478 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.73 ' HB2' HG23 ' A' ' 9' ' ' ILE . 33.8 m -72.4 59.84 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.39 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.467 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 62.0 pttt -75.19 122.54 23.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.004 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 m -98.68 87.58 3.83 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.87 -126.39 8.03 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.996 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' O ' ' OE2' ' A' ' 48' ' ' GLU . 28.5 m-20 -72.56 -43.59 63.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.655 HG12 ' CD2' ' A' ' 49' ' ' LEU . 58.3 t -70.82 137.29 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.865 ' C ' HD22 ' A' ' 49' ' ' LEU . 22.1 mp0 -126.22 137.69 53.56 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.56 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.865 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.8 mm? -136.08 135.83 39.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.649 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.749 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 56.1 pttt -166.38 -165.26 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.058 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.506 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -78.02 -46.33 21.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.876 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.7 t -65.36 -51.62 59.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.647 0.26 . . . . 0.0 111.542 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.44 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 46.4 m-20 -71.79 -51.44 22.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 50' ' ' LYS . . . -86.03 -47.18 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.81 -26.15 1.08 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.785 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.419 ' HG3' ' N ' ' A' ' 57' ' ' VAL . 22.7 pt20 -41.57 -38.95 1.46 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.964 0.411 . . . . 0.0 111.796 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.1 m -65.66 -32.21 57.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.558 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.71 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 22.4 mt -68.62 122.54 18.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.36 . . . . 0.0 110.554 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.5 p -74.74 155.81 37.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.331 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.21 -42.11 60.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.321 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.21 -20.02 38.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.169 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.693 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 28.5 m-20 -68.64 3.31 1.92 Allowed 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.588 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.7 OUTLIER -39.49 -67.46 0.28 Allowed Pre-proline 0 N--CA 1.463 0.18 0 CA-C-N 117.758 0.254 . . . . 0.0 111.466 -179.107 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 58.7 Cg_endo -70.43 76.39 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.311 2.007 . . . . 0.0 112.18 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.858 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -76.94 141.92 40.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.989 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.507 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 4.4 mmmp? -67.41 69.67 0.1 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.454 0.645 . . . . 0.0 110.615 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.816 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.8 m 58.5 162.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.15 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.651 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.8 -27.47 12.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.733 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.494 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 15.6 pt-20 -58.36 -49.69 76.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.555 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.507 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -73.54 -32.27 64.11 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.07 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.972 HG21 HG21 ' A' ' 24' ' ' ILE . 60.6 t -64.79 -39.65 86.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.888 0.375 . . . . 0.0 110.62 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.802 ' HB1' ' CG ' ' A' ' 10' ' ' ARG . . . -63.69 -49.54 72.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -68.46 -41.11 80.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.168 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.8 m -58.85 -51.63 69.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.513 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.651 HG23 ' HB1' ' A' ' 54' ' ' ALA . 75.0 mt -59.17 -53.57 46.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.316 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 72' ' ' ALA . 11.1 m -59.82 -42.1 87.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.945 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -61.54 -53.45 56.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.679 0.276 . . . . 0.0 111.513 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.478 ' HE3' ' HB ' ' A' ' 57' ' ' VAL . 27.7 mtpp -71.85 -39.68 69.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.597 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.92 69.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.812 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.34 -55.4 0.41 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.808 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 17.9 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.958 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 112.524 -0.231 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 80.0 p -178.01 -47.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.854 0.359 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -65.58 -53.11 46.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 ttp 177.75 136.48 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.579 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -122.43 -50.73 1.98 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.21 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.556 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 83.3 mtp 48.35 115.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.979 0.419 . . . . 0.0 111.523 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.19 -130.8 2.0 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.243 -0.98 . . . . 0.0 113.131 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.8 p -67.34 -5.7 4.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 46.2 tttm -44.72 -47.05 10.7 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.798 -0.761 . . . . 0.0 108.999 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.39 -34.33 54.92 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.759 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.706 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 65.4 m-20 -63.03 -52.05 64.38 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.534 HG13 HG22 ' A' ' 5' ' ' VAL . 31.1 mt -66.23 -47.7 83.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.838 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 42.3 ttp180 -55.02 -28.85 55.29 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.98 -43.93 92.62 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 68.7 mt-30 -67.08 -30.83 70.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.746 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 9' ' ' ILE . 68.0 mt -70.77 -42.64 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.781 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.2 mm -57.82 -53.53 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.359 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.27 -37.56 92.99 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.011 178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.41 -30.91 69.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.072 0.463 . . . . 0.0 111.081 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.103 HD22 HD12 ' A' ' 24' ' ' ILE . 46.5 mt -81.27 -29.44 34.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.513 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.82 125.25 21.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.716 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.62 -35.2 3.11 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.465 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.655 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.37 -176.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.842 0.353 . . . . 0.0 111.378 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.577 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.85 -119.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 177.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.729 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -59.66 177.44 0.27 Allowed Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.877 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 53.6 Cg_endo -65.11 65.86 0.31 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 CA-C-N 119.949 1.017 . . . . 0.0 112.372 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.103 HD12 HD22 ' A' ' 17' ' ' LEU . 26.9 mm 109.53 61.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 178.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.696 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.7 m120 -63.14 65.23 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.589 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.8 p 57.37 154.33 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.68 ' O ' ' CB ' ' A' ' 31' ' ' MET . 61.6 Cg_exo -48.21 -32.32 18.99 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.23 1.287 . . . . 0.0 112.748 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -53.0 -57.32 10.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.431 0.634 . . . . 0.0 110.591 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.6 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.1 tp10 -76.27 -57.65 3.74 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.901 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.2 pp -50.12 -35.15 24.58 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.805 ' HG3' ' HB2' ' A' ' 39' ' ' ASP . 30.8 ttm -66.96 -37.01 83.49 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.19 -23.98 64.9 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.659 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.655 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -74.0 -46.59 42.67 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 30' ' ' LEU . 5.6 mp -36.08 144.91 0.24 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 121.241 0.543 . . . . 0.0 112.404 -177.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.46 ' HG2' HG21 ' A' ' 40' ' ' THR . 4.8 Cg_endo -47.77 -50.36 11.8 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.202 3.268 . . . . 0.0 115.141 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.465 HD21 ' N ' ' A' ' 40' ' ' THR . 0.1 OUTLIER -72.27 -15.6 61.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.363 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.46 ' N ' HD22 ' A' ' 36' ' ' ASN . . . 105.33 -69.28 0.24 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.674 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 86.6 Cg_endo -84.35 44.82 1.59 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.688 2.259 . . . . 0.0 113.026 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.805 ' HB2' ' HG3' ' A' ' 31' ' ' MET . 10.8 t70 62.37 95.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.156 0.503 . . . . 0.0 111.729 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.553 HG22 HD23 ' A' ' 34' ' ' LEU . 3.9 t -65.48 133.0 50.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.096 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 m -79.82 126.86 31.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.392 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.2 m -101.61 42.71 1.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.185 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.572 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . 22.5 pttp -75.85 149.18 37.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.634 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.6 m -142.05 136.4 30.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.023 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.39 -63.41 0.41 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.707 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -175.16 27.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.848 0.356 . . . . 0.0 111.106 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.729 HG12 ' CD2' ' A' ' 49' ' ' LEU . 48.7 t -128.08 125.49 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.255 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.908 ' C ' HD22 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -117.42 131.1 56.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.488 0.661 . . . . 0.0 112.271 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.908 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.4 mm? -143.95 133.28 23.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.721 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 60.6 pttt -169.73 -170.57 1.06 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 111.472 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.505 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -62.2 -52.4 63.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -178.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.414 ' OG ' ' HE3' ' A' ' 50' ' ' LYS . 85.3 p -72.74 -51.23 20.01 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.42 ' OD1' ' CE ' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -69.15 -49.92 52.47 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.717 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -90.81 -45.67 8.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -54.22 -21.66 19.5 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.985 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -44.07 -31.4 0.92 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.016 0.436 . . . . 0.0 111.072 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.9 m -77.65 27.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.636 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.536 HD21 HG22 ' A' ' 74' ' ' THR . 34.6 mt -129.33 117.32 20.45 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.922 0.391 . . . . 0.0 110.637 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.445 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 72.6 p -71.84 158.26 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.615 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.73 -39.38 51.75 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.369 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -50.92 -27.28 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.035 0.445 . . . . 0.0 110.737 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.555 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 61.2 m-20 -70.73 3.68 3.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.458 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.676 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -42.12 -69.4 0.22 Allowed Pre-proline 0 C--O 1.226 -0.147 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.378 -179.244 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 51.6 Cg_endo -68.2 76.55 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.254 1.97 . . . . 0.0 111.475 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 62' ' ' ASP . 0.2 OUTLIER -77.01 142.63 39.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.137 -178.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 87.6 tttt -69.8 64.97 0.21 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.818 0.818 . . . . 0.0 111.24 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.877 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 64.8 m 64.07 161.25 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.728 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.553 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -53.38 -27.2 22.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.765 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -65.12 -39.35 92.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.17 0.509 . . . . 0.0 109.666 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 66' ' ' LYS . 8.0 tp10 -66.23 -43.53 86.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.681 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.986 ' CG2' HG21 ' A' ' 24' ' ' ILE . 63.2 t -67.74 -41.1 84.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.544 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.857 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -55.9 -44.67 78.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.08 0.467 . . . . 0.0 110.015 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.47 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.3 m-20 -72.71 -46.66 52.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.17 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.536 HG22 HD21 ' A' ' 58' ' ' LEU . 62.6 m -56.48 -48.78 76.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.708 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.477 HG23 ' CB ' ' A' ' 54' ' ' ALA . 68.3 mt -62.58 -54.31 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.656 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 72' ' ' ALA . 12.9 m -60.12 -42.07 88.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 75.4 m-20 -62.65 -50.6 70.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.685 0.279 . . . . 0.0 111.483 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HB2' HG21 ' A' ' 57' ' ' VAL . 67.7 mttm -72.13 -43.01 65.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.794 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.542 ' HB1' HD12 ' A' ' 49' ' ' LEU . . . -67.54 -30.06 69.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.38 -56.56 0.41 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.869 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.5 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.083 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 47.4 t -178.23 136.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -176.79 45.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp 63.19 134.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.058 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -71.7 136.7 47.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.361 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -68.53 130.44 42.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.966 0.412 . . . . 0.0 111.142 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.15 -27.41 73.81 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.786 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.713 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.5 p -60.99 -7.12 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HE2' ' NH2' ' A' ' 10' ' ' ARG . 82.3 tttt -45.12 -43.24 9.58 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -77.72 -37.14 50.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.836 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.713 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 10.4 m-20 -62.6 -51.77 66.0 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.484 HG13 HG22 ' A' ' 5' ' ' VAL . 30.2 mt -63.92 -45.76 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.756 ' CG ' ' HB1' ' A' ' 72' ' ' ALA . 28.3 ttm180 -56.25 -29.95 61.76 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.4 -41.13 98.21 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 68.1 mt-30 -68.9 -30.12 68.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.747 -0.727 . . . . 0.0 109.755 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 10' ' ' ARG . 70.1 mt -71.17 -45.6 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.829 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 14' ' ' ILE . 9.9 mm -58.2 -52.55 57.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.34 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.44 -37.47 94.49 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.351 -0.928 . . . . 0.0 110.815 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -60.62 -31.0 70.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.176 -0.512 . . . . 0.0 110.785 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.026 HD22 HD12 ' A' ' 24' ' ' ILE . 64.2 mt -80.87 -29.34 35.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.574 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.95 138.08 49.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.15 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.66 -33.14 6.53 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.798 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.717 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.4 -177.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.951 0.405 . . . . 0.0 111.62 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.606 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -59.81 -122.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.389 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.83 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -59.68 -171.5 0.03 OUTLIER Pre-proline 0 N--CA 1.454 -0.227 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.835 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.3 Cg_endo -70.02 62.66 1.93 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 120.718 1.292 . . . . 0.0 112.012 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.052 HG21 HG21 ' A' ' 71' ' ' VAL . 49.3 mm 109.57 65.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.647 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -63.73 65.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 O-C-N 122.038 -0.414 . . . . 0.0 111.857 178.438 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.603 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 35.8 p 60.1 154.54 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.606 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 52.0 Cg_exo -49.57 -33.32 30.49 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.197 1.265 . . . . 0.0 112.715 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -53.99 -54.88 32.97 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.649 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.647 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 5.9 tp10 -75.2 -57.76 3.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.915 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.27 -41.87 51.2 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.758 ' N ' HD12 ' A' ' 30' ' ' LEU . 36.1 ttm -64.29 -32.34 73.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -70.3 -28.75 65.43 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.399 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -71.0 -35.92 72.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.59 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.712 ' HB3' HG22 ' A' ' 40' ' ' THR . 8.8 mp -29.27 139.29 0.12 Allowed Pre-proline 0 N--CA 1.471 0.625 0 CA-C-O 121.078 0.466 . . . . 0.0 112.178 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.9 -45.31 25.04 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.281 3.321 . . . . 0.0 115.868 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.53 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -72.15 -25.39 61.68 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.351 -177.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . 104.72 -65.74 0.3 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.733 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 84.5 Cg_endo -81.64 46.54 2.26 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.57 2.18 . . . . 0.0 113.171 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.435 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER 65.29 90.4 0.09 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.473 178.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.712 HG22 ' HB3' ' A' ' 34' ' ' LEU . 8.8 t -76.27 134.41 39.8 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.751 0.31 . . . . 0.0 111.176 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.458 ' OG1' ' HD2' ' A' ' 50' ' ' LYS . 29.2 m -92.72 125.1 37.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.148 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -93.41 41.31 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . 60.8 pttt -75.85 129.16 36.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.183 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.0 m -106.31 118.21 36.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.13 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.53 -130.02 45.66 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.626 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' OD1' HG23 ' A' ' 47' ' ' VAL . 41.8 p-10 -74.61 -36.66 62.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.805 0.336 . . . . 0.0 111.396 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.637 HG12 ' CD2' ' A' ' 49' ' ' LEU . 56.9 t -66.82 143.34 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.544 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.882 ' C ' HD22 ' A' ' 49' ' ' LEU . 69.0 mt-10 -138.0 127.6 25.06 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.863 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.5 mm? -142.14 135.05 28.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.591 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.53 ' NZ ' ' HB2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -171.64 -171.96 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.967 -179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.425 ' O ' ' CA ' ' A' ' 55' ' ' GLY . . . -69.38 -50.12 49.06 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.472 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 35.4 t -66.47 -48.6 69.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.809 0.338 . . . . 0.0 111.562 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.439 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 28.8 m-20 -70.32 -54.14 13.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.744 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -94.6 -46.85 6.78 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -47.23 -26.1 3.1 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.871 -0.681 . . . . 0.0 113.047 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -43.69 -30.13 0.59 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 111.647 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 54' ' ' ALA . 29.7 m -74.16 28.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.773 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 22.2 mt -132.67 116.37 16.55 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.4 p -70.85 155.93 40.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 111.698 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.28 -39.42 21.54 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.438 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -50.84 -27.64 7.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.941 0.401 . . . . 0.0 110.578 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.593 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.4 m-20 -71.59 3.17 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.083 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.603 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.2 OUTLIER -37.25 -53.48 2.15 Favored Pre-proline 0 N--CA 1.463 0.204 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.435 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 3.5 Cg_endo -83.27 78.47 3.19 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.87 2.38 . . . . 0.0 112.127 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.881 ' CD2' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.19 143.52 38.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.625 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 3.3 mptp? -68.64 67.14 0.13 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.565 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.835 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 34.2 m 60.53 160.98 0.05 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.19 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.621 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.47 -31.17 22.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.431 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.499 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 22.1 pt-20 -57.52 -46.91 83.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.371 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.487 ' HG3' ' HD2' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -69.77 -35.63 75.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.5 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.052 HG21 HG21 ' A' ' 24' ' ' ILE . 61.6 t -61.9 -45.85 97.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 0.0 110.769 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.846 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -56.23 -49.93 72.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.986 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.51 -38.3 80.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.262 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 95.2 m -63.81 -51.36 65.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.0 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.427 HG23 ' CB ' ' A' ' 54' ' ' ALA . 70.2 mt -59.3 -52.17 63.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.269 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 72' ' ' ALA . 6.8 m -59.51 -39.91 80.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -62.36 -56.1 21.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.77 0.319 . . . . 0.0 111.702 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.549 ' HB2' HG21 ' A' ' 57' ' ' VAL . 98.6 mttt -69.46 -39.78 77.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.831 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.744 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.08 -29.86 69.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.134 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.76 -55.43 0.42 Allowed Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.273 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 20.5 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.292 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 80.7 p -178.48 138.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.781 0.324 . . . . 0.0 110.834 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -173.12 127.85 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.942 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt -74.79 150.63 39.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.493 ' HB3' ' NZ ' ' A' ' 2' ' ' LYS . 6.4 ttpm? -51.25 -24.01 4.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.462 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 ttt -37.54 131.08 0.96 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.08 0.467 . . . . 0.0 111.825 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.07 -132.46 1.76 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.686 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.745 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.5 p -72.8 -6.07 7.41 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.842 0 CA-C-N 116.839 0.319 . . . . 0.0 110.965 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.579 ' HA ' HD13 ' A' ' 81' ' ' LEU . 81.4 tttt -45.66 -51.13 12.75 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -77.87 -28.57 50.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.843 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.745 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 3.8 t70 -65.77 -52.65 49.19 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.505 HG13 HG22 ' A' ' 5' ' ' VAL . 15.3 mt -65.4 -42.22 92.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.903 ' NH2' HG21 ' A' ' 13' ' ' ILE . 3.1 tpt180 -60.25 -26.0 66.12 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.93 -44.74 94.13 Favored Glycine 0 CA--C 1.503 -0.675 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 23.3 mt-30 -63.43 -27.51 69.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.768 -0.716 . . . . 0.0 109.329 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.903 HG21 ' NH2' ' A' ' 10' ' ' ARG . 64.3 mt -75.03 -47.3 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.721 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.455 ' HA ' HD13 ' A' ' 14' ' ' ILE . 4.7 mm -56.4 -52.2 55.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 120.749 0.309 . . . . 0.0 110.2 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.23 -37.08 94.31 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -62.25 -27.34 68.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.184 -0.508 . . . . 0.0 110.834 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.055 HD22 HD12 ' A' ' 24' ' ' ILE . 40.4 mt -80.5 -29.52 37.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.283 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.42 133.38 49.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.871 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.17 -34.03 5.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.465 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.694 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.37 -178.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.838 0.351 . . . . 0.0 111.348 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.605 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 78.6 m-20 -60.88 -120.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.746 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -59.44 179.8 0.18 Allowed Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.816 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 50.0 Cg_endo -65.46 63.98 0.37 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 CA-C-N 119.827 0.974 . . . . 0.0 112.363 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.055 HD12 HD22 ' A' ' 17' ' ' LEU . 33.7 mm 108.65 60.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.605 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.6 m120 -62.48 65.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.584 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 61.5 p 57.64 154.42 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.635 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 60.2 Cg_exo -48.93 -32.44 22.99 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.305 1.336 . . . . 0.0 112.689 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -53.04 -57.38 10.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.41 0.624 . . . . 0.0 110.415 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.593 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 41.4 tp10 -76.2 -57.6 3.77 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.892 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.6 pp -50.16 -43.05 52.02 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.735 ' HA ' HD13 ' A' ' 34' ' ' LEU . 43.0 ttm -66.01 -31.58 72.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -67.2 -31.11 71.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.371 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.694 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -69.75 -39.03 76.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.284 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.1 mp -30.0 137.33 0.17 Allowed Pre-proline 0 N--CA 1.47 0.546 0 CA-C-O 121.026 0.441 . . . . 0.0 111.831 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.04 -49.82 13.16 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.842 3.028 . . . . 0.0 115.754 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.534 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -72.35 -25.71 61.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.441 ' H ' HD22 ' A' ' 36' ' ' ASN . . . 103.86 -65.18 0.35 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.255 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.534 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 88.9 Cg_endo -82.02 52.53 4.21 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.622 2.215 . . . . 0.0 112.43 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 2.6 p30 52.49 93.31 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.549 0.69 . . . . 0.0 112.517 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.517 ' N ' HD21 ' A' ' 36' ' ' ASN . 6.2 t -69.54 127.46 33.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.235 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 7.8 m -84.72 125.75 32.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.509 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.2 m -92.16 45.99 1.24 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.98 0.419 . . . . 0.0 110.094 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.439 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 22.2 pttp -75.44 145.29 41.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.083 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.4 m -137.62 127.69 25.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.896 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.29 -51.41 0.8 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.024 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -169.57 -40.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.976 0.417 . . . . 0.0 110.44 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.703 HG12 ' CD2' ' A' ' 49' ' ' LEU . 38.3 t -66.76 134.72 29.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.768 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.903 ' C ' HD22 ' A' ' 49' ' ' LEU . 26.7 mt-10 -117.99 135.58 54.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.746 0.308 . . . . 0.0 111.045 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.903 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.1 mm? -141.38 128.98 21.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.167 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 22.5 pttp -168.47 157.88 9.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.612 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.461 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.75 -37.63 13.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.134 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.0 t -63.81 -52.48 60.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -72.25 -50.69 25.36 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.892 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -91.91 -47.15 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.81 -29.6 2.06 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.052 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -45.55 -30.93 1.6 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.074 0.464 . . . . 0.0 111.17 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.8 m -75.11 28.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.666 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.576 HD13 ' CE2' ' A' ' 65' ' ' PHE . 38.5 mt -132.26 116.47 16.96 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.2 p -73.19 156.1 38.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.944 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.67 -37.3 12.63 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.018 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -51.0 -29.21 11.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.146 0.498 . . . . 0.0 110.187 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.605 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -72.05 3.6 4.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.556 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.584 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.1 t80 -38.99 -51.86 3.95 Favored Pre-proline 0 CA--C 1.527 0.092 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 86.5 Cg_endo -87.62 78.89 1.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.923 2.416 . . . . 0.0 112.061 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.944 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -77.14 140.59 40.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.971 0.415 . . . . 0.0 111.448 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 27.3 tptp -66.48 69.95 0.07 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.753 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.816 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 38.0 m 58.07 161.8 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.796 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.715 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.74 -30.12 21.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.935 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 10.7 pt-20 -57.41 -47.62 81.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.678 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -72.87 -37.89 67.18 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.724 -179.68 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.982 ' CG2' HG21 ' A' ' 24' ' ' ILE . 42.9 t -60.1 -34.56 57.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.934 0.397 . . . . 0.0 110.693 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.752 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -68.72 -56.03 9.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.463 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.4 m-20 -66.19 -35.09 79.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.584 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.5 m -62.58 -49.98 73.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.903 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.676 HD12 HH22 ' A' ' 10' ' ' ARG . 73.0 mt -64.12 -51.02 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -52.38 -38.5 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.206 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -60.63 -55.26 35.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 111.319 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB2' HG21 ' A' ' 57' ' ' VAL . 62.0 mttp -71.91 -38.66 69.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.832 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.738 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.84 -30.11 70.2 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.2 -55.47 0.43 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 119.869 -1.158 . . . . 0.0 113.477 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.643 HD12 HG12 ' A' ' 76' ' ' VAL . 14.1 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.25 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.549 -0.22 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 52.8 m -60.1 -43.98 95.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.856 0.36 . . . . 0.0 110.932 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -64.72 133.91 53.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.961 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt 62.56 130.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.98 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' HG2' ' CD2' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -95.87 42.8 1.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.274 0.559 . . . . 0.0 111.532 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.2 mtp 50.26 31.69 5.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.436 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 43.99 31.87 2.17 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.042 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.73 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.2 p -77.14 -5.59 7.81 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 62.9 tttp -45.33 -48.71 13.17 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.082 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -77.7 -30.1 51.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.835 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.73 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 23.0 m-20 -65.21 -52.07 57.06 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.883 HD13 HD23 ' A' ' 49' ' ' LEU . 23.9 mt -69.74 -48.45 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.779 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 23.2 ttp180 -56.17 -28.57 58.6 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.04 -44.32 91.67 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.52 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 66.2 mt-30 -66.38 -32.16 73.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.818 -0.691 . . . . 0.0 109.826 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 70.5 mt -70.58 -48.22 60.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.187 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 69' ' ' GLU . 7.5 mm -53.94 -54.19 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.275 . . . . 0.0 110.8 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.7 -36.17 92.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.956 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -63.9 -22.06 66.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.115 -0.543 . . . . 0.0 111.478 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.043 HD22 HD12 ' A' ' 24' ' ' ILE . 56.0 mt -90.44 -29.64 17.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.882 -178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 83.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.803 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 169.34 -38.48 0.2 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.384 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.749 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -51.38 -177.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.555 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -58.3 -120.52 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.71 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -58.69 175.46 0.32 Allowed Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 176.492 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.899 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 39.4 Cg_endo -63.89 65.41 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 120.853 1.036 . . . . 0.0 112.835 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.128 HG23 HD22 ' A' ' 30' ' ' LEU . 11.1 mm 109.84 61.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 177.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.587 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 3.1 m120 -65.81 64.06 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.668 ' C ' HD23 ' A' ' 30' ' ' LEU . 87.6 p 57.43 150.53 0.06 OUTLIER Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.88 ' O ' ' HB2' ' A' ' 31' ' ' MET . 86.9 Cg_exo -46.15 -28.5 5.54 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.09 1.86 . . . . 0.0 112.654 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -55.87 -57.31 12.61 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.579 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 5.6 tp10 -77.38 -57.37 3.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.128 HD22 HG23 ' A' ' 24' ' ' ILE . 1.4 pp -50.04 -34.36 21.24 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.68 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.88 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -77.87 -29.87 50.57 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -61.79 -28.2 69.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.749 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -81.95 -35.95 28.5 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.066 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 31' ' ' MET . 6.4 mp -33.29 130.48 0.37 Allowed Pre-proline 0 N--CA 1.467 0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 111.689 -178.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.45 -33.08 45.48 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.503 2.802 . . . . 0.0 114.358 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.714 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 7.2 t30 -72.11 -27.46 62.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.9 -74.16 0.39 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.489 -0.863 . . . . 0.0 113.015 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 78.2 Cg_endo -83.43 43.87 1.52 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.724 2.282 . . . . 0.0 112.502 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.81 97.97 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.272 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.714 ' HB ' ' HB3' ' A' ' 36' ' ' ASN . 5.2 t -69.49 137.74 52.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.352 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.5 m -101.03 95.41 6.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.722 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.4 m -72.38 57.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.9 0.381 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 8.8 ptpp? -75.65 150.34 37.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.267 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.3 m -157.05 130.05 7.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.576 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 46' ' ' ASP . . . 58.43 49.55 75.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.298 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 11.4 m-20 79.04 -42.07 0.29 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.465 0.306 . . . . 0.0 111.578 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.715 HG12 HD21 ' A' ' 49' ' ' LEU . 40.9 t -66.55 139.0 21.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.863 0.364 . . . . 0.0 111.095 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.829 ' C ' HD22 ' A' ' 49' ' ' LEU . 31.5 mt-10 -127.27 133.08 50.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.298 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.883 HD23 HD13 ' A' ' 9' ' ' ILE . 2.4 mm? -133.41 139.85 46.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.998 0.427 . . . . 0.0 111.648 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 56.1 pttt -177.96 -164.72 0.09 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.69 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.758 ' HB1' ' HB3' ' A' ' 27' ' ' PRO . . . -77.58 -44.67 27.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.373 0.606 . . . . 0.0 111.505 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.404 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 23.2 t -59.63 -56.37 22.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.365 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' OD2' ' HE2' ' A' ' 50' ' ' LYS . 58.7 m-20 -72.78 -54.33 9.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.76 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -91.45 -43.21 9.85 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -45.62 -25.6 1.49 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.095 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -43.93 -40.16 4.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.144 0.497 . . . . 0.0 110.91 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 54' ' ' ALA . 35.4 m -65.68 -32.59 58.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.157 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.762 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 38.7 mt -71.36 70.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.183 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.402 ' N ' ' OD2' ' A' ' 62' ' ' ASP . 71.7 p -47.94 156.8 0.32 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.595 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -43.63 -40.67 4.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.005 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -50.97 -27.92 8.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.886 0.374 . . . . 0.0 110.849 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.618 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 57.2 m-20 -73.33 3.45 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.625 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -40.82 -66.8 0.35 Allowed Pre-proline 0 N--CA 1.463 0.194 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.125 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 70.2 Cg_endo -72.93 75.97 2.61 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.408 2.072 . . . . 0.0 111.953 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.969 ' CG ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -77.01 142.37 39.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.357 -179.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.494 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 84.2 tttt -67.73 71.48 0.14 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.391 0.615 . . . . 0.0 110.703 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.899 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.7 m 59.31 161.37 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.003 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.73 -30.43 22.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.646 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.484 ' HA ' HD11 ' A' ' 14' ' ' ILE . 15.5 pt-20 -58.28 -47.63 83.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.636 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.571 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -74.38 -31.68 62.46 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.635 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.972 ' CG2' HG21 ' A' ' 24' ' ' ILE . 60.9 t -66.64 -51.68 53.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.779 ' HB1' ' HG2' ' A' ' 10' ' ' ARG . . . -55.61 -42.14 74.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.067 0.461 . . . . 0.0 109.801 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.431 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 47.5 t0 -64.52 -46.46 82.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.218 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.47 HG22 HD21 ' A' ' 58' ' ' LEU . 98.6 m -58.81 -47.52 84.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.949 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 79' ' ' ALA . 69.7 mt -57.31 -49.56 79.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.507 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 15.6 m -63.4 -40.41 88.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.431 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.5 m-20 -64.63 -55.94 17.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.57 -40.49 73.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.608 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.1 -30.0 69.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.26 -56.01 0.38 Allowed Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.214 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.0 mt . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.323 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 51.9 m -60.55 132.9 55.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.726 0.298 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -74.36 -143.3 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.49 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm 60.11 33.74 21.21 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.79 0.329 . . . . 0.0 111.088 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -90.6 143.45 26.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.19 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.8 mtm -128.8 -61.2 1.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.601 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.06 -33.35 0.43 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.535 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.72 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.6 p -61.36 -5.11 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.846 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.733 ' HE3' HG21 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -44.62 -50.47 9.75 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -77.46 -30.29 53.15 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.968 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.72 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 71.5 m-20 -64.41 -52.28 58.93 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.672 HD11 ' HB3' ' A' ' 44' ' ' SER . 15.9 mt -63.75 -43.79 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.898 ' NH2' HG21 ' A' ' 13' ' ' ILE . 0.7 OUTLIER -59.26 -25.94 64.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.008 178.036 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.91 -45.15 89.78 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' A' ' 42' ' ' CYS . 75.8 mt-30 -64.3 -29.87 70.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.739 -0.731 . . . . 0.0 109.724 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.898 HG21 ' NH2' ' A' ' 10' ' ' ARG . 75.7 mt -74.94 -46.15 41.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.863 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.454 ' HA ' HD13 ' A' ' 14' ' ' ILE . 5.1 mm -55.25 -53.09 38.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 110.397 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.4 -34.94 90.88 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.239 -0.981 . . . . 0.0 110.772 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.77 67.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.315 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.077 HD22 HD12 ' A' ' 24' ' ' ILE . 38.4 mt -83.2 -29.74 28.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 110.47 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.16 117.08 5.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.569 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.82 -36.22 1.96 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.455 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.674 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -53.92 -172.37 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.477 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.571 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -62.06 -119.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.776 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -60.79 179.62 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.815 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 42.7 Cg_endo -65.39 66.76 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 120.778 0.986 . . . . 0.0 112.561 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.077 HD12 HD22 ' A' ' 17' ' ' LEU . 30.2 mm 108.19 61.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 22' ' ' PHE . 2.7 m120 -64.39 64.76 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.6 p 58.15 155.23 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.641 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 64.5 Cg_exo -49.17 -32.29 24.26 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.359 1.373 . . . . 0.0 112.775 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -52.82 -57.6 9.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.502 0.668 . . . . 0.0 110.333 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.591 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 46.5 tp10 -76.5 -57.78 3.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.871 HD22 HG23 ' A' ' 24' ' ' ILE . 3.6 pp -50.12 -41.68 49.09 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.729 ' HA ' HD13 ' A' ' 34' ' ' LEU . 39.5 ttm -66.55 -32.46 73.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.3 -30.77 71.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.462 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.674 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -69.93 -40.77 75.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.403 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.729 HD13 ' HA ' ' A' ' 31' ' ' MET . 9.1 mp -28.24 127.34 0.22 Allowed Pre-proline 0 N--CA 1.468 0.453 0 CA-C-O 121.061 0.458 . . . . 0.0 111.871 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.7 -30.76 57.67 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.513 2.809 . . . . 0.0 114.119 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.618 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 11.2 t30 -72.2 -27.49 62.58 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.06 -75.68 0.45 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.829 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 98.6 Cg_endo -82.18 52.65 4.23 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.542 2.161 . . . . 0.0 111.666 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 38' ' ' PRO . 7.6 p-10 50.61 95.02 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.682 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.594 ' HB ' ' CB ' ' A' ' 36' ' ' ASN . 3.2 t -58.98 136.21 57.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.183 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.419 ' CG2' ' HB3' ' A' ' 48' ' ' GLU . 28.5 m -102.73 91.33 4.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.757 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.424 ' HB3' ' OE1' ' A' ' 12' ' ' GLN . 59.3 m -70.24 57.96 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.921 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.44 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.1 pttp -75.74 129.99 37.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.189 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.672 ' HB3' HD11 ' A' ' 9' ' ' ILE . 43.9 p -81.99 87.74 6.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.51 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.12 -57.78 0.41 Allowed Glycine 0 CA--C 1.519 0.281 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.148 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -130.87 -46.39 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.781 0.324 . . . . 0.0 110.573 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.755 HG12 ' CD2' ' A' ' 49' ' ' LEU . 44.7 t -66.93 130.62 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.524 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.888 ' C ' HD22 ' A' ' 49' ' ' LEU . 8.9 mp0 -114.95 133.85 55.66 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.945 0.403 . . . . 0.0 111.533 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.888 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -144.66 135.44 24.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.661 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.571 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 57.9 pttt -171.66 -176.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.976 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.472 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -66.91 -41.78 86.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.129 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.2 t -63.87 -56.13 17.66 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.435 ' OD2' ' HE2' ' A' ' 50' ' ' LYS . 59.6 m-20 -72.28 -44.87 62.14 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.613 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -90.25 -49.76 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.95 -28.42 1.77 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.503 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 15.8 pt20 -42.85 -35.61 1.24 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.078 0.466 . . . . 0.0 111.707 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 54' ' ' ALA . 24.6 m -65.53 -33.26 62.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.92 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.678 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 34.8 mt -63.88 124.26 21.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 110.638 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.6 p -75.13 155.91 36.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.444 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.17 -41.42 60.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.403 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -57.28 -21.79 37.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.078 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.599 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 16.6 m-20 -69.13 3.33 2.18 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.3 m-85 -41.71 -66.67 0.38 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 118.055 0.389 . . . . 0.0 111.35 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 56.8 Cg_endo -69.54 74.89 1.16 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.337 2.025 . . . . 0.0 112.064 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.913 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -76.95 142.89 39.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.221 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.505 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 14.3 mmmm -68.34 70.53 0.17 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.484 0.659 . . . . 0.0 110.509 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.815 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 46.2 m 58.41 160.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.948 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.704 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.65 -27.37 11.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.803 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.2 pt-20 -58.94 -48.39 81.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.525 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.505 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -73.78 -35.29 64.93 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.065 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.977 ' CG2' HG21 ' A' ' 24' ' ' ILE . 49.0 t -62.23 -36.51 74.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.022 0.439 . . . . 0.0 110.431 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.865 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -66.11 -57.64 7.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.259 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 m-20 -63.88 -42.13 97.56 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.55 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.3 m -55.01 -48.35 73.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.96 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.613 HG23 ' HB1' ' A' ' 54' ' ' ALA . 83.1 mt -64.32 -50.49 76.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.733 HG21 ' HE3' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -51.78 -38.07 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.37 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.0 m-20 -63.97 -51.86 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 111.19 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.439 ' HB2' HG21 ' A' ' 57' ' ' VAL . 61.3 mttp -70.64 -41.97 71.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.682 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.504 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.45 -29.95 69.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.964 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.53 -54.08 0.47 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.969 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 6' ' ' LYS . 15.1 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.166 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 48.0 t -178.47 -44.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.791 0.329 . . . . 0.0 110.951 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -59.79 130.62 47.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.07 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttp 179.39 -46.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.543 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 3' ' ' MET . 59.8 tttm -178.54 120.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.365 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.544 ' CE ' ' HA ' ' A' ' 3' ' ' MET . 0.2 OUTLIER -152.52 134.29 14.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -179.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.0 -140.09 5.63 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.421 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.758 ' CG2' ' HB3' ' A' ' 8' ' ' ASP . 1.5 p -77.16 -5.36 7.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 N-CA-C 111.278 0.103 . . . . 0.0 111.278 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 39.2 tttm -45.3 -52.24 9.98 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -78.3 -25.94 46.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.29 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.758 ' HB3' ' CG2' ' A' ' 5' ' ' VAL . 54.8 t0 -68.03 -52.69 32.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.858 0.361 . . . . 0.0 111.882 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.511 HG13 HG22 ' A' ' 5' ' ' VAL . 14.4 mt -64.66 -44.49 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.85 ' HD2' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -59.62 -26.65 65.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.822 177.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.07 -42.89 99.47 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 71.0 mt-30 -64.37 -27.71 69.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.429 -0.885 . . . . 0.0 109.508 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.808 HD12 ' NE ' ' A' ' 10' ' ' ARG . 61.5 mt -74.89 -45.3 43.76 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.114 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.285 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.588 HD11 ' HB2' ' A' ' 72' ' ' ALA . 15.1 mm -56.84 -54.21 32.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.811 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.61 -36.6 93.56 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.299 -0.953 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 12' ' ' GLN . . . -65.0 -24.57 67.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.131 -0.534 . . . . 0.0 111.392 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.078 HD22 HD12 ' A' ' 24' ' ' ILE . 48.4 mt -84.2 -29.83 26.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.831 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.67 124.14 18.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.971 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.64 -34.1 3.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.852 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.714 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -53.23 -174.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 0.0 111.583 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.604 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 9.3 m-20 -61.45 -118.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.753 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -59.73 179.51 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 176.331 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.813 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 55.6 Cg_endo -65.99 66.3 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.901 1.0 . . . . 0.0 112.213 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.078 HD12 HD22 ' A' ' 17' ' ' LEU . 42.8 mm 109.29 61.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.652 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 2.4 m120 -63.23 66.11 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.61 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 57.6 p 57.26 155.93 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.756 ' O ' ' HB2' ' A' ' 31' ' ' MET . 55.6 Cg_exo -49.6 -32.94 29.47 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.365 1.377 . . . . 0.0 113.054 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -53.33 -57.29 11.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.375 0.607 . . . . 0.0 110.561 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.598 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 40.6 tp10 -74.96 -57.05 4.14 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.899 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.5 pp -49.92 -42.32 48.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.776 ' HA ' HD13 ' A' ' 34' ' ' LEU . 27.0 mtm -64.67 -31.96 73.41 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -66.01 -28.66 69.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.48 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -74.46 -38.96 62.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.776 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.2 mp -33.2 131.96 0.35 Allowed Pre-proline 0 N--CA 1.469 0.482 0 CA-C-O 121.128 0.49 . . . . 0.0 111.803 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.27 -34.93 72.26 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 124.1 3.2 . . . . 0.0 115.172 -177.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.548 HD21 ' C ' ' A' ' 39' ' ' ASP . 15.3 p-10 -72.0 -27.24 62.61 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.35 -69.31 0.27 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.496 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 94.8 Cg_endo -81.4 38.25 0.74 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.655 2.236 . . . . 0.0 112.978 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.548 ' C ' HD21 ' A' ' 36' ' ' ASN . 0.6 OUTLIER 61.6 95.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.3 0.571 . . . . 0.0 112.071 179.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.514 HG22 HD23 ' A' ' 34' ' ' LEU . 2.7 t -64.34 138.35 58.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.249 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.473 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 19.8 m -93.77 123.17 36.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.404 ' CB ' HG23 ' A' ' 9' ' ' ILE . 60.0 m -91.04 45.91 1.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 0.0 110.609 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.468 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -75.67 155.06 36.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.171 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.4 m -150.65 128.63 11.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.294 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.45 -53.5 0.65 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.091 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -167.51 -41.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.978 0.418 . . . . 0.0 110.172 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.762 HG12 ' CD2' ' A' ' 49' ' ' LEU . 38.5 t -66.79 130.62 32.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.586 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.885 ' C ' HD22 ' A' ' 49' ' ' LEU . 35.6 mt-10 -115.9 132.55 56.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.885 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -138.09 139.33 39.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.128 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.473 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 59.1 pttt -178.83 157.52 0.91 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.891 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.583 ' HB3' ' CG ' ' A' ' 31' ' ' MET . . . -47.73 -27.77 2.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.89 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 t -71.99 -61.31 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 59.9 m-20 -72.41 -54.52 9.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.697 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -73.35 -43.39 60.8 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.87 -22.71 3.06 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.326 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 26.5 pt20 -41.22 -40.71 1.67 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.08 0.467 . . . . 0.0 111.691 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.7 m -65.79 -30.64 50.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.256 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.609 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 14.3 mt -72.2 113.58 9.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.738 0.304 . . . . 0.0 110.458 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.7 p -79.52 158.39 27.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.453 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -46.51 -40.16 12.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.248 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -53.06 -26.97 17.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.652 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.5 m-20 -71.08 3.16 3.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.217 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.61 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.3 OUTLIER -38.87 -64.68 0.46 Allowed Pre-proline 0 N--CA 1.462 0.156 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.391 -178.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 59.3 Cg_endo -71.04 79.37 1.35 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.276 1.984 . . . . 0.0 111.444 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.609 ' CZ ' HD13 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -76.82 140.09 40.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.456 -179.245 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 2.7 mppt? -67.44 62.36 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.404 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.813 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 49.4 m 64.98 161.89 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.493 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.537 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -52.01 -28.61 17.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.679 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 15.5 pt-20 -65.3 -39.2 92.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' HG3' ' CD2' ' A' ' 65' ' ' PHE . 17.7 tp10 -63.52 -43.2 97.84 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.215 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.799 ' CG2' HG21 ' A' ' 24' ' ' ILE . 88.1 t -57.64 -46.59 86.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.807 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.839 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -53.77 -56.13 20.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.206 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.446 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 1.4 m-20 -65.61 -44.3 86.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.907 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.5 m -56.53 -47.42 79.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.191 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.706 HG22 HH12 ' A' ' 10' ' ' ARG . 65.2 mt -66.31 -51.88 53.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.85 HG13 ' HD2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -56.88 -41.85 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.973 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 77.3 m-20 -63.79 -54.58 32.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HB2' HG21 ' A' ' 57' ' ' VAL . 43.7 mtpt -74.87 -40.83 60.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 75' ' ' ILE . . . -67.06 -29.98 69.91 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.24 -52.41 0.48 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.515 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.59 ' HB2' HG12 ' A' ' 76' ' ' VAL . 15.5 mt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.354 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . 0.423 ' HB3' ' HE3' ' A' ' 1' ' ' MET . 58.2 m -167.06 137.38 3.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.9 0.381 . . . . 0.0 110.812 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.39 -31.68 69.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.705 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 10.6 mmt 63.06 143.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.827 0.346 . . . . 0.0 110.831 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.459 ' HE3' ' HA ' ' A' ' 81' ' ' LEU . 20.2 ttmm -165.87 138.04 3.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.109 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.6 mtt -159.19 33.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.48 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.13 -122.78 2.15 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.867 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.705 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.1 p -77.32 -5.75 8.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 CA-C-N 115.833 -0.184 . . . . 0.0 111.189 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 48.9 tttp -44.89 -47.1 11.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -77.54 -33.35 54.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.905 177.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.705 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 16.4 m-20 -64.02 -52.24 60.43 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.717 HG23 ' HB2' ' A' ' 42' ' ' CYS . 30.2 mt -66.06 -47.09 86.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.871 ' HG2' ' HB1' ' A' ' 72' ' ' ALA . 45.6 ttp180 -55.26 -29.52 58.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.81 -44.49 96.12 Favored Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -67.57 -28.78 68.06 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.652 -0.774 . . . . 0.0 109.725 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 10' ' ' ARG . 71.3 mt -70.16 -43.03 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.4 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 69' ' ' GLU . 13.5 mm -58.45 -48.83 84.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.004 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.16 -38.38 93.84 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.448 -0.882 . . . . 0.0 110.908 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.585 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -60.75 -34.02 73.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 0.0 110.694 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.013 HD22 HD12 ' A' ' 24' ' ' ILE . 79.0 mt -83.9 -29.17 27.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.692 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.56 60.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.485 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.551 ' C ' ' HB1' ' A' ' 33' ' ' ALA . . . 179.45 31.2 0.06 OUTLIER Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.994 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 33' ' ' ALA . . . -114.45 -168.4 1.36 Allowed 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.957 0.408 . . . . 0.0 110.796 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.66 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 83.6 m-20 -59.32 -119.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.805 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -61.35 -171.16 0.04 OUTLIER Pre-proline 0 N--CA 1.454 -0.269 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 176.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.806 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.2 Cg_endo -70.89 64.21 2.46 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 120.72 1.293 . . . . 0.0 112.163 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.013 HD12 HD22 ' A' ' 17' ' ' LEU . 50.2 mm 109.0 66.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.674 ' HB2' ' CB ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -65.42 65.85 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.881 -0.512 . . . . 0.0 111.449 178.183 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.633 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 51.4 p 57.48 158.97 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.737 ' O ' ' HB2' ' A' ' 31' ' ' MET . 51.5 Cg_exo -50.06 -33.33 34.43 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.344 1.362 . . . . 0.0 112.819 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -51.29 -57.32 9.16 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.64 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.674 ' CB ' ' HB2' ' A' ' 25' ' ' ASN . 45.7 tp10 -75.73 -58.53 3.23 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.807 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.5 pp -50.1 -40.16 44.92 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.771 ' HG3' ' HB3' ' A' ' 51' ' ' ALA . 29.9 ttm -63.53 -35.08 79.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.33 -30.91 69.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.303 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . . . -65.34 -38.87 91.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.593 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.785 ' CG ' HG22 ' A' ' 40' ' ' THR . 6.4 mp -39.53 134.55 1.24 Allowed Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.725 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -47.7 -29.8 11.59 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.393 2.729 . . . . 0.0 112.9 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.671 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 18.5 t30 -72.01 -26.36 62.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.528 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . 103.9 -64.65 0.36 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.958 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 60.4 Cg_endo -83.93 -38.64 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.754 2.302 . . . . 0.0 113.722 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.622 ' HB3' ' SD ' ' A' ' 31' ' ' MET . 53.5 p-10 174.21 71.12 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.785 HG22 ' CG ' ' A' ' 34' ' ' LEU . 6.2 t -59.22 140.71 55.69 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.661 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 3.1 t -114.99 124.21 51.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.033 0.444 . . . . 0.0 111.295 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.717 ' HB2' HG23 ' A' ' 9' ' ' ILE . 36.0 m -75.45 59.12 1.06 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.776 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.449 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 22.3 pttp -75.17 140.5 43.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.679 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.6 m -132.46 124.47 28.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.258 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.506 ' O ' ' OD1' ' A' ' 46' ' ' ASP . . . 67.09 -69.71 0.2 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.705 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 45' ' ' GLY . 67.8 m-20 -140.98 -46.04 0.39 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.766 0.317 . . . . 0.0 111.475 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.716 HG12 HD21 ' A' ' 49' ' ' LEU . 48.2 t -66.79 130.23 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.938 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.803 ' C ' HD22 ' A' ' 49' ' ' LEU . 55.3 mt-10 -113.14 133.24 55.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.379 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.803 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.6 mm? -127.88 130.15 48.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.63 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.824 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 19.1 ptpt -156.28 -165.87 2.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.582 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.771 ' HB3' ' HG3' ' A' ' 31' ' ' MET . . . -78.61 -41.87 30.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.481 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.3 t -67.26 -55.61 13.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.709 0.29 . . . . 0.0 111.443 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 35.6 m-20 -69.39 -44.4 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.793 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 50' ' ' LYS . . . -92.73 -51.63 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -53.53 -22.25 16.15 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.474 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -43.35 -31.98 0.75 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 117.114 0.457 . . . . 0.0 111.203 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 54' ' ' ALA . 35.3 m -80.2 27.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.653 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 19.1 mt -132.48 109.13 9.58 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 p -68.08 156.59 37.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.825 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.23 -37.99 17.38 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.077 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -52.56 -26.22 12.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.63 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.565 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -72.24 3.07 4.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.295 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.633 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.5 OUTLIER -39.05 -61.12 1.0 Allowed Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.334 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.87 77.08 3.16 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.483 2.122 . . . . 0.0 111.847 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.882 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -76.63 142.53 40.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.096 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 58.1 mtpt -68.68 66.7 0.13 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.377 0.608 . . . . 0.0 110.463 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.806 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 24.2 m 61.05 161.14 0.06 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.085 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.602 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.54 -30.22 19.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.499 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 22.1 pt-20 -59.17 -45.72 90.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.483 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.533 ' HG3' ' HD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -70.47 -34.39 72.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.247 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.982 HG21 HG21 ' A' ' 24' ' ' ILE . 67.2 t -63.61 -41.98 94.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.015 0.436 . . . . 0.0 110.09 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.871 ' HB1' ' HG2' ' A' ' 10' ' ' ARG . . . -56.66 -50.18 72.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.785 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.49 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 24.8 m-20 -67.8 -47.31 69.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.128 0.489 . . . . 0.0 110.746 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.429 HG22 HD21 ' A' ' 58' ' ' LEU . 90.8 m -54.71 -48.97 71.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.857 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.813 HG23 ' HB1' ' A' ' 54' ' ' ALA . 67.0 mt -60.95 -56.11 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.559 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 72' ' ' ALA . 15.7 m -58.82 -40.49 80.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 77.7 m-20 -62.88 -55.17 28.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.375 . . . . 0.0 111.715 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' CB ' HG21 ' A' ' 57' ' ' VAL . 67.3 mttm -72.76 -40.16 66.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.253 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.01 -29.97 69.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.66 -56.16 0.4 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.88 -1.152 . . . . 0.0 113.41 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.459 ' HA ' ' HE3' ' A' ' 2' ' ' LYS . 22.9 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.401 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.6 -0.2 . . . . 0.0 112.6 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 47.5 t -60.91 131.6 51.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 110.943 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -67.45 138.88 56.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.987 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mtp 63.02 45.63 5.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.173 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 3' ' ' MET . 77.2 tttt -60.98 -63.19 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.656 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.422 ' O ' ' O ' ' A' ' 2' ' ' LYS . 26.5 mmt 57.46 132.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.448 0.642 . . . . 0.0 112.003 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.62 -144.71 10.22 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.049 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.734 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.0 p -77.4 -5.63 7.93 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 C-N-CA 121.533 -0.067 . . . . 0.0 111.012 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.654 ' HE2' HG21 ' A' ' 76' ' ' VAL . 12.3 tmtt? -45.35 -51.67 10.84 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.9 -25.94 48.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.115 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.734 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 33.1 m-20 -67.86 -52.57 35.12 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.455 HG13 HG22 ' A' ' 5' ' ' VAL . 12.8 mt -65.7 -43.01 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.888 ' NH2' HG21 ' A' ' 13' ' ' ILE . 2.8 tpt180 -59.42 -29.07 67.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.62 -43.32 99.42 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.46 ' NE2' ' HB3' ' A' ' 42' ' ' CYS . 6.4 tt0 -64.32 -29.01 70.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.835 -0.683 . . . . 0.0 109.334 177.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.888 HG21 ' NH2' ' A' ' 10' ' ' ARG . 63.6 mt -74.37 -45.9 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.821 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.452 ' HA ' HD13 ' A' ' 14' ' ' ILE . 4.6 mm -56.42 -50.3 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.776 0.322 . . . . 0.0 110.329 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.47 -36.34 93.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.348 -0.93 . . . . 0.0 110.892 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HB1' HD23 ' A' ' 34' ' ' LEU . . . -65.07 -27.22 68.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.222 -0.489 . . . . 0.0 111.251 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.013 HD22 ' CD1' ' A' ' 24' ' ' ILE . 49.9 mt -84.13 -26.22 29.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.872 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.72 61.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.381 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 17' ' ' LEU . . . 174.14 35.02 0.04 OUTLIER Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.826 ' HB2' ' HB2' ' A' ' 33' ' ' ALA . . . -106.0 -175.97 2.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 110.99 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.594 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 53.4 m-20 -52.72 -66.97 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.758 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -116.86 -174.33 0.27 Allowed Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.825 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 59.7 Cg_endo -68.86 59.09 1.18 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 CA-C-N 120.512 1.218 . . . . 0.0 111.987 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.013 ' CD1' HD22 ' A' ' 17' ' ' LEU . 24.7 mm 110.76 61.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.645 ' CB ' ' HB3' ' A' ' 29' ' ' GLU . 2.7 m120 -64.14 64.42 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.595 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 60.2 p 58.66 150.73 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.634 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 72.3 Cg_exo -46.77 -31.68 11.05 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.639 1.559 . . . . 0.0 112.984 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -55.54 -57.68 10.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.614 0.721 . . . . 0.0 110.338 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.645 ' HB3' ' CB ' ' A' ' 25' ' ' ASN . 16.0 tp10 -74.42 -57.08 4.17 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.557 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.982 HD13 HD21 ' A' ' 17' ' ' LEU . 3.3 pp -49.96 -36.54 28.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.663 ' HG2' ' HB3' ' A' ' 51' ' ' ALA . 55.2 mtm -64.04 -37.59 87.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 176.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -67.98 -24.55 65.16 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.477 0.656 . . . . 0.0 109.771 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.826 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . . . -63.88 -50.83 67.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.653 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 30' ' ' LEU . 6.1 mp -43.25 139.18 2.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.361 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -47.95 -32.74 18.55 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.842 3.028 . . . . 0.0 113.151 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.558 ' CB ' ' HB ' ' A' ' 40' ' ' THR . 4.9 t30 -72.16 -25.49 61.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.864 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.01 -76.69 0.24 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.884 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD2' ' ND2' ' A' ' 36' ' ' ASN . 95.7 Cg_endo -83.23 35.89 0.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.419 2.079 . . . . 0.0 112.053 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.534 ' HB2' ' HG2' ' A' ' 31' ' ' MET . 13.8 t70 65.66 99.81 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.479 0.656 . . . . 0.0 111.822 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.558 ' HB ' ' CB ' ' A' ' 36' ' ' ASN . 2.7 t -64.95 141.44 58.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.905 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.511 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 7.3 m -82.74 115.09 21.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.433 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.46 ' HB3' ' NE2' ' A' ' 12' ' ' GLN . 32.3 m -89.2 50.56 1.96 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.018 0.437 . . . . 0.0 110.383 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.452 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.5 pttm -75.41 147.63 39.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.975 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.2 m -137.63 127.84 26.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.031 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.57 -58.39 0.47 Allowed Glycine 0 CA--C 1.519 0.344 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.046 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -159.47 -42.17 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 110.728 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.727 HG12 HD21 ' A' ' 49' ' ' LEU . 45.1 t -66.43 134.59 29.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.985 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.846 ' C ' HD22 ' A' ' 49' ' ' LEU . 51.0 mt-10 -119.04 134.09 55.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.861 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.846 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.9 mm? -135.24 137.26 42.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.672 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 63.6 pttt -175.87 155.6 1.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.645 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.663 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.62 -39.39 16.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.05 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.6 t -63.53 -49.85 71.89 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.437 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.19 -53.86 11.37 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.781 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -92.23 -46.51 7.69 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.93 -29.54 2.12 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.089 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -45.27 -30.3 1.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.507 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 54' ' ' ALA . 33.2 m -77.16 27.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.649 HD13 ' CE2' ' A' ' 65' ' ' PHE . 43.2 mt -133.18 117.24 17.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.889 0.376 . . . . 0.0 110.096 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.5 p -74.55 159.52 32.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.161 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.89 -37.58 31.94 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.085 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -50.97 -29.73 13.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.104 0.478 . . . . 0.0 110.06 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.56 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.5 m-20 -72.64 3.84 4.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.533 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.595 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.5 t80 -39.84 -51.8 5.33 Favored Pre-proline 0 C--O 1.226 -0.147 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 81.4 Cg_endo -87.74 77.31 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.832 2.355 . . . . 0.0 112.131 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.891 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.18 143.46 39.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.215 0.531 . . . . 0.0 111.87 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -68.28 70.8 0.17 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.742 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.825 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 21.7 m 57.04 163.66 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.203 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.597 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.89 -31.97 30.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.201 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -57.26 -49.17 76.9 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.547 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.8 OUTLIER -72.49 -34.69 67.84 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.084 -179.475 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.001 ' CG2' HG21 ' A' ' 24' ' ' ILE . 62.1 t -65.19 -37.02 79.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.817 0.341 . . . . 0.0 111.145 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.664 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -65.35 -55.4 18.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.973 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 m-20 -66.32 -44.85 82.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.66 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.3 m -53.92 -47.65 70.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.76 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.564 HD12 HH22 ' A' ' 10' ' ' ARG . 76.8 mt -62.98 -53.13 50.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.522 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.71 HG13 ' HD3' ' A' ' 10' ' ' ARG . 1.8 m -53.99 -39.33 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.6 m-20 -60.07 -51.92 67.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 0.0 111.753 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.505 ' HB2' HG21 ' A' ' 57' ' ' VAL . 47.7 mtpt -74.88 -40.11 61.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.757 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.81 -30.01 70.09 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 156.93 -54.81 0.4 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.553 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.678 HD12 HG12 ' A' ' 76' ' ' VAL . 8.7 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.099 -178.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 60.8 m -167.3 137.06 2.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.818 0.342 . . . . 0.0 110.797 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 63.54 -121.66 0.54 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.293 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt 60.6 44.06 12.01 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 122.115 -0.366 . . . . 0.0 110.858 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -178.97 134.66 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 ttt -177.7 134.23 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.977 0.418 . . . . 0.0 111.021 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.89 -137.79 3.87 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.142 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.741 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.7 p -75.51 -5.36 7.09 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 O-C-N 122.967 -0.137 . . . . 0.0 111.161 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.691 ' HE2' HG21 ' A' ' 76' ' ' VAL . 12.8 tmtt? -45.34 -51.14 11.49 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -77.78 -27.97 50.39 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.066 177.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.741 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.6 m-20 -65.59 -52.38 52.58 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.479 HG13 HG22 ' A' ' 5' ' ' VAL . 16.7 mt -65.41 -43.28 94.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.893 ' NH2' HG21 ' A' ' 13' ' ' ILE . 1.1 tpt180 -60.16 -25.73 65.77 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.42 -45.18 87.69 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 178.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -64.39 -31.58 72.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.768 -0.716 . . . . 0.0 109.774 178.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.893 HG21 ' NH2' ' A' ' 10' ' ' ARG . 73.6 mt -73.88 -45.24 50.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.964 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HA ' HD13 ' A' ' 14' ' ' ILE . 4.0 mm -55.54 -53.33 37.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.784 0.326 . . . . 0.0 110.305 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.09 -34.59 88.53 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.739 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -65.46 -26.76 68.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.052 -0.574 . . . . 0.0 111.189 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.0 HD22 HD12 ' A' ' 24' ' ' ILE . 51.5 mt -80.21 -29.53 38.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.434 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.2 134.38 56.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.002 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.1 -32.25 6.06 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.898 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.714 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.44 -174.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.031 0.443 . . . . 0.0 111.592 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.601 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 72.5 m-20 -60.23 -120.31 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.806 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -62.14 -169.59 0.03 OUTLIER Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.597 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.828 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 60.3 Cg_endo -71.61 62.08 2.91 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 CA-C-N 120.888 1.353 . . . . 0.0 112.305 178.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.0 HD12 HD22 ' A' ' 17' ' ' LEU . 48.5 mm 110.59 65.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 177.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.713 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -65.68 66.26 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.976 -0.452 . . . . 0.0 111.328 178.031 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.551 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 53.9 p 59.39 156.02 0.1 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.603 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 64.9 Cg_exo -49.17 -33.73 28.55 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.45 1.433 . . . . 0.0 112.948 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.51 -54.46 36.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.04 0.448 . . . . 0.0 110.697 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.713 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 17.4 tp10 -75.93 -57.57 3.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.918 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.9 pp -50.03 -39.79 42.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.817 ' HA ' HD13 ' A' ' 34' ' ' LEU . 72.0 mtm -66.67 -32.97 74.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -66.51 -28.35 68.49 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 121.215 0.531 . . . . 0.0 110.253 179.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -70.28 -46.9 63.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.94 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.817 HD13 ' HA ' ' A' ' 31' ' ' MET . 8.9 mp -33.73 139.39 0.27 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 112.186 -177.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -47.62 -42.95 29.1 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 124.014 3.142 . . . . 0.0 114.417 -178.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.492 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 15.7 p-10 -72.58 -27.39 62.16 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.62 -70.54 0.25 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.797 -0.715 . . . . 0.0 112.061 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.492 ' HD2' ' C ' ' A' ' 36' ' ' ASN . 88.8 Cg_endo -80.22 49.5 3.23 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.746 2.298 . . . . 0.0 112.533 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.67 ' HA ' HD22 ' A' ' 34' ' ' LEU . 2.3 p30 49.25 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.682 HG22 HD23 ' A' ' 34' ' ' LEU . 1.7 t -56.89 134.06 55.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.149 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.499 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 16.8 m -81.58 118.55 22.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.265 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 61.7 m -92.34 43.79 1.14 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.256 0.55 . . . . 0.0 109.553 178.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.492 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 23.9 pttm -75.54 143.57 42.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.919 -179.125 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.0 m -133.87 122.3 23.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.544 178.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.28 -132.45 30.4 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.185 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -79.24 -26.91 42.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.738 HG12 ' CD2' ' A' ' 49' ' ' LEU . 33.1 t -85.24 138.48 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.882 ' C ' HD22 ' A' ' 49' ' ' LEU . 7.5 mp0 -126.77 135.11 50.63 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.293 179.24 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.6 mm? -141.11 140.81 34.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.094 0.473 . . . . 0.0 111.347 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 61.7 pttt -178.21 152.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.369 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.616 ' HB3' ' HG2' ' A' ' 31' ' ' MET . . . -47.57 -30.74 3.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.005 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.3 t -69.57 -55.89 8.86 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.644 -179.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.422 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 43.2 m-20 -72.41 -51.9 18.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.798 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -84.79 -45.57 12.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -45.1 -28.49 1.92 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.207 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 18.1 pt20 -43.7 -31.82 0.87 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.038 0.447 . . . . 0.0 111.329 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 54' ' ' ALA . 34.8 m -77.09 27.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.667 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.563 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 43.4 mt -132.3 108.37 9.17 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.236 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.3 p -66.97 155.95 37.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.849 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.63 -37.69 13.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.229 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.67 -26.46 13.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.606 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.641 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.3 m-20 -73.21 3.17 6.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.37 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.551 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.0 OUTLIER -41.13 -61.91 1.19 Allowed Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 117.682 0.219 . . . . 0.0 111.35 -179.337 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 63.3 Cg_endo -72.67 73.95 2.83 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.441 2.094 . . . . 0.0 111.963 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.907 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -76.77 141.58 40.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.431 -179.44 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HB3' ' CG ' ' A' ' 70' ' ' GLU . 41.4 ttmt -67.8 69.07 0.11 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.398 0.618 . . . . 0.0 110.706 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.828 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 31.5 m 59.37 161.42 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.962 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.712 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.61 -29.81 18.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.757 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.469 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.0 pt-20 -58.63 -46.03 87.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.532 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.533 ' CG ' ' HB3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -73.96 -35.48 64.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.891 -179.562 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.962 HG21 HG21 ' A' ' 24' ' ' ILE . 45.7 t -62.87 -40.8 90.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.968 0.413 . . . . 0.0 110.417 179.433 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.836 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -61.73 -55.67 27.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.168 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.498 ' O ' HG23 ' A' ' 76' ' ' VAL . 27.8 m-20 -64.11 -43.91 93.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.43 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.8 m -53.79 -46.95 71.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.926 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.553 HD12 ' NH2' ' A' ' 10' ' ' ARG . 81.0 mt -64.79 -49.95 77.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.735 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.691 HG21 ' HE2' ' A' ' 6' ' ' LYS . 1.3 m -55.77 -38.22 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.272 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 79.9 m-20 -63.24 -52.78 60.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 0.0 111.396 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HB2' HG21 ' A' ' 57' ' ' VAL . 95.9 mttt -72.68 -41.77 64.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.999 -179.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.637 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.3 -29.87 69.57 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.15 -54.11 0.45 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.982 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.476 HD12 HG12 ' A' ' 76' ' ' VAL . 16.0 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.193 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 112.434 -0.267 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 53.7 m 60.52 54.25 3.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -51.42 130.4 27.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.179 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mmm -67.32 -33.66 75.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.143 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.413 ' HE2' ' CB ' ' A' ' 6' ' ' LYS . 28.3 tptp -144.22 141.21 29.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.466 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.475 ' O ' ' HG2' ' A' ' 3' ' ' MET . 49.5 ttp -160.07 38.58 0.18 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.806 0.336 . . . . 0.0 111.351 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.4 -38.65 1.02 Allowed Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.823 -0.703 . . . . 0.0 114.385 178.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.751 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.4 p -58.63 -6.21 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 CA-C-N 117.452 0.626 . . . . 0.0 112.276 -178.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.579 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 46.9 tttm -45.67 -51.07 12.87 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.617 -0.833 . . . . 0.0 108.947 -179.325 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.78 -25.99 49.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.057 177.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.751 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.6 m-20 -68.18 -52.56 33.02 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.543 HD13 HD23 ' A' ' 49' ' ' LEU . 14.4 mt -66.02 -42.4 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.935 ' NH2' HG21 ' A' ' 13' ' ' ILE . 3.0 tpt180 -59.84 -27.18 66.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.7 177.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.02 -44.37 95.99 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 178.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -64.1 -27.68 69.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.642 -0.779 . . . . 0.0 109.439 177.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.935 HG21 ' NH2' ' A' ' 10' ' ' ARG . 64.4 mt -74.8 -50.25 26.32 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.86 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 14' ' ' ILE . 3.0 mm -53.77 -49.14 59.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.0 -36.67 93.79 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 178.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.839 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -63.63 -27.99 69.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.125 -0.538 . . . . 0.0 110.857 179.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.965 HD22 HD12 ' A' ' 24' ' ' ILE . 71.6 mt -78.8 -29.46 44.88 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.503 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.32 136.5 43.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.114 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.12 -33.5 6.35 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.814 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.741 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.8 -179.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 111.467 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.593 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 71.3 m-20 -58.25 -122.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.249 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.726 ' CG ' ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -62.66 -174.99 0.11 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 177.071 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.881 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 48.9 Cg_endo -66.55 61.78 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 CA-C-N 120.103 1.072 . . . . 0.0 112.723 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.998 HG21 HG21 ' A' ' 71' ' ' VAL . 36.6 mm 108.24 64.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 177.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.674 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.5 m120 -63.9 65.14 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.303 -0.248 . . . . 0.0 111.55 178.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.629 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 58.2 p 59.5 151.79 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.636 ' O ' ' HB2' ' A' ' 31' ' ' MET . 73.7 Cg_exo -46.88 -29.69 8.56 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.53 1.486 . . . . 0.0 112.642 -179.102 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.04 -57.12 13.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.511 0.672 . . . . 0.0 110.565 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.674 ' HG2' ' HB2' ' A' ' 25' ' ' ASN . 17.1 tp10 -73.39 -57.23 4.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.017 -179.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.929 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.9 pp -50.89 -38.21 48.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -178.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.636 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 61.0 mtm -67.13 -31.99 72.82 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.98 -29.69 67.96 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.65 179.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.741 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -71.48 -38.74 71.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.43 -179.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.839 ' HG ' ' HB1' ' A' ' 16' ' ' ALA . 10.9 mp -38.37 143.77 0.41 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 121.158 0.504 . . . . 0.0 112.093 -178.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -47.68 -40.35 30.88 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 124.013 3.142 . . . . 0.0 114.361 -178.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.461 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -71.84 -16.66 62.16 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.845 -178.904 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' N ' HD22 ' A' ' 36' ' ' ASN . . . 108.11 -67.28 0.23 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.286 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.596 ' O ' ' HB3' ' A' ' 31' ' ' MET . 64.0 Cg_endo -77.88 -54.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.209 1.939 . . . . 0.0 112.644 -179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.504 ' HA ' HD22 ' A' ' 34' ' ' LEU . 4.5 p-10 174.53 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.893 0.477 . . . . 0.0 110.293 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.557 HG22 HD23 ' A' ' 34' ' ' LEU . 9.4 t -71.17 135.2 47.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.863 0.363 . . . . 0.0 111.337 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.481 ' OG1' ' HD3' ' A' ' 50' ' ' LYS . 10.9 m -82.38 126.37 32.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.357 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.9 m -93.61 47.63 1.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.04 0.448 . . . . 0.0 110.217 178.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 24.3 pttm -75.26 145.48 41.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.156 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.0 m -137.28 127.33 25.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.935 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.64 -58.3 0.49 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.971 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -159.48 -42.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 110.72 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.769 HG12 HD21 ' A' ' 49' ' ' LEU . 38.8 t -66.7 133.26 31.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.892 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.867 ' C ' HD22 ' A' ' 49' ' ' LEU . 26.5 mt-10 -116.01 135.06 54.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.866 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.867 HD22 ' C ' ' A' ' 48' ' ' GLU . 2.9 mm? -138.64 137.18 36.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.183 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.481 ' HD3' ' OG1' ' A' ' 41' ' ' THR . 61.6 pttt -177.66 157.92 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.735 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HB3' ' CG ' ' A' ' 31' ' ' MET . . . -47.86 -37.81 14.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.937 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.4 t -61.77 -51.96 66.16 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.376 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -72.41 -54.22 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.894 ' O ' HG22 ' A' ' 57' ' ' VAL . . . -91.51 -44.42 9.1 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.87 -28.44 1.73 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.938 -179.307 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -44.3 -31.49 1.04 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.007 0.432 . . . . 0.0 110.813 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 54' ' ' ALA . 35.9 m -76.96 27.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.352 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.696 HD23 ' O ' ' A' ' 57' ' ' VAL . 30.8 mt -134.35 92.06 2.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.913 0.387 . . . . 0.0 110.354 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.9 p -55.7 155.92 5.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.83 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.17 -36.62 8.85 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.384 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -50.81 -30.26 13.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 110.422 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.572 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 53.3 m-20 -72.71 3.81 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.747 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.629 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.0 t80 -38.0 -52.07 3.0 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.481 0.182 . . . . 0.0 111.396 -178.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 80.0 Cg_endo -86.39 78.42 2.09 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.681 2.254 . . . . 0.0 111.83 179.155 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.964 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -76.69 143.35 40.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.005 0.431 . . . . 0.0 111.741 -179.37 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.509 ' HB2' ' CD ' ' A' ' 70' ' ' GLU . 14.4 mmmm -67.17 70.68 0.1 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.634 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.881 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 47.5 m 58.73 158.74 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.69 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.794 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.83 -28.04 14.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.922 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.452 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.8 pt-20 -59.53 -47.39 85.71 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.419 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.509 ' CD ' ' HB2' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -72.04 -37.32 69.74 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.758 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.998 HG21 HG21 ' A' ' 24' ' ' ILE . 43.6 t -59.76 -36.28 65.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.98 0.419 . . . . 0.0 110.799 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -67.94 -57.83 5.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.442 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 m-20 -63.83 -42.29 97.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.701 -179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.8 m -54.01 -52.63 60.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.744 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.645 HD12 HH22 ' A' ' 10' ' ' ARG . 84.5 mt -60.03 -50.45 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.583 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.72 HG13 ' HD3' ' A' ' 10' ' ' ARG . 2.8 m -58.43 -39.75 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.32 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -52.96 -56.08 18.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.33 . . . . 0.0 110.936 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.405 ' NZ ' ' HB ' ' A' ' 57' ' ' VAL . 51.1 mtpt -75.08 -39.1 61.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.163 0.506 . . . . 0.0 110.886 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.663 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -68.87 32.03 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -179.164 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.97 -53.36 3.96 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.566 179.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 18.7 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.157 -178.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 84.0 p 52.18 40.55 29.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.815 0.341 . . . . 0.0 111.121 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.33 -14.73 63.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.404 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt -57.64 136.23 56.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.884 0.373 . . . . 0.0 111.175 -179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -123.24 132.08 53.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.583 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.9 mtt -63.78 125.03 23.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.952 0.406 . . . . 0.0 111.053 -179.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.19 -34.32 51.91 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.362 179.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.742 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.5 p -65.24 -5.17 2.33 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 40.7 tttm -44.94 -51.7 9.48 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.105 -178.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -77.84 -27.19 49.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.077 177.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.742 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.7 m-20 -67.22 -52.29 42.89 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.791 HD11 ' HB2' ' A' ' 44' ' ' SER . 14.0 mt -63.81 -43.44 97.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.94 ' HD2' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -60.46 -26.48 66.8 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.582 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.2 -42.04 99.48 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 177.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 84.2 mt-30 -64.33 -28.76 69.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.362 177.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.824 HD12 ' NE ' ' A' ' 10' ' ' ARG . 67.5 mt -74.38 -46.06 44.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.234 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 72' ' ' ALA . 9.4 mm -56.99 -53.7 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.636 0.255 . . . . 0.0 110.525 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.47 -36.71 92.97 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.628 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -63.94 -27.3 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.08 -0.56 . . . . 0.0 110.92 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.015 HD22 HD12 ' A' ' 24' ' ' ILE . 61.6 mt -79.64 -29.45 40.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.448 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.96 136.66 57.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.002 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.07 -33.11 6.35 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.774 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.698 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.79 -179.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.807 0.337 . . . . 0.0 111.493 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.623 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 73.1 m-20 -59.98 -121.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.739 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -58.99 177.35 0.25 Allowed Pre-proline 0 N--CA 1.454 -0.263 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 176.44 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.792 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 43.5 Cg_endo -64.26 67.63 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 119.897 0.999 . . . . 0.0 112.105 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.015 HD12 HD22 ' A' ' 17' ' ' LEU . 44.4 mm 105.89 61.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 178.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.623 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 2.6 m120 -64.1 65.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 178.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.559 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 63.5 p 57.37 156.5 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.608 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 54.2 Cg_exo -50.43 -32.26 33.55 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.438 1.425 . . . . 0.0 112.829 -179.011 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -53.49 -57.35 10.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.452 0.644 . . . . 0.0 110.3 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.605 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.7 tp10 -76.02 -57.98 3.55 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -179.272 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.861 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -50.56 -43.72 56.39 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.738 ' N ' HD12 ' A' ' 30' ' ' LEU . 30.7 ttm -65.52 -30.69 71.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -69.95 -29.69 66.88 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.597 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.698 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -67.76 -40.32 84.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.087 -179.414 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.733 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.1 mp -25.34 135.43 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.568 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.001 -179.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.13 26.23 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.588 2.859 . . . . 0.0 115.279 -178.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.52 HD21 ' C ' ' A' ' 39' ' ' ASP . 13.2 p-10 -129.48 -27.46 2.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 118.351 0.523 . . . . 0.0 111.927 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.45 -71.34 0.28 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.732 -179.437 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 85.2 Cg_endo -83.86 41.37 1.03 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.699 2.266 . . . . 0.0 113.515 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.52 ' C ' HD21 ' A' ' 36' ' ' ASN . 1.2 m-20 61.74 94.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 178.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.651 HG22 HD23 ' A' ' 34' ' ' LEU . 5.7 t -70.05 141.62 52.82 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.767 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.54 HG23 ' HD3' ' A' ' 50' ' ' LYS . 32.2 m -100.29 121.96 42.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.902 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.8 m -92.79 46.57 1.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 110.014 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.441 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 20.8 ptmt -75.53 125.72 29.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.938 -179.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.791 ' HB2' HD11 ' A' ' 9' ' ' ILE . 64.7 m -107.62 120.39 42.08 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.197 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.68 -127.36 39.04 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.136 -1.031 . . . . 0.0 111.536 -178.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -79.67 -40.2 29.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.743 0.306 . . . . 0.0 111.436 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.676 HG12 ' CD2' ' A' ' 49' ' ' LEU . 28.5 t -68.5 141.48 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.636 -179.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.866 ' C ' HD22 ' A' ' 49' ' ' LEU . 38.4 mt-10 -125.84 134.11 51.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.8 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.866 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.3 mm? -138.5 138.95 38.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.05 0.452 . . . . 0.0 110.968 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.54 ' HD3' HG23 ' A' ' 41' ' ' THR . 60.7 pttt -177.46 153.64 0.93 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.446 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.576 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -47.49 -29.24 2.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.809 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.417 ' HA ' ' HE1' ' A' ' 31' ' ' MET . 44.4 t -71.18 -56.06 6.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.663 0.268 . . . . 0.0 111.585 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -72.28 -54.42 9.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.35 . . . . 0.0 111.922 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.692 ' HB1' HG23 ' A' ' 75' ' ' ILE . . . -78.34 -48.08 16.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.936 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -48.39 -26.91 5.31 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.37 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -40.21 -35.97 0.46 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.555 0.693 . . . . 0.0 111.024 179.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 54' ' ' ALA . 11.0 m -79.14 27.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.021 -177.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.576 HD13 ' CZ ' ' A' ' 65' ' ' PHE . 32.7 mt -130.21 109.9 11.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.934 0.397 . . . . 0.0 110.057 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.6 p -70.81 157.24 38.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.885 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.81 -36.89 12.52 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.754 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -51.32 -29.45 15.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.163 179.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' HB3' ' CE1' ' A' ' 65' ' ' PHE . 1.3 m-20 -72.23 3.34 4.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.597 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.559 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 2.0 t80 -38.37 -51.71 3.4 Favored Pre-proline 0 C--O 1.227 -0.09 0 N-CA-C 111.308 0.114 . . . . 0.0 111.308 -178.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 63' ' ' PHE . 87.0 Cg_endo -88.08 81.45 1.03 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.837 2.358 . . . . 0.0 112.046 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.748 ' CD2' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -76.93 141.8 40.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.875 -179.855 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.535 ' CA ' ' HG2' ' A' ' 70' ' ' GLU . 47.6 mmtm -68.53 66.54 0.12 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.531 0.682 . . . . 0.0 110.516 179.005 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.792 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 15.4 m 61.34 160.93 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.197 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.652 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.46 -31.09 22.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.889 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.6 pt-20 -59.86 -47.01 87.47 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.331 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.535 ' HG2' ' CA ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -67.61 -33.38 74.88 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.36 -179.77 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.827 ' CG2' HG21 ' A' ' 24' ' ' ILE . 94.5 t -59.14 -47.08 91.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.922 0.391 . . . . 0.0 110.394 179.223 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.756 ' O ' HG22 ' A' ' 76' ' ' VAL . . . -56.71 -55.11 38.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.311 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.47 -36.36 83.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.585 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 88.4 m -65.95 -49.35 68.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.026 -179.211 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.743 HG22 HH12 ' A' ' 10' ' ' ARG . 74.1 mt -59.88 -49.7 82.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.705 -179.035 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.94 HG13 ' HD2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -57.49 -40.24 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.247 179.861 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -62.93 -54.7 34.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.876 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.512 ' HB2' HG21 ' A' ' 57' ' ' VAL . 96.5 mttt -74.06 -40.33 62.88 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -66.97 -29.91 69.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.186 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.12 -51.5 0.52 Allowed Glycine 0 CA--C 1.509 -0.342 0 C-N-CA 119.817 -1.182 . . . . 0.0 113.16 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.591 HD12 HG12 ' A' ' 76' ' ' VAL . 16.8 mt . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.349 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 51.6 m 60.13 46.82 10.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.906 0.384 . . . . 0.0 110.905 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -176.11 -44.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt -79.21 50.29 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.475 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt 69.29 -120.84 0.14 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.7 mtt -87.5 -35.11 18.38 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 122.035 -0.416 . . . . 0.0 110.804 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.99 -43.52 2.85 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.861 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.728 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 2.1 p -69.89 -6.08 6.11 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.894 0 CA-C-N 116.734 0.267 . . . . 0.0 111.411 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.886 ' HE2' HG21 ' A' ' 76' ' ' VAL . 11.2 tmtt? -45.37 -49.03 13.37 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -77.37 -30.31 53.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.043 177.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.728 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 71.9 m-20 -66.44 -52.32 47.63 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.568 HG22 ' NH2' ' A' ' 10' ' ' ARG . 17.7 mt -62.26 -51.07 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.178 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.936 ' CD ' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -57.96 -25.58 61.18 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.369 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.42 -38.58 94.99 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 177.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -68.82 -35.26 76.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.383 -0.908 . . . . 0.0 110.569 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.594 HD11 ' NH2' ' A' ' 10' ' ' ARG . 11.7 mt -69.91 -43.75 79.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.442 ' HA ' HD13 ' A' ' 14' ' ' ILE . 13.4 mm -54.51 -52.46 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.717 0.294 . . . . 0.0 110.612 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.01 -37.25 94.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.935 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.52 -25.02 67.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.22 -0.49 . . . . 0.0 111.365 179.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.069 HD22 HD12 ' A' ' 24' ' ' ILE . 33.4 mt -85.82 -29.37 23.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.978 -179.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.64 81.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.719 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.83 -35.8 0.13 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.921 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.717 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -53.03 -173.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.182 0.515 . . . . 0.0 111.904 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.588 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.7 OUTLIER -60.25 -119.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.018 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.771 ' HB2' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -59.97 179.79 0.2 Allowed Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 177.033 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HD2' ' HB2' ' A' ' 22' ' ' PHE . 47.9 Cg_endo -65.23 65.34 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 120.801 1.001 . . . . 0.0 112.358 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.069 HD12 HD22 ' A' ' 17' ' ' LEU . 28.6 mm 107.78 62.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 177.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.601 ' HB2' ' CG ' ' A' ' 29' ' ' GLU . 2.7 m120 -63.98 64.16 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 15.7 p 59.1 152.65 0.08 OUTLIER Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.647 ' HA ' ' HG ' ' A' ' 30' ' ' LEU . 77.8 Cg_exo -48.0 -30.47 13.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.46 1.44 . . . . 0.0 112.707 -179.245 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -54.72 -57.49 11.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.492 0.663 . . . . 0.0 110.289 179.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.601 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.3 tp10 -76.11 -57.85 3.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.054 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.861 HD13 HD21 ' A' ' 17' ' ' LEU . 3.5 pp -50.29 -45.53 54.53 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.679 ' N ' HD12 ' A' ' 30' ' ' LEU . 33.8 ttm -66.05 -29.78 70.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -69.08 -30.12 68.37 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -72.73 -38.92 67.28 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.61 HD23 HG22 ' A' ' 40' ' ' THR . 7.1 mp -27.92 128.12 0.21 Allowed Pre-proline 0 N--CA 1.47 0.563 0 CA-C-O 120.949 0.404 . . . . 0.0 111.79 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.98 -25.32 69.62 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.569 2.846 . . . . 0.0 114.071 -178.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.663 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 9.1 t30 -72.04 -27.43 62.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.06 -74.23 0.45 Allowed Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.925 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 36' ' ' ASN . 80.7 Cg_endo -84.5 47.14 2.09 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.833 2.355 . . . . 0.0 112.512 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.68 95.28 0.05 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.553 179.451 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' ' 36' ' ' ASN . 6.6 t -65.31 141.15 58.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.22 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.7 m -105.92 115.8 30.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -89.46 44.03 1.18 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.098 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . 22.3 pttp -79.68 124.05 28.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.255 -179.043 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 61.2 m -101.38 122.13 43.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.249 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.15 -129.48 37.77 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.174 -1.013 . . . . 0.0 111.762 -178.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 47' ' ' VAL . 40.6 p-10 -78.97 -38.88 35.8 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.521 HG12 ' CD2' ' A' ' 49' ' ' LEU . 49.0 t -66.97 142.38 16.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.637 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.825 ' C ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -137.48 124.94 22.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.288 0.566 . . . . 0.0 111.813 179.615 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.825 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.8 mm? -136.6 141.07 43.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.366 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HE3' ' HB3' ' A' ' 52' ' ' SER . 61.6 pttt -173.4 -168.81 0.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.937 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.534 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -65.58 -46.14 80.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.867 0.365 . . . . 0.0 111.576 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.456 ' HB3' ' HE3' ' A' ' 50' ' ' LYS . 46.1 t -69.99 -44.45 69.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.69 0.281 . . . . 0.0 111.495 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -67.34 -53.05 32.98 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.822 0.344 . . . . 0.0 111.906 -179.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.905 ' CB ' HG23 ' A' ' 75' ' ' ILE . . . -96.2 -44.05 7.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 51' ' ' ALA . . . -44.64 -30.67 2.28 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.425 -178.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -46.93 -33.96 5.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.105 0.479 . . . . 0.0 110.987 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.857 HG22 ' O ' ' A' ' 54' ' ' ALA . 29.1 m -65.6 -31.1 52.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.548 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.708 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 22.6 mt -66.66 125.39 25.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.773 0.32 . . . . 0.0 110.639 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.8 p -75.63 155.79 35.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.289 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.18 -42.09 60.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.332 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.63 -23.25 26.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.963 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.654 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 14.5 m-20 -67.89 3.16 1.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.6 ' O ' ' HZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -41.03 -56.04 4.39 Favored Pre-proline 0 C--O 1.226 -0.184 0 CA-C-N 117.837 0.289 . . . . 0.0 111.673 -178.949 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 63' ' ' PHE . 2.0 Cg_endo -80.33 76.92 4.27 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.897 2.398 . . . . 0.0 112.017 179.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.869 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -77.16 142.0 39.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.488 -179.752 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.504 ' HB2' ' CG ' ' A' ' 70' ' ' GLU . 38.4 mtmm -67.89 70.5 0.14 Allowed 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.455 0.645 . . . . 0.0 110.419 178.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.756 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 28.9 m 58.43 161.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.162 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.681 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.67 -26.85 9.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.888 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 11.9 pt-20 -59.2 -50.46 73.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.652 -179.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.504 ' CG ' ' HB2' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -72.65 -32.26 65.72 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.976 -179.418 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.005 HG21 HG21 ' A' ' 24' ' ' ILE . 57.9 t -61.98 -40.82 88.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.724 0.297 . . . . 0.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.689 ' HB1' ' CG ' ' A' ' 10' ' ' ARG . . . -65.0 -52.19 57.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 76' ' ' VAL . 32.1 m-20 -64.49 -37.44 87.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.011 0.434 . . . . 0.0 111.202 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.404 HG22 HD21 ' A' ' 58' ' ' LEU . 53.3 m -58.09 -41.93 84.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.442 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.905 HG23 ' CB ' ' A' ' 54' ' ' ALA . 63.5 mt -62.1 -53.72 44.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.134 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.936 HG13 ' CD ' ' A' ' 10' ' ' ARG . 2.5 m -56.94 -43.35 80.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 78.0 m-20 -62.6 -53.72 50.44 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -74.0 -42.41 60.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.078 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.579 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.56 -30.08 69.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.25 -55.77 0.42 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 119.936 -1.125 . . . . 0.0 113.144 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.547 HD12 HG12 ' A' ' 76' ' ' VAL . 21.7 mt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.405 -178.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 53.4 m -61.28 136.65 58.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.839 0.352 . . . . 0.0 111.002 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -175.76 -57.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.7 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt -85.55 135.94 33.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.533 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.527 ' HB3' ' NZ ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -175.38 134.41 0.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.012 -179.84 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.428 ' N ' ' HD2' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -176.9 125.11 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.049 179.731 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.16 -114.98 0.62 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.852 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.729 ' CG2' ' HB2' ' A' ' 8' ' ' ASP . 1.7 p -62.19 -5.19 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 79.8 tttt -44.83 -51.08 9.88 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.362 -0.836 . . . . 0.0 109.211 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -77.6 -29.5 51.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.956 177.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.729 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 72.0 m-20 -64.48 -52.13 59.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.13 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.606 HG23 ' HB2' ' A' ' 42' ' ' CYS . 12.1 mt -63.16 -46.41 95.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.886 ' NH2' HG21 ' A' ' 13' ' ' ILE . 1.8 tpt180 -57.19 -25.94 59.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.166 177.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.37 -48.34 70.11 Favored Glycine 0 CA--C 1.505 -0.531 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -62.63 -29.08 70.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.807 -0.696 . . . . 0.0 109.343 177.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.886 HG21 ' NH2' ' A' ' 10' ' ' ARG . 59.7 mt -70.4 -45.53 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.801 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.464 ' HA ' HD13 ' A' ' 14' ' ' ILE . 7.1 mm -53.69 -48.54 60.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.66 -37.4 94.33 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.816 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.638 ' HB1' ' HG ' ' A' ' 34' ' ' LEU . . . -62.61 -27.81 69.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.918 0.39 . . . . 0.0 110.978 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.024 HD22 HD12 ' A' ' 24' ' ' ILE . 54.1 mt -80.69 -29.56 36.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.378 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.04 135.12 56.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.005 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.38 -33.17 5.67 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.723 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.686 ' CA ' ' HB2' ' A' ' 33' ' ' ALA . . . -52.29 -175.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.931 0.396 . . . . 0.0 111.509 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.592 ' HB2' ' CG ' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -60.26 -122.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.896 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.82 ' HD1' ' N ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -59.93 -173.42 0.05 OUTLIER Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 176.685 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.855 ' HB2' ' HA ' ' A' ' 67' ' ' SER . 58.1 Cg_endo -69.33 61.52 1.5 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 CA-C-N 120.453 1.197 . . . . 0.0 112.592 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.024 HD12 HD22 ' A' ' 17' ' ' LEU . 43.4 mm 111.98 65.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 177.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.655 ' ND2' ' CD2' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -64.31 65.68 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 122.085 -0.385 . . . . 0.0 111.534 178.132 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.571 ' HB3' ' HA ' ' A' ' 63' ' ' PHE . 54.0 p 58.89 155.01 0.09 OUTLIER Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 31' ' ' MET . 54.4 Cg_exo -49.29 -33.71 29.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.236 1.291 . . . . 0.0 112.887 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.04 -56.28 17.33 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.074 0.464 . . . . 0.0 110.787 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.645 ' CG ' ' HB2' ' A' ' 25' ' ' ASN . 16.5 tp10 -74.54 -57.72 3.75 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.296 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.938 HD13 ' CD2' ' A' ' 17' ' ' LEU . 3.8 pp -49.79 -39.76 39.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.675 ' HA ' HD13 ' A' ' 34' ' ' LEU . 65.4 mtm -64.4 -34.85 79.12 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 29' ' ' GLU . . . -68.77 -26.55 65.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.681 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.686 ' HB2' ' CA ' ' A' ' 20' ' ' ALA . . . -71.09 -43.24 68.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.667 -179.318 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.675 HD13 ' HA ' ' A' ' 31' ' ' MET . 10.1 mp -37.33 138.91 0.55 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 121.096 0.474 . . . . 0.0 112.274 -178.406 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -47.86 -31.61 15.68 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.869 3.046 . . . . 0.0 113.518 -178.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.593 ' CB ' ' HB ' ' A' ' 40' ' ' THR . 7.7 t30 -72.16 -25.31 61.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.49 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.63 -73.49 0.21 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.566 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.602 ' O ' ' HB3' ' A' ' 31' ' ' MET . 59.6 Cg_endo -73.69 -54.54 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.967 1.778 . . . . 0.0 111.712 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.45 ' HA ' HD22 ' A' ' 34' ' ' LEU . 6.1 p-10 171.25 98.74 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.247 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.593 ' HB ' ' CB ' ' A' ' 36' ' ' ASN . 7.8 t -80.54 133.29 35.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.656 0.265 . . . . 0.0 110.884 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 50' ' ' LYS . 2.6 t -97.91 123.31 41.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.034 0.445 . . . . 0.0 111.28 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.606 ' HB2' HG23 ' A' ' 9' ' ' ILE . 33.3 m -72.14 64.32 0.54 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.764 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' CB ' ' HG2' ' A' ' 48' ' ' GLU . 21.7 ptmt -74.97 148.53 39.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.667 -178.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.0 m -155.56 129.55 8.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.303 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 46' ' ' ASP . . . 60.7 48.65 85.16 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.237 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 9.0 t70 79.97 -39.55 0.19 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 122.6 0.36 . . . . 0.0 111.94 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.685 HG12 ' CD2' ' A' ' 49' ' ' LEU . 44.5 t -66.51 134.87 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.789 0.328 . . . . 0.0 111.351 -179.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.843 ' C ' HD22 ' A' ' 49' ' ' LEU . 37.3 mt-10 -127.27 133.03 50.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.369 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.843 HD22 ' C ' ' A' ' 48' ' ' GLU . 3.8 mm? -137.7 134.5 35.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.324 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 41' ' ' THR . 19.6 pttm -163.73 -164.67 0.93 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.613 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -78.1 -41.09 36.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.051 0.453 . . . . 0.0 111.317 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.439 ' HB3' ' HE2' ' A' ' 50' ' ' LYS . 39.1 t -63.87 -45.5 89.13 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.647 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.485 ' H ' ' HG3' ' A' ' 50' ' ' LYS . 8.0 t70 -72.21 -52.79 14.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.352 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.851 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -96.34 -48.42 5.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -178.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 51' ' ' ALA . . . -44.77 -28.37 1.66 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.233 -0.508 . . . . 0.0 113.73 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -43.89 -32.55 1.13 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.039 0.447 . . . . 0.0 111.563 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 54' ' ' ALA . 30.4 m -65.51 -33.15 61.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.886 -179.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.668 HD22 ' HZ ' ' A' ' 65' ' ' PHE . 29.1 mt -70.3 124.42 24.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.437 179.486 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -80.8 -176.38 5.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.897 0.38 . . . . 0.0 111.551 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.77 79.54 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.711 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -53.33 -23.99 10.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -179.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.638 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 1.4 m-20 -71.04 3.2 3.58 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.571 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 1.2 m-85 -42.58 -64.59 0.68 Allowed Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.584 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 63' ' ' PHE . 59.5 Cg_endo -71.01 74.94 1.79 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.436 2.091 . . . . 0.0 111.949 179.271 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.874 ' CD1' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -77.04 141.61 40.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.833 -179.349 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.483 ' HB3' ' CD ' ' A' ' 70' ' ' GLU . 23.4 ttmm -67.22 70.37 0.1 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.804 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.855 ' HA ' ' HB2' ' A' ' 23' ' ' PRO . 50.7 m 58.19 162.35 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.164 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.645 ' HA ' HG13 ' A' ' 24' ' ' ILE . . . -51.69 -31.35 25.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.659 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 14.6 pt-20 -56.24 -48.41 76.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.589 -179.587 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.569 ' CG ' ' HD1' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -73.1 -36.99 66.88 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.974 -179.6 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.972 ' CG2' HG21 ' A' ' 24' ' ' ILE . 61.9 t -61.46 -34.34 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.821 ' HB1' ' HG3' ' A' ' 10' ' ' ARG . . . -68.94 -58.22 4.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.365 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 76' ' ' VAL . 31.7 m-20 -64.1 -42.32 96.95 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.99 0.424 . . . . 0.0 111.571 -179.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.2 m -55.37 -48.09 74.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.651 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.496 HD12 ' NH2' ' A' ' 10' ' ' ARG . 82.6 mt -63.05 -51.58 69.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.883 -179.256 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.708 HG13 ' HD3' ' A' ' 10' ' ' ARG . 1.5 m -54.05 -43.61 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.818 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -57.55 -49.55 75.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.748 0.309 . . . . 0.0 111.381 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HB2' HG21 ' A' ' 57' ' ' VAL . 66.9 mttm -73.55 -41.11 63.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.827 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.851 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -67.39 -30.23 69.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.506 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.91 -55.43 0.43 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.419 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.549 HD12 HG12 ' A' ' 76' ' ' VAL . 16.8 mt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.174 -0.917 . . . . 0.0 111.308 -178.638 . . . . . . . . 1 1 . 1 stop_ save_